PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reganold, JP; Glover, JD; Andrews, PK; Hinman, HR				Reganold, JP; Glover, JD; Andrews, PK; Hinman, HR			Sustainability of three apple production systems	NATURE			English	Article							ECOSYSTEM	Escalating production costs, heavy reliance on non-renewable resources, reduced biodiversity, water contamination, chemical residues in food, soil degradation and health risks to farmworkers handling pesticides all bring into question the sustainability of conventional farming systems(1-4). It has been claimed(5,6), however, that organic farming systems are less efficient, pose greater health risks and produce half the yields of conventional farming systems. Nevertheless, organic farming became one of the fastest growing segments of US and European agriculture during the 1990s(7,8). Integrated farming, using a combination of organic and conventional techniques, has been successfully adopted on a wide scale in Europe(9). Here we report the sustainability of organic, conventional and integrated apple production systems in Washington State from 1994 to 1999. All three systems gave similar apple yields. The organic and integrated systems had higher soil quality and potentially lower negative environmental impact than the conventional system. When compared with the conventional and integrated systems, the organic system produced sweeter and less tart apples, higher profitability and greater energy efficiency. Our data indicate that the organic system ranked first in environmental and economic sustainability, the integrated system second and the conventional system last.	Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; Washington State Univ, Dept Agr Econ, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Reganold, JP (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	reganold@wsu.edu						*APPL MAT PROGR, 1986, APPL MAT PROGR HDB; AVERY D, 1999, FEARING FOOD RISK HL, P3; Barrett GW, 2000, BIOSCIENCE, V50, P363, DOI 10.1641/0006-3568(2000)050[0363:TTFCTW]2.3.CO;2; BECHTEL L, 1995, EC ANAL APPL ORCHARD; Brady NC, 1999, NATURE PROPERTIES SO, P468; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DORAN JW, 1994, SSSA SPEC PUBL, P3; DOW AI, 1980, W REG EXT PUB, P43; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Funt R. C., 1980, HDB ENERGY UTILIZATI, P235; Gavlak R. G., 1994, W REG EXT PUB, V125; Glover JD, 2000, AGR ECOSYST ENVIRON, V80, P29, DOI 10.1016/S0167-8809(00)00131-6; Goodland R, 1996, ECOL APPL, V6, P1002, DOI 10.2307/2269583; Greene C., 2000, Agricultural Outlook, P9; Hamm U., 2000, IFOAM 2000: the world grows organic. Proceedings 13th International IFOAM Scientific Conference, Basel, Switzerland, 28 to 31 August, 2000., P507; Kovach J., 1992, METHOD MEASURE ENV I; Leach G., 1976, Energy and Food Production., P71; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Merwin I. A., 1993, HortTechnology, V3, P128; Naveh Z, 2000, BIOSCIENCE, V50, P357, DOI 10.1641/0006-3568(2000)050[0357:TTHEIE]2.3.CO;2; Reed N, 1995, 125 ANN REPORT SECRE, P68; REGANOLD J, 1989, NEW SCI, V122, P49; REGANOLD JP, 1990, SCI AM, V262, P112, DOI 10.1038/scientificamerican0690-112; Sansavini S, 1997, SCI HORTIC-AMSTERDAM, V68, P25, DOI 10.1016/S0304-4238(96)00926-0; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Trewavas A, 1999, NATURE, V402, P231, DOI 10.1038/46157; *USDA, 1999, AGR STAT 1999; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	28	427	454	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					926	930		10.1038/35073574	http://dx.doi.org/10.1038/35073574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309616				2022-12-28	WOS:000168152300045
J	Komarneni, S; Kozai, N; Paulus, WJ				Komarneni, S; Kozai, N; Paulus, WJ			Superselective clay for radium uptake	NATURE			English	Article							EXCHANGE		Penn State Univ, Dept Agron, University Pk, PA 16802 USA; Penn State Univ, Mat Res Lab, University Pk, PA 16802 USA; Japan Atom Energy Res Inst, Dept Environm Sci, Tokai, Ibaraki 3191195, Japan; GM Corp, AC Rochester Div, Dept 32 84, Flint, MI 48556 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Japan Atomic Energy Agency; General Motors	Komarneni, S (corresponding author), Penn State Univ, Dept Agron, University Pk, PA 16802 USA.							Breck D. W., 1984, ZEOLITE MOL SIEVES; FINKELSTEIN MM, 1994, CAN MED ASSOC J, V151, P565; JuradoVargas M, 1997, J RADIOANAL NUCL CH, V218, P153, DOI 10.1007/BF02039327; Komarneni S, 1998, J MATER CHEM, V8, P205, DOI 10.1039/a706050e; KOMARNENI S, 1988, SCIENCE, V239, P1286, DOI 10.1126/science.239.4845.1286; KOMARNENI S, 1982, NATURE, V299, P707, DOI 10.1038/299707a0; LYMAN GH, 1985, JAMA-J AM MED ASSOC, V254, P621, DOI 10.1001/jama.254.5.621; PAULUS WJ, 1992, NATURE, V357, P571, DOI 10.1038/357571a0	8	91	93	2	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					771	771		10.1038/35071173	http://dx.doi.org/10.1038/35071173			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298435				2022-12-28	WOS:000168021900041
J	Boersma, E; Poldermans, D; Bax, JJ; Steyerberg, EW; Thomson, IR; Banga, JD; van de Ven, LLM; van Urk, H; Roelandt, JRTC				Boersma, E; Poldermans, D; Bax, JJ; Steyerberg, EW; Thomson, IR; Banga, JD; van de Ven, LLM; van Urk, H; Roelandt, JRTC		DECREASE Study Grp	Predictors of cardiac events after major vascular surgery - Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STRESS ECHOCARDIOGRAPHY; RISK-ASSESSMENT; MYOCARDIAL-INFARCTION; AORTIC-ANEURYSM; VALIDATION; ATROPINE	Context Patients who undergo major vascular surgery are at increased risk of perioperative cardiac complications. High-risk patients can be identified by clinical factors and noninvasive cardiac testing, such as dobutamine stress echocardiography (DSE); however, such noninvasive imaging techniques carry significant disadvantages. A recent study found that perioperative beta -blocker therapy reduces complication rates in high-risk individuals. Objective To examine the relationship of clinical characteristics, DSE results, beta -blocker therapy, and cardiac events in patients undergoing major vascular surgery. Design and Setting Cohort study conducted in 1996-1999 in the following 8 centers: Erasmus Medical Centre and Sint Clara Ziekenhuis, Rotterdam, Twee Steden Ziekenhuis, Tilburg, Academisch Ziekenhuis Utrecht, Utrecht, and Medisch Centrum Alkmaar, Alkmaar, the Netherlands; Ziekenhuis Middelheim, Antwerp, Belgium; and San Gerardo Hospital, Monza, Istituto di Ricovero e Cura a Carattere Scientifico, San Giovanni Rotondo, Italy. Patients A total of 1351 consecutive patients scheduled for major vascular surgery; DSE was performed in 1097 patients (81%), and 360 (27%) received beta -blocker therapy. Main Outcome Measure Cardiac death or nonfatal myocardial infarction within 30 days after surgery, compared by clinical characteristics, DSE results, and beta -blocker use. Results Forty-five patients (3.3%) had perioperative cardiac death or nonfatal myocardial infarction, In multivariable analysis, important clinical determinants of adverse outcome were age 70 years or older; current or prior angina pectoris; and prior myocardial infarction, heart failure, or cerebrovascular accident. Eighty-three percent of patients had less than 3 clinical risk factors. Among this subgroup, patients receiving beta -blockers had a lower risk of cardiac complications (0.8% [2/263]) than those not receiving beta -blockers (2.3% [20/855]), and DSE had minimal additional prognostic value. In patients with 3 or more risk factors (17%), DSE provided additional prognostic information, for patients without stress-induced ischemia had much lower risk of events than those with stress-induced ischemia (among those receiving beta -blockers, 2.0% [1/50] vs 10.6% [5/47]). Moreover, patients with limited stress-induced ischemia (1-4 segments) experienced fewer cardiac events (2.8%[1/36]) than those with more extensive ischemia (greater than or equal to5 segments, 36% [4/11]). Conclusion The additional predictive value of DSE is limited in clinically low-risk patients receiving beta -blockers. In clinical practice, DSE may be avoided in a large number of patients who can proceed safely for surgery without delay. In clinically intermediate- and high-risk patients receiving beta -blockers, DSE may help identify those in whom surgery can still be performed and those in whom cardiac revascularization should be considered.	Univ Rotterdam Hosp, Dept Surg, NL-3015 GD Rotterdam, Netherlands; Univ Leiden Hosp, NL-2300 RC Leiden, Netherlands; Univ Utrecht Hosp, Utrecht, Netherlands; Univ Manitoba, Winnipeg, MB, Canada	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center; University of Manitoba	Poldermans, D (corresponding author), Univ Rotterdam Hosp, Dept Surg, Room H921,Dr Molewaterplein 40, NL-3015 GD Rotterdam, Netherlands.	poldermans@hlkd.azr.nl	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122				Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Boden WE, 2000, LANCET, V355, P1751, DOI 10.1016/S0140-6736(00)02262-5; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; DAVILAROMAN VG, 1993, J AM COLL CARDIOL, V21, P957, DOI 10.1016/0735-1097(93)90353-3; Eagle KA, 1996, CIRCULATION, V93, P1278; GONG G, 1986, J AM STAT ASSOC, V81, P108, DOI 10.2307/2287975; KENDAL DG, 1962, RANK CORRELATION MET; LALKA SG, 1992, J VASC SURG, V15, P831, DOI 10.1016/0741-5214(92)90718-N; LANGAN EM, 1993, J VASC SURG, V18, P905, DOI 10.1016/0741-5214(93)90544-V; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1999, NEW ENGL J MED, V341, P1838, DOI 10.1056/NEJM199912093412410; LItalien GJ, 1996, J AM COLL CARDIOL, V27, P779, DOI 10.1016/0735-1097(95)00566-8; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607; Mayet J, 2000, LANCET, V355, P500, DOI 10.1016/S0140-6736(00)82059-0; MCNEILL AJ, 1992, AM J CARDIOL, V70, P41, DOI 10.1016/0002-9149(92)91387-J; Pellikka PA, 1996, AM J CARDIOL, V77, P413, DOI 10.1016/S0002-9149(97)89374-5; POLDERMANS D, 1995, J AM COLL CARDIOL, V26, P648, DOI 10.1016/0735-1097(95)00240-5; POLDERMANS D, 1993, CIRCULATION, V87, P1506, DOI 10.1161/01.CIR.87.5.1506; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Poldermans D, 2000, ECHOCARDIOGR-J CARD, V17, P79, DOI 10.1111/j.1540-8175.2000.tb00998.x; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109	22	373	397	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1865	1873		10.1001/jama.285.14.1865	http://dx.doi.org/10.1001/jama.285.14.1865			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308400				2022-12-28	WOS:000167876700027
J	Nisbet, E				Nisbet, E			Heavenly phenomena	NATURE			English	Editorial Material									Univ London Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Nisbet, E (corresponding author), Univ London Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England.							[Anonymous], ACTS, V28; Aratus, 1997, PHAENOMENA	2	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					635	635		10.1038/35070676	http://dx.doi.org/10.1038/35070676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287929				2022-12-28	WOS:000167875400024
J	Schrope, M				Schrope, M			Criticism mounts as Bush backs out of Kyoto accord	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					616	616		10.1038/35070738	http://dx.doi.org/10.1038/35070738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287908	Bronze			2022-12-28	WOS:000167875400005
J	Tsai, CC; Starren, J				Tsai, CC; Starren, J			Patient participation in electronic medical records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Tsai, CC (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.							*ABT ASS, 1997, ABT ASS NAT SURV RUR, P16; Allen A, 1997, Telemed Today, V5, P24; BAKER DB, 1999, J AM MED INF ASS S, V6, P666; CIMINO JJ, 2000, PATIENT ACCESS CLIN; Garshnek V, 1999, J AM MED INFORM ASSN, V6, P26, DOI 10.1136/jamia.1999.0060026; Johnston B, 2000, ARCH FAM MED, V9, P40, DOI 10.1001/archfami.9.1.40; Masys DR, 1997, J AM MED INFORM ASSN, V4, P69, DOI 10.1136/jamia.1997.0040069	7	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1765	1765		10.1001/jama.285.13.1765	http://dx.doi.org/10.1001/jama.285.13.1765			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415FR	11277835	hybrid			2022-12-28	WOS:000167710600034
J	Ahmad, K; Henikoff, S				Ahmad, K; Henikoff, S			Modulation of a transcription factor counteracts heterochromatic gene silencing in Drosophila	CELL			English	Article							POSITION-EFFECT VARIEGATION; MOLECULAR ASPECTS; WHITE GENE; IN-VIVO; DEVELOPMENTAL REGULATION; CHROMATIN STRUCTURE; P-ELEMENT; MELANOGASTER; EXPRESSION; PROTEIN	Variegation is a common feature of gene silencing phenomena, yet the basis for stochastic on/off expression is unknown. We used a conditional system that allows probing of heterochromatin at a reporter GFP gene by altering GAL4 transcription factor levels during Drosophila eye development. Surprisingly, the frequency of gene silencing is exquisitely sensitive to GAL4 levels, as though binding site occupancy affects the silenced state. The silent state is plastic, as spontaneous derepression occasionally occurs in both mitotically active and differentiating cells. By simultaneously assaying expression of a nearby gene, we further show that the size of an activated region within heterochromatin is small. We propose that variegation occurs because heterochromatin inhibits the transient exposure of factor binding sites.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.		Furia, maria/AHD-7483-2022	Henikoff, Steven/0000-0002-7621-8685				Ahmad K, 1996, GENETICS, V144, P657; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; BELYAEVA ES, 1991, CHROMOSOMA, V100, P453, DOI 10.1007/BF00364556; Boivin A, 1998, GENETICS, V150, P1539; Bonifer C, 2000, TRENDS GENET, V16, P310, DOI 10.1016/S0168-9525(00)02029-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CLARK SH, 1986, GENETICS, V114, P819; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; HAYASHI S, 1990, CHROMOSOMA, V99, P391, DOI 10.1007/BF01726690; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; Ito K, 1997, DEVELOPMENT, V124, P761; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; LEVIS R, 1985, EMBO J, V4, P3489, DOI 10.1002/j.1460-2075.1985.tb04108.x; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; Lu BY, 1998, DEVELOPMENT, V125, P2223; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEMAN RR, 1995, GENETICS, V141, P1061; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Sabl JF, 1996, GENETICS, V142, P447; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sass GL, 1999, GENETICS, V152, P595; SPOFFORD J, 1976, GENETICS BIOL DROSOP; Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Talbert PB, 2000, GENETICS, V154, P259; TARTOF KD, 1989, DEV GENET, V10, P162, DOI 10.1002/dvg.1020100306; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Walters MC, 1996, GENE DEV, V10, P185, DOI 10.1101/gad.10.2.185; Widom J, 1999, METH MOL B, V119, P61; WILDER EL, 1995, DEVELOPMENT, V121, P477; Wines DR, 1996, CHROMOSOMA, V104, P332, DOI 10.1007/s004120050123; ZHIMULEV IF, 1988, CHROMOSOMA, V96, P255, DOI 10.1007/BF00302365; ZHIMULEV IF, 1986, CHROMOSOMA, V94, P492, DOI 10.1007/BF00292759	51	129	133	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					839	847		10.1016/S0092-8674(01)00281-1	http://dx.doi.org/10.1016/S0092-8674(01)00281-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290322	Bronze			2022-12-28	WOS:000167869200007
J	Lowe, JB				Lowe, JB			Glycosylation, immunity, and autoimmunity	CELL			English	Review							MOLECULAR-CLONING; BIOSYNTHESIS; MICE; EXPRESSION; RESPONSES; SELECTIN		Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Lowe, JB (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.							Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Granovsky M, 2000, NAT MED, V6, P306; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; LOWE JB, 1999, ESSENTIALS GLYCOBIOL, P479; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; STANLEY P, 1995, FASEB J, V9, P1436, DOI 10.1096/fasebj.9.14.7589985; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P333	18	270	281	3	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					809	812		10.1016/S0092-8674(01)00277-X	http://dx.doi.org/10.1016/S0092-8674(01)00277-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290318	Bronze			2022-12-28	WOS:000167869200003
J	Nance, WE				Nance, WE			Protecting the privacy of family members in research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23284 USA	Virginia Commonwealth University	Nance, WE (corresponding author), Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23284 USA.							Botkin JR, 2001, JAMA-J AM MED ASSOC, V285, P207, DOI 10.1001/jama.285.2.207; Department of Agriculture Department of Energy National Aeronautics and Space Administration Department of Commerce Consumer Product Safety Commission International Development Cooperation Agency Agency for International Development Department of Housing and Urban Development Department of Justice Department of Defense Department of Education Department of Veterans Affairs Environmental Protection Agency Department of Health and Human Services National Science Foundation and Department of Transportation, 1991, FED REGISTER, V56, P28003	2	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1961	1961						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308425				2022-12-28	WOS:000167995900016
J	Polanczyk, CA; Marcantonio, E; Goldman, L; Rohde, LEP; Orav, J; Mangione, CM; Lee, TH				Polanczyk, CA; Marcantonio, E; Goldman, L; Rohde, LEP; Orav, J; Mangione, CM; Lee, TH			Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC RISK-ASSESSMENT; ELECTIVE SURGERY; PULMONARY COMPLICATIONS; MYOCARDIAL-ISCHEMIA; ACTIVITY SCALE; VALIDATION; MORBIDITY; MORTALITY; INDEX; PREDICTION	Background: Major surgical procedures are performed with increasing frequency in elderly persons, but the impact of age on resource use and outcomes is uncertain. Objective: To evaluate the influence of age on perioperative cardiac and noncardiac complications and length of stay in patients undergoing noncardiac surgery. Design: Prospective cohort study. Setting: Urban academic medical center. Patients: Consecutive sample of 4315 patients 50 years of age or older who underwent nonemergent major noncardiac procedures. Measurements: Major perioperative complications (cardiac and noncardiac), in-hospital mortality, and length of stay. Results: Major perioperative complications occurred in 4.3% (44 of 1015) of patients 59 years of age or younger, 5.7% (93 of 1646) of patients 60 to 69 years of age, 9.6% (129 of 1341) of patients 70 to 79 years of age, and 12.5% (39 of 313) of patients 80 years of age or older (P < 0.001). In-hospital mortality was significantly higher in patients 80 years of age or older than in those younger than 80 years of age (0.7% vs. 2.6%, respectively). Multivariate analyses indicated an increased odds ratio for perioperative complications or in-hospital mortality in patients 70 to 79 years of age (1.8 [95% Cl, 1.2 to 2.7]) and those 80 years of age or older (OR, 2.1 [Cl, 1.2 to 3.6]) compared with patients 50 to 59 years of age. Patients 80 years of age or older stayed an average of 1 day more in the hospital, after adjustment for other clinical data (P = 0.001). Conclusions: Elderly patients had a higher rate of major perioperative complications and mortality after noncardiac surgery and a longer length of stay, but even in patients 80 years of age or older, mortality was low.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Lee, TH (corresponding author), Partners Community HealthCare Inc, Prudential Tower,11th Floor,800 Boylston St, Boston, MA 02199 USA.	thlee@partners.org	Rohde, Luis Eduardo/I-4216-2013; Polanczyk, Carisi CAP/D-6208-2013; Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006573] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS06573] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACKERMANN RJ, 1995, J FAM PRACTICE, V40, P129; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; GERSON MC, 1990, AM J MED, V88, P101, DOI 10.1016/0002-9343(90)90456-N; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HEDGES JR, 1992, ANN EMERG MED, V21, P402, DOI 10.1016/S0196-0644(05)82659-9; HOSKING MP, 1989, JAMA-J AM MED ASSOC, V261, P1909; LAHEY SJ, 1992, CIRCULATION, V86, P181; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1996, AM J CARDIOL, V77, P1031, DOI 10.1016/S0002-9149(96)00126-9; LEE TH, 1988, AM HEART J, V115, P203, DOI 10.1016/0002-8703(88)90545-5; LItalien GJ, 1996, J AM COLL CARDIOL, V27, P779, DOI 10.1016/0735-1097(95)00566-8; Macario A, 1997, ANESTHESIOLOGY, V86, P92, DOI 10.1097/00000542-199701000-00013; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607; MANGIONE CM, 1993, J AM GERIATR SOC, V41, P377, DOI 10.1111/j.1532-5415.1993.tb06944.x; Mangione CM, 1997, J GEN INTERN MED, V12, P686, DOI 10.1046/j.1525-1497.1997.07142.x; WONG T, 1992, ANN INTERN MED, V116, P743, DOI 10.7326/0003-4819-116-9-743	21	335	356	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					637	643		10.7326/0003-4819-134-8-200104170-00008	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304103	Green Published			2022-12-28	WOS:000168177500002
J	Ediger, MD; Skinner, JL				Ediger, MD; Skinner, JL			Single molecules rock and roll near the glass transition	SCIENCE			English	Editorial Material							TEMPERATURE; TERPHENYL; DYNAMICS		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ediger, MD (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.		Ediger, Mark/AGZ-4130-2022	Ediger, Mark/0000-0003-4715-8473				Bartko AP, 1999, J PHYS CHEM B, V103, P11237, DOI 10.1021/jp993364q; Deschenes LA, 2001, SCIENCE, V292, P255, DOI 10.1126/science.1056430; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Geva E, 1997, J PHYS CHEM B, V101, P8920, DOI 10.1021/jp971722o; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; REILLY PD, 1995, J CHEM PHYS, V102, P1540, DOI 10.1063/1.468886; Russell E. V., 2000, Nature, V408, P695, DOI 10.1038/35047037; SCHMIDT-ROHR K, 1991, PHYS REV LETT, V66, P3020, DOI 10.1103/PhysRevLett.66.3020; Sillescu H, 1999, J NON-CRYST SOLIDS, V243, P81, DOI 10.1016/S0022-3093(98)00831-X; Tracht U, 1998, PHYS REV LETT, V81, P2727, DOI 10.1103/PhysRevLett.81.2727; Wang CY, 1999, J PHYS CHEM B, V103, P4177, DOI 10.1021/jp984149x; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441	12	16	16	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					233	234		10.1126/science.1060312	http://dx.doi.org/10.1126/science.1060312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305316				2022-12-28	WOS:000168074000032
J	Gupta, A; Tsai, LH				Gupta, A; Tsai, LH			A kinase to dampen the effects of cocaine?	SCIENCE			English	Editorial Material							CYCLIN-DEPENDENT KINASE-5; P35; CDK5; NEURODEGENERATION; ADHESION; MICE; P25		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gupta, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.							Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; BIBB JA, IN PRESS J BIOL CHEM; Bothwell M, 2000, CELL, V102, P271, DOI 10.1016/S0092-8674(00)00032-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JS, 2000, J NEUROSCI, V20, P8965; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Reiner O, 2000, NEURON, V28, P633, DOI 10.1016/S0896-6273(00)00142-2; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9	20	10	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					236	237		10.1126/science.1060028	http://dx.doi.org/10.1126/science.1060028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305318				2022-12-28	WOS:000168074000034
J	Falck, J; Mailand, N; Syljuasen, RG; Bartek, J; Lukas, J				Falck, J; Mailand, N; Syljuasen, RG; Bartek, J; Lukas, J			The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis	NATURE			English	Article							CELL-CYCLE REGULATION; DAMAGE CHECKPOINT; ATAXIA-TELANGIECTASIA; HUMAN CDC25A; FHA DOMAIN; PHOSPHORYLATION; CHK1; P53; ATM; ACTIVATION	When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle(1-3). Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene(4-6). The Cdc25A phosphatase(7) activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis(8,9), but becomes degraded in response to DNA damage(10) or stalled replication(11). Here we report a functional link between ATM, the checkpoint signalling kinase Chk2/Cds1 (Chk2)(12) and Cdc25A, and implicate this mechanism in controlling the S-phase checkpoint. We show that IR-induced destruction of Cdc25A requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on serine 123. An IR-induced loss of Cdc25A protein prevents dephosphorylation of Cdk2 and leads to a transient blockade of DNA replication. We also show that tumour-associated Chk2 alleles(13) cannot bind or phosphorylate Cdc25A, and that cells expressing these Chk2 alleles, elevated Cdc25A or a Cdk2 mutant unable to undergo inhibitory phosphorylation (Cdk2AF) fail to inhibit DNA synthesis when irradiated. These results support Chk2 as a candidate tumour suppressor, and identify the ATM-Chk2-Cdc25A-Cdk2 pathway as a genomic integrity checkpoint that prevents radioresistant DNA synthesis.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Xie GF, 1998, ONCOGENE, V16, P721, DOI 10.1038/sj.onc.1201793; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	30	822	860	1	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					842	847		10.1038/35071124	http://dx.doi.org/10.1038/35071124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298456				2022-12-28	WOS:000168021900062
J	Schrater, PR; Knill, DC; Simoncelli, EP				Schrater, PR; Knill, DC; Simoncelli, EP			Perceiving visual expansion without optic flow	NATURE			English	Article							CHANGING-SIZE; MOTION; PERCEPTION; DEPTH; STIMULI; FIELD; INFORMATION; COLLISION	When an observer moves forward in the environment, the image on his or her retina expands. The rate of this expansion conveys information about the observer's speed(1) and the time to collision(2-4). Psychophysical(5-7) and physiological(8,9) studies have provided abundant evidence that these expansionary motions are processed by specialized mechanisms in mammalian visual systems. It is commonly assumed that the rate of expansion is estimated from the divergence of the optic-flow field (the two-dimensional field of local translational velocities)(10-14). But this rate might also be estimated from changes in the size (or scale) of image features(15). To determine whether human vision uses such scale-change information, we have synthesized stochastic texture stimuli in which the scale of image elements increases gradually over time, while the optic-flow pattern is random. Here we show, using these stimuli, that observers can estimate expansion rates from scale-change information alone, and that pure scale changes can produce motion after-effects. These two findings suggest that the visual system contains mechanisms that are explicitly sensitive to changes in scale.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci & Math, New York, NY 10003 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; New York University; New York University	Schrater, PR (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.			Simoncelli, Eero/0000-0002-1206-527X				ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; BEVERLEY KI, 1983, VISION RES, V23, P1387, DOI 10.1016/0042-6989(83)90150-5; BLAKE R, 1993, VISION RES, V33, P1589, DOI 10.1016/0042-6989(93)90152-M; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Clifford CWG, 1999, VISION RES, V39, P2213, DOI 10.1016/S0042-6989(98)00314-9; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Gibson JJ, 1950, PERCEPTION VISUAL WO; KAISER MK, 1995, PERCEPT PSYCHOPHYS, V57, P817, DOI 10.3758/BF03206797; Kendall MG, 1966, ADV THEORY STAT, V3; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Morrone MC, 1999, CURR BIOL, V9, P763, DOI 10.1016/S0960-9822(99)80338-8; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; PERRONE JA, 1986, PERCEPT PSYCHOPHYS, V39, P1, DOI 10.3758/BF03207577; PERRONE JA, 1992, J OPT SOC AM A, V9, P177, DOI 10.1364/JOSAA.9.000177; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; REGAN D, 1978, VISION RES, V18, P209, DOI 10.1016/0042-6989(78)90188-8; SCHIFF W, 1979, PERCEPTION, V8, P647, DOI 10.1068/p080647; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629; TYLER CW, 1979, VISION RES, V19, P859, DOI 10.1016/0042-6989(79)90019-1; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1991, BIOL CYBERN, V65, P311, DOI 10.1007/BF00216964; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	23	37	37	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					816	819		10.1038/35071075	http://dx.doi.org/10.1038/35071075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420TT	11298449				2022-12-28	WOS:000168021900055
J	van Staa, TP; Wegman, S; de Vries, F; Leufkens, B; Cooper, C				van Staa, TP; Wegman, S; de Vries, F; Leufkens, B; Cooper, C			Use of statins and risk of fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COA REDUCTASE INHIBITORS; ORAL CORTICOSTEROIDS; IN-VITRO; DATABASE; VALIDATION; WOMEN; UK	Context Previous studies have reported lower fracture risks in patients taking 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Objective To investigate risk of fracture among statin users. Design Case-control study of data from the General Practice Research Database (GPRD). Setting A total of 683 general clinical practices in the United Kingdom. Patients Cases were 81 880 patients aged 50 years or older who had a fracture of the vertebrae, clavicle, humerus, radius/ulna, carpus, hip, ankle, or foot occurring between the enrollment date of their practice into the GPRD and Jury 1999, paired with 81 880 age-, sex-, and practice-matched controls. Main Outcome Measure Risk of fracture in current users vs nonusers of statins. Odds ratios were estimated from conditional logistic regression and adjusted for smoking, medications and illnesses associated with fracture risk, and body mass index when known. Results The adjusted odds ratio (OR) for current use of statins compared with non-use was 1.01 (95% confidence interval [CI], 0.88-1.16). For forearm, hip, and vertebral fractures, the ORs were 1.01 (95% CI, 0.80-1.27), 0.59 (95% CI, 0.31-1.13), and 1.15 (95% CI, 0.62-2.14), respectively. Relative to nonuse, a statin dosage of less than 20 mg/d (standardized to simvastatin) was associated with an adjusted OR of fracture of 1.13 (95% CI, 0.96-1.33); this OR was 1.07 (95% CI, 0.82-1.38) at dosages of 20 to 39.9 mg/d and 0.85 (95% CI, 0.47-1.53) at dosages of 40 mg/d or more. The adjusted OR was 0.71 (95% CI, 0.50-1.01) for statin use durations of 0 to 3 months, 1.31 (95% CI, 0.87-1.95) for durations of 3 to 6 months, 1.14 (95%: CI, 0.82-1.58) for durations of 6 to 12 months, and 1.17 (95% CI, 0.99-1.40) for durations of more than 12 months. Conclusion In this study, use of statins at dosages prescribed in clinical practice was not associated with a reduction in risk of fracture.	Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Univ Utrecht, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands; Proctor & Gamble Pharmaceut, Staines, England	University of Southampton; Utrecht University; Procter & Gamble	Cooper, C (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van Staa, Tjeerd/0000-0001-9363-742X; Cooper, Cyrus/0000-0003-3510-0709				Bauer DC, 1999, J BONE MINER RES, V14, pS179; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Grisso Jeane Ann, 1996, P599; HALL G, 1992, PHARMACOEPIDEM DR S, V1, P33; HOLLOWELL J, 1994, GEN PRACTICE RES DAT; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, P164; LaCroix AZ, 2000, J BONE MINER RES, V15, pS155; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; MANN RD, 1992, POSTMARKETING SURVEI, V5, P259; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; *OFF NAT STAT, 1996, GEN PRACT RES DAT IN; PEDERSEN TR, 1994, LANCET, V344, P1383; SENN S, 1997, STAT ISSUES DRUG DEV, P132; Shane Elizabeth, 1996, P925; van Beek E, 1999, J BONE MINER RES, V14, P722, DOI 10.1359/jbmr.1999.14.5.722; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	27	228	231	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1850	1855		10.1001/jama.285.14.1850	http://dx.doi.org/10.1001/jama.285.14.1850			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308398	Bronze			2022-12-28	WOS:000167876700025
J	Ruehm, SG; Goyen, M; Barkhausen, J; Kroger, K; Bosk, S; Ladd, ME; Debatin, JF				Ruehm, SG; Goyen, M; Barkhausen, J; Kroger, K; Bosk, S; Ladd, ME; Debatin, JF			Rapid magnetic resonance angiography for detection of atherosclerosis	LANCET			English	Article							3-DIMENSIONAL MR-ANGIOGRAPHY; PERIPHERAL VASCULAR-DISEASE; LOWER-EXTREMITY; DIGITAL SUBTRACTION; OCCLUSIVE DISEASE; RUNOFF VESSELS; RENAL-ARTERIES; BREATH-HOLD; ARTERIOGRAPHY; SINGLE	Background Choice of treatment for atherosclerosis depends on various clinical factors and radiological techniques. We aimed to assess the diagnostic accuracy of a new three-dimensional magnetic resonance angiography (3D MRA) strategy for the display of arterial vasculature from supraaortic arteries to distal runoff vessels in 72 s. Methods We examined five healthy volunteers and six patients over 6 weeks. Conventional digital subtraction angiography (DSA) was available as reference standard in all six patients. Magnetic resonance imaging was done on a commercially available 1.5 Tesla scanner. The imaging technique was based on the acquisition of five 3D data sets in rapid succession with an optimum single injection protocol. Findings Compared with conventional catheter angiography, according to the findings of two independent and masked readers, whole-body MRA had overall sensitivities of 91% (95% CI 0.76-0.98) and 94% (0.8-0.99), and specificities of 93% (0.85-0.97) and 90% (0.82-0.96) for the detection of substantial vascular disease (luminal narrowing >50%). Interobserver agreement for assessment of whole-body magnetic angiograms was very good (kappa =0.94: 95% CI 0.9-0.98). Interpretation The technique provides a comprehensive noninvasive approach for morphological screening assessment of the arterial vasculature from supra-aortic arteries to the distal runoff arteries.	Univ Hosp Essen, Dept Diagnost Radiol, D-45122 Essen, Germany; Univ Hosp Essen, Dept Angiol, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Ruehm, SG (corresponding author), Univ Hosp Essen, Dept Diagnost Radiol, D-45122 Essen, Germany.		Barkhausen, Joerg/E-3921-2010; Ladd, Mark E./B-3285-2011	Ladd, Mark/0000-0002-4128-9440				CARPENTER JP, 1992, J VASC SURG, V16, P807; Chiowanich P, 2000, AM J ROENTGENOL, V175, P523, DOI 10.2214/ajr.175.2.1750523; DOUEK PC, 1995, AM J ROENTGENOL, V165, P431, DOI 10.2214/ajr.165.2.7618572; Gross CM, 1997, AM J CARDIOL, V80, P1478, DOI 10.1016/S0002-9149(97)00727-3; Hany TF, 1997, RADIOLOGY, V204, P357, DOI 10.1148/radiology.204.2.9240520; Ho KYJAM, 1998, RADIOLOGY, V206, P683, DOI 10.1148/radiology.206.3.9494486; MALDEN ES, 1994, RADIOLOGY, V191, P149, DOI 10.1148/radiology.191.1.8134562; MCCAULEY TR, 1994, RADIOLOGY, V192, P351, DOI 10.1148/radiology.192.2.8029396; Meaney JFM, 1999, RADIOLOGY, V211, P59, DOI 10.1148/radiology.211.1.r99ap1859; OWEN RS, 1993, RADIOLOGY, V187, P627, DOI 10.1148/radiology.187.3.8497607; OWEN RS, 1992, NEW ENGL J MED, V326, P1577, DOI 10.1056/NEJM199206113262428; Picus D, 1991, J Vasc Interv Radiol, V2, P359, DOI 10.1016/S1051-0443(91)72263-X; PRINCE MR, 1993, JMRI-J MAGN RESON IM, V3, P877, DOI 10.1002/jmri.1880030614; Reddy KS, 1998, CIRCULATION, V97, P596; Rubin GD, 2000, RADIOLOGY, V215, P670, DOI 10.1148/radiology.215.3.r00jn18670; Ruehm SG, 2000, AM J ROENTGENOL, V174, P1127, DOI 10.2214/ajr.174.4.1741127; SMITH TP, 1992, AM J ROENTGENOL, V158, P431, DOI 10.2214/ajr.158.2.1729803; SNIDOW JJ, 1995, J VASC INTERV RADIOL, V6, P595, DOI 10.1016/S1051-0443(95)71143-5; SNIDOW JJ, 1995, RADIOLOGY, V196, P371, DOI 10.1148/radiology.196.2.7617847; Snidow JJ, 1996, RADIOLOGY, V198, P725, DOI 10.1148/radiology.198.3.8628861; Wang Y, 1998, RADIOLOGY, V207, P263, DOI 10.1148/radiology.207.1.9530326; YUCEL EK, 1994, AM J ROENTGENOL, V163, P197, DOI 10.2214/ajr.163.1.8010214; YUCEL EK, 1993, RADIOLOGY, V187, P637, DOI 10.1148/radiology.187.3.8497608	23	143	146	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1086	1091		10.1016/S0140-6736(00)04261-6	http://dx.doi.org/10.1016/S0140-6736(00)04261-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297960				2022-12-28	WOS:000167996200011
J	Nakayam, J; Rice, JC; Strahl, BD; Allis, CD; Grewal, SIS				Nakayam, J; Rice, JC; Strahl, BD; Allis, CD; Grewal, SIS			Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly	SCIENCE			English	Article							FISSION YEAST; PROTEIN; CHROMOSOME; DOMAINS; ACETYLATION; INHERITANCE; DROSOPHILA; MUTATIONS; HOMOLOGS; REPEATS	The assembly of higher order chromatin structures has been Linked to the covalent modifications of histone tails. We provide in vivo evidence that lysine 9 of histone H3 (H3 Lys(9)) is preferentially methylated by the Clr4 protein at heterochromatin-associated regions in fission yeast. Both the conserved chromo- and SET domains of Clr4 are required for H3 Lys(9) methylation in vivo. Localization of Swi6, a homolog of Drosophila HP1, to heterochomatic regions is dependent on H3 Lysg methylation. Moreover, an H3-specific deacetylase Clr3 and a beta -propeller domain protein Rik1 are required for H3 Lys(9) methylation by Clr4 and Swi6 Localization. These data define a conserved pathway wherein sequential histone modifications establish a "histone code" essential for the epigenetic inheritance of heterochromatin assembly.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	grewal@cshl.org	Rice, Judd C/B-7806-2009; Nakayama, Jun-ichi/C-6003-2011; jia, xu/A-8386-2016; Strahl, Brian/C-7601-2012	Nakayama, Jun-ichi/0000-0002-5597-8239; Strahl, Brian/0000-0002-4947-6259	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772, R37GM053512, R01GM053512] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53512, GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, UNPUB; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NAKAYAMA J, UNPUB; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Partridge JF, 2000, GENE DEV, V14, P783; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; THON G, 1994, GENETICS, V138, P29; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Holde KE., 1989, SPRINGER SERIES MOL; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000	28	1314	1359	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					110	113		10.1126/science.1060118	http://dx.doi.org/10.1126/science.1060118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11283354				2022-12-28	WOS:000167995200050
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			A 52-year-old suicidal man, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Jacobs DG, 2000, JAMA-J AM MED ASSOC, V283, P2693, DOI 10.1001/jama.283.20.2693	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1757	1757		10.1001/jama.285.13.1757	http://dx.doi.org/10.1001/jama.285.13.1757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277831				2022-12-28	WOS:000167710600030
J	Delaney, BC				Delaney, BC			10-minute consultation - Dyspepsia	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Delaney, BC (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England.		Delaney, Brendan C/C-5578-2008	Delaney, Brendan/0000-0002-3518-0131				DELANEY BC, 2000, COCHRANE DATABASE SY; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; SOO S, 2000, COCHRANE DATABASE SY; VANPINXTEREN B, 2000, COCHRANE DATABASE SY	4	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					776	776		10.1136/bmj.322.7289.776	http://dx.doi.org/10.1136/bmj.322.7289.776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282866	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000167943200029
J	Lucassen, A; Parker, M				Lucassen, A; Parker, M			Revealing false paternity: some ethical considerations	LANCET			English	Editorial Material							NONPATERNITY		Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Univ Oxford, Inst Hlth Sci, Ethox Ctr, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Lucassen, A (corresponding author), Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YD, Hants, England.		Lucassen, Anneke/D-7764-2017	Lucassen, Anneke/0000-0003-3324-4338				[Anonymous], 1983, Fed Regist, V48, P34408; Benkendorf Judith L, 1992, J Genet Couns, V1, P31, DOI 10.1007/BF00960082; BROCK DJH, 1991, LANCET, V338, P1151, DOI 10.1016/0140-6736(91)92013-R; Cerda-Flores RM, 1999, AM J PHYS ANTHROPOL, V109, P281, DOI 10.1002/(SICI)1096-8644(199907)109:3<281::AID-AJPA1>3.0.CO;2-3; FRASER FC, 1974, AM J HUM GENET, V26, P636; HARPER PS, 1998, ANONYMOUS PRACTICAL, P3; Institute of Medicine, 1994, ASS GEN RISKS, P276; KELLY TE, 1986, CLIN GENETICS GENETI; LEROUX MG, 1993, LANCET, V341, P57, DOI 10.1016/0140-6736(93)92536-3; LINCOLN PJ, 1992, LANCET, V340, P1108, DOI 10.1016/0140-6736(92)93139-E; *MRC, 1992, ETH ASP HUM GEN TEST; Ngwena Charles, 1993, Med Law Int, V1, P73; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; Offit K, 1998, CLIN CANC GENETICS, P287; Pencarinha Deborah F, 1992, J Genet Couns, V1, P19, DOI 10.1007/BF00960081; *PRES COMM STUD ET, 1983, AM MED NEWS, V26, P25; Ross LF, 1996, BIOETHICS, V10, P114, DOI 10.1111/j.1467-8519.1996.tb00111.x; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; WERTZ DC, 1990, AM J HUM GENET, V46, P1200; Wertz DC, 1999, NEW GENETICS: FROM RESEARCH INTO HEALTH CARE, P75	20	66	67	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1033	1035		10.1016/S0140-6736(00)04240-9	http://dx.doi.org/10.1016/S0140-6736(00)04240-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293609				2022-12-28	WOS:000167791500036
J	Thakker, RV				Thakker, RV			Genetic developments in hypoparathyroidism	LANCET			English	Editorial Material							MUTATIONS; RECEPTOR		Univ Oxford, Dept Clin Med, Dept Med, Oxford OX3 9DU, England	University of Oxford	Thakker, RV (corresponding author), Univ Oxford, Dept Clin Med, Dept Med, Oxford OX3 9DU, England.			Thakker, Rajesh/0000-0002-1438-3220				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; BILEZIKIAN JP, 1998, CURR OPIN ENDOCRINOL, V4, P427; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; DING C, 2000, AM END SOC M; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088	13	22	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					974	976		10.1016/S0140-6736(00)04254-9	http://dx.doi.org/10.1016/S0140-6736(00)04254-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293637				2022-12-28	WOS:000167791500004
J	Deng, XH; Matsumoto, H				Deng, XH; Matsumoto, H			Rapid magnetic reconnection in the Earth's magnetosphere mediated by whistler waves	NATURE			English	Article							DAYSIDE MAGNETOPAUSE; CURRENT LAYER; FLUX-TRANSFER; COLLISIONLESS	Magnetic reconnection has a crucial role in a variety of plasma environments(1-3) in providing a mechanism for the fast release of stored magnetic energy. During reconnection the plasma forms a 'magnetic nozzle: like the nozzle of a hose, and the rate is controlled by how fast plasma can flow out of the nozzle. But the traditional picture of reconnection has been unable to explain satisfactorily the short timescales associated with the energy release, because the flow is mediated by heavy ions with a slow resultant velocity. Recent theoretical work(4-6) has suggested that the energy release is instead mediated by electrons in waves called 'whistlers', which move much faster for a given perturbation of the magnetic field because of their smaller mass. Moreover, the whistler velocity and associated plasma velocity both increase as the 'nozzle' becomes narrower. A narrower nozzle therefore no longer reduces the total plasma flow-the outflow is independent of the size of the nozzle. Here we report observations demonstrating that reconnection in the magnetosphere is driven by whistlers, in good agreement with the theoretical predictions.	Kyoto Univ, Radio Sci Ctr Space & Atmosphere, Kyoto 6110011, Japan	Kyoto University	Matsumoto, H (corresponding author), Kyoto Univ, Radio Sci Ctr Space & Atmosphere, Kyoto 6110011, Japan.							ANDERSON RR, 1982, J GEOPHYS RES-SPACE, V87, P2087, DOI 10.1029/JA087iA04p02087; BIRN J, IN PRESS J GEOPHYS R; Drake JF, 1997, GEOPHYS RES LETT, V24, P2921, DOI 10.1029/97GL52961; DRAKE JF, 1994, PHYS REV LETT, V73, P1251, DOI 10.1103/PhysRevLett.73.1251; Hesse M, 1999, PHYS PLASMAS, V6, P1781, DOI 10.1063/1.873436; LE G, 1994, GEOPHYS RES LETT, V21, P2451, DOI 10.1029/94GL02292; LEE LC, 1985, GEOPHYS RES LETT, V12, P105, DOI 10.1029/GL012i002p00105; MANDT ME, 1994, GEOPHYS RES LETT, V21, P73, DOI 10.1029/93GL03382; MATSUMOTO H, 1994, J GEOMAGN GEOELECTR, V46, P59, DOI 10.5636/jgg.46.59; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; PETSCHEK HE, 1964, NASA, P425; PRIEST ER, 1981, SOLAR FLARE MAGNETOH; Pritchett PL, 1996, J GEOPHYS RES-SPACE, V101, P27413, DOI 10.1029/96JA02665; RUSSELL CT, 1979, GEOPHYS RES LETT, V6, P33, DOI 10.1029/GL006i001p00033; Shay MA, 1999, GEOPHYS RES LETT, V26, P2163, DOI 10.1029/1999GL900481; SHAY MA, IN PRESS J GEOPHYS R; Song P, 1998, J GEOPHYS RES-SPACE, V103, P26495, DOI 10.1029/98JA02396; Sonnerup B. U. O., 1979, SOLAR SYSTEM PLASMA, P45; URRUTIA JM, 1995, PHYS PLASMAS, V2, P1100, DOI 10.1063/1.871389; Zhu Z, 1996, GEOPHYS RES LETT, V23, P773, DOI 10.1029/96GL00591	20	238	253	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					557	560		10.1038/35069018	http://dx.doi.org/10.1038/35069018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279487				2022-12-28	WOS:000167859300039
J	Schwartz, JCD; Zhang, XW; Fedorov, AA; Nathenson, SG; Almo, SC				Schwartz, JCD; Zhang, XW; Fedorov, AA; Nathenson, SG; Almo, SC			Structural basis for co-stimulation by the human CTLA-4/B7-2 complex	NATURE			English	Article							COUNTER-RECEPTORS CD80; PROTEIN MODELS; SOLUBLE FORM; CD28; BINDING; DIMERIZATION; RECOGNITION; ACTIVATION; B7-1; SITE	Regulation of T-cell activity is dependent on antigen-independent co-stimulatory signals provided by the disulphide-linked homodimeric T-cell surface receptors, CD28 and CTLA-4 (ref, 1), Engagement of CD28 with B7-1 and B7-2 ligands on antigen-presenting cells (APCs) provides a stimulatory signal for T-cell. activation, whereas subsequent engagement of CTLA-4 with these I same ligands results in attenuation of the response(1). Given their central function in immune modulation, CTLA-4- and CD28- associated signalling pathways are primary therapeutic targets for preventing autoimmune disease, graft versus host disease, graft rejection and promoting tumour immunity(1,2). However, little is known about the cell-surface organization of these receptor/ ligand complexes and the structural basis for signal transduction, Here we report the 3.2-Angstrom resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2. The unusual dimerization properties of both CTLA-4 and B7-2 place their respective ligand-binding sites distal to the dimer interface in each molecule and promote the formation of an alternating arrangement of bivalent CTLA-4 and B7-2 dimers that extends throughout the crystal. Direct observation of this CTLA-4/B7-2 network provides a model for the periodic organization of these molecules within the immunological synapse and suggests a distinct mechanism for signalling by dimeric cell-surface receptors.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Almo, SC (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu; almo@aecom.yu.edu	Schwartz, Jean-Claude/U-3163-2019					BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kariv I, 1996, J IMMUNOL, V157, P29; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Morton PA, 1996, J IMMUNOL, V156, P1047; Najafian N, 2000, EXPERT OPIN INV DRUG, V9, P2147, DOI 10.1517/13543784.9.9.2147; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Truneh A, 1996, MOL IMMUNOL, V33, P321, DOI 10.1016/0161-5890(95)00077-1; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9; [No title captured]	32	249	300	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					604	608		10.1038/35069112	http://dx.doi.org/10.1038/35069112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279501				2022-12-28	WOS:000167859300053
J	Schortgen, F; Lacherade, JC; Bruneel, F; Cattaneo, I; Hemery, F; Lemaire, F; Brochard, L				Schortgen, F; Lacherade, JC; Bruneel, F; Cattaneo, I; Hemery, F; Lemaire, F; Brochard, L			Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study	LANCET			English	Article							INTENSIVE-CARE; STARCH HES; FAILURE; VOLUME; RESUSCITATION	Background Hydroxyethylstarch used for volume restoration in brain-dead kidney donors has been associated with impaired kidney function in the transplant recipients. We undertook a multicentre randomised study to assess the frequency of acute renal failure (ARF) in patients with severe sepsis or septic shock treated with hydroxyethylstarch or gelatin. Methods Adults with severe sepsis or septic shock were enrolled prospectively in three intensive-care units in France. They were randomly assigned 6% hydroxyethylstarch (200 kDa, 0.60-0.66 substitution) or 3% fluid-modified gelatin. The primary endpoint was ARF (a two-fold increase in serum creatinine from baseline or need for renal replacement therapy). Analyses were by intention to treat. Findings 129 patients were enrolled over 18 months. Severity of illness and serum creatinine (median 143 [IQR 88-203] vs 114 [91-175] mu mol/L) were similar at baseline in the hydroxyethylstarch and gelatin groups. The frequencies of ARF (27/65 [42%] vs 15/64 [23%], p=0.028) and oliguria (35/62 [56%] vs 23/63 [37%], p=0.025) and the peak serum creatinine concentration (225 [130-339] vs 169 [106-273] mu mol/L, p=0.04) were significantly higher in the hydroxyethylstarch group than in the gelatin group. in a multivariate analysis, risk factors for acute renal failure included mechanical ventilation (odds ratio 4.02 [95% CI 1.37-11.8], p=0.013) and use of hydroxyethylstarch (2.57 [1.13-5.83], p=0.026). Interpretations The use of this preparation of hydroxyethylstarch as a plasma-volume expander is an independent risk factor for ARF in patients with severe sepsis or septic shock.	Univ Paris 12, Assistance Publ Hop Paris, Hop Henri Mondor, Med Intens Care Unit, F-94000 Creteil, France; Univ Paris 12, Assistance Publ Hop Paris, Hop Henri Mondor, Dept Biostat, F-94000 Creteil, France; Univ Paris 07, Assistance Publ Hop Paris, Hop Bichat Claude Bernard, Infect Dis Intens Care Unit, Paris, France; St Camille Hop, Med Surg Intens Care Unit, Bry Sur Mame, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Brochard, L (corresponding author), Univ Paris 12, Assistance Publ Hop Paris, Hop Henri Mondor, Med Intens Care Unit, F-94000 Creteil, France.	laurent.brochard@hmn.ap-hop-paris.fr		Schortgen, Frederique/0000-0003-1756-7508				AHSAN N, 1994, ARCH INTERN MED, V154, P1985, DOI 10.1001/archinte.154.17.1985; Boldt J, 1998, INTENS CARE MED, V24, P28, DOI 10.1007/s001340050511; Boldt J, 1998, INTENS CARE MED, V24, P147, DOI 10.1007/s001340050536; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Deman A, 1999, NEPHROL DIAL TRANSPL, V14, P1517, DOI 10.1093/ndt/14.6.1517; Dickenmann MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2706; DIENES HP, 1986, J HEPATOL, V3, P223, DOI 10.1016/S0168-8278(86)80030-7; DIOMI P, 1970, ANN SURG, V172, P813, DOI 10.1097/00000658-197011000-00006; DISCALA VA, 1965, ANN INTERN MED, V63, P767, DOI 10.7326/0003-4819-63-5-767; Entholzner EK, 2000, ACTA ANAESTH SCAND, V44, P1116, DOI 10.1034/j.1399-6576.2000.440914.x; Hollenberg SM, 1999, CRIT CARE MED, V27, P639; Jamnicki M, 2000, ANESTHESIOLOGY, V93, P1231, DOI 10.1097/00000542-200011000-00016; JOCHIMSEN F, 1990, CRIT CARE MED, V18, P480, DOI 10.1097/00003246-199005000-00003; Kumle B, 1999, ANESTH ANALG, V89, P1124, DOI 10.1213/00000539-199911000-00009; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2959; LEGENDRE C, 1993, LANCET, V342, P248, DOI 10.1016/0140-6736(93)92345-T; LUCAS CE, 1978, J TRAUMA, V18, P564, DOI 10.1097/00005373-197808000-00002; Marik PE, 2000, CRIT CARE MED, V28, P2652, DOI 10.1097/00003246-200007000-00083; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MORAN M, 1987, NEW ENGL J MED, V317, P150, DOI 10.1056/NEJM198707163170306; Moreau J F, 1993, Invest Radiol, V28, P187, DOI 10.1097/00004424-199302000-00028; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Sirtl C, 1999, BRIT J ANAESTH, V82, P510, DOI 10.1093/bja/82.4.510; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thijs A, 1998, KIDNEY INT, V53, pS34; Treib J, 1999, INTENS CARE MED, V25, P258, DOI 10.1007/s001340050833; 1996, REANIMATION URGENCE, V5, P441	33	479	511	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2001	357	9260					911	916		10.1016/S0140-6736(00)04211-2	http://dx.doi.org/10.1016/S0140-6736(00)04211-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289347				2022-12-28	WOS:000167625300009
J	Paradise, JL; Feldman, HM; Campbell, TF; Dollaghan, CA; Colborn, DK; Bernard, BS; Rockette, HE; Janosky, JE; Pitcairn, DL; Sabo, DL; Kurs-Lasky, M; Smith, CG				Paradise, JL; Feldman, HM; Campbell, TF; Dollaghan, CA; Colborn, DK; Bernard, BS; Rockette, HE; Janosky, JE; Pitcairn, DL; Sabo, DL; Kurs-Lasky, M; Smith, CG			Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LANGUAGE; CHILDREN; EFFUSION; SPEECH; LIFE; MYRINGOTOMY; EFFICACY	Background: A main indication for the insertion of tympanostomy tubes in infants and young children is persistent otitis media with effusion, reflecting concern that this condition may cause lasting impairments of speech, language, cognitive, and psychosocial development. However, evidence of such relations is inconclusive, and evidence is lacking that the insertion of tympanostomy tubes prevents developmental impairment. Methods: We enrolled 6350 healthy infants from 2 to 61 days of age and evaluated them regularly for middle-ear effusion. Before the age of three years 429 children with persistent effusion were randomly assigned to have tympanostomy tubes inserted either as soon as possible or up to nine months later if effusion persisted. In 402 of these children we assessed speech, language, cognition, and psychosocial development at the age of three years. Results: By the age of three years, 169 children in the early-treatment group (82 percent) and 66 children in the late-treatment group (34 percent) had received tympanostomy tubes. There were no significant differences between the early-treatment group and the late-treatment group at the age of three years in the mean (+/-SD) scores on the Number of Different Words test, a measure of word diversity (124+/-32 and 126+/-30, respectively); the Percentage of Consonants Correct-Revised test, a measure of speech-sound production (85+/-7 vs. 86+/-7); the General Cognitive Index of McCarthy Scales of Children's Abilities (99+/-14 vs. 101+/-13); or on measures of receptive language, sentence length, grammatical complexity, parent-child stress, and behavior. Conclusions: In children younger than three years of age who have persistent otitis media, prompt insertion of tympanostomy tubes does not measurably improve developmental outcomes at the age of three years. (N Engl J Med 2001;344:1179-87.) Copyright (C) 2001 Massachusetts Medical Society.	Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; Childrens Hosp Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Family Med & Clin Epidemiol, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Paradise, JL (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	jpar@pitt.edu		Feldman, Heidi/0000-0002-4435-0913	NICHD NIH HHS [HD26026] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026026] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABELSON RP, 1963, ANN MATH STAT, V34, P1347, DOI 10.1214/aoms/1177703869; Abidin RR., 1995, PSYCHOL ASSESSMENT R; Achenbach T. M., 1992, MANUAL CHILD BEHAV C; Ah-Tye Collette, 1997, Pediatric Research, V41, p89A; *AM AC OT HEAD NEC, 2000, B AM AC OT HEAD NECK, P10; Brown R., 1973, 1 LANGUAGE EARLY STA; CASSELBRANT ML, 1992, PEDIATR INFECT DIS J, V11, P278, DOI 10.1097/00006454-199204000-00004; Dollaghan CA, 1999, J SPEECH LANG HEAR R, V42, P1432, DOI 10.1044/jslhr.4206.1432; Dunn L.M., 2007, PEABODY PICTURE VOCA; FRIA TJ, 1985, ARCH OTOLARYNGOL, V111, P10; GRAVEL JS, 1992, J SPEECH HEAR RES, V35, P588, DOI 10.1044/jshr.3503.588; LILDHOLDT T, 1983, ACTA OTO-LARYNGOL, P1; MANDEL EM, 1992, PEDIATR INFECT DIS J, V11, P270, DOI 10.1097/00006454-199204000-00003; MANDEL EM, 1989, ARCH OTOLARYNGOL, V115, P1217; Maw R, 1999, LANCET, V354, P1392; McCarthy D., 1972, MANUAL MCCARTHY SCAL; MILLER JF, 1991, RESEARCH ON CHILD LANGUAGE DISORDERS : A DECADE OF PROGRESS, P211; MILLER JF, 1981, J SPEECH HEAR RES, V24, P154, DOI 10.1044/jshr.2402.154; Paradise J L, 1992, Adv Pediatr, V39, P157; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; PARADISE JL, 1981, PEDIATRICS, V68, P869; Paradise JL, 1999, PEDIATRICS, V104, P1264, DOI 10.1542/peds.104.6.1264; Paradise JL, 2000, PEDIATRICS, V105, P1119, DOI 10.1542/peds.105.5.1119; PARADISE JL, 1977, PEDIATRICS, V60, P86; Paradise JL, 1999, JAMA-J AM MED ASSOC, V282, P945, DOI 10.1001/jama.282.10.945; PAUL R, 1993, J SPEECH HEAR RES, V36, P1055, DOI 10.1044/jshr.3605.1055; ROBERTS JE, 1988, J SPEECH HEAR DISORD, V53, P424, DOI 10.1044/jshd.5304.424; Schilder AGM, 1997, CLIN OTOLARYNGOL, V22, P423, DOI 10.1046/j.1365-2273.1997.00047.x; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; STOOL SE, 1994, AHCPR PUBLICATION	30	142	144	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1179	1187		10.1056/NEJM200104193441601	http://dx.doi.org/10.1056/NEJM200104193441601			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309632				2022-12-28	WOS:000168127600001
J	Wu, JY; Feng, LL; Park, HT; Havlioglu, N; Wen, L; Tang, H; Bacon, KB; Jiang, ZH; Zhang, XC; Rao, Y				Wu, JY; Feng, LL; Park, HT; Havlioglu, N; Wen, L; Tang, H; Bacon, KB; Jiang, ZH; Zhang, XC; Rao, Y			The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors	NATURE			English	Article							AXON GUIDANCE; DROSOPHILA-MELANOGASTER; CELL-MIGRATION; PROTEIN; CHEMOKINES; RECEPTORS; ROUNDABOUT; MIDLINE; SYSTEM; CNS	Migration is a basic feature of many cell types in a wide range of species(1). Since the 1800s, cell migration has been proposed to occur in the nervous and immune systems(2,3), and distinct molecular cues for mammalian neurons and leukocytes have been identified. Here we report that Slit, a secreted protein previously known for its role of repulsion in axon guidance and neuronal migration, can also inhibit leukocyte chemotaxis induced by chemotactic factors. Slit inhibition of the chemokine-induced chemotaxis can be reconstituted by the co-expression of a chemokine receptor containing seven transmembrane domains and Roundabout (Robo), a Slit receptor containing a single transmembrane domain. Thus, there is a functional interaction between single and seven transmembrane receptors. Our results reveal the activity of a neuronal guidance cue in regulating leukocyte migration and indicate that there may be a general conservation of guidance mechanisms underlying metazoan cell migration. In addition, we have uncovered an inhibitor of leukocyte chemotaxis, and propose a new therapeutic approach to treat diseases involving leukocyte migration and chemotactic factors.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; Bayer Yakuhin Ltd, Dept Biol, Kizu, Kyoto, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Bayer AG	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Tang, Hao/G-9841-2011		NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967, R01 GM070967-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Downey GP, 1998, J IMMUNOL, V160, P434; HATTEN ME, 1998, FUNDAMENTAL NEUROSCI, P451; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; OBRIEN PJ, 1984, METHOD ENZYMOL, V105, P370; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	30	337	375	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					948	952		10.1038/35073616	http://dx.doi.org/10.1038/35073616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309622	Green Accepted			2022-12-28	WOS:000168152300051
J	Cohen, I; Li, H; Hougland, JL; Mrksich, M; Nagel, SR				Cohen, I; Li, H; Hougland, JL; Mrksich, M; Nagel, SR			Using selective withdrawal to coat microparticles	SCIENCE			English	Article							ISLETS	We report a method that uses the process of selective withdrawal of one fluid through a second immiscible fluid to coat small particles with polymer films. Fluid is withdrawn through a tube with its orifice slightly above a water-oil interface, Upon increasing the flow rate, there is a transition from a state where only oil is withdrawn to a state where the water, containing the particles to be coated and appropriate prepolymer reagents, is entrained in a thin spout along with the oil. The entrained particles eventually cause the spout interface to break, producing a thin coat of controllable thickness around each particle, which can be subsequently polymerized using chemical reagents, Light, or heat. This method allows flexibility in the chemical composition and thickness of the conformal coatings.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Cohen, I (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Mrksich, Milan/G-2469-2011	Mrksich, Milan/0000-0002-4964-796X; Cohen, Itai/0000-0001-9218-043X; Li, Hui/0000-0003-3139-2898; Hougland, James/0000-0003-0444-1017				BLAKE S, 1986, J VOLCANOL GEOTH RES, V27, P153, DOI 10.1016/0377-0273(86)90084-3; COHEN I, UNPUB; Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Ganan-Calvo AM, 1998, PHYS REV LETT, V80, P285, DOI 10.1103/PhysRevLett.80.285; Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LISTER JR, 1989, J FLUID MECH, V198, P231, DOI 10.1017/S002211208900011X; Mathiowitz E., 1999, ENCY CONTROLLED DRUG; Mendonca AJ, 1999, MED RES REV, V19, P451, DOI 10.1002/(SICI)1098-1128(199909)19:5<451::AID-MED10>3.0.CO;2-B; RAYLEIGH, 1892, PHILOS MAG, V34, P177; SAVART, 1883, ANN CHIM, V53, P337; Shuttleworth SJ, 1997, SYNTHESIS-STUTTGART, P1217; Soon-Shiong P, 1999, ADV DRUG DELIVER REV, V35, P259, DOI 10.1016/S0169-409X(98)00076-3; TIMM EE, 1984, Patent No. 4444961; Umbanhowar PB, 2000, LANGMUIR, V16, P347, DOI 10.1021/la990101e; VALGESAGUILERA O, 1992, MACROMOLECULES, V25, P541; WOLTERS GHJ, 1992, J APPL BIOMATER, V3, P281, DOI 10.1002/jab.770030407; YOSHIOKA T, 1990, BIOTECHNOL BIOENG, V35, P66, DOI 10.1002/bit.260350110	19	139	143	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					265	267		10.1126/science.1059175	http://dx.doi.org/10.1126/science.1059175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303097	Green Submitted			2022-12-28	WOS:000168074000040
J	Greenberg, P				Greenberg, P			Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes	LANCET			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; MARROW-CELLS; EXPRESSION; APOPTOSIS; PROLIFERATION; PHENOTYPE; PROTEINS; DISEASE		Stanford Univ, Med Ctr, Palo Alto VA Hlth Care Syst, Div Hematol, Palo Alto, CA 94304 USA	Stanford University	Greenberg, P (corresponding author), Stanford Univ, Med Ctr, Palo Alto VA Hlth Care Syst, Div Hematol, Palo Alto, CA 94304 USA.							Advani R, 1999, BLOOD, V93, P787, DOI 10.1182/blood.V93.3.787.403k30_787_795; Bouscary D, 1997, LEUKEMIA, V11, P839, DOI 10.1038/sj.leu.2400654; Gersuk GM, 1996, BLOOD, V88, P1122, DOI 10.1182/blood.V88.3.1122b.bloodjournal8831122b; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg P, 1999, BLOOD, V94, p383A; Greenberg PL, 1998, LEUKEMIA RES, V22, P1123, DOI 10.1016/S0145-2126(98)00112-X; Greenberg PL, 1999, HEMATOLOGY BASIC PRI, P1106; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Leith CP, 1999, BLOOD, V94, P1086; LIST AF, 1993, J CLIN ONCOL, V11, P1652, DOI 10.1200/JCO.1993.11.9.1652; LIST AF, 1991, BRIT J HAEMATOL, V78, P28, DOI 10.1111/j.1365-2141.1991.tb04378.x; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Poulain S, 2000, BRIT J HAEMATOL, V110, P591, DOI 10.1046/j.1365-2141.2000.02247.x; Rajapaksa R, 1996, BLOOD, V88, P4275; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Shetty V, 1996, LEUKEMIA RES, V20, P891, DOI 10.1016/S0145-2126(96)00008-2; Shimazaki K, 2000, BRIT J HAEMATOL, V110, P584, DOI 10.1046/j.1365-2141.2000.02228.x; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; SONNEVELD P, 1993, LEUKEMIA, V7, P963; WATTEL E, 2000, BRIT J HAEMATOL, V110, P1015	20	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1059	1060		10.1016/S0140-6736(00)04306-3	http://dx.doi.org/10.1016/S0140-6736(00)04306-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297953				2022-12-28	WOS:000167996200004
J	Strauss, JH; Strauss, EG				Strauss, JH; Strauss, EG			Virus evolution: How does an enveloped virus make a regular structure?	CELL			English	Review							MOLECULAR EVOLUTION; GLYCOPROTEIN; ALPHAVIRUSES; PROTEIN		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Strauss, JH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Fauquet C. M., 2000, VIRUS TAXONOMY; FERIENGHI L, 2001, MOL CELL, V7, P603; KUHN RJ, 1995, NATURE, V375, P275, DOI 10.1038/375275a0; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; STRAUSS EG, 1996, FIELDS VIROLOGY, P153; STRAUSS JH, 1995, TRENDS MICROBIOL, V3, P346, DOI 10.1016/S0966-842X(00)88973-8; TAKEDA N, 1994, J VIROL, V68, P854, DOI 10.1128/JVI.68.2.854-862.1994; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K	16	34	34	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					5	8		10.1016/S0092-8674(01)00291-4	http://dx.doi.org/10.1016/S0092-8674(01)00291-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11300997	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000168063300002
J	Downer, J				Downer, J			A tortured tale of supply and demand	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					624	624		10.1038/35070666	http://dx.doi.org/10.1038/35070666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287919	Bronze			2022-12-28	WOS:000167875400015
J	Druker, BJ; Talpaz, M; Resta, DJ; Peng, B; Buchdunger, E; Ford, JM; Lydon, NB; Kantarjian, H; Capdeville, R; Ohno-Jones, S; Sawyers, CL				Druker, BJ; Talpaz, M; Resta, DJ; Peng, B; Buchdunger, E; Ford, JM; Lydon, NB; Kantarjian, H; Capdeville, R; Ohno-Jones, S; Sawyers, CL			Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; POSITIVE CELLS; CRKL; MICE; TRANSFORMATION; NEUTROPHILS; INDUCTION; BCR/ABL; PROTEIN; GROWTH	Background: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML. Methods: We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase. STI571 was administered orally to 83 patients with CML in the chronic phase in whom treatment with interferon alfa had failed. Patients were successively assigned to 1 of 14 doses ranging from 25 to 1000 mg per day. Results: Adverse effects of STI571 were minimal; the most common were nausea, myalgias, edema, and diarrhea. A maximal tolerated dose was not identified. Complete hematologic responses were observed in 53 of 54 patients treated with daily doses of 300 mg or more and typically occurred in the first four weeks of therapy. Of the 54 patients treated with doses of 300 mg or more, cytogenetic responses occurred in 29, including 17 (31 percent of the 54 patients who received this dose) with major responses (0 to 35 percent of cells in metaphase positive for the Philadelphia chromosome); 7 of these patients had complete cytogenetic remissions. Conclusions: STI571 is well tolerated and has significant antileukemic activity in patients with CML in whom treatment with interferon alfa had failed. Our results provide evidence of the essential role of BCR-ABL tyrosine kinase activity in CML and demonstrate the potential for the development of anticancer drugs based on the specific molecular abnormality present in a human cancer. (N Engl J Med 2001;344:1031-7.) Copyright (C) 2001 Massachusetts Medical Society.	Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Nova Pharmaceut Corp, Dept Oncol Clin Res, E Hanover, NJ USA; Nova Pharmaceut Corp, Dept Oncol Clin Res, Basel, Switzerland; Univ Calif Los Angeles, Div Hematol & Oncol, Los Angeles, CA USA	Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Novartis; Novartis; University of California System; University of California Los Angeles	Druker, BJ (corresponding author), Oregon Hlth Sci Univ, Div Hematol & Med Oncol, L592,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Sawyers, Charles/G-5327-2016	Talpaz, Moshe/0000-0003-3361-3981; Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [R01CA065823, R37CA065823] Funding Source: NIH RePORTER; NCI NIH HHS [CA32727, CA65823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*CANC THER EV PROG, 1998, COMM TOX CRIT; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; DRUKER BJ, 1994, J BIOL CHEM, V269, P5387; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; GambacortiPasserini C, 1997, BLOOD CELL MOL DIS, V23, P380, DOI 10.1006/bcmd.1997.0155; Heaney C, 1997, BLOOD, V89, P297, DOI 10.1182/blood.V89.1.297.297_297_306; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; KELLIHER M, 1990, P NATL ACAD SCI USA, V87, P9072; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KOLIBABA KS, 2000, MEDSCAPE ONCOLOGY, V3; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; NICHOLS GL, 1994, BLOOD, V84, P2912; NOWELL PC, 1960, SCIENCE, V132, P1497; ODA T, 1994, J BIOL CHEM, V269, P22925; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Silver RT, 1999, BLOOD, V94, P1517; TENHOEVE J, 1994, BLOOD, V84, P1731	23	3732	3956	4	365	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1031	1037		10.1056/NEJM200104053441401	http://dx.doi.org/10.1056/NEJM200104053441401			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287972	Bronze			2022-12-28	WOS:000167860400001
J	Druker, BJ; Sawyers, CL; Kantarjian, H; Resta, DJ; Reese, SF; Ford, JM; Capdeville, R; Talpaz, M				Druker, BJ; Sawyers, CL; Kantarjian, H; Resta, DJ; Reese, SF; Ford, JM; Capdeville, R; Talpaz, M			Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; MARROW TRANSPLANTATION; POSITIVE CELLS; RESISTANCE; THERAPY; STI571; MECHANISMS; INDUCTION; BIOLOGY; LINES	Background: BCR-ABL, a constitutively activated tyrosine kinase, is the product of the Philadelphia (Ph) chromosome. This enzyme is present in virtually all cases of chronic myeloid leukemia (CML) throughout the course of the disease, and in 20 percent of cases of acute lymphoblastic leukemia (ALL). On the basis of the substantial activity of the inhibitor in patients in the chronic phase, we evaluated STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase, in patients who had CML in blast crisis and in patients with Ph-chromosome-positive ALL. Methods: In this dose-escalating pilot study, 58 patients were treated with STI571; 38 patients had myeloid blast crisis and 20 had ALL or lymphoid blast crisis. Treatment was given orally at daily doses ranging from 300 to 1000 mg. Results: Responses occurred in 21 of 38 patients (55 percent) with a myeloid-blast-crisis phenotype; 4 of these 21 patients had a complete hematologic response. Of 20 patients with lymphoid blast crisis or ALL, 14 (70 percent) had a response, including 4 who had complete responses. Seven patients with myeloid blast crisis continue to receive treatment and remain in remission from 101 to 349 days after starting the treatment. All but one patient with lymphoid blast crisis or ALL has relapsed. The most frequent adverse effects were nausea, vomiting, edema, thrombocytopenia, and neutropenia. Conclusions: The BCR-ABL tyrosine kinase inhibitor STI571 is well tolerated and has substantial activity in the blast crises of CML and in Ph-chromosome-positive ALL. (N Engl J Med 2001;344:1038-42.) Copyright (C) 2001 Massachusetts Medical Society.	Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; Univ Calif Los Angeles, Div Hematol & Oncol, Los Angeles, CA USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; Nova Pharmaceut Corp, Dept Oncol Clin Res, E Hanover, NJ USA; Nova Pharmaceut Corp, Dept Oncol Clin Res, Basel, Switzerland	Oregon Health & Science University; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Novartis; Novartis	Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, L592,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	drukerb@ohsu.edu	Sawyers, Charles/G-5327-2016	Talpaz, Moshe/0000-0003-3361-3981; Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [P01CA032737, R01CA065823, R37CA065823] Funding Source: NIH RePORTER; NCI NIH HHS [CA32737, CA65823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Buchdunger E, 1996, CANCER RES, V56, P100; Cancer Therapy Evaluation Program, 1998, COMM TOX CRIT VERS 2; Clift RA, 1996, BONE MARROW TRANSPL, V17, pS1; COPELAN EA, 1995, BLOOD, V85, P1151, DOI 10.1182/blood.V85.5.1151.bloodjournal8551151; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Gratwohl A, 1996, BONE MARROW TRANSPL, V17, pS7; KANTARJIAN HM, 1991, CANCER-AM CANCER SOC, V68, P1201, DOI 10.1002/1097-0142(19910915)68:6<1201::AID-CNCR2820680604>3.0.CO;2-1; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Sacchi S, 1999, CANCER-AM CANCER SOC, V86, P2632, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; SPENCER A, 1995, BRIT J HAEMATOL, V91, P2, DOI 10.1111/j.1365-2141.1995.tb05236.x; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; WALTERS RS, 1987, CANCER, V60, P1708, DOI 10.1002/1097-0142(19871015)60:8<1708::AID-CNCR2820600803>3.0.CO;2-1; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; WESTBROOK CA, 1992, BLOOD, V80, P2983	20	2146	2266	0	134	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1038	1042		10.1056/NEJM200104053441402	http://dx.doi.org/10.1056/NEJM200104053441402			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287973				2022-12-28	WOS:000167860400002
J	Schwetz, BA				Schwetz, BA			Artificial skin for grafts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-28	WOS:000167710600005
J	Grubb, NR; Furniss, S				Grubb, NR; Furniss, S			Science, medicine, and the future - Radiofrequency ablation for atrial fibrillation	BRITISH MEDICAL JOURNAL			English	Review							CATHETER ABLATION; MAZE PROCEDURE; VENA-CAVA; EXPERIENCE; FLUTTER; CARDIOVERSION; FRAMINGHAM; INITIATION; OUTCOMES; ISTHMUS		Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland; Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Royal Infirmary of Edinburgh; University of Edinburgh; Newcastle Freeman Hospital; Newcastle University - UK	Grubb, NR (corresponding author), Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH3 9YW, Midlothian, Scotland.							ARNOLD AZ, 1992, J AM COLL CARDIOL, V19, P851, DOI 10.1016/0735-1097(92)90530-Z; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COSIO FG, 1993, AM J CARDIOL, V71, P705, DOI 10.1016/0002-9149(93)91014-9; COUMEL P, 1983, PACE, V6, P552, DOI 10.1111/j.1540-8159.1983.tb05295.x; Cox JL, 1999, J THORAC CARDIOV SUR, V118, P833, DOI 10.1016/S0022-5223(99)70052-8; COX JL, 1993, ANN THORAC SURG, V56, P814, DOI 10.1016/0003-4975(93)90338-I; Delfaut P, 1997, Semin Interv Cardiol, V2, P219; DOMANSKI MJ, 1995, CORONARY ARTERY DIS, V6, P95, DOI 10.1097/00019501-199502000-00002; Fitzpatrick AP, 1996, AM HEART J, V131, P499, DOI 10.1016/S0002-8703(96)90528-1; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Haissaguerre M, 1996, J CARDIOVASC ELECTR, V7, P1132, DOI 10.1111/j.1540-8167.1996.tb00492.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Maloney JD, 1998, PACE, V21, P2527, DOI 10.1111/j.1540-8159.1998.tb01213.x; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Nabar A, 1999, CIRCULATION, V99, P1441, DOI 10.1161/01.CIR.99.11.1441; NATALE A, 1994, AM J CARDIOL, V74, P242; Robbins IM, 1998, CIRCULATION, V98, P1769, DOI 10.1161/01.CIR.98.17.1769; SAKSENA S, 1995, AM J CARDIOL, V76, P913, DOI 10.1016/S0002-9149(99)80261-6; *SCOTT IUT GUID NE, 1999, ANT THER NAT CLIN GU; Tieleman RG, 1998, J AM COLL CARDIOL, V31, P167, DOI 10.1016/S0735-1097(97)00455-5; Tsai CF, 1999, J CARDIOVASC ELECTR, V10, P27, DOI 10.1111/j.1540-8167.1999.tb00638.x; Tsai CF, 2000, CIRCULATION, V102, P67, DOI 10.1161/01.CIR.102.1.67; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138	24	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					777	780		10.1136/bmj.322.7289.777	http://dx.doi.org/10.1136/bmj.322.7289.777			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282867	Green Published			2022-12-28	WOS:000167943200030
J	Vazquez, M; LaRussa, PS; Gershon, AA; Steinberg, SP; Freudigman, K; Shapiro, ED				Vazquez, M; LaRussa, PS; Gershon, AA; Steinberg, SP; Freudigman, K; Shapiro, ED			The effectiveness of the varicella vaccine in clinical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTHY-CHILDREN; FOLLOW-UP; EFFICACY; POSTLICENSURE	Background: A live attenuated varicella vaccine was approved for use in the United States in March 1995 and is recommended for all susceptible persons 12 months of age or older. Methods: To assess the effectiveness of the varicella vaccine, we conducted a case-control study with two controls per child with chickenpox, matched according to both age and pediatric practice. Children with potential cases of chickenpox were identified by active surveillance of pediatric practices in the New Haven, Connecticut, area. Research assistants visited the children on day 3, 4, or 5 of the illness, assessed the severity of the illness, and collected samples from lesions to test for varicella-zoster virus by the polymerase chain reaction (PCR). Results: From March 1997 through November 2000, data collection was completed for 330 potential cases, of which 243 (74 percent) were in children who had positive PCR tests for varicella-zoster virus. Of the 56 vaccinated children with chickenpox, 86 percent had mild disease, whereas only 48 percent of the 187 unvaccinated children with chickenpox had mild disease (P<0.001). Among the 202 children with PCR-confirmed varicella-zoster virus and their 389 matched controls, 23 percent of the children with chickenpox and 61 percent of the matched controls had received the vaccine (vaccine effectiveness, 85 percent; 95 percent confidence interval, 78 to 90 percent; P<0.001). Against moderately severe and severe disease the vaccine was 97 percent effective (95 percent confidence interval, 93 to 99 percent). The effectiveness of the vaccine was virtually unchanged (87 percent) after adjustment for potential confounders by means of conditional logistic regression. Conclusions: Varicella vaccine is highly effective as used in clinical practice. (N Engl J Med 2001;344:955-60.) Copyright (C) 2001 Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Childrens Clin Res Ctr, New Haven, CT 06520 USA; Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY USA	Yale University; Yale University; Yale University; Columbia University	Shapiro, ED (corresponding author), Yale Univ, Sch Med, Dept Pediat, POB 208064, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024021, K24AI001703, R01AI041608] Funding Source: NIH RePORTER; NIAID NIH HHS [K24-AI01703, R01-AI24021, R01-AI41608] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; Asano Y, 1996, J INFECT DIS, V174, pS310, DOI 10.1093/infdis/174.Supplement_3.S310; ASANO Y, 1994, PEDIATRICS, V94, P524; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; CLEMENS JD, 1984, REV INFECT DIS, V6, P589; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; CLEMENTS DA, 1995, PEDIATR INFECT DIS J, V14, P874, DOI 10.1097/00006454-199510000-00011; *CYT SOFTW, 1999, EGRET WIND SOFTW AN; GERSHON AA, 1984, JAMA-J AM MED ASSOC, V252, P355, DOI 10.1001/jama.252.3.355; GUSTAFSON TL, 1994, TRUE EPISTAT MANUAL; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Johnson CE, 1997, PEDIATRICS, V100, P761, DOI 10.1542/peds.100.5.761; KUTER BJ, 1991, VACCINE, V9, P643, DOI 10.1016/0264-410X(91)90189-D; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Schaffer SJ, 1999, ARCH PEDIAT ADOL MED, V153, P357; SELVIN S, 1996, MONOGRAPHS EPIDEMIOL, V25; Seward J, 2000, PEDIATR RES, V47, p276A; *SPSS, 1999, SPSS WIND REL 10 0 U; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; WEIBEL RE, 1985, JAMA-J AM MED ASSOC, V254, P2435, DOI 10.1001/jama.254.17.2435	21	261	281	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					955	960		10.1056/NEJM200103293441302	http://dx.doi.org/10.1056/NEJM200103293441302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274621	Bronze			2022-12-28	WOS:000167716600002
J	Broze, GJ				Broze, GJ			Protein-Z and thrombosis	LANCET			English	Editorial Material							ISCHEMIC STROKE; FACTOR-V; PLASMA; INHIBITOR; DIFFERENCE; BOVINE		Washington Univ, Med Ctr, Barnes Jewish Hosp, Dept Internal Med,Div Haematol, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL)	Broze, GJ (corresponding author), Washington Univ, Med Ctr, Barnes Jewish Hosp, Dept Internal Med,Div Haematol, St Louis, MO 63110 USA.							BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; GOODNIGHT SH, 2001, WILLIAMS HEMATOLOGY, P1697; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; HOGG PJ, 1991, BIOCHEM BIOPH RES CO, V178, P801, DOI 10.1016/0006-291X(91)90962-7; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; Kemkes-Matthes B, 2000, BLOOD, V96, p534A; Margaglione M, 1999, ARTERIOSCL THROM VAS, V19, P1751, DOI 10.1161/01.ATV.19.7.1751; MILETICH JP, 1987, BLOOD, V69, P1580; Nowak-Gottl U, 1999, BLOOD, V94, P3678, DOI 10.1182/blood.V94.11.3678.423k34_3678_3682; PROWSE CV, 1977, BIOCHEM SOC T, V5, P255, DOI 10.1042/bst0050255; SEJIMA H, 1990, BIOCHEM BIOPH RES CO, V171, P661, DOI 10.1016/0006-291X(90)91197-Z; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897	14	19	21	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					900	901		10.1016/S0140-6736(00)04229-X	http://dx.doi.org/10.1016/S0140-6736(00)04229-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289341				2022-12-28	WOS:000167625300003
J	Ray, RP; Wharton, KA				Ray, RP; Wharton, KA			Twisted perspective: New insights into extracellular modulation of BMP signaling during development	CELL			English	Review							DROSOPHILA EMBRYO; GASTRULATION; HEDGEHOG; FATE; WNT; DPP; SOG		Brown Univ, Dept Biochem Mol Biol & Cell Biol, Div Biol & Med, Providence, RI 02912 USA	Brown University	Wharton, KA (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, Div Biol & Med, Box G-J160, Providence, RI 02912 USA.							Capdevila J, 1999, CURR OPIN GENET DEV, V9, P427, DOI 10.1016/S0959-437X(99)80065-3; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mullins MC, 1998, TRENDS GENET, V14, P127, DOI 10.1016/S0168-9525(98)01431-0; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; RAY RP, 1991, DEVELOPMENT, V113, P35; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Yu K, 2000, DEVELOPMENT, V127, P2143	17	33	33	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					801	804		10.1016/S0092-8674(01)00275-6	http://dx.doi.org/10.1016/S0092-8674(01)00275-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290316	Bronze			2022-12-28	WOS:000167869200001
J	Greene, M				Greene, M			A tool, not a tyrant	NATURE			English	Editorial Material									Univ Puget Sound, Tacoma, WA 98416 USA		Greene, M (corresponding author), Univ Puget Sound, Tacoma, WA 98416 USA.			Greene, Mott/0000-0002-4864-1806				BRIDGMAN PG, 1927, LOGIC MODERN PHYSICS; FEYNMAN RP, 1965, CHARACTER PHYSICAL L	2	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					875	875		10.1038/35073715	http://dx.doi.org/10.1038/35073715			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309595	Bronze			2022-12-28	WOS:000168152300026
J	Uji, S; Shinagawa, H; Terashima, T; Yakabe, T; Terai, Y; Tokumoto, M; Kobayashi, A; Tanaka, H; Kobayashi, H				Uji, S; Shinagawa, H; Terashima, T; Yakabe, T; Terai, Y; Tokumoto, M; Kobayashi, A; Tanaka, H; Kobayashi, H			Magnetic-field-induced superconductivity in a two-dimensional organic conductor	NATURE			English	Article								The application of a sufficiently strong magnetic field to a superconductor will, in general, destroy the superconducting state. Two mechanisms are responsible for this. The first is the Zeeman effect(1,2), which breaks apart the paired electrons if they are in a spin-singlet (but not a spin-triplet) state. The second is the so-called 'orbital' effect, whereby the vortices penetrate into the superconductors and the energy gain due to the formation of the paired electrons is lost(3). For the case of layered, two-dimensional superconductors, such as the high-T-c copper oxides, the orbital effect is reduced when the applied magnetic field is parallel to the conducting layers(4). Here we report resistance and magnetic-torque experiments on single crystals of the quasi-two-dimensional organic conductor lambda-(BETS)(2) FeCl4, where BETS is bis(ethylenedithio)tetraselenafulvalene(5-8). We find that for magnetic fields applied exactly parallel to the conducting layers of the crystals, superconductivity is induced for fields above 17 T at a temperature of 0.1 K. The resulting phase diagram indicates that the transition temperature increases with magnetic field, that is, the superconducting state is further stabilized with magnetic field.	Natl Res Inst Met, Tsukuba, Ibaraki 3050003, Japan; Electrotech Lab, Tsukuba, Ibaraki 3058568, Japan; Univ Tokyo, Grad Sch Sci, Res Ctr Spectrochem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	National Institute for Materials Science; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Uji, S (corresponding author), Natl Res Inst Met, Tsukuba, Ibaraki 3050003, Japan.		TERASHIMA, Taichi/H-2824-2011; UJI, Shinya/H-2818-2011; Tanaka, Hisashi/F-8212-2017; YAKABE, Taro/H-2558-2011	TERASHIMA, Taichi/0000-0001-9239-0621; UJI, Shinya/0000-0001-9351-6388; Tanaka, Hisashi/0000-0003-0604-5528; YAKABE, Taro/0000-0002-2244-5890				Akutsu H, 1997, J AM CHEM SOC, V119, P12681, DOI 10.1021/ja9733853; BROOKS JS, 1987, REV SCI INSTRUM, V58, P117, DOI 10.1063/1.1139552; Brossard L, 1998, EUR PHYS J B, V1, P439, DOI 10.1007/s100510050207; DUPUIS N, 1993, PHYS REV LETT, V70, P2613, DOI 10.1103/PhysRevLett.70.2613; JACCARINO V, 1962, PHYS REV LETT, V9, P290, DOI 10.1103/PhysRevLett.9.290; KLEMM RA, 1975, PHYS REV B, V12, P877, DOI 10.1103/PhysRevB.12.877; Kobayashi H, 1997, PHYS REV B, V56, pR8526, DOI 10.1103/PhysRevB.56.R8526; Kobayashi H, 1996, J AM CHEM SOC, V118, P368, DOI 10.1021/ja9523350; LEBED AG, 1986, JETP LETT+, V44, P114, DOI 10.1007/BF00660351; MEUL HW, 1984, PHYS REV LETT, V53, P497, DOI 10.1103/PhysRevLett.53.497; Miyazaki M, 1998, J PHYS SOC JPN, V67, P2618, DOI 10.1143/JPSJ.67.2618; SadeMelo CAR, 1996, PHYSICA C, V260, P224, DOI 10.1016/0921-4534(96)00105-0; Shimahara H, 2000, J PHYS SOC JPN, V69, P1966, DOI 10.1143/JPSJ.69.1966; Tanatar MA, 1999, J SUPERCOND, V12, P511, DOI 10.1023/A:1007728000531; Tinkham M., 1975, INTRO SUPERCONDUCTIV	17	603	612	6	123	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					908	910		10.1038/35073531	http://dx.doi.org/10.1038/35073531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309610				2022-12-28	WOS:000168152300039
J	Hergott, LJ				Hergott, LJ			Lost in a dark wood - How wisdom sources can light the way	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Hergott LJ, 1998, ANN INTERN MED, V128, P149, DOI 10.7326/0003-4819-128-2-199801150-00013; Keen Sam, 1991, FIRE BELLY BEING MAN	3	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1938	1939		10.1001/jama.285.15.1938	http://dx.doi.org/10.1001/jama.285.15.1938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308413				2022-12-28	WOS:000167995900001
J	Altman, DG; Schulz, KF; Moher, D; Egger, M; Davidoff, F; Elbourne, D; Gotzsche, PC; Lang, T				Altman, DG; Schulz, KF; Moher, D; Egger, M; Davidoff, F; Elbourne, D; Gotzsche, PC; Lang, T		CONSORT Grp	The revised CONSORT statement for reporting randomized trials: Explanation and elaboration	ANNALS OF INTERNAL MEDICINE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOGISTIC-REGRESSION MODELS; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; CLINICAL-TRIALS; DOUBLE-BLIND; STATISTICS NOTES; CONFIDENCE-INTERVALS; INTERIM ANALYSES; TREAT ANALYSIS	Overwhelming evidence now indicates that the quality of reporting of randomized, controlled trials (RCTs) is less than optimal. Recent methodologic analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which boast the elimination of systematic error as their primary hallmark. Systematic error in RCTs reflects poor science, and poor science threatens proper ethical standards. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have adopted the CONSORT statement. The CONSORT statement facilitates critical appraisal and interpretation of RCTs by providing guidance to authors about how to improve the reporting of their trials. This explanatory and elaboration document is intended to enhance the use, understanding, and dissemination of the CONSORT statement. The meaning and rationale for each checklist item are presented. For most items, at least one published example of good reporting and, where possible, references to relevant empirical studies are provided. Several examples of flow diagrams are included. The CONSORT statement, this explanatory and elaboration document, and the associated Web site (http://www.consort -statement.org) should be helpful resources to improve reporting of randomized trials.	Imperial Canc Res Fund, Med Stat Grp, Oxford, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England; Univ Bristol, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England; London Sch Hyg & Trop Med, London WC1, England; Family Hlth Int, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Thomas C Chalmers Ctr Systemat Reviews, Ottawa, ON, Canada; Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA USA; Nord Cochrane Ctr, Copenhagen, Denmark; Tom Lang Commun, Lakewood, CO USA	University of Oxford; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; American College of Physicians	Altman, DG (corresponding author), Childrens Hosp Eastern Ontario, Thomas C Chalmers Ctr Systemat Reviews, Res Inst, Room R235,401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.		Lang, Tom/AAN-9087-2020	Lang, Tom/0000-0002-7482-7727; Egger, Matthias/0000-0001-7462-5132; Moher, David/0000-0003-2434-4206				Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Ah-See KW, 1998, J LARYNGOL OTOL, V112, P460, DOI 10.1017/S0022215100140770; Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; ALTMAN DG, 1991, BRIT MED J, V302, P1481, DOI 10.1136/bmj.302.6791.1481; Altman DG, 1996, BRIT MED J, V313, P570; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 1997, BRIT MED J, V314, P1874, DOI 10.1136/bmj.314.7098.1874; ALTMAN DG, 1994, NEW ENGL J MED, V330, P1758, DOI 10.1056/NEJM199406163302415; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; ALTMAN DG, 2000, STAT CONFIDENCE CONF, P171; ALTMAN DG, 2000, STAT CONFIDENCE CONF, P6; ALTMAN DG, 2000, STAT CONFIDENCE, P120; Altman DG, 1998, ENCY BIOSTATISTICS, P1000; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1986, LANCET, V2, P57; [Anonymous], 1998, NED TIJDSCHR GENEES, V142, P1089; [Anonymous], 1948, BMJ, V2, P769; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Ausejo M, 1998, Aten Primaria, V21, P351; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bender R, 1996, BRIT MED J, V313, P628; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; BERRY DA, 1985, STAT MED, V4, P521, DOI 10.1002/sim.4780040412; Bland JM, 1997, BRIT MED J, V314, P1907, DOI 10.1136/bmj.314.7098.1907a; Bolliger CT, 2000, BMJ-BRIT MED J, V321, P329, DOI 10.1136/bmj.321.7257.329; Bolton S, 1998, J CLIN PHARMACOL, V38, P408, DOI 10.1002/j.1552-4604.1998.tb04444.x; Bove G, 1998, JAMA-J AM MED ASSOC, V280, P1576, DOI 10.1001/jama.280.18.1576; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; BUYSE M, 1993, STAT MED, V12, P509, DOI 10.1002/sim.4780120517; CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Carley SD, 2000, BMJ-BRIT MED J, V321, P20, DOI 10.1136/bmj.321.7252.20; Chalmers I, 1997, J ROY SOC MED, V90, P379; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Cheng K, 2000, PEDIATR PULM, V29, P1; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006; *COCHR COLL, 2000, COCHR LIB ISS 1; COCHRANE AL, 1972, EFFECTIVENESS EFFICI, P2; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; Dammers JWHH, 1999, BRIT MED J, V319, P884, DOI 10.1136/bmj.319.7214.884; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; DAVEYSMITH G, 1994, BRIT MED J, V308, P72; Davidoff F, 2000, ANN INTERN MED, V133, P229, DOI 10.7326/0003-4819-133-3-200008010-00017; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Docherty M, 1999, BRIT MED J, V318, P1224; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Egger M., 2008, SYSTEMATIC REV HLTH; Enas GG, 1990, DRUG INF J, V24, P541, DOI DOI 10.1177/009286159002400312; FACKLER ML, 1994, ANN INTERN MED, V121, P894, DOI 10.7326/0003-4819-121-11-199412010-00015; FANAROFF AA, 1994, NEW ENGL J MED, V330, P1107, DOI 10.1056/NEJM199404213301602; FIELDS WS, 1970, J AMER MED ASSOC, V211, P1993, DOI 10.1001/jama.211.12.1993; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; Galgiani JN, 2000, ANN INTERN MED, V133, P676, DOI 10.7326/0003-4819-133-9-200011070-00009; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GORE SM, 1977, BRIT MED J, V1, P85, DOI 10.1136/bmj.1.6053.85; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; GOTZSCHE PC, 1995, BRIT MED J, V310, P1495, DOI 10.1136/bmj.310.6993.1495; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Haag U, 1998, DRUG INF J, V32, P7, DOI 10.1177/009286159803200102; Haderslev KV, 2000, GASTROENTEROLOGY, V119, P639, DOI 10.1053/gast.2000.16518; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; HALL JC, 1982, AUST NZ J SURG, V52, P541, DOI 10.1111/j.1445-2197.1982.tb06050.x; Hall JC, 1996, SURGERY, V119, P466, DOI 10.1016/S0039-6060(96)80149-8; Hartley J, 1996, J INFORM SCI, V22, P349, DOI 10.1177/016555159602200503; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; Heit JA, 2000, ANN INTERN MED, V132, P853, DOI 10.7326/0003-4819-132-11-200006060-00002; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; HORTON R, 1995, BRIT MED J, V310, P985, DOI 10.1136/bmj.310.6985.985; Huston P, 1996, CAN MED ASSOC J, V155, P1277; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; JADAD AR, 1999, AHRQ PUBLICATION; JUNI P, IN PRESS BMJ; JUNI P, 2001, SYSTEMATIC REV HLTH; Junker CA, 1998, JAMA-J AM MED ASSOC, V280, P247, DOI 10.1001/jama.280.3.247; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; Khan KS, 1999, OBSTET GYNECOL, V93, P1014, DOI 10.1016/S0029-7844(98)00537-7; Kiviluoto T, 1998, LANCET, V351, P321, DOI 10.1016/S0140-6736(97)08447-X; Kjaergard L, 1999, WORKSH SCI SESS 7 IN; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; KLEIJNEN J, 1997, NONRADOM REFLECTIONS; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lachin JL, 2000, CONTROL CLIN TRIALS, V21, P526, DOI 10.1016/S0197-2456(00)00092-1; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; LANG T, 2000, MEDGENMED, pE25; LANG TA, 1997, REPORT STAT MED ANNO; Lao LX, 1999, ARCH OTOLARYNGOL, V125, P567, DOI 10.1001/archotol.125.5.567; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; Lefebvre C, 2001, SYSTEMATIC REV HLTH, P69; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; LEWIS JA, 1993, BRIT J CANCER, V68, P647, DOI 10.1038/bjc.1993.402; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; Matthews JNS, 1996, BRIT MED J, V313, P808; Matthews JNS, 1996, BRIT MED J, V313, P862; MAY GS, 1981, CIRCULATION, V64, P669, DOI 10.1161/01.CIR.64.4.669; McALISTER FA, 2001, SYSTEMATIC REV HLTH; McDowell I., 1996, MEASURING HLTH GUIDE; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Meinert CL., 1986, CLIN TRIALS DESIGN C; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, IN PRESS LANCET; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; Murray GD, 2000, STAT METHODS MED RES, V9, P17, DOI 10.1191/096228000670253839; Nacul LC, 1997, BMJ-BRIT MED J, V315, P505, DOI 10.1136/bmj.315.7107.505; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; NICOLUCCI A, 1989, JAMA-J AM MED ASSOC, V262, P2101, DOI 10.1001/jama.262.15.2101; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; POCOCK SJ, 1982, STATISTICIAN, V31, P1; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Prasad AS, 2000, ANN INTERN MED, V133, P245, DOI 10.7326/0003-4819-133-4-200008150-00006; Purcell GP, 1998, JAMA-J AM MED ASSOC, V280, P227, DOI 10.1001/jama.280.3.227; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; Roberts C, 1999, STAT MED, V18, P2605, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2605::AID-SIM237>3.0.CO;2-N; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; Sadler LC, 2000, BRIT J OBSTET GYNAEC, V107, P909, DOI 10.1111/j.1471-0528.2000.tb11091.x; Sanders C, 1998, BRIT MED J, V317, P1191, DOI 10.1136/bmj.317.7167.1191; Sandler AD, 1999, NEW ENGL J MED, V341, P1801, DOI 10.1056/NEJM199912093412404; Saunders M, 1997, LANCET, V350, P161, DOI 10.1016/S0140-6736(97)06305-8; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Schachter HM, 2000, EFFICACY SAFETY METH; SCHOR S, 1966, J AMER MED ASSOC, V195, P1123, DOI 10.1001/jama.195.13.1123; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Schulz KF, 1998, CLIN OBSTET GYNECOL, V41, P245, DOI 10.1097/00003081-199806000-00005; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 1996, LANCET, V348, P596, DOI 10.1016/S0140-6736(96)01201-9; Schulz KF, 1996, BRIT MED J, V312, P742; Senn S. J., 1995, Clinical Research and Regulatory Affairs, V12, P171, DOI 10.3109/10601339509019426; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; Shapiro SH, 2000, J CLIN EPIDEMIOL, V53, P973, DOI 10.1016/S0895-4356(00)00227-4; SHEINER LB, 1995, CLIN PHARMACOL THER, V57, P6, DOI 10.1016/0009-9236(95)90260-0; SHUSTER JJ, 1991, J CLIN ONCOL, V9, P191, DOI 10.1200/JCO.1991.9.1.191; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; SINEI SKA, 1990, BRIT J OBSTET GYNAEC, V97, P412, DOI 10.1111/j.1471-0528.1990.tb01828.x; SONIS J, 1994, J FAM PRACTICE, V39, P225; Staquet M, 1996, QUAL LIFE RES, V5, P496, DOI 10.1007/BF00540022; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; Taylor MA, 2000, BMJ-BRIT MED J, V321, P471, DOI 10.1136/bmj.321.7259.471; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; Treasure T, 1998, BRIT MED J, V317, P362; Tu DS, 2000, DRUG INF J, V34, P511, DOI 10.1177/009286150003400220; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; TYSON JE, 1983, J PEDIATR-US, V102, P10, DOI 10.1016/S0022-3476(83)80277-7; van Loon AJ, 1997, LANCET, V350, P1799, DOI 10.1016/S0140-6736(97)05431-7; vanZanten SJOV, 1996, AM J GASTROENTEROL, V91, P660; WILLIAMS DH, 1994, CONTROL CLIN TRIALS, V15, P294, DOI 10.1016/0197-2456(94)90045-0; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; 2001, ANN INTERNAL MED	204	2795	2872	2	148	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					663	694		10.7326/0003-4819-134-8-200104170-00012	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00012			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304107				2022-12-28	WOS:000168177500006
J	Rathore, SS; Weinfurt, KP; Gersh, BJ; Oetgen, WJ; Schulman, KA; Solomon, AJ				Rathore, SS; Weinfurt, KP; Gersh, BJ; Oetgen, WJ; Schulman, KA; Solomon, AJ			Treatment of patients with myocardial infarction who present with a paced rhythm	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTROCARDIOGRAPHIC DIAGNOSIS; MEDICARE; OUTCOMES; PACEMAKERS; HOSPITALS; RISK; CARE	Background: A paced rhythm can mask the electrocardiographic features of an acute myocardial infarction, complicating timely recognition and treatment. Objective: To evaluate characteristics, treatment, and outcomes among patients presenting with paced rhythms during myocardial infarction. Design: Retrospective cohort study. Setting: U.S. acute care hospitals. Patients: 102 249 Medicare beneficiaries at least 65 years of age who were treated for acute myocardial infarction between 1994 and 1996. Measurements: Provision of three treatments for acute myocardial infarction (emergent reperfusion, aspirin, and beta -blockers), death at 30 days, and long-term follow-up. Results: 1954 patients (1.9%) presented with paced rhythms during myocardial infarction. These patients were older; were predominantly male; and had higher rates of congestive heart failure, diabetes, and previous infarction. They were significantly less likely to receive emergent reperfusion (relative risk [RR], 0.27 [95% Cl, 0.22 to 0.33]), aspirin (88 at admission, 0.91 [Cl, 0.88 to 0.94]; RR at discharge, 0.87 [Cl, 0.83 to 0.92]), and beta -blockers at admission (RR, 0.89 [Cl, 0.82 to 0.96]). In addition, there was a trend toward decreased use of beta -blockers at discharge (RR, 0.91 [Cl, 0.76 to 1.06]). Crude mortality rates were higher among patients with paced rhythms than among those without at 30 days (25.8% vs. 21.3%; P = 0.001) and at 1 year (47.1% vs. 36.1%; P = 0.001). Among patients with paced rhythms, risk for death at 30 days decreased after adjustment for illness severity and decreased use of therapy (RR, 1.03 [Cl, 0.93 to 1.14]). Patients with paced rhythms remained at additional risk for long-term mortality (hazard ratio, 1.12 [Cl, 1.06 to 1.18]). Conclusions: Patients with paced rhythms were less likely than those without to receive treatment for acute myocardial infarction and had poorer short- and long-term outcomes. However, this mortality risk diminished after adjustment for treatment This suggests that improved recognition and treatment of myocardial infarction may improve outcomes, particularly in the short term.	Georgetown Univ, Med Ctr, Div Cardiol, Washington, DC 20007 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Maryland HealthCare Associates, Clinton, MD USA; Delmarva Fdn Med Care, Easton, MD USA	Georgetown University; Duke University; Mayo Clinic	Solomon, AJ (corresponding author), Georgetown Univ, Med Ctr, Div Cardiol, Room M4222,3800 Reservoir Rd NW, Washington, DC 20007 USA.	solomona@gunet.georgetown.edu			PHS HHS [500-96-P623, 500-96-P624] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALI M, 1978, ARCH INTERN MED, V138, P1534, DOI 10.1001/archinte.138.10.1534; Barold S S, 1987, Cardiol Clin, V5, P403; BATHEN J, 1973, BRIT HEART J, V35, P1336; Bernstein AD, 1996, AM J CARDIOL, V78, P187, DOI 10.1016/S0002-9149(96)90394-X; *COMM PROF HOSP AC, 1991, INT CLASS DIS 9 REV; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kozlowski FH, 1998, ACAD EMERG MED, V5, P52, DOI 10.1111/j.1553-2712.1998.tb02575.x; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; *NAT RES POL CTR L, 1996, GUID OP AOAS DEF RUR; Rathore SS, 2000, J AM COLL CARDIOL, V35, p396A; Rosner MH, 1999, AM J EMERG MED, V17, P182, DOI 10.1016/S0735-6757(99)90058-X; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Sgarbossa EB, 1996, AM J CARDIOL, V77, P423, DOI 10.1016/S0002-9149(97)89377-0; Shlipak MG, 2000, J AM COLL CARDIOL, V36, P706, DOI 10.1016/S0735-1097(00)00789-0; SMITH EE, 1995, ANN EMERG MED, V25, P274, DOI 10.1016/S0196-0644(95)70342-X; *US CENS BUR, 1992, 1990 CENS POP HOUS; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	20	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					644	651		10.7326/0003-4819-134-8-200104170-00009	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304104				2022-12-28	WOS:000168177500003
J	Lescar, J; Roussel, A; Wien, MW; Navaza, J; Fuller, SD; Wengler, G; Wengler, G; Rey, FA				Lescar, J; Roussel, A; Wien, MW; Navaza, J; Fuller, SD; Wengler, G; Wengler, G; Rey, FA			The fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH	CELL			English	Article							BORNE ENCEPHALITIS-VIRUS; RECOMBINANT SUBVIRAL PARTICLES; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; SPIKE PROTEIN; RECEPTOR-BINDING; ORGANIZATION; COMPLEX; MODEL; HEMAGGLUTININ	Semliki Forest virus (SFV) has been extensively studied as a model for analyzing entry of enveloped viruses into target cells. Here we describe the trace of the polypeptide chain of the SFV fusion glycoprotein, E1, derived from an electron density map at 3.5 Angstrom resolution and describe its interactions at the surface of the virus. E1 is unexpectedly similar to the flavivirus envelope protein, with three structural domains disposed in the same primary sequence arrangement. These results introduce a new class of membrane fusion proteins which display lateral interactions to induce the necessary curvature and direct budding of closed particles. The resulting surface protein lattice is primed to cause membrane fusion when exposed to the acidic environment of the endosome.	CNRS, Lab Genet Virus, UPR 9053, F-91198 Gif Sur Yvette, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Giessen, Inst Virol, D-35392 Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Synchrotron Radiation Facility (ESRF); University of Oxford; Wellcome Centre for Human Genetics; Justus Liebig University Giessen	Rey, FA (corresponding author), CNRS, Lab Genet Virus, UPR 9053, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	rey@gv.cnrs-gif.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988				ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ALLISON SL, 2001, IN PRESS J VIROL; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth BU, 1997, J VIROL, V71, P7857, DOI 10.1128/JVI.71.10.7857-7865.1997; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHENG RH, 1995, CELL, V80, P621; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DUFFUS WA, 1995, J VIROL, V69, P2471, DOI 10.1128/JVI.69.4.2471-2479.1995; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; GAROFF H, 1994, ARCH VIROL, P329; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Harrison S. C., 1986, TOGAVIRIDAE FLAVIVIR, P21; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HELENIUS A, 1976, BIOCHIM BIOPHYS ACTA, V436, P895, DOI 10.1016/0005-2736(76)90421-1; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MATHIEU M, 2001, IN PRESS EMBO J; NAVAZA J, 1987, ACTA CRYSTALLOGR A, V43, P645, DOI 10.1107/S0108767387098787; OMAR A, 1988, VIROLOGY, V166, P17, DOI 10.1016/0042-6822(88)90141-9; OTWINOWSKI Z, 1996, METHOD ENZYMOL, P307; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RICE CM, 1996, VIROLOGY, P931; Rothman JE, 1996, PROTEIN SCI, V5, P185; ROUSSEL A, 1991, SILICON GRAPHICS GEO; RUMENAPF T, 1995, J VIROL, V69, P1741; RUSSELL PK, 1980, TOGAVIRUSES, P501; SCHLESINGER S, 1996, VIROLOGY, P825; Sheehan B, 1996, J STRUCT BIOL, V116, P99, DOI 10.1006/jsbi.1996.0017; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K	57	411	426	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					137	148		10.1016/S0092-8674(01)00303-8	http://dx.doi.org/10.1016/S0092-8674(01)00303-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301009	Bronze			2022-12-28	WOS:000168063300014
J	Kassirer, JP				Kassirer, JP			Pseudoaccountability	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMERICAN-BOARD; OF-INTEREST; CERTIFICATION; POLICIES	The public has long entrusted the medical profession to regulate its own practices, but our efforts to do so have been uneven. In place of rigorous, enforceable standards, we have sometimes reverted to pseudoaccountability: weak regulations that only give the appearance that we have been responsible in setting and enforcing high standards, We have failed to deal effectively with substandard practitioners, lagged in preventing medical errors, inadequately documented patient care in the medical record, slipped up in protecting patients in clinical research projects, and accepted financial arrangements with industry that may affect our judgment. In response, government has intervened, and threatens to intervene further with regulations that sometimes are excessively intrusive and cumbersome. To preserve our remaining autonomy, we must show that we are serious about protecting the public. Professional membership organizations must stop promulgating weak guidelines and offering evaluative methods to assess and regulate their own coveted members. Instead, they must turn over assessment of their members to arm's-length, disinterested groups. Regulatory programs must have provisions with impeccable standards, surveillance processes, and methods to deal with infractions. In planning new self-regulatory approaches, we should invite open discussion and genuine involvement by independent members of the public or the government to help ensure that our decisions about standard setting are not self-serving. Our profession has already lost much authority. We can ill afford to lose more.	Tufts Univ, Sch Med, Off Dean, Boston, MA 02111 USA; Yale Univ, Sch Med, New Haven, CT USA	Tufts University; Yale University	Kassirer, JP (corresponding author), Tufts Univ, Sch Med, Off Dean, 136 Harrison Ave, Boston, MA 02111 USA.							Applebaum Richard, 1999, AM PROSPECT, V46, P71; BOLES T, 1999, MONEY MARKETING 0923, P28; IGLEHART JK, 1991, NEW ENGL J MED, V325, P1820, DOI 10.1056/NEJM199112193252523; Kassirer JP, 1997, NEW ENGL J MED, V337, P338, DOI 10.1056/NEJM199707313370509; Kassirer JP, 1998, NEW ENGL J MED, V339, P1697, DOI 10.1056/NEJM199812033392308; Lo B, 2000, NEW ENGL J MED, V343, P1616, DOI 10.1056/NEJM200011303432206; Martin JB, 2000, NEW ENGL J MED, V343, P1646, DOI 10.1056/NEJM200011303432213; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; NORCINI JJ, 1987, J MED EDUC, V62, P457; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; RELMAN AS, 1992, NEW ENGL J MED, V327, P1522, DOI 10.1056/NEJM199211193272112; SCHUMACHER CF, 1973, ANN INTERN MED, V78, P131, DOI 10.7326/0003-4819-78-1-131; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Weiss G, 1999, BUS WEEK, P154; WOLINSKY H, 1995, SERPENT STAFF UNHEAL	15	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					587	590		10.7326/0003-4819-134-7-200104030-00012	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281741				2022-12-28	WOS:000167931200006
J	Christenson, B; Lundbergh, P; Hedlund, J; Ortqvist, A				Christenson, B; Lundbergh, P; Hedlund, J; Ortqvist, A			Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study	LANCET			English	Article							POLYSACCHARIDE VACCINE; ELDERLY PERSONS; COST-EFFECTIVENESS; EFFICACY; PNEUMONIA; TRIAL; BENEFITS; HEALTH; RISK	Background The effectiveness of influenza and pneumococcal vaccination in the prevention of hospital admissions and death has not been assessed prospectively. We have therefore examined the effects of influenza and pneumococcal vaccination in individuals aged 65 years and older in a 3-year prospective study, between Dec 1, 1998 and May 31, 1999. Methods All individuals in Stockholm County aged 65 years or order (259 627) were invited to take part in a vaccination campaign against influenza and pneumococcal infection. We recorded for all Vaccine recipients (100 242) name, and date of birth, and whether they had been given both or one of the vaccines. All individuals (greater than or equal to 65 years) admitted to hospital in Stockholm County with influenza and pneumonia related diagnoses were identified between Dec 1, 1998, and May 31, 1999. Findings. The incidence (per 100 000 inhabitants per year) of Findings The incidence (per 100 000 inhabitants per year) of hospital treatment was lower in the Vaccinated than in the unvaccinated cohort for all diagnoses: 263 versus 484 (-46% [95% CI 30-56]) for influenza; 2199 versus 3097 (-29% [24-34]) for pneumonia; 64 versus 100 (-36% [3-58]) for pneumococcal pneumonia; and 20 versus 40 (-52% [1-77]) for invasive pneumococcal disease. The total mortality was 57% (55-60) fewer in Vaccinated than in unvaccinated individuals (15.1 vs 34.7 deaths per 1000 inhabitants). Interpretation These findings show that general Vaccination leads to substantial health benefits and to a reduction of mortality from all causes in this age group.	Karolinska Inst, Karolinska Hosp, Dept Communicable Dis Control & Prevent, S-17176 Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Dept Infect Dis, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Christenson, B (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Communicable Dis Control & Prevent, S-17176 Stockholm, Sweden.							Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; FARR BM, 1995, ARCH INTERN MED, V155, P2336, DOI 10.1001/archinte.155.21.2336; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; GILLICK MR, 1991, ARCH INTERN MED, V151, P1742, DOI 10.1001/archinte.151.9.1742; GOAVERT ME, 1994, JAMA-J AM MED ASSOC, V272, P1661; Hoglund D, 2001, Lakartidningen, V98, P156; Honkanen PO, 1999, VACCINE, V17, P2493, DOI 10.1016/S0264-410X(99)00069-9; Koivula I, 1997, AM J MED, V103, P281, DOI 10.1016/S0002-9343(97)00149-6; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; NICHOLSON KG, 1987, VACCINE, V5, P302, DOI 10.1016/0264-410X(87)90156-3; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101	19	174	184	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1008	1011		10.1016/S0140-6736(00)04237-9	http://dx.doi.org/10.1016/S0140-6736(00)04237-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293594				2022-12-28	WOS:000167791500012
J	Fayers, P; Bjordal, K				Fayers, P; Bjordal, K			Should quality-of-life needs influence resource allocation?	LANCET			English	Editorial Material									Univ Aberdeen, Sch Med, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; Norwegian Radium Hosp, Dept Med Oncol & Radiotherapy, N-0310 Oslo, Norway	University of Aberdeen; University of Oslo	Fayers, P (corresponding author), Univ Aberdeen, Sch Med, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.		Fayers, Peter M/A-5999-2010	Fayers, Peter/0000-0003-4778-1513; Bjordal, Kristin/0000-0002-1914-494X				Chapman RH, 2000, MED DECIS MAKING, V20, P451, DOI 10.1177/0272989X0002000409; EDGAR A, 1998, ETHICAL QALY; MASON JM, 1994, PHARMACOECONOMICS, V5, P472, DOI 10.2165/00019053-199405060-00004; Schlenk EA, 1998, QUAL LIFE RES, V7, P57; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3	5	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					978	978		10.1016/S0140-6736(00)04256-2	http://dx.doi.org/10.1016/S0140-6736(00)04256-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416QK	11293639				2022-12-28	WOS:000167791500006
J	Halberthal, M; Halperin, ML; Bohn, D				Halberthal, M; Halperin, ML; Bohn, D			Lesson of the week - Acute hyponatraemia in children admitted to hospital: retrospective analysis of factors contributing to its development and resolution	BRITISH MEDICAL JOURNAL			English	Review							PERMANENT BRAIN-DAMAGE; HYPONATREMIA; WOMEN; WATER		Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1A6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bohn, D (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							ADELMAN RD, 1996, TXB PEDIAT, P207; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Chesney RW, 1998, PEDIATRICS, V102, P399, DOI 10.1542/peds.102.2.399; DARROW DC, 1950, JAMA-J AM MED ASSOC, V143, P365, DOI 10.1001/jama.1950.82910390009011; HALLIDAY M, 1957, PEDIATRICS, V19, P823; HALPERIN ML, 1998, CURRENT THERAPY NEPH, P1; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; Soupart A, 1996, CLIN NEPHROL, V46, P149; SPITAL A, 1989, ARCH INTERN MED, V149, P1255, DOI 10.1001/archinte.149.6.1255; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Sterns Richard H., 1993, P225; WATTAD A, 1992, CLIN PEDIATR, V31, P153, DOI 10.1177/000992289203100305	14	133	143	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					780	782		10.1136/bmj.322.7289.780	http://dx.doi.org/10.1136/bmj.322.7289.780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282868	Green Published			2022-12-28	WOS:000167943200031
J	Kenyon, SL; Taylor, DJ; Tarnow-Mordi, W				Kenyon, SL; Taylor, DJ; Tarnow-Mordi, W		ORACLE Collaborative Grp	Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial	LANCET			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC LUNG-DISEASE; CEREBRAL-PALSY; BIRTH-WEIGHT; INFANTS; PREMATURITY; INCREASE; CERVIX; LABOR	Background Preterm, prelabour rupture of the fetal membranes (pPROM) is the commonest antecedent of preterm birth, and can lead to death, neonatal disease, and long-term disability. Previous small trials of antibiotics for pPROM suggested some health benefits for the neonate, but the results were inconclusive. We did a randomised multicentre trial to try to resolve this issue. Methods 4826 women with pPROM were randomly assigned 250 mg erythromycin (n=1197), 325 mg co-amoxiclav (250 mg amoxicillin plus 125 mg clavulanic acid; n=1212), both (n=1192), or placebo (n=1225) four times daily for 10 days or until delivery. The primary outcome measure was a composite of neonatal death, chronic lung disease, or major cerebral abnormality on ultrasonography before discharge from hospital. Analysis was by intention to treat. Findings Two women were lost to follow-up, and there were 15 protocol violations. Among all 2415 infants born to women allocated erythromycin only or placebo, fewer had the primary composite outcome in the erythromycin group (151 of 1190 [12.7%] vs 186 of 1225 [15.2%],p=0.08) than in the placebo group. Among the 2260 singletons in this comparison, significantly fewer had the composite primary outcome in the erythromycin group (125 of 1111[11.2%] vs 166 of 1149 [14.4%], p=0.02). Co-amoxiclav only and coamoxiclav plus erythromycin had no benefit over placebo with regard to this outcome in all infants or in singletons only. Use of erythromycin was also associated with prolongation of pregnancy, reductions in neonatal treatment with surfactant, decreases in oxygen dependence at 28 days of age and older, fewer major cerebral abnormalities on ultrasonography before discharge, and fewer positive blood cultures. Although co-amoxiclav only and co-amoxiclav plus erythromycin were associated with prolongation of pregnancy, they were also associated with a significantly higher rate of neonatal necrotising enterocolitis. Interpretation Erythromycin for women with pPROM is associated with a range of health benefits for the neonate, and thus a probable reduction in childhood disability. However, co-amoxiclav cannot be routinely recommended for pPROM because of its association with neonatal necrotising enterocolitis. A follow-up study of childhood development and disability after pPROM is planned.	Leicester Royal Infirm, Dept Obstet & Gynaecol, Leicester LE2 7LX, Leics, England	University of Leicester	Kenyon, SL (corresponding author), Leicester Royal Infirm, Dept Obstet & Gynaecol, Robert Kilpatrick Bldg,POB 65, Leicester LE2 7LX, Leics, England.			Kenyon, Sara/0000-0002-0756-9617				AbeleHorn M, 1997, INFECTION, V25, P286, DOI 10.1007/BF01720398; [Anonymous], LANCET; BELL SC, 2000, PLACENTA BASIC SCI C, P187; Cox S. M., 1995, American Journal of Obstetrics and Gynecology, V172, P412; EDWARDS AD, 2000, PLACENTA BASIC SCI C, P204; Gomez R, 1997, PRETERM LABOR, P85; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; KENYON S, 2000, COCHRANE LIB; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kotecha S, 1996, J PEDIATR-US, V128, P464, DOI 10.1016/S0022-3476(96)70355-4; Kotecha S, 1998, ARCH DIS CHILD-FETAL, V78, pF143, DOI 10.1136/fn.78.2.F143; Kotecha S, 1996, PEDIATR RES, V40, P250, DOI 10.1203/00006450-199608000-00010; KOTECHA S, 1996, EUR J PEDIATR, V155, P514; LAWRENCE G, 1982, LANCET, V1, P137; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; McGregor JA, 1997, J SOGC, V19, P835; McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237; McLaren J, 1999, HUM REPROD, V14, P2895, DOI 10.1093/humrep/14.11.2895; Medical Research Council (MRC), 1998, MRC CLIN TRIALS SER; MURPHY DJ, 1995, LANCET, V346, P1449, DOI 10.1016/S0140-6736(95)92471-X; NELSON KB, 1985, JAMA-J AM MED ASSOC, V254, P1473, DOI 10.1001/jama.254.11.1473; OGDEN BE, 1984, AM REV RESPIR DIS, V130, P817; RENDLESHORT TJ, 1962, LANCET, V1, P1188; Romero R, 1999, MED FETUS MOTHER, P1581; SPINILLO A, 1995, BRIT J OBSTET GYNAEC, V102, P882, DOI 10.1111/j.1471-0528.1995.tb10875.x; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9	28	408	432	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					979	988		10.1016/S0140-6736(00)04233-1	http://dx.doi.org/10.1016/S0140-6736(00)04233-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293640				2022-12-28	WOS:000167791500007
J	Ruiz-Irastorza, G; Khamashta, MA; Castellino, G; Hughes, GRV				Ruiz-Irastorza, G; Khamashta, MA; Castellino, G; Hughes, GRV			Systemic lupus erythematosus	LANCET			English	Review							RANDOMIZED CONTROLLED TRIAL; STEM-CELL TRANSPLANTATION; MYCOPHENOLATE-MOFETIL THERAPY; LOW-DOSE ASPIRIN; ANTIPHOSPHOLIPID SYNDROME; SINGLE-CENTER; INTRAVENOUS IMMUNOGLOBULIN; DOUBLE-BLIND; CUTANEOUS MANIFESTATIONS; AUTOIMMUNE-DISEASES	This review covers major advances in clinical issues related to systemic lupus erythematosus (SLE) published between 1995 and 2000. The classification criteria for both SLE and antiphospholipid syndrome (APS) have been updated, and up to 19 different subsets of neuropsychiatric lupus have been defined. New epidemiological data show that the incidence of new cases and the survival of patients with SLE are both increasing. Several randomised controlled trials have defined the role of cyclophosphamide, methotrexate, antimalarials, and hormonal treatment in the management of SLE. New data are available for drugs such as ciclosporin and thalidomide. Finally, several new treatments for severe refractory cases, such as mycophenolate mofetil and stem-cell transplantation, are being increasingly used. New data also refer to management of thrombosis in APS and high-risk pregnancies in women with SLE or APS.	St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England; Hosp Mendaro, Serv Internal Med, Gipuzkoa, Spain	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Khamashta, MA (corresponding author), St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England.		Goebeler, Matthias/F-7118-2013; Wu, Olivia/A-5011-2010; Ruiz-Irastorza, Guillermo/P-7058-2014; Ruiz-Irastorza, Guillermo/C-5573-2009; Crow, Mary/R-8480-2019; Ruiz, Guillermo/E-1724-2012; Ciccone, Giovannino/K-3136-2016; Hiepe, Falk/A-9416-2013; Mackay, Ian R/A-7228-2010	Wu, Olivia/0000-0002-0570-6016; Ruiz-Irastorza, Guillermo/0000-0001-7788-1043; Ciccone, Giovannino/0000-0001-7644-9574; 				ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1265; Alvarez-Nemegyei J, 1998, LUPUS, V7, P414, DOI 10.1191/096120398678920334; Backos M, 1999, BRIT J OBSTET GYNAEC, V106, P102, DOI 10.1111/j.1471-0528.1999.tb08208.x; Boletis JN, 1999, LANCET, V354, P569, DOI 10.1016/S0140-6736(99)01575-5; Boumpas DT, 1999, CLIN NEPHROL, V52, P67; Branch DW, 2000, AM J OBSTET GYNECOL, V182, P122, DOI 10.1016/S0002-9378(00)70500-X; Briggs WA, 1998, AM J KIDNEY DIS, V31, P213, DOI 10.1053/ajkd.1998.v31.pm9469489; *BRIT COMM STAND H, 1998, BRIT J HAEMATOL, V101, P374; Brodsky RA, 1998, ANN INTERN MED, V129, P1031, DOI 10.7326/0003-4819-129-12-199812150-00007; Burt RK, 1997, NEW ENGL J MED, V337, P1777, DOI 10.1056/NEJM199712113372416; Caccavo D, 1997, ARTHRITIS RHEUM, V40, P27, DOI 10.1002/art.1780400106; Carneiro JRM, 1999, J RHEUMATOL, V26, P1275; Cervera R, 1999, MEDICINE, V78, P167, DOI 10.1097/00005792-199905000-00003; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Davis JC, 1998, ARTHRITIS RHEUM, V41, P335, DOI 10.1002/1529-0131(199802)41:2<335::AID-ART18>3.0.CO;2-O; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Davis JC, 1999, ARTHRITIS RHEUM, V42, pS281; DePita O, 1997, LUPUS, V6, P415, DOI 10.1177/096120339700600414; Dooley MA, 1999, J AM SOC NEPHROL, V10, P833; Duddridge M, 1997, ANN RHEUM DIS, V56, P690, DOI 10.1136/ard.56.11.690; ESDAILE J, 1991, NEW ENGL J MED, V324, P150; Fouillard L, 1999, LUPUS, V8, P320, DOI 10.1191/096120399678847894; Gansauge S, 1997, ANN RHEUM DIS, V56, P382, DOI 10.1136/ard.56.6.382; Gaubitz M, 1999, LUPUS, V8, P731, DOI 10.1191/096120399678840927; GINSBERG JS, 1995, BLOOD, V86, P3685, DOI 10.1182/blood.V86.10.3685.bloodjournal86103685; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Glicklich D, 1998, AM J KIDNEY DIS, V32, P318, DOI 10.1053/ajkd.1998.v32.pm9708620; Gourley MF, 1996, ANN INTERN MED, V125, P549, DOI 10.7326/0003-4819-125-7-199610010-00003; Granger KA, 1997, LUPUS, V6, P509, DOI 10.1177/096120339700600606; Greaves M, 1999, LANCET, V353, P1348, DOI 10.1016/S0140-6736(98)10362-8; Harigai M, 1999, LUPUS, V8, P227, DOI 10.1191/096120399678847678; Hiepe F, 1999, ARTHRITIS RHEUM, V42, pS170; Hochberg MC, 1995, LUPUS, V4, P454, DOI 10.1177/096120339500400606; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hunt BJ, 1998, THROMB HAEMOSTASIS, V79, P1060; Jacobsen S, 1999, SCAND J RHEUMATOL, V28, P75; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Ka M M, 1998, Rev Rhum Engl Ed, V65, P471; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Kim WU, 1999, CLIN EXP RHEUMATOL, V17, P539; Kiss E, 1999, CLIN EXP RHEUMATOL, V17, P171; Kontogiannis V, 1999, ANN RHEUM DIS, V58, P653, DOI 10.1136/ard.58.10.653; Kutteh WH, 1996, AM J OBSTET GYNECOL, V174, P1584, DOI 10.1016/S0002-9378(96)70610-5; Kyriakis KP, 2000, INT J DERMATOL, V39, P218, DOI 10.1046/j.1365-4362.2000.00953.x; Lahita RG, 1995, LUPUS, V4, P450, DOI 10.1177/096120339500400605; Levy Y, 1999, LUPUS, V8, P705, DOI 10.1191/096120399678841007; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lima F, 1996, CLIN EXP RHEUMATOL, V14, P131; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Lockshin MD, 2000, ARTHRITIS RHEUM, V43, P440, DOI 10.1002/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N; Manger K, 1996, BRIT J RHEUMATOL, V35, P669; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Marmont AM, 1997, LUPUS, V6, P545, DOI 10.1177/096120339700600613; Meinao IM, 1996, LUPUS, V5, P237, DOI 10.1177/096120339600500313; Murali R, 1997, NATL MED J INDIA, V10, P159; Ordi J, 1998, ARTHRITIS RHEUM, V41, P2273, DOI 10.1002/1529-0131(199812)41:12<2273::AID-ART26>3.3.CO;2-Y; Ordi-Ros J, 2000, J RHEUMATOL, V27, P1429; Pattison NS, 2000, AM J OBSTET GYNECOL, V183, P1008, DOI 10.1067/mob.2000.106754; Petri M, 1997, RHEUM DIS CLIN N AM, V23, P1, DOI 10.1016/S0889-857X(05)70311-2; Petri M, 1999, ARTHRITIS RHEUM, V42, pS303; Petri M, 1999, ARTHRITIS RHEUM, V42, pS170; Piette JC, 1998, ARTHRITIS RHEUM, V41, P751, DOI 10.1002/1529-0131(199804)41:4<751::AID-ART30>3.0.CO;2-W; Rahman P, 1998, J RHEUMATOL, V25, P1526; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; ROSOVE MH, 1992, ANN INTERN MED, V117, P303, DOI 10.7326/0003-4819-117-4-303; Ruiz-Irastorza G, 2000, ISR MED ASSOC J, V2, P462; Ruiz-Irastorza G, 2000, ARTHRITIS RHEUM, V43, pS313; RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550; Sato E I, 1998, Rev Assoc Med Bras (1992), V44, P289, DOI 10.1590/S0104-42301998000400007; Schroeder JO, 1996, J RHEUMATOL, V23, P71; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Sherer Y, 1998, LUPUS, V7, P137, DOI 10.1191/096120398678919903; Stevens RJ, 1997, BRIT J RHEUMATOL, V36, P353; Traynor AE, 2000, LANCET, V356, P701, DOI 10.1016/S0140-6736(00)02627-1; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; Urowitz MB, 1997, J RHEUMATOL, V24, P1061; Urowitz MB, 1999, LUPUS, V8, P253, DOI 10.1191/096120399678847821; van Vollenhoven RF, 1999, LUPUS, V8, P181, DOI 10.1191/096120399678847588; vanVollenhoven RF, 1995, ARTHRITIS RHEUM, V38, P1826, DOI 10.1002/art.1780381216; Viallard JF, 1999, LUPUS, V8, P767, DOI 10.1191/096120399678840954; Walchner M, 2000, INT J DERMATOL, V39, P383, DOI 10.1046/j.1365-4362.2000.00866.x; Wallace DJ, 1998, J CLIN APHERESIS, V13, P163, DOI 10.1002/(SICI)1098-1101(1998)13:4<163::AID-JCA4>3.0.CO;2-1; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weisman MH, 1997, J RHEUMATOL, V24, P314; Welsch S, 1997, RHEUM DIS CLIN N AM, V23, P71, DOI 10.1016/S0889-857X(05)70315-X; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; Xie Shang-Kui, 1998, Journal of Dermatology (Tokyo), V25, P367; Yoshida T, 1996, J RHEUMATOL, V23, P1719	91	203	218	1	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1027	1032		10.1016/S0140-6736(00)04239-2	http://dx.doi.org/10.1016/S0140-6736(00)04239-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293608				2022-12-28	WOS:000167791500035
J	Thomas, DW; Blondel, J; Perret, P; Lambrechts, MM; Speakman, JR				Thomas, DW; Blondel, J; Perret, P; Lambrechts, MM; Speakman, JR			Energetic and fitness costs of mismatching resource supply and demand in seasonally breeding birds	SCIENCE			English	Article							TITS PARUS-CAERULEUS; GREAT TITS; RECRUITMENT; SELECTION; DATE	By advancing spring leaf flush and ensuing food availability, climatic warming results in a mismatch between the timing of peak food supply and nestling demand, shifting the optimal time for reproduction in birds. Two populations of blue tits (Parus caeruleus) that breed at different dates in similar, but spatially distinct, habitat types in Corsica and southern France provide a unique opportunity to quantify the energetic and fitness consequences when breeding is mismatched with local productivity. As food supply and demand become progressively mismatched, the increased cost of rearing young pushes the metabolic effort of adults beyond their apparent sustainable limit, drastically reducing the persistence of adults in the breeding population. We provide evidence that the economics of parental foraging and limits to sustainable metabolic effort are key selective forces underlying synchronized seasonal breeding and long-term shifts in breeding date in response to climatic change.	Univ Sherbrooke, Grp Rech Ecol Nutr & energet, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; CNRS, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; Rowett Res Inst, Aberdeen, Scotland	University of Sherbrooke; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Aberdeen; University of Aberdeen	Thomas, DW (corresponding author), Univ Sherbrooke, Grp Rech Ecol Nutr & energet, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.		Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823				BLONDEL J, 1992, LANDSCAPE ECOL, V6, P213, DOI 10.1007/BF00130032; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; BLONDEL J, 1993, AUK, V110, P511, DOI 10.2307/4088415; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Bryant DM, 1997, P NUTR SOC, V56, P1025, DOI 10.1079/PNS19970107; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Dias PC, 1996, OECOLOGIA, V107, P79, DOI 10.1007/BF00582237; Dias PC, 1996, IBIS, V138, P644, DOI 10.1111/j.1474-919X.1996.tb04766.x; DRENT RH, 1980, ARDEA, V68, P225; Lambrechts MM, 1997, P NATL ACAD SCI USA, V94, P5153, DOI 10.1073/pnas.94.10.5153; LAMBRECHTS MM, 1993, IBIS, V135, P451, DOI 10.1111/j.1474-919X.1993.tb02118.x; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Speakman J.R., 1997, DOUBLY LABELLED WATE; THOMAS DW, IN PRESS ZOOLOGY; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 1999, OIKOS, V85, P445, DOI 10.2307/3546694	21	293	296	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2598	2600		10.1126/science.1057487	http://dx.doi.org/10.1126/science.1057487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283370				2022-12-28	WOS:000167861000040
J	Lakes, RS; Lee, T; Bersie, A; Wang, YC				Lakes, RS; Lee, T; Bersie, A; Wang, YC			Extreme damping in composite materials with negative-stiffness inclusions	NATURE			English	Article							POISSONS RATIO; ALLOYS; BEHAVIOR	When a force deforms an elastic object, practical experience suggests that the resulting displacement will be in the same direction as the force. This property is known as positive stiffness'. Less familiar is the concept of negative stiffness, where the deforming force and the resulting displacement are in opposite directions. (Negative stiffness is distinct from negative Poisson's ratio(2-6), which refers to the occurrence of lateral expansion upon stretching an object.) Negative stiffness can occur, for example, when the deforming object has stored(7) (or is supplied(8) with) energy. This property is usually unstable, but it has been shown theoretically(9) that inclusions of negative stiffness can be stabilized within a positive-stiffness matrix. Here we describe the experimental realization of this composite approach by embedding negative-stiffness inclusions of ferroelastic vanadium dioxide in a pure tin matrix. The resulting composites exhibit extreme mechanical damping and large anomalies in stiffness, as a consequence of the high local strains that result from the inclusions deforming more than the composite as a whole. Moreover, for certain temperature ranges, the negative-stiffness inclusions are more effective than diamond inclusions for increasing the overall composite stiffness. We expect that such composites could be useful as high damping materials, as stiff structural elements or for actuator-type applications.	Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA; Univ Wisconsin, Engn Mech Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA; Univ Wisconsin, Rheol Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lakes, RS (corresponding author), Univ Wisconsin, Dept Engn Phys, 147 Engn Res Bldg,1500 Engn Dr, Madison, WI 53706 USA.		Lee, Taeyong/E-4245-2012; Wang, Yunche/A-4869-2010; Lee, Taeyong/C-5746-2012	Wang, Yunche/0000-0003-4031-9828; 				Baughman RH, 1998, NATURE, V392, P362, DOI 10.1038/32842; Bramble J. H., 1963, P 4 NAT C APPL MECH, P469; BRODT M, 1995, REV SCI INSTRUM, V66, P5292, DOI 10.1063/1.1146101; CREMER L, 1988, STRUCTURE BORNE SOUN, P243; DUFFY W, 1990, J APPL PHYS, V68, P5601, DOI 10.1063/1.346971; FALK F, 1980, ACTA METALL MATER, V28, P1773, DOI 10.1016/0001-6160(80)90030-9; HAERI AY, 1992, SCIENCE, V257, P650; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; HASHIN Z, 1965, J APPL MECH, V32, P630, DOI 10.1115/1.3627270; HECKINGBOTTOM R, 1962, NATURE, V194, P678, DOI 10.1038/194678a0; KNOWLES JK, 1978, J ELASTICITY, V8, P329, DOI 10.1007/BF00049187; LAKES R, 1993, ADV MATER, V5, P293, DOI 10.1002/adma.19930050416; LAKES R, 1993, J MATER SCI, V28, P4667, DOI 10.1007/BF00414256; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lakes RS, 1996, PHIL MAG LETT, V74, P227, DOI 10.1080/095008396180155; Lakes RS, 2001, PHIL MAG LETT, V81, P95, DOI 10.1080/09500830010015332; LAKES RS, UNPUB J MECH PHYS SO; LAKES RS, PHYS REV LETT; PAQUET D, 1980, PHYS REV B, V22, P5284, DOI 10.1103/PhysRevB.22.5284; PUGH JW, 1973, SCIENCE, V181, P271, DOI 10.1126/science.181.4096.271; READ WT, 1950, J APPL PHYS, V21, P671, DOI 10.1063/1.1699729; Ren XB, 1997, NATURE, V389, P579, DOI 10.1038/39277; ROTHENBURG L, 1991, NATURE, V354, P470, DOI 10.1038/354470a0; SALJE E, 1990, PHASE TRANSITIONS FE, V10, P72; THOMPSON JMT, 1979, PHILOS T R SOC A, V292, P1, DOI 10.1098/rsta.1979.0043; THOMPSON JMT, 1982, NATURE, V296, P135, DOI 10.1038/296135a0; Timoshenko S.P., 1970, THEORY ELASTICITY; ZHANG JX, 1995, PHYS REV B, V52, P278, DOI 10.1103/PhysRevB.52.278; 1996, HDB CHEM PHYSICS C, V40, P12	29	344	381	7	215	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					565	567		10.1038/35069035	http://dx.doi.org/10.1038/35069035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279490				2022-12-28	WOS:000167859300042
J	Li, BG; Hartono, C; Ding, RC; Sharma, VK; Ramaswamy, R; Qian, B; Serur, D; Mouradian, J; Schwartz, JE; Suthanthiran, M				Li, BG; Hartono, C; Ding, RC; Sharma, VK; Ramaswamy, R; Qian, B; Serur, D; Mouradian, J; Schwartz, JE; Suthanthiran, M			Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPHOCYTE-MEDIATED CYTOTOXICITY; GRAFT FUNCTION; T-CELLS; EXPRESSION; KIDNEY; TRANSPLANTATION; INDUCTION; BIOPSY; NEEDLE; TRIAL	Background: Acute rejection is a serious and frequent complication of renal transplantation, and its diagnosis is contingent on the invasive procedure of allograft biopsy. A noninvasive diagnostic test for rejection could improve the outcome of transplantation. Methods: We obtained 24 urine specimens from 22 renal-allograft recipients with a biopsy-confirmed episode of acute rejection and 127 samples from 63 recipients without evidence of acute rejection. RNA was isolated from the urinary cells. Messenger RNA (mRNA) encoding the cytotoxic proteins perforin and granzyme B and a constitutively expressed cyclophilin B gene were measured with the use of a competitive, quantitative polymerase-chain-reaction assay, and the level of expression was correlated with allograft status. Results: The log-transformed mean (+/-SE) levels of perforin mRNA and granzyme B mRNA, which encode cytotoxic proteins, but not the levels of constitutively expressed cyclophilin B mRNA, were higher in the urinary cells from the 22 patients with a biopsy-confirmed episode of acute rejection than in the 63 recipients without an episode of acute rejection (perforin, 1.4+/-0.3 vs. -0.6+/-0.2 fg per microgram of total RNA; P<0.001; and granzyme B, 1.2+/-0.3 vs. -0.9+/-0.2 fg per microgram of total RNA; P<0.001). Analysis involving the receiver-operating-characteristic curve demonstrated that acute rejection can be predicted with a sensitivity of 83 percent and a specificity of 83 percent with the use of a cutoff value of 0.9 fg of perforin mRNA per microgram of total RNA, and with a sensitivity of 79 percent and a specificity of 77 percent with the use of a cutoff value of 0.4 fg of granzyme B mRNA per microgram of total RNA. Sequential urine samples were obtained from 37 patients during the first nine days after transplantation, and measurements of the levels of mRNA that encoded cytotoxic proteins identified those in whom acute rejection developed. Conclusions: Measurement of mRNA encoding cytotoxic proteins in urinary cells offers a noninvasive means of diagnosing acute rejection of renal allografts. (N Engl J Med 2001; 344:947-54.) Copyright (C) 2001 Massachusetts Medical Society.	Cornell Univ, Weill Med Coll, Div Nephrol, Dept Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; New York Presbyterian Hosp, Dept Transplantat Med, New York, NY USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; NewYork-Presbyterian Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Suthanthiran, M (corresponding author), Cornell Univ, Weill Med Coll, Div Nephrol, Dept Med, 525 E 68th St,Box 3, New York, NY 10021 USA.	msuthan@med.cornell.edu	Suthanthiran, Manikkam/AAL-9104-2020	Schwartz, Joseph/0000-0002-8944-3566	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI037206] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-37206] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agodoa L, 1997, KIDNEY INT, pS144; ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; Alpert S, 1995, TRANSPLANTATION, V60, P1478, DOI 10.1097/00007890-199560120-00019; Atkinson EA, 1998, J BIOL CHEM, V273, P21261, DOI 10.1074/jbc.273.33.21261; BECKINGHAM IJ, 1994, BRIT J UROL, V73, P13, DOI 10.1111/j.1464-410X.1994.tb07449.x; Benfield MR, 1999, TRANSPLANTATION, V67, P544, DOI 10.1097/00007890-199902270-00010; BERKE G, 1995, IMMUNOL TODAY, V16, P343, DOI 10.1016/0167-5699(95)80152-9; Cecka J M, 1998, Clin Transpl, P1; Cecka J M, 2000, Clin Transpl, P1; CLEMENT MV, 1994, TRANSPLANTATION, V57, P322, DOI 10.1097/00007890-199402150-00002; Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930; Gaber LW, 1999, KIDNEY INT, V55, P2415, DOI 10.1046/j.1523-1755.1999.00494.x; GULANIKAR AC, 1992, TRANSPLANTATION, V53, P323, DOI 10.1097/00007890-199202010-00013; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; HARPER AM, 2000, CLIN TRANSPLANTS 199, P71; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; HURAIB S, 1989, AM J KIDNEY DIS, V14, P13, DOI 10.1016/S0272-6386(89)80087-3; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Krams S M, 1995, Transpl Immunol, V3, P162, DOI 10.1016/0966-3274(95)80043-3; LEGROSMAIDA S, 1994, EUR J IMMUNOL, V24, P229, DOI 10.1002/eji.1830240136; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; LIPMAN ML, 1994, J IMMUNOL, V152, P5120; Littel RC, 1996, SAS SYSTEM MIXED MOD; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Nicholson ML, 2000, KIDNEY INT, V58, P390, DOI 10.1046/j.1523-1755.2000.00177.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; Sharma VK, 1996, TRANSPLANTATION, V62, P1860, DOI 10.1097/00007890-199612270-00031; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; SHULZ M, 1995, EUR J IMMUNOL, V25, P474, DOI 10.1002/eji.1830250225; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; SMYTH MJ, 1995, BIOESSAYS, V17, P891, DOI 10.1002/bies.950171011; Sorof JM, 1995, TRANSPLANTATION, V60, P1215; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; STROM TB, 1975, NEW ENGL J MED, V292, P1257, DOI 10.1056/NEJM197506122922402; SUTHANTHIRAN M, 1993, TRANSPLANTATION, V55, P1008, DOI 10.1097/00007890-199305000-00011	41	464	504	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					947	954		10.1056/NEJM200103293441301	http://dx.doi.org/10.1056/NEJM200103293441301			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274620				2022-12-28	WOS:000167716600001
J	Ward, SA; Bray, PG				Ward, SA; Bray, PG			Is reversal of chloroquine resistance ready for the clinic?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; DESIPRAMINE; MALARIA		Univ Liverpool, Liverpool Sch Trop Med, Dept Pharmacol & Therapeut, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Pharmacol & Therapeut, Liverpool L3 5QA, Merseyside, England.		Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192				BOULTER MK, 1993, T ROY SOC TROP MED H, V87, P303, DOI 10.1016/0035-9203(93)90137-F; BRAY PG, 1998, PHARMACOL THERAPEUT, V1, P1; Haruki K, 2000, ANTIMICROB AGENTS CH, V44, P2706, DOI 10.1128/AAC.44.10.2706-2708.2000; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Sowunmi A, 1998, T ROY SOC TROP MED H, V92, P77, DOI 10.1016/S0035-9203(98)90964-6; Taylor D, 2000, ANTIMICROB AGENTS CH, V44, P2689, DOI 10.1128/AAC.44.10.2689-2692.2000; TSURUO T, 1981, CANCER RES, V41, P1967; VERDIER F, 1985, ANTIMICROB AGENTS CH, V27, P561, DOI 10.1128/AAC.27.4.561; WARSAME M, 1992, T ROY SOC TROP MED H, V86, P235, DOI 10.1016/0035-9203(92)90288-N; Winstanley PA, 2000, PARASITOL TODAY, V16, P146, DOI 10.1016/S0169-4758(99)01622-1	10	12	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					904	904		10.1016/S0140-6736(00)04232-X	http://dx.doi.org/10.1016/S0140-6736(00)04232-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289344				2022-12-28	WOS:000167625300006
J	Nabel, GJ				Nabel, GJ			Challenges and opportunities for development of an AIDS vaccine	NATURE			English	Review							SIMIAN IMMUNODEFICIENCY VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; CYTOTOXIC T-LYMPHOCYTES; VIVO GENE DELIVERY; HIV-1 NEF PROTEIN; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; DNA IMMUNIZATION; NONHUMAN-PRIMATES; IMMUNE-RESPONSE	Among the devastating consequences of AIDS has been its epidemic spread in the developing world. The disease has caused unprecedented suffering, debilitation, loss of life anti disruption of family, social and economic stability. Because of the considerable expense and logistical difficulty in providing antiviral drugs to populations infected with the human immunodeficiency virus throughout the world, the biomedical community is looking towards vaccines to help solve this compelling problem.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.							Andre S, 1998, J VIROL, V72, P1497; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Becker SI, 1998, INFECT IMMUN, V66, P3457, DOI 10.1128/IAI.66.7.3457-3461.1998; BURKE DS, 1992, PERSPECT BIOL MED, V35, P511; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Burton DR, 1997, AIDS, V11, pS87; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Caley IJ, 1999, VACCINE, V17, P3124, DOI 10.1016/S0264-410X(99)00142-5; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chanock RM, 1996, P ASSOC AM PHYSICIAN, V108, P117; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cooper P.D., 1994, STRATEGIES VACCINE D, P125; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; DOLIN R, 1995, J INFECT DIS, V172, P1175, DOI 10.1093/infdis/172.5.1175; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Gallo RC, 1999, J CLIN IMMUNOL, V19, P293, DOI 10.1023/A:1020539524373; Gardner MJ, 1996, J PHARM SCI-US, V85, P1294, DOI 10.1021/js960147h; Garzino-Demo A, 1998, AIDS RES HUM RETROV, V14, pS177; GRAHAM B, 2000, HIV MOL IMMUNOLOGY D; GRAHAM BS, 1998, TXB AIDS MED, P689; Greenough TC, 1999, NEW ENGL J MED, V340, P236, DOI 10.1056/NEJM199901213400314; Huang HV, 1996, CURR OPIN BIOTECH, V7, P531, DOI 10.1016/S0958-1669(96)80057-7; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; JOHNSON PR, 1990, J GEN VIROL, V71, P481, DOI 10.1099/0022-1317-71-2-481; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Letvin NL, 1998, SCIENCE, V280, P1875, DOI 10.1126/science.280.5371.1875; Liu MA, 1996, ANTIBIOT CHEMOTHER, V48, P100; Liu XL, 1999, GENE THER, V6, P293, DOI 10.1038/sj.gt.3300807; Lodmell DL, 1998, NAT MED, V4, P949, DOI 10.1038/nm0898-949; Luciw PA, 1996, FIELD VIROLOGY, P1881; Manickan E, 1995, VIRAL IMMUNOL, V8, P53, DOI 10.1089/vim.1995.8.53; MARTINS LP, 1995, J VIROL, V69, P2574, DOI 10.1128/JVI.69.4.2574-2582.1995; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MASCOLA JR, 1993, AIDS RES HUM RETROV, V9, P1175, DOI 10.1089/aid.1993.9.1175; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Melnick J, 1996, FIELDS VIROLOGY, P655; Monahan PE, 2000, GENE THER, V7, P24, DOI 10.1038/sj.gt.3301109; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Moss B, 1996, Adv Exp Med Biol, V397, P7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novembre FJ, 1997, J VIROL, V71, P4086, DOI 10.1128/JVI.71.5.4086-4091.1997; OHagan D.T., 2000, VACCINE ADJUVANTS; PARREN PWH, 1997, NAT MED, V3, P367; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; POWELL MF, 1995, VFACCINE DESIGN SUBU; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sattentau QJ, 1996, CURR OPIN IMMUNOL, V8, P540, DOI 10.1016/S0952-7915(96)80044-6; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Spriggs D.R., 1991, TOPICS VACCINE ADJUV; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; TARTAGLIA J, 1990, CRIT REV IMMUNOL, V10, P13; Tartaglia J, 1998, AIDS RES HUM RETROV, V14, pS291; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; Tighe H, 1998, IMMUNOL TODAY, V19, P89, DOI 10.1016/S0167-5699(97)01201-2; TRAVIS JA, 1999, SCI NEWS, V156, P300; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wahlfors JJ, 2000, GENE THER, V7, P472, DOI 10.1038/sj.gt.3301122; WANG B, 1994, AIDS RES HUM RETROV, V10, pS35; WANG B, 1994, AIDS RES HUM RETROV, V10, P535; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; WRIN T, 1995, J VIROL, V69, P39, DOI 10.1128/JVI.69.1.39-48.1995; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; YOKOYAMA M, 1995, J VIROL, V69, P2684, DOI 10.1128/JVI.69.4.2684-2688.1995; ZINKERNAGEL R, 2000, ADV IMMUNOL, V27, P51; Zinkernagel R M, 1977, Contemp Top Immunobiol, V7, P179; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	97	155	175	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					1002	1007		10.1038/35073500	http://dx.doi.org/10.1038/35073500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309631	Green Published, Bronze			2022-12-28	WOS:000168152300061
J	Rice, L; Ruiz, W; Driscoll, T; Whitley, CE; Tapia, R; Hachey, DL; Gonzales, GF; Alfrey, CP				Rice, L; Ruiz, W; Driscoll, T; Whitley, CE; Tapia, R; Hachey, DL; Gonzales, GF; Alfrey, CP			Neocytolysis on descent from altitude: A newly recognized mechanism for the control of red cell mass	ANNALS OF INTERNAL MEDICINE			English	Article								Background: studies of space-flight anemia have uncovered a physiologic process, neocytolysis, by which young red blood cells are selectively hemolyzed, allowing rapid adaptation when red cell mass is excessive for a new environment. Objectives: 1) To confirm that neocytolysis occurs in another situation of acute plethora-when high-altitude dwellers with polycythemia descend to sea level; and 2) to clarify the role of erythropoietin suppression. Design: Prospective observational and interventional study. Setting: Cerro de Pasco (4380 m) and Lima (sea level), Peru. Participants: Nine volunteers with polycythemia. Interventions: Volunteers were transported to sea level; three received low-dose erythropoietin. Measurements: Changes in red cell mass, hematocrit, hemoglobin concentration, reticulocyte count, ferritin level, serum erythropoietin, and enrichment of administered C-13 in heme. Results: In six participants, red cell mass decreased by 7% to 10% within a few days of descent; this decrease was mirrored by a rapid increase in serum ferritin level, Reticulocyte production did not decrease, a finding that establishes a hemolytic mechanism. C-13 changes in circulating heme were consistent with hemolysis of young cells. Erythropoietin was suppressed, and administration of exogenous erythropoietin prevented the changes in red cell mass, serum ferritin level, and C-13-heme. Conclusions: Neocytolysis and the role of erythropoietin are confirmed in persons with polycythemia who descend from high altitude. This may have implications that extend beyond space and altitude medicine to renal disease and other situations of erythropoietin suppression, hemolysis, and polycythemia.	Baylor Coll Med, Houston, TX 77030 USA; Univ Peruana Cayetano Heredia, Lima, Peru	Baylor College of Medicine; Universidad Peruana Cayetano Heredia	Rice, L (corresponding author), 6565 Fannin,MS 902-Main, Houston, TX 77030 USA.	lrice@bcm.tmc.edu	Gonzales, Gustavo F/I-9153-2016	Gonzales, Gustavo F/0000-0003-1611-2894				ALFREY C, IN PRESS GRAVITY BIO; Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; [Anonymous], 1980, BRIT J HAEMATOL, V45, P659; ARRIE A, 1996, MASS SPECTROMETRY SO, P1; BESARAB A, 1993, AM J KIDNEY DIS, V22, P13, DOI 10.1016/0272-6386(93)70177-Z; CHRISTENSEN P, 1993, CRIT CARE MED, V21, P1535, DOI 10.1097/00003246-199310000-00023; HANN IM, 1991, FETAL NEONATAL HAEMA, P29; HUFF RL, 1951, MEDICINE, V30, P197, DOI 10.1097/00005792-195109000-00001; KOURY MJ, 1992, EUR J BIOCHEM, V210, P649, DOI 10.1111/j.1432-1033.1992.tb17466.x; LABBE RF, 1957, BIOCHIM BIOPHYS ACTA, V26, P437, DOI 10.1016/0006-3002(57)90033-1; MENTZER WC, 1971, J CLIN INVEST, V50, P688, DOI 10.1172/JCI106539; MERINO CF, 1950, BLOOD, V5, P1; PACE N, 1956, J APPL PHYSIOL, V9, P141, DOI 10.1152/jappl.1956.9.2.141; Rice L, 2000, PFLUG ARCH EUR J PHY, V441, pR91, DOI 10.1007/s004240000333; Rice L, 1999, AM J KIDNEY DIS, V33, P59, DOI 10.1016/S0272-6386(99)70258-1; SAMSON D, 1976, BRIT J HAEMATOL, V34, P33, DOI 10.1111/j.1365-2141.1976.tb00171.x; Trial J, 1999, BLOOD, V94, p405A; UDDEN MM, 1995, J LAB CLIN MED, V125, P442	19	107	116	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					652	656		10.7326/0003-4819-134-8-200104170-00010	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304105				2022-12-28	WOS:000168177500004
J	Jones, TC				Jones, TC			Call for a new approach to the process of clinical trials and drug registration	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Cornell Univ, Coll Med, New York, NY 10021 USA	Cornell University	Jones, TC (corresponding author), Clin Res Consultants, CH-4058 Basel, Switzerland.	100767.711@compuserve.com						Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Angell M, 2000, NEW ENGL J MED, V342, P1902, DOI 10.1056/NEJM200006223422509; [Anonymous], 2000, INT C HARM ICH GUID; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BOHENHEIMER T, 2000, NEW ENGL J MED, V342, P1539; Bradley S. Gaylen, 1995, P161; BURLEY DM, 1985, PHARM MED, P260; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Dunn N, 1999, CLIN EXP ALLERGY, V29, P217, DOI 10.1046/j.1365-2222.1999.0290s3217.x; EICHENWALD K, 1999, NY TIMES        0516; Fazzari M, 2000, CONTROL CLIN TRIALS, V21, P360, DOI 10.1016/S0197-2456(00)00056-8; *FDA CTR DRUG EV R, GUID DOC; Hansen RW., 1995, HAZARDOUS OUR HLTH F, P13; Jones, 1997, Braz J Infect Dis, V1, P266; Jones, 1998, Braz J Infect Dis, V2, P37; LASAGNA L, 1989, PERSPECT BIOL MED, V32, P322; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; LYNN WA, 1995, CLIN INFECT DIS, V20, P143, DOI 10.1093/clinids/20.1.143; NIES AS, 1990, PHARMACOL BASIS THER, P62; STRUCK MM, 1994, BIO-TECHNOL, V12, P674, DOI 10.1038/nbt0794-674; Thall P F, 1995, Cancer Treat Res, V75, P49; WEIHRAUCH TR, 1994, EUR J CLIN RES, V6, P26	22	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					920	923		10.1136/bmj.322.7291.920	http://dx.doi.org/10.1136/bmj.322.7291.920			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302912	Green Published			2022-12-28	WOS:000168311300029
J	Trikalitis, PN; Rangan, KK; Bakas, T; Kanatzidis, MG				Trikalitis, PN; Rangan, KK; Bakas, T; Kanatzidis, MG			Varied pore organization in mesostructured semiconductors based on the [SnSe4] (4-) anion	NATURE			English	Article							LIQUID-CRYSTAL TEMPLATES; MOLECULAR-SIEVES; GERMANIUM SULFIDE; FRAMEWORKS; CLUSTERS	Open framework metal chalcogenide solids, with pore sizes in the nano- and mesoscale, are of potentially broad technological and fundamental interest in research areas ranging from optoelectronics to the physics of quantum confinement(1,2). Although there have been significant advances in the design and synthesis of mesostructured silicas(3,4), the construction of their non-oxidic analogues still remains a challenge. Here we describe a synthetic strategy that allows the preparation of a large class of mesoporous materials based on supramolecular assembly of tetrahedral Zintl anions [SnSe4](4-) with transition metals in the presence of cetylpyridinium (CP) surfactant molecules. These mesostructured semiconducting selenide materials are of the general formulae (CP)(4-2x)MxSnSe4 (where 1.0 < x < 1.3; M = Mn, Fe, Co, Zn, Cd, Hg). The resulting materials are open framework chalcogenides and form mesophases with uniform pore size (with spacings between 35 and 40 Angstrom). The pore arrangement depends on the synthetic conditions and metal used, and include disordered wormhole, hexagonal and even cubic phases. All compounds are medium bandgap semiconductors (varying between 1.4 and 2.5 eV). We expect that such semiconducting porous networks could be used for optoelectronic, photosynthetic and photocatalytic applications.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Univ Ioannina, Dept Phys, GR-45110 Ioannina, Greece	Michigan State University; University of Ioannina	Kanatzidis, MG (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.		Trikalitis, Pantelis N/E-5696-2011	Rangan, Kris/0000-0002-6235-2947; Trikalitis, Pantelis/0000-0002-6286-2955				Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Bowes CL, 1996, ADV MATER, V8, P13, DOI 10.1002/adma.19960080103; Braun PV, 1996, NATURE, V380, P325, DOI 10.1038/380325a0; Ciesla U, 1996, ANGEW CHEM INT EDIT, V35, P541, DOI 10.1002/anie.199605411; KLEPP KO, 1992, Z NATURFORSCH B, V47, P411, DOI 10.1515/znb-1992-0319; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Li HL, 1999, SCIENCE, V283, P1145, DOI 10.1126/science.283.5405.1145; Lippens PE, 1999, PHYS REV B, V60, P4576, DOI 10.1103/PhysRevB.60.4576; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; OZIN GA, 1995, ADV CHEM SER, V245, P335; Pankove J.I., 1975, OPTICAL PROCESSES SE; Rangan KK, 1999, CHEM MATER, V11, P2629, DOI 10.1021/cm990456j; Wachhold M, 2000, J SOLID STATE CHEM, V152, P21, DOI 10.1006/jssc.2000.8673; Wachhold M, 2000, ADV MATER, V12, P85, DOI 10.1002/(SICI)1521-4095(200001)12:2<85::AID-ADMA85>3.0.CO;2-P; WEISS D, 1993, PHYS REV LETT, V70, P4118, DOI 10.1103/PhysRevLett.70.4118; Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E; Zhao DY, 1997, CHEM COMMUN, P1009, DOI 10.1039/a700965h	18	135	136	3	121	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					671	675		10.1038/35070533	http://dx.doi.org/10.1038/35070533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287949				2022-12-28	WOS:000167875400041
J	Kotseva, K; Wood, D; De Backer, G; De Bacquer, D; Pyorala, K; Keil, U; Sans, S; Ambrosio, GB; Amouyel, P; Cokkinos, D; Deckers, JW; Erhardt, L; Graham, I; Gutzwiller, F; Keber, I; Keil, U; Lehto, S; Ostor, E; Pajak, A; Sans, S; Simon, J; Turk, J; Wood, D; Wood, DA; Schofield, B; Bowker, T; Ingham, J; McLennan, N; Kotseva, K; Gollapalli, M; Valay, R; De Backer, G; De Bacquer, D; James, D; Mackness, M; Simon, J; Linhartova, K; Hafman, P; Mayer, O; Rosolova, H; Bocek, P; Hrncarek, M; Lupinek, P; Marek, T; Plaskova, M; Skodova, Z; Cifkova, R; Lehto, S; Lehto, R; Kemppainen, A; Koukkunen, H; Luukkonen, J; Puhakka, M; Karkkainen, K; Savolainen, K; Amouyel, P; Montaye, M; Lemaire, B; Danet, S; Domanievicz, R; Lenoir, M; Beauchant, S; Dusart, A; Bonte, F; Fievet, N; Poissonnier, L; Ledoux, P; Marecaux, N; Steclebout, C; Keil, U; Liese, A; Broxtermann, U; Heimbach, M; Heidrich, J; Kalic, M; Breithardt, G; Enbergs, A; Kerber, S; Scheld, H; Roeder, N; Kleine-Katthofer, P; Assmann, G; Ostor, E; Borbas, S; Podmaniczky, M; Ruzsanyi, T; Janosi, A; Belatiny-Kenez, A; Bradak, A; Adam, Z; Barczy, G; Birtalan, K; Gallai, I; Ambrosio, GB; Leprotti, C; Zardini, P; Rossi, L; Gallo, A; Tavella, D; Stritoni, P; Pedrocco, A; Perissinotto, F; Vanuzzo, D; Pilotto, L; Deckers, JW; Post, F; Jansen, C; Veerhoek, M; Boer, A; Stockx, E; van de Berg, R; Remme, WJ; van Vliet, R; Vos, J; van der Knaap, M; Turk, J; Keber, I; Marn, K; Salapura, V; Skof, E; Span, E; Sans, S; Paluzie, G; Perez, I; Puig, T; Varas, C; Balana, L; Lopez, FN; Sanz, G; Ferrer, C; de Luna, AB; Caralps, JM; Dominguez, M; Monras, P; Rey, M				Kotseva, K; Wood, D; De Backer, G; De Bacquer, D; Pyorala, K; Keil, U; Sans, S; Ambrosio, GB; Amouyel, P; Cokkinos, D; Deckers, JW; Erhardt, L; Graham, I; Gutzwiller, F; Keber, I; Keil, U; Lehto, S; Ostor, E; Pajak, A; Sans, S; Simon, J; Turk, J; Wood, D; Wood, DA; Schofield, B; Bowker, T; Ingham, J; McLennan, N; Kotseva, K; Gollapalli, M; Valay, R; De Backer, G; De Bacquer, D; James, D; Mackness, M; Simon, J; Linhartova, K; Hafman, P; Mayer, O; Rosolova, H; Bocek, P; Hrncarek, M; Lupinek, P; Marek, T; Plaskova, M; Skodova, Z; Cifkova, R; Lehto, S; Lehto, R; Kemppainen, A; Koukkunen, H; Luukkonen, J; Puhakka, M; Karkkainen, K; Savolainen, K; Amouyel, P; Montaye, M; Lemaire, B; Danet, S; Domanievicz, R; Lenoir, M; Beauchant, S; Dusart, A; Bonte, F; Fievet, N; Poissonnier, L; Ledoux, P; Marecaux, N; Steclebout, C; Keil, U; Liese, A; Broxtermann, U; Heimbach, M; Heidrich, J; Kalic, M; Breithardt, G; Enbergs, A; Kerber, S; Scheld, H; Roeder, N; Kleine-Katthofer, P; Assmann, G; Ostor, E; Borbas, S; Podmaniczky, M; Ruzsanyi, T; Janosi, A; Belatiny-Kenez, A; Bradak, A; Adam, Z; Barczy, G; Birtalan, K; Gallai, I; Ambrosio, GB; Leprotti, C; Zardini, P; Rossi, L; Gallo, A; Tavella, D; Stritoni, P; Pedrocco, A; Perissinotto, F; Vanuzzo, D; Pilotto, L; Deckers, JW; Post, F; Jansen, C; Veerhoek, M; Boer, A; Stockx, E; van de Berg, R; Remme, WJ; van Vliet, R; Vos, J; van der Knaap, M; Turk, J; Keber, I; Marn, K; Salapura, V; Skof, E; Span, E; Sans, S; Paluzie, G; Perez, I; Puig, T; Varas, C; Balana, L; Lopez, FN; Sanz, G; Ferrer, C; de Luna, AB; Caralps, JM; Dominguez, M; Monras, P; Rey, M		EUROASPIRE I Grp; EUROASPIRE II Grp	Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries	LANCET			English	Article							SECONDARY PREVENTION; HEART-DISEASE; MYOCARDIAL-INFARCTION; EVENTS; SOCIETY	Background Patients with coronary heart disease (CHD) are the top priority for preventive cardiology. The first EUROASPIRE survey among patients with established CHD in nine countries in 1995-96 showed substantial potential for risk reduction. A second survey (EUROASPIRE II) was done in 1999-2000 in the same countries to see whether preventive cardiology had improved since the first. We compared the proportion of patients in both studies who achieved the lifestyle, risk-factor, and therapeutic goals recommended by the Joint European Societies report on coronary prevention. Methods The surveys were undertaken in the same selected geographical areas and hospitals in the Czech Republic, Finland, France, Germany, Hungary, Italy, the Netherlands, Slovenia, and Spain. Consecutive patients (men and women less than or equal to 70 years of age) were identified after coronary-artery bypass graft or percutaneous transluminal coronary angioplasty, or a hospital admission with acute myocardial infarction or ischaemia, and were interviewed at least 6 months later. Findings 3569 and 3379 patients were interviewed in the first and second surveys, respectively. The prevalence of smoking remained almost unchanged at 19.4% vs 20.8%. The prevalence of obesity (body-mass index greater than or equal to 30 kg/m(2)) increased substantially from 25.3% to 32.8%. The proportion with high blood pressure (greater than or equal to 140/90 mm Hg) was virtually the same (55.4% vs 53.9%), whereas the prevalence of high total cholesterol concentrations (greater than or equal to5.0 mmol/L) decreased substantially from 86.2% to 58.8%. Aspirin or other antiplatelet therapy was as widely used in the second survey as the first (83.9% overall), and reported use of beta -blockers, angiotensin-converting-enzyme inhibitors, and especially lipid-lowering drugs increased. Interpretation The adverse lifestyle trends among European CHD patients are a cause for concern, as is the lack of any improvement in blood-pressure management, and the fact that most CHD patients are still not achieving the cholesterol goal of less than 5 mmol/L. There is a collective failure of medical practice in Europe to achieve the substantial potential among patients with CHD to reduce the risk of recurrent disease and death.	Natl Heart & Lung Inst, Imperial Coll Sch Med, London W6 8RF, England	Imperial College London	Wood, DA (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Charing Cross Campus,Fulham Palace Rd, London W6 8RF, England.	d.wood@ic.ac.uk	De Backer, Guy/AAI-4607-2021; salapura, vladka/GPP-3809-2022; Sans, Susana/ABD-5378-2021; Cífková, Renata/O-5731-2017; De Bacquer, Dirk/HGU-3191-2022	Sans, Susana/0000-0002-0400-5197; Cífková, Renata/0000-0003-2765-3821; De Bacquer, Dirk/0000-0002-3202-7238; Paluzie, Guillermo/0000-0002-5808-6041				[Anonymous], 1997, Eur Heart J, V18, P1569; Balfour D, 2000, EUR HEART J, V21, P438, DOI 10.1053/euhj.1999.1949; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; DEOYA M, 2000, ATHEROSCLEROSIS, V151, P107; deVelasco JA, 1997, REV ESP CARDIOL, V50, P406, DOI 10.1016/S0300-8932(97)73242-1; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; JOLLIFFE JA, 2000, COCHRANE LIB; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Montaye M, 2000, EUR HEART J, V21, P808, DOI 10.1053/euhj.1999.1854; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; PEDERSEN TR, 1994, LANCET, V344, P1383; PYORALA K, 1994, EUR HEART J, V15, P1300; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; van Berkel TFM, 1999, EUR HEART J, V20, P1773, DOI 10.1053/euhj.1999.1658; VANUZZO D, 2000, EUR HEART J, V153, P505; Velasco JA, 1999, ATHEROSCLEROSIS, V147, pS39, DOI 10.1016/S0021-9150(99)00254-3; Wood D, 1998, EUR HEART J, V19, P1434; Yusuf S, 2000, NEW ENGL J MED, V342, P145	19	616	640	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2001	357	9261					995	1001		10.1016/S0140-6736(00)04235-5	http://dx.doi.org/10.1016/S0140-6736(00)04235-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293642				2022-12-28	WOS:000167791500009
J	Parola, P; Dekumyoy, P; Delmont, J; Brouqui, P				Parola, P; Dekumyoy, P; Delmont, J; Brouqui, P			Clinical picture: Gnathostomiasis	LANCET			English	Editorial Material									Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol University	Parola, P (corresponding author), CHU Nord, Serv Malad Infect & Trop, F-13015 Marseille, France.		Parola, Philippe/AAY-4346-2021; Brouqui, Philippe/P-5771-2016	Parola, Philippe/0000-0002-1061-1927; 					0	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1011	1011		10.1016/S0140-6736(00)04246-X	http://dx.doi.org/10.1016/S0140-6736(00)04246-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293595				2022-12-28	WOS:000167791500013
J	Truscott, AG; Strecker, KE; McAlexander, WI; Partridge, GB; Hulet, RG				Truscott, AG; Strecker, KE; McAlexander, WI; Partridge, GB; Hulet, RG			Observation of Fermi pressure in a gas of trapped atoms	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; LI-6; SUPERFLUIDITY; COLLISIONS; RESONANCE	We report the attainment of simultaneous quantum degeneracy in a mixed gas of bosons (lithium-7) and fermions (Lithium-6). The Fermi gas has been cooled to a temperature of 0.25 times the Fermi temperature by thermal collisions with the evaporatively cooled bosons. At this temperature, the spatial size of the gas is strongly affected by the Fermi pressure resulting from the Pauli exclusion principle and gives clear experimental evidence for quantum degeneracy.	Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Rice Univ, Rice Quantum Inst, Houston, TX 77251 USA	Rice University; Rice University	Hulet, RG (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA.	randy@atomcool.rice.edu	Truscott, Andrew/A-8086-2011	Truscott, Andrew/0000-0003-2106-8613; Hulet, Randall/0000-0001-7045-8947				Abraham ERI, 1997, PHYS REV A, V55, pR3299, DOI 10.1103/PhysRevA.55.R3299; Amoruso M, 1998, EUR PHYS J D, V4, P261, DOI 10.1007/s100530050207; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; BAGNATO V, 1987, PHYS REV A, V35, P4354, DOI 10.1103/PhysRevA.35.4354; Baranov MA, 1996, JETP LETT+, V64, P301, DOI 10.1134/1.567187; BENNERMANN KH, 1976, PHYSICS LIQUID SOLID; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Butts DA, 1997, PHYS REV A, V55, P4346, DOI 10.1103/PhysRevA.55.4346; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Geist W, 1999, PHYS REV A, V59, P1500, DOI 10.1103/PhysRevA.59.1500; Holland MJ, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053610; Houbiers M, 1998, PHYS REV A, V57, pR1497, DOI 10.1103/PhysRevA.57.R1497; LARSON DJ, 1986, PHYS REV LETT, V57, P70, DOI 10.1103/PhysRevLett.57.70; Mewes MO, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.011403; Mewes MO, 1996, PHYS REV LETT, V77, P416, DOI 10.1103/PhysRevLett.77.416; Modawi AGK, 1997, J LOW TEMP PHYS, V109, P625; Molmer K, 1998, PHYS REV LETT, V80, P1804, DOI 10.1103/PhysRevLett.80.1804; Myatt CJ, 1997, PHYS REV LETT, V78, P586, DOI 10.1103/PhysRevLett.78.586; O'Hara KM, 2000, PHYS REV LETT, V85, P2092, DOI 10.1103/PhysRevLett.85.2092; Sackett CA, 1997, APPL PHYS B-LASERS O, V65, P433, DOI 10.1007/s003400050293; Shapiro S.L., 1983, BLACK HOLES WHITE DW; Stoof HTC, 1996, PHYS REV LETT, V76, P10, DOI 10.1103/PhysRevLett.76.10; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Timmermans E, 1998, PHYS REV LETT, V80, P3419, DOI 10.1103/PhysRevLett.80.3419; vanAbeelen FA, 1997, PHYS REV A, V55, P4377, DOI 10.1103/PhysRevA.55.4377	26	698	707	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2570	2572		10.1126/science.1059318	http://dx.doi.org/10.1126/science.1059318			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283362				2022-12-28	WOS:000167861000032
J	Musselman, DL; Lawson, DH; Gumnick, JF; Manatunga, AK; Penna, S; Goodkin, RS; Greiner, K; Nemeroff, CB; Miller, AH				Musselman, DL; Lawson, DH; Gumnick, JF; Manatunga, AK; Penna, S; Goodkin, RS; Greiner, K; Nemeroff, CB; Miller, AH			Paroxetine for the prevention of depression induced by high-dose interferon alfa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA THERAPY; BEHAVIOR; ANTIDEPRESSANTS; RELIABILITY; INHIBITION; HEPATITIS; INDUCTION; CYTOKINES; CANCER; STATE	Background: Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with antidepressants have less severe depression-like symptoms after the administration of a cytokine. We sought to determine whether a similar strategy would be effective in humans. Methods: In a double-blind study of 40 patients with malignant melanoma who were eligible for high-dose interferon alfa therapy, we randomly assigned 20 patients to receive the antidepressant paroxetine and 20 to receive placebo. The treatment was begun 2 weeks before the initiation of interferon alfa and continued for the first 12 weeks of interferon alfa therapy. Results: During the first 12 weeks of interferon alfa therapy, symptoms consistent with a diagnosis of major depression developed in 2 of 18 patients in the paroxetine group (11 percent) and 9 of 20 patients in the placebo group (45 percent) (relative risk, 0.24; 95 percent confidence interval, 0.08 to 0.93). Severe depression necessitated the discontinuation of interferon alfa before 12 weeks in 1 of the 20 patients in the paroxetine group (5 percent), as compared with 7 patients in the placebo group (35 percent) (relative risk, 0.14; 95 percent confidence interval, 0.05 to 0.85). The incidence of adverse events was similar in the two groups. Conclusions: In patients with malignant melanoma, pretreatment with paroxetine appears to be an effective strategy for minimizing depression induced by interferon alfa. (N Engl J Med 2001;344:961-6.) Copyright (C) 2001 Massachusetts Medical Society.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health	Miller, AH (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.		Winwood, Peter/A-6363-2008	Nemeroff, Charles/0000-0001-7867-1160	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060723] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR30039] Funding Source: Medline; NIMH NIH HHS [MH00680, MH60723] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alter MJ, 1998, INFECT DIS CLIN N AM, V12, P13, DOI 10.1016/S0891-5520(05)70405-0; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Borden EC, 1998, SEMIN ONCOL, V25, P3; BROWN RR, 1991, ADV EXP MED BIOL, V294, P425; Capuron L, 1999, NEW ENGL J MED, V340, P1370, DOI 10.1056/NEJM199904293401716; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Collett D, 1994, MODELLING SURVIVAL D; FENTIMAN IS, 1985, LANCET, V1, P1166; First M. B., 1998, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GISSLINGER H, 1993, NEUROENDOCRINOLOGY, V57, P489, DOI 10.1159/000126396; Gleason OC, 1999, PSYCHOSOMATICS, V40, P510, DOI 10.1016/S0033-3182(99)71190-4; GOLDMAN LS, 1994, PSYCHOSOMATICS, V35, P41; GRASSI L, 1989, GEN HOSP PSYCHIAT, V11, P404, DOI 10.1016/0163-8343(89)90135-7; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEJNY C, IN PRESS AM J OPHTHA; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; LEVENSON JL, 1993, AM J GASTROENTEROL, V88, P760; LIcinio J, 1998, SEMIN ONCOL, V25, P30; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P370, DOI 10.1016/S0893-133X(98)00088-8; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; SCHULTZ M, 1989, LANCET, V1, P1452; Schutte NS, 1995, SOURCEBOOK ADULT ASS; Taylor JL, 1998, SEMIN ONCOL, V25, P23; Tollefson GD, 1998, TXB PSYCHOPHARMACOLO, p219 237; Valentine AD, 1998, SEMIN ONCOL, V25, P39; VALENTINE AD, 1995, CANCER INVEST, V13, P561, DOI 10.3109/07357909509024923; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd; Yamano M, 2000, J PHARMACOL EXP THER, V292, P181; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	34	759	790	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					961	966		10.1056/NEJM200103293441303	http://dx.doi.org/10.1056/NEJM200103293441303			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415HY	11274622				2022-12-28	WOS:000167716600003
J	Wien, FE; Cooperman, J				Wien, FE; Cooperman, J			Complication of cantor-tube insertion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Barnert Hosp, Paterson, NJ 07514 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Wien, FE (corresponding author), CUNY Mt Sinai Sch Med, New York, NY 10029 USA.								0	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					974	974		10.1056/NEJM200103293441305	http://dx.doi.org/10.1056/NEJM200103293441305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274624				2022-12-28	WOS:000167716600005
J	Wilson, RI; Nicoll, RA				Wilson, RI; Nicoll, RA			Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses	NATURE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; LONG-TERM POTENTIATION; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; MEMBRANE-FUSION; PYRAMIDAL CELLS; CA1 CELLS; N-TYPE; INHIBITION; RECEPTOR	Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1)(1-3), which is expressed throughout the brain at high levels(4). Two endogenous lipids, anandamide and 2-arachidonylglycerol (2-AG), have been identified as CB1 ligands(5,6). Depolarized hippocampal neurons rapidly release both anandamide and 2-AG in a Ca2+-dependent manner(6-8). In the hippocampus, CB1 is expressed mainly by GABA (gamma -aminobutyric acid)-mediated inhibitory interneurons, where CB1 clusters on the axon terminal(9-11). A synthetic CB1 agonist depresses GABA release from hippocampal slices(10,12) These findings indicate that the function of endogenous cannabinoids released by depolarized hippocampal neurons might be to downregulate GABA release. Here we show that the transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons(13) is mediated by retrograde signalling through release of endogenous cannabinoids. Signalling by the endocannabinoid system thus represents a mechanism by which neurons fan communicate backwards across synapses to modulate their inputs.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266				Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BINZ T, 1994, J BIOL CHEM, V269, P1617; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; CAULFIELD MP, 1992, BRIT J PHARMACOL, V106, P231, DOI 10.1111/j.1476-5381.1992.tb14321.x; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Katona I, 1999, J NEUROSCI, V19, P4544; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Morishita W, 2000, HIPPOCAMPUS, V10, P261, DOI 10.1002/1098-1063(2000)10:3<261::AID-HIPO6>3.3.CO;2-T; Morishita W, 1998, J NEUROSCI, V18, P4870; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x	30	1166	1192	3	90	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					588	592		10.1038/35069076	http://dx.doi.org/10.1038/35069076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279497				2022-12-28	WOS:000167859300049
J	Ho, BC; Andreasen, NC				Ho, BC; Andreasen, NC			Long delays in seeking treatment for schizophrenia	LANCET			English	Editorial Material							FIRST-EPISODE SCHIZOPHRENIA; UNTREATED PSYCHOSIS; 1ST EPISODES; DURATION		Univ Iowa, Coll Med, Dept Psychiat, Mental Hlth Clin Res Ctr, Iowa City, IA 52242 USA	University of Iowa	Ho, BC (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Mental Hlth Clin Res Ctr, Iowa City, IA 52242 USA.		Ho, Beng-Choon/D-6959-2011	Ho, Beng-Choon/0000-0003-3976-1555; Andreasen, Nancy/0000-0001-5730-9744				Barnes TRE, 2000, BRIT J PSYCHIAT, V177, P207, DOI 10.1192/bjp.177.3.207; Cornblatt B, 1998, BRIT J PSYCHIAT, V172, P26, DOI 10.1192/S0007125000297626; CROW TJ, 1986, BRIT J PSYCHIAT, V148, P120, DOI 10.1192/bjp.148.2.120; Drake RJ, 2000, BRIT J PSYCHIAT, V177, P511, DOI 10.1192/bjp.177.6.511; FALLOON IRH, 1992, PSYCHIATRY, V55, P4; GLASHAN TH, 1999, BIOL PSYCHIAT, V46, P899; Haas GL, 1998, J PSYCHIAT RES, V32, P151, DOI 10.1016/S0022-3956(98)00008-9; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P806; Johannessen J O, 1998, Seishin Shinkeigaku Zasshi, V100, P511; Jones PB, 2000, EUR ARCH PSY CLIN N, V250, P286, DOI 10.1007/s004060070003; Larsen TK, 1998, BRIT J PSYCHIAT, V172, P45, DOI 10.1192/S0007125000297651; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P241, DOI 10.1093/schbul/22.2.241; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P257, DOI 10.1093/schbul/22.2.257; Lieberman JA, 2000, AM J PSYCHIAT, V157, P1727, DOI 10.1176/appi.ajp.157.11.1727; McGorry P, 1999, RECOGNITION MANAGEME; McGorry PD, 1996, SCHIZOPHRENIA BULL, V22, P305, DOI 10.1093/schbul/22.2.305; Miller T J, 2000, Conn Med, V64, P339; Moller P, 2000, COMPR PSYCHIAT, V41, P184, DOI 10.1016/S0010-440X(00)90046-4; Rabinowitz J, 1998, AM J PSYCHIAT, V155, P1392, DOI 10.1176/ajp.155.10.1392; Verdoux H, 1998, EUR PSYCHIAT, V13, P346, DOI 10.1016/S0924-9338(99)80701-9	20	37	37	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					898	900		10.1016/S0140-6736(00)04228-8	http://dx.doi.org/10.1016/S0140-6736(00)04228-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413RG	11289340				2022-12-28	WOS:000167625300002
J	Wasner, G; Hilpert, F; Baron, R; Pfisterer, J				Wasner, G; Hilpert, F; Baron, R; Pfisterer, J			Clinical picture: Nail changes secondary to docetaxel	LANCET			English	Editorial Material									Univ Kiel Klinikum, Kliniken Neurol, D-24105 Kiel, Germany; Univ Kiel Klinikum, Kliniken Gynakol & Geburtshilfe, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Wasner, G (corresponding author), Univ Kiel Klinikum, Kliniken Neurol, D-24105 Kiel, Germany.		Baron, Ralf/E-4298-2010						0	33	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					910	910		10.1016/S0140-6736(00)04210-0	http://dx.doi.org/10.1016/S0140-6736(00)04210-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289346				2022-12-28	WOS:000167625300008
J	Zhu, H; Bunn, HF				Zhu, H; Bunn, HF			Signal transduction - How do cells sense oxygen?	SCIENCE			English	Editorial Material							TUMOR-SUPPRESSOR PROTEIN; DEGRADATION DOMAIN; ALPHA		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Hematol Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhu, H (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Hematol Div, Boston, MA 02115 USA.		Jaakkola, Panu M/B-4355-2012		NIDDK NIH HHS [F32 DK009678, K01 DK059901-01, F32 DK009678-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009678, K01DK059901] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Fu XW, 2000, P NATL ACAD SCI USA, V97, P4374, DOI 10.1073/pnas.97.8.4374; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KRETZMAN T, 2000, NEWS PHYSIOL SCI, V15, P202; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	16	98	106	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					449	+		10.1126/science.1060849	http://dx.doi.org/10.1126/science.1060849			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11292863	Green Accepted			2022-12-28	WOS:000168187300030
J	Kaul, M; Garden, GA; Lipton, SA				Kaul, M; Garden, GA; Lipton, SA			Pathways to neuronal injury and apoptosis in HIV-associated dementia	NATURE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; METHYL-D-ASPARTATE; NEUROCOGNITIVELY IMPAIRED INDIVIDUALS; CULTURED HIPPOCAMPAL-NEURONS; PLATELET-ACTIVATING-FACTOR; CHEMOKINE RECEPTOR CXCR4; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID	Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors) provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute. These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating these events offer hope for therapeutic intervention.	Burnham Inst, Ctr Neurosci & Aging Res, La Jolla, CA 92037 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Washington; University of Washington Seattle	Kaul, M (corresponding author), Burnham Inst, Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Garden, Gwenn/CAF-9344-2022; Kaul, Marcus/AAS-8955-2020	Garden, Gwenn/0000-0002-8753-6515; Lipton, Stuart/0000-0002-3490-1259				Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bhat NR, 1998, J NEUROSCI, V18, P1633; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; Brew BJ, 1995, J NEUROVIROL, V1, P369, DOI 10.3109/13550289509111026; Brew BJ, 1997, J INFECT DIS, V175, P963, DOI 10.1086/514001; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Canki M, 1997, J NEUROVIROL, V3, P10, DOI 10.3109/13550289709015788; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Clifford DB, 2000, ARCH NEUROL-CHICAGO, V57, P321, DOI 10.1001/archneur.57.3.321; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cunningham PH, 2000, AIDS, V14, P1949, DOI 10.1097/00002030-200009080-00010; Dore GJ, 1997, J ACQ IMMUN DEF SYND, V16, P39, DOI 10.1097/00042560-199709010-00006; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Enting RH, 1998, AIDS, V12, P1941, DOI 10.1097/00002030-199815000-00005; Everall IP, 1999, BRAIN PATHOL, V9, P209; Ferrando S, 1998, AIDS, V12, pF65, DOI 10.1097/00002030-199808000-00002; Fiala M, 1997, MOL MED, V3, P553, DOI 10.1007/BF03401701; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fontana G, 1997, J NEUROSCI RES, V49, P732, DOI 10.1002/(SICI)1097-4547(19970915)49:6<732::AID-JNR7>3.0.CO;2-8; Fox L, 1997, J NEUROPATH EXP NEUR, V56, P360, DOI 10.1097/00005072-199704000-00004; GARDEN GA, 2000, SOC NEUR ABSTR, V26, P1062; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; GENDELMAN HE, 1994, ADV NEUROIMMUNOL, V4, P189, DOI 10.1016/S0960-5428(06)80256-1; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Giulian D, 1996, J NEUROSCI, V16, P3139; GIULIAN D, 1993, P NATL ACAD SCI USA, V90, P2769, DOI 10.1073/pnas.90.7.2769; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; Kalams SA, 1995, CURR TOP MICROBIOL, V202, P79; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Letendre SL, 1999, J INFECT DIS, V180, P310, DOI 10.1086/314866; Limatola C, 2000, EUR J NEUROSCI, V12, P2497, DOI 10.1046/j.1460-9568.2000.00139.x; Lipton SA, 1997, SCIENCE, V276, P1629; LIPTON SA, 1993, TRENDS NEUROSCI, V16, P527, DOI 10.1016/0166-2236(93)90198-U; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; LIPTON SA, 1991, NEURON, V7, P111, DOI 10.1016/0896-6273(91)90079-F; LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Major EO, 2000, SCIENCE, V288, P440; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Michael NL, 1999, NAT MED, V5, P740, DOI 10.1038/10462; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Navia BA, 1998, NEUROLOGY, V51, P221, DOI 10.1212/WNL.51.1.221; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; PETITO CK, 1995, AM J PATHOL, V146, P1121; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; ProsperoGarcia O, 1996, P NATL ACAD SCI USA, V93, P14158, DOI 10.1073/pnas.93.24.14158; PULLIAM L, 1991, J CLIN INVEST, V87, P503, DOI 10.1172/JCI115024; Pulliam L, 1998, J NEUROSCI RES, V54, P530, DOI 10.1002/(SICI)1097-4547(19981115)54:4<530::AID-JNR10>3.0.CO;2-1; Rottman JB, 1997, AM J PATHOL, V151, P1341; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2000, NEUROLOGY, V54, P233, DOI 10.1212/WNL.54.1.233; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; SASSEVILLE VG, 1994, AM J PATHOL, V144, P27; Schifitto G, 1999, NEUROLOGY, V53, P391, DOI 10.1212/WNL.53.2.391; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Tenneti L, 1998, J NEUROCHEM, V71, P946; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Toggas SM, 1996, BRAIN RES, V706, P303, DOI 10.1016/0006-8993(95)01197-8; Toneatto S, 1999, AIDS, V13, P2343, DOI 10.1097/00002030-199912030-00005; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Wesselingh SL, 1997, J NEUROIMMUNOL, V74, P1, DOI 10.1016/S0165-5728(96)00160-9; Wiley CA, 1998, BRAIN PATHOL, V8, P277; WyssCoray T, 1996, J CLIN INVEST, V97, P789, DOI 10.1172/JCI118478; Xiong HG, 2000, J NEUROVIROL, V6, pS14; Yeh MW, 2000, J IMMUNOL, V164, P4265, DOI 10.4049/jimmunol.164.8.4265; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	96	980	1016	2	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					988	994		10.1038/35073667	http://dx.doi.org/10.1038/35073667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309629				2022-12-28	WOS:000168152300059
J	Wolfson, C; Wolfson, DB; Asgharian, M; M'Lan, CE; Ostbye, T; Rockwood, K; Hogan, DB				Wolfson, C; Wolfson, DB; Asgharian, M; M'Lan, CE; Ostbye, T; Rockwood, K; Hogan, DB		Clin Progression Dementia Study Gr	A reevaluation of the duration of survival after the onset of dementia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE PATIENTS; 7-YEAR FOLLOW-UP; INCREASED RISK; DIAGNOSIS; MORTALITY; HEALTH; PREDICTORS; DEATH	Background: Dementia shortens life expectancy; estimates of median survival after the onset of dementia have ranged from 5 to 9.3 years. Previous studies of people with existing dementia, however, may have underestimated the deleterious effects of dementia on survival by failing to consider persons with rapidly progressive illness who died before they could be included in a study (referred to as length bias). Methods: We used data from the Canadian Study of Health and Aging to estimate survival from the onset of symptoms of dementia; the estimate was adjusted for length bias. A random sample of 10,263 subjects 65 years old or older from throughout Canada was screened for cognitive impairment. For those with dementia, we ascertained the date of onset and conducted follow-up for five years. Results: We analyzed data on 821 subjects, of whom 396 had probable Alzheimer's disease, 252 had possible Alzheimer's disease, and 173 had vascular dementia. For the group as a whole, the unadjusted median survival was 6.6 years (95 percent confidence interval, 6.2 to 7.1). After adjustment for length bias, the estimated median survival was 3.3 years (95 percent confidence interval, 2.7 to 4.0). The median survival was 3.1 years for subjects with probable Alzheimer's disease, 3.5 years for subjects with possible Alzheimer's disease, and 3.3 years for subjects with vascular dementia. Conclusions: Median survival after the onset of dementia is much shorter than has previously been estimated. (N Engl J Med 2001;344:1111-6.) Copyright (C) 2001 Massachusetts Medical Society.	McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; McGill Univ, Div Geriatr Med, Montreal, PQ, Canada; McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; Duke Univ, Dept Community & Family Med, Durham, NC USA; Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada; Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada	McGill University; McGill University; McGill University; York University - Canada; Duke University; Dalhousie University; University of Calgary	Wolfson, C (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Ctr Clin Epidemiol & Community Studies, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	tinaw@epid.jgh.mcgill.ca	Hogan, David Bryan/I-4360-2013; Rockwood, Kenneth/AAD-8951-2019	Hogan, David Bryan/0000-0002-9462-5460; 				Aevarsson O, 1998, ARCH NEUROL-CHICAGO, V55, P1226, DOI 10.1001/archneur.55.9.1226; Aguero-Torres H, 1998, J AM GERIATR SOC, V46, P444, DOI 10.1111/j.1532-5415.1998.tb02464.x; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BARCLAY LL, 1986, NEUROLOGY, V36, P1009, DOI 10.1212/WNL.36.7.1009-c; BARCLAY LL, 1985, NEUROLOGY, V35, P834, DOI 10.1212/WNL.35.6.834; BEARD CM, 1994, NEUROLOGY, V44, P1869, DOI 10.1212/WNL.44.10.1869; BONAIUTO S, 1995, ARCH GERONTOL GERIAT, V20, P105, DOI 10.1016/0167-4943(94)00612-B; DIESFELDT HFA, 1986, ACTA PSYCHIAT SCAND, V73, P366, DOI 10.1111/j.1600-0447.1986.tb02697.x; Doraiswamy PM, 1998, J CLIN PSYCHIAT, V59, P6; Gambassi G, 1999, NEUROLOGY, V53, P508, DOI 10.1212/WNL.53.3.508; Geerlings MI, 1997, NEUROLOGY, V49, P798, DOI 10.1212/WNL.49.3.798; Graham JE, 1996, NEUROEPIDEMIOLOGY, V15, P246, DOI 10.1159/000109914; HABBEMA JDF, 1986, NEUROLOGY, V36, P1009, DOI 10.1212/WNL.36.7.1009-b; Heyman A, 1996, NEUROLOGY, V46, P656, DOI 10.1212/WNL.46.3.656; HIER DB, 1989, ARCH NEUROL-CHICAGO, V46, P1213, DOI 10.1001/archneur.1989.00520470073030; Knopman D S, 1998, Am J Med, V104, p2S, DOI 10.1016/S0002-9343(98)00022-9; MAGNUSSON H, 1989, ACTA PSYCHIAT SCAND, V79, P67; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; MCDOWELL I, 1994, CAN J AGING, V13, P470; MCGONIGAL G, 1992, NEUROEPIDEMIOLOGY, V11, P121, DOI 10.1159/000110921; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOLSA PK, 1986, ACTA NEUROL SCAND, V74, P103; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; ROUAH F, IN PRESS INT PSYCHOG; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; STERN Y, 1995, ANN NEUROL, V37, P590, DOI 10.1002/ana.410370508; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TUOKKO H, 1995, J CLIN EXP NEUROPSYC, V17, P352, DOI 10.1080/01688639508405129; VANDIJK PTM, 1991, J AM GERIATR SOC, V39, P603, DOI 10.1111/j.1532-5415.1991.tb03602.x; WALSH JS, 1990, ANN INTERN MED, V113, P429, DOI 10.7326/0003-4819-113-6-429; WANG MC, 1991, J AM STAT ASSOC, V86, P130, DOI 10.2307/2289722; *WHO, 1992, INT STAT CLASS DIS R, P25	35	409	414	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1111	1116		10.1056/NEJM200104123441501	http://dx.doi.org/10.1056/NEJM200104123441501			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297701	Bronze			2022-12-28	WOS:000167990600001
J	Edinger, JD; Wohlgemuth, WK; Radtke, RA; Marsh, GR; Quillian, RE				Edinger, JD; Wohlgemuth, WK; Radtke, RA; Marsh, GR; Quillian, RE			Cognitive behavioral therapy for treatment of chronic primary insomnia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-MAINTENANCE INSOMNIA; LATE-LIFE INSOMNIA; NONPHARMACOLOGIC TREATMENT; PSYCHIATRIC-DISORDERS; TREATMENT EFFICACY; STIMULUS-CONTROL; DRUG USE; DEPRESSION; PREVALENCE; METAANALYSIS	Context Use of nonpharmacological behavioral therapy has been suggested for treatment of chronic primary insomnia, but well-blinded, placebo-controlled trials demonstrating effective behavioral therapy for sleep-maintenance insomnia are lacking. Objective To test the efficacy of a hybrid cognitive behavioral therapy (CBT) compared with both a first-generation behavioral treatment and a placebo therapy for treating primary sleep-maintenance insomnia. Design and Setting Randomized, double-blind, placebo-controlled clinical trial conducted at a single academic medical center, with recruitment from January 1995 to Patients Seventy-five adults (n = 35 women; mean age, 55.3 years) with chronic primary sleep-maintenance insomnia (mean duration of symptoms, 13.6 years). Interventions Patients were randomly assigned to receive CBT (sleep education, stimulus control, and time-in-bed restrictions; n = 25), progressive muscle relaxation training (RT; n = 25), ora quasi-desensitization (placebo) treatment (n = 25). Outpatient treatment lasted 6 weeks, with follow-up conducted at 6 months. Main Outcome Measures Objective (polysomnography) and subjective (steep log) measures of total sleep time, middle and terminal wake time after sleep onset (WASO), and sleep efficiency; questionnaire measures of global insomnia symptoms, sleep related self-efficacy, and mood. Results Cognitive behavioral therapy produced larger improvements across the majority of outcome measures than did RT or placebo treatment. For example, sleep logs showed that CBT-treated patients achieved an average 54% reduction in their WASO whereas RT-treated and placebo-treated patients, respectively, achieved only 16% and 12% reductions in this measure. Recipients of CBT also showed a greater normalization of sleep and subjective symptoms than did the other groups with an average sleep time of more than 6 hours, middle WASO of 26.6 minutes, and sleep efficiency of 85.1%. In contrast, RT-treated patients continued to report a middle WASO of 43.3 minutes and sleep efficiency of 78.8%. Conclusions Our results suggest that CBT represents a viable intervention for primary sleep-maintenance insomnia. This treatment leads to clinically significant sleep improvements within 6 weeks and these improvements appear to endure through 6 months of follow-up.	VA Med Ctr, Psychol Serv 1168, Durham, NC 27705 USA; Duke Univ, Med Ctr, Durham, NC USA	Duke University	Edinger, JD (corresponding author), VA Med Ctr, Psychol Serv 1168, 508 Fulton St, Durham, NC 27705 USA.			Wolever, Ruth Q./0000-0003-2899-218X	NIMH NIH HHS [R01-MH48187] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048187] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1990, STRUCTURED CLIN INTE; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bernstein D.A., 1973, PROGR RELAXATION TRA; Bonnet MH, 1994, PRINCIPLES PRACTICE, P50; BORKOVEC T, 1972, J BEHAV THER EXP PSY, V3, P247; CALLAHAN L F, 1988, Arthritis and Rheumatism, V31, pS76; Carskadon MA., 1994, PRINCIPLES PRACTICE, P943; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Chesson AL, 1999, SLEEP, V22, P1128, DOI 10.1093/sleep/22.8.1128; COURSEY RD, 1975, J ABNORM PSYCHOL, V84, P239, DOI 10.1037/h0076716; Davies R, 1986, Psychol Aging, V1, P233, DOI 10.1037/0882-7974.1.3.233; *DIAGN CLASS STEER, 1990, ICSD INT CLASS SLEEP; EDINGER JD, 1992, PSYCHOL AGING, V7, P282, DOI 10.1037/0882-7974.7.2.282; EDINGER JD, 1988, PSYCHOSOM MED, V50, P77, DOI 10.1097/00006842-198801000-00010; Foley DJ, 1999, SLEEP, V22, pS366; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; *GALL ORG, 1991, SLEEP AM; *GALL ORG, 1995, SLEEP AM; GOLDBERG SC, 1987, PSYCHOPHARMACOLOGY 3, P1005; GREENBLATT DJ, 1992, J CLIN PSYCHIAT, V53, P7; HAURI P, 1994, PRINCIPLES PRACTICE, P494; HOELSCHER TJ, 1989, SLEEP, V12, P133; HOELSCHER TJ, 1988, PSYCHOL AGING, V3, P258, DOI 10.1037/0882-7974.3.3.258; Institute of Medicine, 1979, SLEEP PILLS INS MED; JOHNSON LC, 1982, PSYCHOPHARMACOLOGY, V76, P101, DOI 10.1007/BF00435262; KALES A, 1974, JAMA-J AM MED ASSOC, V227, P513, DOI 10.1001/jama.227.5.513; KALES A, 1976, ARCH GEN PSYCHIAT, V33, P1128; LACKS P, 1983, BEHAV RES THER, V21, P291, DOI 10.1016/0005-7967(83)90211-5; Lacks p, 1987, BEHAV TREATMENT PERS; LIVINGSTON G, 1993, BRIT J GEN PRACT, V43, P445; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; MORIN CM, 1987, J CONSULT CLIN PSYCH, V55, P260, DOI 10.1037/0022-006X.55.2.260; MORIN CM, 1993, J CONSULT CLIN PSYCH, V61, P137, DOI 10.1037/0022-006X.61.1.137; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; *NAT COMM SLEEP DI, 1994, WAK AM NAT SLEEP AL, V2; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; RECHTSHAFFEN A, 1968, MANUAL STANDARDIZED; REHM LP, 1976, BEHAVIORAL ASSESSMEN, P233; SCHRAMM E, 1993, AM J PSYCHIAT, V150, P867; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; SPIELMAN AJ, 1987, SLEEP, V10, P45; STEINMARK SW, 1974, J ABNORM PSYCHOL, V83, P157, DOI 10.1037/h0036489; STOLLER MK, 1994, CLIN THER, V16, P873; THORESEN C E, 1981, Journal of Behavioral Medicine, V4, P41, DOI 10.1007/BF00844846; VOLLRATH M, 1989, EUR ARCH PSY CLIN N, V239, P113, DOI 10.1007/BF01759584; Walsh JK, 1999, SLEEP, V22, P371; Weissman MM, 1997, GEN HOSP PSYCHIAT, V19, P245, DOI 10.1016/S0163-8343(97)00056-X; WEYERER S, 1991, SLEEP, V14, P392; [No title captured]	55	389	410	3	58	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1856	1864		10.1001/jama.285.14.1856	http://dx.doi.org/10.1001/jama.285.14.1856			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418DY	11308399	Bronze			2022-12-28	WOS:000167876700026
J	Kelly, C; Newby, DE; Boon, NA; Douglas, NJ				Kelly, C; Newby, DE; Boon, NA; Douglas, NJ			Support ventilation versus conventional oxygen	LANCET			English	Letter							POSITIVE AIRWAY PRESSURE; CARDIOGENIC PULMONARY-EDEMA; FACE MASK		Univ Edinburgh, Royal Infirm, Dept Resp Med, Edinburgh EH3 9YW, Midlothian, Scotland; Univ Edinburgh, Royal Infirm, Dept Cardiol, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Kelly, C (corresponding author), Univ Edinburgh, Royal Infirm, Dept Resp Med, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.		Newby, David Ernest/AAB-1364-2019; Douglas, Neil/B-1491-2013					BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; RASANEN J, 1985, AM J CARDIOL, V55, P296, DOI 10.1016/0002-9149(85)90364-9	5	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1126	1126		10.1016/S0140-6736(00)04272-0	http://dx.doi.org/10.1016/S0140-6736(00)04272-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11303601				2022-12-28	WOS:000167996200039
J	Tatar, M; Kopelman, A; Epstein, D; Tu, MP; Yin, CM; Garofalo, RS				Tatar, M; Kopelman, A; Epstein, D; Tu, MP; Yin, CM; Garofalo, RS			A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function	SCIENCE			English	Article							REPRODUCTIVE DIAPAUSE; GENE; MELANOGASTER; REDUCTION; EXTENSION; SURVIVAL; DIPTERA; CHICO	The Drosophila melanogaster gene insulin-like receptor (InR) is homologous to mammalian insulin receptors as well as to Caenorhabditis elegans daf-2, a signal transducer regulating worm dauer formation and adult Longevity. We describe a heteroallelic, hypomorphic genotype of mutant InR, which yields dwarf females with up to an 85% extension of adult longevity and dwarf males with reduced Late age-specific mortality. Treatment of the Long-lived InR dwarfs with a juvenile hormone analog restores Life expectancy toward that of wild-type controls. We conclude that juvenile hormone deficiency, which results from InR signal pathway mutation, is sufficient to extend life-span, and that in flies, insulin-like Ligands nonautonomously mediate aging through retardation of growth or activation of specific endocrine tissue.	Brown Univ, Providence, RI 02912 USA; Univ Massachusetts, Amherst, MA 01003 USA; Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA	Brown University; University of Massachusetts System; University of Massachusetts Amherst; Pfizer	Tatar, M (corresponding author), Brown Univ, Providence, RI 02912 USA.	Marc_Tatar@Brown.edu		Tatar, Marc/0000-0003-3232-6884	NATIONAL INSTITUTE ON AGING [R01AG016632] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG16632] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTARATZ M, 1991, MOL CELL ENDOCRINOL, V81, P205, DOI 10.1016/0303-7207(91)90219-I; BARTKE A, 2000, MOL GENETICS AGING, V29; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Davey KG, 2000, INSECT BIOCHEM MOLEC, V30, P877, DOI 10.1016/S0965-1748(00)00061-8; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kimura MT, 1988, FUNCT ECOL, V2, P177, DOI 10.2307/2389693; KIMURA MT, 1992, J INSECT PHYSIOL, V38, P871, DOI 10.1016/0022-1910(92)90098-X; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LUMME J, 1974, J INSECT PHYSIOL, V20, P2023, DOI 10.1016/0022-1910(74)90109-7; MARINHINCAPIE M, 1995, ENDOCRINOLOGY, V136, P2357, DOI 10.1210/en.136.6.2357; Nagi MN, 1995, BIOCHEM MOL BIOL INT, V36, P633; PENER MP, 1992, CHRONOBIOL INT, V9, P102, DOI 10.3109/07420529209064521; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; SAUNDERS DS, 1990, GEN COMP ENDOCR, V79, P174, DOI 10.1016/0016-6480(90)90102-R; SCIACCHITANO S, UNPUB; Spradling Allan C., 1993, P1; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; TATAR M, IN PRESS AM NAT; Tu MP, 2001, J INSECT PHYSIOL, V47, P233, DOI 10.1016/S0022-1910(00)00110-4	29	1175	1234	5	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					107	110		10.1126/science.1057987	http://dx.doi.org/10.1126/science.1057987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292875				2022-12-28	WOS:000167995200049
J	Jayaraman, KS				Jayaraman, KS			Indian rocket fizzles out as test launch fails to fly	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					619	619		10.1038/35070762	http://dx.doi.org/10.1038/35070762			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287916	Bronze			2022-12-28	WOS:000167875400013
J	Ozcan, C; Jahangir, A; Friedman, PA; Patel, PJ; Munger, TM; Rea, RF; Lloyd, MA; Packer, DL; Hodge, DO; Gersh, BJ; Hammill, SC; Shen, WK				Ozcan, C; Jahangir, A; Friedman, PA; Patel, PJ; Munger, TM; Rea, RF; Lloyd, MA; Packer, DL; Hodge, DO; Gersh, BJ; Hammill, SC; Shen, WK			Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CATHETER ABLATION; FOLLOW-UP; PHARMACOLOGICAL TREATMENT; ANTIARRHYTHMIC DRUGS; JUNCTION ABLATION; NATURAL-HISTORY; HEART-FAILURE; MORTALITY; RISK; POPULATION	Background: In patients with atrial fibrillation that is refractory to drug therapy, radio-frequency ablation of the atrioventricular node and implantation of a permanent pacemaker are an alternative therapeutic approach. The effect of this procedure on long-term survival is unknown. Methods: We studied all patients who underwent ablation of the atrioventricular node and implantation of a permanent pacemaker at the Mayo Clinic between 1990 and 1998. Observed survival was compared with the survival rates in two control populations: age- and sex-matched members of the Minnesota population between 1970 and 1990 and consecutive patients with atrial fibrillation who received drug therapy in 1993. Results: A total of 350 patients (mean [+/-SD] age, 68+/-11 years) were studied. During a mean of 36+/-26 months of follow-up, 78 patients died. The observed survival rate was significantly lower than the expected survival rate based on the general Minnesota population (P<0.001). Previous myocardial infarction (P<0.001), a history of congestive heart failure (P=0.02), and treatment with cardiac drugs after ablation (P=0.03) were independent predictors of death. Observed survival among patients without these three risk factors was similar to expected survival (P=0.43). None of the 26 patients with lone atrial fibrillation died during follow-up (37+/-27 months). The observed survival rate among patients who underwent ablation was similar to that among 229 controls with atrial fibrillation (mean age, 67+/-12 years) who received drug therapy (P=0.44). Conclusions: In the absence of underlying heart disease, survival among patients with atrial fibrillation after ablation of the atrioventricular node is similar to expected survival in the general population. Long-term survival is similar for patients with atrial fibrillation, whether they receive ablation or drug therapy. Control of the ventricular rate by ablation of the atrioventricular node and permanent pacing does not adversely affect long-term survival. (N Engl J Med 2001;344:1043-51.) Copyright (C) 2001 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Shen, WK (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1St St SW, Rochester, MN 55905 USA.		Jahangir, Arshad/M-7916-2016					*AM HEART ASS, 1999, 2000 HEART STROK STA; ANTMAN EM, 1990, J AM COLL CARDIOL, V15, P698, DOI 10.1016/0735-1097(90)90649-A; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Brignole M, 1998, CIRCULATION, V98, P953, DOI 10.1161/01.CIR.98.10.953; Brignole M, 1996, PACE, V19, P348, DOI 10.1111/j.1540-8159.1996.tb03337.x; Brignole M, 1997, CIRCULATION, V96, P2617, DOI 10.1161/01.CIR.96.8.2617; Brignole M, 1998, HEART, V79, P531, DOI 10.1136/hrt.79.6.531; COX DR, 1972, J R STAT SOC B, V34, P187; CRIJNS HJ, 1991, AM J CARDIOL, V68, P335, DOI 10.1016/0002-9149(91)90828-9; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Fitzpatrick AP, 1996, AM HEART J, V131, P499, DOI 10.1016/S0002-8703(96)90528-1; GAJEWSKI J, 1981, JAMA-J AM MED ASSOC, V245, P1540; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kay GN, 1998, J INTERV CARD ELECTR, V2, P121, DOI 10.1023/A:1009795330454; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Marshall HJ, 1998, HEART, V79, P543, DOI 10.1136/hrt.79.6.543; Nemec J, 1999, Expert Opin Pharmacother, V1, P81, DOI 10.1517/14656566.1.1.81; OLGIN JE, 1993, J AM COLL CARDIOL, V21, P557, DOI 10.1016/0735-1097(93)90084-E; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; PRITCHETT ELC, 1992, NEW ENGL J MED, V326, P1264; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; SCHEINMAN MM, 1982, JAMA-J AM MED ASSOC, V248, P851, DOI 10.1001/jama.248.7.851; Therneau TMSJ, 1994, TECHNICAL REPORT SER, V52; Touboul P, 1999, AM J CARDIOL, V83, p241D; TROHMAN RG, 1992, AM J CARDIOL, V70, P1438, DOI 10.1016/0002-9149(92)90296-B; TWIDALE N, 1993, PACE, V16, P1275, DOI 10.1111/j.1540-8159.1993.tb01714.x; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; ZEHENDER M, 1992, J AM COLL CARDIOL, V19, P1054, DOI 10.1016/0735-1097(92)90294-W	33	224	231	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1043	1051		10.1056/NEJM200104053441403	http://dx.doi.org/10.1056/NEJM200104053441403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287974	Bronze			2022-12-28	WOS:000167860400003
J	Safran, C				Safran, C			Electronic medical records: A decade of experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTER; CARE		Clinician Support Technol, Framingham, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Safran, C (corresponding author), Clinician Support Technol, Framingham, MA USA.							BLEICH HL, 1985, NEW ENGL J MED, V312, P756, DOI 10.1056/NEJM198503213121205; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; Patel VL, 2000, TEACH LEARN MED, V12, P117, DOI 10.1207/S15328015TLM1203_2; SAFRAN C, 1995, M D COMPUT, V12, P187; Safran C, 1999, METHOD INFORM MED, V38, P308; Safran C, 1998, ARTIF INTELL MED, V12, P137, DOI 10.1016/S0933-3657(97)00047-X; SAFRAN C, 1991, M D COMPUT, V8, P291; SAFRAN C, 1995, LANCET, V346, P341, DOI 10.1016/S0140-6736(95)92226-1	8	25	25	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1766	1766		10.1001/jama.285.13.1766	http://dx.doi.org/10.1001/jama.285.13.1766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277836	hybrid			2022-12-28	WOS:000167710600035
J	Burns, A; Dening, T; Baldwin, R				Burns, A; Dening, T; Baldwin, R			Care of older people - Mental health problems	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; ALZHEIMERS-DISEASE; GENERAL-PRACTICE; ELDERLY PEOPLE; ILL PATIENTS; DEPRESSION; DEMENTIA; INTERVENTION; DONEPEZIL; DIAGNOSIS		Univ Manchester, Withington Hosp, Dept Psychiat, Manchester M20 8LR, Lancs, England; Fulbourne Hosp, Cambridge CB1 5EF, England; Manchester Royal Infirm, Manchester M13 9BX, Lancs, England	University of Manchester; University of Manchester	Burns, A (corresponding author), Univ Manchester, Withington Hosp, Dept Psychiat, Manchester M20 8LR, Lancs, England.		Dening, Tom/E-1335-2013	Dening, Tom/0000-0003-3387-4241; Burns, Alistair/0000-0002-9837-0645				ANSTEY K, 1995, INT J GERIATR PSYCH, V10, P265, DOI 10.1002/gps.930100403; Arthur A, 1999, INT J GERIATR PSYCH, V14, P431, DOI 10.1002/(SICI)1099-1166(199906)14:6<431::AID-GPS937>3.3.CO;2-9; Audit Commission, 2000, FORG ME NOT MENT HLT; BALDWIN RC, 1997, ADV OLD AGE PSYCHIAT, P194; Banerjee S, 1996, BRIT MED J, V313, P1058; BOSENQUET N, 1998, ALZHEIMERS DIS UK BU; BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; BURNS A, 2001, CLIN GUIDELINES OLD; Burns A., 1999, ASSESSMENT SCALES OL; Collinson Y, 1998, INT J GERIATR PSYCH, V13, P159, DOI 10.1002/(SICI)1099-1166(199803)13:3<159::AID-GPS747>3.3.CO;2-D; Crawford MJ, 1998, INT J GERIATR PSYCH, V13, P172, DOI 10.1002/(SICI)1099-1166(199803)13:3<172::AID-GPS754>3.3.CO;2-3; Dening T, 1998, INT J GERIATR PSYCH, V13, P863; Donaldson C, 1998, INT J GERIATR PSYCH, V13, P248; Donaldson C, 1997, BRIT J PSYCHIAT, V170, P62, DOI 10.1192/bjp.170.1.62; Draper B, 2000, INT J GERIATR PSYCH, V15, P687, DOI 10.1002/1099-1166(200008)15:8<687::AID-GPS181>3.0.CO;2-K; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; Evans M, 1997, INT J GERIATR PSYCH, V12, P817, DOI 10.1002/(SICI)1099-1166(199708)12:8<817::AID-GPS645>3.0.CO;2-4; FRIEDHOFF AJ, 1992, JAMA-J AM MED ASSOC, V268, P1018, DOI 10.1001/jama.1992.03490080092032; Furniss L, 2000, BRIT J PSYCHIAT, V176, P563, DOI 10.1192/bjp.176.6.563; Greenberg SM, 2000, ARCH NEUROL-CHICAGO, V57, P94, DOI 10.1001/archneur.57.1.94; Howard R, 2000, AM J PSYCHIAT, V157, P172, DOI 10.1176/appi.ajp.157.2.172; ILIFFE S, 1991, BRIT J GEN PRACT, V41, P9; JACKSON R, 1993, AGE AGEING, V22, P349, DOI 10.1093/ageing/22.5.349; JACOBY R, 1993, BRIT J PSYCHIAT, V162, P175; Kitwood T., 1997, DEMENTIA RECONSIDERE; Koder DA, 1996, INT J GERIATR PSYCH, V11, P97, DOI 10.1002/(SICI)1099-1166(199602)11:2<97::AID-GPS310>3.0.CO;2-W; Lebowitz BD, 1997, JAMA-J AM MED ASSOC, V278, P1186, DOI 10.1001/jama.278.14.1186; LINDESAY J, 1997, INT J GERIATRIC PSYC, V12, P155; LoGiudice D, 1999, INT J GERIATR PSYCH, V14, P626, DOI 10.1002/(SICI)1099-1166(199908)14:8<626::AID-GPS990>3.0.CO;2-5; Lovestone S, 1997, LANCET, V350, P232, DOI 10.1016/S0140-6736(05)62221-0; Marriott A, 2000, BRIT J PSYCHIAT, V176, P557, DOI 10.1192/bjp.176.6.557; Matthews HP, 2000, INT J GERIATR PSYCH, V15, P713, DOI 10.1002/1099-1166(200008)15:8<713::AID-GPS187>3.0.CO;2-I; MELZER D, IN PRESS HLTH CARE N; MITTELMAN MS, 1993, GERONTOLOGIST, V33, P730, DOI 10.1093/geront/33.6.730; MUTRAN EJ, 1995, J GERONTOL, V50, P354; PALMER C, 1999, EVIDENCE BASED BRIEF; Pinner G, 2000, BRIT J PSYCHIAT, V176, P514, DOI 10.1192/bjp.176.6.514; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; *SCOTT INT GUID NE, 1997, INT MAN BEH PSYCH AS; Slaets JPJ, 1997, PSYCHOSOM MED, V59, P585, DOI 10.1097/00006842-199711000-00005; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; van Crevel H, 1999, J NEUROL, V246, P73, DOI 10.1007/s004150050311; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445	45	24	24	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					789	791		10.1136/bmj.322.7289.789	http://dx.doi.org/10.1136/bmj.322.7289.789			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419HL	11282872	Green Published			2022-12-28	WOS:000167943200035
J	Singer, PA; Benatar, SR				Singer, PA; Benatar, SR			Beyond Helsinki: a vision for global health ethics - Improving ethical behaviour depends on strengthening	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Toronto; University of Cape Town	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada.							Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824; Benatar SR, 2000, CAMB Q HEALTHC ETHIC, V9, P562, DOI 10.1017/S096318010000414X; Galbraith, 2018, ATLANTIC; Hofman K, 2000, J LAW MED ETHICS, V28, P174, DOI 10.1111/j.1748-720X.2000.tb00007.x; Iglehart JK, 1999, NEW ENGL J MED, V340, P70, DOI 10.1056/NEJM199901073400122; Nandy S, 2000, LANCET, V356, P1525, DOI 10.1016/S0140-6736(05)73275-X; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1; STEPHENS J, 2000, WASHINGTON POST 1217, pA10; Stross JK, 1996, J CONTIN EDUC HEALTH, V16, P167; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; WAKHWEYA AM, 1995, BRIT MED J, V311, P717	11	43	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					747	748		10.1136/bmj.322.7289.747	http://dx.doi.org/10.1136/bmj.322.7289.747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282846	Green Submitted, Green Published			2022-12-28	WOS:000167943200003
J	Taguchi, Y; Oohara, Y; Yoshizawa, H; Nagaosa, N; Tokura, Y				Taguchi, Y; Oohara, Y; Yoshizawa, H; Nagaosa, N; Tokura, Y			Spin chirality, Berry phase, and anomalous Hall effect in a frustrated ferromagnet	SCIENCE			English	Article							MAGNETORESISTANCE; MAGNETOTRANSPORT; R2MO2O7	An electron hopping on non-coplanar spin sites with spin chirality obtains a complex phase factor (Berry phase) in its quantum mechanical amplitude that acts as an internal magnetic field, and is predicted to manifest itself in the Hall effect when it is not cancelled. The present combined work of transport measurement, neutron scattering, and theoretical calculation provides evidence that the gigantic anomalous Hall effect observed in Nd2Mo2O7, a pyrochlore ferromagnet with geometrically frustrated Lattice structure, is mostly due to the spin chirality and the associated Berry phase originating from the Mo spin tilting.	Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Tokai, Ibaraki 3191106, Japan; CERC, Tsukuba, Ibaraki 3050046, Japan; JRCAT, Tsukuba, Ibaraki 3050046, Japan	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Taguchi, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.		Tokura, Yoshinori/C-7352-2009; Taguchi, Yasujiro/A-3048-2010; Nagaosa, Naoto/G-7057-2012	Tokura, Yoshinori/0000-0002-2732-4983; 				ALI N, 1989, J SOLID STATE CHEM, V83, P178, DOI 10.1016/0022-4596(89)90067-4; ANDERSON PW, 1955, PHYS REV, V100, P675, DOI 10.1103/PhysRev.100.675; BASKARAN G, 1988, PHYS REV B, V37, P580, DOI 10.1103/PhysRevB.37.580; Chun SH, 2000, PHYS REV LETT, V84, P757, DOI 10.1103/PhysRevLett.84.757; GAULIN BD, 1992, PHYS REV LETT, V69, P3244, DOI 10.1103/PhysRevLett.69.3244; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; JAN JP, 1952, PHYSICA, V18, P339, DOI 10.1016/S0031-8914(52)80157-0; KARPLUS R, 1954, PHYS REV, V95, P1154, DOI 10.1103/PhysRev.95.1154; Katsufuji T, 2000, PHYS REV LETT, V84, P1998, DOI 10.1103/PhysRevLett.84.1998; KONDO J, 1962, PROG THEOR PHYS, V27, P772, DOI 10.1143/PTP.27.772; LEE RS, 1967, PHYS REV, V162, P431, DOI 10.1103/PhysRev.162.431; Matl P, 1998, PHYS REV B, V57, P10248, DOI 10.1103/PhysRevB.57.10248; NAGAOSA N, 1990, PHYS REV LETT, V64, P2450, DOI 10.1103/PhysRevLett.64.2450; Ohgushi K, 2000, PHYS REV B, V62, pR6065, DOI 10.1103/PhysRevB.62.R6065; OOHARA Y, UNPUB; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; RAMIREZ AP, 1994, ANNU REV MATER SCI, V24, P453, DOI 10.1146/annurev.ms.24.080194.002321; Ye JW, 1999, PHYS REV LETT, V83, P3737, DOI 10.1103/PhysRevLett.83.3737	18	648	649	7	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2573	2576		10.1126/science.1058161	http://dx.doi.org/10.1126/science.1058161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283363				2022-12-28	WOS:000167861000033
J	Ng, CKY; Carr, K; McAinsh, MR; Powell, B; Hetherington, AM				Ng, CKY; Carr, K; McAinsh, MR; Powell, B; Hetherington, AM			Drought-induced guard cell signal transduction involves sphingosine-1-phosphate	NATURE			English	Article							CYTOSOLIC-FREE CALCIUM; STOMATAL CLOSURE; CHANNELS; OSCILLATIONS; ELEVATION; KINASE; CA-2+	Stomata form pores on leaf surfaces that regulate the uptake of CO2 for photosynthesis and the loss of water vapour during transpiration(1), An increase in the cytosolic concentration of free calcium ions ([Ca2+](cyt)) is a common intermediate in many of the pathways leading to either opening or closure of the stomatal pore(2,3). This observation has prompted investigations into how specificity is controlled in calcium-based signalling systems in plants. One possible explanation is that each stimulus generates a unique increase in [Ca2+](cyt), or 'calcium signature: that dictates the outcome of the final response(4). It has been suggested that the key to generating a calcium signature, and hence to understanding how specificity is controlled, is the ability to access differentially the cellular machinery controlling calcium influx and release from internal stores(2-5). Here we report that sphingosine-1-phosphate is a new calcium-mobilizing molecule in plants. We show that after drought treatment sphingosine-1-phosphate levels increase, and we present evidence that this molecule is involved in the signal-transduction pathway linking the perception of abscisic acid to reductions in guard cell turgor.	Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England; Avecia Ltd, Manchester M9 8ZS, Lancs, England	Lancaster University; Avecia	Hetherington, AM (corresponding author), Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England.		Ng, Carl K/B-4626-2013	Hetherington, Alistair/0000-0001-6060-9203; McAinsh, Martin Robert/0000-0003-4294-6470				Berger A, 1996, MOL PHARMACOL, V50, P451; Blatt MR, 2000, CURR OPIN PLANT BIOL, V3, P196, DOI 10.1016/S1369-5266(00)00064-9; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Merrill Jr A. H., 1996, BIOCH LIPIDS LIPOPRO, P309; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SPIEGEL S, 1997, SPHINGOLIPID MEDIATE, P121; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Sullards MC, 2000, J MASS SPECTROM, V35, P347, DOI 10.1002/(SICI)1096-9888(200003)35:3<347::AID-JMS941>3.0.CO;2-3; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8	20	260	274	0	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					596	599		10.1038/35069092	http://dx.doi.org/10.1038/35069092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279499	Green Submitted			2022-12-28	WOS:000167859300051
J	Piscitelli, SC; Gallicano, KD				Piscitelli, SC; Gallicano, KD			Drug therapy: Interactions among drugs for HIV and opportunistic infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR SAQUINAVIR; ST-JOHNS-WORT; P-GLYCOPROTEIN; GRAPEFRUIT JUICE; PHARMACOKINETIC INTERACTION; IN-VITRO; INDINAVIR CONCENTRATIONS; MULTIDRUG TRANSPORTER; FLUCONAZOLE THERAPY		NIH, Clin Pharmacokinet Res Lab, Dept Pharm, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Ottawa Hosp, Clin Invest Unit, Ottawa, ON, Canada; Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada	National Institutes of Health (NIH) - USA; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Piscitelli, SC (corresponding author), Virco Labs, Johns Hopkins Bayview Campus,Alpha Ctr,3rd Fl,521, Baltimore, MD 21224 USA.							Acosta EP, 1999, PHARMACOTHERAPY, V19, P708, DOI 10.1592/phco.19.9.708.31544; ACOSTA EP, 1999, PROMISE THERAPEUTIC; ALTICE FL, 1999, 6 C RETR OPP INF CHI, P137; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P1; BACK D, 1996, 11 INT C AIDS VANC B, V1, P88; BACK DJ, 2000, J INT ASS PHYSICIANS, V6, P34; Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; BALDWIN JR, 1999, 39 INT C ANT AG CHEM, P24; Barry M, 1999, CLIN PHARMACOKINET, V36, P289, DOI 10.2165/00003088-199936040-00004; Benet LZ, 1999, J CONTROL RELEASE, V62, P25, DOI 10.1016/S0168-3659(99)00034-6; BLUM RA, 1991, ANN INTERN MED, V114, P755, DOI 10.7326/0003-4819-114-9-755; Boruchoff SE, 2000, CLIN PHARMACOL THER, V67, P351, DOI 10.1067/mcp.2000.105151; BURGER DM, 1998, 12 WORLD AIDS C GEN, P828; Cato A, 1998, CLIN PHARMACOL THER, V63, P414, DOI 10.1016/S0009-9236(98)90036-4; CLARKE S, 2000, 7 C RETR OPP INF SAN, P91; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; COX SR, 1997, 4 C RETR OPP INF WAS, P133; CRUSSELLPORTER LL, 1993, ARCH INTERN MED, V153, P102, DOI 10.1001/archinte.153.1.102; DALVI RR, 1992, TOXICOL LETT, V60, P299, DOI 10.1016/0378-4274(92)90288-U; Drewe J, 1999, BIOCHEM PHARMACOL, V57, P1147, DOI 10.1016/S0006-2952(99)00026-X; Eagling VA, 1999, BRIT J CLIN PHARMACO, V48, P543, DOI 10.1046/j.1365-2125.1999.00052.x; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Ferry JJ, 1998, J ACQ IMMUN DEF SYND, V18, P252, DOI 10.1097/00042560-199807010-00009; FICHTENBAUM C, 2000, 7 C RETR OPP INF SAN, P236; FISKE W, 1998, 12 WORLD AIDS C GEN, P827; FISKE WD, 1997, 4 C RETR OPP INF WAS, P169; FISKE WD, 1998, 5 C RETR OPP INF CHI, P144; FLOCKHART D, 2000, CYTOCHROME P450 DRUG; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FOSTER BC, 1998, CAN J INFECT DIS SA, V9, pP472; Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69; Fuhr U, 1998, DRUG SAFETY, V18, P251, DOI 10.2165/00002018-199818040-00002; Gallicano KD, 1999, BRIT J CLIN PHARMACO, V48, P168, DOI 10.1046/j.1365-2125.1999.00987.x; GERBER JG, 2000, 1 INT WORKSH CLIN PO, P14; GERBER JG, 2000, 13 INT AIDS C DURB S, P81; Greenblatt DJ, 2000, CLIN PHARMACOL THER, V67, P335, DOI 10.1067/mcp.2000.105757; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; GUIBERT A, 1997, 37 INT C ANT AG CHEM, P12; Hafner R, 1998, ANTIMICROB AGENTS CH, V42, P631, DOI 10.1128/AAC.42.3.631; HAMZEH F, 2000, 7 C RETR OPP INF SAN, P92; HARRIS S, 1995, CLIN PHARMACOL THER, V58, P310, DOI 10.1016/0009-9236(95)90247-3; HAVLIR DV, 1998, 5 C RETR OPP INF CHI, P79; HENDRIX CW, 2000, 7 C RETR OPP INF SAN, P90; Hoggard PG, 1997, ANTIMICROB AGENTS CH, V41, P1231, DOI 10.1128/AAC.41.6.1231; Hsu A, 1998, ANTIMICROB AGENTS CH, V42, P2784, DOI 10.1128/AAC.42.11.2784; Hsu A, 1998, CLIN PHARMACOKINET, V35, P473, DOI 10.1007/BF03259712; Hsu A, 1998, CLIN PHARMACOL THER, V63, P453, DOI 10.1016/S0009-9236(98)90041-8; Hsu A, 1997, ANTIMICROB AGENTS CH, V41, P898, DOI 10.1128/AAC.41.5.898; HSU A, 1998, 5 C RETR OPP INF CHI, P143; Hsu Ann, 1996, P89; Hugen PWH, 2000, ANN PHARMACOTHER, V34, P465; Johne A, 1999, CLIN PHARMACOL THER, V66, P338, DOI 10.1053/cp.1999.v66.a101944; JORGA K, 1999, 39 INT C ANT AG CHEM, P20; Khaliq Y, 2000, CLIN PHARMACOL THER, V68, P637, DOI 10.1067/mcp.2000.112363; Khaliq Y, 1998, AIDS, V12, pS28; Kim RB, 1999, PHARMACEUT RES, V16, P408; KOLARS JC, 1994, PHARMACOGENETICS, V4, P247, DOI 10.1097/00008571-199410000-00003; KORNHAUSER DM, 1989, LANCET, V2, P473; Kostrubsky VE, 1999, DRUG METAB DISPOS, V27, P887; Koudriakova T, 1998, DRUG METAB DISPOS, V26, P552; Kupferschmidt HHT, 1998, BRIT J CLIN PHARMACO, V45, P355, DOI 10.1046/j.1365-2125.1998.00687.x; LAL R, 1998, 5 C RETR OPP INF CHI, P201; Laroche M., 1998, CAN J INFECT DIS, V9, p471P; LASKIN OL, 1982, ANTIMICROB AGENTS CH, V21, P804, DOI 10.1128/AAC.21.5.804; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; LEHTO P, 1994, ANTIMICROB AGENTS CH, V38, P248, DOI 10.1128/AAC.38.2.248; Li AP, 1997, CHEM-BIOL INTERACT, V107, P17, DOI 10.1016/S0009-2797(97)00071-9; Merrill DP, 1997, J INFECT DIS, V176, P265, DOI 10.1086/517263; Merry C, 1999, AIDS, V13, pF101, DOI 10.1097/00002030-199910220-00001; Michalets EL, 1998, PHARMACOTHERAPY, V18, P84; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Moore KHP, 1996, CLIN PHARMACOL THER, V59, P550, DOI 10.1016/S0009-9236(96)90183-6; Moyle G J, 1999, Expert Opin Investig Drugs, V8, P473, DOI 10.1517/13543784.8.4.473; Muirhead GJ, 2000, BRIT J CLIN PHARMACO, V50, P99, DOI 10.1046/j.1365-2125.2000.00245.x; Murphy RL, 1999, J INFECT DIS, V179, P1116, DOI 10.1086/314703; NARANG PK, 1994, NEW ENGL J MED, V330, P1316, DOI 10.1056/NEJM199405053301817; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Ouellet D, 1998, BRIT J CLIN PHARMACO, V46, P111, DOI 10.1046/j.1365-2125.1998.00749.x; Ouellet D, 1998, CLIN PHARMACOL THER, V64, P355, DOI 10.1016/S0009-9236(98)90065-0; Pai VB, 1999, ANN PHARMACOTHER, V33, P325, DOI 10.1345/aph.18089; Palmer S, 1999, ANTIMICROB AGENTS CH, V43, P2046, DOI 10.1128/AAC.43.8.2046; Piketty C, 1999, AIDS, V13, pF71, DOI 10.1097/00002030-199907300-00001; PISCITELLI S, 2000, 7 C RETR OPP INF SAN, P90; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; PISCITELLI SC, 1991, ANTIMICROB AGENTS CH, V35, P1765, DOI 10.1128/AAC.35.9.1765; Piscitelli SC, 1998, PHARMACOTHERAPY, V18, P1212; PISCITELLI SC, 1999, LTD VALUE THERAPEUTI; PISCITELLI SC, 2000, USE COMPLEMENTARY ME; Profit L, 1999, AIDS, V13, P1623, DOI 10.1097/00002030-199909100-00004; Reinach B, 1999, CHEM-BIOL INTERACT, V121, P37, DOI 10.1016/S0009-2797(99)00089-7; Reiss WG, 1998, BIODRUGS, V9, P389, DOI 10.2165/00063030-199809050-00004; RENTON KW, 1990, CAN J PHYSIOL PHARM, V68, P777, DOI 10.1139/y90-119; Roby CA, 2000, CLIN PHARMACOL THER, V67, P451, DOI 10.1067/mcp.2000.106793; SAAH AJ, 1999, 6 C RETR OPP INF CHI, P136; SAHAI J, 1993, CLIN PHARMACOL THER, V53, P292, DOI 10.1038/clpt.1993.24; SAHAI J, 1994, J INFECT DIS, V169, P1103, DOI 10.1093/infdis/169.5.1103; SAHAI J, 1997, 4 C RETR OPP INF WAS, P178; SCHWARZ TL, 1990, NEURON, V2, P119; SHELTON MJ, 2000, 40 INT C ANT AG CHEM, P14; Sim SM, 1998, AIDS RES HUM RETROV, V14, P1661, DOI 10.1089/aid.1998.14.1661; SKOWRON G, 1998, 5 C RETR OPP INF CHI, P145; Soldner A, 1999, PHARMACEUT RES, V16, P478, DOI 10.1023/A:1011902625609; SUN E, 1996, 11 INT C AIDS VANC B, V1, P18; Trapnell CB, 1996, ANN INTERN MED, V124, P573, DOI 10.7326/0003-4819-124-6-199603150-00006; van Heeswijk RPG, 1999, AIDS, V13, pF95, DOI 10.1097/00002030-199910010-00001; Varhe A, 1996, BRIT J CLIN PHARMACO, V42, P465, DOI 10.1111/j.1365-2125.1996.tb00009.x; Veal GJ, 1996, AIDS, V10, P546, DOI 10.1097/00002030-199605000-00016; Veldkamp AI, 1999, CLIN INFECT DIS, V29, P1586, DOI 10.1086/313548; Wacher VJ, 1998, J PHARM SCI-US, V87, P1322, DOI 10.1021/js980082d; WALLACE RJ, 1995, J INFECT DIS, V171, P747, DOI 10.1093/infdis/171.3.747; Washington CB, 1998, J ACQ IMMUN DEF SYND, V19, P203, DOI 10.1097/00042560-199811010-00001; Weissman SB, 1999, CLIN INFECT DIS, V29, P223, DOI 10.1086/520172; WHITTINGTON R, 1993, DRUGS, V46, P446, DOI 10.2165/00003495-199346030-00009; WORKMAN C, 1999, 6 C RETR OPP INF CHI, P195; WYNN H, 1999, 39 INT C ANT AG CHEM, P25; ZIMMERMANN T, 1994, EUR J CLIN PHARMACOL, V46, P147, DOI 10.1007/BF00199879; 2000, MMWR MORB MORTAL WKL, V49, P185	117	202	211	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					984	996		10.1056/NEJM200103293441307	http://dx.doi.org/10.1056/NEJM200103293441307			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274626				2022-12-28	WOS:000167716600007
J	Elliott, PM; Blanes, JRG; Mahon, NG; Poloniecki, JD; McKenna, WJ				Elliott, PM; Blanes, JRG; Mahon, NG; Poloniecki, JD; McKenna, WJ			Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy	LANCET			English	Article							BLOOD-PRESSURE RESPONSE; SUDDEN CARDIAC DEATH; BINDING PROTEIN-C; TROPONIN-T; EXERCISE; MUTATIONS; FEATURES; EXTENT; RISK; GENE	Background A previous study suggested that severe left-ventricular hypertrophy (maximum wall thickness greater than or equal to 30 mm) in patients with hypertrophic cardiomyopathy is associated with a risk of sudden cardiac death sufficient to warrant consideration for implantation of a cardioverter defibrillator (ICD). However, the prognostic significance of left-ventricular hypertrophy in relation to other clinical risk factors is poorly characterised. Methods We studied 630 patients consecutively referred to one hospital in London, UK (mean age 37 years [SD 16]; 382 male; mean follow-up 59 months). Patients underwent two dimensional and doppler echocardiography, upright exercise testing, and Holter monitoring. Findings 39 patients died suddenly or had an appropriate ICD discharge; nine died from progressive heart failure; 11 from other cardiovascular causes and 23 from non-cardiac causes. There was a trend towards higher probability of sudden death or ICD discharge with increasing wall thickness (p=0.029, relative risk per 5 mm increment 1.31 [95% CI 1.03-1.66]). Of the 39 patients who died suddenly or had an ICD discharge, ten had a wall thickness of 30 mm or more. Patients with wall thickness of 30 mm or more had higher probability of sudden death or ICD discharge than patients with wall thickness less than 30 mm (p=0.049, 2.07 [1.00-4.25]. When considered together, the number of additional risk factors (one to three) was a better predictor of risk of sudden death or ICD discharge than wall thickness (p=0.0001, relative risk per additional factor 2.00 [1.43-2.79] vs p=0.058, 1.26 per 5 mm increment [0.99-1.60]). There was no relation between the pattern of hypertrophy and survival. Interpretation The risk of sudden death associated with a wall thickness of 30 mm or more in patients without other risk factors is insufficient to justify aggressive prophylactic therapy. Most sudden deaths occurred in patients with wall thickness less than 30 mm, so the presence of mild hypertrophy cannot be used to reassure patients that they are at low risk.	Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England	St Georges University London	Elliott, PM (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England.	pelliott@sghms.ac.uk	Elliott, Perry/AAR-3430-2020; Blanes, Juan R Gimeno/I-4269-2015; McKenna, William J/C-3243-2008	Elliott, Perry/0000-0003-3383-3984; Blanes, Juan R Gimeno/0000-0001-5818-1754; McKenna, William J/0000-0001-7994-2460; Mahon, Niall/0000-0002-2872-2297				Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; COUNIHAN PJ, 1991, CIRCULATION, V84, P686, DOI 10.1161/01.CIR.84.2.686; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; FRENNEAUX MP, 1990, CIRCULATION, V82, P1995, DOI 10.1161/01.CIR.82.6.1995; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P57, DOI 10.1016/S0735-1097(86)80092-4; Maki S, 1998, AM J CARDIOL, V82, P774, DOI 10.1016/S0002-9149(98)00455-X; MARON BJ, 1981, AM J CARDIOL, V48, P252, DOI 10.1016/0002-9149(81)90604-4; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1982, CIRCULATION, V65, P1388, DOI 10.1161/01.CIR.65.7.1388; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; MCKENNA WJ, 1981, BRIT HEART J, V46, P168; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; NakajimaTaniguchi C, 1997, J MOL CELL CARDIOL, V29, P839, DOI 10.1006/jmcc.1996.0322; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Oliveira VLL, 1999, HYPERTENSION, V33, P1086; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1990, J AM COLL CARDIOL, V15, P1521, DOI 10.1016/0735-1097(90)92820-R; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6	24	317	337	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					420	424		10.1016/S0140-6736(00)04005-8	http://dx.doi.org/10.1016/S0140-6736(00)04005-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273061				2022-12-28	WOS:000166865600010
J	Guss, KA; Nelson, CE; Hudson, A; Kraus, ME; Carroll, SB				Guss, KA; Nelson, CE; Hudson, A; Kraus, ME; Carroll, SB			Control of a genetic regulatory network by a selector gene	SCIENCE			English	Article							LONG-RANGE ACTION; DORSAL-VENTRAL BOUNDARY; SPLIT COMPLEX GENES; WING FORMATION; SYNERGISTIC ACTIVATION; DROSOPHILA; EXPRESSION; NOTCH; DPP; TRANSCRIPTION	The formation of many complex structures is controlled by a special class of transcription factors encoded by selector genes. it is shown that SCALLOPED, the DNA binding component of the selector protein complex for the Drosophila wing field, binds to and directly regulates the cis-regulatory elements of many individual target genes within the genetic regulatory network controlling wing development. Furthermore, combinations of binding sites for SCALLOPED and transcriptional effecters of signaling pathways are necessary and sufficient to specify wing-specific responses to different signaling pathways. The obligate integration of selector and signaling protein inputs on cis-regulatory DNA may be a general mechanism by which selector proteins control extensive genetic regulatory networks during development.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu						BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Certel K, 2000, DEVELOPMENT, V127, P3173; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Goodman RH, 2000, GENE DEV, V14, P1553; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; Hudson JB, 1998, DEVELOPMENT, V125, P1407; JACK J, 1991, DEVELOPMENT, V113, P735; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Liu XF, 2000, DEV BIOL, V228, P287, DOI 10.1006/dbio.2000.9939; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; NELSON CE, UNPUB; NELSON HB, 1993, ROUX ARCH DEV BIOL, V202, P341, DOI 10.1007/BF00188733; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Vaudin P, 1999, DEVELOPMENT, V126, P4807; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	35	101	103	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1164	1167		10.1126/science.1058312	http://dx.doi.org/10.1126/science.1058312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11303087				2022-12-28	WOS:000168609200060
J	Hanif, J; Frosh, A; Marnane, C; Ghufoor, K; Rivron, R; Sandhu, G				Hanif, J; Frosh, A; Marnane, C; Ghufoor, K; Rivron, R; Sandhu, G			Lesson of the week - "High" ear piercing and the rising incidence of perichondritis of the pinna	BRITISH MEDICAL JOURNAL			English	Review									Univ Wales Hosp, Dept Ear Nose & Throat, Cardiff CF14 4XW, S Glam, Wales; Lister Hosp, Dept Ear Nose & Throat, Stevenage SG1 4AB, Herts, England; Royal Natl Throat Nose & Ear Hosp, London WC1X 8EE, England; Royal Glamorgan Hosp, Dept Ear Nose & Throat, Ynysmaerdy CF75 8XR, Wales	Cardiff University; Lister Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London	Hanif, J (corresponding author), Univ Wales Hosp, Dept Ear Nose & Throat, Cardiff CF14 4XW, S Glam, Wales.							BRINDLE D, 2000, GUARDIAN        0405; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; MCCARTHY VP, 1988, PEDIATR INFECT DIS J, V7, P741, DOI 10.1097/00006454-198810000-00020; Staley R, 1997, PEDIATRICS, V99, P610, DOI 10.1542/peds.99.4.610; TURKELTAUB SH, 1990, ANN PLAS SURG, V24, P279, DOI 10.1097/00000637-199003000-00015; WIDICK MH, 1992, OTOLARYNG HEAD NECK, V107, P803, DOI 10.1177/019459988910700618.1	6	31	32	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					906	907		10.1136/bmj.322.7291.906	http://dx.doi.org/10.1136/bmj.322.7291.906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302908	Green Published			2022-12-28	WOS:000168311300025
J	Jha, P; Nagelkerke, NJD; Ngugi, EN; Rao, JVRP; Willbond, B; Moses, S; Plummer, FA				Jha, P; Nagelkerke, NJD; Ngugi, EN; Rao, JVRP; Willbond, B; Moses, S; Plummer, FA			Public health - Reducing HIV transmission in developing countries	SCIENCE			English	Editorial Material							SEXUALLY-TRANSMITTED DISEASES; COST-EFFECTIVENESS; CONDOM PROMOTION; INFECTION; TANZANIA; AFRICA; TRIAL; PREVENTION; IMPACT		Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Med, Winnipeg, MB R3E 0W3, Canada; WHO, Econ Advisory Serv, CH-1211 Geneva, Switzerland; Univ Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; Natl Inst Publ Hlth & Environm, Amsterdam, Netherlands; Univ Nairobi, Dept Community Hlth, Nairobi, Kenya; Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; Hlth Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; World Health Organization; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; University of Nairobi; Health Canada	Plummer, FA (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada.							[Anonymous], INT ACT HIV AIDS AFR; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Investing in Health Research and Development, 1996, REP AD HOC COMM HLTH; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; MACHEKANO R, 1998, 5 C RETR OPP INF CHI; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tarantola D, 2000, B WORLD HEALTH ORGAN, V78, P236; *WORLD BANK, 1998, CONFR AIDS PUBL PRIO	15	56	57	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					224	225		10.1126/science.1058187	http://dx.doi.org/10.1126/science.1058187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305312				2022-12-28	WOS:000168074000026
J	Mastrolorenzo, G; Petrone, PP; Pagano, M; Incoronato, A; Baxter, PJ; Canzanella, A; Fattore, L				Mastrolorenzo, G; Petrone, PP; Pagano, M; Incoronato, A; Baxter, PJ; Canzanella, A; Fattore, L			Herculaneum victims of vesuvius in AD 79 - The eruption's first surge instantly killed some people sheltering from the impact.	NATURE			English	Article							BODIES		Osservatorio Vesuviano, I-80123 Naples, Italy; Univ Naples Federico II, Museo Antropol, Ctr Musei Sci Nat, I-80134 Naples, Italy; Univ Naples Federico II, Serv Anal Geomineral, Ctr Interdipartimentale, I-80134 Naples, Italy; Univ Naples Federico II, Dipartimento Biol Evolut & Comparata, I-80134 Naples, Italy; Univ Naples Federico II, Dipartimento Sci Terra, I-80138 Naples, Italy; Soprintendenza Archeol Pompei, Scavi Ercolano, I-80056 Ercolano, Italy; Univ Cambridge, Addenbrookes Hosp, Sch Clin, Cambridge CB2 2QQ, England	Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Incoronato, A (corresponding author), Osservatorio Vesuviano, Via Manzoni 249, I-80123 Naples, Italy.			Petrone, Pier Paolo/0000-0002-8897-8171; Fattore, Luciano/0000-0001-7447-2295				BAXTER PJ, 1990, B VOLCANOL, V52, P532, DOI 10.1007/BF00301534; Bohnert M, 1997, FORENSIC SCI INT, V87, P55, DOI 10.1016/S0379-0738(97)02136-1; Bohnert M, 1998, FORENSIC SCI INT, V95, P11, DOI 10.1016/S0379-0738(98)00076-0; BRINKMANN B, 1979, RECHTSMEDIZIN, V83, P1; Butler R.F, 1992, PALEOMAGNETISM MAGNE, P319; CAREY S, 1987, GEOL SOC AM BULL, V99, P303, DOI 10.1130/0016-7606(1987)99<303:TVICHA>2.0.CO;2; HOLCK P, 1986, THESIS U OSLO; HOLDEN JL, 1995, FORENSIC SCI INT, V74, P17, DOI 10.1016/0379-0738(95)01734-Z; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; Yamamoto K, 1990, Bull Kanagawa Dent Coll, V18, P55	11	54	54	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					769	770		10.1038/35071167	http://dx.doi.org/10.1038/35071167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298433				2022-12-28	WOS:000168021900039
J	Oram, RJ; Daum, RS; Seal, JB; Lauderdale, DS				Oram, RJ; Daum, RS; Seal, JB; Lauderdale, DS			Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION; PEDIATRICIANS; VACCINATION; PREVENTION; INFANTS	Context In July 1999, due to concerns about thimerosal content, the American Academy of Pediatrics (AAP) and the Public Health Service (PHS) recommended suspending hepatitis B virus (HBV) Vaccination at birth except for mothers who had positive or unknown hepatitis B surface antigen (HBsAg) status. In September 1999, the Centers for : Disease Control and Prevention recommended that hospitals resume HBV vaccination at birth with a new thimerosal-free vaccine. Whether the 2 changes in recommendations within 3 months led to less-than-optimal compliance in hospital nurseries is unknown. Objective To determine hospital HBV vaccination policy before the recommendation for delay of HBV Vaccination and 1 year later, Design, Setting, and Participants Survey of aff 46 hospitals with obstetric services and neonatal nurseries in Cook County. Illinois. Main Outcome Measures Hepatitis B virus immunization practices before July 1999 and in August 2000; hospital factors associated with routine HBV immunization and compliance with AAP and PHS recommendations. Results Before July 1999, 74% of surveyed hospital nurseries offered HBV vaccine to all neonates; only 39% did so in August 2000. Being located in the Chicago city-limits (88 % vs 57%, P = .02) and having an academic affiliation (93% vs 66%; P = .05) were positively associated with routine neonatal immunization before July 1999. Both academic affiliation and city location were associated with routine immunization in August: 2000 (71% vs 25% [P = .003] and 60% vs 14% [P = .002], respectively) and with:compliance with recommendations for suspension (57% vs 25% [P = .03] and 56% vs 10% [P = .001]). Conclusions We documented a 35% decrease in hospital nurseries that routinely offered HBV immunization 1 year after the AAP and PHS recommendations were made. Special efforts may be required to make at-birth administration of HBV vaccination universal.	Univ Chicago, Pediat Immunizat Program, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Oram, RJ (corresponding author), Univ Chicago, Pediat Immunizat Program, 5841 S Maryland Ave,MC 6054, Chicago, IL 60637 USA.	roram@peds.bsd.uchicago.edu						Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; *AM AC PED, 1999, PEDC AAP MEMB A 0715; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BALL LK, IN PRESS PEDIATRICS; BEASLEY RP, 1983, LANCET, V2, P1099; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P94; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P563; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P996; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P780; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P651; *CHIC DEP PUBL HLT, 1999, THIM FREE HEP B VACC; *COOK COUNT DEP PU, 1999, COMM BIRTH HOSP SUB; *COTH MEMB CRIT, 2000, COUNC TEACH HOSP HLT; FREED GL, 1993, PEDIATRICS, V91, P699; Freed GL, 1998, ARCH PEDIAT ADOL MED, V152, P285; FREED GL, 1993, J FAM PRACTICE, V36, P153; FREED GL, 1994, PEDIATRICS, V93, P747; HALL CB, 1993, PEDIATRICS, V91, P841; HALL CB, 1992, PEDIATRICS, V89, P795; *HEALTHC INF INC, 2000, AM HOSP ASS GUID HLT; *HLTH CAR FIN ADM, 2000, PROSP PAYM SYST PPS; HURIE MB, 1995, PEDIATRICS, V96, P875; *IL DEP UBL HLTH, 2000, ILL PROJ LOC ASS NEE; Lauderdale DS, 1999, JAMA-J AM MED ASSOC, V282, P1725, DOI 10.1001/jama.282.18.1725; PICKERING LK, 2000, AAP NEWS, V16, P1; SEAL JB, IN PRESS PEDIATRICS; Takayama JI, 1999, PREV MED, V28, P160, DOI 10.1006/pmed.1998.0390; WATSON B, 1999, UNPUB NAT VACC ADV C; XU ZY, 1985, PEDIATRICS, V76, P713; Yusuf HR, 2000, JAMA-J AM MED ASSOC, V284, P978, DOI 10.1001/jama.284.8.978	30	25	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1874	1879		10.1001/jama.285.14.1874	http://dx.doi.org/10.1001/jama.285.14.1874			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308401	Bronze			2022-12-28	WOS:000167876700028
J	Paassilta, P; Lohiniva, J; Goring, HHH; Perala, M; Raina, SS; Karppinen, J; Hakala, M; Palm, T; Kroger, H; Kaitila, I; Vanharanta, H; Ott, J; Ala-Kokko, L				Paassilta, P; Lohiniva, J; Goring, HHH; Perala, M; Raina, SS; Karppinen, J; Hakala, M; Palm, T; Kroger, H; Kaitila, I; Vanharanta, H; Ott, J; Ala-Kokko, L			Identification of a novel common genetic risk factor for lumbar disk disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; IX COLLAGEN; FAMILIAL PREDISPOSITION; MUTATIONS; DEGENERATION; COL9A2; CARTILAGE; ALLELE; CHAIN; SPINE	Context Lumbar disk disease (LDD) is one of the most common musculoskeletal diseases, with a prevalence of about 5%, A tryptophan (Trp) allele (Trp2) was recently discovered in the COL9A2 gene that is associated with dominantly inherited LDD but is only present in about 4% of Finnish patients with LDD. Objective To determine if other collagen IX gene sequence variations play a role in the pathogenesis of LDD. Design and Setting Case-control study conducted from February 1997 to May 1998 at university hospitals in Finland. Participants A total of 171 individuals with LDD (evaluated clinically and by magnetic resonance imaging or computed tomography) and 321 controls without LDD (186 healthy individuals, 83 patients with primary osteoarthritis, 31 with rheumatoid arthritis, and 21 with chondrodysplasias). Main Outcome Measures Frequencies of sequence variations covering the entire coding sequences and exon boundaries of the collagen IX genes, COL9A1, COL9A2, and COL9A3, which code for the alpha1, alpha2, and alpha3 chains of the protein, detected by conformation-sensitive gel electrophoresis and confirmed by sequencing, compared between individuals with and without LDD, Results Mutation analysis of all 3 collagen IX genes resulted in identification of an Arg103 --> Trp (arginine --> tryptophan) substitution in the alpha3 chain (Trp3 allele). The frequency of the Trp3 allele was 12.2% in LDD cases, excluding 7 individuals who were carriers of the previously identified Gln326 --> Trp (glutamine --> tryptophan) substitution in the a2 chain (Trp2 allele), and was 4.7% among controls. The difference in the frequency was statistically significant (P = .000013). Presence of at least 1 Trp3 allele increases risk of LDD about 3-fold. Conclusion This study led to the identification of a novel common genetic risk factor for LDD, confirming that genetic risk factors likely play a significant role in LDD.	Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland; Univ Oulu, Bioctr, Collagen Res Unit, SF-90220 Oulu, Finland; Univ Oulu, Dept Phys Med & Rehabil, SF-90220 Oulu, Finland; Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Kuopio, Dept Surg, SF-70210 Kuopio, Finland; Univ Helsinki Hosp, Dept Clin Genet, Helsinki, Finland; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Med Coll Penn & Hahnemann Univ, Ctr Gene Therapy, Philadelphia, PA USA	University of Oulu; University of Oulu; University of Oulu; University of Oulu; Columbia University; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; Rockefeller University; Drexel University	Paassilta, P (corresponding author), Univ Oulu, Dept Med Biochem, Aapistie 7, SF-90220 Oulu, Finland.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045982] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008] Funding Source: Medline; NIAMS NIH HHS [AR45982] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BREWTON RG, 1994, EXTRACELLULAR MATRIX, P129; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DERBY R, 1992, SPINE, V17, pS176, DOI 10.1097/00007632-199206001-00020; Fairbank J C, 1980, Physiotherapy, V66, P271; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Frymoyer J W, 1992, Instr Course Lect, V41, P217; Frymoyer John W., 1996, P8; Guillausseau PJ, 1997, DIABETES METAB, V23, P14; HANKE M, 1994, BIOTECHNIQUES, V17, P858; HELIOVAARA M, 1989, ANN MED, V21, P254, DOI 10.3109/07853898909149202; HELIOVAARA M, 1987, J EPIDEMIOL COMMUN H, V41, P251, DOI 10.1136/jech.41.3.251; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; KARPPINEN J, IN PRESS SPINE; KEEGAN JJ, 1948, ANAT REC, V102, P409, DOI 10.1002/ar.1091020403; Kimura T, 1996, INT ORTHOP, V20, P177, DOI 10.1007/s002640050058; KORKKO J, 1993, AM J HUM GENET, V53, P55; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; MATSUI H, 1992, SPINE, V17, P1323, DOI 10.1097/00007632-199211000-00011; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; Nelson C L, 1972, Clin Orthop Relat Res, V88, P142, DOI 10.1097/00003086-197210000-00025; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Pihlajamaa T, 1998, MATRIX BIOL, V17, P237, DOI 10.1016/S0945-053X(98)90063-4; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rimoin DL, 1998, AM J MED GENET, V79, P376; Scapinelli R, 1993, Acta Orthop Belg, V59, P371; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; Tiller GE, 1998, CYTOGENET CELL GENET, V81, P205, DOI 10.1159/000015031; Tilley L, 1998, J CLIN PATHOL-MOL PA, V51, P293, DOI 10.1136/mp.51.6.293; VARLOTTA GP, 1991, J BONE JOINT SURG AM, V73A, P124, DOI 10.2106/00004623-199173010-00016; VIKKULA M, 1994, ANN MED, V26, P107; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; WARMAN ML, 1994, GENOMICS, V23, P158, DOI 10.1006/geno.1994.1472; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Weishaupt D, 1998, RADIOLOGY, V209, P661, DOI 10.1148/radiology.209.3.9844656	51	169	187	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1843	1849		10.1001/jama.285.14.1843	http://dx.doi.org/10.1001/jama.285.14.1843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308397	Bronze			2022-12-28	WOS:000167876700024
J	Marquardt, T; Ashery-Padan, R; Andrejewski, N; Scardigli, R; Guillemot, F; Gruss, P				Marquardt, T; Ashery-Padan, R; Andrejewski, N; Scardigli, R; Guillemot, F; Gruss, P			Pax6 is required for the multipotent state of retinal progenitor cells	CELL			English	Article							XENOPUS-RETINA; EYE DEVELOPMENT; AMACRINE CELLS; DEVELOPING CNS; HOMEOBOX GENE; BHLH GENES; NEURONAL DIFFERENTIATION; MAMMALIAN RETINA; NERVOUS-SYSTEM; GANGLION-CELLS	The molecular mechanisms mediating the retinogenic potential of multipotent retinal progenitor cells (RPCs) are poorly defined. Prior to initiating retinogenesis, RPCs express a limited set of transcription factors implicated in the evolutionary ancient genetic network that initiates eye development. We elucidated the function of one of these factors, Pax6, in the RPCs of the intact developing eye by conditional gene targeting. Upon Pax6 inactivation, the potential of RPCs becomes entirely restricted to only one of the cell fates normally available to RPCs, resulting in the exclusive generation of amacrine interneurons. Our findings demonstrate furthermore that Pax6 directly controls the transcriptional activation of retinogenic bHLH factors that bias subsets of RPCs toward the different retinal cell fates, thereby mediating the full retinogenic potential of RPCs.	Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; Univ Strasbourg 1, CNRS, INSERM, IGBMC, F-67404 Illkirch, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gruss, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Fassberg 11, D-37077 Gottingen, Germany.		Guillemot, Francois/AAV-1482-2021	Scardigli, Raffaella/0000-0003-1369-0496				Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Brown NL, 1998, DEVELOPMENT, V125, P4821; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chow RL, 1999, DEVELOPMENT, V126, P4213; Collinson JM, 2000, DEVELOPMENT, V127, P945; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fode C, 2000, GENE DEV, V14, P67; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GalliResta L, 1997, J NEUROSCI, V17, P7831; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hogan B, 1994, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Jensen AM, 1997, DEV BIOL, V188, P267, DOI 10.1006/dbio.1997.8645; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Oliver G, 1997, TRENDS NEUROSCI, V20, P415, DOI 10.1016/S0166-2236(97)01082-5; Oliver G, 1995, DEVELOPMENT, V121, P4045; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Porter FD, 1997, DEVELOPMENT, V124, P2935; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Sears S, 2000, INVEST OPHTH VIS SCI, V41, P971; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Strettoi E, 1996, P NATL ACAD SCI USA, V93, P14906, DOI 10.1073/pnas.93.25.14906; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Verma-Kurvari S, 1998, DEV BIOL, V197, P106, DOI 10.1006/dbio.1998.8873; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETTS R, 1989, DEV BIOL, V136, P245; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	71	701	708	1	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					43	55		10.1016/S0092-8674(01)00295-1	http://dx.doi.org/10.1016/S0092-8674(01)00295-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301001	hybrid, Green Published			2022-12-28	WOS:000168063300006
J	Dudley, RA; Luft, HS				Dudley, RA; Luft, HS			Managed care in transition.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS; RISE; GO		Univ Calif San Francisco, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Dudley, RA (corresponding author), Univ Calif San Francisco, San Francisco, CA 94118 USA.							Balas EA, 1996, J GEN INTERN MED, V11, P584, DOI 10.1007/BF02599025; BERGTHOLD L, 1984, J HEALTH POLIT POLIC, V9, P203, DOI 10.1215/03616878-9-2-203; BERNSTEIN S, 2001, LOS ANGELES TIM 0104, pC2; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; Bodenheimer T, 1999, JAMA-J AM MED ASSOC, V281, P2045, DOI 10.1001/jama.281.21.2045; Dudley RA, 1998, MILBANK Q, V76, P649, DOI 10.1111/1468-0009.00109; *FAM US, 1999, STAT MAN CAR PAT PRO; Gabel J, 2000, HEALTH AFFAIR, V19, P144, DOI 10.1377/hlthaff.19.5.144; GONZALEZ ML, 1997, PHYSICIAN MARKETPLAC; Hash M, 2000, JAMA-J AM MED ASSOC, V284, P2988, DOI 10.1001/jama.284.23.2988; JACKSON C, 2001, AM NEWS, V44, P1; JAKLEVIC MC, 1997, MOD HEALTHCARE, V27, P9; JAKLEVIC MC, 1997, MOD HEALTHCARE, V27, P4; Kletke PR, 1996, JAMA-J AM MED ASSOC, V276, P555, DOI 10.1001/jama.276.7.555; Legnini MW, 2000, HEALTH AFFAIR, V19, P173, DOI 10.1377/hlthaff.19.3.173; Mariner WK, 2000, NEW ENGL J MED, V343, P592, DOI 10.1056/NEJM200008243430823; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; *PAC BUS GROUP HLT, 2000, CAL CONS HEALTHSC; Reinhardt UE, 2000, HEALTH AFFAIR, V19, P42, DOI 10.1377/hlthaff.19.1.42; Robinson JC, 1998, JAMA-J AM MED ASSOC, V279, P144, DOI 10.1001/jama.279.2.144; SHINKMAN R, 1999, MOD HEALTHCARE, V29, P24	21	62	67	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1087	1092		10.1056/NEJM200104053441410	http://dx.doi.org/10.1056/NEJM200104053441410			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287981				2022-12-28	WOS:000167860400010
J	Goodwin, I				Goodwin, I			Bush appoints venture capitalist as technology adviser	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					617	617		10.1038/35070748	http://dx.doi.org/10.1038/35070748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287911	Bronze			2022-12-28	WOS:000167875400008
J	Miguel, MC; Vespignani, A; Zapperi, S; Weiss, J; Grasso, JR				Miguel, MC; Vespignani, A; Zapperi, S; Weiss, J; Grasso, JR			Intermittent dislocation flow in viscoplastic deformation	NATURE			English	Article							ACOUSTIC-EMISSION; SINGLE-CRYSTALS; DYNAMICS; SIMULATION; PATTERNS; LINES; ICE	The viscoplastic deformation (creep) of crystalline materials under constant stress involves the motion of a large number of interacting dislocations(1). Analytical methods and sophisticated 'dislocation dynamics' simulations have proved very effective in the study of dislocation patterning, and have led to macroscopic constitutive laws of plastic deformation(2-9). Yet, a statistical analysis of the dynamics of an assembly of interacting dislocations has not hitherto been performed. Here we report acoustic emission measurements on stressed ice single crystals, the results of which indicate that dislocations move in a scale-free intermittent fashion. This result is confirmed by numerical simulations of a model of interacting dislocations that successfully reproduces the main features of the experiment. We rnd that dislocations generate a slowly evolving configuration landscape which coexists with rapid collective rearrangements. These rearrangements involve a comparatively small fraction of the dislocations and lead to an intermittent behaviour of the net plastic response. This basic dynamical picture appears to be a generic feature in the deformation of many other materials(10-12). Moreover, it should provide a framework for discussing fundamental aspects of plasticity that goes beyond standard mean-field approaches that see plastic deformation as a smooth laminar flow.	Abdus Salam Int Ctr Theoret Phys, I-34100 Trieste, Italy; Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; Univ La Sapienza, INFM, I-00185 Rome, Italy; CNRS, LGGE, F-38402 St Martin Dheres, France; LGIT, F-38041 Grenoble 9, France	Abdus Salam International Centre for Theoretical Physics (ICTP); University of Barcelona; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Miguel, MC (corresponding author), Abdus Salam Int Ctr Theoret Phys, POB 586, I-34100 Trieste, Italy.		Zapperi, Stefano/C-9473-2009; grasso, jean-robert/I-8383-2012; Vespignani, Alessandro/A-8794-2009; Miguel, M. Carmen/I-3087-2014	Zapperi, Stefano/0000-0001-5692-5465; Miguel, M. Carmen/0000-0001-9050-1412; Vespignani, Alessandro/0000-0003-3419-4205				AMODEO RJ, 1990, PHYS REV B, V41, P6958, DOI 10.1103/PhysRevB.41.6958; Ananthakrishna G, 1999, PHYS REV E, V60, P5455, DOI 10.1103/PhysRevE.60.5455; Becker R, 1932, Z PHYS, V79, P566, DOI 10.1007/BF01330508; BENGUS VZ, 1966, PHYS STATUS SOLIDI, V14, P215, DOI 10.1002/pssb.19660140121; DUVAL P, 1983, J PHYS CHEM-US, V87, P4066, DOI 10.1021/j100244a014; Fournet R, 1996, PHYS REV B, V53, P6283, DOI 10.1103/PhysRevB.53.6283; GROMA I, 1993, PHILOS MAG A, V67, P1459, DOI 10.1080/01418619308225367; Hahner P, 1996, APPL PHYS A-MATER, V62, P473, DOI 10.1007/BF01567120; Hahner P, 1998, PHYS REV LETT, V81, P2470, DOI 10.1103/PhysRevLett.81.2470; Hirth IP, 1992, THEORY DISLOCATIONS; Jensen Henrik Jeldtoft., 1998, SELF ORG CRITICALITY; Kardar M, 1998, PHYS REP, V301, P85, DOI 10.1016/S0370-1573(98)00007-6; LEPINOUX J, 1987, SCRIPTA METALL MATER, V21, P833, DOI 10.1016/0036-9748(87)90332-2; Neuhauser H., 1983, Dislocations in solids. Vol.6. Applications and recent advances, P319; PETRENKO VF, 1994, 9412 US ARM COLD REG; ROUBY D, 1983, PHILOS MAG A, V47, P671, DOI 10.1080/01418618308245257; SEVILLANO JG, 1991, SCRIPTA METALL MATER, V25, P355, DOI 10.1016/0956-716X(91)90192-4; Thomson R, 1998, PHYS REV LETT, V81, P3884, DOI 10.1103/PhysRevLett.81.3884; Weiss J, 2000, J GEOPHYS RES-SOL EA, V105, P433, DOI 10.1029/1999JB900312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Zaiser M, 1999, ACTA MATER, V47, P2463, DOI 10.1016/S1359-6454(99)00096-8	21	420	426	4	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					667	671		10.1038/35070524	http://dx.doi.org/10.1038/35070524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287948	Green Submitted			2022-12-28	WOS:000167875400040
J	Pierce-Shimomura, JT; Faumont, S; Gaston, MR; Pearson, BJ; Lockery, SR				Pierce-Shimomura, JT; Faumont, S; Gaston, MR; Pearson, BJ; Lockery, SR			The homeobox gene lim-6 is required for distinct chemosensory representations in C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NEURONS; CHEMOTAXIS; EXPRESSION; SYSTEM	The ability to discriminate between different chemical stimuli is crucial for food detection, spatial orientation and other adaptive behaviours in animals. In the nematode Caenorhabditis elegans, spatial orientation in gradients of soluble chemoattractants (chemotaxis) is controlled mainly by a single pair of chemosensory neurons(1). These two neurons, ASEL and ASER, are left-right homologues in terms of the disposition of their somata and processes, morphology of specialized sensory endings, synaptic partners and expression profile of many genes(2,3). However, recent gene-expression studies have revealed unexpected asymmetries between ASEL and ASER. ASEL expresses the putative receptor guanylyl cyclase genes gcy-6 and gcy-7, whereas ASER expresses gcy-5 (ref. 4). In addition, only ASEL expresses the homeobox gene lim-6, an orthologue of the human LMX1 subfamily of homeobox genes(5). Here we show, using laser ablation of neurons and whole-cell patch-clamp electrophysiology, that the asymmetries between ASEL and ASER extend to the functional level. ASEL is primarily sensitive to sodium, whereas ASER is primarily sensitive to chloride and potassium. Furthermore, we rnd that lim-6 is required for this functional asymmetry and for the ability to distinguish sodium from chloride. Thus, a homeobox gene increases the representational capacity of the nervous system by establishing asymmetric functions in a bilaterally symmetrical neuron pair.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Lockery, SR (corresponding author), Univ Oregon, Inst Neurosci, 1254, Eugene, OR 97403 USA.			Pearson, Bret/0000-0002-3473-901X				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hobert O, 1999, DEVELOPMENT, V126, P1547; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Lockery SR, 1998, METHOD ENZYMOL, V293, P201; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	20	136	143	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					694	698		10.1038/35070575	http://dx.doi.org/10.1038/35070575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287956				2022-12-28	WOS:000167875400048
J	[Anonymous]				[Anonymous]			Gathering the evidence on medical marijuana	NATURE			English	Editorial Material																		2001, NATURE, V410, P505	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					613	613						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287904				2022-12-28	WOS:000167875400001
J	Reid, S; Wessely, S; Crayford, T; Hotopf, M				Reid, S; Wessely, S; Crayford, T; Hotopf, M			Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PERSISTENT SOMATIZING PATIENTS; PSYCHIATRIC MORBIDITY; GENERAL-PRACTICE; CHRONIC PAIN; SOMATIZATION; USERS	Objective To estimate the prevalence of medically unexplained symptoms in patients who most frequently attend outpatient services. Design Retrospective cohort study over three years with review of case notes. Setting Secondary care services in the South Thames (West) NHS region, Participants Outpatient attenders with new appointments in 1993. Main outcome measures Number of outpatient appointments, and number of consultation episodes for medically unexplained conditions. Results Medical records of 361 of 400 sampled frequent attenders were examined, and 971 consultation episodes were recorded. Ninety seven (27%) had one or more consultation episodes in which the condition was medically unexplained; 208 (21%) of the 971 consultation episodes were medically unexplained. Abdominal pain, chest pain, headache, and back pain were commonly found to be medically unexplained. Conclusions Medically unexplained symptoms present in most hospital specialties and account for a considerable proportion of consultations by frequent attenders in secondary care.	Guys Kings Coll, Acad Dept Psychol Med, London SE5 8AZ, England; St Thomas Hosp, Sch Med, London SE5 8AZ, England; Inst Psychiat, London SE5 8AZ, England; Bromley Hlth Author, Bromley BR2 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Reid, S (corresponding author), Guys Kings Coll, Acad Dept Psychol Med, London SE5 8AZ, England.	steve.reid@kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Wessely, Simon C/A-8713-2008	Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929				Bass C, 1999, GEN HOSP PSYCHIAT, V21, P30, DOI 10.1016/S0163-8343(98)00062-0; ESCOBAR JI, 1987, ARCH GEN PSYCHIAT, V44, P713; FINK P, 1992, PSYCHOL MED, V22, P173, DOI 10.1017/S0033291700032827; FINK P, 1992, J PSYCHOSOM RES, V36, P439, DOI 10.1016/0022-3999(92)90004-L; Garfinkel S A, 1988, Health Care Financ Rev, V9, P41; Hamilton J, 1996, J ROY COLL PHYS LOND, V30, P18; Hotopf M, 1999, AM J PSYCHIAT, V156, P1796; KARLSSON H, 1995, GEN HOSP PSYCHIAT, V17, P19, DOI 10.1016/0163-8343(94)00059-M; KATON W, 1991, AM J PSYCHIAT, V148, P34; Kerwick S, 1997, BRIT J GEN PRACT, V47, P225; Kouyanou K, 1998, PAIN, V76, P417, DOI 10.1016/S0304-3959(98)00074-8; Kouyanou K, 1997, PSYCHOSOM MED, V59, P597, DOI 10.1097/00006842-199711000-00007; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; LIN EHB, 1991, J GEN INTERN MED, V6, P241, DOI 10.1007/BF02598969; Nimnuan C, 2000, QJM-INT J MED, V93, P21, DOI 10.1093/qjmed/93.1.21; Portegijs PJM, 1996, SOC PSYCH PSYCH EPID, V31, P29, DOI 10.1007/BF00789119; Reid S, 1999, J PSYCHOSOM RES, V47, P483, DOI 10.1016/S0022-3999(99)00052-5; SMITH GR, 1986, ARCH INTERN MED, V146, P69, DOI 10.1001/archinte.146.1.69; VANHEMERT AM, 1993, PSYCHOL MED, V23, P167, DOI 10.1017/S0033291700038952; Wamoscher Z, 1966, J Coll Gen Pract, V11, P166; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WILKIE A, 1994, BRIT J HOSP MED, V51, P421; ZOOK CJ, 1980, NEW ENGL J MED, V302, P996, DOI 10.1056/NEJM198005013021804	23	135	146	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					767	769		10.1136/bmj.322.7289.767	http://dx.doi.org/10.1136/bmj.322.7289.767			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419HL	11282861	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000167943200025
J	Zhang, Y; Kalderon, D				Zhang, Y; Kalderon, D			Hedgehog acts as a somatic stem cell factor in the Drosophila ovary	NATURE			English	Article							SONIC HEDGEHOG; HUMAN HOMOLOG; CUBITUS INTERRUPTUS; SIGNALING PATHWAY; HAIR FOLLICLE; CARCINOMAS; SKIN; PHOSPHORYLATION; PROLIFERATION; INDUCTION	Secreted signalling molecules of the Hedgehog (Hh) family have many essential patterning roles during development of diverse organisms including Drosophila and humans(1,2). Although Hedge hog proteins most commonly affect cell fate, they can also stimulate cell proliferation, In humans several distinctive cancers, including basal-cell carcinoma, result from mutations that aberrantly activate Hh signal transduction(3). In Drosophila, Hh directly stimulates proliferation of ovarian somatic cells(4-6). Here we show that Hh acts specifically on stem cells in the Drosophila ovary. These cells cannot proliferate as stem cells in the absence of Hh signalling, whereas excessive Hh signalling produces supernumerary stem cells. We deduce that Hh is a stem-cell factor and suggest that human cancers due to excessive Hh signalling might result from aberrant expansion of stem cell pools.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kalderon, D (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kruger K, 1999, ARCH DERMATOL RES, V291, P253, DOI 10.1007/s004030050405; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Price MA, 1999, DEVELOPMENT, V126, P4331; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Spradling Allan C., 1993, P1; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang Y, 2000, DEVELOPMENT, V127, P2165	29	631	690	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					599	604		10.1038/35069099	http://dx.doi.org/10.1038/35069099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279500				2022-12-28	WOS:000167859300052
J	Goyal, L				Goyal, L			Cell death inhibition: Keeping caspases in check	CELL			English	Review							UBIQUITIN-PROTEIN LIGASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; NMR STRUCTURE; APOPTOSIS; XIAP; MUTAGENESIS; SMAC/DIABLO		Cell Press, Cambridge, MA 02138 USA		Goyal, L (corresponding author), Cell Press, 1100 Massachusetts Ave, Cambridge, MA 02138 USA.	lgoyal@cell.com						Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Renatus M, 2000, STRUCT FOLD DES, V8, P789, DOI 10.1016/S0969-2126(00)00165-9; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	20	223	231	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					805	808		10.1016/S0092-8674(01)00276-8	http://dx.doi.org/10.1016/S0092-8674(01)00276-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290317	Bronze			2022-12-28	WOS:000167869200002
J	Faul, UH				Faul, UH			Melt retention and segregation beneath mid-ocean ridges	NATURE			English	Article							U-SERIES DISEQUILIBRIA; UPPER-MANTLE; CARBONATE MELTS; MIDOCEAN RIDGES; EVOLUTION; ROCKS; PERMEABILITIES; PETROGENESIS; EQUILIBRIA; EXTRACTION	Geochemical models of melting at mid-ocean ridges-particularly those based on trace elements and uranium-decay-series isotopes-predict that melt segregates from the matrix at very low porosities(1-8), of order 0.1%. Some of these models also require that the melt ascends rapidly(3,5). But these predictions appear to conflict with seismic data obtained by the mantle electromagnetic and tomography (MELT) experiment(9). These data reveal, beneath the East Pacific Rise (at 17 degreesS), a region of low velocities several hundred kilometres wide, which is best explained by the presence of 1-2% melt, distributed on a grain scale in disk-shaped geometries(10). Here I show that these apparently contradictory constraints can be reconciled by taking into account the geometry and resulting permeability of the intergranular network of melt, together with the changing character of the melt as it ascends. A deep, volatile-rich melt with low viscosity and density is mobile at 0.1% porosity, but basaltic melt only becomes mobile at a porosity above 1%. While the volumetric contribution of the volatile-rich melt to the erupted basalts is small, the isotopic disequilibria (except for radium) generated by porous flow of this melt are preserved if melt transport is rapid at the onset of high-productivity melting. Also, because of incomplete extraction, some melt is retained in a broad zone, consistent with the MELT observations.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University	Faul, UH (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.			Faul, Ulrich/0000-0001-5036-4572				Asimow PD, 1999, J PETROL, V40, P475, DOI 10.1093/petrology/40.3.475; BLUNDY JD, 1991, NATURE, V349, P321, DOI 10.1038/349321a0; BOURBIE T, 1985, J GEOPHYS RES-SOLID, V90, P1524, DOI 10.1029/JB090iB13p11524; Dobson DP, 1996, EARTH PLANET SC LETT, V143, P207, DOI 10.1016/0012-821X(96)00139-2; Faul UH, 1997, J GEOPHYS RES-SOL EA, V102, P10299, DOI 10.1029/96JB03460; FAUL UH, 1994, GEOPHYS RES LETT, V21, P29, DOI 10.1029/93GL03051; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; GALER SJG, 1986, CHEM GEOL, V56, P45, DOI 10.1016/0009-2541(86)90109-9; GREEN DH, 1976, TECTONOPHYSICS, V32, P61, DOI 10.1016/0040-1951(76)90086-X; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HUNTER RH, 1989, EARTH PLANET SC LETT, V92, P347, DOI 10.1016/0012-821X(89)90059-9; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283, DOI 10.1098/rsta.1997.0010; Lundstrom CC, 1999, J GEOPHYS RES-SOL EA, V104, P13035, DOI 10.1029/1999JB900081; LUNDSTROM CC, 1995, SCIENCE, V270, P1958, DOI 10.1126/science.270.5244.1958; Lundstrom CC, 2000, CHEM GEOL, V162, P105, DOI 10.1016/S0009-2541(99)00122-9; Lundstrom CC, 1998, EARTH PLANET SC LETT, V157, P151, DOI 10.1016/S0012-821X(98)00038-7; MCKENZIE D, 1989, EARTH PLANET SC LETT, V95, P53, DOI 10.1016/0012-821X(89)90167-2; Mibe K, 1998, GEOPHYS RES LETT, V25, P1233, DOI 10.1029/98GL00872; MICHAEL P, 1995, EARTH PLANET SC LETT, V131, P301, DOI 10.1016/0012-821X(95)00023-6; NIELSEN RL, 2000, GEOCHEM GEOPHYS GEOS, V1; PLANK T, 1992, J GEOPHYS RES-SOL EA, V97, P19749, DOI 10.1029/92JB01769; RICHARDSON C, 1994, EARTH PLANET SC LETT, V128, P425, DOI 10.1016/0012-821X(94)90160-0; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; SPIEGELMAN M, 2000, GEOCHEM GEOPHYS GEOS, V1; Turcotte D., 2014, GEODYNAMICS, V3rd edn.; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Wark DA, 1998, EARTH PLANET SC LETT, V164, P591, DOI 10.1016/S0012-821X(98)00252-0; Wood BJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1613, DOI 10.1016/S0016-7037(98)00302-0; Yaxley GM, 2000, CONTRIB MINERAL PETR, V139, P326, DOI 10.1007/s004100000134; ZHANG YX, 1993, EARTH PLANET SC LETT, V117, P331, DOI 10.1016/0012-821X(93)90088-Q; ZHU WL, 1995, J GEOPHYS RES-SOL EA, V100, P15451, DOI 10.1029/95JB00958	33	109	111	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					920	923		10.1038/35073556	http://dx.doi.org/10.1038/35073556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309614				2022-12-28	WOS:000168152300043
J	Weiss, RA				Weiss, RA			Gulliver's travels in HIVland	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; MALE CIRCUMCISION; VACCINE; AIDS; RECOMBINANT; ERADICATION; CHALLENGES; HISTORY; AFRICA	The emergence of HIV and AIDS is narrated here through the eyes of the legendary Irish traveller Gulliver, observing the replication, cross-species origin, evolution, diversity and transmission of HIV. Ethical problems of vaccine trials, the social impact of AIDS, and prospects for its prevention, including the development of topical virucidal lotions, are discussed. The existence of a growing proportion of HIV-infected, immunocompromised children and adults may significantly affect current immunization programmes and the evolution of opportunistic infections.	UCL, Windeyer Inst Med Sci, Dept Immunol & Mol Pathol, Wohl Virion Ctr, London, England	University of London; University College London	Weiss, RA (corresponding author), UCL, Windeyer Inst Med Sci, Dept Immunol & Mol Pathol, Wohl Virion Ctr, 46 Cleveland St, London, England.	r.weiss@ucl.ac.uk						Anderson RM, 1996, LANCET, V348, P1010, DOI 10.1016/S0140-6736(96)07100-0; [Anonymous], 2000, NATURE, V406, P15, DOI 10.1038/35017662; BERRY N, IN PRESS NATURE; BLANCOU P, IN PRESS NATURE; Bynum WF, 2000, NATURE, V407, P943, DOI 10.1038/35039628; Carael M, 1997, AIDS, V11 Suppl B, pS23; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P305; Chitsike I, 1999, BRIT MED J, V318, P841, DOI 10.1136/bmj.318.7187.841; Cohen Jon, 2001, SHOTS DARK WAYWARD S; CreweBrown HH, 1997, CLIN INFECT DIS, V25, P1165, DOI 10.1086/516104; Dalgleish AG, 1999, IMMUNOL LETT, V66, P81, DOI 10.1016/S0165-2478(98)00163-1; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAMILTON WD, 1995, NARROW ROADS GENE LA; HILL R, 2000, INT J PHARM MED, V14, P271; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KORBER B, IN PRESS B MED B; Kurth R, 1996, J NIH RES, V8, P33; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Levy JA, 1998, HIV PATHOGENESIS AID; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; MARX PA, IN PRESS PHIL T R B, V356; McCormack S, 2001, BRIT MED J, V322, P410, DOI 10.1136/bmj.322.7283.410; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; MCKNIGHT A, 1995, J VIROL, V69, P3167, DOI 10.1128/JVI.69.5.3167-3170.1995; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; MENDELSON M, 2001, MICROBIOL TODAY, V28, P10; Montelaro R. C., 1993, The Retroviridae, volume 2., P257; Morgan D, 2001, NAT MED, V7, P143, DOI 10.1038/84564; Moss WJ, 1999, CLIN INFECT DIS, V29, P106, DOI 10.1086/520136; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Peeters M, 1999, J VIROL, V73, P7368, DOI 10.1128/JVI.73.9.7368-7375.1999; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; QUETEL C, 1990, HIST SYPHILIS; RANGER T, 1992, EPIDEMICS IDEAS HIST; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Sala M, 2000, J MOL EVOL, V51, P12, DOI 10.1007/s002390010062; SHAFER RW, 1992, CLIN INFECT DIS, V15, P161, DOI 10.1093/clinids/15.1.161; Shilts R., 1987, BAND PLAYED POLITICS; Swift Jonathan, 1967, GULLIVERS TRAVELS; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Takehisa J, 1999, J VIROL, V73, P6810, DOI 10.1128/JVI.73.8.6810-6820.1999; Vidal N, 2000, AIDS RES HUM RETROV, V16, P2059, DOI 10.1089/088922200750054800; WAINHOBSON S, 2001, PHIL T R SOC LOND B, V356; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WHITTLE H, 1994, AIDS, V8, P1617, DOI 10.1097/00002030-199411000-00015; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; Ziegler P., 1970, BLACK DEATH	53	51	52	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					963	967		10.1038/35073632	http://dx.doi.org/10.1038/35073632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309625	Bronze			2022-12-28	WOS:000168152300055
J	Shelton, RC; Keller, MB; Gelenberg, A; Dunner, DL; Hirschfeld, R; Thase, ME; Russell, J; Lydiard, RB; Crits-Cristoph, P; Gallop, R; Todd, L; Hellerstein, D; Goodnick, P; Keitner, G; Stahl, SM; Halbreich, U				Shelton, RC; Keller, MB; Gelenberg, A; Dunner, DL; Hirschfeld, R; Thase, ME; Russell, J; Lydiard, RB; Crits-Cristoph, P; Gallop, R; Todd, L; Hellerstein, D; Goodnick, P; Keitner, G; Stahl, SM; Halbreich, U			Effectiveness of St John's Wort in major depression - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD-MODERATE DEPRESSION; ALTERNATIVE MEDICINE; DOUBLE-BLIND; HYPERICUM EXTRACT; CLINICAL-TRIALS; PLACEBO; IMIPRAMINE; LI-160; MULTICENTER; DISORDER	Context Extracts of St John's wort are widely used to treat depression. Although more than 2 dozen clinical trials have been conducted with St John's wort, most have significant flaws in design and do not enable meaningful interpretation. Objective To compare the efficacy and safety of a standardized extract of St John's wort with placebo in outpatients with major depression. Design and Setting Randomized, double-blind, placebo-controlled clinical trial conducted between November 1998 and January 2000 in 11 academic medical centers in the United States. Participants Two hundred adult outpatients (mean age, 42.4 years; 67.0% female; 85.9% white) diagnosed as having major depression and having a baseline Hamilton Rating Scale for Depression (HAM-D) score of at least 20. Intervention Participants completed a 1-week, single-blind run-in of placebo, then were randomly assigned to receive either St John's wort extract (n=98; 900 mg/d for 4 weeks, increased to 1200 mg/d in the absence of an adequate response thereafter) or placebo (n=102) for 8 weeks. Main Outcome Measures The primary outcome measure was rate of change on the HAM-D over the treatment period. Secondary measures included the Beck Depression Inventory (BDI), Hamilton Rating Scale for Anxiety (HAM-A), the Global Assessment of Function (CAF) scale, and the Clinical Global impression-Severity and -Improvement scales (CGI-S and CGI-I). Results The random coefficient analyses for the HAM-D, HAM-A, CGI-S, and CGI-I all showed significant effects for time but not for treatment or time-by-treatment interaction (for HAM-D scores, P<.001, P=.16, and P=.58, respectively). Analysis of covariance showed nonsignificant effects for BDI and GAF scores. The proportion of participants achieving an a priori definition of response did not differ between groups. The number reaching remission of illness was significantly higher with St John's wort than with placebo (P=.02), but the rates were very low in the full intention-to-treat analysis (14/98 [14.3%] vs 5/102 [4.9%], respectively), St John's wort was safe and well tolerated. Headache was the only adverse event that occurred with greater frequency with St John's wort than placebo (39/95 [41%] vs 25/100 [25%], respectively). Conclusion In this study, St John's wort was not effective for treatment of major depression.	Vanderbilt Univ, Dept Psychiat, Nashville, TN USA; Brown Univ, Butler Hosp, Dept Psychiat, Providence, RI 02912 USA; Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ USA; Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Univ Texas, Dept Psychiat, Galveston, TX 77555 USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ S Carolina, Dept Psychiat, Charleston, SC USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Beth Israel Med Ctr, Dept Psychiat, New York, NY 10003 USA; Univ Miami, Sch Med, Dept Psychiat, Miami, FL 33152 USA; Brown Univ, Rhode Isl Hosp, Dept Psychiat, Providence, RI 02903 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; SUNY Buffalo, Ctr Clin, Dept Psychiat, Buffalo, NY 14260 USA	Vanderbilt University; Brown University; Butler Hospital Rhode Island; University of Arizona; University of Arizona Health Sciences; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of South Carolina; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; University of Miami; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shelton, RC (corresponding author), 1500 21st Ave S,Suite 2200, Nashville, TN 37212 USA.		Crits-Christoph, Paul/X-4682-2018	Crits-Christoph, Paul/0000-0001-6858-8451	NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH001741, U01MH061590] Funding Source: NIH RePORTER; NIMH NIH HHS [U01 MH061590, K24-MH01741] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERGMANN R, 1993, THERAPIEWOCHE NEUROL, V7, P235; BIALIK RJ, 1995, J PSYCHIATR NEUROSCI, V20, P265; Brenner R, 2000, CLIN THER, V22, P411, DOI 10.1016/S0149-2918(00)89010-4; DITZLER K, 1994, COMPLEMENT THER MED, V2, P5; Ernst E, 1999, LANCET, V354, P2014, DOI 10.1016/S0140-6736(99)00418-3; First M.B., 2014, STRUCTURED CLIN INTE; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Gaster B, 2000, ARCH INTERN MED, V160, P152, DOI 10.1001/archinte.160.2.152; GUY W, 1967, ECDEU ASSESSMENT MAN, P217; HALAMA P, 1991, NERVENHEILKUNDE, V10, P250; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HANSGEN KD, 1994, J GERIATR PSYCHIA S1, V7, P15; HARRER G, 1991, TW NEUROL PSYCHIATR, V5, P710; HARRER G, 1994, J GERIATR PSYCHIA S1, V7, P24; Hoffmann J, 1979, ZFA (Stuttgart), V55, P776; HUBNER WD, 1994, J GERIATR PSYCHIA S1, V7, P12; Jonas WB, 1998, JAMA-J AM MED ASSOC, V280, P1616, DOI 10.1001/jama.280.18.1616; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; KLERMAN GL, 1992, ARCH GEN PSYCHIAT, V49, P831; KNIEBEL R, 1988, Z ALLG MED, V64, P689; KONIG CD, 1993, THESIS U BASEL BASEL; KUGLER J, 1990, Z ALLG MED, V66, P21; Leber PD, 1998, CONTROL CLIN TRIALS, V19, P178, DOI 10.1016/S0197-2456(97)00118-9; LEHRL S, 1993, NERVENHEILKUNDE, V12, P281; LIEBER P, 1991, PSYCHOPHARMACOL B, V22, P30; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; Linde K, 1999, BRIT MED J, V319, P1539; LINDE K, 2000, ST JOHNS WORT DEPRES; Miller CA, 1997, PSYCHOPHARMACOL BULL, V33, P647; OSTERHEIDER M, 1992, FORTSCHR NEUROL PSYC, V60, P210; Pablos-Mendez A, 1998, JAMA-J AM MED ASSOC, V279, P222, DOI 10.1001/jama.279.3.222; Philipp M, 1999, BRIT MED J, V319, P1534, DOI 10.1136/bmj.319.7224.1534; QUANDT J, 1993, ALLGEMEINARZT, V2, P97; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; REH C, 1992, THERAPIEWOCHE, V42, P1576; RIIS P, 2000, JAMA-J AM MED ASSOC, V23, P3045; Schlich D, 1987, PSYCHO, V13, P440; Schmidt U, 1993, Fortschr Med, V111, P339; SCHMIDT U, 1989, PSYCHO, V15, P665; Schrader E, 1998, HUM PSYCHOPHARM CLIN, V13, P163, DOI 10.1002/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.3.CO;2-9; Schrader E, 2000, INT CLIN PSYCHOPHARM, V15, P61, DOI 10.1097/00004850-200015020-00001; SOMMER H, 1994, J GERIATR PSYCHIA S1, V7, P9; STEGER W, 1985, Z ALLG MED, V61, P914; Vastag B, 2000, JAMA-J AM MED ASSOC, V284, P2983, DOI 10.1001/jama.284.23.2983; Vorbach EU, 1997, PHARMACOPSYCHIATRY, V30, P81, DOI 10.1055/s-2007-979524; VORBACH EU, 1994, J GERIATR PSYCHIA S1, V7, P19; WARNECKE G, 1986, Z ALLGEMEINMED, V62, P1111; WERTH W, 1989, KASSENARZT, V15, P64; Wheatley D, 1997, PHARMACOPSYCHIATRY, V30, P77, DOI 10.1055/s-2007-979523; *WHO, 2000, JAMA-J AM MED ASSOC, V284, P3043; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Witte B, 1995, Fortschr Med, V113, P404; Woelk H, 2000, BMJ-BRIT MED J, V321, P536, DOI 10.1136/bmj.321.7260.536	58	251	261	1	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1978	1986		10.1001/jama.285.15.1978	http://dx.doi.org/10.1001/jama.285.15.1978			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308434	Bronze			2022-12-28	WOS:000167995900026
J	Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G				Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G		Norwegian Childhood Diabet Study G	Birth weight and childhood onset type 1 diabetes: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA-CELL ACTIVITY; PERINATAL DETERMINANTS; RISK-FACTORS; MORTALITY; MELLITUS; INCREASE; CHILDREN; SIZE; LIFE; AGE	Objective To assess the associations between birth weight or gestational age and risk of type 1 diabetes. Design Population based cohort study by record linkage of the medical birth registry and the National Childhood Diabetes Registry, Setting Two national registries in Norway. Participants. All live births in Norway between 1974 and 1998 (1 382 602 individuals) contributed a maximum of 15 years of observation, a total of 8 184 994 person) ears of observation in the period 1989 to 1998. 1824 children with thpe 1 diabetes were diagnosed between 1989 and 1998, Main outcome measures Estimates of rate ratios with 95% confidence intervals for type 1 diabetes from Poisson regression analyses. Results The incidence rate of type 1 diabetes increased almost linearly with birth weight The rate ratio for children with birth weights 4500 g or more compared with those with birth weights less than 2000 g was 2.21 (95% confidence interval 1.24 to 3.94), test for bend P = 0.0001, There was no significant association between gestational age and type 1 diabetes. The results persisted after adjustment for maternal diabetes and other potential confounders. Conclusion There is a relatively weak but significant association between birth weight and increased risk of type 1 diabetes consistent over a wide range of birth weights.	Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, N-0403 Oslo, Norway; Ulleval Hosp, Dept Paediat, Aker Univ Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Ulleval Hosp, Dept Paediat, Ulleval Univ Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Stene, LC (corresponding author), Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, POB 4404 Nydalen, N-0403 Oslo, Norway.	lars.christian.stene@folkehelsa.no						ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; Barker DJP, 1998, MOTHERS BABIES HLTH; BJORK E, 1993, AUTOIMMUNITY, V16, P181, DOI 10.3109/08916939308993326; BLOM L, 1989, DIABETOLOGIA, V32, P7; BOCK T, 1994, DIABETES CARE, V17, P1154, DOI 10.2337/diacare.17.10.1154; CHANDRA RK, 1977, BIOL NEONATE, V31, P15; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Green A, 2000, LANCET, V355, P873; HILL D E, 1980, Clinical Obstetrics and Gynecology, V23, P837; JOHANSSON C, 1994, DIABETOLOGIA, V37, P91; Joner G, 2000, DIABETOLOGIA, V43, pA27; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; KYVIK KO, 1992, DIABETIC MED, V9, P233, DOI 10.1111/j.1464-5491.1992.tb01767.x; Kyvik KO, 2000, DIABETIC MED, V17, P158, DOI 10.1046/j.1464-5491.2000.00249.x; LAWLERHEAVNER J, 1994, DIABETES RES CLIN PR, V24, P153, DOI 10.1016/0168-8227(94)90110-4; LESLIE RDG, 1994, DIABETES, V43, P843, DOI 10.2337/diabetes.43.7.843; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; METCALFE MA, 1992, ARCH DIS CHILD, V67, P731, DOI 10.1136/adc.67.6.731; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; PEDERSEN CR, 1994, AUTOIMMUNITY, V17, P261, DOI 10.3109/08916939409010666; Podar T, 1999, DIABETES CARE, V22, P2092, DOI 10.2337/diacare.22.12.2092a; PRESTON D. L., 1993, EPICURE USERS GUIDE; READ JS, 1994, AM J EPIDEMIOL, V140, P721, DOI 10.1093/oxfordjournals.aje.a117320; Samuelsen SO, 1998, AM J EPIDEMIOL, V148, P983, DOI 10.1093/oxfordjournals.aje.a009575; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499	31	123	125	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					889	892		10.1136/bmj.322.7291.889	http://dx.doi.org/10.1136/bmj.322.7291.889			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302899	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168311300017
J	Bilham, R; England, P				Bilham, R; England, P			Plateau 'pop-up' in the great 1897 Assam earthquake	NATURE			English	Article							SHILLONG PLATEAU; NORTHEAST INDIA; TECTONICS; DEFORMATION; HIMALAYA; REGIONS; ZONES	The great Assam earthquake of 12 June 1897 reduced to rubble all masonry buildings within a region of northeastern India roughly the size of England, and was felt over an area exceeding that of the great 1755 Lisbon earthquake(1). Hitherto it was believed that rupture occurred on a north-dipping Himalayan thrust fault propagating south of Bhutan(2-5). But here we show that the northern edge of the Shillong plateau rose violently by at least 11 m during the Assam earthquake, and that this was due to the rupture of a buried reverse fault approximately 110 km in length and dipping steeply away from the Himalaya. The stress drop implied by the rupture geometry and the prodigious fault slip of 18 +/- 7 m explains epicentral accelerations observed to exceed 1g vertically and surface velocities exceeding 3 ms(-1) (ref. 1). This quantitative observation of active deformation of a 'pop-up' structure confirms that faults bounding such structures can penetrate the whole crust. Plateau uplift in the past(2-5) million years has caused the Indian plate to contract locally by 4 +/- 2 mm yr(-1), reducing seismic risk in Bhutan but increasing the risk in northern Bangladesh.	Univ Colorado, CIRES, Boulder, CO 80309 USA; Univ Oxford, Oxford OX1 3PR, England	University of Colorado System; University of Colorado Boulder; University of Oxford	Bilham, R (corresponding author), Univ Colorado, CIRES, Boulder, CO 80309 USA.		England, Philip C/A-1920-2010	England, Philip C/0000-0002-9024-8901; Bilham, Roger/0000-0002-5547-4102				Ambraseys N, 2000, CURR SCI INDIA, V79, P1237; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; Bilham R, 2000, CURR SCI INDIA, V79, P1259; Bond J., 1899, ANN REPORT TRIANGULA, pxii; BURRARD SG, 1909, N E LONGITUDINAL SER, V35; CHEN WP, 1990, J GEOPHYS RES-SOLID, V95, P12527, DOI 10.1029/JB095iB08p12527; DAS JD, 1995, INT J REMOTE SENS, V16, P1633, DOI 10.1080/01431169508954501; Dickinson W.R., 1978, LARAMIDE FOLDING ASS, V151, P355, DOI DOI 10.1130/MEM151-P355; Evans P., 1964, J GEOLOGICAL SOC IND, V5, P80; FRANK FC, 1966, B SEISMOL SOC AM, V56, P35; GAHALAUT VK, 1992, TECTONOPHYSICS, V204, P163, DOI 10.1016/0040-1951(92)90277-D; GOMBERG J, 1994, J GEOPHYS RES-SOL EA, V99, P20299, DOI 10.1029/94JB00039; JOHNSON SY, 1991, GEOL SOC AM BULL, V103, P1513, DOI 10.1130/0016-7606(1991)103<1513:SATOTS>2.3.CO;2; JORDAN TE, 1983, GEOL SOC AM BULL, V94, P341, DOI 10.1130/0016-7606(1983)94<341:ATRTGO>2.0.CO;2; Khattri K.N., 1992, MEM GEOL SOC INDIA, V23, P275; LEDAIN AY, 1984, J GEOPHYS RES, V89, P453, DOI 10.1029/JB089iB01p00453; LIPMAN PW, 1971, SCIENCE, V174, P821, DOI 10.1126/science.174.4011.821; LYONCAEN H, 1985, TECTONICS, V4, P513, DOI 10.1029/TC004i006p00513; MOLNAR P, 1987, J GEOL SOC INDIA, V30, P13; MOLNAR P, 1989, P INDIAN AS-EARTH, V98, P61, DOI 10.1007/BF02880376; Murthy MVN., 1969, B OIL NAT GAS COMM, V6, P57; Nagar V. K., 1992, MEM GEOL SOC INDIA, V23, P265; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Oldham RD., 1899, GEOL SOC AM MEM, V29, P1; Paul J, 2001, GEOPHYS RES LETT, V28, P647, DOI 10.1029/2000GL011832; ROGERS J, 1987, AM J SCI, V287, P661, DOI DOI 10.2475/AJS.287.7.661; Seeber L, 1981, M EWING SERIES AM GE, P259; Sibson RH, 1998, B SEISMOL SOC AM, V88, P1014; STRAHAN G, 1891, GREAT TRIGONOMETRICA, V32; Sukhija BS, 1999, TECTONOPHYSICS, V308, P53, DOI 10.1016/S0040-1951(99)00082-7; VERMA RK, 1977, TECTONOPHYSICS, V42, P283, DOI 10.1016/0040-1951(77)90171-8; WILSON CAK, 1939, TRIANGULATION ASSAM	32	377	383	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					806	809		10.1038/35071057	http://dx.doi.org/10.1038/35071057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298446				2022-12-28	WOS:000168021900052
J	Luther, GW; Rozan, TF; Taillefert, M; Nuzzio, DB; Di Meo, C; Shank, TM; Lutz, RA; Cary, SC				Luther, GW; Rozan, TF; Taillefert, M; Nuzzio, DB; Di Meo, C; Shank, TM; Lutz, RA; Cary, SC			Chemical speciation drives hydrothermal vent ecology	NATURE			English	Article							RIFTIA-PACHYPTILA JONES; IRON(II) MONOSULFIDE; ALVINELLA-POMPEJANA; AQUEOUS-SOLUTIONS; PYRITE FORMATION; H2S OXIDATION; TUBE WORM; SULFIDE; 125-DEGREES-C; ENVIRONMENT	The physiology and biochemistry of many taxa inhabiting deep-sea hydrothermal vents have been elucidated(1-4); however, the physicochemical factors controlling the distribution of these organisms at a given vent site remain an enigma after 20 years of research(5-11). The chemical speciation of particular elements has been suggested as key to controlling biological community structure in these extreme aquatic environments(7,11,12). Implementation of electrochemical technology(13,14) has allowed us to make in situ measurements of chemical speciation at vents located at the East Pacific Rise (9 degrees 50' N) and on a scale relevant to the biology. Here we report that significant differences in oxygen, iron and sulphur speciation strongly correlate with the distribution of specific taxa in different microhabitats. In higher temperature (>30 degreesC) microhabitats, the appreciable formation of soluble iron-sulphide molecular clusters markedly reduces the availability of free H2S/ HS- to vent (micro)organisms, thus controlling the available habitat.	Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA; Analyt Instrument Syst Inc, Ringoes, NJ 08851 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	University of Delaware; Woods Hole Oceanographic Institution; Rutgers State University New Brunswick	Luther, GW (corresponding author), Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA.		Luther, George/A-6384-2008; Carneiro, Fernanda/E-9513-2013	Luther, George/0000-0002-0780-885X; Carneiro, Fernanda/0000-0001-6389-4564; Cary, Stephen/0000-0002-2876-2387				BRENDEL PJ, 1995, ENVIRON SCI TECHNOL, V29, P751, DOI 10.1021/es00003a024; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; CHILDRESS JJ, 1982, MAR BIOL LETT, V3, P73; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Desbruyeres D, 1998, DEEP-SEA RES PT II, V45, P383, DOI 10.1016/S0967-0645(97)00083-0; Di Meo CA, 1999, DEEP-SEA RES PT I, V46, P1279, DOI 10.1016/S0967-0637(99)00002-3; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; Goffredi SK, 1997, J EXP BIOL, V200, P2609; JOHNSON KS, 1986, SCIENCE, V231, P1139, DOI 10.1126/science.231.4742.1139; JUNIPER SK, 1995, AM ZOOL, V35, P74; LUTHER GW, 1991, BIOGEOCHEMISTRY, V14, P57; Luther GW, 1999, ENVIRON SCI TECHNOL, V33, P4352, DOI 10.1021/es9904991; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Rickard D, 1997, GEOCHIM COSMOCHIM AC, V61, P115, DOI 10.1016/S0016-7037(96)00321-3; Rickard D, 1997, GEOCHIM COSMOCHIM AC, V61, P135, DOI 10.1016/S0016-7037(96)00322-5; Rozan TF, 2000, ANAL CHIM ACTA, V415, P175, DOI 10.1016/S0003-2670(00)00844-8; Sarradin PM, 1998, CAH BIOL MAR, V39, P159; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Theberge SM, 1997, AQUAT GEOCHEM, V3, P191, DOI 10.1023/A:1009648026806; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]	24	277	288	1	134	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					813	816		10.1038/35071069	http://dx.doi.org/10.1038/35071069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298448				2022-12-28	WOS:000168021900054
J	Cullinan, T				Cullinan, T			Drug-resistant tuberculosis: desperate measures?	LANCET			English	Editorial Material									Merlin, London SE1 1DB, England		Cullinan, T (corresponding author), Merlin, 5-13 Trin St, London SE1 1DB, England.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1124	1124		10.1016/S0140-6736(00)04268-9	http://dx.doi.org/10.1016/S0140-6736(00)04268-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297986				2022-12-28	WOS:000167996200036
J	Imbert-Bismut, F; Ratziu, V; Pieroni, L; Charlotte, F; Benhamou, Y; Poynard, T				Imbert-Bismut, F; Ratziu, V; Pieroni, L; Charlotte, F; Benhamou, Y; Poynard, T		MULTIVIRC grp	Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study	LANCET			English	Article							GROWTH-FACTOR; ALPHA-2-MACROGLOBULIN; INDEX; HEPATOCYTES; EXPRESSION; PROTEIN; MATRIX	Background Liver biopsy is thought mandatory for management of patients with hepatitis C virus (HCV) infection, especially for staging fibrosis. We aimed, in our prospective study, to assess the predictive value of a combination of basic serum biochemical markers for diagnosis of clinically significant fibrosis (Including early stages). Methods We assessed liver-biopsy patients with detectable HCV by PCR, for eligibility, and took a blood sample on the day of the procedure. The analysis was done in a first-year period for 205 patients and then tested in a second period on 134 patients. We devised a fibrosis index that included the most informative markers (combined with age and sex) for the first-year group. 11 serum markers were assessed as well as fibrosis stage: F0=no fibrosis and F1=portal fibrosis; and for clinically significant fibrosis, F2=few septa, F3=many septa, and F4=cirrhosis. Statistical analysis was by logistic regression, neural connection,and receiver-operating characteristic (ROC) curves. Findings First-year and second-year patient-group characteristics and biochemical markers did not differ. The overall frequency of clinically significant fibrosis was 40% (138 patients). The most informative markers were: alpha (2) macroglobulin, alpha (2) globulin (or haptoglobin), gamma globulin, apolipoprotein A(1). gamma glutamyltranspeptidase, and total bilirubin. The areas (SD) under the ROC curves for the first-year (0.836 [0.430]) and second-year groups (0.870 [0.340]) did not differ (p=0.44). With the best index, a high negative predictive value (100% certainty of absence of F2, F3, or F4) was obtained for scores ranging from zero to 0.10 (12% [41] of all patients), and high positive predictive value (>90% certainty of presence of F2, F3, or F4) for scores ranging from 0.60 to 1.00 (34% [115] of all patients). Interpretation A combination of basic serum markers could be used to substantially reduce the number of liver biopsies done in patients with chronic HCV infection.	Hosp Pitie Salpetriere, Dept Biochem, Paris, France; Hosp Pitie Salpetriere, Dept Hepatogastroenterol, Paris, France; Hosp Pitie Salpetriere, Dept Pathol, Paris, France; Univ Paris 05, Fac Sci Pharmaceut & Biol Paris, Lab Immunol Tumeurs, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Poynard, T (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France.	tpoynard@teaser.fr	Hug, Balthasar L./G-1568-2010; Poynard, Thierry/C-1355-2010	Poynard, Thierry/0000-0002-3726-7230; Charlotte, Frederic/0000-0003-2803-6606; Poynard, Thierry/0000-0002-2050-640X				BACQ Y, 1993, GASTROEN CLIN BIOL, V17, P364; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; EDWARDS AM, 1987, CARCINOGENESIS, V8, P1837, DOI 10.1093/carcin/8.12.1837; *EUR ASS STUD LIV, 2000, J HEPATOL, V30, P956; Guechot J, 1996, CLIN CHEM, V42, P558; Guillen MI, 1996, HEPATOLOGY, V23, P1345, DOI 10.1053/jhep.1996.v23.pm0008675150; HINTZE JL, 1997, NCSS 97 USERS GUIDE; Kawser CA, 1998, CLIN SCI, V95, P179, DOI 10.1042/CS19980020; Louagie HK, 1996, J HEPATOL, V25, P10, DOI 10.1016/S0168-8278(96)80321-7; Mc Rosenberg W, 2000, HEPATOLOGY, V32, p183A; Meisse D, 1998, FEBS LETT, V422, P346, DOI 10.1016/S0014-5793(98)00038-6; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; NAVEAU S, 1994, DIGEST DIS SCI, V39, P2426, DOI 10.1007/BF02087661; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; Paradis V, 1996, CELL MOL BIOL, V42, P525; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; POYNARD T, 1991, GASTROENTEROLOGY, V100, P1397; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Sabile A, 1999, HEPATOLOGY, V30, P1064, DOI 10.1002/hep.510300429; SAKUMOTO I, 1976, Gastroenterologia Japonica, V11, P224; *SPSS, 1995, NEUR CONN 1 0 US GUI; TEARE JP, 1993, LANCET, V342, P895, DOI 10.1016/0140-6736(93)91946-J; Tiggelman AMBC, 1997, J HEPATOL, V26, P1220, DOI 10.1016/S0168-8278(97)80455-2; Tiggelman AMBC, 1996, HEPATOLOGY, V23, P1260; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x	32	1114	1185	1	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1069	1075		10.1016/S0140-6736(00)04258-6	http://dx.doi.org/10.1016/S0140-6736(00)04258-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297957				2022-12-28	WOS:000167996200008
J	Sink, H; Rehm, EJ; Richstone, L; Bulls, YM; Goodman, CS				Sink, H; Rehm, EJ; Richstone, L; Bulls, YM; Goodman, CS			sidestep encodes a target-derived attractant essential for motor axon guidance in Drosophila	CELL			English	Article							GROWTH CONE GUIDANCE; GENETIC-ANALYSIS; FASCICLIN-II; ADHESION MOLECULE; SYNAPSE FORMATION; MUSCLE; EXPRESSION; DEFASCICULATION; PROJECTIONS; PROTEIN	At specific choice points in the periphery, subsets of motor axons defasciculate from other axons in the motor nerves and steer into their muscle target regions. Using a large-scale genetic screen in Drosophila, we identified the sidestep (side) gene as essential for motor axons to leave the motor nerves and enter their muscle targets, side encodes a target-derived transmembrane protein (Side) that is a novel member of the immunoglobulin superfamily (IgSF). Side is expressed on embryonic muscles during the period when motor axons leave their nerves and extend onto these muscles. In side mutant embryos, motor axons fail to extend onto muscles and instead continue to extend along their motor nerves. Ectopic expression of Side results in extensive and prolonged motor axon contact with inappropriate tissues expressing Side.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; NYU, Sch Med, Dept Pharmacol, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; New York University	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 519 LSA, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038530] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38530] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BATE M, 1990, DEVELOPMENT, V110, P791; BIEBER AJ, 1994, METHODS CELL BIOL; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; CROSSLEY AC, 1978, GENETICS BIOL DROS B, V2; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KANIA A, 1993, NEURON, V11, P673, DOI 10.1016/0896-6273(93)90078-6; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; Landgraf M, 1999, CURR BIOL, V9, P589, DOI 10.1016/S0960-9822(99)80262-0; Landgraf M, 1997, J NEUROSCI, V17, P9642; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rose D, 1997, DEVELOPMENT, V124, P1561; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Schmid A, 1999, DEVELOPMENT, V126, P4653; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SINK H, 1991, DEVELOPMENT, V112, P307; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; YOUNOSSIHARTENSTEIN A, 1993, DEV BIOL, V158, P430, DOI 10.1006/dbio.1993.1201; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	39	60	60	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					57	67		10.1016/S0092-8674(01)00296-3	http://dx.doi.org/10.1016/S0092-8674(01)00296-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301002	Bronze			2022-12-28	WOS:000168063300007
J	Winter, CG; Wang, B; Ballew, A; Royou, A; Karess, R; Axelrod, JD; Luo, LQ				Winter, CG; Wang, B; Ballew, A; Royou, A; Karess, R; Axelrod, JD; Luo, LQ			Drosophila Rho-associated kinase (Drok) links frizzled-mediated planar cell polarity signaling to the actin cytoskeleton	CELL			English	Article							UNCONVENTIONAL MYOSINS; TISSUE POLARITY; NONMUSCLE MYOSIN; GENETIC-ANALYSIS; PROTEIN-KINASE; STRESS FIBERS; LIGHT-CHAIN; ROLES; PHOSPHORYLATION; MORPHOGENESIS	Frizzled (Fz) and Dishevelled (Dsh) are components of an evolutionarily conserved signaling pathway that regulates planar cell polarity. How this signaling pathway directs asymmetric cytoskeletal reorganization and polarized cell morphology remains unknown. Here, we show that Drosophila Rho-associated kinase (Drok) works downstream of Fz/Dsh to mediate a branch of the planar polarity pathway involved in ommatidial rotation in the eye and in restricting actin bundle formation to a single site in developing wing cells. The primary output of Drok signaling is regulating the phosphorylation of nonmuscle myosin regulatory light chain, and hence the activity of myosin II. Drosophila myosin VIIA, the homolog of the human Usher Syndrome 1B gene, also functions in conjunction with this newly defined portion of the Fz/Dsh signaling pathway to regulate the actin cytoskeleton.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Karess, Roger/0000-0002-7299-0600; Luo, Liqun/0000-0001-5467-9264; Wang, Bruce/0000-0003-3486-5494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036623] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS36623] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ashburner M, 1999, GENETICS, V153, P179; Ashburner M., 1989, DROSOPHILA LAB HDB; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN T-L, 1991, Journal of Cell Biology, V115, p330A; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; GUBB D, 1984, CHROMOSOMA, V91, P54, DOI 10.1007/BF00286485; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leung T, 1996, MOL CELL BIOL, V16, P5313; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mizuno T, 1999, GENE, V238, P437, DOI 10.1016/S0378-1119(99)00351-0; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Self T, 1998, DEVELOPMENT, V125, P557; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Spradling AC, 1999, GENETICS, V153, P135; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; THEISEN H, 1994, DEVELOPMENT, V120, P347; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Weber U, 2000, DEVELOPMENT, V127, P3619; WEIL D, 1995, NATURE, V374, P62; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; ZHENG L, 1995, DEVELOPMENT, V121, P3045	53	432	433	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					81	91		10.1016/S0092-8674(01)00298-7	http://dx.doi.org/10.1016/S0092-8674(01)00298-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301004	Bronze			2022-12-28	WOS:000168063300009
J	Rashbass, J				Rashbass, J			The patient-owned, population-based electronic medical record: A revolutionary resource for clinical medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Cambridge, Cambridge, England	University of Cambridge	Rashbass, J (corresponding author), Univ Cambridge, Cambridge, England.							Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012	1	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1769	1769		10.1001/jama.285.13.1769-a	http://dx.doi.org/10.1001/jama.285.13.1769-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277840				2022-12-28	WOS:000167710600038
J	Behrenfeld, MJ; Randerson, JT; McClain, CR; Feldman, GC; Los, SO; Tucker, CJ; Falkowski, PG; Field, CB; Frouin, R; Esaias, WE; Kolber, DD; Pollack, NH				Behrenfeld, MJ; Randerson, JT; McClain, CR; Feldman, GC; Los, SO; Tucker, CJ; Falkowski, PG; Field, CB; Frouin, R; Esaias, WE; Kolber, DD; Pollack, NH			Biospheric primary production during an ENSO transition	SCIENCE			English	Article							1997-98 EL-NINO; SOUTHERN-OCEAN; INTERANNUAL VARIATIONS; EQUATORIAL PACIFIC; SATELLITE; SURFACE; MODEL; SEAWIFS; PHOTOSYNTHESIS; LIGHT	The Sea-viewing Wide Field-of-view Sensor (SeaWiFS) provides global monthly measurements of both oceanic phytoplankton chlorophyll biomass and light harvesting by land plants. These measurements allowed the comparison of simultaneous ocean and land net primary production (NPP) responses to a major El Nino to La Nina transition. Between September 1997 and August 2000, biospheric NPP varied by 6 petagrams of carbon per year (from 111 to 117 petagrams of carbon per year). Increases in ocean NPP were pronounced in tropical regions where EL Nino-Southern Oscillation (ENSO) impacts on upwelling and nutrient availability were greatest. Globally, land NPP did not exhibit a clear ENSO response, although regional changes were substantial.	NASA, Goddard Space Flight Ctr, Sci Syst & Applicat Inc, Greenbelt, MD 20771 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Wales, Dept Geog, Swansea SA2 8PP, W Glam, Wales; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Scripps Inst Oceanog, La Jolla, CA 92037 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; California Institute of Technology; California Institute of Technology; Rutgers State University New Brunswick; Carnegie Institution for Science; University of California System; University of California San Diego; Scripps Institution of Oceanography	Behrenfeld, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Sci Syst & Applicat Inc, Greenbelt, MD 20771 USA.		Los, Sietse/Q-6261-2019; Randerson, James/Y-2550-2019; Los, Sietse/G-8985-2012	Los, Sietse/0000-0002-1325-3555; Randerson, James/0000-0001-6559-7387; 				Barnes RA, 1999, APPL OPTICS, V38, P4649, DOI 10.1364/AO.38.004649; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Chen JM, 1996, IEEE T GEOSCI REMOTE, V34, P1353, DOI 10.1109/36.544559; Dierssen HM, 2000, J GEOPHYS RES-OCEANS, V105, P26301, DOI 10.1029/1999JC000296; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; FROUIN R, 1992, J APPL METEOROL, V31, P1056, DOI 10.1175/1520-0450(1992)031<1056:ATFGMO>2.0.CO;2; Hooker S.B., 1993, EOS T AM GEOPHYS UN, V74, P241, DOI [10.1029/93EO00945, DOI 10.1029/93EO00945]; Los SO, 2000, J HYDROMETEOROL, V1, P183, DOI 10.1175/1525-7541(2000)001<0183:AGYBLS>2.0.CO;2; MAISONGRANDE P, 1995, TELLUS B, V47, P178, DOI 10.1034/j.1600-0889.47.issue1.15.x; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Meinen CS, 2000, J CLIMATE, V13, P3551, DOI 10.1175/1520-0442(2000)013<3551:OOWWVC>2.0.CO;2; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; MOREL A, 1991, PROG OCEANOGR, V26, P263, DOI 10.1016/0079-6611(91)90004-6; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; *NASA, 2000, NASA TECHN MEM SER, V9; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Tucker CJ, 1999, AMBIO, V28, P587	28	409	428	6	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2594	2597		10.1126/science.1055071	http://dx.doi.org/10.1126/science.1055071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283369	Green Submitted			2022-12-28	WOS:000167861000039
J	Wells, L; Vosseller, K; Hart, GW				Wells, L; Vosseller, K; Hart, GW			Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; LINKED GLCNAC; IN-VIVO; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; HEXOSAMINE PATHWAY; SKELETAL-MUSCLE; NUCLEAR; PHOSPHORYLATION; TRANSFERASE	The dynamic glycosylation of serine or threonine residues on nuclear and cytosolic proteins by O-Linked beta -N-acetylglucosamine (O-GLcNAc) is abundant in all multicellular eukaryotes, On several proteins, O-GLcNAc and O-phosphate alternatively occupy the same or adjacent sites, Leading to the hypothesis that one function of this saccharide is to transiently block phosphorylation, The diversity of proteins modified by O-GlcNAc implies its importance in many basic cellular and disease processes. Here we systematically examine the current data implicating O-GlcNAc as a regulatory modification important to signal transduction cascades.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Hart, GW (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363; Hart, Gerald/0000-0001-7812-4351	NCI NIH HHS [CA42486, CA83261] Funding Source: Medline; NICHD NIH HHS [HD13563] Funding Source: Medline; NIGMS NIH HHS [GM20528] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486, F32CA083261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; CHENG X, 2001, IN PRESS J BIOL CHEM; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU T, 1995, J BIOL CHEM, V270, P1896; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; COMER FI, UNPUB; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; GAO Y, 2001, IN PRESS J BIOL CHEM; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Gupta R., UNPUB; Haltiwanger RS, 1997, BIOCHEM BIOPH RES CO, V231, P237, DOI 10.1006/bbrc.1997.6110; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Haynes PA, 2000, ANAL CHEM, V72, P5402, DOI 10.1021/ac000512w; HOLT GD, 1986, J BIOL CHEM, V261, P8049; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lubas WA, 1997, J BIOL CHEM, V272, P9316; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Parekh RB, 1997, CURR OPIN BIOTECH, V8, P718, DOI 10.1016/S0958-1669(97)80126-7; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; RAY MK, 1992, P NATL ACAD SCI USA, V89, P539, DOI 10.1073/pnas.89.2.539; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shaw P, 1996, ONCOGENE, V12, P921; TORRES CR, 1984, J BIOL CHEM, V259, P3308; VOSSELLER K, UNPUB; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0	34	757	825	4	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2376	2378		10.1126/science.1058714	http://dx.doi.org/10.1126/science.1058714			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269319				2022-12-28	WOS:000167618700046
J	Rosen, MR				Rosen, MR			The heart remembers: clinical implications	LANCET			English	Editorial Material							TERM CARDIAC MEMORY; T-WAVE; LONG; EVOLUTION; MYOCYTES		Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University	Rosen, MR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, PH7W-321, New York, NY 10032 USA.	mrr1@columbia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028958, R01HL053956] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-53956, HL-28958] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anyukhovsky EP, 1996, CIRCULATION, V94, P1981, DOI 10.1161/01.CIR.94.8.1981; DELBALZO U, 1992, CIRCULATION, V85, P1464, DOI 10.1161/01.CIR.85.4.1464; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Kandel E R, 1989, J Neuropsychiatry Clin Neurosci, V1, P103; KATZ AM, 1992, J CARDIOVASC ELECTR, V3, P150, DOI 10.1111/j.1540-8167.1992.tb01104.x; Meghji P, 1997, J MOL CELL CARDIOL, V29, P3147, DOI 10.1006/jmcc.1997.0545; Members of the Sicilican Gambit, 1994, ANT THER PATH APPR; Plotnikov AN, 1999, CIRCULATION, V100, P50; Ricard P, 1999, J CARDIOVASC ELECTR, V10, P545, DOI 10.1111/j.1540-8167.1999.tb00711.x; Rosen MR, 1998, CARDIOVASC RES, V40, P469, DOI 10.1016/S0008-6363(98)00208-9; ROSEN MR, 1997, CIRCULATION, V96, P358; ROSENBAUM MB, 1982, AM J CARDIOL, V50, P213, DOI 10.1016/0002-9149(82)90169-2; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Saffitz JE, 1997, AM HEART MONOGR S, P89; Shvilkin A, 1998, CIRCULATION, V97, P1810, DOI 10.1161/01.CIR.97.18.1810; Yu HG, 1999, CIRCULATION, V99, P1898, DOI 10.1161/01.CIR.99.14.1898	17	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					468	471		10.1016/S0140-6736(00)04020-4	http://dx.doi.org/10.1016/S0140-6736(00)04020-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273084				2022-12-28	WOS:000166865600038
J	Haile, SM; Boysen, DA; Chisholm, CRI; Merle, RB				Haile, SM; Boysen, DA; Chisholm, CRI; Merle, RB			Solid acids as fuel cell electrolytes	NATURE			English	Article							SUPERPROTONIC CONDUCTIVITY; EXCHANGE; CSHSO4; PROTON	Fuel cells are attractive alternatives to combustion engines for electrical power generation because of their very high efficiencies and low pollution levels. Polymer electrolyte membrane fuel cells are generally considered to be the most viable approach for mobile applications. However, these membranes require humid operating conditions, which limit the temperature of operation to less than 100 degreesC; they are also permeable to methanol and hydrogen, which lowers fuel efficiency. Solid, inorganic, acid compounds (or simply, solid acids) such as CsHSO4 and Rb3H(SeO4)(2) have been widely studied because of their high proton conductivities and phase-transition behaviour. For fuel-cell applications they offer the advantages of anhydrous proton transport and high-temperature stability (up to 250 degreesC). Until now, however, solid acids have not been considered viable fuel-cell electrolyte alternatives owing to their solubility in water and extreme ductility at raised temperatures (above approximately 125 degreesC). Here we show that a cell made of a CsHSO4 electrolyte membrane (about 1.5 mm thick) operating at 150-160 degreesC in a H-2/O-2 configuration exhibits promising electrochemical performances: open circuit voltages of 1.11 V and current densities of 44 mA cm(-2) at short circuit. Moreover, the solid-acid properties were not affected by exposure to humid atmospheres. Although these initial results show promise for applications, the use of solid acids in fuel cells will require the development of fabrication techniques to reduce electrolyte thickness, and an assessment of possible sulphur reduction following prolonged exposure to hydrogen.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Haile, SM (corresponding author), CALTECH, Pasadena, CA 91125 USA.		Haile, Sossina M/I-3448-2015					Baranov A.I., 1988, FERROELECTRICS, V81, P183, DOI [10.1080/00150198808008840, DOI 10.1080/00150198808008840]; BARANOV AI, 1982, JETP LETT+, V36, P459; Chisholm CRI, 2000, SOLID STATE IONICS, V136, P229, DOI 10.1016/S0167-2738(00)00315-5; CHISHOLM CRI, IN PRESS SOLID STATE; CROCE F, 1982, SOLID STATE IONICS, V6, P201, DOI 10.1016/0167-2738(82)90039-X; GASKELL DR, 1981, INTRO METALLURGICAL, P574; Haile SM, 1997, SOLID STATE IONICS, V97, P145, DOI 10.1016/S0167-2738(97)00066-0; HAILE SM, 1995, SOLID STATE IONICS, V77, P128, DOI 10.1016/0167-2738(94)00291-Y; HAILE SM, 2000, Patent No. 09439377; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; MINH NQ, 1993, P 14 RIS INT S MAT S, P337; NORBY T, 1995, SOLID STATE IONICS, V77, P105, DOI 10.1016/0167-2738(94)00228-K; PAWLOWSKI A, 1990, SOLID STATE IONICS, V44, P17, DOI 10.1016/0167-2738(90)90038-S; RAMASASTRY C, 1981, J MATER SCI, V16, P2011, DOI 10.1007/BF00540653; SLADE RCT, 1992, SOLID STATE IONICS, V58, P195, DOI 10.1016/0167-2738(92)90119-A; SRINIVASAN S, 1991, J POWER SOURCES, V36, P299, DOI 10.1016/0378-7753(91)87009-Z; WELLS AF, 1984, STRUCTURAL INORGANIC, P300	17	754	785	9	307	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					910	913		10.1038/35073536	http://dx.doi.org/10.1038/35073536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309611				2022-12-28	WOS:000168152300040
J	Bond, DW; Charlton, CPJ; Gregson, RM				Bond, DW; Charlton, CPJ; Gregson, RM			Benign intracranial hypertension secondary to nasal fluticasone propionate	BRITISH MEDICAL JOURNAL			English	Letter							CHILDHOOD											GRANT DN, 1971, ARCH DIS CHILD, V46, P651, DOI 10.1136/adc.46.249.651; HOSKING GP, 1978, BRIT MED J, V1, P550, DOI 10.1136/bmj.1.6112.550-a; NEVILLE BGR, 1970, BRIT MED J, V3, P554, DOI 10.1136/bmj.3.5722.554; NEWTON M, 1994, GUT, V35, P423, DOI 10.1136/gut.35.3.423; VYAS CK, 1981, POSTGRAD MED J, V57, P181, DOI 10.1136/pgmj.57.665.181	5	8	8	3	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					897	897		10.1136/bmj.322.7291.897	http://dx.doi.org/10.1136/bmj.322.7291.897			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302904	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168311300022
J	Bedell, SE; Cadenhead, K; Graboys, TB				Bedell, SE; Cadenhead, K; Graboys, TB			The doctor's letter of condolence.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATIENT DEATH; PHYSICIAN		Lown Cardiovasc Ctr, Brookline, MA 02446 USA		Bedell, SE (corresponding author), Lown Cardiovasc Ctr, Brookline, MA 02446 USA.							ALLEN JE, 2000, LOS ANGELES TIM 0221, P1; ARIES P, 1975, DEATH AM; Lindemann E, 1944, AM J PSYCHIAT, V101, P141, DOI 10.1176/ajp.101.2.141; MEAD M, 1996, WAY SEEING NEW BEACO, P381; Moseley J R, 1988, Oncol Nurs Forum, V15, P151; PUTNAM JJ, 1906, MEMOIR J JACKSON, P389; Rabow MW, 2000, JAMA-J AM MED ASSOC, V283, P771, DOI 10.1001/jama.283.6.771; RANDO TA, 1993, TREATMENT COMPLICATE, P495; SCHLANT E, 1999, LANGUAGE SILENCE W G; SCHMIDT TA, 1990, ANN EMERG MED, V19, P125, DOI 10.1016/S0196-0644(05)81794-9; Schorsch Anita, 1976, MOURNING BECOMES AM; SERAVALLI EP, 1988, NEW ENGL J MED, V319, P1728, DOI 10.1056/NEJM198812293192609; Sudnow, 1967, PASSING; TOLLE SW, 1989, ACAD MED, V64, P505, DOI 10.1097/00001888-198909000-00004; TOLLE SW, 1984, ARCH INTERN MED, V144, P2389, DOI 10.1001/archinte.144.12.2389; TOLLE SW, 1983, ARCH INTERN MED, V143, P1447, DOI 10.1001/archinte.143.7.1447; Webb M, 1997, GOOD DEATH NEW AM SE; [No title captured]	18	66	66	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1162	1164		10.1056/NEJM200104123441510	http://dx.doi.org/10.1056/NEJM200104123441510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11302139				2022-12-28	WOS:000167990600010
J	Holmes, LB; Harvey, EA; Coull, BA; Huntington, KB; Khoshbin, S; Hayes, AM; Ryan, LM				Holmes, LB; Harvey, EA; Coull, BA; Huntington, KB; Khoshbin, S; Hayes, AM; Ryan, LM			The teratogenicity of anticonvulsant drugs.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL-HYDANTOIN SYNDROME; BIRTH-DEFECTS; ANTIEPILEPTIC DRUGS; GROWTH-RETARDATION; PARENTAL EPILEPSY; NEWBORN-INFANTS; PREGNANCY; MALFORMATIONS; CARBAMAZEPINE; WOMEN	Background: The frequency of major malformations, growth retardation, and hypoplasia of the midface and fingers, known as anticonvulsant embryopathy, is increased in infants exposed to anticonvulsant drugs in utero. However, whether the abnormalities are caused by the maternal epilepsy itself or by exposure to anticonvulsant drugs is not known. Methods: We screened 128,049 pregnant women at delivery to identify three groups of infants: those exposed to anticonvulsant drugs, those unexposed to anticonvulsant drugs but with a maternal history of seizures, and those unexposed to anticonvulsant drugs with no maternal history of seizures (control group). The infants were examined systematically for the presence of major malformations, signs of hypoplasia of the midface and fingers, microcephaly, and small body size. Results: The combined frequency of anticonvulsant embryopathy was higher in 223 infants exposed to one anticonvulsant drug than in 508 control infants (20.6 percent vs. 8.5 percent; odds ratio, 2.8; 95 percent confidence interval, 1.1 to 9.7). The frequency was also higher in 93 infants exposed to two or more anticonvulsant drugs than in the controls (28.0 percent vs. 8.5 percent; odds ratio, 4.2; 95 percent confidence interval, 1.1 to 5.1). The 98 infants whose mothers had a history of epilepsy but took no anticonvulsant drugs during the pregnancy did not have a higher frequency of those abnormalities than the control infants. Conclusions: A distinctive pattern of physical abnormalities in infants of mothers with epilepsy is associated with the use of anticonvulsant drugs during pregnancy, rather than with epilepsy itself. (N Engl J Med 2001;344:1132-8.) Copyright (C) 2001 Massachusetts Medical Society.	Massachusetts Gen Hosp, Serv Pediat, Genet & Teratol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Holmes, LB (corresponding author), Massachusetts Gen Hosp, Serv Pediat, Genet & Teratol Unit, Warren 801,55 Fruit St, Boston, MA 02114 USA.		Ryan, Louise M/A-4562-2009	Ryan, Louise M/0000-0001-5957-2490	NINDS NIH HHS [NS 24125] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024125] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; BARRON WM, 1994, MED DISORDERS PREGNA, P443; BENNETT JC, 1995, CECIL TXB MED, V2, P2123; BUEHLER BA, 1990, NEW ENGL J MED, V322, P1567, DOI 10.1056/NEJM199005313222204; DALESSIO DJ, 1985, NEW ENGL J MED, V312, P559, DOI 10.1056/NEJM198502283120906; DANSKY LV, 1991, REPROD TOXICOL, V5, P301, DOI 10.1016/0890-6238(91)90091-S; DANSKY LV, 1987, ANN NEUROL, V21, P176, DOI 10.1002/ana.410210210; DUNN PM, 1976, BRIT MED BULL, V32, P71, DOI 10.1093/oxfordjournals.bmb.a071327; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GAILY E, 1988, J PEDIATR-US, V112, P520, DOI 10.1016/S0022-3476(88)80162-8; HANSON JW, 1975, J PEDIATR-US, V87, P285, DOI 10.1016/S0022-3476(75)80604-4; HANSON JW, 1976, J PEDIATR-US, V89, P662, DOI 10.1016/S0022-3476(76)80414-3; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; HILL RM, 1974, AM J DIS CHILD, V127, P645, DOI 10.1001/archpedi.1974.02110240031002; Holmes LB, 2000, PEDIATR RES, V47, p82A; HOLMES LB, 1994, TERATOLOGY, V49, P202, DOI 10.1002/tera.1420490316; Holmes LB, 2000, TERATOLOGY, V61, P196, DOI 10.1002/(SICI)1096-9926(200003)61:3<196::AID-TERA7>3.0.CO;2-T; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; KRAUSS CM, 1984, J PEDIATR-US, V105, P750, DOI 10.1016/S0022-3476(84)80295-4; LEFKOPOULOU M, 1989, J AM STAT ASSOC, V84, P810, DOI 10.2307/2289671; LINDHOUT D, 1984, EPILEPSIA, V25, P77, DOI 10.1111/j.1528-1157.1984.tb04158.x; Lu MCK, 2000, TERATOLOGY, V61, P277, DOI 10.1002/(SICI)1096-9926(200004)61:4<277::AID-TERA6>3.0.CO;2-W; McCarver DG, 1997, J PHARMACOL EXP THER, V283, P1095; MINKOFF H, 1985, OBSTET GYNECOL, V65, pS22; MONSON RR, 1973, NEW ENGL J MED, V289, P1049, DOI 10.1056/NEJM197311152892001; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; Nulman I, 1997, AM J MED GENET, V68, P18, DOI 10.1002/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U; Olafsson E, 1998, EPILEPSIA, V39, P887, DOI 10.1111/j.1528-1157.1998.tb01186.x; Ornoy A, 1996, ARCH DIS CHILD, V75, P517, DOI 10.1136/adc.75.6.517; Orup H. I. Jr., 1997, Teratology, V55, P34; PREUS M, 1972, AM J DIS CHILD, V124, P933, DOI 10.1001/archpedi.1972.02110180135022; ROSA FW, 1991, NEW ENGL J MED, V324, P674, DOI 10.1056/NEJM199103073241006; Sabry MA, 1996, AM J MED GENET, V62, P410, DOI 10.1002/ajmg.1320620403; SEIP M, 1976, ACTA PAEDIATR SCAND, V65, P617, DOI 10.1111/j.1651-2227.1976.tb04941.x; SHAPIRO S, 1976, LANCET, V1, P272; SHAPIRO S, 1977, J PEDIATR-US, V90, P673, DOI 10.1016/S0022-3476(77)80421-6; SPEIDEL BD, 1972, LANCET, V2, P839; STRICKLER SM, 1985, LANCET, V2, P746; Wells PG, 1996, CRIT REV BIOCHEM MOL, V31, P1, DOI 10.3109/10409239609110574; WONG KS, 1972, BIOL NEONATE, V20, P175; Woodbury CF., 1982, OTHER ANTIEPILEPTIC; YERBY MS, 1992, NEUROLOGY, V42, P132; YOGMAN MW, 1989, J PEDIATR-US, V115, P799, DOI 10.1016/S0022-3476(89)80665-1	44	419	431	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1132	1138		10.1056/NEJM200104123441504	http://dx.doi.org/10.1056/NEJM200104123441504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297704				2022-12-28	WOS:000167990600004
J	Savrasov, SY; Kotliar, G; Abrahams, E				Savrasov, SY; Kotliar, G; Abrahams, E			Correlated electrons in delta-plutonium within a dynamical mean-field picture	NATURE			English	Article							ALPHA; TRANSITION; SPECTRA; SYSTEMS; PU	Given the practical importance of metallic plutonium, there is considerable interest(1-3) in understanding its fundamental properties. Plutonium undergoes a 25 per cent increase in volume(4) when transformed from its alpha -phase (which is stable below 400 K) to the delta -phase (stable at around 600 K), an effect that is crucial for issues of long-term storage and disposal. It has long been suspected that this unique property is a consequence of the special location of plutonium in the periodic table, on the border between the light and heavy actinides-here, electron wave-particle duality (or itinerant versus localized behaviour) is important(5). This situation has resisted previous theoretical treatment. Here we report an electronic structure method, based on dynamical mean-field theory, that enables interpolation between the band-like and atomic-like behaviour of the electron. Our approach enables us to study the phase diagram of plutonium, by providing access to the energetics and one-electron spectra of strongly correlated systems. We explain the origin of the volume expansion between the alpha- and delta -phases, predict the existence of a strong quasiparticle peak near the Fermi level and give a new viewpoint on the physics of plutonium, in which the alpha- and delta -phases are on opposite sides of the interaction-driven localization-delocalization transition.	Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Mat Theory, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Savrasov, SY (corresponding author), Rutgers State Univ, Dept Phys & Astron, POB 849, Piscataway, NJ 08854 USA.	savrasov@physics.rutgers.edu	Savrasov, Sergey Y/M-7157-2015					ANDERSEN OK, 1975, PHYS REV B, V12, P3060, DOI 10.1103/PhysRevB.12.3060; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P7359, DOI 10.1088/0953-8984/9/35/010; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Arko AJ, 2000, PHYS REV B, V62, P1773, DOI 10.1103/PhysRevB.62.1773; Boring A.M., 2000, LOS ALAMOS SCI, V26, P91; Bouchet J, 2000, J PHYS-CONDENS MAT, V12, P1723, DOI 10.1088/0953-8984/12/8/315; BROAD WJ, 2000, NY TIMES        0125; DESCLAUX JP, 1984, HDB PHYSICS CHEM ACT, V1; Freeman A.J., 1974, ACTINIDES ELECT STRU, V1; Freeman A.J., 1974, ACTINIDES ELECT STRU, V2; Fresard R, 1997, PHYS REV B, V56, P12909, DOI 10.1103/PhysRevB.56.12909; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; HECKER S.S., 2000, LOS ALAMOS SCI, V26, P244; HUBBARD J, 1964, PROC R SOC LON SER-A, V281, P401, DOI 10.1098/rspa.1964.0190; Jeanloz R, 2000, PHYS TODAY, V53, P44, DOI 10.1063/1.1341914; JOHANSSON B, 1974, PHILOS MAG, V30, P469, DOI 10.1080/14786439808206574; Jones MD, 2000, PHYS REV B, V61, P4644, DOI 10.1103/PhysRevB.61.4644; LALLEMENT R, 1963, J PHYS CHEM SOLIDS, V24, P1617, DOI 10.1016/0022-3697(63)90105-7; Nekrasov IA, 2000, EUR PHYS J B, V18, P55, DOI 10.1007/s100510070077; NOLTING W, 1989, PHYS REV B, V39, P6962, DOI 10.1103/PhysRevB.39.6962; Savrasov SY, 2000, PHYS REV LETT, V84, P3670, DOI 10.1103/PhysRevLett.84.3670; SODERLIND P, 1994, PHYS REV B, V50, P7291, DOI 10.1103/PhysRevB.50.7291; SOLOVYEV IV, 1991, PHYS REV B, V43, P14414, DOI 10.1103/PhysRevB.43.14414	24	449	453	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					793	795		10.1038/35071035	http://dx.doi.org/10.1038/35071035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298442				2022-12-28	WOS:000168021900048
J	Baker, BS; Taylor, BJ; Hall, JC				Baker, BS; Taylor, BJ; Hall, JC			Are complex behaviors specified by dedicated regulatory genes? Reasoning from Drosophila	CELL			English	Review							SEXUAL-BEHAVIOR; EXPRESSION PATTERNS; FRUITLESS MUTANTS; PROTEIN; MELANOGASTER; MUSCLE; DIFFERENTIATION; ORIENTATION; MUTATIONS; COURTSHIP		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Stanford University; Oregon State University; Brandeis University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@cmgm.stanford.edu						Albright TD, 2000, CELL, V100, pS1; Alcock J., 1998, ANIMAL BEHAV EVOLUTI; ANAND A, 2001, IN PRESS GENETICS; [Anonymous], 1995, ANIMAL BEHAV INTRO B; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; BAKER BS, 1980, GENETICS, V94, P383; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BENTLEY DR, 1972, ANIM BEHAV, V20, P478, DOI 10.1016/S0003-3472(72)80012-5; Bottjer SW, 1997, BIOESSAYS, V19, P1109, DOI 10.1002/bies.950191210; Carlson N.R., 1998, PHYSL BEHAV; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; CLINE TW, 1979, DEV BIOL, V72, P266, DOI 10.1016/0012-1606(79)90117-9; DAWSON WD, 1988, BEHAV GENET, V18, P371, DOI 10.1007/BF01260937; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DILGER WC, 1962, SCI AM, V206, P89; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; GAILEY DA, 1991, DEVELOPMENT, V113, P879; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Goodwin SF, 2000, GENETICS, V154, P725; Gorczyca M, 1999, J NEUROBIOL, V39, P447, DOI 10.1002/(SICI)1097-4695(19990605)39:3<447::AID-NEU10>3.0.CO;2-Q; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; GREENSPAN RJ, 2000, IN PRESS ANN REV GEN; Gronenberg W, 1996, J EXP BIOL, V199, P2021; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1980, STADLER S, V12, P43; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Heisenberg M, 1997, BIOESSAYS, V19, P1065, DOI 10.1002/bies.950191205; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; LEE G, 2001, IN PRESS J NEUROBIOL; Lessing D, 1999, CURR OPIN NEUROBIOL, V9, P766, DOI 10.1016/S0959-4388(99)00035-5; LEVINE RB, 1983, BRAIN RES, V279, P335, DOI 10.1016/0006-8993(83)90205-6; LEWIS EB, 1996, NOBELSTIFTELSEN PRIX, P232; LORENZ KZ, 1950, SYM SOC EXP BIOL, V4, P221; MCKEOWN M, 1988, CELL, V53, P887, DOI 10.1016/S0092-8674(88)90369-8; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Miller J.P., 1987, P109; MILLER LA, 1979, J COMP PHYSIOL, V131, P113, DOI 10.1007/BF00619071; Modolell J, 1998, INT J DEV BIOL, V42, P275; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pankratz Michael J., 1993, P467; Restifo LL, 1998, MOL CELL NEUROSCI, V11, P134, DOI 10.1006/mcne.1998.0683; ROEDER KD, 1965, SCI AM, V212, P94, DOI 10.1038/scientificamerican0465-94; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SIEGEL RW, 1984, BEHAV GENET, V14, P383, DOI 10.1007/BF01065442; Smith DJ, 1997, HUM MOL GENET, V6, P1729, DOI 10.1093/hmg/6.10.1729; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; THODAY J. M., 1959, HEREDITY, V13, P187, DOI 10.1038/hdy.1959.22; THOMAS JH, 1990, GENETICS, V124, P855; Tinbergen N, 1951, STUDY INSTINCT; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Waterbury JA, 1999, GENETICS, V152, P1653; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551	70	158	163	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					13	24		10.1016/S0092-8674(01)00293-8	http://dx.doi.org/10.1016/S0092-8674(01)00293-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11300999	Bronze			2022-12-28	WOS:000168063300004
J	Martinez, LM; Angell, CA				Martinez, LM; Angell, CA			A thermodynamic connection to the fragility of glass-forming liquids	NATURE			English	Article							CONFIGURATIONAL ENTROPY; ENERGY LANDSCAPE; VISCOUS-LIQUIDS; RELAXATION; TRANSITION; HEAT; DYNAMICS; MODEL; VISCOSITY; LINK	Although liquids normally crystallize on cooling, there are members of all liquid types (including molecular, ionic and metallic) that supercool and then solidify at their glass transition temperature, T-g. This continuous solidification process exhibits great diversity within each class of liquid-both in the steepness of the viscosity-temperature profile, and in the rate at which the excess entropy of the liquid over the crystalline phase changes as T-g is approached. However, the source of the diversity is unknown. The viscosity and associated relaxation time behaviour have been classified between 'strong' and 'fragile' extremes, using T-g as a scaling parameter(1), but attempts to correlate such kinetic properties with the thermodynamic behaviour have been controversial(2,3). Here we show that the kinetic fragility can be correlated with a scaled quantity representing excess entropy, using data over the entire fragility range and embracing liquids of all classes. The excess entropy used in our correlation contains both configurational and vibration-related contributions. In order to reconcile our correlation with existing theory and simulations, we propose that variations in the fragility of liquids originate in differences between their vibrational heat capacities, harmonic and anharmonic, which we interpret in terms of an energy landscape. The differences evidently relate to behaviour of low-energy modes near and below the boson peak.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Angell, CA (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	caa@asu.edu	Martínez, Luz María/H-3988-2012	Martinez, Luz Maria/0000-0002-5449-1621				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Angell A, 1998, NATURE, V393, P521, DOI 10.1038/31110; Angell CA, 1997, J RES NATL INST STAN, V102, P171, DOI 10.6028/jres.102.013; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; Buchner S, 1999, PHYS REV E, V60, P6507, DOI 10.1103/PhysRevE.60.6507; Coluzzi B, 2000, J CHEM PHYS, V112, P2933, DOI 10.1063/1.480866; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; GOLDSTEIN M, 1976, J CHEM PHYS, V64, P4767, DOI 10.1063/1.432063; GREET RJ, 1967, J CHEM PHYS, V47, P2185, DOI 10.1063/1.1712251; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; Johari GP, 2000, J CHEM PHYS, V112, P7518, DOI 10.1063/1.481349; Kob W, 2000, EUROPHYS LETT, V49, P590, DOI 10.1209/epl/i2000-00191-8; MAGILL JH, 1967, J CHEM PHYS, V47, P2802, DOI 10.1063/1.1712301; Ngai KL, 1999, J CHEM PHYS, V111, P10403, DOI 10.1063/1.480394; PHILLIPS WA, 1989, PHYS REV LETT, V63, P2381, DOI 10.1103/PhysRevLett.63.2381; Richert R, 1998, J CHEM PHYS, V108, P9016, DOI 10.1063/1.476348; RICHET P, 1984, GEOCHIM COSMOCHIM AC, V48, P453, DOI 10.1016/0016-7037(84)90274-6; RICHET P, 1984, GEOCHIM COSMOCHIM AC, V48, P471, DOI 10.1016/0016-7037(84)90275-8; Roland CM, 1999, J CHEM PHYS, V111, P5593, DOI 10.1063/1.479861; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sastry S, 2001, NATURE, V409, P164, DOI 10.1038/35051524; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; Speedy RJ, 1999, J PHYS CHEM B, V103, P4060, DOI 10.1021/jp983830w; Speedy RJ, 1998, MOL PHYS, V95, P169, DOI 10.1080/00268979809483148; STARR FW, 2000, CONDMAT0007487; STARR FW, IN PRESS PHYS REV E; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983; TAKAHARA S, 1995, J PHYS CHEM-US, V99, P9589, DOI 10.1021/j100023a042; TAKAHARA S, 1994, J NON-CRYST SOLIDS, V171, P259, DOI 10.1016/0022-3093(94)90195-3; Wischnewski A, 1998, PHILOS MAG B, V77, P579, DOI 10.1080/13642819808204986	32	588	597	6	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					663	667		10.1038/35070517	http://dx.doi.org/10.1038/35070517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287947				2022-12-28	WOS:000167875400039
J	Schwetz, BA				Schwetz, BA			New formulation of Tripedia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-28	WOS:000167710600003
J	Cohen, JD				Cohen, JD			ABCs of secondary prevention of CHD: easier said than done	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; ASSOCIATION TASK-FORCE; LOWERING-THERAPY; RISK; CARDIOLOGY		St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA	Saint Louis University	Cohen, JD (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA.	cohenjd@slu.edu						[Anonymous], 1997, ARCH INTERN MED, V157, P2413; *EUROASPIRE STUD G, 1997, EUR HEART J, V18, P1562; Feely J, 1999, ATHEROSCLEROSIS, V147, pS31, DOI 10.1016/S0021-9150(99)00253-1; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Grundy SM, 1997, CIRCULATION, V95, P1683; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Lowensteyn I, 1998, PREV MED, V27, P730, DOI 10.1006/pmed.1998.0351; Martinez M, 1998, EUR J CLIN PHARMACOL, V54, P203, DOI 10.1007/s002280050446; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; PIWONSKI J, 2000, KARDIOL POL, V539, P223; PYORALA K, 1994, EUR HEART J, V15, P1300; Shepherd J, 1997, J Cardiovasc Risk, V4, P373, DOI 10.1097/00043798-199710000-00010; SMITH SC, 1995, CIRCULATION, V92, P2; VANBERKEL TF, 1999, EUR HEAT J, V20, P1617; Velasco JA, 1999, ATHEROSCLEROSIS, V147, pS39, DOI 10.1016/S0021-9150(99)00254-3; Wood D, 1998, EUR HEART J, V19, P1434; Yusuf S, 2000, NEW ENGL J MED, V342, P145	18	26	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2001	357	9261					972	973		10.1016/S0140-6736(00)04252-5	http://dx.doi.org/10.1016/S0140-6736(00)04252-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293635				2022-12-28	WOS:000167791500002
J	Wessely, S; Hotopf, M				Wessely, S; Hotopf, M			Are some public-health problems better neglected?	LANCET			English	Editorial Material							STRESS; TRENDS; LIFE		Guys Kings & St Thomas Sch Med, Dept Psychol Med, London SE5 8AF, England; Inst Psychiat, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Wessely, S (corresponding author), Guys Kings & St Thomas Sch Med, Dept Psychol Med, London SE5 8AF, England.	s.wessely@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010	Wessely, Simon Charles/0000-0002-6743-9929; Hotopf, Matthew/0000-0002-3980-4466				BARSKY AJ, 1988, NEW ENGL J MED, V318, P414, DOI 10.1056/NEJM198802183180705; Croft P, 2000, BRIT MED J, V320, P1552, DOI 10.1136/bmj.320.7249.1552; Dubois P., 1909, PSYCHIC TREATMENT NE; Hotopf M, 1997, J PSYCHOSOM RES, V43, P1, DOI 10.1016/S0022-3999(97)00115-3; MCCORD J, 1978, AM PSYCHOL, V33, P284; MCCORMICK A, 1995, MORBIDITY STAT GEN P, V5; Moncrieff J, 2000, J PUBLIC HEALTH MED, V22, P59, DOI 10.1093/pubmed/22.1.59; PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM; Sennett R., 1998, CORROSION CHARACTER; Stewart-Brown S, 2000, J PUBLIC HEALTH MED, V22, P492, DOI 10.1093/pubmed/22.4.492; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Wainwright D, 2000, EUR J PUBLIC HEALTH, V10, P231, DOI 10.1093/eurpub/10.3.231; WARR P, 1987, UNEMPLOYMENT MENTAL; Wessely S., 2000, DEPRESSION ANXIETY N; WILKINSON G, 1991, BRIT MED J, V302, P191, DOI 10.1136/bmj.302.6770.191; 1909, BMJ, V2, P97	16	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2001	357	9261					976	978		10.1016/S0140-6736(00)04255-0	http://dx.doi.org/10.1016/S0140-6736(00)04255-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416QK	11293638				2022-12-28	WOS:000167791500005
J	Vollrath, F; Knight, DP				Vollrath, F; Knight, DP			Liquid crystalline spinning of spider silk	NATURE			English	Review							AMINO-ACID-COMPOSITION; MAJOR AMPULLATE SILK; MECHANICAL-PROPERTIES; DRAGLINE SILK; WEB; PROTEINS; PHASE; MORPHOLOGY; EXPRESSION; SECRETION	Spider silk has outstanding mechanical properties despite being spun at close to ambient temperatures and pressures using water as the solvent The spider achieves this feat of benign fibre processing by judiciously controlling the folding and crystallization of the main protein constituents, and by adding auxiliary compounds, to create a composite material of defined hierarchical structure, Because the 'spinning dope' (the material from which silk is spun) is liquid crystalline, spiders can draw it during extrusion into a hardened fibre using minimal forces. This process involves an unusual internal drawdown within the spider's spinneret that is not seen in industrial fibre processing, followed by a conventional external drawdown after the dope has left the spinneret Successful copying of the spider's internal processing and precise control over protein folding, combined with knowledge of the gene sequences of its spinning dopes, could permit industrial production of silk-based fibres with unique properties under benign conditions.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Dept Zool, DK-8000 Aarhus C, Denmark	University of Oxford	Vollrath, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	fritz.vollrath@zoo.ox.ac.uk		Vollrath, Fritz/0000-0003-3484-9005				AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; ANDERSEN SO, 1970, COMP BIOCHEM PHYSIOL, V35, P705, DOI 10.1016/0010-406X(70)90988-6; Asakura T., 1994, ENCY AGR SCI, V4, P1; Askeland D. R., 1996, SCI ENG MAT, P120; Bunning JD, 1996, LIQ CRYST, V20, P381, DOI 10.1080/02678299608032050; CANDELAS G, 1983, BIOCHEM BIOPH RES CO, V116, P1033, DOI 10.1016/S0006-291X(83)80246-0; Case ST, 1999, INT J BIOL MACROMOL, V24, P89, DOI 10.1016/S0141-8130(98)00077-4; Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; DONALD AM, 1992, LIQUID CRYSTALLINE P, P1; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; ENGSTER MS, 1976, CELL TISSUE RES, V169, P77; *FIB EC BUR, 1999, MAN FIB REV      JAN, P2; Foelix R., 2011, BIOL SPIDERS; Frische S, 1998, J MICROSC-OXFORD, V189, P64, DOI 10.1046/j.1365-2818.1998.00285.x; FUNG YC, 1981, BIOMECHANICS, P1; GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HENDERSON G, 1995, VET DERMATOL, V6, P159, DOI 10.1111/j.1365-3164.1995.tb00060.x; HEPBURN HR, 1988, APIDOLOGIE, V19, P25, DOI 10.1051/apido:19880102; Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN M, 1993, MATER RES SOC SYMP P, V292, P25; HUNT S, 1970, COMP BIOCHEM PHYSIOL, V34, P773, DOI 10.1016/0010-406X(70)90998-9; KAPLAN D, 1994, ACS SYM SER, V544, P2; KAPLAN DL, 1994, SILK POLYM MAT SCI B, P1; KAPLAN DL, 1995, BIOCHEMISTRY-US, V34, P10879; KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KNIGHT DP, IN PRESS NATURWISSEN; Kovoor J., 1987, P160; KOVOOR J, 1977, Annee Biologique, V16, P97; KOVOOR J, 1982, TISSUE CELL, V14, P519, DOI 10.1016/0040-8166(82)90044-1; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; LOMBARDI SJ, 1990, J ARACHNOL, V18, P297; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; MAGOSHI J, 1985, POLYM COMMUN, V26, P309; Magoshi J., 1985, J APPL POLYM SCI APP, V41, P187; MAHONEY DV, 1994, ACS SYM SER, V544, P196; Mello C. M., 1994, SILK POLYM MAT SCI B, P67; NAKAMAE K, 1989, POLYMER, V30, P1243, DOI 10.1016/0032-3861(89)90042-6; NORTHOLT MG, 1991, ADV POLYM SCI, V98, P115; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; PETERS HM, 1955, Z NATURFORSCH PT B, V10, P395; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1; RIEKEL G, IN PRESS BIOL MACROM; SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Shao Z, 1999, POLYMER, V40, P4709, DOI 10.1016/S0032-3861(99)00072-5; Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3; Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sirichaisit J, 2000, POLYMER, V41, P1223, DOI 10.1016/S0032-3861(99)00293-1; SIVINSKI J, 1982, ECOL ENTOMOL, V7, P443, DOI 10.1111/j.1365-2311.1982.tb00686.x; Sun YY, 1997, J POLYM SCI POL PHYS, V35, P1405, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1405::AID-POLB10>3.0.CO;2-A; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; THIEL BL, 1995, MRS BULL, V20, P52, DOI 10.1557/S0883769400034941; TILLINGHAST EK, 1984, J INSECT PHYSIOL, V30, P591, DOI 10.1016/0022-1910(84)90088-X; TIRRELL JG, 1994, CHEM ENG NEWS, V72, P40, DOI 10.1021/cen-v072n051.p040; TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203; van Beek JD, 1999, INT J BIOL MACROMOL, V24, P173, DOI 10.1016/S0141-8130(98)00083-X; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vincent J. F. V., 1982, STRUCTURAL MAT, P1; Viney C., 1994, SILK POLYM MAT SCI B, P120; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447; Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2000, EXPTL BIOL REV, P315; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; VOLLRATH F, IN PRESS P R SOC LON; VOLLRATH F, 1999, Patent No. 0004489; Weiskopf A, 1996, GLYCOBIOLOGY, V6, P1703; Willcox PJ, 1996, MACROMOLECULES, V29, P5106, DOI 10.1021/ma960588n; Winkler S, 2000, J Biotechnol, V74, P85; WINKLER S, IN PRESS REV MOL BIO; WORK RW, 1984, T AM MICROSC SOC, V103, P113, DOI 10.2307/3226233; WORK RW, 1987, J ARACHNOL, V15, P65; Yeh WY, 1999, POLYMER, V40, P857, DOI 10.1016/S0032-3861(98)00308-5; YOON HN, 1992, ADV MATER, V4, P206, DOI 10.1002/adma.19920040311; ZEMLIN JC, 1968, STUDY MECH BEHAVIOR, P1; [No title captured]	97	1200	1277	42	765	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					541	548		10.1038/35069000	http://dx.doi.org/10.1038/35069000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279484				2022-12-28	WOS:000167859300036
J	Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP				Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP			Neuroperception - Early visual experience and face processing	NATURE			English	Article							CONFIGURATION; RECOGNITION; INVERSION		McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Le Grand, R (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.							BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ellemberg D, 1999, VISION RES, V39, P3480, DOI 10.1016/S0042-6989(99)00078-4; Farah MJ., 2000, COGNITIVE NEUROSCIEN; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; GELDART S, 2000, THESIS MCMASTER U; Kanwisher N, 1997, J NEUROSCI, V17, P4302; MAURER D, IN PRESS CLIN NEUROS; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301	13	336	337	2	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					890	890		10.1038/35073749	http://dx.doi.org/10.1038/35073749			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	423AG	11309606				2022-12-28	WOS:000168152300035
J	McMichael, AJ; Rowland-Jones, SL				McMichael, AJ; Rowland-Jones, SL			Cellular immune responses to HIV	NATURE			English	Review							CYTOTOXIC T-LYMPHOCYTES; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; FAS LIGAND EXPRESSION; IN-VIVO; PERIPHERAL-BLOOD; INTERFERON-GAMMA; BETA-CHEMOKINES; ESCAPE VARIANTS; INFECTED-CELLS	The cellular immune response to the human immunodeficiency virus, mediated by T lymphocytes, seems strong but fails to control the infection completely. In most virus infections, T cells either eliminate the virus or suppress it indefinitely as a harmless, persisting infection. But the human immunodeficiency virus undermines this control by infecting key immune cells, thereby impairing the response of both the infected CD4(+) T cells and the uninfected CD8(+) T cells. The failure of the latter to function efficiently facilitates the escape of virus from immune control and the collapse of the whole immune system.	John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	McMichael, AJ (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.							Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bangham CRM, 1996, SEMIN VIROL, V7, P1, DOI 10.1006/smvy.1996.0001; Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; BOLLINGER RC, 1993, AIDS RES HUM RETROV, V9, P1067, DOI 10.1089/aid.1993.9.1067; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590; CALLAN MFC, 1996, NAT MED, V2, P205; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; COPELAND KFT, 1995, AIDS RES HUM RETROV, V11, P1321, DOI 10.1089/aid.1995.11.1321; Dunbar PR, 1998, CURR BIOL, V8, P413, DOI 10.1016/S0960-9822(98)70161-7; EMILIE D, 1992, J BIOL CHEM, V267, P20565; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; GALLIMORE A, 1995, NAT MED, V1, P1167, DOI 10.1038/nm1195-1167; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GOTCH FM, 1990, INT IMMUNOL, V2, P707, DOI 10.1093/intimm/2.8.707; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Goulder PJR, 2000, J EXP MED, V192, P1819, DOI 10.1084/jem.192.12.1819; Gray CM, 1999, J IMMUNOL, V162, P1780; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hadida F, 1999, J IMMUNOL, V163, P1105; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; HARRER T, 1993, J ACQ IMMUN DEF SYND, V6, P865; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Janssens W, 1997, AIDS, V11, P705, DOI 10.1097/00002030-199706000-00002; JASSOY C, 1993, J VIROL, V67, P2844, DOI 10.1128/JVI.67.5.2844-2852.1993; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jones IM, 1998, REV MED VIROL, V8, P87, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;87::AID-RMV220&gt;3.0.CO;2-B; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kalams SA, 1996, J EXP MED, V183, P1669, DOI 10.1084/jem.183.4.1669; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Klenerman P, 1996, P NATL ACAD SCI USA, V93, P15323, DOI 10.1073/pnas.93.26.15323; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J VIROL, V73, P1573, DOI 10.1128/JVI.73.2.1573-1579.1999; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LEWIS DE, 1994, J IMMUNOL, V153, P412; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; McMichael AJ, 2000, PHILOS T R SOC B, V355, P363, DOI 10.1098/rstb.2000.0575; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Mortara L, 1998, J VIROL, V72, P1403, DOI 10.1128/JVI.72.2.1403-1410.1998; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MOSS PAH, 1995, P NATL ACAD SCI USA, V92, P5773, DOI 10.1073/pnas.92.13.5773; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; PANTALEO G, 1990, J IMMUNOL, V144, P1696; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; PRICE P, 1995, CLIN IMMUNOL IMMUNOP, V74, P100, DOI 10.1006/clin.1995.1014; Putkonen P, 1997, J VIROL, V71, P4981, DOI 10.1128/JVI.71.7.4981-4984.1997; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; RIDDELL SR, 1995, ANNU REV IMMUNOL, V13, P545; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shankar P, 1999, BLOOD, V94, P3084, DOI 10.1182/blood.V94.9.3084.421k02_3084_3093; Tan LC, 1999, J IMMUNOL, V162, P1827; Tan RS, 1999, BLOOD, V93, P1506, DOI 10.1182/blood.V93.5.1506.405a38_1506_1510; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; WODARZ, IN PRESS P R SOC L B; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZHANG WH, 1994, VIROLOGY, V203, P101, DOI 10.1006/viro.1994.1459	110	481	502	0	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					980	987		10.1038/35073658	http://dx.doi.org/10.1038/35073658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309628	Bronze			2022-12-28	WOS:000168152300058
J	Moher, D; Schulz, KF; Altman, D				Moher, D; Schulz, KF; Altman, D		CONSORT Grp	The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; TREAT ANALYSIS; INTENTION	To comprehend the results of a randomized controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through complete transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by using a checklist and flow diagram. The revised CONSORT statement presented in this article incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Comment. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting the information is associated with biased estimates of treatment effect or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT, The revised flow diagram depicts information from 4 stages of a trial (enrollment, intervention allocation, follow-up, and analysis). The diagram explicitly includes the number of participants, according to each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have performed an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.	Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Reviews, Room R235,401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Thomas C Chalmers Ctr Systemat Reviews, Ottawa, ON, Canada; Family Hlth Int, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; Inst Hlth Sci, Imperial Canc Res Fund, Med Stat Grp, Oxford, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; University of Oxford	Moher, D (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Reviews, Room R235,401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.		Lang, Tom/AAN-9087-2020	Lang, Tom/0000-0002-7482-7727				Altman DG, 1996, BRIT MED J, V313, P570; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bentzen SM, 1998, RADIOTHER ONCOL, V46, P5, DOI 10.1016/S0167-8140(97)00226-0; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; Davidoff F, 2000, ANN INTERN MED, V133, P229, DOI 10.7326/0003-4819-133-3-200008010-00017; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Elbourne DR, 2001, STAT MED, V20, P489, DOI 10.1002/1097-0258(20010215)20:3<489::AID-SIM806>3.0.CO;2-S; Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Huston P, 1996, CAN MED ASSOC J, V155, P1277; JADAD AR, 2000, TREATMENT ATTENTION; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, 1995, JAMA-J AM MED ASSOC, V285, P1992; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; OToole LB, 1997, BRIT MED J, V314, P1127; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; Schulz KF, 1997, ANN NEUROL, V41, P569, DOI 10.1002/ana.410410504; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181	28	1451	1502	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1987	1991		10.1001/jama.285.15.1987	http://dx.doi.org/10.1001/jama.285.15.1987			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308435	Green Published, Bronze			2022-12-28	WOS:000167995900027
J	Moher, D; Jones, A; Lepage, L				Moher, D; Jones, A; Lepage, L		CONSORT Grp	Use of the CONSORT statement and quality of reports of randomized trials - A comparative before-and-after evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; READERS	Context The Consolidated Standards for Reporting of Trials (CONSORT) statement was developed to help improve the quality of reports of randomized controlled trials (RCTs). To date, a paucity of data exists regarding whether it has achieved this goal. Objective To determine whether use of the CONSORT statement is associated with improvement in the quality of reports of RCTs. Design and Setting Comparative before-and-after evaluation in which reports of RCTs published in 1994 (pre-CONSORT) were compared with RCT reports from the same journals published in 1998 (post-CONSORT), We included 211 reports from BMI, JAMA, and The Lancet (journals that adopted CONSORT) as well as The New England Journal of Medicine (a journal that did not adopt CONSORT and was used as a comparator). Main Outcome Measures Number of CONSORT items included in a report, frequency of unclear reporting of allocation concealment, and overall trial quality score based on the Jadad scale, a 5-point quality assessment instrument. Results Compared with 1994, the number of CONSORT checklist items in reports of RCTs increased in all 4 journals in 1998, and this increase was statistically significant for the 3 adopter journals (pre-CONSORT, 23.4; mean change, 3.7; 95% confidence interval [CI], 2.1-5.3). The frequency of unclear reporting of allocation concealment decreased for each of the 4 journals, and this change was statistically significant for adopters (pre-CONSORT, 61%, mean change, -22%; 95% CI, -38% to -6%), Similarly, 3 of the 4 journals showed an improvement in the quality score for reports of RCTs, and this increase was statistically significant for adopter journals overall (pre-CONSORT, 2.7; mean change, 0.4; 95% CI, 0.1-0.8). Conclusion Use of the CONSORT statement is associated with improvements in the quality of reports of RCTs.	Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Reviews, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	Lepage, L (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Reviews, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.			Moher, David/0000-0003-2434-4206				Altman DG, 1996, BRIT MED J, V313, P570; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Campbell D. T, 1966, EXPT QUASI EXPT DESI, P13; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Docherty M, 1999, BRIT MED J, V318, P1224; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; LEBEAU DL, 1998, HAS RANDOMIZED CONTR; McNamee D, 1996, LANCET, V348, P562; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; PRUSAKOWSKI N, 2000, CONTROLLED CLIN TRIA, V21, pS65; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408	15	758	805	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1992	1995		10.1001/jama.285.15.1992	http://dx.doi.org/10.1001/jama.285.15.1992			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308436				2022-12-28	WOS:000167995900028
J	Episkopou, V; Arkell, R; Timmons, PM; Walsh, JJ; Andrew, RL; Swan, D				Episkopou, V; Arkell, R; Timmons, PM; Walsh, JJ; Andrew, RL; Swan, D			Induction of the mammalian node requires Arkadia function in the extraembryonic lineages	NATURE			English	Article							EMBRYONIC STEM-CELLS; VISCERAL ENDODERM; PRIMITIVE ENDODERM; MOUSE; EXPRESSION; TISSUES; GENE; FOREBRAIN; GASTRULATION; ORGANIZER	The early mammalian embryo is patterned by signals emanating from extraembryonic and embryonic signalling centres, most notably the anterior visceral endoderm (AVE) and the node, respectively(1). The AVE is responsible for anterior development, whereas further axis specification depends on the node, the equivalent of Spemann's organizer(2,3). Formation of the node, at the anterior primitive streak, depends on expression of the transcription factor HNF3 beta (ref. 4). However, both the source and the nature of the signals responsible for inducing the node have been unknown. Here we describe a recessive lethal mutation, arkadia, generated using gene-trap mutagenesis. Mutant embryos establish an AVE but fail to maintain anterior embryonic structures and lack a node. The mutation has disrupted the Arkadia gene, which encodes a putative intracellular protein containing a RING domain. Arkadia is essential for HNF3 beta expression in the anterior primitive streak. Analysis with chimaeras, however, shows that Arkadia functions within extraembryonic tissues, revealing that these are required to induce the node. Furthermore, our experiments show that Arkadia interacts genetically with the transforming growth factor (TGF)beta -like factor Nodal(5-7), implying that Nodal mediates the function of Arkadia in node induction.	Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr, London W12 0NN, England	Imperial College London	Episkopou, V (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	vasso.episkopou@csc.mrc.ac.uk	Greiver, Michelle/N-8764-2015; Swan, Daniel/A-7167-2008; arkell, ruth m/D-1525-2009; Arkell, Ruth/AAR-8471-2021; Episkopou, Vasso/E-2952-2010	Greiver, Michelle/0000-0001-8957-0285; arkell, ruth m/0000-0002-6213-7323; Arkell, Ruth/0000-0002-6213-7323; Swan, Daniel/0000-0001-8978-8129	MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBANO RM, 1994, INT J DEV BIOL, V38, P543; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1991, DEVELOPMENT, V111, P969; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Dufort D, 1998, DEVELOPMENT, V125, P3015; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Filosa S, 1997, DEVELOPMENT, V124, P2843; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Rhinn M, 1998, DEVELOPMENT, V125, P845; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Varlet I, 1997, DEVELOPMENT, V124, P1033; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	30	83	86	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					825	830		10.1038/35071095	http://dx.doi.org/10.1038/35071095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298452				2022-12-28	WOS:000168021900058
J	Midgley, M				Midgley, M			Being objective - The idea of scientists as impartial observers is hard to shake, but is complete detachment justified?	NATURE			English	Article									Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK									0	1	1	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					753	753		10.1038/35071193	http://dx.doi.org/10.1038/35071193			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298421	Bronze			2022-12-28	WOS:000168021900030
J	Murray, N; Holman, M				Murray, N; Holman, M			The role of chaotic resonances in the Solar System	NATURE			English	Review							MEAN MOTION RESONANCES; OUTER ASTEROID BELT; UPSILON ANDROMEDAE; 3/1 COMMENSURABILITY; PLANETARY SYSTEM; EARTHS OBLIQUITY; KIRKWOOD GAP; ORIGIN; METEORITES; STABILITY	Our understanding of the Solar System has been revolutionized over the past decade by the finding that the orbits of the planets are inherently chaotic. In extreme cases, chaotic motions can change the relative positions of the planets around stars, and even eject a planet from a system. Moreover, the spin axis of a planet-Earth's spin axis regulates our seasons-may evolve chaotically, with adverse effects on the climates of otherwise biologically interesting planets. Some of the recently discovered extrasolar planetary systems contain multiple planets, and it is likely that some of these are chaotic as well.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Toronto	Holman, M (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	mholman@cfa.harvard.edu		Murray, Norman/0000-0002-8659-3729				AKSNES K, 1984, P IAU C, V75, P479; Arnold V. I., 1963, USPEHI MAT NAUK, V18, P13; Butler RP, 1999, ASTROPHYS J, V526, P916, DOI 10.1086/308035; Chirikov B V, 1960, J NUCL ENERGY C, V1, P253, DOI [DOI 10.1088/0368-3281/1/4/311, 10.1088/0368-3281/1/4/311]; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; Darwin GH., 1879, PHILOS T ROY SOC LON, V170, P447, DOI [10.1098/rstl.1879.0073, DOI 10.1098/RSTL.1879.0073]; deSurgy ON, 1997, ASTRON ASTROPHYS, V318, P975; Ferraz-Mello S, 1998, ASTRON J, V116, P1491, DOI 10.1086/300488; FERRAZMELLO S, 1991, NATO ADV SCI I B-PHY, V272, P177; FROESCHLE C, 1981, ASTRON ASTROPHYS, V93, P62; GIFFEN R, 1973, ASTRON ASTROPHYS, V23, P387; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; GOLDREIC.P, 1966, ASTRON J, V71, P1, DOI 10.1086/109844; GOLDREICH P, 1977, NATURE, V269, P783, DOI 10.1038/269783b0; GOLDREICH P, 1982, COSMOLOGY ASTROPHYSI, P121; HENON M, 1964, ASTRON J, V69, P73, DOI 10.1086/109234; HENRARD J, 1986, CELESTIAL MECH, V39, P213, DOI 10.1007/BF01234307; Holman MJ, 1996, ASTRON J, V112, P1278, DOI 10.1086/118098; KIRKWOOD D, 1867, METEORIC ASTRONOMY T, P105; LAPLACE PS, 1997, OEUVRES COMPLETE LAP, V8, P144; LASKAR J, 1989, NATURE, V338, P237, DOI 10.1038/338237a0; LASKAR J, 1993, NATURE, V361, P615, DOI 10.1038/361615a0; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LASKAR J, 1990, P IAU S, V152, P1; Laughlin G, 1999, ASTROPHYS J, V526, P881, DOI 10.1086/308046; LICHTENBERG AJ, 1992, REGUL CHAOTIC DYN, P245; Malhotra R., 2000, Protostars and planets 4, P1231; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221, DOI 10.1146/annurev.ea.20.050192.001253; MORBIDELLI A, 1993, ICARUS, V102, P316, DOI 10.1006/icar.1993.1052; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Morbidelli A, 1999, ICARUS, V139, P295, DOI 10.1006/icar.1999.6097; MOSER J, 1962, NACHR AKAD WISS GO K, V1, P87; Murray N, 1998, ASTRON J, V116, P2583, DOI 10.1086/300586; Murray N, 1997, ASTRON J, V114, P1246, DOI 10.1086/118558; Murray N, 1999, SCIENCE, V283, P1877, DOI 10.1126/science.283.5409.1877; Nesvorny D, 1998, ASTRON J, V116, P3029, DOI 10.1086/300632; Peirce B., 1849, ASTRON J, V1, P1, DOI [10.1086/100002, DOI 10.1086/100002]; Rivera EJ, 2000, ASTROPHYS J, V530, P454, DOI 10.1086/308345; SUSSMAN GJ, 1988, SCIENCE, V241, P433, DOI 10.1126/science.241.4864.433; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; TENNYSON J, 1979, AIP C P, V57, P158; Tisserand F., 1896, TRAITE MECANIQUE CEL, VIV; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; WARD WR, 1982, ICARUS, V50, P444, DOI 10.1016/0019-1035(82)90134-8; WARD WR, 1991, ICARUS, V94, P160, DOI 10.1016/0019-1035(91)90146-K; WARD WR, 1973, SCIENCE, V181, P260, DOI 10.1126/science.181.4096.260; WETHERILL GW, 1988, ICARUS, V76, P1, DOI 10.1016/0019-1035(88)90138-8; WISDOM J, 1984, ICARUS, V58, P137, DOI 10.1016/0019-1035(84)90032-0; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0; WISDOM J, 1982, ASTRON J, V87, P577, DOI 10.1086/113132; WISDOM J, 1985, ICARUS, V63, P272, DOI 10.1016/0019-1035(85)90011-9; WISDOM J, 1983, ICARUS, V56, P51, DOI 10.1016/0019-1035(83)90127-6; WISDOM J, 1980, ASTRON J, V85, P1122, DOI 10.1086/112778	56	44	45	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					773	779		10.1038/35071000	http://dx.doi.org/10.1038/35071000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298438	Green Submitted			2022-12-28	WOS:000168021900044
J	Rupert, PB; Ferre-D'Amare, AR				Rupert, PB; Ferre-D'Amare, AR			Crystal structure of a hairpin ribozyme-inhibitor complex with implications for catalysis	NATURE			English	Article							DELTA VIRUS RIBOZYME; TERTIARY STRUCTURE FORMATION; LOOP-B DOMAIN; GUANOSINE REQUIREMENT; SECONDARY STRUCTURE; BINDING-SITES; METAL-IONS; IN-VITRO; RNA; CLEAVAGE	The hairpin ribozyme catalyses sequence-specific cleavage of RNA. The active site of this natural RNA results from the docking of two irregular helices: stems A and B. One strand of stem A harbours the scissile bond. The 2.4 Angstrom resolution structure of a hairpin ribozyme-inhibitor complex reveals that the ribozyme aligns the 2'-OH nucleophile and the 5'-oxo leaving group by twisting apart the nucleotides that flank the scissile phosphate. The base of the nucleotide preceding the cleavage site is stacked within stem A; the next nucleotide, a conserved guanine, is extruded from stem A and accommodated by a highly complementary pocket in the minor groove of stem B. Metal ions are absent from the active site. The bases of four conserved purines are positioned potentially to serve as acid-base catalysts. This is the first structure determination of a fully assembled ribozyme active site that catalyses a phosphodiester cleavage without recourse to metal ions.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.							Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTCHER SE, 1994, BIOCHEMISTRY-US, V33, P992, DOI 10.1021/bi00170a018; BUTCHER SE, 1995, J BIOL CHEM, V270, P29648; Butcher SE, 2000, BIOCHEMISTRY-US, V39, P2174, DOI 10.1021/bi9923454; Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHOWRIRA BM, 1991, NATURE, V354, P320, DOI 10.1038/354320a0; CHOWRIRA BM, 1993, J BIOL CHEM, V268, P19458; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8515; COWAN JA, 1993, J INORG BIOCHEM, V49, P171, DOI 10.1016/0162-0134(93)80002-Q; Earnshaw DJ, 1997, J MOL BIOL, V274, P197, DOI 10.1006/jmbi.1997.1405; Fedor MJ, 1999, BIOCHEMISTRY-US, V38, P11040, DOI 10.1021/bi991069q; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; FINDLAY D, 1962, BIOCHEM J, V85, P152, DOI 10.1042/bj0850152; GRASBY JA, 1995, BIOCHEMISTRY-US, V34, P4068, DOI 10.1021/bi00012a025; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P175; MCKAY DB, 1999, RNA WORLD, P265; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Murchie AIH, 1998, MOL CELL, V1, P873, DOI 10.1016/S1097-2765(00)80086-6; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Nowakowski J, 1999, NAT STRUCT BIOL, V6, P151; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; RICHARDS FM, 1971, COLD SPRING HARB SYM, V36, P35, DOI 10.1101/SQB.1972.036.01.008; ROBERTS GCK, 1969, P NATL ACAD SCI USA, V62, P1151, DOI 10.1073/pnas.62.4.1151; Ryder SP, 1999, J MOL BIOL, V291, P295, DOI 10.1006/jmbi.1999.2959; Saenger W., 1984, PRINCIPLES NUCL ACID; Schmidt S, 1996, NUCLEIC ACIDS RES, V24, P573, DOI 10.1093/nar/24.4.573; Shin C, 1996, NUCLEIC ACIDS RES, V24, P2685, DOI 10.1093/nar/24.14.2685; Shippy R, 1998, BIOCHEMISTRY-US, V37, P564, DOI 10.1021/bi9721288; Siwkowski A, 1997, BIOCHEMISTRY-US, V36, P3930, DOI 10.1021/bi9628735; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971; Walter F, 1998, BIOCHEMISTRY-US, V37, P14195, DOI 10.1021/bi981513+; Walter F, 1998, BIOCHEMISTRY-US, V37, P17629, DOI 10.1021/bi9821115; Walter NG, 1998, EMBO J, V17, P2378, DOI 10.1093/emboj/17.8.2378; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Walter NG, 2000, J MOL BIOL, V298, P539, DOI 10.1006/jmbi.2000.3691; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555; Young KJ, 1999, J MOL BIOL, V288, P853, DOI 10.1006/jmbi.1999.2748; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	50	377	388	1	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					780	786		10.1038/35071009	http://dx.doi.org/10.1038/35071009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298439				2022-12-28	WOS:000168021900045
J	Serruys, PW; Unger, F; Sousa, JE; Jatene, A; Bonnier, HJRM; Schonberger, JPAM; Buller, N; Bonser, R; van den Brand, MJB; van Herwerden, LA; Morel, MAM; van Hout, BA				Serruys, PW; Unger, F; Sousa, JE; Jatene, A; Bonnier, HJRM; Schonberger, JPAM; Buller, N; Bonser, R; van den Brand, MJB; van Herwerden, LA; Morel, MAM; van Hout, BA		Arterial Revascularization Therapi	Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANGINA-PECTORIS; CARDIOPULMONARY BYPASS; COST-EFFECTIVENESS; Q-WAVE; ANGIOPLASTY; REVASCULARIZATION; TRIAL	Background: The recent recognition that coronary-artery stenting has improved the short- and long-term outcomes of patients treated with angioplasty has made it necessary to reevaluate the relative benefits of bypass surgery and percutaneous interventions in patients with multivessel disease. Methods: A total of 1205 patients were randomly assigned to undergo stent implantation or bypass surgery when a cardiac surgeon and an interventional cardiologist agreed that the same extent of revascularization could be achieved by either technique. The primary clinical end point was freedom from major adverse cardiac and cerebrovascular events at one year. The costs of hospital resources used were also determined. Results: At one year, there was no significant difference between the two groups in terms of the rates of death, stroke, or myocardial infarction. Among patients who survived without a stroke or a myocardial infarction, 16.8 percent of those in the stenting group underwent a second revascularization, as compared with 3.5 percent of those in the surgery group. The rate of event-free survival at one year was 73.8 percent among the patients who received stents and 87.8 percent among those who underwent bypass surgery (P<0.001 by the log-rank test). The costs for the initial procedure were $4,212 less for patients assigned to stenting than for those assigned to bypass surgery, but this difference was reduced during follow-up because of the increased need for repeated revascularization; after one year, the net difference in favor of stenting was estimated to be $2,973 per patient. Conclusions: As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction. However, stenting is associated with a greater need for repeated revascularization. (N Engl J Med 2001;344:1117-24.) Copyright (C) 2001 Massachusetts Medical Society.	Acad Ziekenhuis Rotterdam Dijkzigt, Rotterdam, Netherlands; Klin Herzchirurg, Salzburg, Austria; Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; Catharina Ziekenhuis, Eindhoven, Netherlands; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; Cardialysis, Rotterdam, Netherlands; Inst Med Technol Assessment, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Instituto Dante Pazzanese de Cardiologia; Catharina Hospital; University of Birmingham; Cardialysis	Serruys, PW (corresponding author), Erasmus Univ, Dept Intervent Cardiol, Ctr Heart, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.			van Herwerden, Lex A./0000-0003-1087-1275				[Anonymous], 1999, Int J Cardiovasc Intervent, V2, P41; Benetti F, 1996, J THORAC CARDIOV SUR, V112, P1478, DOI 10.1016/S0022-5223(96)70006-5; Bergsma TM, 1998, CIRCULATION, V97, P2402, DOI 10.1161/01.CIR.97.24.2402; Bernstein SJ, 1997, HEALTH POLICY, V42, P15, DOI 10.1016/S0168-8510(97)00039-0; Borst C, 1996, J AM COLL CARDIOL, V27, P1356, DOI 10.1016/0735-1097(96)00039-3; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Buller CE, 1999, CIRCULATION, V100, P236, DOI 10.1161/01.CIR.100.3.236; Calafiore AM, 1998, J THORAC CARDIOV SUR, V115, P763, DOI 10.1016/S0022-5223(98)70353-8; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; COHEN DJ, 1994, CIRCULATION, V89, P1859, DOI 10.1161/01.CIR.89.4.1859; COX DR, 1967, BIOMETRIKA, V54, P567; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; EDLAVITCH SA, 1991, CIRCULATION, V83, P492, DOI 10.1161/01.CIR.83.2.492; Eeckhout E, 1999, EUR HEART J, V20, P1014, DOI 10.1053/euhj.1998.1395; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Gu YJ, 1998, ANN THORAC SURG, V65, P420, DOI 10.1016/S0003-4975(97)01127-2; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; Hodakowski GT, 1996, J THORAC CARDIOV SUR, V112, P1447, DOI 10.1016/S0022-5223(96)70002-8; Jackson NW, 1999, HEART, V81, P367, DOI 10.1136/hrt.81.4.367; Lieu TA, 1997, J AM COLL CARDIOL, V30, P1741, DOI 10.1016/S0735-1097(97)00391-4; Malenka D J, 1998, Jt Comm J Qual Improv, V24, P594; MOSHKOVITZ Y, 1995, J THORAC CARDIOV SUR, V110, P979, DOI 10.1016/S0022-5223(05)80165-5; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; *PROT BYP ANG REV, 1991, CIRCULATION S5, V84, P2; Rigter H, 1997, HEART, V77, P211, DOI 10.1136/hrt.77.3.211; SCULPHER MJ, 1994, LANCET, V344, P927, DOI 10.1016/S0140-6736(94)92274-8; Serruys P, 1998, LANCET, V352, P1478; TEO KK, 1998, CIRCULATION, V2, P29; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 2000, LANCET, V355, P1104; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Unger F, 1999, COR EUROPAEUM, V7, P128; Unger F., 1999, COR EUR, V7, P177; van Hout BA, 1999, PROG CARDIOVASC DIS, V42, P167, DOI 10.1016/S0033-0620(99)70016-2; VANDENBRAND M, 1990, EUR HEART J, V11, P765; Versaci F, 1997, NEW ENGL J MED, V336, P817, DOI 10.1056/NEJM199703203361201	39	809	877	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1117	1124		10.1056/NEJM200104123441502	http://dx.doi.org/10.1056/NEJM200104123441502			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297702	Green Published			2022-12-28	WOS:000167990600002
J	Prasad, KR; Lodge, JPA				Prasad, KR; Lodge, JPA			ABC of diseases of liver, pancreas, and biliary system - Transplantation of the liver and pancreas	BRITISH MEDICAL JOURNAL			English	Review									St James Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Prasad, KR (corresponding author), St James Hosp, Leeds LS9 7TF, W Yorkshire, England.								0	1	2	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					845	847		10.1136/bmj.322.7290.845	http://dx.doi.org/10.1136/bmj.322.7290.845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290642	Green Published			2022-12-28	WOS:000168063000028
J	Berger, SL				Berger, SL			Molecular biology - The histone modification circus	SCIENCE			English	Editorial Material							H3; PHOSPHORYLATION; ACETYLATION; BROMODOMAIN; TAF(II)250		Wistar Inst, Mol Genet Program, Philadelphia, PA 19104 USA	The Wistar Institute	Berger, SL (corresponding author), Wistar Inst, Mol Genet Program, Philadelphia, PA 19104 USA.			Berger, Shelley/0000-0001-5398-4400				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X	15	36	37	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					64	65						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294220				2022-12-28	WOS:000167995200035
J	Bossuyt, F; Milinkovitch, MC				Bossuyt, F; Milinkovitch, MC			Amphibians as indicators of early tertiary "out-of-India" dispersal of vertebrates	SCIENCE			English	Article							BOUNDARY; VOLCANISM; EVOLUTION	Sixty-five million years ago, massive volcanism produced on the India-Seychelles Landmass the largest continental Lava deposit (Deccan Traps) of the past 200 million years. Using a molecular clock-independent approach for inferring dating information from molecular phylogenies, we show that multiple Lineages of frogs survived Deccan Traps volcanism after millions of years of isolation on drifting India. The collision between the Indian and Eurasian plates was followed by wide dispersal of several of these lineages. This "out-of-India" scenario reveals a zoogeographical pattern that might reconcile paleontological and molecular data in other vertebrate groups.	Free Univ Brussels, Inst Mol Biol & Med, Unit Evolutionary Genet, CP 300, B-6041 Gosselies, Belgium		Milinkovitch, MC (corresponding author), Free Univ Brussels, Inst Mol Biol & Med, Unit Evolutionary Genet, CP 300, Rue Jeener & Brachet 12, B-6041 Gosselies, Belgium.	mcmilink@ulb.ac.be		Bossuyt, Franky/0000-0001-6804-9271; Milinkovitch, Michel/0000-0002-2553-0724				BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; BHANDARI N, 1995, GEOPHYS RES LETT, V22, P433, DOI 10.1029/94GL03271; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman WE, 1999, PATTERNS DISTRIBUTIO; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; JAEGER JJ, 1989, GEOLOGY, V17, P316, DOI 10.1130/0091-7613(1989)017<0316:PVOTAO>2.3.CO;2; KRAUSE DW, 1999, GSA TODAY, V9, P1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Maas M. C., 1990, GEOL SOC AM SPEC PAP, V243, P71; Macey JR, 2000, SYST BIOL, V49, P233, DOI 10.1093/sysbio/49.2.233; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; Pethiyagoda R, 1998, OCC PAP WILDL HERITA, V2, P1; Richards CM, 1998, HERPETOL J, V8, P41; SAVAGE JM, 1973, BIOL ANURANS CONT RE, P351; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; THEWISSEN JGM, 1992, SYST BIOL, V41, P248, DOI 10.2307/2992525; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892	23	188	202	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					93	95		10.1126/science.1058875	http://dx.doi.org/10.1126/science.1058875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292870				2022-12-28	WOS:000167995200044
J	Clancy, DJ; Gems, D; Harshman, LG; Oldham, S; Stocker, H; Hafen, E; Leevers, SJ; Partridge, L				Clancy, DJ; Gems, D; Harshman, LG; Oldham, S; Stocker, H; Hafen, E; Leevers, SJ; Partridge, L			Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein	SCIENCE			English	Article							BODY-SIZE; PHOSPHOINOSITIDE 3-KINASE; GROWTH-HORMONE; ORGAN GROWTH; DWARF MICE; HOMOLOG; CELL; REPRODUCTION; RESTRICTION; PATHWAYS	The Drosophila melanogaster gene chico encodes an insulin receptor substrate that functions in an insulin/insulin-like growth factor (IGF) signaling pathway. in the nematode Caenorhabditis elegans, insulin/IGF signaling regulates adult longevity. We found that mutation of chico extends fruit fly median Life-span by up to 48% in homozygotes and 36% in heterozygotes. Extension of Life-span was not a result of impaired oogenesis in chico females, nor was it consistently correlated with increased stress resistance. The dwarf phenotype of chico homozygotes was also unnecessary for extension of Life-span. The role of insulin/IGF signaling in regulating animal aging is therefore evolutionarily conserved.	UCL, Dept Biol, London NW1 2HE, England; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of Nebraska System; University of Nebraska Lincoln; University of Zurich; Ludwig Institute for Cancer Research; University of London; University College London	Gems, D (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	david.gems@ucl.ac.uk	Clancy, David J/F-4882-2011; Partridge, Linda/A-5501-2010; Stoecker, Horst/F-8382-2012; Partridge, Linda/E-7342-2015	Stoecker, Horst/0000-0002-3282-3664; Partridge, Linda/0000-0001-9615-0094; Clancy, David John/0000-0002-0299-7946; Gems, David/0000-0002-6653-4676				Bartke A, 2000, RES PRO CEL, V29, P181; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; KRZLSNIK C, 1999, J ENDOCR GENET, V1, P9; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB455, DOI 10.1093/gerona/55.9.B455; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Riddle DL, 1997, C ELEGANS, P739; SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521; STOCKER H, UNPUB; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606; [No title captured]	26	1072	1112	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					104	106		10.1126/science.1057991	http://dx.doi.org/10.1126/science.1057991			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292874	Green Published			2022-12-28	WOS:000167995200048
J	Walport, MJ				Walport, MJ			Advances in immunology: Complement (First of two parts).	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMOLYTIC-UREMIC SYNDROME; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MANNAN-BINDING PROTEIN; INHERITED COMPLETE DEFICIENCY; DECAY-ACCELERATING FACTOR; FACTOR-H DEFICIENCY; INAB PHENOTYPE; ANGIO-EDEMA; VIRUS TYPE-1; INFECTIONS		Univ London Imperial Coll Sci Technol & Med, Div Med, Rheumatol Sect, London, England	Imperial College London	Walport, MJ (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Div Med, Du Cane Rd, London W12 0NN, England.			Walport, Mark/0000-0001-7220-5273				AULAK KS, 1988, BIOCHEM J, V253, P615, DOI 10.1042/bj2530615; Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Boccuni P, 2000, CRIT REV ONCOL HEMAT, V33, P25, DOI 10.1016/S1040-8428(99)00052-9; Cicardi M, 1996, CLIN EXP IMMUNOL, V106, P475, DOI 10.1046/j.1365-2249.1996.d01-866.x; FISHELSON Z, 1994, SPRINGER SEMIN IMMUN, V15, P345, DOI 10.1007/BF01837365; FISHELSON Z, 1994, SPRINGER SEMIN IMMUN, V16, P129; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Friedman HM, 2000, J IMMUNOL, V165, P4528, DOI 10.4049/jimmunol.165.8.4528; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; Hillmen P, 2000, BRIT J HAEMATOL, V108, P470, DOI 10.1046/j.1365-2141.2000.01802.x; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; INAI S, 1989, INT ARCH ALLER A IMM, V90, P274, DOI 10.1159/000235037; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; LACHMANN PJ, 1987, BRIT J RHEUMATOL, V26, P409; LEHNER PJ, 1992, LANCET, V340, P1379, DOI 10.1016/0140-6736(92)92561-S; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7; Lubinski J, 1998, SEMIN CELL DEV BIOL, V9, P329, DOI 10.1006/scdb.1998.0242; Luzzatto L, 1996, Curr Opin Hematol, V3, P101; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MARSCHANG P, 1995, EUR J IMMUNOL, V25, P285, DOI 10.1002/eji.1830250147; Mathieson PW, 1997, NEPHROL DIAL TRANSPL, V12, P1804, DOI 10.1093/ndt/12.9.1804; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MERRY AH, 1989, BRIT J HAEMATOL, V73, P248, DOI 10.1111/j.1365-2141.1989.tb00260.x; NAGATA M, 1989, J PEDIATR-US, V114, P260, DOI 10.1016/S0022-3476(89)80793-0; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; ORREN A, 1987, IMMUNOLOGY, V62, P249; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; PETERS DK, 1973, LANCET, V2, P535; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; SAIFUDDIN M, 1995, J EXP MED, V182, P501, DOI 10.1084/jem.182.2.501; SCHLESINGER M, 1990, CLIN EXP IMMUNOL, V81, P423; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; Shichishima T, 1999, BRIT J HAEMATOL, V104, P303, DOI 10.1046/j.1365-2141.1999.01188.x; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; SOOTHILL JF, 1976, ARCH DIS CHILD, V51, P91, DOI 10.1136/adc.51.2.91; SOOTHILL JF, 1977, CLIN EXP IMMUNOL, V27, P30; Speth C, 1997, IMMUNOL REV, V159, P49, DOI 10.1111/j.1600-065X.1997.tb01006.x; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; TELEN MJ, 1989, BLOOD, V74, P437; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; WALPORT MJ, 1994, Q J MED, V87, P609; Warwicker P, 1999, NEPHROL DIAL TRANSPL, V14, P1229, DOI 10.1093/ndt/14.5.1229; Waytes AT, 1996, NEW ENGL J MED, V334, P1630, DOI 10.1056/NEJM199606203342503; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHITE RT, 1992, J BIOL CHEM, V267, P9210; WILLIAMS DG, 1998, OXFORD TXB CLIN NEPH, V1, P591; Wurzner R, 1992, Immunodefic Rev, V3, P123; WYATT RJ, 1982, J CLIN IMMUNOL, V2, P110, DOI 10.1007/BF00916894; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707	62	2202	2333	2	183	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1058	1066		10.1056/NEJM200104053441406	http://dx.doi.org/10.1056/NEJM200104053441406			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287977				2022-12-28	WOS:000167860400006
J	Satcher, D				Satcher, D			Global mental health: Its time has come	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	12	13	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1697	1697		10.1001/jama.285.13.1697	http://dx.doi.org/10.1001/jama.285.13.1697			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277813				2022-12-28	WOS:000167710600006
J	Kenyon, SL; Taylor, DJ; Tarnow-Mordi, W				Kenyon, SL; Taylor, DJ; Tarnow-Mordi, W		ORACLE Collaborative Grp	Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial	LANCET			English	Article							BACTERIAL VAGINOSIS; RABBIT MODEL; METRONIDAZOLE; PREGNANCY; WOMEN; BIRTH	Background Preterm birth after spontaneous preterm labour is associated with death, neonatal disease, and long-term disability. Previous small trials of antibiotics for spontaneous preterm labour have reported inconclusive results. We did a randomised multicentre trial to resolve this issue. Methods 6295 women in spontaneous preterm labour with intact membranes and without evidence of clinical infection were randomly assigned 250 mg erythromycin (n=1611), 325 mg co-amoxiclav (250 mg amoxicillin and 125 mg clavulanic acid; n=1550), both (n=1565), or placebo (n=1569) four times daily for 10 days or until delivery, whichever occurred earlier. The primary outcome measure was a composite of neonatal death, chronic lung disease, or major cerebral abnormality on ultrasonography before discharge from hospital. Analysis was by intention to treat. Findings None of the trial antibiotics was associated with a lower rate of the composite primary outcome than placebo (erythromycin 90 [5.6%], co-amoxiclav 76 [5.0%], both antibiotics 91 [5.9%], vs placebo 78 [5.0%]). However, antibiotic prescription was associated with a lower occurrence of maternal infection. Interpretation This trial provides evidence that antibiotics should not be routinely prescribed for women in spontaneous preterm labour without evidence of clinical infection.	Leicester Royal Infirm, Dept Obstet & Gynaecol, Leicester LE2 7LX, Leics, England	University of Leicester	Kenyon, SL (corresponding author), Leicester Royal Infirm, Dept Obstet & Gynaecol, Robert Kilpatrick Bldg,POB 65, Leicester LE2 7LX, Leics, England.	oracle@le.ac.uk		Kenyon, Sara/0000-0002-0756-9617				BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; DOMBROSKI RA, 1990, AM J OBSTET GYNECOL, V163, P1938, DOI 10.1016/0002-9378(90)90777-5; FIELD D, 1999, TRENT NEONATAL SURVE; Gomez R, 1997, PRETERM LABOR, P85; GONIK B, 1986, AM J OBSTET GYNECOL, V154, P3, DOI 10.1016/0002-9378(86)90383-2; GUZICK DS, 1985, OBSTET GYNECOL, V65, P11; Hall M. H., 1997, PRETERM LABOR, P1; HALLIDAY HL, 1992, HIGH RISK PREGNANCY, P332; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; HEDDLESTON L, 1993, AM J OBSTET GYNECOL, V169, P708, DOI 10.1016/0002-9378(93)90647-2; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; KING J, 2000, COCHRANE LIB; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; NAEYE RL, 1980, LANCET, V1, P192; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P764, DOI 10.1016/0002-9378(93)90003-2; Romero R, 1997, PRETERM LABOR, P29; Russel P., 1979, AM J DIAG GYN OBSTET, V1, P127; SMAILL F, 2001, COCHRANE LIB	19	261	270	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2001	357	9261					989	994		10.1016/S0140-6736(00)04234-3	http://dx.doi.org/10.1016/S0140-6736(00)04234-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293641				2022-12-28	WOS:000167791500008
J	Phillips, RJ; Zuber, MT; Solomon, SC; Golombek, MP; Jakosky, BM; Banerdt, WB; Smith, DE; Williams, RME; Hynek, BM; Aharonson, O; Hauck, SA				Phillips, RJ; Zuber, MT; Solomon, SC; Golombek, MP; Jakosky, BM; Banerdt, WB; Smith, DE; Williams, RME; Hynek, BM; Aharonson, O; Hauck, SA			Ancient geodynamics and global-scale hydrology on Mars	SCIENCE			English	Article							INTERNAL STRUCTURE; EVOLUTION; TOPOGRAPHY; SURVEYOR; SUPPORT; GRAVITY; RISE	Loading of the Lithosphere of Mars by the Tharsis rise explains much of the global shape and Long-wavelength gravity field of the planet, including a ring of negative gravity anomalies and a topographic trough around Tharsis, as well as gravity anomaly and topographic highs centered in Arabia Terra and extending northward toward Utopia. The Tharsis-induced trough and antipodal high were largely in place by the end of the Noachian Epoch and exerted control on the location and orientation of valley networks. The release of carbon dioxide and water accompanying the emplacement of similar to3 x 10(8) Cubic kilometers of Tharsis magmas may have sustained a warmer climate than at present, enabling the formation of ancient valley networks and fluvial landscape denudation in and adjacent to the large-scale trough.	Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63110 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63110 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	Washington University (WUSTL); Washington University (WUSTL); Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder	Phillips, RJ (corresponding author), Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63110 USA.		Hauck, Steven A/A-7865-2008; Banerdt, William/Q-7324-2019	Hauck, Steven A/0000-0001-8245-146X; Banerdt, William/0000-0003-3125-1542; Williams, Rebecca/0000-0003-1571-6952; Aharonson, Oded/0000-0001-9930-2495				Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; ANDERSON RC, IN PRESS J GEOPHYS R; BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; BANERDT WB, 1992, MARS, P249; BANERDT WB, 2000, LUNAR PLANET SCI, V31; BRAIN DA, 1998, J GEOPHYS RES, V103, P22; Carr M.H, 1996, WATER MARS; CARR MH, 1995, J GEOPHYS RES-PLANET, V100, P7479, DOI 10.1029/95JE00260; CARR MH, 1999, J GEOPHYS RES, V104, P21; CHAN K, IN PRESS PHYS REV E; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; GERLACH TM, 1985, NATURE, V313, P273, DOI 10.1038/313273a0; HYNEK BM, IN PRESS GEOLOGY; McEwen AS, 1999, NATURE, V397, P584, DOI 10.1038/17539; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; Saunders R. S, 1980, P LUNAR PLANETARY C, V11, P2423; SCHULTZ RA, 1994, J GEOPHYS RES-PLANET, V99, P8371, DOI 10.1029/94JE00277; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; Tanaka K. L., 1992, MARS, P345; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; WILLEMANN RJ, 1982, J GEOPHYS RES, V87, P9793, DOI 10.1029/JB087iB12p09793; Zuber MT, 1997, J GEOPHYS RES-PLANET, V102, P28673, DOI 10.1029/97JE02527; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	28	380	382	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2587	2591		10.1126/science.1058701	http://dx.doi.org/10.1126/science.1058701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283367				2022-12-28	WOS:000167861000037
J	Mattingley, JB; Rich, AN; Yelland, G; Bradshaw, JL				Mattingley, JB; Rich, AN; Yelland, G; Bradshaw, JL			Unconscious priming eliminates automatic binding of colour and alphanumeric form in synaesthesia	NATURE			English	Article							PERCEPTION	Synaesthesia is an unusual perceptual phenomenon in which events in one sensory modality induce vivid sensations in another(1,2). Individuals may 'taste' shapes(3),'hear' colours', or 'feel' sounds(5). Synaesthesia was first described over a century ago(6), but little is known about its underlying causes or its effects on cognition. Most reports have been anecdotal or have focused on isolated unusual cases(3,7-9). Here we report an investigation of 15 individuals with colour-graphemic synaesthesia, each of whom experiences idiosyncratic but highly consistent colours for letters and digits. Using a colour-form interference paradigm, we show that induced synaesthetic experiences cannot be consciously suppressed even when detrimental to task performance. In contrast, if letters and digits are presented briefly and masked, so that they are processed but unavailable for overt report, the synaesthesia is eliminated. These results show that synaesthetic experiences fan be prevented despite substantial processing of the sensory stimuli that otherwise trigger them. We conclude that automatic binding of colour and alphanumeric form in synaesthesia arises after initial processes of letter and digit recognition are complete.	Univ Melbourne, Sch Behav Sci, Parkville, Vic 3010, Australia; Monash Univ, Dept Psychol, Clayton, Vic 3800, Australia	University of Melbourne; Monash University	Mattingley, JB (corresponding author), Univ Melbourne, Sch Behav Sci, Parkville, Vic 3010, Australia.		Mattingley, Jason/J-1537-2014	Mattingley, Jason/0000-0003-0929-9216; Rich, Anina/0000-0002-5702-6450; Yelland, Gregory/0000-0002-9439-253X				Baron-Cohen S., 1997, SYNAESTHESIA CLASSIC; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Cytowic RE., 1989, SYNESTHESIA UNION SE; Cytowic RE, 1993, MAN WHO TASTED SHAPE; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; GROSSENBACHER PG, 1997, SYNAESTHESIA CLASSIC; LURIA AR, 1969, MIND MNEMONIST; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; Odgaard EC, 1999, PERCEPTION, V28, P651, DOI 10.1068/p2910; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wollen KA, 1983, J MENT IMAG, V7, P83	19	219	222	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					580	582		10.1038/35069062	http://dx.doi.org/10.1038/35069062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417WW	11279495				2022-12-28	WOS:000167859300047
J	Hausdorff, WP; Siber, G; Paradiso, PR				Hausdorff, WP; Siber, G; Paradiso, PR			Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children	LANCET			English	Article							CONJUGATE VACCINE FORMULATION; STREPTOCOCCUS-PNEUMONIAE; INFECTIONS; EPIDEMIOLOGY; SEROGROUPS; OPPORTUNITIES; RESISTANCE; INCREASE; AGE	The development of glycoconjugate vaccines for Streptococcus pneumoniae that are effective in very young children has renewed interest in identification of which among the more than 90 pneumococcal serotypes are most likely to cause Invasive pneumococcal disease (IPD), Serotype distribution is thought to vary geographically, even between regions as socioeconomically similar as western Europe and North America. To explain these variations, we note the considerable variation that exists between reported rates of IPD in young children in the USA and west European countries. We postulate that this variation is attributable to different blood-culture rates and practices, and that mild IPD is probably underdiagnosed and under-reported in western Europe. On the basis of a comparison of serotype distributions between the two regions, we also postulate that those serotypes found at similar frequencies in both regions are virulent and rarely cause mild disease. As a result, reported distributions of IPD serotypes, especially when expressed as percentages, might be strongly skewed by the distribution of clinical presentations in a particular study population.	Wyeth Lederle Vaccines, W Henrietta, NY 14586 USA; Wyeth Lederle Vaccines, Pearl River, NY USA	Pfizer; Pfizer	Hausdorff, WP (corresponding author), Wyeth Lederle Vaccines, W Henrietta, NY 14586 USA.							Austrian R, 1997, MICROB DRUG RESIST, V3, P111, DOI 10.1089/mdr.1997.3.111; BAER M, 1995, LANCET, V345, P661, DOI 10.1016/S0140-6736(95)90570-7; BARAFF LJ, 1993, PEDIATRICS, V92, P1; BUTLER JC, 1995, J INFECT DIS, V171, P885, DOI 10.1093/infdis/171.4.885; *CDCP, 2000, MMWR, V49; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; DOMINGO JD, 1999, 17 ANN M EUR SOC PAE, P140; Ekdahl K, 1998, SCAND J INFECT DIS, V30, P257, DOI 10.1080/00365549850160891; ESKOLA J, 1992, JAMA-J AM MED ASSOC, V268, P3323, DOI 10.1001/jama.268.23.3323; FEDSON DS, 1999, VACCINES, P553; FINLAND M, 1977, J CLIN MICROBIOL, V5, P154; GEORGE RC, 1997, J CLIN MICROBIOL S2, V3, P130; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; KALTOFT MS, 1999, 17 ANN M EUR SOC PAE, P140; Kornelisse RF, 1995, CLIN INFECT DIS, V21, P1390, DOI 10.1093/clinids/21.6.1390; LAGOS R, 2000, 2 INT S PNEUM PNEUM; Liddle J, 1999, J PAEDIATR CHILD H, V35, P67, DOI 10.1046/j.1440-1754.1999.00333.x; Nielsen SV, 1996, EPIDEMIOL INFECT, V117, P411, DOI 10.1017/S0950268800059057; Schonheyder HC, 1997, LANCET, V349, P1554, DOI 10.1016/S0140-6736(05)62135-6; Scott JAG, 1998, CLIN INFECT DIS, V27, P1442, DOI 10.1086/515013; Smith MD, 1998, EPIDEMIOL INFECT, V120, P117, DOI 10.1017/S0950268897008522; Urwin G, 1996, EPIDEMIOL INFECT, V117, P95, DOI 10.1017/S0950268800001175; Venetz I, 1998, INT J EPIDEMIOL, V27, P1101, DOI 10.1093/ije/27.6.1101; von Kries R, 2000, CLIN INFECT DIS, V31, P482, DOI 10.1086/313984; VOSS L, 1994, PEDIATR INFECT DIS J, V13, P873, DOI 10.1097/00006454-199410000-00005; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752	27	157	182	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					950	952		10.1016/S0140-6736(00)04222-7	http://dx.doi.org/10.1016/S0140-6736(00)04222-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289365				2022-12-28	WOS:000167625300034
J	McCusker, SM; Curran, MD; Dynan, KB; McCullagh, CD; Urquhart, DD; Middleton, D; Patterson, CC; McIlroy, SP; Passmore, AP				McCusker, SM; Curran, MD; Dynan, KB; McCullagh, CD; Urquhart, DD; Middleton, D; Patterson, CC; McIlroy, SP; Passmore, AP			Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study	LANCET			English	Article							CEREBRAL-ISCHEMIA; PROMOTER REGION; DEPOSITION; INFLAMMATION; MECHANISMS; PROTEIN; DAMAGE	Background Deposition of beta -amyloid in the brains of patients with Alzheimer's disease is thought to precede a chain of events that leads to an inflammatory response by the brain. We postulated that genetic variation in the regulatory region of the gene for the proinflammatory cytokine tumour necrosis factor alpha (TNF-alpha) leads to increased risk of Alzheimer's disease and vascular dementia. Methods A polymorphism in the regulatory region of the TNF-alpha gene was analysed in a case-control study. The polymorphism (C-850T) was typed in 242 patients with sporadic Alzheimer's disease, 81 patients with vascular dementia, 61 stroke patients without dementia, and 235 normal controls. These groups of individuals were also genotyped for the apolipoprotein E polymorphism, and the vascular dementia and stroke groups were typed at the HLA-DR locus. Findings The distribution of TNF-alpha genotypes in the vascular dementia group differed significantly from that in the stroke and normal control groups, giving an odds ratio of 2.51 (95% CI 1.49-4.21) for the development of vascular dementia for individuals with a CT or TT genotype. Logistic regression analysis indicated that the possession of the T allele significantly increased the risk of Alzheimer's disease associated with carriage of the apolipoprotein E epsilon4 allele (odds ratio 2.73 [1.68-4.44] for those with apolipoprotein E epsilon4 but no TNF-alpha T, vs 4.62 [2.38-8.96] for those with apolipoprotein E epsilon4 and TNF-alpha T; p=0.03). Interpretation Possession of the TNF-alpha T allele significantly increases the risk of vascular dementia, and increases the risk of Alzheimer's disease associated with apolipoprotein E. Although further research is needed, these findings suggest a potential role for anti-inflammatory therapy in vascular dementia and Alzheimer's disease, and perhaps especially in patients who have had a stroke.	Queens Univ Belfast, Dept Geriatr Med, Belfast BT9 7BL, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT9 7BL, Antrim, North Ireland; No Ireland Reg Tissue Typing Lab, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	McIlroy, SP (corresponding author), Queens Univ Belfast, Dept Geriatr Med, Whitla Med Bldg, Belfast BT9 7BL, Antrim, North Ireland.	s.mcilroy@qub.ac.uk						ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; CHOCKE J, 1997, HUM GENET, V100, P189; CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6; Eikelenboom P, 1998, EXP NEUROL, V154, P89, DOI 10.1006/exnr.1998.6920; Floyd RA, 1999, FREE RADICAL BIO MED, V26, P1346, DOI 10.1016/S0891-5849(98)00293-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; ISHII T, 1992, RES IMMUNOL, V143, P614, DOI 10.1016/0923-2494(92)80043-K; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Kato T, 1999, AM J MED GENET, V88, P301, DOI 10.1002/(SICI)1096-8628(19990820)88:4<301::AID-AJMG4>3.0.CO;2-3; Klegeris A, 1997, BRAIN RES, V747, P114, DOI 10.1016/S0006-8993(96)01229-2; Lin BW, 1999, ACTA NEUROPATHOL, V97, P359, DOI 10.1007/s004010050999; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIDDLETON D, 1993, TISSUE ANTIGENS, V42, P160, DOI 10.1111/j.1399-0039.1993.tb02187.x; Middleton D, 1999, ALZHEIMERS REP, V2, P147; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; PAAKKARI I, 1995, ANN MED, V27, P369, DOI 10.3109/07853899509002590; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Sutton ET, 1997, EXP CELL RES, V230, P368, DOI 10.1006/excr.1996.3440; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0	29	160	170	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					436	439		10.1016/S0140-6736(00)04008-3	http://dx.doi.org/10.1016/S0140-6736(00)04008-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273064				2022-12-28	WOS:000166865600013
J	Piot, P; Bartos, M; Ghys, PD; Walker, N; Schwartlander, B				Piot, P; Bartos, M; Ghys, PD; Walker, N; Schwartlander, B			The global impact of HIV/AIDS	NATURE			English	Review							SEXUALLY-TRANSMITTED-DISEASES; HIV-1; INFECTION; TRENDS; PREVENTION; BEHAVIOR; SPREAD; STATES; MEN	The scale of the human immunodeficiency virus (HIV)/AIDS epidemic has exceeded all expectations since its identification 20 years ago. Globally, an estimated 36 million people are currently living with HIV, and some 20 million people have already died, with the worst of the epidemic centred on sub-Saharan Africa. But just as the spread of HIV has been greater than predicted, so too has been its impact on social capital, population structure and economic growth. Responding to AIDS on a scale commensurate with the epidemic is a global imperative, and the tools for an effective response are known. Nothing less than a sustained social mobilization is necessary to combat one of the most serious crises facing human development.	UNAIDS, Joint United Nations Programme HIV AIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Piot, P (corresponding author), UNAIDS, Joint United Nations Programme HIV AIDS, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	bartosm@unaids.org						*AIDS, 2000, REP SER BEH SURV STD; ARNDT C, 2000, S AFRICAN J EC, V68, P1; AYIEKO M, 1998, STUDY UNDP, V7; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; BLUMENTHAL RN, 2000, AIDS, V14, P605; BOLDING G, 2000, 13 INT AIDS C DURB S; Bollinger L, 1999, EC IMPACT AIDS; BONNEL R, 2000, EC ANAL HIV AIDS BAC; *BOTSW I DEV POL A, 2000, MACR IMP HIV AIDS EP; Carael M, 1997, AIDS, V11 Suppl B, pS23; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; CAZEIN F, 2000, SIDA VIH MST ET DONN; *CDCP, 2000, 12 HIVAIDS CDCP, P35; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P861; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Dehne KL, 2000, AIDS, V14, pS75; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; Egger M, 2000, LANCET, V355, P2101, DOI 10.1016/S0140-6736(00)02376-X; ENGH ID, 2000, HIV AIDS NAMIBIA IMP; EVIAN C, 2000, 13 INT AIDS C DURB S; *GLOB PROG AIDS, 1991, CURR FUT DIM HIV AID; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; *I VEILL SAN SURV, 2000, B EP HEBD, P38; *INT LAB ORG, 2000, HIV AIDS THREAT DEC; *JOINT UN PROG HIV, 2000, AIDS EP UPD; *JOINT UN PROGR, 2000, MON AIDS PAND STAT T; *JOINT UN PROGR, 2000, AIDS AFR COUNTR COUN; *JOINT UN PROGR, 2000, REP GLOB HIV AIDS EP; *JOINT UN PROGR, 1998, FORC CHANG WORLD AID; JORDANHARDER B, 2000, HOPE TANZANIA LESSON; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KHAMBOONRUANG C, 2000, 13 INT AIDS C DURB S; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; MICHAEL K, 2000, 13 INT AIDS C DURB S; MJR MM, 2001, 18 COMM HUM SETTL C; Monterroso ER, 2000, J ACQ IMMUN DEF SYND, V25, P63, DOI 10.1097/00126334-200009010-00009; NAMPANYASERPELL N, 2000, AIDS EC S DURB 7 8 J; *NAT CTR HIV EP CL, 2000, HIV AIDS 2000 HEP CA; *PPO DIV, 1999, TECHN M NEW YORK 10; *PUBL HLTH LAB SER, 2000, 10 PUBL HLTH LAB SER, P453; QU S, 2000, 13 INT AIDS C DURB S; Schwartlander B, 2000, SCIENCE, V289, P64, DOI 10.1126/science.289.5476.64; Sena AC, 2000, CLIN INFECT DIS, V30, P742, DOI 10.1086/313742; SHAUKAT M, 2000, 13 INT AIDS C DURB S; Smith DK, 2000, AIDS, V14, P1237, DOI 10.1097/00002030-200006160-00022; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; *UN CHILDR FUND, 2000, PROGR NAT 2000; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; VANDERMOORTELE J, 2000, CURR ISSUES COMP ED, V3; World Health Organization, 2000, WORLD HLTH REP 2000	51	254	265	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					968	973		10.1038/35073639	http://dx.doi.org/10.1038/35073639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309626				2022-12-28	WOS:000168152300056
J	McCarron, P; Okasha, M; McEwen, J; Smith, GD				McCarron, P; Okasha, M; McEwen, J; Smith, GD			Changes in blood pressure among students attending Glasgow University between 1948 and 1968: analyses of cross sectional surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; TRENDS; ADULTHOOD; MORTALITY; PATTERNS	Objectives To examine the changes in blood pressure over time in a cohort of young adults attending university between 1948 and 1968. Design Cross sectional study. Setting Glasgow University. Participants 12 414 students aged 16-25 years-9248 men (mean age 19.9 years) and 3164 women (19.2 years)-who participated in health screening on entering university between 1948 and 1968. Main outcome measures Systolic and diastolic blood pressure. Results in male students mean systolic blood pressure adjusted for age decreased from 134.5 (95% confidence interval 133.8 to 135.2) mm Hg in those born before 1929 to 125.7 (125.0 to 126.3) mm Hg in those born after 1945, and diastolic blood pressure dropped from 80.3 (79.8 to 80.8) mm Hg to 74.7 (74.2 to 75.1) nlm Hg. For female students the corresponding declines were from 129.0 (127.5 to 130.5) mm Hg to 120.6 (119.8 to 121.4) mm Hg and from 79.7 78.7 to 80.6) mm Hg to 77.0 (76.5 to 77.5) mm Hg. Adjustment for potential confounding factors made little difference to these findings. The proportion of students with hypertension declined substantially in both sexes. Conclusions Substantial declines in systolic and diastolic blood pressure over time were occurring up to 50 years ago in young adults who were not taking antihypertensive medication. Since blood pressure tracks into adult life, the results of the cross sectional comparisons suggest that factors acting in early life may be important in determining population risk of cardiovascular disease. Changes in such factors may have made important contributions to the decline in rates of cardiovascular diseases, particularly stroke, seen in developed countries during the past century.	NCI, Surveillance Res Program, Div Canc Control & Populat, Bethesda, MD 20892 USA; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol; University of Glasgow	McCarron, P (corresponding author), NCI, Surveillance Res Program, Div Canc Control & Populat, 6130 Execut Blvd,Execut Plaza N,Suite 4097, Bethesda, MD 20892 USA.	mccarrop@mail.nih.gov	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				[Anonymous], 1997, ARCH INTERN MED, V157, P2413; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BAINES A H, 1963, Nutr Abstr Rev, V33, P653; BENNETT S, 1994, J CLIN EPIDEMIOL, V47, P293, DOI 10.1016/0895-4356(94)90010-8; Berkey CS, 1998, OBES RES, V6, P187, DOI 10.1002/j.1550-8528.1998.tb00336.x; BONITA R, 1990, STROKE, V21, P989, DOI 10.1161/01.STR.21.7.989; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Charlton J, 1997, HLTH ADULT BRITAIN 1; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; Falkner B, 1998, HYPERTENSION, V31, P145, DOI 10.1161/01.HYP.31.1.145; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Harland R W, 1980, Ulster Med J, V49, P37; JOHNSTON W, 1962, BRIT J PREV SOC MED, V16, P76; Law CM, 1996, J HYPERTENS, V14, P935; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; McCarron P, 1999, PUBLIC HEALTH, V113, P265, DOI 10.1016/S0033-3506(99)00178-X; *MIN FOOD, 1951, URB WORK CLASS HOUS; *MIN FOOD, 1952, DOM FOOD CONS EXP 19; Montgomery SM, 2000, ARCH DIS CHILD, V82, P358, DOI 10.1136/adc.82.5.358; NELSON MJ, 1992, AM J EPIDEMIOL, V136, P633, DOI 10.1093/oxfordjournals.aje.a116543; Orr J.B., 1936, FOOD HLTH INCOME; POWER C, 1994, BRIT MED J, V308, P1270, DOI 10.1136/bmj.308.6939.1270; *STAT, 1998, STATS STAT SOFTW REL; THOMAS CB, 1969, B NEW YORK ACAD MED, V45, P831; WARD W, 1993, BIRTH WEIGHT EC GROW	26	39	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					885	888		10.1136/bmj.322.7291.885	http://dx.doi.org/10.1136/bmj.322.7291.885			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302898	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168311300015
J	Cunningham, ML; Titus, RG; Turco, SJ; Beverley, SM				Cunningham, ML; Titus, RG; Turco, SJ; Beverley, SM			Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin	SCIENCE			English	Article							DIHYDROFOLATE-REDUCTASE; PTERIDINE REDUCTASE-1; THYMIDYLATE SYNTHASE; GENE REPLACEMENT; PROMASTIGOTES; LOCUS; RESISTANCE; PTR1; IDENTIFICATION; TARENTOLAE	A critical step in the infectious cycle of Leishmania is the differentiation of parasites within the sand fly vector to the highly infective metacyclic promastigote stage, Here, we establish tetrahydrobiopterin (H4B) levels as an important factor controlling the extent of metacyclogenesis, H4B Levels decline substantially during normal development, and genetic or nutritional manipulations showed that Low H4B caused elevated metacyclogenesis. Mutants Lacking pteridine reductase 1 (PTR1) had Low Levels of H4B, remained infectious to mice, and induced Larger cutaneous Lesions (hypervirulence), Thus, the control of pteridine metabolism has relevance to the mechanism of Leishmania differentiation and the Limitation of virulence during evolution.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Pathol, Ft Collins, CO 80523 USA; Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA	Washington University (WUSTL); Colorado State University; University of Kentucky	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.			Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [AI31078, AI21903] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021903, R01AI031078, R37AI021903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; BLAKLEY RL, 1985, FOLATES PTERINS, V2; COULSON RMR, 1990, MOL BIOCHEM PARASIT, V40, P63, DOI 10.1016/0166-6851(90)90080-6; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CUNNINGHAM ML, IN PRESS MOL BIOCH P; GUILLAMON JJ, 1988, BIOCHEM BIOPH RES CO, V152, P49, DOI 10.1016/S0006-291X(88)80678-8; HADWIGER JA, 1994, P NATL ACAD SCI USA, V91, P10566, DOI 10.1073/pnas.91.22.10566; Hardy LW, 1997, EXP PARASITOL, V87, P157, DOI 10.1006/expr.1997.4207; IVANETICH KM, 1990, EXP PARASITOL, V70, P367, DOI 10.1016/0014-4894(90)90119-W; Kaufman S., 1997, TETRAHYDROBIOPTERIN; KNUEPFER E, IN PRESS BIOCH J; Kundig C, 1999, NUCLEIC ACIDS RES, V27, P3653, DOI 10.1093/nar/27.18.3653; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; MIWA S, 1992, FOLIA PHARMACOL JPN, V100, P367, DOI 10.1254/fpj.100.367; MOORE JS, UNPUB; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Nare B, 1997, PARASITOLOGY, V114, pS101, DOI 10.1017/S0031182097001133; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P7310; PEIXOTO MP, 1987, ANTIMICROB AGENTS CH, V31, P1575, DOI 10.1128/AAC.31.10.1575; PUENTES SM, 1990, J IMMUNOL, V145, P4311; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; TIWARI M, UNPUB; Wang JY, 1997, ARCH BIOCHEM BIOPHYS, V342, P197, DOI 10.1006/abbi.1997.0126	26	101	108	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					285	287		10.1126/science.1057740	http://dx.doi.org/10.1126/science.1057740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303103				2022-12-28	WOS:000168074000046
J	del Portillo, HA; Fernandez-Becerra, C; Bowman, S; Oliver, K; Preuss, M; Sanchez, CP; Schneider, NK; Villalobos, JM; Rajandream, MA; Harris, D; da Silva, LHP; Barrell, B; Lanzer, M				del Portillo, HA; Fernandez-Becerra, C; Bowman, S; Oliver, K; Preuss, M; Sanchez, CP; Schneider, NK; Villalobos, JM; Rajandream, MA; Harris, D; da Silva, LHP; Barrell, B; Lanzer, M			A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax	NATURE			English	Article							ANTIGENIC VARIATION; HUMAN-ERYTHROCYTES; FALCIPARUM; MALARIA; SURFACE; SEQUENCE; FAMILY; EXPRESSION; RIF; DNA	The malarial parasite Plasmodium vivax causes disease in humans, including chronic infections and recurrent relapses, but the course of infection is rarely fatal(1,2), unlike that caused by Plasmodium falciparum. To investigate differences in pathogenicity between P. vivax and P. falciparum, we have compared the subtelomeric domains in the DNA of these parasites. In P. falciparum, subtelomeric domains are conserved and contain ordered arrays of members of multigene families, such as var(3-5), rif(6,7) and stevor(8), encoding virulence determinants of cytoadhesion and antigenic variation. Here we identify, through the analysis of a continuous 155,711-base-pair sequence of a P. vivax chromosome end, a multigene family called vir, which is specific to P. vivax. The vir genes are present at about 600-1,000 copies per haploid genome and encode proteins that are immunovariant in natural infections, indicating that they may have a functional role in establishing chronic infection through antigenic variation.	Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508900 Sao Paulo, Brazil; Sanger Ctr, Pathogen Sequencing Unit, Hinxton CB10 1SA, England; Heidelberg Univ, Inst Hyg, Abt Parasitol, INF 324, D-69120 Heidelberg, Germany; Ctr Pesquisa Med Trop, BR-78900000 Porto Velho, Rondonia, Brazil	Universidade de Sao Paulo; Wellcome Trust Sanger Institute; Ruprecht Karls University Heidelberg	del Portillo, HA (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Av Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	hernando@icb.usp.br	del Portillo, Hernando A/L-2131-2014; Fernandez Becerra, Carmen/L-2069-2014; Lanzer, Michael/E-9752-2013	del Portillo, Hernando A/0000-0002-5278-3452; Fernandez Becerra, Carmen/0000-0001-5154-0013; Lanzer, Michael/0000-0002-0220-6526				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camargo AA, 1997, GENOMICS, V42, P467, DOI 10.1006/geno.1997.4758; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; DAVID PH, 1988, BIOL CELL, V64, P251, DOI 10.1016/0248-4900(88)90084-6; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; HALL R, 1984, NATURE, V311, P379, DOI 10.1038/311379a0; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LEVITUS G, 1994, AM J TROP MED HYG, V51, P68, DOI 10.4269/ajtmh.1994.51.68; MCCUTCHAN TF, 1984, SCIENCE, V225, P808, DOI 10.1126/science.6382604; MENDIS KN, 1988, AM J TROP MED HYG, V38, P42, DOI 10.4269/ajtmh.1988.38.42; OLIVEIRA CI, 1999, VACCINE, V17, P2959; Persson B, 2000, EXS, V88, P215; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; VAUDIN M, 1995, NUCLEIC ACIDS RES, V23, P670, DOI 10.1093/nar/23.4.670; VERNICK KD, 1988, MOL BIOCHEM PARASIT, V28, P85, DOI 10.1016/0166-6851(88)90055-2; VOLLER A, 1971, B WORLD HEALTH ORGAN, V45, P524	26	179	183	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					839	842		10.1038/35071118	http://dx.doi.org/10.1038/35071118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298455				2022-12-28	WOS:000168021900061
J	Hippisley-Cox, J; Pringle, M; Crown, N; Meal, A; Wynn, A				Hippisley-Cox, J; Pringle, M; Crown, N; Meal, A; Wynn, A			Sex inequalities in ischaemic heart disease in general practice: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANGINA; WOMEN; ACCESS; MEN	Objective To study differences in treatment for men and women with ischaemic heart disease by using. standards defined in England's national service framework for coronary artery disease. Design Cross sectional survey using routinely collected data. Setting 18 practices in 18 primary care groups in Trent Region. Subjects 5891 men and women aged over 35 years with a diagnosis of ischaemic hart disease or prescription for nitrates recorded on computer. Min outcome measure Difference in the proportion of men and women with ischaemic heart disease and taking lipid lowering treatment. Results Women were less likely than men to have a recording of body mass index (79% (2197/2783) v 82% (2552/3102), P = 0.002), smoking (86% (2386) v 89% (2779), P<0.0001), and blood pressure (95% (2643) v 96% (2986), P=0.04). Women were also less likely to have a recording of fasting cholesterol concentration (35% (968) v 50% (1550), P < 0.0001) but were more likely to be obese (25% (558/2197) v 20% (514/2552), P < 0.0001) and have their most recently recorded blood pressure value over the recommended 140/85 mm Hg (60% (1598/2643) v 52% (1553/2986), P < 0.0001). Although a higher proportion of women had a raised serum cholesterol concentration (77% (749/968) v 67% (1043/1550), P<0.0001), men were more likely to take aspirin (76% (2358) v 71% (1979), P<0.0001), have a recorded diagnosis of hyperlipidaemia, (13% (418) v 10% (274), P<0.0001), and be prescribed lipid lowering drugs (31% (973) v 21% (596), P<0.0001). These differences remained despite adjustments for the practice where the patient is registered, age, smoking status, obesity, diabetes, and hypertension. Conclusion The results suggest a systematic bias towards men compared with women in terms of secondary prevention of ischaemic heart disease.	Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England; Collingham Med Ctr, Collingham NG23 7LB, England; Queens Med Ctr, Sch Med, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020; Meal, Andy/B-9083-2008	Hippisley-Cox, Julia/0000-0002-2479-7283; 				Bouvy ML, 1999, BRIT J GEN PRACT, V49, P299; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CANNON PJ, 1988, LANCET, V1, P979; *DEP HLTH, 1998, OUR HLTH NAT; Department of Health, 2000, NAT SERV FRAM COR AR; HAMMERSLEY V, 1998, J INF PRIMARY CARE, V1, P3; Hippisley-Cox J, 2000, BRIT J GEN PRACT, V50, P449; KEE F, 1993, BRIT MED J, V307, P1305, DOI 10.1136/bmj.307.6915.1305; MCLAUGHLIN T, 1996, ARCH INTERN MED, P156; PEDERSEN TR, 1994, LANCET, V344, P1383; Royal College of General Practitioners Office of Population Consensus & Survey. Department of Health, 1995, MORB STAT GEN PRACT; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SPENCER I, 1995, BRIT MED J, V310, P1576, DOI 10.1136/bmj.310.6994.1576; Vogels EA, 1999, BRIT J GEN PRACT, V49, P963; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181	15	98	98	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2001	322	7290					832	834A		10.1136/bmj.322.7290.832	http://dx.doi.org/10.1136/bmj.322.7290.832			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290638	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168063000025
J	Jones, RB; Atkinson, JM; Coia, DA; Paterson, L; Morton, AR; McKenna, K; Craig, N; Morrison, J; Gilmour, WH				Jones, RB; Atkinson, JM; Coia, DA; Paterson, L; Morton, AR; McKenna, K; Craig, N; Morrison, J; Gilmour, WH			Randomised trial of personalised computer based information for patients with schizophrenia	BRITISH MEDICAL JOURNAL			English	Article							EDUCATION; OUTPATIENTS; PREVALENCE; DISORDERS	Objectives To compare use, effect and cost of personalised computer education with community psychiatric nurse education for patients with schizophrenia. Design Randomised trial of three interventions. Modelling of costs of alternatives. Participants 112 patients with schizophrenia in contact with community services; 67 completed the intervention. Interventions Three interventions of five educational sessions: (a computer intervention combining information from patient's medical record with general information about schizophrenia; (b) sessions with a community psychiatric nurse; (c) "combination" (first and last sessions with nurse and remainder with computer). Main outcome measures Patients' attendance, opinions, change in knowledge, and psychological state; costs of interventions and patients' use of NHS community services; modelling of costs for these three, and alternative, interventions. Results Rates of completion of intervention did not differ significantly (71% for combination intervention, 61% for computer only, 46% for nurse only). Computer sessions were shorter than sessions with nurse (14 minutes v 60 minutes). More patients given nurse based education thought the information relevant Of 20 patients in combination group, 13 preferred the sessions with the nurse and seven preferred the computer. There were no significant differences between groups in psychological outcomes. Because of the need to transport patients to the computer for their sessions, there was no difference between interventions in costs, but computer sessions combined with other patient contacts would be substantially cheaper. Conclusions The computer based patient education offered no advantage over sessions with a community psychiatric nurse, Investigation of computer use combined with other health service contacts would be worth while.	Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Glasgow Primary Care & Mental Hlth Trust, Florence St Resource Ctr, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Jones, RB (corresponding author), Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland.							Atkinson Jacqueline M., 1996, British Journal of Psychiatry, V168, P199, DOI 10.1192/bjp.168.2.199; BARROWCLOUGH C, 1987, BRIT J PSYCHIAT, V151, P1, DOI 10.1192/bjp.151.1.1; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; Eysenbach G, 2000, BMJ-BRIT MED J, V320, P1713, DOI 10.1136/bmj.320.7251.1713; Gillispie M. A., 1993, Journal of Medical Systems, V17, P119, DOI 10.1007/BF00996935; Haynes RB, 1996, LANCET, V348, P383; Hintikka J, 1999, AUST NZ J PSYCHIAT, V33, P226, DOI 10.1046/j.1440-1614.1999.00538.x; Jones R, 1999, BRIT MED J, V319, P1241, DOI 10.1136/bmj.319.7219.1241; Jones R B, 1993, Health Bull (Edinb), V51, P34; JONES R B, 1992, Health Bulletin (Edinburgh), V50, P143; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; KELLY GR, 1990, MED CARE, V28, P1181, DOI 10.1097/00005650-199012000-00006; KNAPP M, 1995, EC EVALUATION MENT H; MacPherson R, 1996, BRIT J PSYCHIAT, V168, P709, DOI 10.1192/bjp.168.6.709; McCreadie RG, 1997, BRIT J PSYCHIAT, V170, P31, DOI 10.1192/bjp.170.1.31; MCEVOY JP, 1981, HOSP COMMUNITY PSYCH, V32, P856; Morton AR, 1998, CURRENT PERSPECTIVES, P94; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Parkin A, 2000, BRIT MED J, V321, P615, DOI 10.1136/bmj.321.7261.615; PHELAN M, 1994, SOC PSYCH PSYCH EPID, V29, P205, DOI 10.1007/BF00796379; SKINNER CS, 1993, PATIENT EDUC COUNS, V22, P27, DOI 10.1016/0738-3991(93)90086-C; Smith J., 1992, J MENTAL HLTH, V1, P61; SMITH K, 1995, BRIT J PSYCHIAT, V166, P9, DOI 10.1192/bjp.166.1.9	24	35	35	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					835	840		10.1136/bmj.322.7290.835	http://dx.doi.org/10.1136/bmj.322.7290.835			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290639	Green Submitted, Green Published			2022-12-28	WOS:000168063000026
J	Swift, CG				Swift, CG			Care of older people - Falls in late life and their consequences - implementing effective services	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED TRIAL; HIP-FRACTURES; POPULATION; PREVENTION; COMMUNITY; REDUCE; HOME		Guys Kings & St Thomass Sch Med, Dept Hlth Care Elderly, London SE22 8PT, England	University of London; King's College London	Swift, CG (corresponding author), Guys Kings & St Thomass Sch Med, Dept Hlth Care Elderly, London SE22 8PT, England.							Armstrong A L, 1994, Acta Orthop Belg, V60 Suppl 1, P85; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Calder SJ, 1996, BRIT MED J, V312, P1515, DOI 10.1136/bmj.312.7045.1515; CAMERON ID, 2000, COCHRANE DATABASE SY; Campbell A. J., 1981, AGE AGEING, V10, P262; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; *DEP TRAD IND, 1997, HOM ACC SURV SYST AC; HOLLINGWORTH W, 1995, J PUBLIC HEALTH MED, V17, P269; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; LACH HW, 1991, J AM GERIATR SOC, V39, P197, DOI 10.1111/j.1532-5415.1991.tb01626.x; LILLEY JM, 1995, AGE AGEING, V24, P346, DOI 10.1093/ageing/24.4.346; Office for National Statistics, 1999, 1997 MORT STAT INJ P; Prudham D, 1981, Age Ageing, V10, P141; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; Royal College of Physicians, 1999, OST CLIN GUID PREV T; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; SATTIN RW, 1990, AM J EPIDEMIOL, V131, P1028, DOI 10.1093/oxfordjournals.aje.a115594; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Wolfson L I, 1985, Clin Geriatr Med, V1, P649	24	38	43	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					855	857		10.1136/bmj.322.7290.855	http://dx.doi.org/10.1136/bmj.322.7290.855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290646	Green Published			2022-12-28	WOS:000168063000031
J	Kiesecker, JM; Blaustein, AR; Belden, LK				Kiesecker, JM; Blaustein, AR; Belden, LK			Complex causes of amphibian population declines	NATURE			English	Article							UV-B PENETRATION; EL-NINO; CLIMATE-CHANGE; CONSEQUENCES; RADIATION; ACIDIFICATION; VARIABILITY; MORTALITY; AMERICA; TRENDS	Amphibian populations have suffered widespread declines and extinctions in recent decades. Although climatic changes, increased exposure to ultraviolet-B (UV-B) radiation and increased prevalence of disease have all been implicated at particular localities(1-6), the importance of global environmental change remains unclear. Here we report that pathogen outbreaks in amphibian populations in the western USA are linked to climate-induced changes in UV-B exposure. Using long-term observational data and a field experiment, we examine patterns among interannual variability in precipitation, UV-B exposure and infection by a pathogenic oomycete, Saprolegnia ferax. Our findings indicate that climate-induced reductions in water depth at oviposition sites have caused high mortality of embryos by increasing their exposure to UV-B radiation and, consequently, their vulnerability to infection(1). Precipitation, and thus water depth/UV-B exposure, is strongly linked to El Nino/Southern Oscillation cycles, underscoring the role of large-scale climatic patterns involving the tropical Pacific(7). Elevated sea-surface temperatures in this region since the mid-1970s, which have affected the climate over much of the world(8), could be the precursor for pathogen-mediated amphibian declines in many regions(1,3,4,9).	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oregon State University	Kiesecker, JM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.			Belden, Lisa/0000-0002-3514-3920				BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; BLAUSTEIN AR, 1997, EFFECTS OZONE DEPLET, P175; BLUMTHALER M, 1990, SCIENCE, V248, P206, DOI 10.1126/science.2326634; Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347; GRAHAM NE, 1995, SCIENCE, V267, P661; Guilderson TP, 1998, SCIENCE, V281, P240, DOI 10.1126/science.281.5374.240; Hader DP, 1999, PHOTOCHEM PHOTOBIOL, V69, p23S; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; KERR JB, 1993, SCIENCE, V262, P1032, DOI 10.1126/science.262.5136.1032; Kiesecker JM, 1997, CONSERV BIOL, V11, P214, DOI 10.1046/j.1523-1739.1997.95509.x; Kiesecker JM, 1999, ECOLOGY, V80, P2442, DOI 10.1890/0012-9658(1999)080[2442:PRCBLA]2.0.CO;2; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; NUSSBAUM RA, 1983, AMPHIBIAN REPTILES P; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; REDMOND KT, 1991, WATER RESOUR RES, V27, P2381, DOI 10.1029/91WR00690; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; STOLARSKI R, 1992, SCIENCE, V256, P342, DOI 10.1126/science.256.5055.342; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0	30	512	603	3	200	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					681	684		10.1038/35070552	http://dx.doi.org/10.1038/35070552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287952				2022-12-28	WOS:000167875400044
J	Pockley, P				Pockley, P			Climate change transforms island ecosystem	NATURE			English	News Item																			0	5	6	1	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					616	616		10.1038/35070741	http://dx.doi.org/10.1038/35070741			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287909	Bronze			2022-12-28	WOS:000167875400006
J	Chilvers, C; Dewey, M; Fielding, K; Gretton, V; Miller, P; Palmer, B; Weller, D; Churchill, R; Williams, I; Bedi, N; Duggan, C; Lee, A; Harrison, G				Chilvers, C; Dewey, M; Fielding, K; Gretton, V; Miller, P; Palmer, B; Weller, D; Churchill, R; Williams, I; Bedi, N; Duggan, C; Lee, A; Harrison, G		Counselling Versus Antidepressants	Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH SURVEY QUESTIONNAIRE	Objectives To compare the efficacy of antidepressant drugs and generic counselling for treating mild to moderate depression in general practice. To determine whether the outcomes were similar for patients with randomly allocated treatment and those expressing a treatment preference. Design Randomised controlled trial, with patient preference arms. Follow up at 8 weeks and 12 months and abstraction of GP case notes. Setting 31 general practices in Trent region. Participants Patients aged 18-70 who met research diagnostic criteria for major depression; 103 patients were randomised and 220 patients were recruited to the preference arms. Main outcome measures Difference in mean Beck depression inventory score; time to remission; global outcome assessed by a psychiatrist using all data sources; and research diagnostic criteria. Results At 12 months there was no difference between the mean Beck scores in the randomised arms. Combining the randomised and patient preference groups, the difference in Beck scores was 0.4 (95% confidence interval -2.7 to 3.5). Patients choosing: counselling did better than those randomised to it (mean difference in Beck score 4.6, 0.0 to 9.2). There was no difference in the psychiatrist's overall assessment of outcome between any of the groups. 221/265(83%) of participants with a known outcome had a remission. Median time to remission was shorter in the group randomised to antidepressants than the other three groups (2 months v 3 months). 33/221 (15%) patients had a relapse. Conclusions Genetic counselling seems to be as effective as antidepressant treatment for mild to moderate depressive illness, although patients receiving antidepressants may recover more quickly. General practitioners should allow patients to have their preferred treatment.	Univ Nottingham, Sch Med, Queens Med Ctr, Trent Inst Hlth Serv Res, Nottingham NG7 2UH, England; Univ Nottingham, Sch Med, Queens Med Ctr, Div Gen Practice, Nottingham NG7 2RD, England; Univ Edinburgh, Dept Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland; Nottingham Healthcare NHS Trust, Div Psychiat, Nottingham NG3 6AA, England; Univ Leicester, Div Forens Mental Hlth, Leicester LE5 0LE, Leics, England; Univ Hosp, Queens Med Ctr, Dept Psychiat, Nottingham, England; Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England	University of Nottingham; University of Nottingham; University of Edinburgh; University of Leicester; Nottingham University Hospital NHS Trust; University of Nottingham; University of Bristol	Chilvers, C (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Trent Inst Hlth Serv Res, Nottingham NG7 2UH, England.		Greiver, Michelle/N-8764-2015; Dewey, Michael E/E-2049-2010	Greiver, Michelle/0000-0001-8957-0285; Dewey, Michael E/0000-0002-7522-3677; Churchill, Richard/0000-0003-0049-8200				*AM PSYCH ASS, 1993, AM J PSYCHIAT S, V150, P4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Churchill R, 1999, BRIT J GEN PRACT, V49, P738; Churchill R, 2000, BRIT J GEN PRACT, V50, P905; *COUNS VERS ANT PR, 2000, BRIT J PSYCHIAT, V177, P312; FRANK E, 1991, J CLIN PSYCHIAT S2, V52, P2; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANTEL N, 1959, J NATL CANCER I, V22, P719; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383	13	176	176	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2001	322	7289					772	775		10.1136/bmj.322.7289.772	http://dx.doi.org/10.1136/bmj.322.7289.772			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282864	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167943200028
J	Phillips, DIW; Handelsman, DJ; Eriksson, JG; Forsen, T; Osmond, C; Barker, DJP				Phillips, DIW; Handelsman, DJ; Eriksson, JG; Forsen, T; Osmond, C; Barker, DJP			Prenatal growth and subsequent marital status: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; ANZAC Res Inst, Sydney, NSW 2006, Australia; Concord Hosp, Dept Androl, Sydney, NSW 2006, Australia	University of Southampton; Finland National Institute for Health & Welfare; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital	Phillips, DIW (corresponding author), Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Handelsman, David/AAR-9580-2021; Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Handelsman, David/0000-0002-4200-7476; Osmond, Clive/0000-0002-9054-4655	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barker DJP, 1998, MOTHERS BABIES HLTH; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019	4	52	52	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					771	771		10.1136/bmj.322.7289.771	http://dx.doi.org/10.1136/bmj.322.7289.771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282863	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167943200027
J	Balmford, A; Moore, JL; Brooks, T; Burgess, N; Hansen, LA; Williams, P; Rahbek, C				Balmford, A; Moore, JL; Brooks, T; Burgess, N; Hansen, LA; Williams, P; Rahbek, C			Conservation conflicts across Africa	SCIENCE			English	Article							PATTERNS; DISTRIBUTIONS; PRODUCTIVITY; ENDEMISM	There is increasing evidence that areas of outstanding conservation importance may coincide with dense human settlement or impact. We tested the generality of these findings using 1 degrees -resolution data for sub-Saharan Africa. We find that human population density is positively correlated with species richness of birds, mammals, snakes, and amphibians. This association holds for widespread, narrowly endemic, and threatened species and looks set to persist in the face of foreseeable population growth. Our results contradict earlier expectations of low conflict based on the idea that species richness decreases and human impact increases with primary productivity. We find that across Africa, both variables instead exhibit unimodal relationships with productivity. Modifying priority-setting to take account of human density shows that, at this scale, conflicts between conservation and development are not easily avoided, because many densely inhabited grid cells contain species found nowhere else.	Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen O, Denmark; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Wildlife Conservat Soc Tanzania, Morogoro, Tanzania; Nat Hist Museum, Biogeog & Conservat Lab, London SW7 5BD, England	University of Cambridge; University of Copenhagen; Conservation International; Natural History Museum London	Balmford, A (corresponding author), Univ Cambridge, Dept Zool, Conservat Biol Grp, Downing St, Cambridge CB2 3EJ, England.	a.balmford@zoo.cam.ac.uk	Moore, Joslin L/C-5270-2009; Moore, Joslin/AAE-3819-2020; Rahbek, Carsten/D-9372-2013; Rahbek, Carsten/L-1129-2013	Moore, Joslin L/0000-0001-9809-5092; Moore, Joslin/0000-0001-9809-5092; Rahbek, Carsten/0000-0003-4585-0300; Balmford, Andrew/0000-0002-0144-3589; Brooks, Thomas/0000-0001-8159-3116				Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Adams Jonathan S., 1992, MYTH WILD AFRICA; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 1997, GUNS GERMS STEEL; BALMFORD A, 1994, NATURE, V372, P623, DOI 10.1038/372623a0; Bell R.H.V., 1987, P79; BROOKS T, IN PRESS BIOSCIENCE; Burgess N. D., 1998, SPECIES, V30, P16; *CIESIN IFPRI WRI, 2000, GRIDD POP WORLD GPW; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cliff A. D., 1981, SPATIAL PROCESSES MO; DEICHMANN U, 1997, POPULATION DENSITY A; DEKLERK H, 1998, THESIS U CAPE TOWN C; FJELDSA J, 1997, TROPICAL FOREST REMN; Gaston Kevin J., 1996, P202; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; HUSTON M, 1994, SCIENCE, V265, P458, DOI 10.1126/science.265.5171.458; IUCN, 2000, 2000 IUCN RED LIST T; Lan DY, 2000, ORYX, V34, P275, DOI 10.1017/S0030605300031343; LARSEN JB, 1997, THESIS U COPENHAGEN; LEGENDRE P, PERMUTE VERSION 3 4; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Musters CJM, 2000, SCIENCE, V287, P1759, DOI 10.1126/science.287.5459.1759; Nantel P, 1998, BIOL CONSERV, V84, P223, DOI 10.1016/S0006-3207(97)00133-X; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Rahbek C, 2000, P ROY SOC B-BIOL SCI, V267, P2259, DOI 10.1098/rspb.2000.1277; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCOTT JM, 1993, WILDLIFE MONOGR, P1; *UN, 2000, REV WORLD POP EST PR; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wessels KJ, 2000, ANIM CONSERV, V3, P67, DOI 10.1017/S1367943000000755; WILLIAMS PH, 1996, WORLDMAP 4 WINDOWS S; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; Wright David H., 1993, P66; [No title captured]	36	395	416	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2616	2619		10.1126/science.291.5513.2616	http://dx.doi.org/10.1126/science.291.5513.2616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283376				2022-12-28	WOS:000167861000046
J	Stamper, CC; Zhang, Y; Tobin, JF; Erbe, DV; Ikemizu, S; Davis, SJ; Stahl, ML; Seehra, J; Somers, WS; Mosyak, L				Stamper, CC; Zhang, Y; Tobin, JF; Erbe, DV; Ikemizu, S; Davis, SJ; Stahl, ML; Seehra, J; Somers, WS; Mosyak, L			Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses	NATURE			English	Article							MOLECULAR-BASIS; CELL-ADHESION; SOLUBLE FORM; CTLA-4; COSTIMULATION; ACTIVATION; BLOCKADE; RECEPTOR; SYSTEM	Optimal immune responses require both an antigen-specific and a co-stimulatory signal. The shared ligands B7-1 and B7-2 on antigen-presenting cells deliver the co-stimulatory signal through CD28 and CTLA-4 on T cells. Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling attenuates it. Numerous animal studies(1,2) and recent clinical trials(3,4) indicate that manipulating these interactions holds considerable promise for immunotherapy, With the consequences of these signals well established, and details of the downstream signalling events emerging(5-7), understanding the molecular nature of these extracellular interactions becomes crucial. Here we report the crystal structure of the human CTLA-4/B7-1 co-stimulatory complex at 3.0 Angstrom resolution. In contrast to other interacting cell-surface molecules, the relatively small CTLA-4/B7-1 binding interface exhibits an unusually high degree of shape complementarity. CTLA-4 forms homodimers through a newly defined interface of highly conserved residues. In the crystal lattice, CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent CTLA-4 homodimers bridge bivalent B7-1 homodimers. This zipper-like oligomerization provides the structural basis for forming unusually stable signalling complexes at the T-cell surface, underscoring the importance of potent inhibitory signalling in human immune responses.	Wyeth Ayerst Res, Dept Biol Chem, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Musculoskeletal Sci, Cambridge, MA 02140 USA; Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Pfizer; Pfizer; University of Oxford; University of Oxford	Somers, WS (corresponding author), Wyeth Ayerst Res, Dept Biol Chem, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	wsomers@genetics.com; lmosyak@genetics.com						Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Bachmann MF, 1999, J IMMUNOL, V163, P1128; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4	30	331	412	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					608	611		10.1038/35069118	http://dx.doi.org/10.1038/35069118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279502				2022-12-28	WOS:000167859300054
J	Chiang, SH; Baumann, CA; Kanzaki, M; Thurmond, DC; Watson, RT; Neudauer, CL; Macara, IG; Pessin, JE; Saltiel, AR				Chiang, SH; Baumann, CA; Kanzaki, M; Thurmond, DC; Watson, RT; Neudauer, CL; Macara, IG; Pessin, JE; Saltiel, AR			Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10	NATURE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; RHO-GTPASES; FACTOR C3G; C-CBL; KINASE	The stimulation of glucose uptake by insulin in muscle and adipose tissue requires translocation of the GLUT4 glucose transporter protein from intracellular storage sites to the cell surface(1-6). Although the cellular dynamics of GLUT4 vesicle trafficking are well described, the signalling pathways that link the insulin receptor to GLUT4 translocation remain poorly understood. Activation of phosphatidylinositol-3-OH kinase (PI(3)K) is required for this trafficking event, but it is not sufficient to produce GLUT4 translocation(7). We previously described a pathway involving the insulin-stimulated tyrosine phosphorylation of Cbl, which is recruited to the insulin receptor by the adapter protein CAP(8,9). On phosphorylation, Cbl is translocated to lipid rafts. Blocking this step completely inhibits the stimulation of GLUT4 translocation by insulin(10). Here we show that phosphorylated Cbl recruits the CrkII-C3G complex to lipid rafts, where C3G specifically activates the small GTP-binding protein TC10. This process is independent of PI(3)K, but requires the translocation of Cbl, Crk and C3G to the lipid raft. The activation of TC10 is essential for insulin-stimulated glucose uptake and GLUT4 translocation. The TC10 pathway functions in parallel with PI(3)K to stimulate fully GLUT4 translocation in response to insulin.	Pfizer Global Res & Dev, Dept Cell Biol, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Physiol & Med, Ann Arbor, MI 48109 USA; Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Pfizer; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; University of Virginia	Saltiel, AR (corresponding author), Pfizer Global Res & Dev, Dept Cell Biol, Ann Arbor, MI 48105 USA.		Saltiel, Alan/L-3632-2019; Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955; Saltiel, Alan/0000-0002-9726-9828				Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; HOLMAN GD, 1990, J BIOL CHEM, V265, P81172; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; OKADA T, 1994, J BIOL CHEM, V269, P3568; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; PIPER RC, 1991, AM J PHYSIOL, V260, P570; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442	27	453	477	0	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					944	948		10.1038/35073608	http://dx.doi.org/10.1038/35073608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309621	Green Published			2022-12-28	WOS:000168152300050
J	Turney, J				Turney, J			Strings and things - Language is stretched to its limits in an effort to describe mathematics.	NATURE			English	Editorial Material									UCL, Dept Sci & Technol Studies, London WC1E 6BT, England	University of London; University College London	Turney, J (corresponding author), UCL, Dept Sci & Technol Studies, Gower St, London WC1E 6BT, England.								0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					873	873		10.1038/35073712	http://dx.doi.org/10.1038/35073712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309594	Bronze			2022-12-28	WOS:000168152300025
J	Abramson, JL; Williams, SA; Krumholz, HM; Vaccarino, V				Abramson, JL; Williams, SA; Krumholz, HM; Vaccarino, V			Moderate alcohol consumption and risk of heart failure among older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; ATRIAL-NATRIURETIC-PEPTIDE; US MALE PHYSICIANS; TYPE-2 DIABETES-MELLITUS; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; ETHANOL INTAKE; DISEASE; MORTALITY	Context Heavy consumption of alcohol can lead to heart failure, but the relationship between moderate alcohol consumption and risk of heart failure is largely unknown. Objective To determine whether moderate alcohol consumption predicts heart failure risk among older persons, independent of the association of moderate alcohol consumption with lower risk of myocardial infarction (MI). Design Prospective cohort study conducted from 1982 through 1996, with a maximum follow-up of 14 years. Setting and Participants Population-based sample of 2235 noninstitutionalized elderly persons (mean age, 73.7 years; 41.2% male; 21.3% nonwhite) residing in New Haven, Conn, who were free of heart failure at baseline. Persons who reported alcohol consumption of more than 70 oz in the month prior to baseline were excluded. Main Outcome Measure Time to first fatal or nonfatal heart failure event, according to the amount of alcohol consumed in the month prior to baseline. Results Increasing alcohol consumption in the moderate range was associated with decreasing heart failure rates. For persons consuming no alcohol (50.0%), 1 to 20 oz (40.2%), and 21 to 70 oz (9.8%) in the month prior to baseline, crude heart failure rates per 1000 years of follow-up were 16.1, 12.2, and 9.2, respectively. After adjustment for age, sex, race, education, angina, history of MI and diabetes, MI during follow-up, hypertension, pulse pressure, body mass index, and current smoking, the relative risks of heart failure for those consuming no alcohol, 1 to 20 oz, and 21 to 70 oz in the month prior to baseline were 1.00 (referent), 0.79 (95% confidence interval [CI], 0.60-1.02), and 0.53 (95% CI, 0.32-0.88) (P for trend =.02). Conclusions Increasing levels of moderate alcohol consumption are associated with a decreasing risk of heart failure among older persons. This association is independent of a number of confounding factors and does not appear to be entirely mediated by a reduction in MI risk.	Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30306 USA; AstraZeneca, Wayne, PA USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA	Emory University; AstraZeneca; Yale University; Yale University	Abramson, JL (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, 1256 Briarcliff Rd NE,Suite 1 N, Atlanta, GA 30306 USA.	jerome@ecor.cardio.emory.edu	, Harlan/AAI-2875-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG002105] Funding Source: NIH RePORTER; NIA NIH HHS [N01-AG-02105] Funding Source: Medline; NIMH NIH HHS [2T32 MH14235] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; BRANDT RR, 1993, J AM COLL CARDIOL, V22, pA86, DOI 10.1016/0735-1097(93)90468-G; Camargo CA, 1997, ANN INTERN MED, V126, P372, DOI 10.7326/0003-4819-126-5-199703010-00005; COLANTONIO D, 1991, LIFE SCI, V48, P635, DOI 10.1016/0024-3205(91)90538-M; Cooper HA, 2000, J AM COLL CARDIOL, V35, P1753, DOI 10.1016/S0735-1097(00)00625-2; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; COX DR, 1972, J R STAT SOC B, V34, P187; CRISCIONE L, 1989, HYPERTENSION, V13, P964, DOI 10.1161/01.HYP.13.6.964; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Gianoulakis C, 1997, ALCOHOL CLIN EXP RES, V21, P162; GILLMAN MW, 1995, HYPERTENSION, V25, P1106, DOI 10.1161/01.HYP.25.5.1106; GOLDSMITH SR, 1983, J AM COLL CARDIOL, V1, P1385, DOI 10.1016/S0735-1097(83)80040-0; GREENBERG BH, 1982, ANN INTERN MED, V97, P171, DOI 10.7326/0003-4819-97-2-171; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Guillaume P, 1996, ALCOHOL CLIN EXP RES, V20, P1653, DOI 10.1111/j.1530-0277.1996.tb01712.x; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; HOWE PRC, 1989, HYPERTENSION, V13, P607, DOI 10.1161/01.HYP.13.6.607; JACKSON R, 1985, AM J EPIDEMIOL, V122, P1037, DOI 10.1093/oxfordjournals.aje.a114185; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KOZAK LJ, 1999, VITAL HLTH STAT, V144, P1; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MALIN H, 1986, 1983 NHIS ALCOHOL HL, P490; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mukamal KJ, 1999, AM HEART J, V138, P926, DOI 10.1016/S0002-8703(99)70019-0; *NIH, 1998, DRINK US MAIN FIND 1; RIDKER PM, 1994, JAMA-J AM MED ASSOC, V272, P929, DOI 10.1001/jama.272.12.929; RUBIN E, 1994, ALCOHOL CLIN EXP RES, V18, P111, DOI 10.1111/j.1530-0277.1994.tb00889.x; Rubin R, 1999, ALCOHOL CLIN EXP RES, V23, P1114, DOI 10.1111/j.1530-0277.1999.tb04234.x; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; SHAPER AG, 1988, LANCET, V2, P1267; Solomon CG, 2000, CIRCULATION, V102, P494; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Valmadrid CT, 1999, JAMA-J AM MED ASSOC, V282, P239, DOI 10.1001/jama.282.3.239; Vasdev S, 1999, MOL CELL BIOCHEM, V200, P85, DOI 10.1023/A:1006950414560; WANNAMETHEE G, 1992, BRIT HEART J, V68, P443	38	145	150	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1971	1977		10.1001/jama.285.15.1971	http://dx.doi.org/10.1001/jama.285.15.1971			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308433	Bronze			2022-12-28	WOS:000167995900025
J	Bell, JS; Campbell, DM; Graham, WJ; Penney, GC; Ryan, M; Hall, MH				Bell, JS; Campbell, DM; Graham, WJ; Penney, GC; Ryan, M; Hall, MH			Do obstetric complications explain high caesarean section rates among women over 30? A retrospective analysis	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; RISE		Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen, Scotland; Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Bell, JS (corresponding author), Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen, Scotland.		Hall, Mei-Hua/GLR-9172-2022	Hall, Mei-Hua/0000-0002-4558-7023; Graham, Wendy/0000-0003-1473-5342; Bell, Jacqueline/0000-0003-1784-0180				BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; Leitch CR, 1998, BRIT J OBSTET GYNAEC, V105, P621, DOI 10.1111/j.1471-0528.1998.tb10176.x; MARTEL M, 1987, AM J OBSTET GYNECOL, V156, P305, DOI 10.1016/0002-9378(87)90273-0; Rosenthal AN, 1998, BRIT J OBSTET GYNAEC, V105, P1064, DOI 10.1111/j.1471-0528.1998.tb09937.x; SAMPHIER ML, 1981, PROSPECTIVE LONGITUD	5	45	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					894	895		10.1136/bmj.322.7291.894	http://dx.doi.org/10.1136/bmj.322.7291.894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302901	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168311300019
J	Levitt, JB				Levitt, JB			Function following form	SCIENCE			English	Editorial Material							VISUAL-CORTEX; CONNECTIONS; MORPHOLOGY; PATHWAYS; NEURONS; MOTION; COLOR		CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Levitt, JB (corresponding author), CUNY City Coll, Dept Biol, 138th St & Convent Ave, New York, NY 10031 USA.							EINSTEIN G, 1991, J COMP NEUROL, V303, P132, DOI 10.1002/cne.903030112; Gegenfurtner KR, 1996, TRENDS NEUROSCI, V19, P394, DOI 10.1016/S0166-2236(96)10036-9; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; Matsubara JA, 1996, J COMP NEUROL, V366, P93; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916	8	3	3	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					232	233		10.1126/science.1060779	http://dx.doi.org/10.1126/science.1060779			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305315				2022-12-28	WOS:000168074000031
J	Markewitz, D; Davidson, EA; Figueiredo, RDO; Victoria, RL; Krusche, AV				Markewitz, D; Davidson, EA; Figueiredo, RDO; Victoria, RL; Krusche, AV			Control of cation concentrations in stream waters by surface soil processes in an Amazonian watershed	NATURE			English	Article							EASTERN AMAZONIA; BRAZILIAN AMAZON; ATMOSPHERIC CO2; PASTURES; FORESTS; CARBON; PLANTS; CYCLES	The chemical composition of ground waters and stream waters is thought to be determined primarily by weathering of parent rock(1-5). In relatively young soils such as those occurring in most temperate ecosystems, dissolution of primary minerals by carbonic acid is the predominant weathering pathway that liberates Ca2+, Mg2+ and K+ and generates alkalinity in the hydrosphere(6). But control of water chemistry in old and highly weathered soils that have lost reservoirs of primary minerals (a common feature of many tropical soils) is less well understood. Here we present soil and water chemistry data from a 10,000-hectare watershed on highly weathered soil in the Brazilian Amazon. Streamwater cation concentrations and alkalinity are positively correlated to each other and to streamwater discharge, suggesting that cations and bicarbonate are mainly flushed from surface soil layers by rainfall rather than being the products of deep soil weathering carried by groundwater flow. These patterns contrast with the seasonal patterns widely recognized in temperate ecosystems with less strongly weathered soils(2,7). In this particular watershed, partial forest clearing and burning 30 years previously enriched the soils in cations and so may have increased the observed wet season leaching of cations. Nevertheless, annual inputs and outputs of cations from the watershed are low and nearly balanced, and thus soil cations from forest burning will remain available for forest regrowth over the next few decades. Our observations suggest that increased root and microbial respiration during the wet season generates CO2 that drives cation-bicarbonate leaching, resulting in a biologically mediated process of surface soil exchange controlling the streamwater inputs of cations and alkalinity from these highly weathered soils.	Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Inst Pesquisa Ambiental Amazonia, BR-66035100 Belem, Para, Brazil; Ctr Energia Nucl Agr, BR-13400970 Piracicaba, SP, Brazil	Woods Hole Research Center	Markewitz, D (corresponding author), Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA.		Krusche, Alex V/H-8988-2012; Figueiredo, Ricardo de Oliveira/A-6967-2013; Victoria, Reynaldo/F-5348-2012; Davidson, Eric A/K-4984-2013	Figueiredo, Ricardo de Oliveira/0000-0002-0933-4854; Davidson, Eric A/0000-0002-8525-8697; Krusche, Alex/0000-0001-7094-5577; Markewitz, Daniel/0000-0002-2697-9865				BERNER RA, 1992, GEOCHIM COSMOCHIM AC, V56, P3225, DOI 10.1016/0016-7037(92)90300-8; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; Broecker WS, 1998, GLOBAL BIOGEOCHEM CY, V12, P403, DOI 10.1029/98GB01927; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; Drever J. I., 1997, GEOCHEMISTRY NATURAL, P138; EWEL J, 1981, ECOLOGY, V62, P816, DOI 10.2307/1937748; Furch K., 1984, AMAZON LIMNOLOGY LAN, P167, DOI DOI 10.1007/978-94-009-6542-3_6; GARRELS RM, 1967, EQUILIBRIUM CONCEPTS, P222; HOLLAND HD, 1984, CHEM EVOLUTION ATMOS, P128; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; LIKENS GE, 1995, BIOGEOCHEMISTRY FORE, P46; MCCOLL J G, 1968, Northwest Science, V42, P134; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Ohte N, 1999, GLOBAL BIOGEOCHEM CY, V13, P969, DOI 10.1029/1999GB900029; RANTZ SZ, 1982, MEASUREMENT COMPUTAT, V1; RICHTER DD, 1991, ADV ECOL RES, V21, P315, DOI 10.1016/S0065-2504(08)60100-2; Sombroek W. G., 1984, The Amazon: limnology and landscape ecology of a mighty tropical river and its basin, P521; SOMBROEK WG, 1996, AMAZON SOIL RECONNAI; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P872; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; [No title captured]	26	113	119	0	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					802	805		10.1038/35071052	http://dx.doi.org/10.1038/35071052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298445				2022-12-28	WOS:000168021900051
J	Walport, MJ				Walport, MJ			Advances in immunology: Complement (Second of two parts).	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REACTIVE PROTEIN; P COMPONENT BINDS; APOPTOTIC CELLS; IGG AUTOANTIBODIES; ANTIBODY-RESPONSES; ACTIVATION; DEFICIENCY; DISEASE; INNATE		Univ London Imperial Coll Sci Technol & Med, Div Med, Rheumatol Sect, London, England	Imperial College London	Walport, MJ (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, Div Med, Du Cane Rd, London W12 0NN, England.			Walport, Mark/0000-0001-7220-5273				Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; BREATHNACH SM, 1989, J EXP MED, V170, P1433, DOI 10.1084/jem.170.4.1433; Caliezi C, 2000, PHARMACOL REV, V52, P91; Carroll M C, 2000, Adv Immunol, V74, P61; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; DAVIES KA, 1994, SPRINGER SEMIN IMMUN, V15, P397, DOI 10.1007/BF01837367; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DONALDSON VH, 1977, ANN INTERN MED, V86, P312, DOI 10.7326/0003-4819-86-3-312; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; ENTMAN ML, 1991, FASEB J, V5, P2529, DOI 10.1096/fasebj.5.11.1868978; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; HASSIG A, 1964, PATHOL MICROBIOL, V27, P542, DOI 10.1159/000161504; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HINTNER H, 1988, J INVEST DERMATOL, V91, P22, DOI 10.1111/1523-1747.ep12463283; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Korb LC, 1997, J IMMUNOL, V158, P4525; Makrides SC, 1998, PHARMACOL REV, V50, P59; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; PEPYS MB, 1972, NATURE-NEW BIOL, V237, P157, DOI 10.1038/newbio237157a0; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Pickering M C, 2000, Adv Immunol, V76, P227; ROSSEN RD, 1994, CIRC RES, V75, P546, DOI 10.1161/01.RES.75.3.546; Siegert CEH, 1999, CLIN EXP IMMUNOL, V116, P4; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; WEISMAN HF, 1990, T ASSOC AM PHYSICIAN, V103, P64; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938	35	1134	1190	0	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1140	1144		10.1056/NEJM200104123441506	http://dx.doi.org/10.1056/NEJM200104123441506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297706				2022-12-28	WOS:000167990600006
J	Orlic, D; Kajstura, J; Chimenti, S; Jakoniuk, I; Anderson, SM; Li, BS; Pickel, J; McKay, R; Nadal-Ginard, B; Bodine, DM; Leri, A; Anversa, P				Orlic, D; Kajstura, J; Chimenti, S; Jakoniuk, I; Anderson, SM; Li, BS; Pickel, J; McKay, R; Nadal-Ginard, B; Bodine, DM; Leri, A; Anversa, P			Bone marrow cells regenerate infarcted myocardium	NATURE			English	Article							GROWTH-FACTOR-I; STEM-CELLS; ADULT MICE; C-KIT; EXPRESSION; HEART; VIVO; DIFFERENTIATE; PROLIFERATION; HYPERTROPHY	Myocardial infarction leads to loss of tissue and impairment of cardiac performance. The remaining myocytes are unable to reconstitute the necrotic tissue, and the post-infarcted heart deteriorates with time(1). Injury to a target organ is sensed by distant stem cells, which migrate to the site of damage and undergo alternate stem cell differentiation(2-5); these events promote structural and functional repair(6-8). This high degree of stem cell plasticity prompted us to test whether dead myocardium could be restored by transplanting bone marrow cells in infarcted mice. We sorted lineage-negative (Lin(-)) bone marrow cells from transgenic mice expressing enhanced green fluorescent protein(9) by fluorescence-activated cell sorting on the basis of c-kit expression(10). Shortly after coronary ligation, Lin(-) c-kit(POS) cells were injected in the contracting wall bordering the infarct. Here we report that newly formed myocardium occupied 68% of the infarcted portion of the ventricle 9 days after transplanting the bone marrow cells. The developing tissue comprised proliferating myocytes and vascular structures. Our studies indicate that locally delivered bone marrow cells can generate de novo myocardium, ameliorating the outcome of coronary artery disease.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; NHGRI, Hematopoiesis Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	New York Medical College; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Anversa, P (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.							Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Leri A, 1998, CIRCULATION, V97, P194, DOI 10.1161/01.CIR.97.2.194; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Vogel G, 2000, SCIENCE, V290, P1672, DOI 10.1126/science.290.5497.1672	30	4037	4667	6	546	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					701	705		10.1038/35070587	http://dx.doi.org/10.1038/35070587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287958				2022-12-28	WOS:000167875400050
J	Margallo-Lana, M; Reichelt, K; Hayes, P; Lee, L; Fossey, J; O'Brien, J; Ballard, C				Margallo-Lana, M; Reichelt, K; Hayes, P; Lee, L; Fossey, J; O'Brien, J; Ballard, C			Longitudinal comparison of depression, coping, and turnover among NHS and private sector staff caring for people with dementia	BRITISH MEDICAL JOURNAL			English	Article									Newcastle Gen Hosp, MRC, Neurochem Pathol Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Churchill Hosp, Fulbrook Ctr, Oxford OX3 7LJ, England; Dene Lodge Nursing Home, Newcastle Upon Tyne NE15 7SX, Tyne & Wear, England; Newcastle Gen Hosp, Neurorehabil & Elderly Programme, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Newcastle Gen Hosp, Inst Hlth Elderly, Wolfson Res Ctr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Bensham Hosp, Gateshead NE8 4YL, Tyne & Wear, England	Newcastle General Hospital; University of Oxford; Newcastle General Hospital; Newcastle General Hospital; Newcastle University - UK	Ballard, C (corresponding author), Newcastle Gen Hosp, MRC, Neurochem Pathol Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.			Ballard, Clive/0000-0003-0022-5632; O'Brien, John/0000-0002-0837-5080				CAPLAN RP, 1994, BRIT MED J, V309, P1261, DOI 10.1136/bmj.309.6964.1261; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; SAAD K, 1995, AGE AGEING, V24, P495, DOI 10.1093/ageing/24.6.495; SCHULZ R, 1991, PSYCHOL AGING, V6, P569, DOI 10.1037/0882-7974.6.4.569	4	16	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					769	770		10.1136/bmj.322.7289.769	http://dx.doi.org/10.1136/bmj.322.7289.769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419HL	11282862	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167943200026
J	Bugoslavsky, Y; Perkins, GK; Qi, X; Cohen, LF; Caplin, AD				Bugoslavsky, Y; Perkins, GK; Qi, X; Cohen, LF; Caplin, AD			Vortex dynamics in superconducting MgB2 and prospects for applications	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; CRYSTALS	The recently discovered(1) superconductor magnesium diboride, MgB2, has a transition temperature, T-c, approaching 40 K, placing it intermediate between the families of low- and high-temperature superconductors. In practical applications, superconductors ale permeated by quantized vortices of magnetic flux. When a supercurrent flows, there is dissipation of energy unless these vortices are 'pinned' in some way, and so inhibited from moving under the influence of the Lorentz force. Such vortex motion ultimately determines the critical current density, J(c), which the superconductor can support. Vortex behaviour has proved to be more complicated in high-temperature superconductors than in low-temperature superconductors and, although this has stimulated extensive theoretical and experimental research(2), it has also impeded applications. Here we describe the vortex behaviour in MgB2, as reflected in J(c) and in the vortex creep rate, S, the latter being a measure of how fast the 'persistent' supercurrents decay. Our results show that naturally occurring grain boundaries are highly transparent to supercurrents, a desirable property which contrasts with the behaviour of the high-temperature superconductors, On the other hand, we observe a steep, practically deleterious decline in J(c) with increasing magnetic field, which is likely to reflect the high degree of crystalline perfection in our samples, and hence a low vortex pinning energy.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Ctr High Temp Superconduct, London SW7 2BZ, England	Imperial College London	Bugoslavsky, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Ctr High Temp Superconduct, Prince Consort Rd, London SW7 2BZ, England.		Qi, Xiaoding/O-9091-2015	Qi, Xiaoding/0000-0002-7105-1193; Cohen, Lesley/0000-0002-5123-5171				BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; CANFIELD PC, 2001, CONDMAT0102289; CAPLIN AD, 1994, SUPERCOND SCI TECH, V7, P412, DOI 10.1088/0953-2048/7/6/014; Cohen LF, 1997, REP PROG PHYS, V60, P1581, DOI 10.1088/0034-4885/60/12/003; Cucolo AM, 1996, PHYS REV LETT, V76, P1920, DOI 10.1103/PhysRevLett.76.1920; FINNEMORE DK, 2001, CONDMAT0102114; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; MANNHART J, 1988, PHYS REV LETT, V61, P2476, DOI 10.1103/PhysRevLett.61.2476; Miyakawa N, 1999, PHYS REV LETT, V83, P1018, DOI 10.1103/PhysRevLett.83.1018; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Perkins GK, 1996, PHYS REV B, V54, P12551, DOI 10.1103/PhysRevB.54.12551; PUST L, 1990, J LOW TEMP PHYS, V78, P179, DOI 10.1007/BF00686099; TAKANO Y, 2001, CONDMAT0102167	13	199	208	0	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					563	565		10.1038/35069029	http://dx.doi.org/10.1038/35069029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279489				2022-12-28	WOS:000167859300041
J	Giles, J				Giles, J			Think like a bee	NATURE			English	News Item																		[Anonymous], 1994, SPRINGER INT SERIES; Arreguit X, 1996, IEEE J SOLID-ST CIRC, V31, P1916, DOI 10.1109/4.545813; Boahen KA, 1997, ANALOG INTEGR CIRC S, V13, P53, DOI 10.1023/A:1008215524165; Delbruck T., 1994, 30 CNS CALTECH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Liu SC, 1998, ADV NEUR IN, V10, P712; Mahowald M., 1992, THESIS CALTECH; Mead C.A., 1989, ANALOG VLSI NEURAL S; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0	9	6	6	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					510	512		10.1038/35069236	http://dx.doi.org/10.1038/35069236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279459	Bronze			2022-12-28	WOS:000167859300014
J	Sasaki, S; Nakamura, K; Hamabe, Y; Kurahashi, E; Hiroi, T				Sasaki, S; Nakamura, K; Hamabe, Y; Kurahashi, E; Hiroi, T			Production of iron nanoparticles by laser irradiation in a simulation of lunar-like space weathering	NATURE			English	Article							S-TYPE ASTEROIDS; ORDINARY CHONDRITE; REGOLITH; METEORITE; SAMPLES	'Space weathering' is the term applied to the darkening and reddening of planetary surface materials with time, along with the changes to the depths of absorption bands in their optical spectra. It has been invoked to explain the mismatched spectra of lunar rocks and regolith, and between those of asteroids and meteorites(1-6). The formation of nanophase iron particles on regolith grains as a result of micrometeorite impacts or irradiation by the solar wind has been proposed as the main cause of the change in the optical properties(7,8). But laboratory simulations(9-14) have not revealed the presence of these particles, although nanosecond-pulse laser irradiation did reproduce the optical changes(12) Here we report observations by transmission electron microscopy of olivine samples subjected to pulse laser irradiation. We fmd within the amorphous vapour-deposited rims of olivine grains nanophase iron particles similar to those observed in the rims of space-weathered lunar regolith grains(15,16). Reduction by hydrogen atoms implanted by the solar wind is therefore not necessary to form the particles. Moreover, the results support the idea that ordinary chondrites came from S-type asteroids(5), and thereby provides some constraints on the surface exposure ages of those asteroids.	Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Tokyo; Kobe University; Brown University	Sasaki, S (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	sho@eps.s.u-tokyo.ac.jp						ADAMS JB, 1971, SCIENCE, V171, P567, DOI 10.1126/science.171.3971.567; ALLEN CC, 1993, ICARUS, V104, P291, DOI 10.1006/icar.1993.1102; Binzel RP, 1996, SCIENCE, V273, P946, DOI 10.1126/science.273.5277.946; Chapman CR, 1996, METEORIT PLANET SCI, V31, P699, DOI 10.1111/j.1945-5100.1996.tb02107.x; CHAPMAN CR, 1973, ICARUS, V19, P507, DOI 10.1016/0019-1035(73)90078-X; CLARK BE, 1995, J GEOPHYS RES-PLANET, V100, P14443, DOI 10.1029/95JE00720; CLARK BE, 1992, ICARUS, V97, P288, DOI 10.1016/0019-1035(92)90135-T; GAFFEY MJ, 1978, SPACE SCI REV, V21, P555, DOI 10.1007/BF00240908; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; GRUN E, 1991, ASTROPHYS SPACE SC L, V173, P21; HAPKE B, 1975, MOON PLANETS, V13, P339, DOI 10.1007/BF00567525; HAPKE B, 2000, LUNAR PLANET SCI, V31, P1087; HIROI T, UNPUB METEOR PLANET; HIROI T, 1999, LUNAR PLANET SCI, V30, P1444; KELLER LP, 1993, SCIENCE, V261, P1305, DOI 10.1126/science.261.5126.1305; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; Moroz LV, 1996, ICARUS, V122, P366, DOI 10.1006/icar.1996.0130; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101; Wetherill G., 1988, METEORITES EARLY SOL, P35; Yamada M, 1999, EARTH PLANETS SPACE, V51, P1255, DOI 10.1186/BF03351599; YAMADA M, 1998, ANTARCTIC METEORITES, V23, P173; [No title captured]	23	282	291	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					555	557		10.1038/35069013	http://dx.doi.org/10.1038/35069013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279486				2022-12-28	WOS:000167859300038
J	Westerterp, KR				Westerterp, KR			Pattern and intensity of physical activity	NATURE			English	Article							EXERCISE		Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands	Maastricht University	Westerterp, KR (corresponding author), Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Netherlands.	k.westerterp@hb.unimaas.nl						BALLOR DL, 1995, EUR J APPL PHYSIOL O, V71, P535, DOI 10.1007/BF00238557; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; Grundy SM, 1999, MED SCI SPORT EXER, V31, pS502, DOI 10.1097/00005768-199911001-00003; KEMPEN KPG, 1995, AM J CLIN NUTR, V62, P722, DOI 10.1093/ajcn/62.4.722; Westerterp KR, 1996, BRIT J NUTR, V76, P785, DOI 10.1079/BJN19960086; Westerterp KR, 1998, AM J CLIN NUTR, V68, p970S, DOI 10.1093/ajcn/68.4.970S	8	175	177	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					539	539		10.1038/35069142	http://dx.doi.org/10.1038/35069142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279482	Bronze, Green Published			2022-12-28	WOS:000167859300034
J	Jones, LJF; Carballido-Lopez, R; Errington, J				Jones, LJF; Carballido-Lopez, R; Errington, J			Control of cell shape in bacteria: Helical, actin-like filaments in Bacillus subtilis	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI; SEPTUM PLACEMENT; ROD SHAPE; GENE; DIVISION; CHROMOSOME; SEQUENCE; CYCLE; CYTOSKELETON	In the absence of an overt cytoskeleton, the external cell wall of bacteria has traditionally been assumed to be the primary determinant of cell shape. In the Grampositive bacterium Bacillus subtilis, two related genes, mreB and mbl, were shown to be required for different aspects of cell morphogenesis. Subcellular localization of the MreB and Mbl proteins revealed that each forms a distinct kind of filamentous helical structure lying close to the cell surface. The distribution of the proteins in different species of bacteria, and the similarity of their sequence to eukaryotic actins, suggest that the MreB-like proteins have a cytoskeletal, actin-like role in bacterial cell morphogenesis.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Errington, J (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Errington, Jeff/G-1832-2011; LOPEZ, RUT CARBALLIDO/G-2283-2015	Errington, Jeff/0000-0002-6977-9388; LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811				ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; ASYCOUGH KR, 1996, ANNU REV CELL DEV BI, V12, P129; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; FEUCHT A, 2001, IN PRESS MOL MICROBI; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; HAUSER PM, 1995, J BACTERIOL, V177, P3923, DOI 10.1128/jb.177.14.3923-3931.1995; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HOLMES M, 1980, J BACTERIOL, V142, P254, DOI 10.1128/JB.142.1.254-261.1980; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; LEVIN PA, 1992, J BACTERIOL, V174, P6717, DOI 10.1128/JB.174.21.6717-6728.1992; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mata J, 1998, TRENDS CELL BIOL, V8, P163, DOI 10.1016/S0962-8924(98)01224-0; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; NGUYEN LH, 1993, PROT OVEREXP PURIF, V4, P452; Pruyne D, 2000, J CELL SCI, V113, P571; Sambrook J., 2002, MOL CLONING LAB MANU; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; STEVENS CM, 1992, J BACTERIOL, V174, P586, DOI 10.1128/jb.174.2.586-594.1992; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VARLEY AW, 1992, J BACTERIOL, V174, P6729, DOI 10.1128/JB.174.21.6729-6742.1992; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014	35	719	735	2	114	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					913	922		10.1016/S0092-8674(01)00287-2	http://dx.doi.org/10.1016/S0092-8674(01)00287-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290328	Bronze			2022-12-28	WOS:000167869200013
J	Nelson, FE; Anisimov, OA; Shiklomanov, NI				Nelson, FE; Anisimov, OA; Shiklomanov, NI			Subsidence risk from thawing permafrost - The threat to man-made structures across regions in the far north can be monitored.	NATURE			English	Article							GENERAL-CIRCULATION MODELS		Univ Delaware, Dept Geog, Newark, DE 19716 USA; Univ Delaware, Ctr Climat Res, Newark, DE 19716 USA; State Hydrol Inst, St Petersburg 199053, Russia	University of Delaware; University of Delaware	Nelson, FE (corresponding author), Univ Delaware, Dept Geog, Newark, DE 19716 USA.	fnelson@udel.edu	Anisimov, Oleg/D-8052-2017	Anisimov, Oleg/0000-0002-9515-4576; Shiklomanov, NIkolay/0000-0002-8609-0240				Anisimov OA, 1997, GLOBAL PLANET CHANGE, V15, P61, DOI 10.1016/S0921-8181(97)00009-X; Anisimov OA, 1997, CLIMATIC CHANGE, V35, P241, DOI 10.1023/A:1005315409698; Greco S., 1994, CLIMATE SCENARIOS SO; Kattenberg A., 1996, CLIMATE CHANGE 1995, P285; Linden E., 2000, TIME, V156, P52; Monmonier Mark, 1997, CARTOGRAPHIES DANGER, DOI 10.7208/chicago/9780226534299.001.0001; RISEBOROUGH DW, P 5 CAN PERM C, P199; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; STAUB B, 1987, GLOBAL GRIDDED DATA	9	276	306	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					889	890		10.1038/35073746	http://dx.doi.org/10.1038/35073746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309605				2022-12-28	WOS:000168152300034
J	Yasuda, R; Noji, H; Yoshida, M; Kinosita, K; Itoh, H				Yasuda, R; Noji, H; Yoshida, M; Kinosita, K; Itoh, H			Resolution of distinct rotational substeps by submillisecond kinetic analysis of F-1-ATPase	NATURE			English	Article							ESCHERICHIA-COLI F1-ATPASE; HEAVY-MEROMYOSIN MOLECULES; THERMOPHILIC BACILLUS PS3; CATALYTIC SITE; ATP SYNTHASE; ALPHA(3)BETA(3)GAMMA COMPLEX; NUCLEOTIDE-BINDING; INHIBITORY MGADP; MOTOR; AFFINITY	The enzyme F-1-ATPase has been shown to be a rotary motor in which the central gamma -subunit rotates inside the cylinder made of alpha (3)beta (3) subunits. At low ATP concentrations, the motor rotates in discrete 120 degrees steps, consistent with sequential ATP hydrolysis on the three beta -subunits. The mechanism of stepping is unknown. Here we show by high-speed imaging that the 120 degrees step consists of roughly 90 degrees and 30 degrees substeps, each taking only a fraction of a millisecond. ATP binding drives the 90 degrees substep, and the 30 degrees substep is probably driven by release of a hydrolysis product. The two substeps are separated by two reactions of about 1 ms, which together occupy most of the ATP hydrolysis cycle. This scheme probably applies to rotation at full speed (similar to 130 revolutions per second at saturating ATP) down to occasional stepping at nanomolar ATP concentrations, and supports the binding-change model for ATP synthesis by reverse rotation of F-1-ATPase.	Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan; Teikyo Univ, Biotechnol Ctr 3F, CREST Genet Programming Team 13, Kawasaki, Kanagawa 2160001, Japan; Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan	Keio University; Japan Science & Technology Agency (JST); Teikyo University; Tokyo Institute of Technology; Hamamatsu Photonics	Kinosita, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; COX GB, 1984, BIOCHIM BIOPHYS ACTA, V768, P201, DOI 10.1016/0304-4173(84)90016-8; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; KATO Y, 1995, BBA-BIOENERGETICS, V1231, P275, DOI 10.1016/0005-2728(95)00087-Y; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Kinosita K Jr, 2000, Essays Biochem, V35, P3; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; Kunioka Y, 1996, J BIOCHEM-TOKYO, V119, P1024; MANNHERZ HG, 1974, EUR J BIOCHEM, V48, P287, DOI 10.1111/j.1432-1033.1974.tb03767.x; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Milgrom YM, 1998, BIOCHEM J, V330, P1037; MITCHELL P, 1985, FEBS LETT, V182, P1, DOI 10.1016/0014-5793(85)81142-X; MIYATA H, 1994, J BIOCHEM, V115, P644, DOI 10.1093/oxfordjournals.jbchem.a124389; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WOLCOTT RG, 1974, BIOCHEM BIOPH RES CO, V57, P709, DOI 10.1016/0006-291X(74)90604-4; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; ZHOU JM, 1993, J BIOL CHEM, V268, P1531	37	669	687	4	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					898	904		10.1038/35073513	http://dx.doi.org/10.1038/35073513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309608				2022-12-28	WOS:000168152300037
J	Relman, AS				Relman, AS			Separating continuing medical education from pharmaceutical marketing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; INDUSTRY		Harvard Univ, Sch Med, Channing Lab, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Relman, AS (corresponding author), Harvard Univ, Sch Med, Channing Lab, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.							*ACCR COUNC CONT M, 1992, STAND COM SUPP CONT, P18; *AM MED ASS, PHYS REC AW INF BOOK; AMA, 2000, COD MED ETH CURR OP; [Anonymous], 2000, LANCET, V356, P781; Martin JB, 2000, NEW ENGL J MED, V343, P1646, DOI 10.1056/NEJM200011303432213; Pellegrino ED, 1999, JAMA-J AM MED ASSOC, V282, P984, DOI 10.1001/jama.282.10.984; ROSS JS, 2000, MED MARKET MEDIA, V24, P40; Tenery RM, 2000, JAMA-J AM MED ASSOC, V283, P391, DOI 10.1001/jama.283.3.391; VERGANO D, 2000, USA TODAY       0309, pD1; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	10	115	117	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					2009	2012		10.1001/jama.285.15.2009	http://dx.doi.org/10.1001/jama.285.15.2009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308441				2022-12-28	WOS:000167995900033
J	McAlister, FA; Straus, SE				McAlister, FA; Straus, SE			Evidence based treatment of hypertension - Measurement of blood presssure: an evidence based review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRESSURE-MEASUREMENT; HOME; MORTALITY; SELF; REPRODUCIBILITY; PREVALENCE; PREDICTION; DIAGNOSIS		Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada; Mt Sinai Hosp, Div Gen Internal Med, Toronto, ON M5G 1X5, Canada	University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	McAlister, FA (corresponding author), Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada.	Finlay.McAlister@ualberta.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341				APPEL LJ, 1993, ANN INTERN MED, V118, P867, DOI 10.7326/0003-4819-118-11-199306010-00008; Birkett NJ, 1997, J HYPERTENS, V15, P237, DOI 10.1097/00004872-199715030-00004; Campbell NRC, 1999, CAN MED ASSOC J, V161, P277; HARRISON EG, 1960, CIRCULATION, V22, P419, DOI 10.1161/01.CIR.22.3.419; Jula A, 1999, HYPERTENSION, V34, P261, DOI 10.1161/01.HYP.34.2.261; Khattar RS, 1999, CIRCULATION, V100, P1071, DOI 10.1161/01.CIR.100.10.1071; Khattar RS, 1999, CIRCULATION, V100, P1760; Le Pailleur C, 1998, AM J HYPERTENS, V11, P203, DOI 10.1016/S0895-7061(97)00403-2; LITTENBERG B, 1995, ANN INTERN MED, V122, P937, DOI 10.7326/0003-4819-122-12-199506150-00008; MacDonald MB, 1999, CAN MED ASSOC J, V161, P265; MCALISTER FA, 2001, EVIDENCE BASED HYPER, P11; MCKAY DW, 1990, J HUM HYPERTENS, V4, P639; Mochizuki Y, 1998, AM J HYPERTENS, V11, P403, DOI 10.1016/S0895-7061(97)00497-4; Netea RT, 1998, J HYPERTENS, V16, P263, DOI 10.1097/00004872-199816030-00002; NEUFELD PD, 1986, CAN MED ASSOC J, V135, P633; Ohkubo T, 1997, J HYPERTENS, V15, P357, DOI 10.1097/00004872-199715040-00006; Ohkubo T, 1998, HYPERTENSION, V32, P255, DOI 10.1161/01.HYP.32.2.255; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; PALATINI P, 1994, HYPERTENSION, V23, P211, DOI 10.1161/01.HYP.23.2.211; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; PERLOFF D, 1983, JAMA-J AM MED ASSOC, V249, P2792, DOI 10.1001/jama.249.20.2792; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; PICKERING TG, 1994, LANCET, V344, P31; POTTER JF, 1986, HYPERTENSION, V8, P625, DOI 10.1161/01.HYP.8.7.625; REEVES RA, 1991, CLIN INVEST MED, V14, P251; REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.1995.03520390071036; RUSSELL AE, 1989, J HYPERTENS, V7, P607, DOI 10.1097/00004872-198908000-00002; SCRIVEN AJI, 1984, J CARDIOVASC PHARM, V6, P954, DOI 10.1097/00005344-198409000-00033; SOGHIKIAN K, 1992, MED CARE, V30, P855, DOI 10.1097/00005650-199209000-00009; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Stergiou GS, 1998, AM J HYPERTENS, V11, P820, DOI 10.1016/S0895-7061(98)00038-7; STOLT M, 1993, CLIN PHYSIOL, V13, P611, DOI 10.1111/j.1475-097X.1993.tb00476.x; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; WAALMANNING HJ, 1987, J CLIN HYPERTENS, V3, P624	35	107	113	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					908	911		10.1136/bmj.322.7291.908	http://dx.doi.org/10.1136/bmj.322.7291.908			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302909	Green Published			2022-12-28	WOS:000168311300026
J	Levitus, S; Antonov, JI; Wang, JL; Delworth, TL; Dixon, KW; Broccoli, AJ				Levitus, S; Antonov, JI; Wang, JL; Delworth, TL; Dixon, KW; Broccoli, AJ			Anthropogenic warming of Earth's climate system	SCIENCE			English	Article							OCEAN-ATMOSPHERE MODEL; 20TH-CENTURY TEMPERATURE	We compared the temporal variability of the heat content of the world ocean, of the global atmosphere, and of components of Earth's cryosphere during the Latter half of the 20th century. Each component has increased its heat content (the atmosphere and the ocean) or exhibited melting (the cryosphere). The estimated increase of observed global ocean heat content lover the depth range from 0 to 3000 meters) between the 1950s and 1990s is at least one order of magnitude Larger than the increase in heat content of any other component. Simulation results using an atmosphere-ocean general circulation model that includes estimates of the radiative effects of observed temporal variations in greenhouse gases, sulfate aerosols, solar irradiance, and volcanic aerosols over the past century agree with our observation-based estimate of the increase in ocean heal content. The results we present suggest that the observed increase in ocean heat content may largely be due to the increase of anthropogenic gases in Earth's atmosphere.	NOAA, NODC, Air Resources Lab, EOC5, Silver Spring, MD 20910 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Levitus, S (corresponding author), NOAA, NODC, Air Resources Lab, EOC5, 1315 East West Highway, Silver Spring, MD 20910 USA.		Wang, Julian/C-3188-2016; Delworth, Thomas L/C-5191-2014; Dixon, Keith W/L-7120-2015; Broccoli, Anthony J/D-9186-2014	Delworth, Thomas L/0000-0003-4865-5391; Dixon, Keith W/0000-0003-3044-326X; Broccoli, Anthony J/0000-0003-2619-1434				BRIFFA KR, 1995, NATURE, V376, P156, DOI 10.1038/376156a0; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; Haywood JM, 1997, GEOPHYS RES LETT, V24, P1335, DOI 10.1029/97GL01163; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; MANABE S, 1991, J CLIMATE, V4, P785, DOI 10.1175/1520-0442(1991)004<0785:TROACO>2.0.CO;2; MANABE S, 1994, J CLIMATE, V7, P5, DOI 10.1175/1520-0442(1994)007<0005:MCROAC>2.0.CO;2; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Park J, 1999, J HIGH ENERGY PHYS; Rothrock DA, 1999, GEOPHYS RES LETT, V26, P3469, DOI 10.1029/1999GL010863; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Vaughan Stephen, 2000, Polar Record, V36, P345; [No title captured]; [No title captured]; [No title captured]	21	365	390	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					267	270		10.1126/science.1058154	http://dx.doi.org/10.1126/science.1058154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303098				2022-12-28	WOS:000168074000041
J	Yabuta, NH; Sawatari, A; Callaway, EM				Yabuta, NH; Sawatari, A; Callaway, EM			Two functional channels from primary visual cortex to dorsal visual cortical areas	SCIENCE			English	Article							MONKEY STRIATE CORTEX; BROAD-BAND CHANNELS; MACAQUE MONKEY; COLOR-OPPONENT; OWL MONKEY; NEURONS; CONNECTIONS; PATHWAYS; STREAMS; MT	Relationships between the M and P retino-geniculo-cortical visual pathways and "dorsal" visual areas were investigated by measuring the sources of Local excitatory input to individual neurons in Layer 4B of primary visual cortex. We found that contributions of the M and P pathways to Layer 4B neurons are dependent on cell type. Spiny stellate neurons receive strong M input through Layer 4C alpha and no significant P input through Layer 4C beta. In contrast, pyramidal neurons in Layer 4B receive strong input from both Layers 4C alpha and 4C beta. These observations, along with evidence that direct input from Layer 4B to area MT arises predominantly from spiny stellates, suggest that these different cell types constitute two functionally specialized subsystems.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267	NATIONAL EYE INSTITUTE [R01EY010742, R01EY006837, R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [EY10742, EY06837] Funding Source: Medline; NIGMS NIH HHS [GM08107] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berezovskii VK, 2000, J NEUROSCI, V20, P1157, DOI 10.1523/JNEUROSCI.20-03-01157.2000; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BURKHALTER A, 1986, VISION RES, V26, P63, DOI 10.1016/0042-6989(86)90071-4; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOBKINS KR, 1993, VISION RES, V33, P1019, DOI 10.1016/0042-6989(93)90238-R; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; LACHICA EA, 1992, P NATL ACAD SCI USA, V89, P3566, DOI 10.1073/pnas.89.8.3566; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Movshon JA, 1996, J NEUROSCI, V16, P7733; ROCKLAND KS, 1992, CEREB CORTEX, V2, P38, DOI 10.1093/cercor/2.1.38; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Yabuta NH, 1998, J NEUROSCI, V18, P9489; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	29	89	91	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					297	300		10.1126/science.1057916	http://dx.doi.org/10.1126/science.1057916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303106	Green Submitted			2022-12-28	WOS:000168074000050
J	Brown, P				Brown, P			Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease	BRITISH MEDICAL JOURNAL			English	Review							GREAT-BRITAIN; BSE; MICE; SCRAPIE; RISK; CJD		Natl Inst Neurol Disorders & Blindness, Lab Cent Nervous Syst Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Brown, P (corresponding author), Natl Inst Neurol Disorders & Blindness, Lab Cent Nervous Syst Dis, NIH, Bethesda, MD 20892 USA.							BRADLEY R, 1995, B INT DAIRY FED, V301, P58; Brown P, 2001, EMERG INFECT DIS, V7, P6, DOI 10.3201/eid0701.010102; Brown P, 1997, JAMA-J AM MED ASSOC, V278, P1008, DOI 10.1001/jama.278.12.1008; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; *BSE INQ, 2000, REP EV SUPP PAP INQ, P12380; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; *EUR COMM, 1997, REP SCI VET COMM RIS; FOSTER JD, 1994, ANN NY ACAD SCI, V724, P300, DOI 10.1111/j.1749-6632.1994.tb38920.x; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Gibbs C.J., 1979, SLOW TRANSMISSIBLE D, V1, P87; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Purdey Mark, 1994, Journal of Nutritional Medicine, V4, P43, DOI 10.3109/13590849409034540; Stevenson MA, 2000, VET REC, V147, P349, DOI 10.1136/vr.147.13.349; Taylor DM, 1998, VET REC, V143, P6, DOI 10.1136/vr.143.1.6; Tiwana H, 1999, INFECT IMMUN, V67, P6591; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Wilesmith JW, 1997, VET REC, V141, P250, DOI 10.1136/vr.141.10.250; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	19	42	44	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					841	844		10.1136/bmj.322.7290.841	http://dx.doi.org/10.1136/bmj.322.7290.841			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290640	Green Published			2022-12-28	WOS:000168063000027
J	Peterson, BJ; Wollheim, WM; Mulholland, PJ; Webster, JR; Meyer, JL; Tank, JL; Marti, E; Bowden, WB; Valett, HM; Hershey, AE; McDowell, WH; Dodds, WK; Hamilton, SK; Gregory, S; Morrall, DD				Peterson, BJ; Wollheim, WM; Mulholland, PJ; Webster, JR; Meyer, JL; Tank, JL; Marti, E; Bowden, WB; Valett, HM; Hershey, AE; McDowell, WH; Dodds, WK; Hamilton, SK; Gregory, S; Morrall, DD			Control of nitrogen export from watersheds by headwater streams	SCIENCE			English	Article							INORGANIC NITROGEN; FOREST STREAM; AMMONIUM; SIZE; ECOSYSTEMS; PHOSPHORUS; SATURATION; RETENTION; STORAGE; CHANNEL	A comparative N-15-tracer study of nitrogen dynamics in headwater streams from biomes throughout North America demonstrates that streams exert control over nutrient exports to rivers, Lakes, and estuaries. The most rapid uptake and transformation of inorganic nitrogen occurred in the smallest streams. Ammonium entering these streams was removed from the water within a few tens to hundreds of meters. Nitrate was also removed from stream water but traveled a distance 5 to 10 times as long, on average, as ammonium. Despite low ammonium concentration in stream water, nitrification rates were high, indicating that small streams are potentially important sources of atmospheric nitrous oxide. During seasons of high biological activity, the reaches of headwater streams typically export downstream Less than half of the input of dissolved inorganic nitrogen from their watersheds.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; Ctr Estudis Avancats Blanes, Blanes 17300, Girona, Spain; Landcare Res, Lincoln 8152, New Zealand; Univ N Carolina, Dept Biol, Greensboro, NC 27402 USA; Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; Procter & Gamble Co, Expt Stream Facil, Milford, OH 45150 USA	Marine Biological Laboratory - Woods Hole; United States Department of Energy (DOE); Oak Ridge National Laboratory; Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Landcare Research - New Zealand; University of North Carolina; University of North Carolina Greensboro; University System Of New Hampshire; University of New Hampshire; Kansas State University; Michigan State University; Oregon State University; Procter & Gamble	Peterson, BJ (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.		Wollheim, Wilfred/AAA-3516-2022; Hamilton, Stephen K/N-2979-2014; Martí, Eugènia/J-9146-2012; Mulholland, Patrick/C-3142-2012; McDowell, William H/E-9767-2010	Hamilton, Stephen K/0000-0002-4702-9017; Martí, Eugènia/0000-0002-6910-4874; McDowell, William H/0000-0002-8739-9047; Wollheim, Wilfred/0000-0002-5009-3212; Dodds, Walter/0000-0002-6666-8930				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; BORMANN FH, 1968, SCIENCE, V159, P882, DOI 10.1126/science.159.3817.882; Dent CL, 1999, ECOLOGY, V80, P2283, DOI 10.1890/0012-9658(1999)080[2283:SHOSWN]2.0.CO;2; DODDS WK, 1991, J PLANKTON RES, V13, P1339, DOI 10.1093/plankt/13.6.1339; DODDS WK, IN PRESS ECOSYSTEMS; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; HAMILTON SK, IN PRESS BIOGEOCHEMI; HOPKINSON CS, 1995, ESTUARIES, V18, P598, DOI 10.2307/1352380; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Jordan TE, 1996, BIOSCIENCE, V46, P655, DOI 10.2307/1312895; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Lovett GM, 2000, ECOL APPL, V10, P73, DOI 10.1890/1051-0761(2000)010[0073:NSARIF]2.0.CO;2; Meyer JL, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P295; Mulholland PJ, 2000, ECOL MONOGR, V70, P471, DOI 10.1890/0012-9615(2000)070[0471:NCIAFS]2.0.CO;2; MULHOLLAND PJ, IN PRESS VERH INT VE; Nadelhoffer K, 1999, ENVIRON MONIT ASSESS, V55, P187, DOI 10.1023/A:1006190222768; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; NEWBOLD JD, 1983, FRESHWATER BIOL, V13, P193, DOI 10.1111/j.1365-2427.1983.tb00671.x; NNAIMAN RJ, 1983, PERIPHYTON FRESHWATE, P191; PETERSON BJ, 1985, TELLUS B, V37, P117, DOI 10.1111/j.1600-0889.1985.tb00060.x; Peterson BJ, 1997, CAN J FISH AQUAT SCI, V54, P2361, DOI 10.1139/cjfas-54-10-2361; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Tank JL, 2000, LIMNOL OCEANOGR, V45, P1013, DOI 10.4319/lo.2000.45.5.1013; TRISKA FJ, 1994, BIOGEOCHEMISTRY, V26, P67, DOI 10.1007/BF02182880; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WEBSTER JR, 1979, ECOL MONOGR, V49, P51, DOI 10.2307/1942572; Wollheim WM, 2001, LIMNOL OCEANOGR, V46, P1, DOI 10.4319/lo.2001.46.1.0001	28	1065	1154	23	534	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					86	90		10.1126/science.1056874	http://dx.doi.org/10.1126/science.1056874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292868				2022-12-28	WOS:000167995200042
J	Smethurst, DP; Williams, HC				Smethurst, DP; Williams, HC			Power laws - Are hospital waiting lists self-regulating?	NATURE			English	Article									Univ Nottingham Hosp, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England	University of Nottingham	Smethurst, DP (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England.			williams, hywel/0000-0002-5646-3093				Bak P., 1996, NATURE WORKS SCI SEL; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Harrison A, 2000, J Health Serv Res Policy, V5, P64; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MANDELBROT BB, 1963, J BUS, V33, P394; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; Williams HC, 1997, HLTH CARE NEEDS ASSE, P261	7	40	41	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					652	653		10.1038/35070647	http://dx.doi.org/10.1038/35070647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287943				2022-12-28	WOS:000167875400035
J	van Ee, R; Anderson, BL				van Ee, R; Anderson, BL			Motion direction, speed and orientation in binocular matching	NATURE			English	Article							STEREOPSIS; DISPARITY; NEURONS; MONKEY; DEPTH; AREA; SENSITIVITY; PARALLAX; MASKING	The spatial differences between the images seen by the two eyes, called binocular disparities, can be used to recover the volumetric (three-dimensional) aspects of a scene. The computation of disparity depends upon the correct identification of corresponding features in the two images. Understanding what image features are used by the brain to solve this matching problem is one of the main issues in stereoscopic vision(1). Many cortical neurons in visual areas V1 (ref. 2), MT (refs 3, 4) and MST (refs 5, 6) that are tuned to binocular disparity are also tuned to orientation, motion direction and speed. Although psychophysical work has shown that motion direction(7) can facilitate binocular matching, the psychophysical literature on the role of orientation is mixed(8,9), and it has been argued that speed differences are ineffective in aiding correspondence(7). Here we use a different psychophysical paradigm to show that the visual system uses similarities in orientation, motion direction and speed to achieve binocular correspondence. These results indicate that cells that multiplex orientation, motion direction, speed and binocular disparity may help to solve the binocular matching problem.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Utrecht, Helmholtz Inst, NL-3584 CC Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Utrecht University	Anderson, BL (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.		van Ee, Raymond/C-4881-2013	Anderson, Barton/0000-0003-0313-4285				BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; Bradshaw MF, 1997, P ROY SOC B-BIOL SCI, V264, P1421, DOI 10.1098/rspb.1997.0198; Howard IP, 1995, BINOCULAR VISION STE; Julesz B., 1971, FDN CYCLOPEAN PERCEP; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; MANSFIELD JS, 1993, VISION RES, V33, P1535, DOI 10.1016/0042-6989(93)90146-N; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAYHEW JEW, 1978, PERCEPTION, V7, P431, DOI 10.1068/p070431; POGGIO GF, 1981, J PHYSIOL-LONDON, V315, P469, DOI 10.1113/jphysiol.1981.sp013759; RICHARDS W, 1985, J OPT SOC AM A, V2, P343, DOI 10.1364/JOSAA.2.000343; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; ROY JP, 1992, J NEUROSCI, V12, P2478; TITTLE JS, 1993, PERCEPT PSYCHOPHYS, V54, P157, DOI 10.3758/BF03211751	15	51	51	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					690	694		10.1038/35070569	http://dx.doi.org/10.1038/35070569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287955	Green Published			2022-12-28	WOS:000167875400047
J	Shah, M				Shah, M			Grassroots computing: Palmtops in health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									PatientKeeper Inc, Cambridge, MA USA		Shah, M (corresponding author), PatientKeeper Inc, Cambridge, MA USA.							FISHER J, 2000, CURE IS HAND; *PDA, 2001, PDA SAL SOAR 2000	2	12	12	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1768	1768		10.1001/jama.285.13.1768	http://dx.doi.org/10.1001/jama.285.13.1768			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277838	hybrid			2022-12-28	WOS:000167710600037
J	Santini, V; Kantarjian, HM; Issa, JP				Santini, V; Kantarjian, HM; Issa, JP			Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE; RISK MYELODYSPLASTIC SYNDROME; ACUTE MYELOID LEUKEMIAS; TUMOR-SUPPRESSOR GENE; RANDOMIZED PHASE-II; SICKLE-CELL-ANEMIA; FAZARABINE ARA-AC; 5-AZACYTIDINE NSC-102816; CPG ISLAND	Methylation of DNA is a biochemical modification that can influence gene expression acid is involved in inactivating one of the two X chromosomes in women, Evidence that has accumulated in the past 10 years suggests that cancer cells usurp this physiologic mechanism and use it to their benefit by inactivating tumor suppressor genes and related proteins. However, the primary structure of the affected proteins remains intact; reversal of abnormalities in DNA methylation may therefore restore the tumor-suppressive function of these genes and provide a novel approach to cancer therapy. Two demethylating drugs, 5-azacytidine and 5-azadeoxycytidine, are currently being tested in clinical trials, and several others are in preclinical development. In this article, the biological rationale for targeting aberrant methylation in cancer therapy is reviewed and completed phase I and II trials of this approach, some of which show promise for treatment of hematologic malignancies, are summarized.	Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Univ Florence, Florence, Italy	University of Texas System; UTMD Anderson Cancer Center; University of Florence	Kantarjian, HM (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Box 61,1515 Holcombe Blvd, Houston, TX 77030 USA.		SANTINI, VALERIA/AAL-3135-2020	SANTINI, VALERIA/0000-0002-5439-2172; Issa, Jean-Pierre/0000-0003-2258-5030				ABELE R, 1987, EUR J CANCER CLIN ON, V23, P1921, DOI 10.1016/0277-5379(87)90060-5; Ahuja N, 1998, CANCER RES, V58, P5489; ATTADIA V, 1993, LEUKEMIA, V7, P9; ATTADIA V, 1990, 5-AZA-2-DEOXYCYTIDINE : PRECLINICAL AND CLINICAL STUDIES, P89; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BAYLIN SB, 1986, CANCER RES, V46, P2917; Baylin SB, 1998, ADV CANCER RES, V72, P141; BELLET RE, 1974, CANCER CHEMOTH REP 1, V58, P217; Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bender CM, 1998, PHARM RES-DORDR, V15, P175, DOI 10.1023/A:1011946030404; Bender CM, 1998, CANCER RES, V58, P95; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHABOT GG, 1990, 5-AZA-2-DEOXYCYTIDINE : PRECLINICAL AND CLINICAL STUDIES, P105; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cote S, 1997, ANTI-CANCER DRUG, V8, P56; COVEY JM, 1985, EUR J CANCER CLIN ON, V21, P109, DOI 10.1016/0277-5379(85)90207-X; COVEY JM, 1984, CANCER TREAT REP, V68, P1475; CREAGAN ET, 1993, AM J CLIN ONCOL-CANC, V16, P243, DOI 10.1097/00000421-199306000-00010; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; CUNNINGHAM TJ, 1974, CANCER CHEMOTH REP 1, V58, P677; CURT GA, 1985, CANCER RES, V45, P3359; DASKALAKIS M, 1998, BLOOD, V94, pA306; DORE BT, 1992, ANTI-CANCER DRUG, V3, P281, DOI 10.1097/00001813-199206000-00012; DUTCHER JP, 1992, LEUKEMIA, V6, P770; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; GOLDBERG J, 1993, AM J HEMATOL, V43, P286, DOI 10.1002/ajh.2830430411; Goldberg RM, 1997, CLIN CANCER RES, V3, P2363; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1997, CANCER RES, V57, P837; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Issa JPJ, 1997, LEUKEMIA, V11, pS7; Issa JPJ, 1996, CANCER RES, V56, P973; Issa JPJ, 1997, CANCER RES, V57, P1678; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kanai Y, 1997, INT J CANCER, V71, P355; Kane MF, 1997, CANCER RES, V57, P808; Kantarjian HM, 1997, LEUKEMIA, V11, P1617, DOI 10.1038/sj.leu.2400796; Kantharidis P, 1997, CLIN CANCER RES, V3, P2025; KARON M, 1973, BLOOD, V42, P359, DOI 10.1182/blood.V42.3.359.359; Kawano S, 1999, BLOOD, V94, P1113; KORNBLITH AB, 1998, P AN M AM SOC CLIN, V77, pA49; Koshy M, 2000, BLOOD, V96, P2379, DOI 10.1182/blood.V96.7.2379.h8002379_2379_2384; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; LEY TJ, 1983, BLOOD, V62, P370; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lopez-Baena M, 1998, MUTAT RES-FUND MOL M, V421, P109, DOI 10.1016/S0027-5107(98)00162-6; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; MCCREDIE KB, 1973, CANCER CHEMOTH REP 1, V57, P319; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; MOERTEL CG, 1972, CANCER CHEMOTH REP 1, V56, P649; MOMPARLER RL, 1985, LEUKEMIA RES, V9, P1361, DOI 10.1016/0145-2126(85)90123-7; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P277, DOI 10.1016/0163-7258(85)90052-X; Momparler RL, 1997, ANTI-CANCER DRUG, V8, P358, DOI 10.1097/00001813-199704000-00008; MOMPARLER RL, 1990, LEUKEMIA RES, V14, P751, DOI 10.1016/0145-2126(90)90067-J; MOMPARLER RL, 1990, 5-AZA-2-DEOXYCYTIDINE : PRECLINICAL AND CLINICAL STUDIES, P9; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Noyer-Weidner M, 1993, EXS, V64, P39; PETTI MC, 1993, LEUKEMIA, V7, P36; PINTO A, 1984, BLOOD, V64, P922; PINTO A, 1989, BONE MARROW TRANSPL, V4, P28; POWELL WC, 1988, CANCER CHEMOTH PHARM, V21, P117; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Rees JKH, 1996, BRIT J HAEMATOL, V94, P89, DOI 10.1046/j.1365-2141.1996.d01-1769.x; RICHEL DJ, 1991, BRIT J CANCER, V64, P144, DOI 10.1038/bjc.1991.258; RICHEL DJ, 1988, BRIT J CANCER, V58, P730, DOI 10.1038/bjc.1988.298; RIVARD GE, 1981, LEUKEMIA RES, V5, P453, DOI 10.1016/0145-2126(81)90116-8; Sacchi S, 1999, CANCER-AM CANCER SOC, V86, P2632, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A; SAIKI JH, 1981, CANCER, V47, P1739, DOI 10.1002/1097-0142(19810401)47:7<1739::AID-CNCR2820470702>3.0.CO;2-2; SAKAI T, 1991, AM J HUM GENET, V48, P880; Samuels BL, 1998, CANCER, V82, P1578; SCHIFFER CA, 1982, CANCER TREAT REP, V66, P267; Schwartsmann G, 1997, LEUKEMIA, V11, pS28; SESSA C, 1990, EUR J CANCER, V26, P137, DOI 10.1016/0277-5379(90)90295-5; Silverman Lewis R., 1994, Leukemia Research, V18, P21, DOI 10.1016/0145-2126(94)90171-6; SILVERMAN LR, 1993, LEUKEMIA, V7, P21; SILVERMAN LR, 1998, ONCOLOGY, V17, pA14; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Steuber CP, 1996, J CLIN ONCOL, V14, P1521, DOI 10.1200/JCO.1996.14.5.1521; SZYF M, 1985, J BIOL CHEM, V260, P8653; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Thibault A, 1998, TUMORI, V84, P87, DOI 10.1177/030089169808400120; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vogelzang NJ, 1997, CANCER, V79, P2237, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2237::AID-CNCR23>3.0.CO;2-W; VOGLER WR, 1995, LEUKEMIA, V9, P1456; VOGLER WR, 1976, BLOOD, V48, P331; Von Hoff D D, 1976, Ann Intern Med, V85, P237; WALTERS RS, 1992, INVEST NEW DRUG, V10, P43, DOI 10.1007/BF01275480; WEISS AJ, 1972, CANCER CHEMOTH REP 1, V56, P413; WEISS AJ, 1977, CANCER TREAT REP, V61, P55; Weissbach A, 1993, EXS, V64, P1; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; Wijermans P, 1999, BLOOD, V94, p306A; Wijermans PW, 1997, LEUKEMIA, V11, pS19, DOI 10.1038/sj.leu.2400526; Willemze R, 1997, LEUKEMIA, V11, pS24; WILLEMZE R, 1993, LEUKEMIA, V7, P49; WINTON EF, 1985, CANCER TREAT REP, V69, P807; Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869; ZITTOUN R, 1989, BLOOD, V73, P896	111	331	360	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					573	586		10.7326/0003-4819-134-7-200104030-00011	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00011			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281740				2022-12-28	WOS:000167931200005
J	Faust, J; Schreiner, O				Faust, J; Schreiner, O			A swallowed toothbrush	LANCET			English	Editorial Material							BULIMIA-NERVOSA		Univ Mainz, Dept Med, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Faust, J (corresponding author), Univ Mainz, Dept Med, Langenbeckstr 1, D-55131 Mainz, Germany.							Faris PL, 2000, LANCET, V355, P792, DOI 10.1016/S0140-6736(99)09062-5; Kaye WH, 2000, ANNU REV MED, V51, P299, DOI 10.1146/annurev.med.51.1.299; KIRK AD, 1988, ARCH SURG-CHICAGO, V123, P382; RIDDLESBERGER MM, 1991, PEDIATR RADIOL, V21, P262, DOI 10.1007/BF02018618; WILCOX DT, 1994, J PEDIATR SURG, V29, P1596, DOI 10.1016/0022-3468(94)90230-5	5	16	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1012	1012		10.1016/S0140-6736(00)04238-0	http://dx.doi.org/10.1016/S0140-6736(00)04238-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293596				2022-12-28	WOS:000167791500014
J	Gillon, J; Yakir, D				Gillon, J; Yakir, D			Influence of carbonic anhydrase activity in terrestrial vegetation on the O-18 content of atmospheric CO2	SCIENCE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; ISOTOPIC COMPOSITION; C-4 PHOTOSYNTHESIS; DISCRIMINATION; DELTA-O-18; OXYGEN; PLANTS; LEAVES; WATER; (COO)-O-18-O-16	The oxygen-18 (O-18) content of atmospheric carbon dioxide (CO2) is an important indicator of CO2 uptake on land. It has generally been assumed that during photosynthesis, oxygen in CO2 reaches isotopic equilibrium with oxygen in O-18-enriched water in leaves. We show, however, large differences in the activity of carbonic anhydrase (which catalyzes CO2 hydration and O-18 exchange in leaves) among major plant groups that cause variations in the extent of O-18 equilibrium (theta (eq)). A clear distinction in theta (eq) between C-3 trees and shrubs, and C-4 grasses makes atmospheric (COO)-O-18 a potentially sensitive indicator to changes in C-3 and C-4 productivity. We estimate a global mean theta (eq) value of similar to0.8, which reasonably reconciles inconsistencies between O-18 budgets of atmospheric O-2 (Dole effect) and CO2.	Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yakir, D (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.		Yakir, Dan/K-1500-2012					BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; BENDER M, 1985, NATURE, V318, P349, DOI 10.1038/318349a0; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5873, DOI 10.1029/96JD02361; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P219, DOI 10.1007/BF01323191; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; FLANAGAN LB, 1994, AUST J PLANT PHYSIOL, V21, P221, DOI 10.1071/PP9940221; FORSTEL H, 1978, P 3 INT S ENV BIOG G, P811; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; GILLON J, UNPUB; Gillon JS, 2000, PLANT CELL ENVIRON, V23, P903, DOI 10.1046/j.1365-3040.2000.00597.x; Gillon JS, 2000, PLANT PHYSIOL, V123, P201, DOI 10.1104/pp.123.1.201; Harwood KG, 1998, PLANT CELL ENVIRON, V21, P269, DOI 10.1046/j.1365-3040.1998.00276.x; HATCH MD, 1990, PLANT PHYSIOL, V93, P825, DOI 10.1104/pp.93.2.825; HOFFMANN GW, UNPUB; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; MAKINO A, 1992, PLANT PHYSIOL, V100, P1737, DOI 10.1104/pp.100.4.1737; Mills GA, 1940, J AM CHEM SOC, V62, P1019, DOI 10.1021/ja01862a010; Peylin P, 1999, TELLUS B, V51, P642, DOI 10.1034/j.1600-0889.1999.t01-2-00006.x; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Tans PP, 1998, TELLUS B, V50, P163, DOI 10.1034/j.1600-0889.1998.t01-1-00004.x; Trolier M, 1996, J GEOPHYS RES-ATMOS, V101, P25897, DOI 10.1029/96JD02363; UTSONIYAMA E, 1993, PHYSIOL PLANTARUM, V88, P413; Wang XF, 1998, GLOBAL CHANGE BIOL, V4, P835, DOI 10.1046/j.1365-2486.1998.00197.x; Waring R. H., 1985, FOREST ECOSYSTEMS; Williams TG, 1996, PLANT PHYSIOL, V112, P319, DOI 10.1104/pp.112.1.319; YAKIR D, 1994, PLANT CELL ENVIRON, V17, P73, DOI 10.1111/j.1365-3040.1994.tb00267.x; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0	36	135	149	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2584	2587		10.1126/science.1056374	http://dx.doi.org/10.1126/science.1056374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283366				2022-12-28	WOS:000167861000036
J	Woodward, FI				Woodward, FI			Carbon cycle - Discriminating plants	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; LEAF WATER; OXYGEN; C-3		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Woodward, FI (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Woodward, Ian F/B-7762-2008; Woodward, Frank Ian/P-4530-2019					Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5873, DOI 10.1029/96JD02361; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; FLANAGAN LB, 1994, AUST J PLANT PHYSIOL, V21, P221, DOI 10.1071/PP9940221; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Gillon JS, 2000, PLANT PHYSIOL, V123, P201, DOI 10.1104/pp.123.1.201; Helliker BR, 2000, P NATL ACAD SCI USA, V97, P7894, DOI 10.1073/pnas.97.14.7894; HELLIKER BR, COMMUNICATION; KEELING CD, 2000, TRENDS COMPENDIUM DA; STILL C, UNPUB	9	3	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2562	2563		10.1126/science.1059472	http://dx.doi.org/10.1126/science.1059472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286281				2022-12-28	WOS:000167861000030
J	Butler, D				Butler, D			The battle of Tugen Hills	NATURE			English	News Item																		FLEAUX R, 2001, SCI AVENIR, P18; Gitonga E, 2001, SCIENCE, V291, P986; Pickford M, 2001, SCIENCE, V291, P986; PICKFORD M, 1975, NATURE, V256, P279, DOI 10.1038/256279a0; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; 2000, SCIENCE, V290, P2065	6	3	3	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					508	509		10.1038/35069232	http://dx.doi.org/10.1038/35069232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279458				2022-12-28	WOS:000167859300013
J	deMenocal, PB				deMenocal, PB			Cultural responses to climate change during the Late Holocene	SCIENCE			English	Review							NORTH-AMERICA; VARIABILITY; COLLAPSE; DROUGHT; EMPIRE; SOLAR	Modern complex societies exhibit marked resilience to interannual-to-decadal droughts, but cultural responses to multidecadal-to-multicentury droughts can only be addressed by integrating detailed archaeological and paleoclimatic records. Four case studies drawn from New and Old World civilizations document societal responses to prolonged drought, including population dislocations, urban abandonment, and state collapse. Further study of past cultural adaptations to persistent climate change may provide valuable perspective on possible responses of modern societies to future climate change.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	deMenocal, PB (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	peter@ldeo.columbia.edu	demenocal, peter/B-1386-2013	demenocal, peter/0000-0002-7191-717X				Adams R. E., 1973, CLASSIC MAYA COLLAPS, P21; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; BarMatthews M, 1997, QUATERNARY RES, V47, P155, DOI 10.1006/qres.1997.1883; Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Binford MW, 1997, QUATERNARY RES, V47, P235, DOI 10.1006/qres.1997.1882; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BRADNOCK RW, 1995, J ROY ASIATIC SOC, V5, P150, DOI 10.1017/S1356186300013912; BRENNER M, 2001, INTERHEMISPHERIC CLI, P87, DOI DOI 10.1016/B978-012472670-3/50009-4; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; CANE MA, 1994, NATURE, V370, P204, DOI 10.1038/370204a0; Coe M. D., 1987, MAYA; Cook ER, 1997, J CLIMATE, V10, P1343, DOI 10.1175/1520-0442(1997)010<1343:ANAOPS>2.0.CO;2; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; COOK ER, 2000, DATA CONTRIBUTION SE; Cordell L. S., 1997, ARCHAEOLOGY SW; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Cullen HM, 2000, INT J CLIMATOL, V20, P853, DOI 10.1002/1097-0088(20000630)20:8&lt;853::AID-JOC497&gt;3.0.CO;2-M; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dean WE, 1996, HOLOCENE, V6, P145, DOI 10.1177/095968369600600202; Dean WE, 1997, GEOLOGY, V25, P331, DOI 10.1130/0091-7613(1997)025<0331:RTACOH>2.3.CO;2; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; Douglass A.E., 1929, NATL GEOGR MAG, V54, P737; Dwyer GS, 2000, GEOCHEM GEOPHY GEOSY, V1; Gill Richardson, 2000, GREAT MAYA DROUGHTS; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Hodell David A., 2000, IMPERFECT BALANCE LA, P13; Hutton James, 1795, THEORY EARTH; Jones TL, 1999, CURR ANTHROPOL, V40, P137, DOI 10.1086/200002; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; Keigwin LD, 2000, P NATL ACAD SCI USA, V97, P1343, DOI 10.1073/pnas.97.4.1343; Kolata A. L, 1996, TIWANAKU ITS HINTERL; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lemcke G, 1997, NATO ASI SER SER I, V49, P653; Lowe JW, 1985, DYNAMICS APOCALYPSE; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Overpeck J, 2000, P NATL ACAD SCI USA, V97, P1335, DOI 10.1073/pnas.97.4.1335; Overpeck JT, 1996, SCIENCE, V271, P1820, DOI 10.1126/science.271.5257.1820; PAULSEN AC, 1976, WORLD ARCHAEOL, V8, P121, DOI 10.1080/00438243.1976.9979658; Postgate J.N., 1992, EARLY MESOPOTAMIA; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; SHIMADA I, 1991, WORLD ARCHAEOL, V22, P247, DOI 10.1080/00438243.1991.9980145; Stahle DW, 1998, SCIENCE, V280, P564, DOI 10.1126/science.280.5363.564; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; THOMPSON LG, 1994, HUM ECOL, V22, P83, DOI 10.1007/BF02168764; VANWEST CR, 1991, RECONSTRUCTING PREHI; WARRICK RA, 1980, NASA P SER CLIM CONS; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Weiss H., 2000, ENV DISASTER ARCHAEO, P75; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	57	696	749	10	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					667	673		10.1126/science.1059827	http://dx.doi.org/10.1126/science.1059827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	428TX	11303088				2022-12-28	WOS:000168478300038
J	Jaakkola, P; Mole, DR; Tian, YM; Wilson, MI; Gielbert, J; Gaskell, SJ; von Kriegsheim, A; Hebestreit, HF; Mukherji, M; Schofield, CJ; Maxwell, PH; Pugh, CW; Ratcliffe, PJ				Jaakkola, P; Mole, DR; Tian, YM; Wilson, MI; Gielbert, J; Gaskell, SJ; von Kriegsheim, A; Hebestreit, HF; Mukherji, M; Schofield, CJ; Maxwell, PH; Pugh, CW; Ratcliffe, PJ			Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; UBIQUITIN-LIGASE COMPLEX; DEPENDENT PROTEOLYSIS; ERYTHROPOIETIN GENE; FACTOR-I; HYPOXIA; HIF-1-ALPHA; ACTIVATION; BINDING	Hypoxia-inducible factor (HIF) is a transcriptional complex that plays a central role in the regulation of gene expression by oxygen. In oxygenated and iron replete cells, HIF-alpha subunits are rapidly destroyed by a mechanism that involves ubiquitylation by the von Hippel-Lindau tumor suppressor (pVHL) E3 Ligase complex. This process is suppressed by hypoxia and iron chelation, allowing transcriptional activation. Here we show that the interaction between human pVHL and a specific domain of the HIF-1 alpha subunit is regulated through hydroxylation of a proline residue (HIF-1 alpha P564) by an enzyme we have termed HIF-alpha prolyl-hydroxylase (HIF-PH). An absolute requirement for dioxygen as a cosubstrate and iron as cofactor suggests that HIF-PH functions directly as a cellular oxygen sensor.	Univ Oxford, Oxford OX3 7BN, England; Univ Manchester, Inst Sci & Technol, Dept Chem, Michael Barber Ctr Mass Spectrometry, Manchester M60 1QD, Lancs, England; Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England; Univ Oxford, Dyson Perrins Lab, Oxford Ctr Mol Sci, Oxford OX1 3QY, England	University of Oxford; University of Manchester; University of Oxford; University of Oxford	Maxwell, PH (corresponding author), Univ Oxford, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.		Gielbert, Adriana/C-5188-2011; Jaakkola, Panu M/B-4355-2012; von Kriegsheim, Alex/C-2371-2016; Maxwell, Patrick H/C-5557-2008	Gielbert, Adriana/0000-0003-1597-9373; von Kriegsheim, Alex/0000-0002-4952-8573; Maxwell, Patrick H/0000-0002-0338-2679; Jaakkola, Panu/0000-0002-2365-4985; Ratcliffe, Peter/0000-0002-2853-806X; Schofield, Christopher/0000-0002-0290-6565; Pugh, Chris/0000-0002-5170-1662; Mole, David/0000-0002-0984-300X				Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; CUNLIFFE CJ, 1992, J MED CHEM, V35, P2652, DOI 10.1021/jm00092a016; Ehleben W, 1997, KIDNEY INT, V51, P483, DOI 10.1038/ki.1997.67; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jansen GA, 1999, J LIPID RES, V40, P2244; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; MASSON N, UNPUB; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MUKHERJI M, UNPUB; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268	32	4246	4420	15	450	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					468	472		10.1126/science.1059796	http://dx.doi.org/10.1126/science.1059796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11292861				2022-12-28	WOS:000168187300036
J	Hansel, DE; Eipper, BA; Ronnett, GV				Hansel, DE; Eipper, BA; Ronnett, GV			Neuropeptide Y functions as a neuroproliferative factor	NATURE			English	Article							NERVOUS-SYSTEM; MAP KINASE; STEM-CELLS; PEPTIDE YY; RECEPTORS; RAT; EXPRESSION; NEURONS; TUBULIN	Neuropeptide Y (NPY) has a number of functions in mammalian physiology(1-6). Here we identify a role for NPY in promoting proliferation of postnatal neuronal precursor cells. NPY is synthesized in the postnatal olfactory epithelium by sustentacular cells, previously proposed to function only in structural support(7). Mice with a targeted deletion of NPY8 contain half as many dividing olfactory neuronal precursor cells as do controls. Furthermore, NPY-deficient mice develop significantly fewer olfactory neurons by adulthood. NPY acts on multipotent neuronal precursor or basal cells to activate rapidly and transiently the extracellular signal-regulated kinase (ERK)1/2 subgroup of mitogen-activated protein kinases. The NPY Y1 receptor subtype appears to mediate this effect. The ability of NPY to induce neuronal precursor proliferation is mediated by protein kinase C (PKC), indicating an upstream PKC-dependent activation of ERK1/2. These results indicate that NPY may regulate neuronal precursor proliferation in the adult mammal.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Univ Vermont, Hlth Sci Ctr, Dept Physiol, Burlington, VT 05405 USA	Johns Hopkins University; Johns Hopkins University; University of Vermont	Ronnett, GV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							ADRIAN TE, 1983, LANCET, V2, P540; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Balasubramaniam A, 1997, PEPTIDES, V18, P445, DOI 10.1016/S0196-9781(96)00347-6; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; DANGER JM, 1990, FUNDAM CLIN PHARM, V4, P307, DOI 10.1111/j.1472-8206.1990.tb00497.x; Davis JA, 1996, J NEUROSCI, V16, P5082; DICKERSON IM, 1990, ENDOCRINOLOGY, V127, P133, DOI 10.1210/endo-127-1-133; ELITSUR Y, 1994, NEUROPEPTIDES, V26, P289, DOI 10.1016/0143-4179(94)90113-9; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goldberg Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1207, DOI 10.1152/ajpcell.1998.275.5.C1207; Hokfelt T, 1998, BRAIN RES REV, V26, P154, DOI 10.1016/S0165-0173(97)00052-0; Huard JMT, 1998, J COMP NEUROL, V400, P469; Keffel S, 1999, J PHARMACOL EXP THER, V291, P1172; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Mannon PJ, 1998, BIOCHEM BIOPH RES CO, V246, P91, DOI 10.1006/bbrc.1998.8577; MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104; Michel MC, 1998, PHARMACOL REV, V50, P143; MORRISON EE, 1995, HDB OLFACTION GUSTAT, P79; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; RIJZEWIJK JJ, 1989, ACTA DERM-VENEREOL, V69, P512; RONNETT GV, 1991, J NEUROSCI, V11, P1243; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; SHIGERI Y, 1993, NEUROSCI LETT, V149, P19, DOI 10.1016/0304-3940(93)90337-K; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5	30	289	299	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					940	944		10.1038/35073601	http://dx.doi.org/10.1038/35073601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309620				2022-12-28	WOS:000168152300049
J	Moher, D; Schulz, KF; Altman, DG				Moher, D; Schulz, KF; Altman, DG		CONSORT Grp	The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-TRIALS; TREAT ANALYSIS; INTENTION	To comprehend the results of a randomized, controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through complete transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by using a checklist and flow diagram. The revised CONSORT statement presented in this paper incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting the information is associated with biased estimates of treatment effect or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrollment, intervention allocation, follow-up, and analysis). The diagram explicitly includes the number of participants, for each intervention group, that are included in the primary data analysis. inclusion of these numbers allows the reader to judge whether the authors have performed an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.	Childrens Hosp Eastern Ontario, Thomas C Chalmers Ctr Systemat Reviews, Res Inst, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario	Moher, D (corresponding author), Childrens Hosp Eastern Ontario, Thomas C Chalmers Ctr Systemat Reviews, Res Inst, Room R235,401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.		Lang, Tom/AAN-9087-2020	Lang, Tom/0000-0002-7482-7727				Altman DG, 1996, BRIT MED J, V313, P570; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bentzen SM, 1998, RADIOTHER ONCOL, V46, P5, DOI 10.1016/S0167-8140(97)00226-0; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; Davidoff F, 2000, ANN INTERN MED, V133, P229, DOI 10.7326/0003-4819-133-3-200008010-00017; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; EGGER M, IN PRESS JAMA; Elbourne DR, 2001, STAT MED, V20, P489, DOI 10.1002/1097-0258(20010215)20:3<489::AID-SIM806>3.0.CO;2-S; Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Huston P, 1996, CAN MED ASSOC J, V155, P1277; JADAD AR, 2000, 11 MCM U; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, IN PRESS JAMA; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; OToole LB, 1997, BRIT MED J, V314, P1127; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; Schulz KF, 1997, ANN NEUROL, V41, P569, DOI 10.1002/ana.410410504; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181	29	631	649	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					657	662		10.7326/0003-4819-134-8-200104170-00011	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304106	Green Published			2022-12-28	WOS:000168177500005
J	Blackmer, T; Larsen, EC; Takahashi, M; Martin, TFJ; Alford, S; Hamm, HE				Blackmer, T; Larsen, EC; Takahashi, M; Martin, TFJ; Alford, S; Hamm, HE			G protein beta gamma subunit-mediated presynaptic inhibition: Regulation of exocytotic fusion downstream of Ca2+ entry	SCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; DEPENDENT CALCIUM CHANNELS; MOTOR-NERVE ENDINGS; SENSORY NEURONS; DIRECT BINDING; K+ CHANNEL; RAT-BRAIN; MODULATION; ACTIVATION; MECHANISM	The nervous system can modulate neurotransmitter release by neurotransmitter activation of heterotrimeric GTP-binding protein (G protein)-coupled receptors. We found that microinjection of G protein beta gamma subunits (G beta gamma) mimics serotonin's inhibitory effect on neurotransmission. Release of free G beta gamma was critical for this effect because a G beta gamma scavenger blocked serotonin's effect. G beta gamma bad no effect on fast, action potential-evoked intracellular Ca2+ release that triggered neurotransmission. Inhibition of neurotransmitter release by serotonin was still seen after blockade of all classical G beta gamma effector pathways. Thus, G beta gamma blocked neurotransmitter release downstream of Ca2+ entry and may directly target the exocytotic fusion machinery at the presynaptic terminal.	Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60608 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Northwestern University; Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison	Alford, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.		Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246				ALFORD S, 1991, J NEUROSCI, V11, P3718; Betty M, 1998, NEUROSCIENCE, V85, P475, DOI 10.1016/S0306-4522(97)00623-4; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BUCHANAN JT, 1991, NEUROSCI LETT, V122, P71, DOI 10.1016/0304-3940(91)90196-Z; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOLPHIN AC, 1993, BIOCHEM SOC T, V21, P391, DOI 10.1042/bst0210391; ECCLES JC, 1963, J NEUROPHYSIOL, V26, P506, DOI 10.1152/jn.1963.26.3.506; ElManira A, 1997, J NEUROSCI, V17, P1786; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HOLZ GG, 1989, J NEUROSCI, V9, P657; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUINI A, 1990, J NEUROCHEM, V54, P30, DOI 10.1111/j.1471-4159.1990.tb13279.x; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Mirotznik RR, 2000, J NEUROSCI, V20, P7614; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Singer JH, 1996, SLEEP, V19, pS146; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; UMEMIYA M, 1995, J NEUROPHYSIOL, V73, P1192, DOI 10.1152/jn.1995.73.3.1192; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940	34	195	199	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					293	297		10.1126/science.1058803	http://dx.doi.org/10.1126/science.1058803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303105				2022-12-28	WOS:000168074000049
J	Leuenberger, MN; Loss, D				Leuenberger, MN; Loss, D			Quantum computing in molecular magnets	NATURE			English	Article							MAGNETIZATION; MN-12-ACETATE; NANOMAGNETS	Shor and Grover demonstrated that a quantum computer can outperform any classical computer in factoring numbers(1) and in searching a database(2) by exploiting the parallelism of quantum mechanics. Whereas Shor's algorithm requires both superposition and entanglement of a many-particle system(3), the superposition of single-particle quantum states is sufficient for Grover's algorithm(4). Recently, the latter has been successfully implemented(5) using Rydberg atoms. Here we propose an implementation of Grover's algorithm that uses molecular magnets(6-10), which are solid-state systems with a large spin; their spin eigenstates make them natural candidates for single-particle systems. We show theoretically that molecular magnets can be used to build dense and efficient memory devices based on the Grover algorithm. In particular, one single crystal can serve as a storage unit of a dynamic random access memory device. Fast electron spin resonance pulses can be used to decode and read out stored numbers of up to 10(5), with access times as short as 10(-10) seconds. We show that our proposal should be feasible using the molecular magnets Fe-8 and Mn-12.	Univ Basel, Dept Phys & Astron, CH-4056 Basel, Switzerland	University of Basel	Loss, D (corresponding author), Univ Basel, Dept Phys & Astron, Klingelbergstr 82, CH-4056 Basel, Switzerland.		Loss, Daniel/A-3721-2008; Leuenberger, Michael N/L-4501-2013	Loss, Daniel/0000-0001-5176-3073; Cador, Olivier/0000-0003-2064-6223				Ahn J, 2000, SCIENCE, V287, P463, DOI 10.1126/science.287.5452.463; Barra AL, 1997, PHYS REV B, V56, P8192, DOI 10.1103/PhysRevB.56.8192; COHENTANNOUDJI C, QUANTUM MECH, V2, P1323; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Fitzgerald R, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.1325228; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Grover LK, 1997, PHYS REV LETT, V79, P4709, DOI 10.1103/PhysRevLett.79.4709; Leuenberger MN, 2000, PHYS REV B, V61, P1286, DOI 10.1103/PhysRevB.61.1286; Leuenberger MN, 2000, PHYS REV B, V61, P12200, DOI 10.1103/PhysRevB.61.12200; Mirebeau I, 1999, PHYS REV LETT, V83, P628, DOI 10.1103/PhysRevLett.83.628; Sangregorio C, 1997, PHYS REV LETT, V78, P4645, DOI 10.1103/PhysRevLett.78.4645; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Thiaville A, 1999, SCIENCE, V284, P1939, DOI 10.1126/science.284.5422.1939; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Wernsdorfer W, 2000, EUROPHYS LETT, V50, P552, DOI 10.1209/epl/i2000-00305-x	15	2375	2384	8	425	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					789	793		10.1038/35071024	http://dx.doi.org/10.1038/35071024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298441	Green Submitted			2022-12-28	WOS:000168021900047
J	Mork, J; Lie, AK; Glattre, E; Clark, S; Hallmans, G; Jellum, E; Koskela, P; Moller, B; Pukkala, E; Schiller, JT; Youngman, L; Lehtinen, M; Dillner, J				Mork, J; Lie, AK; Glattre, E; Clark, S; Hallmans, G; Jellum, E; Koskela, P; Moller, B; Pukkala, E; Schiller, JT; Youngman, L; Lehtinen, M; Dillner, J			Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; ORAL-CANCER; TYPE-16; ASSOCIATION; TONSILLAR; WOMEN; HPV; PREVALENCE; PROTEINS; TOBACCO	Background: Oncogenic human papillomaviruses (HPVs), especially HPV type 16 (HPV-16), cause anogenital epithelial cancers and are suspected of causing epithelial cancers of the head and neck. Methods: To examine the relation between head and neck cancers and HPVs, we performed a nested case-control study within a joint Nordic cohort in which serum samples were collected from almost 900,000 subjects. Samples collected at enrollment from 292 persons in whom squamous-cell carcinoma of the head and neck developed, on average, 9.4 years after enrollment and from 1568 matched controls were analyzed for antibodies against HPV-16, HPV-18, HPV-33, and HPV-73 and for cotinine levels as a marker of smoking habits. Polymerase-chain-reaction (PCR) analyses for HPV DNA were performed in tumor tissue from 160 of the study patients with cancer. Results: After adjustment for cotinine levels, the odds ratio for squamous-cell carcinoma of the head and neck in subjects who were seropositive for HPV-16 was 2.2 (95 percent confidence interval, 1.4 to 3.4). No increased risk was observed for other HPV types. Fifty percent of oropharyngeal and 14 percent of tongue cancers contained HPV-16 DNA, according to PCR analysis. Conclusions: HPV-16 infection may be a risk factor for squamous-cell carcinoma of the head and neck. (N Engl J Med 2001;344:1125-31.) Copyright (C) 2001 Massachusetts Medical Society.	Natl Hosp Norway, Dept Otolaryngol, N-0027 Oslo, Norway; Canc Registry Norway, Oslo, Norway; Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; No Sweden Hlth & Dis Study, Umea, Sweden; Norwegian Canc Soc, Janus Comm, Oslo, Norway; Natl Publ Hlth Inst, Oulu, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland; NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England; Natl Publ Hlth Inst, Helsinki, Finland; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Finland National Institute for Health & Welfare; Finnish Cancer Registry; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Oxford; Finland National Institute for Health & Welfare; Karolinska Institutet	Mork, J (corresponding author), Natl Hosp Norway, Dept Otolaryngol, N-0027 Oslo, Norway.	jon.mork@ioks.uio.no	Schiller, John/ABK-8287-2022; Møller, Bjørn/K-7152-2012	lehtinen, matti/0000-0002-9481-0535				Af Geijersstam V, 1999, INT J CANCER, V80, P489, DOI 10.1002/(SICI)1097-0215(19990209)80:4<489::AID-IJC1>3.0.CO;2-9; Andl T, 1998, CANCER RES, V58, P5; ARENDS MJ, 1991, J PATHOL, V165, P301, DOI 10.1002/path.1711650405; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Bjorge T, 1997, CANCER RES, V57, P3989; Bjorge T, 1997, BRIT MED J, V315, P646, DOI 10.1136/bmj.315.7109.646; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Cruz IBF, 1996, ORAL ONCOL, V32B, P55, DOI 10.1016/0964-1955(95)00060-7; Dillner J, 1997, J NATL CANCER I, V89, P1293, DOI 10.1093/jnci/89.17.1293; DILLNER J, 1995, BRIT MED J, V311, P1346, DOI 10.1136/bmj.311.7016.1346; EVANDER M, 1995, J INFECT DIS, V171, P1026, DOI 10.1093/infdis/171.4.1026; Frisch M, 1999, LANCET, V354, P1442, DOI 10.1016/S0140-6736(99)92824-6; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; HAGMAR B, 1992, MED ONCOL TUMOR PHAR, V9, P113; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; KIRNBAUER R, 1994, JNCI-J NATL CANCER I, V86, P494, DOI 10.1093/jnci/86.7.494; Kjellberg L, 1999, J GEN VIROL, V80, P391, DOI 10.1099/0022-1317-80-2-391; Lehtinen M, 1996, BMJ-BRIT MED J, V312, P537, DOI 10.1136/bmj.312.7030.537; Lie AK, 1999, INT J GYNECOL PATHOL, V18, P5, DOI 10.1097/00004347-199901000-00002; MADEN C, 1992, AM J EPIDEMIOL, V135, P1093, DOI 10.1093/oxfordjournals.aje.a116209; McKaig RG, 1998, HEAD NECK-J SCI SPEC, V20, P250, DOI 10.1002/(SICI)1097-0347(199805)20:3<250::AID-HED11>3.0.CO;2-O; MORK J, 1995, APMIS, V103, P375, DOI 10.1111/j.1699-0463.1995.tb01121.x; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Paz IB, 1997, CANCER-AM CANCER SOC, V79, P595, DOI 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y; PECORARO G, 1989, P NATL ACAD SCI USA, V86, P563, DOI 10.1073/pnas.86.2.563; PRESTON D. L., 1993, EPICURE USERS GUIDE; RICHMOND R, 1986, BRIT MED J, V293, P1280, DOI 10.1136/bmj.293.6557.1280; ROTHMAN K, 1972, J CHRON DIS, V25, P711, DOI 10.1016/0021-9681(72)90006-9; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Schwartz Stephen M., 1998, Journal of the National Cancer Institute (Bethesda), V90, P1626, DOI 10.1093/jnci/90.21.1626; Smith EM, 1998, LARYNGOSCOPE, V108, P1098, DOI 10.1097/00005537-199807000-00027; SNIJDERS PJF, 1992, INT J CANCER, V51, P845, DOI 10.1002/ijc.2910510602; Snijders PJF, 1996, INT J CANCER, V66, P464, DOI 10.1002/(SICI)1097-0215(19960516)66:4<464::AID-IJC9>3.0.CO;2-U; TIEBEN LM, 1993, J VIROL METHODS, V42, P265, DOI 10.1016/0166-0934(93)90038-S; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; West AB, 1996, CANCER-AM CANCER SOC, V77, P2440; World Health Organization, 1955, INT CLASS DIS	42	663	681	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1125	1131		10.1056/NEJM200104123441503	http://dx.doi.org/10.1056/NEJM200104123441503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297703				2022-12-28	WOS:000167990600003
J	Schreiber, K; Crawford, JD; Fetter, M; Tweed, D				Schreiber, K; Crawford, JD; Fetter, M; Tweed, D			The motor side of depth vision	NATURE			English	Article							LISTINGS PLANE; EYE POSITION; STEREOPSIS; ROTATION; VERGENCE; LAW; CYCLOVERGENCE; CONVERGENCE; DISPARITY	To achieve stereoscopic vision, the brain must search for corresponding image features on the two retinas(1). As long as the eyes stay still, corresponding features are confined to narrow bands called epipolar lines(2,3). But when the eyes change position, the epipolar lines migrate on the retinas(4-6). To rnd the matching features, the brain must either search different retinal bands depending on current eye position, or search retina-fixed zones that are large enough to cover all usual locations of the epipolar lines. Here we show, using a new type of stereogram in which the depth image vanishes at certain gaze elevations, that the search zones are retina-fixed. This being the case, motor control acquires a crucial function in depth vision: we show that the eyes twist about their lines of sight in a way that reduces the motion of the epipolar lines, allowing stereopsis to get by with smaller search zones and thereby lightening its computational load.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Grp Act & Percept, Toronto, ON, Canada; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada; Univ Tubingen Hosp, Dept Neurol, D-72072 Tubingen, Germany	University of Toronto; University of Toronto; Institute for Work & Health; York University - Canada; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Tweed, D (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Schreiber, Kai/A-1832-2009	Crawford, Doug/0000-0003-2288-1286				ALLEN M J, 1954, Am J Optom Arch Am Acad Optom, V31, P297; Carpenter RHS, 1988, MOVEMENTS EYES; CRONE RA, 1975, A GRAEF ARCH KLIN EX, V195, P231, DOI 10.1007/BF00414936; Farell B, 1998, NATURE, V395, P689, DOI 10.1038/27192; GARDING J, 1995, VISION RES, V35, P703, DOI 10.1016/0042-6989(94)00162-F; HEPP K, 1990, COMMUN MATH PHYS, V132, P285, DOI 10.1007/BF02278012; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hooge ITC, 2000, J NEUROPHYSIOL, V83, P2757, DOI 10.1152/jn.2000.83.5.2757; HOOTEN K, 1979, A GRAEF ARCH KLIN EX, V210, P65, DOI 10.1007/BF00414790; HOWARD IP, 1993, EXP BRAIN RES, V97, P349; JULESZ B, 1960, BELL SYST TECH J, V39, P1152; Kapoula Z, 1999, EXP BRAIN RES, V126, P175, DOI 10.1007/s002210050727; KERTESZ AE, 1978, VISION RES, V18, P567, DOI 10.1016/0042-6989(78)90204-3; MINKEN AWH, 1994, EXP BRAIN RES, V101, P331, DOI 10.1007/BF00228754; MOK D, 1992, VISION RES, V32, P2055, DOI 10.1016/0042-6989(92)90067-S; NIELSEN KRK, 1984, VISION RES, V24, P1133, DOI 10.1016/0042-6989(84)90167-6; Ogle K. N., 1950, RES BINOCULAR VISION; PRAZDNY K, 1985, B PSYCHONOMIC SOC, V23, P413; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROGERS BJ, 1996, INVEST OPHTHALMOL  S, V37, P31; Steffen H, 2000, INVEST OPHTH VIS SCI, V41, P715; Stevenson SB, 1997, VISION RES, V37, P2717, DOI 10.1016/S0042-6989(97)00097-7; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D; Tweed D, 1997, VISION RES, V37, P1939, DOI 10.1016/S0042-6989(97)00002-3; VANRIJN LJ, 1993, VISION RES, V33, P691, DOI 10.1016/0042-6989(93)90189-4; von Helmholtz H., 1967, HDB PHYSL OPTIK	26	67	71	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					819	822		10.1038/35071081	http://dx.doi.org/10.1038/35071081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298450				2022-12-28	WOS:000168021900056
J	Aspden, RM; Scheven, BAA; Hutchison, JD				Aspden, RM; Scheven, BAA; Hutchison, JD			Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism	LANCET			English	Article							TRABECULAR BONE; FEMORAL-HEAD; CHOLESTEROL; PHENOTYPE; PLATE; WOMEN; SERUM; GENE; HIP	For many years articular cartilage has been the focus of research aimed at improving understanding of and treatment for osteoarthritis. Although much Is known about the tissue, research has had little success In elucidating the pathogenesis of generalised osteoarthritis. A new hypothesis is required. Substantial changes in many tissues, including bone, muscle, ligaments, and joint capsule, as well as cartilage, are Increasingly recognised in this disease, and not all these changes are localised to the affected joints. There is also a well established link with obesity. These observations, the common origins of the mesenchymal cells that maintain these tissues, and the possible role of neuroendocrine factors that can regulate bone mass, result in the hypothesis that systemic factors that include altered lipid metabolism could explain the diversity of physiological changes in generalised osteoarthritis. If proven, this hypothesis could have important implications for a new approach to pharmacological intervention in the early stages of the disease.	Univ Aberdeen, Dept Orthopaed Surg, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Aspden, RM (corresponding author), Univ Aberdeen, Dept Orthopaed Surg, Aberdeen AB25 2ZD, Scotland.	r.aspden@abdn.ac.uk		Aspden, Richard/0000-0002-0693-1194				Anderson-MacKenzie JM, 1999, BIOCHEM BIOPH RES CO, V258, P763, DOI 10.1006/bbrc.1999.0713; Cooper C, 1996, J RHEUMATOL, V23, P1938; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; DEDRICK DK, 1993, ARTHRITIS RHEUM, V36, P1460, DOI 10.1002/art.1780361019; DEQUEKER J, 1995, J RHEUMATOL, V22, P98; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; Hurley Michael V., 1998, Current Opinion in Rheumatology, V10, P246, DOI 10.1097/00002281-199805000-00015; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Li BH, 1997, J BONE MINER RES, V12, P641, DOI 10.1359/jbmr.1997.12.4.641; Li BH, 1999, J ANAT, V195, P101, DOI 10.1046/j.1469-7580.1999.19510101.x; LIPPIELLO L, 1990, P SOC EXP BIOL MED, V195, P282, DOI 10.3181/00379727-195-43149; LIPPIELLO L, 1991, METABOLISM, V40, P571, DOI 10.1016/0026-0495(91)90046-Y; Madsen OR, 1997, CLIN RHEUMATOL, V16, P39, DOI 10.1007/BF02238761; NEVITT MC, 1995, ARTHRITIS RHEUM-US, V38, P907, DOI 10.1002/art.1780380706; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RADIN EL, 1991, SEMIN ARTHRITIS RHEU, V21, P12, DOI 10.1016/0049-0172(91)90036-Y; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Sturmer T, 1998, J RHEUMATOL, V25, P1827; Vogel G, 1999, SCIENCE, V286, P1825; Watkins BA, 1996, P SOC EXP BIOL MED, V212, P153, DOI 10.3181/00379727-212-44003	26	125	136	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1118	1120		10.1016/S0140-6736(00)04264-1	http://dx.doi.org/10.1016/S0140-6736(00)04264-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297982				2022-12-28	WOS:000167996200032
J	Rostrup, M; Ford, N				Rostrup, M; Ford, N			Aid and safety for Guinea's refugees	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5F, England	Doctors Without Borders	Rostrup, M (corresponding author), Med Sans Frontieres, 124-32 Clerkenwell Rd, London EC1R 5F, England.								0	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1123	1123		10.1016/S0140-6736(00)04266-5	http://dx.doi.org/10.1016/S0140-6736(00)04266-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297984				2022-12-28	WOS:000167996200034
J	Choi, HJ; Kim, SJ; Mukhopadhyay, P; Cho, S; Woo, JR; Storz, G; Ryu, SE				Choi, HJ; Kim, SJ; Mukhopadhyay, P; Cho, S; Woo, JR; Storz, G; Ryu, SE			Structural basis of the redox switch in the OxyR transcription factor	CELL			English	Article							CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ESCHERICHIA-COLI; REVERSIBLE INACTIVATION; SALMONELLA-TYPHIMURIUM; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; REGIONS IMPORTANT; INDUCIBLE GENES	The Escherichia coli OxyR transcription factor senses H2O2 and is activated through the formation of an intramolecular disulfide bond. Here we present the crystal structures of the regulatory domain of OxyR in its reduced and oxidized forms, determined at 2.7 Angstrom and 2.3 Angstrom resolutions, respectively. In the reduced form, the two redox-active cysteines are separated by approximately 17 Angstrom. Disulfide bond formation in the oxidized form results in a significant structural change in the regulatory domain. The structural remodeling, which leads to different oligomeric associations, accounts for the redox-dependent switch in OxyR and provides a novel example of protein regulation by "fold editing" through a reversible disulfide bond formation within a folded domain.	Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, Taejon 305600, South Korea; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ryu, SE (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, POB 115, Taejon 305600, South Korea.		MUKHOPADHYAY, PARTHA/G-3890-2010	MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P32; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lin K, 1996, SCIENCE, V273, P1539, DOI 10.1126/science.273.5281.1539; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Muse WB, 1999, J BACTERIOL, V181, P934, DOI 10.1128/JB.181.3.934-940.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; TAO K, 1993, MOL MICROBIOL, V7, P859, DOI 10.1111/j.1365-2958.1993.tb01176.x; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P2038; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tyrrell R, 1997, STRUCTURE, V5, P1017, DOI 10.1016/S0969-2126(97)00254-2; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; [No title captured]	39	409	422	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					103	113		10.1016/S0092-8674(01)00300-2	http://dx.doi.org/10.1016/S0092-8674(01)00300-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301006	Bronze			2022-12-28	WOS:000168063300011
J	Mason, AC; Oshinsky, ML; Hoy, RR				Mason, AC; Oshinsky, ML; Hoy, RR			Hyperacute directional hearing in a microscale auditory system	NATURE			English	Article							FLY ORMIA-OCHRACEA; PARASITOID FLY; TEMPORAL HYPERACUITY; ELECTRIC FISH; TACHINIDAE; NEURONS; DIPTERA	The physics of sound propagation imposes fundamental constraints on sound localization: for a given frequency, the smaller the receiver, the smaller the available cues(1). Thus, the creation of nanoscale acoustic microphones with directional sensitivity is very difficult. The fly Ormia ochracea possesses an unusual 'ear' that largely overcomes these physical constraints(2-5); attempts to exploit principles derived from O. ochracea for improved hearing aids are now in progress(6). Here we report that O. ochracea can behaviourally localize a salient sound source with a precision equal to that of humans(7). Despite its small size and minuscule interaural cues, the fly localizes sound sources to within 2 degrees azimuth. As the fly's eardrums are less than 0.5 mm apart, localization cues are around 50 ns. Directional information is represented in the auditory system by the relative timing of receptor responses in the two ears. Low-jitter, phasic receptor responses are pooled to achieve hyperacute timecoding(8,9). These results demonstrate that nanoscale/microscale directional microphones patterned after O. ochracea have the potential for highly accurate directional sensitivity, independent of their size. Notably, in the fly itself this performance is dependent on a newly discovered set of specific coding strategies employed by the nervous system.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Mason, AC (corresponding author), Univ Toronto, Div Life Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.			Mason, Andrew/0000-0001-7719-8500; Oshinsky, Michael/0000-0002-0976-1047				Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Batschelet E., 1981, CIRCULAR STAT BIOL; Cade WH, 1996, CAN J ZOOL, V74, P393, DOI 10.1139/z96-046; CARR CE, 1986, J NEUROSCI, V6, P107; Fay R. R., 1988, HEARING VERTEBRATES; GIBBONS C, 2000, P IMECE ASME ORL FLO, P5; KAWASAKI M, 1988, NATURE, V336, P173, DOI 10.1038/336173a0; Marsalek PR, 1997, P NATL ACAD SCI USA, V94, P735, DOI 10.1073/pnas.94.2.735; MICHELSEN A, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P61; Miles RN, 1995, J ACOUST SOC AM, V98, P3059, DOI 10.1121/1.413830; RAMSAUER N, 1999, THESIS U ZURICH; Rieke F, 1997, SPIKES; Robert D, 2000, CELL TISSUE RES, V301, P447, DOI 10.1007/s004410000257; Robert D, 1996, CELL TISSUE RES, V284, P435, DOI 10.1007/s004410050604; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Robert D, 1998, J COMP PHYSIOL A, V183, P443, DOI 10.1007/s003590050270; ROSE G, 1985, NATURE, V318, P178, DOI 10.1038/318178a0; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119	18	154	161	1	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					686	690		10.1038/35070564	http://dx.doi.org/10.1038/35070564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287954				2022-12-28	WOS:000167875400046
J	Nikkels, AF; Pierard, GE				Nikkels, AF; Pierard, GE			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Liege, B-4000 Liege, Belgium	University of Liege	Nikkels, AF (corresponding author), Univ Liege, B-4000 Liege, Belgium.			Nikkels, Arjen/0000-0001-5240-4806					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1057	1057		10.1056/NEJM200104053441405	http://dx.doi.org/10.1056/NEJM200104053441405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287976	Bronze			2022-12-28	WOS:000167860400005
J	Hug, HJ; Lantz, MA; Abdurixit, A; van Schendel, PJA; Hoffmann, R; Kappenberger, P; Baratoff, A				Hug, H. J.; Lantz, M. A.; Abdurixit, A.; van Schendel, P. J. A.; Hoffmann, R.; Kappenberger, P.; Baratoff, A.			Subatomic Features in Atomic Force Microscopy Images	SCIENCE			English	Editorial Material									[Hug, H. J.; Lantz, M. A.; Abdurixit, A.; van Schendel, P. J. A.; Hoffmann, R.; Kappenberger, P.; Baratoff, A.] Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland	University of Basel	Hug, HJ (corresponding author), Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	hans-josef.hug@unibas.ch	Hoffmann-Vogel, Regina C/A-6385-2008	Hoffmann-Vogel, Regina/0000-0002-5771-7956				Abdurixit A, 2000, APPL SURF SCI, V157, P355, DOI 10.1016/S0169-4332(99)00566-8; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; We thank F, GIESSIBL SUPPLYING U	3	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2509	2509		10.1126/science.291.5513.2509a	http://dx.doi.org/10.1126/science.291.5513.2509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VK1VG	11283360				2022-12-28	WOS:000662209200001
J	Jaenisch, R; Wilmut, I				Jaenisch, R; Wilmut, I			Developmental biology - Don't clone humans!	SCIENCE			English	Editorial Material							NUCLEAR TRANSFER; SOMATIC-CELLS; ADULT; FETAL		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.							Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Daniels R, 2000, BIOL REPROD, V63, P1034, DOI 10.1095/biolreprod63.4.1034; De Sousa P A, 1999, Cloning, V1, P63, DOI 10.1089/15204559950020102; JANEISCH R, UNPUB; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; *NBAC, 1997, CLON HUM BEINGS, pR2; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; STERN A, 2001, BOSTON GLOBE    0127, pA7; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	14	82	83	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2552	2552		10.1126/science.1060463	http://dx.doi.org/10.1126/science.1060463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286275				2022-12-28	WOS:000167861000023
J	Margoliash, D				Margoliash, D			Neuroscience - The sone does not remain the same	SCIENCE			English	Editorial Material							ZEBRA FINCHES; PHONOLOGY		Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.							CLARK CW, 1987, ETHOLOGY, V76, P101; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; Konishi M., 1978, PERCEPTION EXPERIENC, P105; MARGOLIASH D, 1994, BEHAVIOUR, V131, P39, DOI 10.1163/156853994X00208; Marler P, 1997, J NEUROBIOL, V33, P501; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; VU ET, 1994, J NEUROSCI, V14, P6924; WILLIAMS H, 1993, J NEUROBIOL, V24, P903, DOI 10.1002/neu.480240704; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	12	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2559	2561		10.1126/science.1060338	http://dx.doi.org/10.1126/science.1060338			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286279				2022-12-28	WOS:000167861000028
J	Pellman, D				Pellman, D			Cancer - A CINtillating new job for the APC tumor suppressor	SCIENCE			English	Editorial Material							PROTEIN		Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu						Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; MIRNORIKIYOSUE Y, 2000, CURR BIOL, V10, P865; MIRNORIKIYOSUE Y, 2000, J CELL BIOL, V148, P505; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Schuyler SC, 2001, J CELL SCI, V114, P247; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309	16	20	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2555	2556		10.1126/science.1057337	http://dx.doi.org/10.1126/science.1057337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286276				2022-12-28	WOS:000167861000025
J	Rowe, T; Ketcham, RA; Denison, C; Colbert, M; Xu, X; Currie, PJ				Rowe, T; Ketcham, RA; Denison, C; Colbert, M; Xu, X; Currie, PJ			Forensic palaeontology - The Archaeoraptor forgery	NATURE			English	Article									Univ Texas, Dept Geol Sci, High Resolut Xray Comp Tomog Facil, Austin, TX 78712 USA; Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Royal Tyrrel Museum Paleontol, Drumheller, AB T0J 0Y0, Canada	University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Rowe, T (corresponding author), Univ Texas, Dept Geol Sci, High Resolut Xray Comp Tomog Facil, C1100, Austin, TX 78712 USA.	rowe@mail.utexas.edu	Currie, Philip J/A-2628-2014; Ketcham, Richard/B-5431-2011	Currie, Philip J/0000-0001-6857-3161; Ketcham, Richard/0000-0002-2748-0409				Dalton R, 2000, NATURE, V404, P696, DOI 10.1038/35008237; Dalton R, 2000, NATURE, V403, P689, DOI 10.1038/35001723; Dingus L., 1997, MISTAKEN EXTINCTION; Holden C, 2000, SCIENCE, V288, P238; JAHN ME, 1963, LYING STONES JBA BER; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Rowe T, 1997, GEOTIMES, V42, P23; Sloan C.P., 1999, NATL GEOGR, V196, P98; Weiner J. S., 1955, THE PILTDOWN FORGERY; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	11	34	36	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					539	540		10.1038/35069145	http://dx.doi.org/10.1038/35069145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279483				2022-12-28	WOS:000167859300035
J	Steiner, G; Hamsten, A; Hosking, J; Stewart, D; McLaughlin, P; Gladstone, P; Sole, M; Syvanne, M; Hamsten, A; Camelon, K; Schloegl, G; Genest, J; Reeves, F; Savard, R; Letarte, A; Bellavance, N; Touchette, J; Latour, Y; Marchand, P; Rondeau, C; Rivard-Gervais, N; Belanger, A; Hamel, D; Dumas, R; Sandri, M; Morin, N; Caponi, E; Barbeau, C; Gauthier, S; Ooi, TC; Davies, RF; Braaten, JT; Baker, A; Favreau, C; Collar, C; Zinman, B; Gladstone, P; Aldridge, H; Donat, DJ; Tsui, E; Barnie, A; DiMonte, L; MacLean, S; Bond, M; Camelon, K; Martin, C; Zawacki, R; Dziuran, K; Gouveia, MR; Taskinen, MR; Nieminen, M; Nikkila, K; Virtanen, K; Makimattila, S; Malmstrom, R; Kohtamaki, H; Jamsen, P; Salo, A; Puupponen, M; Kesaniemi, A; Ikaheimo, M; Ukkola, O; Salmela, P; Savolainen, M; Huikuri, H; Airaksinen, J; Koistinen, J; Mannermaa, L; Ukkola, L; Ketonen, K; Silaste, ML; Salovaara, A; Efendic, S; Svane, B; Hellekant, C; Bavenholm, P; Karlen, A; Hadell, K; Hamsten, A; Franson, K; Mohlkert, D; Nordlander, R; Ehrenstig, L; Tan, MH; Title, LM; Johnstone, D; Winch, S; Higgins-Bowser, I; Shlossberg, A; Murdock, H; Elliott, T; Fung, A; Jalbert, A; Leung, S; Turnbull, S; Norman, E; Valensi, P; Farez, C; Tavolaro, O; Sachs, RN; Sedjari, F; Laakso, M; Kettunen, R; Eranen, J; Lehto, S; Raisanen, R; Jantunen, A; Valve, R; Toivanen, A; Frohlich, J; Vannetta, H; Bowden, F; Seccombe, DW; Ehnholm, C; Gref, CG; Ikonen, M; Sundvall, J; Seccombe, DW; McGuinness, C; Ho, A; Hamilton, J; Pritchard, H; McLaughlin, P; Gladstone, P; Allard, N; Bond, M; Bui, S; Van der Wal, H; Hosking, J; Davis, CE; Tyroler, HA; Stewart, D; Curtis, RC; Miles, M; Khaltaev, N; Sole, M; Kirkeeide, R; Frick, H; Hata, Y; Rifkind, B; Zimmet, P; Gent, M; Schonfeld, G; de Bono, D; Reeves, F; Carter, A; Ansquer, JC; Fraitag, B; Guivarc'h, PH; Irvine, A; Jacovella, J; Munoz, A; Rode, H; Yacine, A; Asmar-Kristiansen, D; Bonnefous, F; Belanger, F; Bond, M; Brown, M; DeLorme, L; Galos, C; Jenkins, R; Lanoue, C; Moussalli, R; Murtomaki, E; Zandomenighi, F				Steiner, G; Hamsten, A; Hosking, J; Stewart, D; McLaughlin, P; Gladstone, P; Sole, M; Syvanne, M; Hamsten, A; Camelon, K; Schloegl, G; Genest, J; Reeves, F; Savard, R; Letarte, A; Bellavance, N; Touchette, J; Latour, Y; Marchand, P; Rondeau, C; Rivard-Gervais, N; Belanger, A; Hamel, D; Dumas, R; Sandri, M; Morin, N; Caponi, E; Barbeau, C; Gauthier, S; Ooi, TC; Davies, RF; Braaten, JT; Baker, A; Favreau, C; Collar, C; Zinman, B; Gladstone, P; Aldridge, H; Donat, DJ; Tsui, E; Barnie, A; DiMonte, L; MacLean, S; Bond, M; Camelon, K; Martin, C; Zawacki, R; Dziuran, K; Gouveia, MR; Taskinen, MR; Nieminen, M; Nikkila, K; Virtanen, K; Makimattila, S; Malmstrom, R; Kohtamaki, H; Jamsen, P; Salo, A; Puupponen, M; Kesaniemi, A; Ikaheimo, M; Ukkola, O; Salmela, P; Savolainen, M; Huikuri, H; Airaksinen, J; Koistinen, J; Mannermaa, L; Ukkola, L; Ketonen, K; Silaste, ML; Salovaara, A; Efendic, S; Svane, B; Hellekant, C; Bavenholm, P; Karlen, A; Hadell, K; Hamsten, A; Franson, K; Mohlkert, D; Nordlander, R; Ehrenstig, L; Tan, MH; Title, LM; Johnstone, D; Winch, S; Higgins-Bowser, I; Shlossberg, A; Murdock, H; Elliott, T; Fung, A; Jalbert, A; Leung, S; Turnbull, S; Norman, E; Valensi, P; Farez, C; Tavolaro, O; Sachs, RN; Sedjari, F; Laakso, M; Kettunen, R; Eranen, J; Lehto, S; Raisanen, R; Jantunen, A; Valve, R; Toivanen, A; Frohlich, J; Vannetta, H; Bowden, F; Seccombe, DW; Ehnholm, C; Gref, CG; Ikonen, M; Sundvall, J; Seccombe, DW; McGuinness, C; Ho, A; Hamilton, J; Pritchard, H; McLaughlin, P; Gladstone, P; Allard, N; Bond, M; Bui, S; Van der Wal, H; Hosking, J; Davis, CE; Tyroler, HA; Stewart, D; Curtis, RC; Miles, M; Khaltaev, N; Sole, M; Kirkeeide, R; Frick, H; Hata, Y; Rifkind, B; Zimmet, P; Gent, M; Schonfeld, G; de Bono, D; Reeves, F; Carter, A; Ansquer, JC; Fraitag, B; Guivarc'h, PH; Irvine, A; Jacovella, J; Munoz, A; Rode, H; Yacine, A; Asmar-Kristiansen, D; Bonnefous, F; Belanger, F; Bond, M; Brown, M; DeLorme, L; Galos, C; Jenkins, R; Lanoue, C; Moussalli, R; Murtomaki, E; Zandomenighi, F		Diabet Atherosclerosis Interventio	Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; MYOCARDIAL-INFARCTION; ASYMPTOMATIC HYPERGLYCEMIA; LOWERING THERAPY; MORTALITY; MELLITUS; MEN; TRIAL; DAIS	Background Atherosclerosis is the most common complication of diabetes. Correction of hyperglycaemia helps to prevent microvascular complications but has little effect on macrovascular disease. Post-hoc analyses of diabetic subpopulations in lipid intervention trials suggest that correction of lipoprotein abnormalities will lead to a decrease in coronary-artery disease. The Diabetes Atherosclerosis Intervention Study (DAIS) was specifically designed to assess the effects of correcting lipoprotein abnormalities on coronary atherosclerosis in type 2 diabetes. Methods 731 men and women with type 2 diabetes were screened by metabolic and angiographic criteria. 418 were randomly assigned micronised fenofibrate (200 mg/day) or placebo for at least 3 years. They were in good glycaemic control (mean haemoglobin A(10) 7.5%), had mild lipoprotein abnormalities, typical of type 2 diabetes, and at least one visible coronary lesion. Half had no previous clinical coronary disease. Initial and final angiograms followed a standard protocol and were analysed by a computer-assisted quantitative approach. Missing data for the primary endpoints (minimum lumen diameter, mean segment diameter, and mean percentage stenosis) were imputed. Analyses were by intention to treat. Findings Total plasma cholesterol, HDL-cholesterol. LDL-cholesterol, and triglyceride concentrations all changed significantly more from baseline in the fenofibrate group (n=207) than in the placebo group (n=211). The fenofibrate group showed a significantly smaller increase in percentage diameter stenosis than the placebo group (mean 2.11 [SE 0.594] vs 3.65 [0.608]%, p=0.02), a significantly smaller decrease in minimum lumen diameter (-0.06 [0.016] vs -0.10 [0.016] mm, p=0.029), and a non-significantly smaller decrease in mean segment diameter (-0.06 [0.017] vs -0.08 [0.018] mm, p=0.171). The trial was not powered to examine clinical endpoints, but there were fewer in the fenofibrate group than the placebo group (38 vs 50). Interpretation DAIS suggests that treatment with fenofibrate reduces the angiographic progression of coronary-artery disease in type 2 diabetes. This effect is related, at least partly, to the correction of lipoprotein abnormalities, even those previously judged not to need treatment.	Toronto Gen Hosp, Univ Hlth Network, DAIS Project Off, Toronto, ON M5G 2C4, Canada; St Pauls Hosp, Biochem Labs, Vancouver, BC V6Z 1Y6, Canada; Canadian Reference Lab, Vancouver, BC, Canada; Core Angiog Lab, Toronto, ON, Canada; Stat Coordinating Ctr, Chapel Hill, NC USA; WHO, CH-1211 Geneva, Switzerland; Labs Fournier, Daix, France	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; St. Paul's Hospital; University of Saskatchewan; World Health Organization	Steiner, G (corresponding author), Toronto Gen Hosp, Univ Hlth Network, DAIS Project Off, Room NUW 9-107,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.		Ansquer, JeanClaude/A-1308-2011; Zimmet, Paul/O-8486-2019; Zinman, Bernard/E-7266-2013; Jantunen, Ari/D-2658-2009; Airaksinen, Juhani/AAC-7857-2021; Taskinen, Marja-Riitta/AAN-5432-2020	Zimmet, Paul/0000-0003-0627-0776; Jantunen, Ari/0000-0002-0761-6882; Airaksinen, Juhani/0000-0002-0193-568X; Taskinen, Marja-Riitta/0000-0002-6229-3588				ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Archbold RA, 1999, CURR OPIN LIPIDOL, V10, P527, DOI 10.1097/00041433-199912000-00008; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; ERICSSON CG, 1996, LANCET, V344, P1383; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULLER JH, 1979, J CHRON DIS, V32, P721, DOI 10.1016/0021-9681(79)90051-1; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Haffner SM, 1998, ENDOCR REV, V19, P583, DOI 10.1210/er.19.5.583; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Laakso M, 1996, ANN INTERN MED, V124, P127, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00009; LEHTO S, 1994, J INTERN MED, V236, P291, DOI 10.1111/j.1365-2796.1994.tb00799.x; Manley SE, 1997, DIABETES CARE, V20, P1683; McGuinness C, 2000, CLIN BIOCHEM, V33, P15, DOI 10.1016/S0009-9120(99)00081-8; McLaughlin PR, 1998, CATHETER CARDIO DIAG, V44, P249, DOI 10.1002/(SICI)1097-0304(199807)44:3<249::AID-CCD1>3.0.CO;2-5; MYKKANEN L, 1992, DIABETES CARE, V15, P1020, DOI 10.2337/diacare.15.8.1020; Pajunen P, 1997, AM J CARDIOL, V80, P550, DOI 10.1016/S0002-9149(97)00420-7; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STAMLER R, 1979, J CHRON DIS, V32, P683, DOI 10.1016/0021-9681(79)90047-X; STEINER G, 1985, ADV EXP MED BIOL, V189, P277; Steiner G, 1996, DIABETOLOGIA, V39, P1655, DOI 10.1007/s001250050630; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vokonas PS, 1996, CLIN GERIATR MED, V12, P69, DOI 10.1016/S0749-0690(18)30245-3; Waters David, 1996, Cardiology Clinics, V14, P31; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; ZUANETTI G, 1993, J AM COLL CARDIOL, V22, P1788, DOI 10.1016/0735-1097(93)90758-S	30	635	649	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					905	910						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289345				2022-12-28	WOS:000167625300007
J	Kawakami, Y; Capdevila, J; Buscher, D; Itoh, T; Esteban, CR; Belmonte, JCI				Kawakami, Y; Capdevila, J; Buscher, D; Itoh, T; Esteban, CR; Belmonte, JCI			WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo	CELL			English	Article							FIBROBLAST GROWTH-FACTORS; APICAL ECTODERMAL RIDGE; PATTERN-FORMATION; VERTEBRATE LIMB; ADDITIONAL LIMB; EXPRESSION; BUD; GENE; OUTGROWTH; INVOLVEMENT	A regulatory loop between the fibroblast growth factors FGF-8 and FGF-10 plays a key role in limb initiation and AER induction in vertebrate embryos. Here, we show that three WNT factors signaling through beta -catenin act as key regulators of the FGF-8/FGF-10 loop. The Wnt-2b gene is expressed in the intermediate mesoderm and the lateral plate mesoderm in the presumptive chick forelimb region. Cells expressing Wnt-2b are able to induce Fgf-10 and generate an extra limb when implanted into the flank. In the presumptive hindlimb region, another Wnt gene, Wnt-8c, controls Fgf-10 expression, and is also capable of inducing ectopic limb formation in the flank. Finally, we also show that the induction of Fgf-8 in the limb ectoderm by FGF-10 is mediated by the induction of Wnt-3a. Thus, three WNT signals mediated by beta -catenin control both limb initiation and AER induction in the vertebrate embryo.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Itoh, Tohru/GYQ-8698-2022	Itoh, Tohru/0000-0002-6579-1638				Altabef M, 1997, DEVELOPMENT, V124, P4547; BALINSKY BI, 1965, INTRO EMBRYOLOGY, P405; Capdevila J, 1998, DEV BIOL, V193, P182, DOI 10.1006/dbio.1997.8806; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Esteve P, 2000, MECH DEVELOP, V97, P217, DOI 10.1016/S0925-4773(00)00421-4; FernandezTeran M, 1997, DEV BIOL, V189, P246, DOI 10.1006/dbio.1997.8680; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; GEDUSPAN JS, 1992, DEV BIOL, V151, P212; Grieshammer U, 1996, DEVELOPMENT, V122, P3851; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HUME CR, 1993, DEVELOPMENT, V119, P1147; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Katoh M, 1996, ONCOGENE, V13, P873; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; KIENY M, 1969, CR ACAD SCI D NAT, V268, P3183; Kimmel RA, 2000, GENE DEV, V14, P1377; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Ohuchi H, 1999, CELL TISSUE RES, V296, P45, DOI 10.1007/s004410051265; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1995, BIOCHEM BIOPH RES CO, V209, P809, DOI 10.1006/bbrc.1995.1572; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PINOT M, 1970, Journal of Embryology and Experimental Morphology, V23, P109; Ros MA, 1996, DEVELOPMENT, V122, P2319; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; SHIMIZU H, 1997, CELL GROWTH DIFFER, V8, P349; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STEPHENS TD, 1993, PROG CLIN BIOL RES, V383, P317; STEPHENS TD, 1989, DEV BIOL, V133, P1, DOI 10.1016/0012-1606(89)90290-X; Szebenyi G, 1999, INT REV CYTOL, V185, P45; TANDA N, 1995, DNA SEQUENCE, V5, P277, DOI 10.3109/10425179509030981; Tickle C, 1999, SEMIN CELL DEV BIOL, V10, P345, DOI 10.1006/scdb.1999.0294; Vogel A, 1996, DEVELOPMENT, V122, P1737; WILKINSON DG, 1993, IN SITU HYBRIDIZATIO; Zakin LDJ, 1998, MECH DEVELOP, V73, P107, DOI 10.1016/S0925-4773(98)00040-9	45	265	276	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					891	900		10.1016/S0092-8674(01)00285-9	http://dx.doi.org/10.1016/S0092-8674(01)00285-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290326	Bronze			2022-12-28	WOS:000167869200011
J	Pershagen, G				Pershagen, G			Environmental public-health surveillance systems for chemical incidents	LANCET			English	Editorial Material							EXPOSURE		Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden	Karolinska Institutet	Pershagen, G (corresponding author), Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden.			Pershagen, Goran/0000-0002-9701-1130				BERGLUND M, 1994, ARCH ENVIRON HEALTH, V49, P17, DOI 10.1080/00039896.1994.9934410; BERGLUND M, 1993, SCAND J WORK ENV S2, V19; Bowen HJ, 2000, J EPIDEMIOL COMMUN H, V54, P870, DOI 10.1136/jech.54.11.870; DEMARCHI B, 1991, RISK ANAL, V11, P207; EDLING A, 1998, HALLANDSASEN REPORT; KarlsonStiber C, 1996, J INTERN MED, V239, P451, DOI 10.1046/j.1365-2796.1996.484820000.x; Rosenlund M, 1999, ARCH ENVIRON HEALTH, V54, P52, DOI 10.1080/00039899909602237; ZAIDI SH, 1986, AM J IND MED, V9, P215	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					411	412		10.1016/S0140-6736(00)04025-3	http://dx.doi.org/10.1016/S0140-6736(00)04025-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273057				2022-12-28	WOS:000166865600006
J	Pfeiffer, T; Schuster, S; Bonhoeffer, S				Pfeiffer, T; Schuster, S; Bonhoeffer, S			Cooperation and competition in the evolution of ATP-producing pathways	SCIENCE			English	Article							MECHANISTIC STOICHIOMETRY; DIMORPHISM; METABOLISM; GLUCOSE; EFFICIENCY; GROWTH; ORIGIN	Heterotrophic organisms generally face a trade-off between rate and yield of adenosine triphosphate (ATP) production. This trade-off may result in an evolutionary dilemma, because cells with a higher rate but lower yield of ATP production may gain a selective advantage when competing for shared energy resources. Using an analysis of model simulations and biochemical observations, we show that ATP production with a low rate and high yield can be viewed as a form of cooperative resource use and may evolve in spatially structured environments. Furthermore, we argue that the high ATP yield of respiration may have facilitated the evolutionary transition from unicellular to undifferentiated multicellular organisms.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Friedrich Miescher Institute for Biomedical Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bonhoeffer, S (corresponding author), Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.	bonhoeffer@eco.umnw.ethz.ch	Pfeiffer, Thomas/R-1339-2019; Bonhoeffer, Sebastian/A-2735-2008	Pfeiffer, Thomas/0000-0002-0592-577X; Bonhoeffer, Sebastian/0000-0001-8052-3925				ANGULOBROWN F, 1995, NUOVO CIMENTO D, V17, P87, DOI 10.1007/BF02451604; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; BEAVIS AD, 1986, EUR J BIOCHEM, V158, P315, DOI 10.1111/j.1432-1033.1986.tb09753.x; Bonner John Tyler, 1998, Integrative Biology, V1, P27; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DICKERSON RE, 1980, SCI AM, V242, P137; Fiechter A, 1989, Adv Biochem Eng Biotechnol, V39, P1; FITTON V, 1994, BIOCHEMISTRY-US, V33, P9692, DOI 10.1021/bi00198a039; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heinrich R., 1996, REGULATION CELLULAR; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; INDERLIED CB, 1978, J BACTERIOL, V133, P1282, DOI 10.1128/JB.133.3.1282-1286.1978; Lee CP, 1996, FASEB J, V10, P345, DOI 10.1096/fasebj.10.2.8641569; MAC ARTHUR ROBERT H., 1967; Margulis L., 1993, SYMBIOSIS CELL EVOLU; NEIJSSEL OM, 1994, MOL MICROBIOL, V13, P179, DOI 10.1111/j.1365-2958.1994.tb00413.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; ROFF D, 1992, EVOLUTION LIF HIST; ROGERS PJ, 1974, J BACTERIOL, V119, P282, DOI 10.1128/JB.119.1.282-293.1974; SCHULZ BE, 1974, J GEN MICROBIOL, V82, P1; Stearns S.C., 1992, pi; STUCKI JW, 1980, EUR J BIOCHEM, V109, P269, DOI 10.1111/j.1432-1033.1980.tb04792.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; Vetterling V., 1992, NUMERICAL RECIPES, V693, P59; Voet D., 1995, BIOCHEMISTRY; Waddell TG, 1999, BIOCHEM EDUC, V27, P12, DOI 10.1016/S0307-4412(98)00266-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	34	853	872	1	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					504	507		10.1126/science.1058079	http://dx.doi.org/10.1126/science.1058079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11283355				2022-12-28	WOS:000168187300047
J	Rebello, G; Hallam, N; Smart, G; Farquharson, D; McCafferty, J				Rebello, G; Hallam, N; Smart, G; Farquharson, D; McCafferty, J			Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study	BRITISH MEDICAL JOURNAL			English	Article							NEOPLASIA		Lothian Univ Hosp NHS Trust, Reg Clin Virol Lab, City Hosp, Edinburgh EH10 5SB, Midlothian, Scotland; Lothian Univ Hosp NHS Trust, Royal Infirm Edinburgh, Colposcopy Clin, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Hallam, N (corresponding author), Lothian Univ Hosp NHS Trust, Reg Clin Virol Lab, City Hosp, Edinburgh EH10 5SB, Midlothian, Scotland.							Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1999, HLTH TECHNOL ASSESS, V3; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605	5	30	31	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					893	894		10.1136/bmj.322.7291.893	http://dx.doi.org/10.1136/bmj.322.7291.893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302900	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000168311300018
J	LaDeau, SL; Clark, JS				LaDeau, SL; Clark, JS			Rising CO2 levels and the fecundity of forest trees	SCIENCE			English	Article							ELEVATED ATMOSPHERIC CO2; RECRUITMENT LIMITATION; PINUS-TAEDA; GROWTH; PHOTOSYNTHESIS; PLANTS; REPRODUCTION; ENRICHMENT; RESPONSES; FIELD	We determined the reproductive response of 19-year-old loblolly pine (Pinus taeda) to 4 years of carbon dioxide (CO2) enrichment (ambient concentration plus 200 microliters per liter) in an intact forest. After 3 years of CO2 fumigation, trees were twice as likely to be reproductively mature and produced three times as many cones and seeds as trees at ambient CO2 concentration. A disproportionate carbon allocation to reproduction under CO2 enrichment results in trees reaching maturity sooner and at a smaller size. This reproductive response to future increases in atmospheric CO2 concentration is expected to change Loblolly dispersal and recruitment patterns.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Univ Program Ecol, Durham, NC 27708 USA	Duke University; Duke University	LaDeau, SL (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.			LaDeau, Shannon/0000-0003-4825-5435				CEULEMANS R, 1994, NEW PHYTOL, V127, P425, DOI 10.1111/j.1469-8137.1994.tb03961.x; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; CLARK JS, 1995, AM NAT, V146, P72, DOI 10.1086/285788; CONNER KF, 1998, PRODUCTIVITY SUSTAIN, V128, P103; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; FARNSWORTH EJ, 1995, OECOLOGIA, V104, P454, DOI 10.1007/BF00341343; Fischer M, 1997, J ECOL, V85, P681, DOI 10.2307/2960538; Fiscus EL, 1997, J EXP BOT, V48, P307, DOI 10.1093/jxb/48.2.307; GARBUTT K, 1984, NEW PHYTOL, V98, P433, DOI 10.1111/j.1469-8137.1984.tb04136.x; Grunzweig JM, 2000, GLOB CHANGE BIOL, V6, P631, DOI 10.1046/j.1365-2486.2000.00346.x; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; IDSO SB, 1992, AGR FOREST METEOROL, V60, P145, DOI 10.1016/0168-1923(92)90080-N; LAWLOR W, 1991, IMPACT GLOBAL CLIMAT, P431; Lee HSJ, 1995, J BIOGEOGR, V22, P323, DOI 10.2307/2845927; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lovelock CE, 1999, PLANT CELL ENVIRON, V22, P49, DOI 10.1046/j.1365-3040.1999.00370.x; Naumburg E, 2000, OECOLOGIA, V122, P163, DOI 10.1007/PL00008844; Reid CD, 1998, J EXP BOT, V49, P885, DOI 10.1093/jexbot/49.322.885; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Schappi B, 1996, OECOLOGIA, V106, P93, DOI 10.1007/BF00334411; SCHULTZ RP, 1997, LOBLOLLY PINE; SHMIDA A, 1984, VEGETATIO, V58, P29; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Tissue DT, 1996, TREE PHYSIOL, V16, P49; Tissue DT, 1997, PLANT CELL ENVIRON, V20, P1123, DOI 10.1046/j.1365-3040.1997.d01-140.x; Ward JK, 1997, PLANT CELL ENVIRON, V20, P254, DOI 10.1046/j.1365-3040.1997.d01-59.x; Zamski E., 1995, SEED DEV GERMINATION, P25	31	140	153	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					95	98		10.1126/science.1057547	http://dx.doi.org/10.1126/science.1057547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292871				2022-12-28	WOS:000167995200045
J	Keefe, AD; Szostak, JW				Keefe, AD; Szostak, JW			Functional proteins from a random-sequence library	NATURE			English	Article							IN-VITRO SELECTION; RNA; BINDING; FUSIONS	Functional primordial proteins presumably originated from random sequences, but it is not known how frequently functional, or even folded, proteins occur in collections of random sequences. Here we have used in vitro selection of messenger RNA displayed proteins, in which each protein is covalently linked through its carboxy terminus to the 3' end of its encoding mRNA(1), to sample a large number of distinct random sequences. Starting from a library of 6 x 10(12) proteins each containing 80 contiguous random amino acids, we selected functional proteins by enriching for those that bind to ATP. This selection yielded four new ATP-binding proteins that appear to be unrelated to each other or to anything found in the current databases of biological proteins. The frequency of occurrence of functional proteins in random-sequence libraries appears to be similar to that observed for equivalent RNA libraries(2,3).	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu	lu, zhenghui/N-2903-2014		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cho G, 2000, J MOL BIOL, V297, P309, DOI 10.1006/jmbi.2000.3571; CONSIDINE DM, 1989, VANNOSTRANDS SCI ENC, P3067; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Keefe A. D., 2001, CURRENT PROTOCOLS MO; Liu RH, 2000, METHOD ENZYMOL, V318, P268; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; WANG Y, 1993, J BIOL CHEM, V268, P13947; WILSON D, 2000, CURRENT PROTOCOLS MO; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WILSON DS, IN PRESS P NATL ACAD	15	395	458	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					715	718		10.1038/35070613	http://dx.doi.org/10.1038/35070613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287961	Green Accepted			2022-12-28	WOS:000167875400053
J	Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BHC				Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BHC			Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine	ANNALS OF INTERNAL MEDICINE			English	Article								Background: outcomes may differ in treated and untreated patients because of a contraindication for treatment in the latter that is independently associated with the outcome of interest. Objective: To evaluate the effects of confounding by contraindication on risk factors for death in patients taking ibopamine after its use was restricted in early September 1995. Design: Retrospective cohort study, Setting: The Netherlands, Patients: 1146 patients with congestive heart failure who were prescribed ibopamine at least once and for whom medication history and medical data were available, Measurements: Cardiovascular risk factors, clinical characteristics, and medication use. Each patient was assigned an index date (the date of death, or a random date for patients still alive at the end of the study). Results: In univariate analyses comparing patients with an index date before and those with an index date after 8 September 1995, the relative risk for death associated with current use of ibopamine was 3.02 (95% CI, 2.12 to 4.30) compared with 0.71 (CI, 0.53 to 0.96), respectively. In multivariate analyses, the risk for death was 2.62 (CI, 1.76 to 3.90) and 0.93 (CI, 0.84 to 1.02), respectively. Conclusion: The marked inversion of the relative risk estimate can be considered a practical example of confounding by contraindication.	Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Inspectorate Hlth Care, Rijswijk, Netherlands; Univ Utrecht, Sch Med, Julius Ctr Patient Oriented Res, Utrecht, Netherlands	Erasmus University Rotterdam; Utrecht University	Stricker, BHC (corresponding author), Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, Box 1738, NL-3000 DR Rotterdam, Netherlands.							DATTA M, 1993, LANCET, V342, P345, DOI 10.1016/0140-6736(93)91478-5; Feenstra J, 1998, BRIT J CLIN PHARMACO, V46, P71, DOI 10.1046/j.1365-2125.1998.00046.x; Grobbee DE, 1997, BRIT MED J, V315, P1151; Hampton JR, 1997, LANCET, V349, P971, DOI 10.1016/S0140-6736(96)10488-8; Sjahid SI, 1998, BRIT J CLIN PHARMACO, V45, P591, DOI 10.1046/j.1365-2125.1998.00716.x; Walker AM, 1996, LANCET, V348, P489, DOI 10.1016/S0140-6736(05)64664-8; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8; 1995, NED TIJDSCHR GENEESK, V139, P2059	8	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					569	572		10.7326/0003-4819-134-7-200104030-00010	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281739				2022-12-28	WOS:000167931200004
J	Lawlor, DA; Hopker, SW				Lawlor, DA; Hopker, SW			The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							AEROBIC EXERCISE; MENTAL-HEALTH; PHYSICAL-ACTIVITY; MAJOR DEPRESSION; OLDER ADULTS; CLINICAL DEPRESSION; GENERAL-PRACTICE; MOOD STATES; SYMPTOMS; METAANALYSIS	Objective To determine the effectiveness of exercise as an intervention in the management of depression. Design Systematic review and meta-regression analysis of randomised controlled trials obtained from five electronic databases (Medline, Embase, Sports Discus, PsycLIT, Cochrane Library) and through contact with experts in the field, bibliographic searches, and hand searches of recent copies of relevant journals, Main outcome measures Standardised mean difference in effect size and weighted mean difference in Beck depression inventory score between exercise and no treatment and between exercise and cognitive therapy Results All of the 14 studies analysed had important methodological weaknesses; randomisation was adequately concealed in only three studies, intention to treat analysis was undertaken in only two, and assessment of outcome was blinded in only one. The participants in most studies were community volunteers, and diagnosis was determined by their score on the Beck depression inventory. When compared with no treatment, exercise reduced symptoms of depression (standardised mean difference in effect size -1.1 (95% confidence interval -1.5 to -0.6); weighted mean difference in Beck depression inventory -7.3 (-10.0 to - 4.6)). The effect size: was significantly seater. in those trials with shorter follow up and in two trials reported only as conference abstracts. The effect of exercise was similar to that of cognitive therapy (standardised mean difference -0.3 (95%, confidence interval -0.7 to 0.1)), Conclusions The effectiveness of exercise in reducing symptoms of depression cannot be determined because of a lack of good quality research on clinical populations with adequate follow up.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Bradford Community Trust, Shipley BD18 3BP, W Yorkshire, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	D.A.Lawlor@bristol.ac.uk		Lawlor, Debbie A/0000-0002-6793-2262				ANTONELLI F, 1982, INT J SPORT PSYCHOL, V13, P187; AUCHUS MP, 1994, PSYCHOSOC REHABIL J, V18, P99, DOI 10.1037/h0095510; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; Biddle S, 1995, RES Q EXERCISE SPORT, V66, P292, DOI 10.1080/02701367.1995.10607914; BIDDLE S, 1989, BRIT J HOSP MED, V42, P267; BIDDLE SJH, 1994, PHYSICAL ACTIVITY PR; BLUE FR, 1979, PERCEPT MOTOR SKILL, V48, P228, DOI 10.2466/pms.1979.48.1.228; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; BOSSCHER RJ, 1993, INT J SPORT PSYCHOL, V24, P170; Broocks A, 1997, PSYCHOTHER PSYCH MED, V47, P379; BURBACH FR, 1997, J MENT HEALTH, V6, P543, DOI DOI 10.1080/09638239718428; BYRNE A, 1993, J PSYCHOSOM RES, V37, P565, DOI 10.1016/0022-3999(93)90050-P; CARLSON DL, 1991, THESIS U WISCONSIN M; CONROY RW, 1982, HOSP COMMUNITY PSYCH, V33, P641; Craft LL, 1998, J SPORT EXERCISE PSY, V20, P339, DOI 10.1123/jsep.20.4.339; DAMATO G, 1990, THESIS HOFSTRA U HEM; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiLorenzo TM, 1999, PREV MED, V28, P75, DOI 10.1006/pmed.1998.0385; DISHMAN RK, 1995, QUEST, V47, P362, DOI 10.1080/00336297.1995.10484164; DOYNE EJ, 1983, BEHAV THER, V14, P434, DOI 10.1016/S0005-7894(83)80106-3; DOYNE EJ, 1987, J CONSULT CLIN PSYCH, V55, P748, DOI 10.1037/0022-006X.55.5.748; EMERY CF, 1990, GERONTOLOGIST, V30, P516, DOI 10.1093/geront/30.4.516; EMERY CF, 1990, GERONTOLOGIST, V30, P184, DOI 10.1093/geront/30.2.184; EPSTEIN D, 1986, THESIS U NEVADA RENO; FENTEM P, 1994, BRIT MED J, V308, P1291, DOI 10.1136/bmj.308.6939.1291; FETSCH RJ, 1983, AM MENT HLTH COUNSEL, V5, P75; Fox K, 1997, BRIT J GEN PRACT, V47, P367; FREMONT J, 1987, COGNITIVE THER RES, V11, P241, DOI 10.1007/BF01183268; GIARDINELLI L, 1996, MINERVA PSICHIATR, V37, P179; Glenister D, 1996, J ROY SOC HEALTH, V116, P7, DOI 10.1177/146642409611600102; GLESER J, 1990, ISRAEL J PSYCHIAT, V27, P99; GREIST JH, 1979, COMPR PSYCHIAT, V20, P41, DOI 10.1016/0010-440X(79)90058-0; HALES RE, 1987, MIL MED, V152, P299, DOI 10.1093/milmed/152.6.299; HANNAFORD CP, 1988, PSYCHOL REC, V38, P37, DOI 10.1007/BF03395005; HARTZ GW, 1982, PERCEPT MOTOR SKILL, V55, P1217, DOI 10.2466/pms.1982.55.3f.1217; HESSHOMEIER MJ, 1981, THESIS U MONTANA MIS; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; JOHNSON DAW, 1973, BRIT MED J, V2, P18, DOI 10.1136/bmj.2.5857.18; KAPLAN K, 1983, OCCUP THER J RES, V3, P173, DOI 10.1177/153944928300300304; KLEIN MH, 1985, INT J MENT HEALTH, V13, P148, DOI 10.1080/00207411.1984.11448982; Kolbjornsrud O-B., 1989, NORDISK PSYKIATRISK, V43, P521; LAFONTAINE TP, 1992, SPORTS MED, V13, P160, DOI 10.2165/00007256-199213030-00002; Leith L. M, 1994, FDN EXERCISE MENTAL, P17; Lepore SJ, 1997, J PERS SOC PSYCHOL, V73, P1030, DOI 10.1037/0022-3514.73.5.1030; MARTINSEN EW, 1993, INT J SPORT PSYCHOL, V24, P185; MARTINSEN EW, 1985, BRIT MED J, V291, P109, DOI 10.1136/bmj.291.6488.109; MARTINSEN EW, 1989, COMPR PSYCHIAT, V30, P324, DOI 10.1016/0010-440X(89)90057-6; MARTINSEN EW, 1994, ACTA PSYCHIAT SCAND, V89, P23, DOI 10.1111/j.1600-0447.1994.tb05797.x; MARTINSEN EW, 1987, STRESS MEDICINE, V3, P93, DOI 10.1002/smi.2460030205; Martinsen EW., 1988, P SPORT HLTH PSYCH E, P77; Martinsen EW, 1988, P SPORT HLTH PSYCH E, P84; MARTINSEN EW, 1989, NORD PSYKIATR TIDSSK, V43, P411; MCCANN IL, 1984, J PERS SOC PSYCHOL, V46, P1142, DOI 10.1037/0022-3514.46.5.1142; MCNEIL JK, 1991, PSYCHOL AGING, V6, P487, DOI 10.1037/0882-7974.6.3.487; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moore KA, 1998, ALTERN THER HEALTH M, V4, P48; Mutrie N., 1988, P SPORT HLTH PSYCH E, P96; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Netz Yael, 1994, Clinical Gerontologist, V15, P47, DOI 10.1300/J018v15n01_06; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Palleschi L, 1998, ARCH GERONTOL GERIAT, P381; PAPPAS GP, 1990, PSYCHOSOMATICS, V31, P112, DOI 10.1016/S0033-3182(90)72232-3; Pelham T. W., 1993, PSYCHOSOC REHABIL, V16, P75, DOI DOI 10.1037/H0095650; PERRI S, 1985, INT J AGING HUM DEV, V20, P1984; PEZZAROSSA B, 1991, ANAL PSYCHOTHER PSYC, V10, P163; PLANTE TG, 1996, J PSYCHOS NURS MENT, V34, P39; RAGLIN JS, 1990, SPORTS MED, V9, P323, DOI 10.2165/00007256-199009060-00001; REUTER M, 1984, THESIS PENNSYLVANIA; Rief W, 1996, BRIT J CLIN PSYCHOL, V35, P605, DOI 10.1111/j.2044-8260.1996.tb01216.x; Rosenthal R, 1994, HDB RES SYNTHESIS, P231; ROTH DL, 1987, PSYCHOSOM MED, V49, P355, DOI 10.1097/00006842-198707000-00004; Sachs M L, 1981, Top Clin Nurs, V3, P77; SACHS ML, 1982, J HUMANISTIC ED DEV, V21, P51; Salmon P, 1990, Br J Hosp Med, V43, P107; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SCOTT MG, 1960, RES QUART, V31, P307; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; SEXTON H, 1989, ACTA PSYCHIAT SCAND, V80, P231, DOI 10.1111/j.1600-0447.1989.tb01332.x; SIMONS AD, 1985, CLIN PSYCHOL REV, V5, P553, DOI 10.1016/0272-7358(85)90034-0; Singh NA, 1997, J GERONTOL A-BIOL, V52, pM27, DOI 10.1093/gerona/52A.1.M27; Sonstroem R J, 1997, Med Health R I, V80, P295; Stewart N J, 1994, Arch Psychiatr Nurs, V8, P22; Streiner DL, 1998, CAN J PSYCHIAT, V43, P1026, DOI 10.1177/070674379804301008; THOMSON J, 1982, PSYCHOL MED, V12, P741, DOI 10.1017/S0033291700049047; THOREN P, 1990, MED SCI SPORT EXER, V22, P417; VANCOPPENHOLLE H, 1993, ISSUES SPECIAL ED RE, V8, P29; VEALE D, 1992, J ROY SOC MED, V85, P541; VEALE D, 1988, P SPORT HLTH PSYCH E, P106; VEALE DMWD, 1987, ACTA PSYCHIAT SCAND, V76, P113, DOI 10.1111/j.1600-0447.1987.tb02872.x; WEINSTEIN WS, 1983, J SPORT PSYCHOL, V5, P288, DOI 10.1123/jsp.5.3.288; WEYERER S, 1994, SPORTS MED, V17, P108, DOI 10.2165/00007256-199417020-00003; WILLIAMS JM, 1986, PERCEPT MOTOR SKILL, V63, P1099, DOI 10.2466/pms.1986.63.3.1099	93	510	520	4	178	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2001	322	7289					763	767		10.1136/bmj.322.7289.763	http://dx.doi.org/10.1136/bmj.322.7289.763			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419HL	11282860	Green Published, Green Submitted			2022-12-28	WOS:000167943200024
J	de Lozanne, A				de Lozanne, A			Atomic force microscopy - You may squeeze the atoms but don't mangle the surface!	SCIENCE			English	Editorial Material									Univ Texas, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	de Lozanne, A (corresponding author), Univ Texas, Dept Phys, Austin, TX 78712 USA.	lozanne@physics.utexas.edu	de Lozanne, Alex L/C-9693-2013	de Lozanne, Alex L/0000-0003-2950-4707				Barwich V, 2000, APPL SURF SCI, V157, P269, DOI 10.1016/S0169-4332(99)00538-3; Bennewitz R, 2000, APPL SURF SCI, V157, pV; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fishlock TW, 2000, NATURE, V404, P743, DOI 10.1038/35008030; Foster AS, 2001, PHYS REV LETT, V86, P2373, DOI 10.1103/PhysRevLett.86.2373; GIESSIBL, 2001, B AM PHYS SOC, V46, P846; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; GIESSIBL FJ, 2001, SCIENCE         0330; GLESSIBL FJ, 1995, SCIENCE, V267, P68; HUG HJ, 2001, SCIENCE         0330; Jarvis SP, 1996, NATURE, V384, P247, DOI 10.1038/384247a0; KITAMURA S, 1995, JPN J APPL PHYS 2, V34, pL145, DOI 10.1143/JJAP.34.L145; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; MORITA S, 1999, APPL SURF SCI, V140, P1; Sincell M, 2000, SCIENCE, V290, P1530, DOI 10.1126/science.290.5496.1530	18	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2561	2562						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286280				2022-12-28	WOS:000167861000029
J	Weber, W				Weber, W			Freiburg oncologist found guilty of scientific misconduct	LANCET			English	News Item													Weber, Wim EJ/F-7741-2010					2000, LANCET, V356, P53	1	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					780	780		10.1016/S0140-6736(05)71214-9	http://dx.doi.org/10.1016/S0140-6736(05)71214-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11280314				2022-12-28	WOS:000167400900032
J	Kang, WN; Kim, HJ; Choi, EM; Jung, CU; Lee, SL				Kang, WN; Kim, HJ; Choi, EM; Jung, CU; Lee, SL			MgB2 superconducting thin films with a transition temperature of 39 kelvin	SCIENCE			English	Article								We fabricated high-quality c axis-oriented epitaxial MgB2 thin films using a pulsed laser deposition technique. The thin films grown on (1 (1) over bar 0 2) Al2O3 substrates have a transition temperature of 39 kelvin. The critical current density in zero field is similar to6 x 10(6) amperes per cubic centimeter at 5 kelvin and similar to3 x 10(5) amperes per cubic centimeter at 35 kelvin, which suggests that this compound has potential for electronic device applications, such as microwave devices and superconducting quantum interference devices. For the films deposited on Al2O3, x-ray diffraction patterns indicate a highly c axis-oriented crystal structure perpendicular to the substrate surface.	Pohang Univ Sci & Technol, Dept Phys, Natl Creat Res Initiat Ctr Superconduct, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kang, WN (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Natl Creat Res Initiat Ctr Superconduct, Pohang 790784, South Korea.	wnkang@postech.ac.kr	JUNG, Chang Uk/E-9870-2012					Bud'ko SL, 2001, PHYS REV LETT, V86, P1877, DOI 10.1103/PhysRevLett.86.1877; Canfield PC, 2001, PHYS REV LETT, V86, P2423, DOI 10.1103/PhysRevLett.86.2423; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; GUPTA A, 1994, SCIENCE, V265, P1075, DOI 10.1126/science.265.5175.1075; Kang WN, 1998, APPL PHYS LETT, V73, P381, DOI 10.1063/1.121841; KRUSINELBAUM L, 1995, NATURE, V373, P679, DOI 10.1038/373679a0; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039	8	438	457	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1521	1523		10.1126/science.1060822	http://dx.doi.org/10.1126/science.1060822			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11303089	Green Submitted			2022-12-28	WOS:000168963800037
J	Jarillo, JA; Gabrys, H; Capel, J; Alonso, JM; Ecker, JR; Cashmore, AR				Jarillo, JA; Gabrys, H; Capel, J; Alonso, JM; Ecker, JR; Cashmore, AR			Phototropin-related NPL1 controls chloroplast relocation induced by blue light	NATURE			English	Article							LEMNA-TRISULCA L; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; NPH1; PHOTORECEPTORS; RECEPTOR; DOMAINS	In photosynthetic cells, chloroplasts migrate towards illuminated sites to optimize photosynthesis and move away from excessively illuminated areas to protect the photosynthetic machinery(1). Although this movement of chloroplasts in response to light has been known for over a century, the photoreceptor mediating this process has not been identified. The Arabidopsis gene NPL1 (ref. 2) is a paralogue of the NPH1 gene, which encodes phototropin, a photoreceptor for phototropic bending(3). Here we show that NPL1 is required for chloroplast relocation induced by blue light. A loss-of-function npl1 mutant showed no chloroplast avoidance response in strong blue light, whereas the accumulation of chloroplasts in weak light was normal. These results indicate that NPL1 may function as a photoreceptor mediating chloroplast relocation.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Jagiellonian Univ, Inst Mol Biol, PL-31120 Krakow, Poland; Univ Almeria, Dept Biol Aplicada, Almeria 04120, Spain	University of Pennsylvania; Jagiellonian University; Universidad de Almeria	Cashmore, AR (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Alonso, Jose M/K-6826-2014; Capel, Juan/M-3772-2018; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Capel, Juan/0000-0002-4327-0604; Ecker, Joseph R/0000-0001-5799-5895; Jarillo, Jose Antonio/0000-0002-2963-7641				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Kadota A, 2000, PLANTA, V210, P932, DOI 10.1007/s004250050700; Kagawa T, 2000, PLANT CELL PHYSIOL, V41, P84, DOI 10.1093/pcp/41.1.84; Kanegae H, 2000, PLANT CELL PHYSIOL, V41, P415, DOI 10.1093/pcp/41.4.415; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; MALEC P, 1994, J THEOR BIOL, V169, P189, DOI 10.1006/jtbi.1994.1140; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; WADA M, 1993, J PHOTOCH PHOTOBIO B, V17, P3, DOI 10.1016/1011-1344(93)85002-P; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Zacherl M, 1998, PLANT PHYSIOL, V116, P869; ZXURZXYCKI J, 1980, BLUE LIGHT SYNDROME, P50	20	363	374	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					952	954		10.1038/35073622	http://dx.doi.org/10.1038/35073622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309623				2022-12-28	WOS:000168152300052
J	Martin, PR; Lee, BB; White, AJR; Soloman, SG; Ruttiger, L				Martin, PR; Lee, BB; White, AJR; Soloman, SG; Ruttiger, L			Chromatic sensitivity of ganglion cells in the peripheral primate retina	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; MACAQUE MONKEY; RHESUS-MONKEY; VISUAL-FIELD; COLOR-VISION; HUMAN EYE; LUMINANCE; CIRCUITS; CONTRAST; NEURONS	Visual abilities change over the visual field. For example, our ability to detect movement is better in peripheral vision than in foveal vision, but colour discrimination is markedly worse(1,2). The deterioration of colour vision has been attributed to reduced colour specificity in cells of the midget, parvocellular (PC) visual pathway in the peripheral retina(3-5). We have measured the colour specificity (red-green chromatic modulation sensitivity) of PC cells at eccentricities between 20 and 50 degrees in the macaque retina. Here we show that most peripheral PC cells have red-green modulation sensitivity close to that of foveal PC cells. This result is incompatible with the view that PC pathway cells in peripheral retina make indiscriminate connections ('random wiring') with retinal circuits devoted to different spectral types of cone photoreceptors(4,6,7). We show that selective cone connections can be maintained by dendritic field anisotropy, consistent with the morphology of PC cell dendritic fields in peripheral retina(8,9). Our results also imply that postretinal mechanisms contribute to the psychophysically demonstrated deterioration of colour discrimination in the peripheral visual field.	Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; Univ Sydney, Inst Biomed Res, Sydney, NSW 2006, Australia; Max Planck Inst Biophys Chem, Neurobiol Grp, D-37077 Gottingen, Germany; SUNY Coll Optometry, New York, NY 10036 USA	University of Sydney; University of Sydney; Max Planck Society; State University of New York (SUNY) System; SUNY Optometry	Martin, PR (corresponding author), Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.	paulm@physiol.usyd.edu.au	White, Andrew JR/E-8462-2013; Solomon, Samuel/C-8779-2009; Martin, Paul R/A-4346-2009	Martin, Paul R/0000-0002-5166-9658; Solomon, Samuel/0000-0001-5321-0288				[Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DREHER B, 1976, J PHYSIOL-LONDON, V258, P433, DOI 10.1113/jphysiol.1976.sp011429; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; GOURAS P, 1979, SCIENCE, V205, P587, DOI 10.1126/science.109925; KAPLAN E, 1989, NEW VIEWS PRIMATE RE, V9, P273; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P47, DOI 10.1017/S0952523898151015; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Mullen KT, 1996, VISION RES, V36, P1995, DOI 10.1016/0042-6989(95)00261-8; MULLEN KT, 1991, VISION RES, V31, P119, DOI 10.1016/0042-6989(91)90079-K; NAVARRO R, 1993, J OPT SOC AM A, V10, P201, DOI 10.1364/JOSAA.10.000201; NOORLANDER C, 1983, VISION RES, V23, P1, DOI 10.1016/0042-6989(83)90035-4; Packer OS, 1996, J NEUROSCI, V16, P2251; RODIECK RW, 1991, NATO ADV SCI I A-LIF, V203, P83; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; ROORDA A, IN PRESS VISION RES; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; SMITH EL, 1990, VISUAL NEUROSCI, V5, P525, DOI 10.1017/S0952523800000699; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Wong WT, 2000, J NEUROSCI, V20, P5024	27	110	111	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					933	936		10.1038/35073587	http://dx.doi.org/10.1038/35073587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309618	Green Published			2022-12-28	WOS:000168152300047
J	Pachepsky, E; Crawford, JW; Bown, JL; Squire, G				Pachepsky, E; Crawford, JW; Bown, JL; Squire, G			Towards a general theory of biodiversity	NATURE			English	Article							POPULATION-DYNAMICS; COMMUNITY STRUCTURE; ANNUALS	The study of patterns in living diversity is driven by the desire to rnd the universal rules that underlie the organization of ecosystems(1,2). The relative abundance distribution, which characterizes the total number and abundance of species in a community, is arguably the most fundamental measure in ecology. Considerable effort has been expended in striving for a general theory that can explain the form of the distribution(3,4). Despite this, a mechanistic understanding of the form in terms of physiological and environmental parameters remains elusive(5). Recently, it has been proposed that space plays a central role in generating the patterns of diversity(6,7). Here we show that an understanding of the observed form of the relative abundance distribution requires a consideration of how individuals pack in time. We present a framework for studying the dynamics of communities which generalizes the prevailing species-based approach to one based on individuals that are characterized by their physiological traits. The observed form of the abundance distribution and its dependence on richness and disturbance are reproduced, and can be understood in terms of the trade-off between time to reproduction and fecundity.	Univ Albertay Dundee, Sch Comp, SIMBIOS Ctr, Dundee DD1 1HG, Scotland; Scottish Crop Res Inst, Vegetat Syst Unit, Dundee DD2 5DA, Scotland	University of Abertay Dundee; James Hutton Institute	Crawford, JW (corresponding author), Univ Albertay Dundee, Sch Comp, SIMBIOS Ctr, Dundee DD1 1HG, Scotland.			Crawford, John/0000-0002-7139-0355				CRAWLEY MJ, 1987, J THEOR BIOL, V125, P475, DOI 10.1016/S0022-5193(87)80215-1; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Giplin M, 1991, METAPOPULATION DYNAM; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Huston M. A., 1994, BIOL DIVERSITY; Kareiva, 1997, SPATIAL ECOLOGY; Legendre L, 1983, NUMERICAL ECOLOGY; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; PACALA SW, 1986, THEOR POPUL BIOL, V29, P262, DOI 10.1016/0040-5809(86)90011-0; PEARSON TH, 1983, MAR ECOL PROG SER, V12, P237, DOI 10.3354/meps012237; Putman R. J., 1994, COMMUNITY ECOLOGY; ROSENZWEIG ML, 1995, SPACIES DIVERSITY SP; Sole RV, 1999, TRENDS ECOL EVOL, V14, P156, DOI 10.1016/S0169-5347(98)01518-3; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; UGLAND KI, 1982, OIKOS, V39, P171, DOI 10.2307/3544482; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Winkler E, 1999, OIKOS, V85, P217, DOI 10.2307/3546488; [No title captured]	18	69	72	0	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					923	926		10.1038/35073563	http://dx.doi.org/10.1038/35073563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309615				2022-12-28	WOS:000168152300044
J	Holmer, AF				Holmer, AF			Industry strongly supports continuing medical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Pharmaceut Res & Manufacturers Amer, Washington, DC USA		Holmer, AF (corresponding author), Care of Oman A, Pharmaceut Res & Manufacturers Amer, 1100 15th St NW, Washington, DC 20005 USA.							*AM MED ASS, 1990, AMA GUID GIFTS PHYS; DAUGHERTY JM, 2000, MED MARKETING ME DEC, V35, P88; *PHARM RES MAN AM, NEW DRUG APPR 1980 1; *US DEP HHS, 2001, GUID IND IND SUPP SC	4	39	39	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					2012	2014		10.1001/jama.285.15.2012	http://dx.doi.org/10.1001/jama.285.15.2012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308442				2022-12-28	WOS:000167995900034
J	Binswanger, HP				Binswanger, HP			Public health - HIV/AIDS treatment for millions	SCIENCE			English	Editorial Material													Binswanger, Hans/M-6883-2013	Binswanger, Hans/0000-0002-6323-1418				Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Castro-Leal F, 1999, WORLD BANK RES OBSER, V14, P49, DOI 10.1093/wbro/14.1.49; *MCKINS CO, 2000, INCR ACC ARV TREATM; SCHOOFS M, 2000, WALL STREET J   0307, pA1; SUBBARAO K, 1997, SAFETY NET PROGRAMS, pCH4; *UNAIDS IAS WHO, US ANT TREATM AD PAR; *UNAIDS UNICEF WHO, 2000, SEL DRUGS US CAR PEO; *UNAIDS WHO, 2000, PAT SIT HIV AIDS REL; VONPISCHKE JD, 1991, FINANCES FRONTIER; WEHRWEIN P, 1999, HARVARD PUBL HLTH RE, V32, P32; *WORLD BANK, 2000, AIDS CAMP TEAM AFR A	12	28	29	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					221	+		10.1126/science.1057504	http://dx.doi.org/10.1126/science.1057504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305311				2022-12-28	WOS:000168074000025
J	Di Marzo, V; Goparaju, SK; Wang, L; Liu, J; Batkai, S; Jarai, Z; Fezza, F; Miura, GI; Palmiter, RD; Sugiura, T; Kunos, G				Di Marzo, V; Goparaju, SK; Wang, L; Liu, J; Batkai, S; Jarai, Z; Fezza, F; Miura, GI; Palmiter, RD; Sugiura, T; Kunos, G			Leptin-regulated endocannabinoids are involved in maintaining food intake	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; RECEPTOR MESSENGER-RNA; NEUROPEPTIDE-Y; RAT-BRAIN; CB1; ANTAGONIST; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; INACTIVATION; ANANDAMIDE	Leptin is the primary signal through which the hypothalamus senses nutritional state and modulates food intake and energy balance(1). Leptin reduces food intake by upregulating anorexigenic (appetite-reducing) neuropeptides, such as a-melanocyte-stimulating hormone(2,3), and downregulating orexigenic (appetite-stimulating) factors, primarily neuropeptide Y-4. Genetic defects in anorexigenic signalling, such as mutations in the melanocortin-4 (ref. 5) or leptin receptors(6), cause obesity. However, alternative orexigenic pathways maintain food intake in mice deficient in neuropeptide Y-7. CB1 cannabinoid receptors(8) and the endocannabinoids anandamide and 2-arachidonoyl glycerol are present in the hypothalamus(9), and marijuana(10) and anandamide(11,12) stimulate food intake. Here we show that following temporary food restriction, CB1 receptor knockout mice eat less than their wild-type littermates, and the CB1 antagonist SR141716A reduces food intake in wild-type but not knockout mice. Furthermore, defective leptin signalling is associated with elevated hypothalamic, but not cerebellar, levels of endocannabinoids in obese db/db and ob/ob mice and Zucker rats. Acute leptin treatment of normal rats and ob/ob mice reduces anandamide and 2-arachidonoyl glycerol in the hypothalamus. These findings indicate that endocannabinoids in the hypothalamus may tonically activate CB1 receptors to maintain food intake and form part of the neural circuitry regulated by leptin.	CNR, Ist Chim Mol Interesse Biol, Endocannabinoid Res Grp, I-80072 Arco Felice Napoli, Naples, Italy; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 1990195, Japan	Consiglio Nazionale delle Ricerche (CNR); Virginia Commonwealth University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Teikyo University	Kunos, G (corresponding author), NIAAA, NIH, MSC-8115, Bethesda, MD 20892 USA.	gkunos@mail.nih.gov	Di Marzo, Vincenzo/AAD-7742-2019; Goparaju, Sravan/H-3422-2011; Batkai, Sandor/G-3889-2010; Batkai, Sandor/H-7983-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; 	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Chaperon F, 1998, PSYCHOPHARMACOLOGY, V135, P324, DOI 10.1007/s002130050518; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Funahashi H, 1999, NEUROSCI LETT, V264, P117, DOI 10.1016/S0304-3940(99)00186-X; Gonzalez S, 1999, NEUROENDOCRINOLOGY, V70, P137, DOI 10.1159/000054468; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Lopez M, 2000, BIOCHEM BIOPH RES CO, V269, P41, DOI 10.1006/bbrc.2000.2245; Mechoulam R, 1998, PROGR MED CHEM, V35, P199, DOI 10.1016/S0079-6468(08)70037-7; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; White R, 1998, BRIT J PHARMACOL, V125, P689, DOI 10.1038/sj.bjp.0702127; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	29	1221	1263	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					822	825		10.1038/35071088	http://dx.doi.org/10.1038/35071088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298451				2022-12-28	WOS:000168021900057
J	Waite, JH; Gladstone, GR; Lewis, WS; Goldstein, R; McComas, DJ; Riley, P; Walker, RJ; Robertson, P; Desai, S; Clarke, JT; Young, DT				Waite, JH; Gladstone, GR; Lewis, WS; Goldstein, R; McComas, DJ; Riley, P; Walker, RJ; Robertson, P; Desai, S; Clarke, JT; Young, DT			An auroral flare at Jupiter	NATURE			English	Article							SOLAR-WIND CONTROL; IO FLUX TUBE; FOOTPRINT; FIELD; EMISSIONS; PRESSURE; MODELS	Jupiter's aurora is the most powerful in the Solar System(1). It is powered largely by energy extracted from planetary rotation(2), although there seems also to be a contribution from the solar wind(3,4). This contrasts with Earth's aurora, which is generated through the interaction of the solar wind with the magnetosphere. The major features of Jupiter's aurora (based on far-ultraviolet(5-7), near-infrared(8,9) and visible-wavelength(10) observations) include a main oval that generally corotates with the planet and a region of patchy, diffuse emission inside the oval on Jupiter's dusk side. Here we report the discovery of a rapidly evolving, very bright and localized emission poleward of the northern main oval, in a region connected magnetically to Jupiter's outer magnetosphere. The intensity of the emission increased by a factor of 30 within 70s, and then decreased on a similar timescale, all captured during a single four-minute exposure. This type of flaring emission has not previously been reported for Jupiter (similar, but smaller, transient events have been observed at Earth), and it may be related directly to changes in the solar wind.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; SW Res Inst, San Antonio, TX 78228 USA; SAIC, San Diego, CA 92121 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; Southwest Research Institute; Science Applications International Corporation (SAIC); University of California System; University of California Los Angeles	Waite, JH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.		Clarke, John/C-8644-2013; McComas, David J/H-6202-2011	McComas, David J/0000-0001-6160-1158				Baron RL, 1996, ICARUS, V120, P437, DOI 10.1006/icar.1996.0063; Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; Clarke JT, 1996, SCIENCE, V274, P404, DOI 10.1126/science.274.5286.404; Clarke JT, 1998, J GEOPHYS RES-PLANET, V103, P20217, DOI 10.1029/98JE01130; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; CRAVEN JD, 1986, SOLAR WIND MAGNETOSP, P367; DESCH MD, 1984, J GEOPHYS RES-SPACE, V89, P6819, DOI 10.1029/JA089iA08p06819; Gosling JT, 1996, GEOPHYS RES LETT, V23, P2867, DOI 10.1029/96GL02843; Hill T. W., 1983, PHYSICS JOVIAN MAGNE, P353, DOI DOI 10.1017/CBO9780511564574.012; INTRILIGATOR DS, 1976, STUDIES INTERIOR ATM, P848; Khurana KK, 1997, J GEOPHYS RES-SPACE, V102, P11295, DOI 10.1029/97JA00563; McComas DJ, 1998, SPACE SCI REV, V86, P563, DOI 10.1023/A:1005040232597; Ogino T, 1998, J GEOPHYS RES-SPACE, V103, P225, DOI 10.1029/97JA02247; PRANGE R, 1998, J GEOPHYS RES, V103, P21095; SANDHOLT PE, 1994, J GEOPHYS RES-SPACE, V99, P17323, DOI 10.1029/94JA00679; Satoh T, 1999, ICARUS, V141, P236, DOI 10.1006/icar.1999.6173; Vasavada AR, 1999, J GEOPHYS RES-PLANET, V104, P27133, DOI 10.1029/1999JE001055; Zhou XY, 1999, GEOPHYS RES LETT, V26, P1097, DOI 10.1029/1999GL900173	20	112	112	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					787	789		10.1038/35071018	http://dx.doi.org/10.1038/35071018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298440	Green Published			2022-12-28	WOS:000168021900046
J	Borras, JM; Sanchez-Hernandez, A; Navarro, M; Martinez, M; Mendez, E; Ponton, JLL; Espinas, JA; Germa, JR				Borras, JM; Sanchez-Hernandez, A; Navarro, M; Martinez, M; Mendez, E; Ponton, JLL; Espinas, JA; Germa, JR			Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE; CARE; PREFERENCES; THERAPY	Objective To compare chemotherapy given at home with outpatient treatment in terms of colorectal cancer patients' safety, compliance: use of health services, quality of life, and satisfaction with treatment. Design Randomised controlled trial. Setting Large teaching hospital. Participants 87 patients receiving adjuvant or palliative chemotherapy for colorectal cancer. Interventions Treatment with fluorouracil (with or without folinic acid or levamisole) at outpatient clinic or at home. Main outcome measures Treatment toxicity patients' compliance with treatment, quality of life, satisfaction with care, and use of health resources. Results 49 patients were treated at outpatient clinic and 45 at home. The two groups were balanced in terms of age, ses, site of cancer, and disease stage. Treatment related toxicity was similar in the two groups (difference 7%, (95% confidence interval - 12% to 26%), but there were more voluntary: withdrawals from treatment in the outpatient group than in the home group (14% v 2%: difference 12% (1% to 24%)). There were no differences between groups in terms of quality of life scores during and after treatment. Levels of patient satisfaction were higher in the home treatment group, specifically with regard to information received and nursing care. There were no significant differences in use of health services. Conclusions Home chemotherapy seemed an acceptable and safe alternative to hospital treatment for patients with colorectal cancer that mall improve compliance and satisfaction with treatment.	Catalan Inst Oncol, Canc Prevent & Control Unit, Hospitalet 08907, Spain; Catalan Inst Oncol, Dept Med Oncol, Hospitalet 08907, Spain; Catalan Inst Oncol, Dept Pharm, Hospitalet 08907, Spain	Catalan Institute of Oncology; Catalan Institute of Oncology; Catalan Institute of Oncology	Borras, JM (corresponding author), Catalan Inst Oncol, Canc Prevent & Control Unit, Gran Via Km 2,7 S-N, Hospitalet 08907, Spain.			Borras, Josep M/0000-0001-7330-6308				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; BAROFSKY I, 1968, HLTH ED Q S, V10, P43; BENJAMIN AE, 1993, MILBANK Q, V71, P129, DOI 10.2307/3350277; CLOSE P, 1995, PEDIATRICS, V95, P896; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; GREEN JA, 1983, BRIT MED J, V287, P778, DOI 10.1136/bmj.287.6395.778; Karnofsky DA, 1949, EVALUATION CHEMOTHER; King MT, 2000, INT J HEALTH SERV, V30, P557, DOI 10.2190/CY03-EV15-K38Y-X4AA; LEWIS C, 1983, AM J MED, V74, P673, DOI 10.1016/0002-9343(83)91026-4; LOWENTHAL RM, 1999, BRIT MED J, V319, P1547; MARKS L, 1992, HOME HOSP CARE REDRA; MCCUSKER J, 1984, MED CARE, V22, P476, DOI 10.1097/00005650-198405000-00011; MOR V, 1988, J CLIN EPIDEMIOL, V41, P771, DOI 10.1016/0895-4356(88)90164-3; Nunally J. C., 1994, PSYCHOMETRIC THEORY; PAYNE SA, 1992, SOC SCI MED, V35, P1505, DOI 10.1016/0277-9536(92)90053-S; PFISTER DG, 1996, BRINGING HOSP HOME, P65; RICHARDSON JL, 1988, J CLIN ONCOL, V6, P1746, DOI 10.1200/JCO.1988.6.11.1746; Rischin D, 2000, MED J AUSTRALIA, V173, P125, DOI 10.5694/j.1326-5377.2000.tb125563.x; SHEPPERD S, COCHRANE COLLABORATI, P98; Smeenk FWJM, 1998, BRIT MED J, V316, P1939, DOI 10.1136/bmj.316.7149.1939; Soderstrom L, 1999, CAN MED ASSOC J, V160, P1151; 1980, NEOPLASMA, V20, P37	22	106	108	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					826	828A		10.1136/bmj.322.7290.826	http://dx.doi.org/10.1136/bmj.322.7290.826			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290635	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168063000022
J	Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Andersson, LC; Tervahartiala, P; Tuveson, D; Silberman, SL; Capdeville, R; Dimitrijevic, S; Druker, B; Demetri, GD				Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Andersson, LC; Tervahartiala, P; Tuveson, D; Silberman, SL; Capdeville, R; Dimitrijevic, S; Druker, B; Demetri, GD			Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-KIT; MUTATIONS; LEIOMYOSARCOMAS		Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Radiol, FIN-00029 Helsinki, Finland; Univ Turku, Cent Hosp, Dept Surg, FIN-20520 Turku, Finland; Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; MIT, Dept Biol, Cambridge, MA USA; MIT, Howard Hughes Med Inst, Cambridge, MA USA; Dana Farber Canc Inst, Dept Adult Oncol, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Novartis Oncol, E Hanover, NJ USA; Novartis Oncol, Basel, Switzerland; Oregon Hlth Sci Univ, Dept Med Oncol, Portland, OR 97201 USA	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis; Novartis; Oregon Health & Science University	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4,POB 180, FIN-00029 Helsinki, Finland.		ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Druker, Brian/0000-0001-8331-8206				Cancer Therapy Evaluation Program, 1998, COMM TOX CRIT VERS 2; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Lasota J, 1999, AM J PATHOL, V154, P53, DOI 10.1016/S0002-9440(10)65250-9; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Plaat BEC, 2000, J CLIN ONCOL, V18, P3211, DOI 10.1200/JCO.2000.18.18.3211; Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	10	1487	1599	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1052	1056		10.1056/NEJM200104053441404	http://dx.doi.org/10.1056/NEJM200104053441404			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287975				2022-12-28	WOS:000167860400004
J	Cantor, JD				Cantor, JD			Privacy protections for cybercharts: An update on the law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELECTRONIC HEALTH INFORMATION		Yale Univ, Sch Med, New Haven, CT 06510 USA	Yale University	Cantor, JD (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.							*GEORG U LAW CTR H, 1999, CAL HEALTHC FDN SURV; Halamka JD, 1997, J AM MED INFORM ASSN, V4, P458, DOI 10.1136/jamia.1997.0040458; Hodge JG, 1999, JAMA-J AM MED ASSOC, V282, P1466, DOI 10.1001/jama.282.15.1466; Lo B, 2000, JAMA-J AM MED ASSOC, V283, P801, DOI 10.1001/jama.283.6.801; 2000, FED REG 82462   1228, V65	5	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1767	1767		10.1001/jama.285.13.1767	http://dx.doi.org/10.1001/jama.285.13.1767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415FR	11277837	hybrid			2022-12-28	WOS:000167710600036
J	Schwartz, GG; Olsson, AG; Ezekowitz, MD; Ganz, P; Oliver, MF; Waters, D; Zeiher, A; Chaitman, BR; Leslie, S; Stern, T				Schwartz, GG; Olsson, AG; Ezekowitz, MD; Ganz, P; Oliver, MF; Waters, D; Zeiher, A; Chaitman, BR; Leslie, S; Stern, T		Myocardial Ischemia Reduction Agg	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVES ENDOTHELIAL FUNCTION; BASE-LINE; CHOLESTEROL; HYPERLIPIDEMIA; SIMVASTATIN; PRAVASTATIN; INHIBITION; REDUCTION	Context Patients experience the highest rate of death and recurrent ischemic events during the early period after an acute coronary syndrome, but it is not known whether early initiation of treatment with a statin can reduce the occurrence of these early events. Objective To determine whether treatment with atorvastatin, 80 mg/d, initiated 24 to 96 hours after an acute coronary syndrome, reduces death and nonfatal ischemic events. Design and Setting A randomized, double-blind trial conducted from May 1997 to September 1999, with follow-up through 16 weeks at 122 clinical centers in Europe, North America, South Africa, and Australasia. Patients A total of 3086 adults aged 18 years or older with unstable angina or non-Q-wave acute myocardial infarction. Interventions Patients were stratified by center and randomly assigned to receive treatment with atorvastatin (80 mg/d) or matching placebo between 24 and 96 hours after hospital admission. Main Outcome Measures Primary end point event defined as death, nonfatal acute myocardial infarction, cardiac arrest with resuscitation, or recurrent symptomatic myocardial ischemia with objective evidence and requiring emergency rehospitalization. Results A primary end point event occurred in 228 patients (14.8%) in the atorvastatin group and 269 patients (17.4%) in the placebo group (relative risk [RR], 0.84; 95% confidence interval [CI], 0.70-1.00; P = .048). There were no significant differences in risk of death, nonfatal myocardial infarction, or cardiac arrest between the atorvastatin group and the placebo group, although the atorvastatin group had a lower risk of symptomatic ischemia with objective evidence and requiring emergency rehospitalization (6.2% vs 8.4%; RR, 0.74; 95% CI, 0.57-0.95; P = .02). Likewise, there were no significant differences between the atorvastatin group and the placebo group in the incidence of secondary outcomes of coronary revascularization procedures, worsening heart failure, or worsening angina, although there were fewer strokes in the atorvastatin group than in the placebo group (12 vs 24 events; P = .045). In the atorvastatin group, mean low-density lipoprotein cholesterol level declined from 124 mg/dL (3.2 mmol/L) to 72 mg/dL (1.9 mmol/L). Abnormal liver transaminases (>3 times upper limit of normal) were more common in the atorvastatin group than in the placebo group (2.5% vs 0.6%; P < .001). Conclusion For patients with acute coronary syndrome, lipid-lowering therapy with atorvastatin, 80 mg/d, reduces recurrent ischemic events in the first 16 weeks, mostly recurrent symptomatic ischemia requiring rehospitalization.	Denver VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden; Med Coll Penn & Hahnemann Univ, Philadelphia, PA USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Goethe Univ Frankfurt, Dept Cardiol, D-6000 Frankfurt, Germany; St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA; Pfizer Pharmaceut Res, New York, NY USA; Pfizer Pharmaceut Res, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Linkoping University; Drexel University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Goethe University Frankfurt; Saint Louis University; Pfizer; Pfizer	Schwartz, GG (corresponding author), Denver VA Med Ctr, Cardiol Sect 111B, 1055 Clermont St, Denver, CO 80220 USA.	Gregory.Schwartz@med.va.gov	Ezekowitz, Michael/AAJ-2543-2021	Ganz, Peter/0000-0002-0437-8882				Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2; COX DR, 1972, J R STAT SOC B, V34, P187; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Huggins GS, 1998, CIRCULATION, V98, P1291, DOI 10.1161/01.CIR.98.13.1291; Knatterud GL, 2000, CIRCULATION, V102, P157, DOI 10.1161/01.CIR.102.2.157; LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *NIH, 1993, 2 NIH CHOL ED; NOTARBARTOLO A, 1995, ARTERIOSCL THROM VAS, V15, P247, DOI 10.1161/01.ATV.15.2.247; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; PEDERSEN TR, 1994, LANCET, V344, P1383; *PLAT REC INH ISCH, 1998, NEW ENGL J MED, V388, P1488; RAUTAHARJU PM, 1992, J ELECTROCARDIOL, V24, P179; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 1998, AM J CARDIOL, V81, P578, DOI 10.1016/S0002-9149(97)00963-6; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wallentin L, 1999, LANCET, V354, P708	19	1864	2022	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1711	1718		10.1001/jama.285.13.1711	http://dx.doi.org/10.1001/jama.285.13.1711			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277825	Bronze			2022-12-28	WOS:000167710600024
J	Green, DG				Green, DG			Stakeholder health, insurance: empowering the poorest patients	BRITISH MEDICAL JOURNAL			English	Article									Inst Study Civil Soc, London SE1 7NQ, England		Green, DG (corresponding author), Inst Study Civil Soc, Elizabeth House, London SE1 7NQ, England.							ENTHOVEN AC, 1994, HEALTH AFFAIR, V13, P81, DOI 10.1377/hlthaff.13.1.81; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P24, DOI 10.1377/hlthaff.12.suppl_1.24; GREEN DG, 2000, STAKEHOLDER HLTH INS; *OFF PERS MAN FED, 1999, HDB ENR EMPL OFF	4	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					786	788		10.1136/bmj.322.7289.786	http://dx.doi.org/10.1136/bmj.322.7289.786			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282871	Green Published			2022-12-28	WOS:000167943200033
J	Abu-Elheiga, L; Matzuk, MM; Abo-Hashema, KAH; Wakil, SJ				Abu-Elheiga, L; Matzuk, MM; Abo-Hashema, KAH; Wakil, SJ			Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2	SCIENCE			English	Article							COENZYME-A CARBOXYLASE; MALONYL-COA; SKELETAL-MUSCLE; MOLECULAR-CLONING; PROTEIN-KINASE; RAT-LIVER; PHOSPHORYLATION; GENE; IDENTIFICATION; PURIFICATION	Malonyl-coenzyme A (malonyl-CoA), generated by acetyl-CoA carboxylases ACC1 and ACC2, is a key metabolite in the regulation of energy homeostasis. Here, we show that Acc2(-/-) mutant mice have a normal life span, a higher fatty acid oxidation rate, and lower amounts of fat. In comparison to the wild type, Acc2-deficient mice had 10- and 30-fold lower levels of malonyl-CoA in heart and muscle, respectively. The fatty acid oxidation rate in the soleus muscle of the Acc2(-/-) mice was 30% higher than that of wild-type mice and was not affected by addition of insulin; however, addition of insulin to the wild-type muscle reduced fatty acid oxidation by 45%. The mutant mice accumulated 50% less fat in their adipose tissue than did wild-type mice. These results raise the possibility that pharmacological manipulation of ACC2 may lead to loss of body fat in the context of normal caloric intake.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wakil, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.			Abu-Elheiga, Lutfi/0000-0002-7366-3556	NIGMS NIH HHS [GM19091] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; ABUELHEIGA L, UNPUB; Alam N, 1998, BIOCHEM J, V334, P233, DOI 10.1042/bj3340233; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; BRESSLER R, 1961, J BIOL CHEM, V236, P1643; CHAUDRY IH, 1969, BIOCHIM BIOPHYS ACTA, V177, P527, DOI 10.1016/0304-4165(69)90315-8; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; EVANS JL, 1989, BIOCHEM J, V259, P821, DOI 10.1042/bj2590821; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; IVERSON AJ, 1990, BIOCHEM J, V269, P365, DOI 10.1042/bj2690365; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; LOPASCHUK GD, 1994, CAN J PHYSIOL PHARM, V72, P1101, DOI 10.1139/y94-156; MABROUK GM, 1990, J BIOL CHEM, V265, P6330; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MOHAMED AH, 1994, J BIOL CHEM, V269, P6859; OShea D, 1997, ENDOCRINOLOGY, V138, P196, DOI 10.1210/en.138.1.196; Rasmussen BB, 1997, J APPL PHYSIOL, V83, P1104, DOI 10.1152/jappl.1997.83.4.1104; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; THAMPY KG, 1988, J BIOL CHEM, V263, P6447; THAMPY KG, 1988, J BIOL CHEM, V263, P6454; THAMPY KG, 1989, J BIOL CHEM, V264, P17631; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WAKIL SJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P225, DOI 10.1016/0006-3002(58)90177-X; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	704	756	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2613	2616		10.1126/science.1056843	http://dx.doi.org/10.1126/science.1056843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283375				2022-12-28	WOS:000167861000045
J	Roska, B; Werblin, F				Roska, B; Werblin, F			Vertical interactions across ten parallel, stacked representations in the mammalian retina	NATURE			English	Article							CONE BIPOLAR CELLS; GANGLION-CELLS; FUNCTIONAL ARCHITECTURE; RESPONSES; INHIBITION; RECEPTORS; CAT; ROD	The mammalian visual system analyses the world through a set of separate spatio-temporal channels(1,2). The organization of these channels begins in the retina(1,3), where the precise laminations of both the axon terminals of bipolar cells and the dendritic arborizations of ganglion cells suggests the presence of a vertical stack of neural strata at the inner plexiform layer (IPL)(3-11), Conversely, many inhibitory amacrine cell classes are multiply or diffusely stratified(12), indicating that they might convey information between strata, On the basis of the diverse stratification and physiological properties of ganglion cells, it was suggested that the IPL contains a parallel set of representations of the visual world(3,7) embodied in the strata and conveyed to higher centres by the classes of ganglion cells whose dendrites ramify at that stratum. Here we show that each stratum receives unique and substantively different excitatory and inhibitory neural inputs that are integrated to form at least ten different, parallel spacetime spiking outputs. The response properties of these strata are ordered in the time domain. Inhibition through GABA(C) receptors extracts spatial edges in neural representations and seems to separate the functional properties of the strata, We describe a new form of neuronal interaction that we call 'vertical inhibition' that acts not laterally, but between strata.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Werblin, F (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 145 LSA, Berkeley, CA 94720 USA.	werblin@socrates.berkeley.edu	Roska, Botond/AAD-7268-2021					Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; BLOOMFIELD SA, 1986, J NEUROSCI, V6, P1; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Cajal SR., 1893, CELLULE, V9, P119; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Enz R, 1996, J NEUROSCI, V16, P4479; Euler T, 1996, J NEUROSCI, V16, P2934; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FISHER SK, 1974, PROC R SOC SER B-BIO, V186, P317, DOI 10.1098/rspb.1974.0052; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Rodieck R.W., 1998, 1 STEPS SEEING; Roska B, 2000, J NEUROSCI, V20, P1941; Shields CR, 2000, J NEUROSCI, V20, P2673; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Zhang J, 1999, INVEST OPHTH VIS SCI, V40, pS812	26	371	375	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					583	587		10.1038/35069068	http://dx.doi.org/10.1038/35069068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279496				2022-12-28	WOS:000167859300048
J	Woolhouse, M; Donaldson, A				Woolhouse, M; Donaldson, A			Managing foot-and-mouth - The science of controlling disease outbreaks.	NATURE			English	Editorial Material							VACCINATION; EPIDEMICS; DYNAMICS		Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Inst Anim Hlth, Woking GU24 0NF, Surrey, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.			Woolhouse, Mark/0000-0003-3765-8167				ANDERSON R M, 1991; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; Donaldson AI, 1996, REV SCI TECH OIE, V15, P863, DOI 10.20506/rst.15.3.957; DONALDSON AI, 1999, DIS SHEEP, P254; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Knowles NJ, 2001, VET REC, V148, P258; Salt J. S., 1997, VET VACCINOLOGY, P641; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westergaard J., 1982, REPORT ERADICATION F; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; 2001, VET REC, V148, P286	14	52	54	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					515	516		10.1038/35069250	http://dx.doi.org/10.1038/35069250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279464				2022-12-28	WOS:000167859300018
J	Giurfa, M; Zhang, SW; Jenett, A; Menzel, R; Srinivasan, MV				Giurfa, M; Zhang, SW; Jenett, A; Menzel, R; Srinivasan, MV			The concepts of 'sameness' and 'difference' in an insect	NATURE			English	Article							HONEYBEES; PIGEONS; NAVIGATION; PATTERNS; STIMULI; ODDITY; MEMORY	Insects process and learn information flexibly to adapt to their environment. The honeybee Apis mellifera constitutes a traditional model for studying learning and memory at behavioural, cellular and molecular levels(1). Earlier studies focused on elementary associative and non-associative forms of learning determined by either olfactory conditioning of the proboscis extension reflex(1) or the learning of visual stimuli(2) in an operant context. However, research has indicated that bees are capable of cognitive performances that were thought to occur only in some vertebrate species. For example, honeybees can interpolate visual information(3), exhibit associative recall(4,5), categorize visual information(6-8) and learn contextual information(9). Here we show that honeybees can form 'sameness' and 'difference' concepts. They learn to solve 'delayed matching-to-sample' tasks, in which they are required to respond to a matching stimulus, and 'delayed non-matching-to-sample' tasks, in which they are required to respond to a different stimulus; they can also transfer the learned rules to new stimuli of the same or a different sensory modality. Thus, not only can bees learn specific objects and their physical parameters, but they can also master abstract inter-relationships, such as sameness and difference.	Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; Univ Toulouse 3, F-30162 Toulouse 4, France; Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia	Free University of Berlin; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Australian National University	Giurfa, M (corresponding author), Free Univ Berlin, Inst Biol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.		Giurfa, Martin MG/A-7322-2008; Zhang, Shaowu/C-9139-2009; Giurfa, Martin/AAS-4945-2020; Srinivasan, Mandyam V/G-5571-2010; Giurfa, Martin/H-5140-2016	Zhang, Shaowu/0000-0002-3551-5587; Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; Jenett, Arnim/0000-0003-3039-2060				COLLETT TS, 1995, J COMP PHYSIOL A, V177, P287, DOI 10.1007/BF00192418; Collett TS, 1997, J COMP PHYSIOL A, V181, P343, DOI 10.1007/s003590050120; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; Davey G., 1989, ECOLOGICAL LEARNING; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HATEREN JH, 1990, J COMP PHYSIOL A, V167, P649; HERMAN L M, 1974, Journal of the Experimental Analysis of Behavior, V21, P19, DOI 10.1901/jeab.1974.21-19; HOLMES PW, 1979, J EXP ANAL BEHAV, V31, P103, DOI 10.1901/jeab.1979.31-103; HORRIDGE GA, 1995, J INSECT PHYSIOL, V41, P681, DOI 10.1016/0022-1910(95)00021-L; LOMBARDI CM, 1984, ANIM LEARN BEHAV, V12, P2, DOI 10.3758/BF03199807; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; MOON LE, 1955, J COMP PHYSIOL PSYCH, V48, P188, DOI 10.1037/h0046959; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Strong PN, 1966, PSYCHON SCI, V5, P13, DOI 10.3758/BF03328254; THOMAS RK, 1973, ANIM LEARN BEHAV, V1, P151, DOI 10.3758/BF03214583; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Wright A.A., 1983, QUANTITATIVE ANAL BE, V4, P295; ZENTALL TR, 1978, J EXP ANAL BEHAV, V30, P177, DOI 10.1901/jeab.1978.30-177; Zhang SW, 1999, NEUROBIOL LEARN MEM, V72, P180, DOI 10.1006/nlme.1998.3901	23	394	403	3	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					930	933		10.1038/35073582	http://dx.doi.org/10.1038/35073582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	423AG	11309617				2022-12-28	WOS:000168152300046
J	Lu, YF; Yang, Y; Sellinger, A; Lu, MC; Huang, JM; Fan, HY; Haddad, R; Lopez, G; Burns, AR; Sasaki, DY; Shelnutt, J; Brinker, CJ				Lu, YF; Yang, Y; Sellinger, A; Lu, MC; Huang, JM; Fan, HY; Haddad, R; Lopez, G; Burns, AR; Sasaki, DY; Shelnutt, J; Brinker, CJ			Self-assembly of mesoscopically ordered chromatic polydiacetylene/silica nanocomposites	NATURE			English	Article							MESOPOROUS SILICA; FILMS; ACID; TRANSITION; NANOSTRUCTURES; COMPOSITES; LIPOSOMES; LAYER	Nature abounds with intricate composite architectures composed of hard and soft materials synergistically intertwined to provide both useful functionality and mechanical integrity. Recent synthetic efforts to mimic such natural designs have focused on nanocomposites(1-5), prepared mainly by slow procedures like monomer or polymer infiltration of inorganic nanostructures(6,7) or sequential deposition(8,9). Here we report the self-assembly of conjugated polymer/silica nanocomposite films with hexagonal, cubic or lamellar mesoscopic order using polymerizable amphiphilic diacetylene molecules as both structure-directing agents and monomers. The self-assembly procedure is rapid and incorporates the organic monomers uniformly within a highly ordered, inorganic environment. Polymerization results in polydiacetylene/silica nanocomposites that are optically transparent and mechanically robust. Compared to ordered diacetylene-containing films prepared as Langmuir monolayers(10) or by Langmuir-Blodgett deposition(10), the nanostructured inorganic host alters the diacetylene polymerization behaviour, and the resulting nanocomposite exhibits unusual chromatic changes in response to thermal, mechanical and chemical stimuli. The inorganic framework serves to protect, stabilize, and orient the polymer, and to mediate its function. The nanocomposite architecture also provides sufficient mechanical integrity to enable integration into devices and microsystems.	Univ New Mexico, Ctr Microengineered Ceram, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; Sandia Natl Labs, Adv Mat Lab, Albuquerque, NM 87106 USA	University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories	Brinker, CJ (corresponding author), Univ New Mexico, Ctr Microengineered Ceram, Albuquerque, NM 87131 USA.		Shelnutt, John A/A-9987-2009; Sellinger, Alan/C-6250-2015	Shelnutt, John A/0000-0001-7368-582X; Sellinger, Alan/0000-0001-6705-1548				Asefa T, 2000, J MATER CHEM, V10, P1751, DOI 10.1039/b000950o; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; BURNS AR, IN PRESS TRIBOL LETT; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Cheng Q, 1998, LANGMUIR, V14, P1974, DOI 10.1021/la980185b; Cheng Q, 2000, LANGMUIR, V16, P5333, DOI 10.1021/la9916169; COLLINS MA, 1988, J POLYM SCI POL PHYS, V26, P367, DOI 10.1002/polb.1988.090260212; Dagani R, 1999, CHEM ENG NEWS, V77, P25, DOI 10.1021/cen-v077n023.p025; DAY D, 1978, J POLYM SCI POL LETT, V16, P205, DOI 10.1002/pol.1978.130160501; DAY DR, 1981, J APPL POLYM SCI, V26, P1605, DOI 10.1002/app.1981.070260516; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; FRANKEL DA, 1991, J AM CHEM SOC, V113, P7436, DOI 10.1021/ja00019a059; FRYE GC, 1988, MATER RES SOC S P, V121, P349; GAINES GL, 1966, INSOLUBLE MONOLAYERS, P281; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, pCH17; KELLER SW, 1994, J AM CHEM SOC, V116, P8817, DOI 10.1021/ja00098a055; KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370; Kuriyama K, 1996, LANGMUIR, V12, P6468, DOI 10.1021/la960164m; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Mazumdar S, 2000, SCIENCE, V288, P630, DOI 10.1126/science.288.5466.630; Menzel H, 1998, J PHYS CHEM B, V102, P9550, DOI 10.1021/jp9830023; Moller K, 1998, CHEM MATER, V10, P1841, DOI 10.1021/cm980020o; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; Nguyen TQ, 2000, SCIENCE, V288, P652, DOI 10.1126/science.288.5466.652; PATEL GN, 1979, J CHEM PHYS, V70, P4387, DOI 10.1063/1.438012; Sasaki DY, 2000, J COLLOID INTERF SCI, V229, P490, DOI 10.1006/jcis.2000.7043; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; Smith RC, 1997, J AM CHEM SOC, V119, P4092, DOI 10.1021/ja963837w; SPEVAK W, 1993, J AM CHEM SOC, V115, P1146, DOI 10.1021/ja00056a047; SUZUOKI Y, 1991, P 7 INT S EL IEEE NE, P850	32	506	529	6	280	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					913	917		10.1038/35073544	http://dx.doi.org/10.1038/35073544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309612				2022-12-28	WOS:000168152300041
J	Xie, JY; Black, DL				Xie, JY; Black, DL			A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels	NATURE			English	Article							PRE-MESSENGER-RNA; ACTIVATED POTASSIUM CHANNELS; ADRENAL CHROMAFFIN CELLS; COMBINATORIAL CONTROL; BINDING-PROTEIN; HAIR-CELLS; EXPRESSION; MECHANISM; VARIANTS; KINASE	Calcium regulation of gene expression is critical for the longlasting activity-dependent changes in cellular electrical properties that underlie important physiological functions such as learning and memory(1). Cellular electrical properties are diversified through the extensive alternative splicing of ion channel premessenger RNAs2; however, the regulation of splicing by cell signalling pathways has not been well explored. Here we show that depolarization of GH(3) pituitary cells represses splicing of the STREX exon(3) in BK potassium channel transcripts through the action of Ca2+/calmodulin-dependent protein kinases (CaMKs). Overexpressing constitutively active CaMK IV, but not CaMK I or II, specifically decreases STREX inclusion in the mRNA. This decrease is prevented by mutations in particular RNA repressor sequences. Transferring 54 nucleotides from the 3' splice site upstream of STREX to a heterologous gene is sufficient to confer CaMK IV repression on an otherwise constitutive exon. These experiments define a CaMK IV-responsive RNA element (CaRRE), which mediates the alternative splicing of ion channel pre-mRNAs. The CaRRE presents a unique molecular target for inducing long-term adaptive changes in cellular electrical properties. It also provides a model system for dissecting the effect of signal transduction pathways on alternative splicing.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Ferrer J, 1996, DIABETOLOGIA, V39, P891, DOI 10.1007/BF00403907; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Hille B., 1992, IONIC CHANNELS EXCIT; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Lingle C J, 1996, Ion Channels, V4, P261; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; ROSE ML, 1997, CARDIOVASC ENG, V2, P19; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Spitzer NC, 1998, J NEUROBIOL, V37, P190, DOI 10.1002/(SICI)1097-4695(199810)37:1<190::AID-NEU14>3.3.CO;2-2; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530; Zhang L, 1996, RNA, V2, P682	30	197	203	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					936	939		10.1038/35073593	http://dx.doi.org/10.1038/35073593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309619				2022-12-28	WOS:000168152300048
J	Goodburn, E; Campbell, O				Goodburn, E; Campbell, O			Reducing maternal mortality in the developing world: sector-wide approaches may be the key	BRITISH MEDICAL JOURNAL			English	Article							SAFE MOTHERHOOD; COUNTRIES		John Snow Int UK, Ctr Sexual & Reprod Hlth, London NW5 1TL, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Maternal Hlth Programme, London WC1B 3DP, England	University of London; London School of Hygiene & Tropical Medicine	Goodburn, E (corresponding author), John Snow Int UK, Ctr Sexual & Reprod Hlth, London NW5 1TL, England.			Campbell, Oona/0000-0002-9311-0115				Campbell OM, 1999, SAFE MOTHERHOOD INIT, P31; CASSELS A, 1997, GUIDE SECTOR WIDE AP; Central Statistical Office (Zimbabwe) and Macro International Inc, 1995, ZIMB DEM HLTH SURV 1; *DEP INT DEV, 2000, BETT HLTH POOR PEOPL, P12; *EUR COMM UN POP F, 2000, EC UNFPA IN REPR HLT; *FAM CAR INT, 1994, CAIR INT C POP DEV P, P16; Garner P, 2000, BMJ-BRIT MED J, V321, P129, DOI 10.1136/bmj.321.7254.129; GRAHAM WJ, 1997, QUESTION SURVIVAL RE; Hilton M.J., 2021, RAKIURA DUNE RESTORA; *INT GROUP SAF MOT, 1998, SAF MOTH ACT AG PRIO, P25; *INT GROUP SAF MOT, 1998, SAF MOTH ACT AG PRIO, P15; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Kaufman J, 1997, IDS BULL-I DEV STUD, V28, P61; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; LUSH L, INT COOPERATION HLTH; Maine D, 1991, SAFE MOTHERHOOD PROG; WHO, 1994, MOTH BAB PACK IMPL S; *WHO UN CHILDR FUN, 1996, REV 1990 EST MAT MOR; World Bank, 1993, WORLD DEV REP INV HL; ZEITLIN J, 1994, POPULATION POLICIES, P233	20	75	79	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					917	920		10.1136/bmj.322.7291.917	http://dx.doi.org/10.1136/bmj.322.7291.917			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302911	Green Published, Green Accepted			2022-12-28	WOS:000168311300028
J	Smith, IC; Jones, MW				Smith, IC; Jones, MW			Surgeons' attitudes to intraoperative death: questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Dept Trauma & Orhtopaed, Bangor LL57 2PW, Gwynedd, Wales		Smith, IC (corresponding author), Dept Trauma & Orhtopaed, Bangor LL57 2PW, Gwynedd, Wales.	lasoksmith@aol.com						Firth-Cozens J, 1999, HOSP MED, V60, P751, DOI 10.12968/hosp.1999.60.10.1222; Gottlieb S, 1999, BRIT MED J, V318, P349	2	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					896	897		10.1136/bmj.322.7291.896	http://dx.doi.org/10.1136/bmj.322.7291.896			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302903	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168311300021
J	Tian, B; Reser, D; Durham, A; Kustov, A; Rauschecker, JP				Tian, B; Reser, D; Durham, A; Kustov, A; Rauschecker, JP			Functional specialization in rhesus monkey auditory cortex	SCIENCE			English	Article							SOUND-LOCALIZATION BEHAVIOR; MACAQUE MONKEYS; CEREBRAL-CORTEX; COMPLEX SOUNDS; CONNECTIONS; NEURONS; AREAS; SUBDIVISIONS; STREAMS; HUMANS	Neurons in the Lateral belt areas of rhesus monkey auditory cortex prefer complex sounds to pure tones, but functional specializations of these multiple maps in the superior temporal region have not been determined. We tested the specificity of neurons in the Lateral belt with species-specific communication calls presented at different azimuth positions. We found that neurons in the anterior belt are more selective for the type of call, whereas neurons in the caudal belt consistently show the greatest spatial selectivity. These results suggest that cortical processing of auditory spatial and pattern information is performed in specialized streams rather than one homogeneously distributed system.	Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA	Georgetown University	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA.		Rauschecker, Josef P/A-4120-2013	Reser, David/0000-0002-5130-1255; Rauschecker, Josef P./0000-0003-4353-9084	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003489, R03DC003845] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03-DC03845, R01-DC03489] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bregman A.S., 1990, AUDITORY SCENE ANAL; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Hauser, 1996, EVOL COMMUN; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Jones E. G., 1985, CEREB CORTEX, V4, P3; JONES EG, 1995, J COMP NEUROL, V362, P153, DOI 10.1002/cne.903620202; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Konishi M., 1988, AUDITORY FUNCTION NE, P721; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; RAJAN R, 1990, J NEUROPHYSIOL, V64, P872, DOI 10.1152/jn.1990.64.3.872; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549	31	512	518	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					290	293		10.1126/science.1058911	http://dx.doi.org/10.1126/science.1058911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303104				2022-12-28	WOS:000168074000048
J	Osendarp, SJM; van Raaij, JMA; Darmstadt, GL; Baqui, AH; Hautvast, JGAJ; Fuchs, GJ				Osendarp, SJM; van Raaij, JMA; Darmstadt, GL; Baqui, AH; Hautvast, JGAJ; Fuchs, GJ			Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomised placebo controlled trial	LANCET			English	Article							BODY-COMPOSITION; INFECTIOUS-DISEASES; IMMUNE FUNCTION; CHILDREN; INTERVENTION; MORTALITY; DIARRHEA; SIZE; TERM; AGE	Background infant malnutrition and mortality rates are high in less-developed countries especially in low-birthweight infants. Zinc deficiency is also widely prevalent in these circumstances. We aimed to assess the effect of daily zinc supplements given to pregnant mothers on their infants' growth and morbidity. Methods We did a double-blind, placebo controlled. randomised trial in 199 and 221 Bangladeshi infants whose mothers took 30 mg daily elemental zinc or placebo, respectively, from 12 to 16 weeks' gestation until delivery. Infants were followed up until 6 months of age. We obtained data for morbidity every week by mothers' recall. Infants' anthropometric measurements were done every month, and their serum zinc was assessed at 1 and 6 months of age. Findings Infants of mothers who received zinc during pregnancy had at age 6 months reduced risks compared with those in the placebo group for acute diarrhoea (risk ratio 0.84; 95% CI 0.72-0.98), dysentery (0.36; 0.25-0.84). and impetigo (0.53; 0.34-0.82). These reductions were seen in low-birthweight infants but not in those with normal birthweight. There were no differences in infant growth or serum zinc concentrations between treatment groups. Interpretation Maternal zinc supplementation during pregnancy resulted in a reduction of the health risks in Bangladeshi low-birthweight infants. although this intervention did not improve birthweight. Whether zinc should be added to usual antenatal supplements in regions with high rates of low birthweight should be reviewed.	Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, Dhaka 1000, Bangladesh; Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, NL-6700 HB Wageningen, Netherlands; Univ Washington, Sch Med, Dept Paediat, Seattle, WA USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Johns Hopkins Med Inst, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Louisiana State Univ, Sch Med, Dept Pediat, New Orleans, LA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Wageningen University & Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Medicine; Louisiana State University System	Fuchs, GJ (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, GPO Box 128, Dhaka 1000, Bangladesh.	gjfuchs@bigfoot.com	Fuchs, George/GLV-1285-2022; Darmstadt, Gary/AAU-7488-2020	Fuchs, George/0000-0002-8679-8265; 				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 1998, AM J CLIN NUTR, V68, p476S, DOI 10.1093/ajcn/68.2.476S; Brown KH, 1998, BIBL NUTR DIET, P76; CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0; CASTILLODURAN C, 1995, J PEDIATR-US, V127, P206, DOI 10.1016/S0022-3476(95)70296-2; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; Caulfield LE, 1999, J NUTR, V129, P1563, DOI 10.1093/jn/129.8.1563; DARMSTADT GL, 1992, ARCH DERMATOL, V128, P1358, DOI 10.1001/archderm.128.10.1358; de Onis M, 1998, EUR J CLIN NUTR, V52, pS83; Dewey KG, 1999, AM J CLIN NUTR, V69, P679; Ferro-Luzzi A, 1998, EUR J CLIN NUTR, V52, pS97; Gardner JMM, 1998, EUR J CLIN NUTR, V52, P34, DOI 10.1038/sj.ejcn.1600509; GOLUB MS, 1984, AM J CLIN NUTR, V40, P1290, DOI 10.1093/ajcn/40.6.1192; Hashim Z, 1996, INT J FOOD SCI NUTR, V47, P383, DOI 10.3109/09637489609006951; Kikafunda JK, 1998, AM J CLIN NUTR, V68, P1261, DOI 10.1093/ajcn/68.6.1261; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; Krebs NF, 1998, AM J CLIN NUTR, V68, p509S, DOI 10.1093/ajcn/68.2.509S; KUSIN JA, 1992, LANCET, V340, P623, DOI 10.1016/0140-6736(92)92168-F; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Osendarp SJM, 2000, AM J CLIN NUTR, V71, P114; POJDA J, 2000, 18 ACCSCN NUTR POL; Rosado JL, 1997, AM J CLIN NUTR, V65, P13, DOI 10.1093/ajcn/65.1.13; Ruz M, 1997, AM J CLIN NUTR, V66, P1406, DOI 10.1093/ajcn/66.6.1406; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Tamura T, 2000, AM J CLIN NUTR, V71, P109; THWIN AA, ICDDR B SPECIAL PUBL; VICTORA CG, 1988, PEDIATRICS, V81, P807	31	103	104	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1080	1085		10.1016/S0140-6736(00)04260-4	http://dx.doi.org/10.1016/S0140-6736(00)04260-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297959				2022-12-28	WOS:000167996200010
J	Giger, RJ; Kolodkin, AL				Giger, RJ; Kolodkin, AL			Silencing the siren: Guidance cue hierarchies at the CNS midline	CELL			English	Review							AXON GUIDANCE; NETRIN-1; SLIT		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu						Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Rusch J, 2000, NEURON, V28, P637, DOI 10.1016/S0896-6273(00)00143-4; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Zinn K, 1999, CELL, V97, P1, DOI 10.1016/S0092-8674(00)80707-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	12	39	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					1	4		10.1016/S0092-8674(01)00290-2	http://dx.doi.org/10.1016/S0092-8674(01)00290-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11300996	Bronze			2022-12-28	WOS:000168063300001
J	Hernandez, PA; Notsu, K; Salazar, JM; Mori, T; Natale, G; Okada, H; Virgili, G; Shimoike, Y; Sato, M; Perez, NM				Hernandez, PA; Notsu, K; Salazar, JM; Mori, T; Natale, G; Okada, H; Virgili, G; Shimoike, Y; Sato, M; Perez, NM			Carbon dioxide degassing by advective flow from Usu volcano, Japan	SCIENCE			English	Article							VULCANO-ISLAND; EMISSIONS; CO2; ERUPTIONS; SOILS	Magmatic carbon dioxide (CO2) degassing has been documented before the 31 March 2000 eruption of Usu volcano, Hokkaido, Japan. Six months before the eruption, an increase in CO2 flux was detected on the summit caldera, from 120 (September 1998) to 340 metric tons per day (September 1999), followed by a sudden decrease to 39 metric tons per day in June 2000, 3 months after the eruption. The change in CO2 flux and seismic observations suggests that before the eruption, advective processes controlled gas migration toward the surface. The decrease in flux after the eruption at the summit caldera could be due to a rapid release of CO2 during the eruption from ascending dacitic dikes spreading away from the magma chamber beneath the caldera.	Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan; Inst Tecnol & Energias Renovables, Div Environm Res, Granadilla De Abona 38611, Santa Cruz De T, Spain; Hokkaido Univ, Usu Volcano Observ, Sohbetsu, Hokkaido 0520103, Japan; WEST Syst, I-56025 Pontedera, PI, Italy	University of Tokyo; Hokkaido University	Hernandez, PA (corresponding author), Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan.		Rodríguez, Nemesio M. Pérez/H-9295-2015; SALAZAR, JOSÉ MIGUEL LORENZO/H-6385-2017; HERNANDEZ, PEDRO A/H-8079-2015	Rodríguez, Nemesio M. Pérez/0000-0003-1410-7717; SALAZAR, JOSÉ MIGUEL LORENZO/0000-0002-5135-2861; HERNANDEZ, PEDRO A/0000-0003-4707-515X; Mori, Toshiya/0000-0003-4570-0951				ALLARD P, 1991, NATURE, V351, P387, DOI 10.1038/351387a0; BAUBRON JC, 1990, NATURE, V344, P51, DOI 10.1038/344051a0; BAUBRON JC, 1991, J GEOL SOC LONDON, V148, P571, DOI 10.1144/gsjgs.148.3.0571; BAUBRON JC, 1991, NAP 91 INT ACT VOLC; Carbonnelle J., 1982, B PIRPSEV CNRS, V55; Chiodini G, 1998, APPL GEOCHEM, V13, P543, DOI 10.1016/S0883-2927(97)00076-0; Chiodini G, 1996, B VOLCANOL, V58, P41, DOI 10.1007/s004450050124; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; GERLACH TM, 1985, NATURE, V313, P273, DOI 10.1038/313273a0; Gerlach TM, 1998, GEOPHYS RES LETT, V25, P1947, DOI 10.1029/98GL01298; GIGGENBACH WF, 1991, APPL GEOCHEM, V6, P125, DOI 10.1016/0883-2927(91)90024-J; GREENLAND LP, 1985, GEOCHIM COSMOCHIM AC, V49, P125, DOI 10.1016/0016-7037(85)90196-6; Hedenquist J.W., 1992, 279 GEOL SURV JAP, V279; Journel A.G., 1988, PRINCIPLES ENV SAMPL, P45; LAI SH, 1976, SOIL SCI SOC AM J, V40, P3, DOI 10.2136/sssaj1976.03615995004000010006x; Oba Y., 1966, JOUR FS HOKKAIDO UNI, V4, P185; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Penman HL, 1940, J AGR SCI, V30, P437, DOI 10.1017/S0021859600048164; SANO Y, 1985, J GEOPHYS RES-SOLID, V90, P8729, DOI 10.1029/JB090iB10p08729; *SIMTHS I, 2000, B GLOB VOLC NETW, V25, P2; Sinclair A. J., 1974, J GEOCHEM EXPLOR, V3, P129, DOI [10.1016/0375-6742(74)90030-2, DOI 10.1016/0375-6742(74)90030-2]; Smithsonian Institution, 2000, B GLOBAL VOLCANISM N, V25, P2; Yokoyama I, 2000, EARTH PLANETS SPACE, V52, P73, DOI 10.1186/BF03351616	23	112	114	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					83	86		10.1126/science.1058450	http://dx.doi.org/10.1126/science.1058450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292867				2022-12-28	WOS:000167995200041
J	Monteverde, M; Nunez-Regueiro, M; Rogado, N; Regan, KA; Hayward, MA; He, T; Loureiro, SM; Cava, RJ				Monteverde, M; Nunez-Regueiro, M; Rogado, N; Regan, KA; Hayward, MA; He, T; Loureiro, SM; Cava, RJ			Pressure dependence of the superconducting transition temperature of magnesium diboride	SCIENCE			English	Article							CASI2; PHASE; 150-K	We studied the pressure and temperature dependence of the electrical resistivity of the superconducting compound magnesium diboride (MgB2). The superconducting transition temperature decreases monotonically with pressure, being parabolic or linear, depending on samples. The rate of decrease under pressure is higher than in conventional superconductors. We discuss our results in terms of the semimetallic character of the electronic band structure of MgB2.	CNRS, Ctr Rech Tres Basses Temp, F-38042 Grenoble 09, France; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Mat Inst, Princeton, NJ 08544 USA	Centre National de la Recherche Scientifique (CNRS); Princeton University; Princeton University	Nunez-Regueiro, M (corresponding author), CNRS, Ctr Rech Tres Basses Temp, BP 166, F-38042 Grenoble 09, France.	nunez@polycnrs-gre.fr	Monteverde, Miguel/F-8984-2011; Hayward, Michael/B-8005-2008	Hayward, Michael/0000-0002-6248-2063				ABELES B, 1975, ADV PHYS, V24, P407, DOI 10.1080/00018737500101431; AKIMITSU J, 2001, S TRANS MET OX SEND; Anderson PW, 2000, SCIENCE, V288, P480, DOI 10.1126/science.288.5465.480; Bordet P, 2000, PHYS REV B, V62, P11392, DOI 10.1103/PhysRevB.62.11392; Bud'ko SL, 2001, PHYS REV LETT, V86, P1877, DOI 10.1103/PhysRevLett.86.1877; CAO L, 1994, PHYS REV A, V50, P4244, DOI 10.1103/PhysRevA.50.4244; CAVA RJ, 1994, NATURE, V367, P146, DOI 10.1038/367146a0; CHU CW, 1993, NATURE, V365, P323, DOI 10.1038/365323a0; GINSBURG VL, 1982, HIGH TEMPERATURE SUP; HIRSCH JE, CONDMAT0102115; HORN PM, 1977, PHYS REV B, V16, P491, DOI 10.1103/PhysRevB.16.491; KORTUS J, CONDMAT0101446; MATTHIAS BT, 1972, SUPERCONDUCTIVITY D, P367; MCMILLAN WL, 1968, PHYS REV, V167, P331, DOI 10.1103/PhysRev.167.331; Nunez-Regueiro M., 1997, STUD HIGH T, V24, P203; NUNEZREGUEIRO M, 1993, SCIENCE, V262, P97, DOI 10.1126/science.262.5130.97; NUNEZREGUEIRO MD, 1994, PHYSICA C, V235, P991, DOI 10.1016/0921-4534(94)91720-5; Sanfilippo S, 2000, PHYS REV B, V61, pR3800, DOI 10.1103/PhysRevB.61.R3800; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; TAKAGI H, 1992, PHYS REV LETT, V69, P2975, DOI 10.1103/PhysRevLett.69.2975	20	117	121	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					75	77		10.1126/science.1059775	http://dx.doi.org/10.1126/science.1059775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11283353				2022-12-28	WOS:000167995200038
J	Srinivasarao, M; Collings, D; Philips, A; Patel, S				Srinivasarao, M; Collings, D; Philips, A; Patel, S			Three-dimensionally ordered array of air bubbles in a polymer film	SCIENCE			English	Article							CRYSTAL; CRYSTALLIZATION; LITHOGRAPHY; SUPPRESSION; COALESCENCE; POLYSTYRENE; COPOLYMERS; TEMPLATES; SILICA	We report the formation of a three-dimensionally ordered array of air bubbles of monodisperse pore size in a polymer film through a templating mechanism based on thermocapillary convection. Dilute solutions of a simple, coil-like polymer in a volatile solvent are cast on a glass slide in the presence of moist air flowing across the surface, Evaporative cooling and the generation of an ordered array of breath figures Leads to the formation of multilayers of hexagonally packed water droplets that are preserved in the final, solid polymer film as spherical air bubbles. The dimensions of these bubbles can be controlled simply by changing the velocity of the airflow across the surface. When these three-dimensionally ordered macroporous materials have pore dimensions comparable to the wavelength of visible Light, they are of interest as photonic band gaps and optical stop-bands.	Georgia Inst Technol, Sch Text & Fiber Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; N Carolina State Univ, Dept Bot, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Text Engn Chem & Sci, Raleigh, NC 27695 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Alcatel-Lucent; Lucent Technologies; AT&T	Srinivasarao, M (corresponding author), Georgia Inst Technol, Sch Text & Fiber Engn, Atlanta, GA 30332 USA.		Srinivasarao, Mohan/M-9810-2013; Srinivasarao, Mohan/L-4041-2019	Collings, David/0000-0003-3863-5979				Aitkek J, 1911, NATURE, V86, P516, DOI DOI 10.1038/086516A0; BAKER JT, 1922, PHILOS MAG, V56, P752; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; BEYSENS D, 1986, PHYS REV LETT, V57, P1433, DOI 10.1103/PhysRevLett.57.1433; BEYSENS D, 1991, PHASE TRANSIT, V31, P219, DOI 10.1080/01411599108206932; Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; BRAGG WL, 1947, P ROY SOC LOND A MAT, V190, P474; BRISCOE BJ, 1990, J PHYS D APPL PHYS, V23, P422, DOI 10.1088/0022-3727/23/4/005; Busch K, 1999, PHYS REV LETT, V83, P967, DOI 10.1103/PhysRevLett.83.967; Dam TH, 1999, REV SCI INSTRUM, V70, P3982, DOI 10.1063/1.1150024; Davis SA, 1997, NATURE, V385, P420, DOI 10.1038/385420a0; Dell'Aversana P, 1998, PHYS TODAY, V51, P38, DOI 10.1063/1.882133; DellAversana P, 1997, PHYS FLUIDS, V9, P2475, DOI 10.1063/1.869471; DellAversana P, 1996, PHYS FLUIDS, V8, P15, DOI 10.1063/1.868811; DUSHKIN CD, 1993, LANGMUIR, V9, P3695, DOI 10.1021/la00036a055; FAMILY F, 1988, PHYS REV LETT, V61, P428, DOI 10.1103/PhysRevLett.61.428; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Imhof A, 1997, NATURE, V389, P948, DOI 10.1038/40105; Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Karthaus O, 2000, LANGMUIR, V16, P6071, DOI 10.1021/la0001732; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kulinowski KM, 2000, ADV MATER, V12, P833, DOI 10.1002/(SICI)1521-4095(200006)12:11<833::AID-ADMA833>3.0.CO;2-X; Li Z, 1996, J AM CHEM SOC, V118, P10892, DOI 10.1021/ja961713d; Limaye AV, 1996, PHYS REV LETT, V76, P3762, DOI 10.1103/PhysRevLett.76.3762; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; MORKVED TL, 1994, APPL PHYS LETT, V64, P422, DOI 10.1063/1.111118; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Pitois O, 1999, EUR PHYS J B, V8, P225, DOI 10.1007/s100510050685; Pitois O, 1999, COLLOID POLYM SCI, V277, P574, DOI 10.1007/s003960050427; Rayleigh, 1911, NATURE, V86, P416, DOI 10.1038/086416d0; RAYLEIGH, 1899, PHILOS MAG, V36, P21; RAYLEIGH, 1912, NATURE, V90, P436; RAYLEIGH, 1882, P ROY SOC LONDON, V34, P130; Rayleigh Lord, 1879, P ROY SOC LONDON, V28, P406; Reynolds O., 1881, CHEM NEWS, V44, P211; Rossier JS, 1999, ANAL CHEM, V71, P4294, DOI 10.1021/ac981382i; SRINIVASARAO M, UNPUB; Velev OD, 1997, NATURE, V389, P447, DOI 10.1038/38921; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; Walker J., 1978, SCI AM, V238, P123; WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yan HW, 1999, ADV MATER, V11, P1003, DOI 10.1002/(SICI)1521-4095(199908)11:12<1003::AID-ADMA1003>3.0.CO;2-K; ZHONG XF, 1994, MACROMOLECULES, V27, P1751, DOI 10.1021/ma00085a013	46	789	827	11	428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					79	83		10.1126/science.1057887	http://dx.doi.org/10.1126/science.1057887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292866				2022-12-28	WOS:000167995200040
J	Borgstein, J				Borgstein, J			A sense sf language	LANCET			English	Editorial Material									Univ Rotterdam Hosp, NL-3015 GD Rotterdam, Netherlands; Natl Inst Resp Dis, Mexico City, DF, Mexico; Natl Autonomous Univ Mexico, Mexico City 04510, DF, Mexico	Erasmus University Rotterdam; Erasmus MC; Universidad Nacional Autonoma de Mexico	Borgstein, J (corresponding author), Univ Rotterdam Hosp, Dr Molewaterpl 60, NL-3015 GD Rotterdam, Netherlands.								0	2	2	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1036	1037		10.1016/S0140-6736(00)04241-0	http://dx.doi.org/10.1016/S0140-6736(00)04241-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293610				2022-12-28	WOS:000167791500037
J	Tabazadeh, A; Jensen, EJ; Toon, OB; Drdla, K; Schoeberl, MR				Tabazadeh, A; Jensen, EJ; Toon, OB; Drdla, K; Schoeberl, MR			Role of the stratospheric polar freezing belt in denitrification	SCIENCE			English	Article							NITRIC-ACID TRIHYDRATE; HYDROGEN-CHLORIDE; PARTICLE-SIZE; OZONE; CLOUDS; HNO3; WINTER; NITRATE; LOSSES; GROWTH	Homogeneous freezing of nitric acid hydrate particles can produce a polar freezing belt in either hemisphere that can cause denitrification. Computed denitrification profiles for one Antarctic and two Arctic cold winters are presented. The vertical range over which denitrification occurs is normally quite deep in the Antarctic but limited in the Arctic. A 4 kelvin decrease in the temperature of the Arctic stratosphere due to anthropogenic and/or natural effects can trigger the occurrence of widespread severe denitrification. Ozone loss is amplified in a denitrified stratosphere, so the effects of falling temperatures in promoting denitrification must be considered in assessment studies of ozone recovery trends.	NASA, Ames Res Ctr, Div Earth Sci, Moffett Field, CA 94035 USA; Univ Colorado, Program Atmospher & Ocean Sci, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tabazadeh, A (corresponding author), NASA, Ames Res Ctr, Div Earth Sci, MS-245-4, Moffett Field, CA 94035 USA.	atabazadeh@mail.arc.nasa.gov						Bertram AK, 2000, J GEOPHYS RES-ATMOS, V105, P9283, DOI 10.1029/1999JD901174; CARSLAW KS, 1994, GEOPHYS RES LETT, V21, P2479, DOI 10.1029/94GL02799; CRUTZEN PJ, 1986, NATURE, V324, P651, DOI 10.1038/324651a0; DYE JE, 1992, J GEOPHYS RES-ATMOS, V97, P8015, DOI 10.1029/91JD02740; Fahey DW, 2001, SCIENCE, V291, P1026, DOI 10.1126/science.1057265; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; HANSON D, 1988, GEOPHYS RES LETT, V15, P855, DOI 10.1029/GL015i008p00855; Hintsa EJ, 1998, GEOPHYS RES LETT, V25, P501, DOI 10.1029/98GL00115; JENSEN EJ, 1994, J GEOPHYS RES-ATMOS, V99, P10443, DOI 10.1029/94JD00226; Kondo Y, 2000, GEOPHYS RES LETT, V27, P337, DOI 10.1029/1999GL011081; Manney GL, 2000, GEOPHYS RES LETT, V27, P2589, DOI 10.1029/2000GL011703; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; MOLINA MJ, 1987, SCIENCE, V238, P1253, DOI 10.1126/science.238.4831.1253; SALAWITCH RJ, 1989, NATURE, V339, P525, DOI 10.1038/339525a0; Salcedo D, 2001, J PHYS CHEM A, V105, P1433, DOI 10.1021/jp001639s; Santee ML, 2000, GEOPHYS RES LETT, V27, P3213, DOI 10.1029/2000GL011738; Santee ML, 1999, J GEOPHYS RES-ATMOS, V104, P8225, DOI 10.1029/1998JD100089; SCHOEBERL MR, 1993, J GEOPHYS RES-ATMOS, V98, P2949, DOI 10.1029/92JD02517; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STANFORD JL, 1974, B AM METEOROL SOC, V55, P213, DOI 10.1175/1520-0477(1974)055<0213:ACOSCR>2.0.CO;2; Tabazadeh A, 2000, GEOPHYS RES LETT, V27, P1111, DOI 10.1029/1999GL010966; Tabazadeh A, 2000, SCIENCE, V288, P1407, DOI 10.1126/science.288.5470.1407; TABAZADEH A, 1994, GEOPHYS RES LETT, V21, P1619, DOI 10.1029/94GL01368; Tolbert MA, 1996, SCIENCE, V272, P1597, DOI 10.1126/science.272.5268.1597; TOLBERT MA, 1987, SCIENCE, V238, P1258, DOI 10.1126/science.238.4831.1258; TOON OB, 1986, GEOPHYS RES LETT, V13, P1284, DOI 10.1029/GL013i012p01284; TOON OB, 1990, GEOPHYS RES LETT, V17, P445, DOI 10.1029/GL017i004p00445; Toon OB, 2000, J GEOPHYS RES-ATMOS, V105, P20589, DOI 10.1029/2000JD900144; Voigt C, 2000, SCIENCE, V290, P1756, DOI 10.1126/science.290.5497.1756; *WMO, 1999, 44 WMO, pCH3; WORSNOP DR, 1993, SCIENCE, V259, P71, DOI 10.1126/science.259.5091.71	32	88	88	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2591	2594		10.1126/science.1057228	http://dx.doi.org/10.1126/science.1057228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283368				2022-12-28	WOS:000167861000038
J	Roig, FA; Le-Quesne, C; Boninsegna, JA; Briffa, KR; Lara, A; Grudd, H; Jones, PD; Villagran, C				Roig, FA; Le-Quesne, C; Boninsegna, JA; Briffa, KR; Lara, A; Grudd, H; Jones, PD; Villagran, C			Climate variability 50,000 years ago in mid-latitude Chile as reconstructed from tree rings	NATURE			English	Article							SOUTHERN LAKE DISTRICT; LLANQUIHUE GLACIATION; ISLA GRANDE; CHRONOLOGY; PLEISTOCENE; ICE	High-resolution proxies of past climate are essential for a better understanding of the climate system(1). Tree rings are routinely used to reconstruct Holocene climate variations at high temporal resolution(2), but only rarely have they offered insight into climate variability during earlier periods(3). Fitzroya cupressoides-a South American conifer which attains ages up to 3,600 years-has been shown to record summer temperatures in northern Patagonia during the past few millennia(4). Here we report a floating 1,229-year chronology developed from subfossil stumps of F. cupressoides in southern Chile that dates back to approximately 50,000 C-14 years before present. We use this chronology to calculate the spectral characteristics of climate variability in this time, which was probably an interstadial (relatively warm) period. Growth oscillations at periods of 150-250, 87-94, 45.5, 24.1, 17.8, 9.3 and 2.7-5.3 years are identified in the annual subfossil record. A comparison with the power spectra of chronologies derived from living F. cupressoides trees shows strong similarities with the 50,000-year-old chronology, indicating that similar growth forcing factors operated in this glacial interstadial phase as in the current interglacial conditions.	Consejo Nacl Invest Cient & Tecn, IANIGLA, Lab Dendrocronol, RA-5500 Mendoza, Argentina; Univ Oviedo, Fac Biol, Dept Bot, E-33006 Oviedo, Spain; Univ Austral Chile, Inst Silvicultura, Valdivia, Chile; Univ E Anglia, Sch Environm Sci, Climate Res Unit, Norwich NR4 7TJ, Norfolk, England; Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden; Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of Oviedo; Universidad Austral de Chile; University of East Anglia; Stockholm University; Universidad de Chile	Roig, FA (corresponding author), Consejo Nacl Invest Cient & Tecn, IANIGLA, Lab Dendrocronol, CC 330, RA-5500 Mendoza, Argentina.	froig@lab.cricyt.edu.ar	Grudd, Håkan/G-7952-2012; Briffa, Keith/C-8834-2009; Jones, Philip Douglas/C-8718-2009	Grudd, Håkan/0000-0002-9033-2505; Jones, Philip Douglas/0000-0001-5032-5493; Lara, Antonio/0000-0003-4998-4584; Briffa, Keith/0000-0003-3323-3639				[Anonymous], 1987, DIGITAL SPECTRAL ANA; BONINSEGNA JA, 1992, CLIMATE A D 1500; BRADLEY RS, 1992, QUATERNARY PALEOCLIM; Burg J. P, 1978, MODERN SPECTRUM ANAL, P42; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; COOK JA, 1995, PSYCHOTHERAPY REHABI, V4, P5; Denton GH, 1999, GEOGR ANN A, V81A, P167, DOI 10.1111/1468-0459.00057; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; Fritts H.C., 1991, RECONSTRUCTING LARGE; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Heusser CJ, 2000, J QUATERNARY SCI, V15, P115, DOI 10.1002/(SICI)1099-1417(200002)15:2<115::AID-JQS502>3.0.CO;2-F; Jenkins G., 1968, SPECTRAL ANAL ITS AP; KLOHN C, 1976, Z NATURFREUNDE WANDE, P75; Lamy F, 1998, PALAEOGEOGR PALAEOCL, V141, P233, DOI 10.1016/S0031-0182(98)90052-9; LARA A, 1993, SCIENCE, V260, P1104, DOI 10.1126/science.260.5111.1104; LARA A, 2000, DENDROCRONOLOGIA AM, P217; Lara A., 1991, THESIS U COLORADO; Leventer A, 1996, GEOL SOC AM BULL, V108, P1626, DOI 10.1130/0016-7606(1996)108<1626:PCOYIT>2.3.CO;2; Lomnitz C., 1970, SODERDRUCK GEOLOGISC, P938, DOI [10.1007/BF02042278, DOI 10.1007/BF02042278]; Markgraf V, 1992, CLIM DYNAM, V6, P193, DOI 10.1007/BF00193532; Miller A, 1976, WORLD SURVEY CLIMATO, V12, P113; OLDFIELD F, 1998, 45 IGBP; PILCHER JR, 1984, NATURE, V312, P150, DOI 10.1038/312150a0; PORTER SC, 1981, QUATERNARY RES, V16, P263, DOI 10.1016/0033-5894(81)90013-2; Roig F, 1996, HOLOCENE, V6, P469, DOI 10.1177/095968369600600410; ROIG FA, 1996, THESIS BASEL U; SALINGER MJ, 1981, NATURE, V291, P106, DOI 10.1038/291106a0; STUIVER M, 1989, NATURE, V338, P405, DOI [10.1038/338405a0, 10.1038/286868a0]; VILLALBA R, 1994, CLIMATIC CHANGE, V26, P183, DOI 10.1007/BF01092413; Villalba R., 1996, CLIMATIC VARIATIONS, P161, DOI [10.1007/978-3-642-61113-1_9, DOI 10.1007/978-3-642-61113-1_9]	31	65	72	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					567	570		10.1038/35069040	http://dx.doi.org/10.1038/35069040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279491				2022-12-28	WOS:000167859300043
J	Lamolet, B; Pulichino, AM; Lamonerie, T; Gauthier, Y; Brue, T; Enjalbert, A; Drouin, J				Lamolet, B; Pulichino, AM; Lamonerie, T; Gauthier, Y; Brue, T; Enjalbert, A; Drouin, J			A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins	CELL			English	Article							RECEPTOR STEROIDOGENIC FACTOR-1; HOLT-ORAM SYNDROME; TRANSGENIC MICE; PROOPIOMELANOCORTIN GENE; MOUSE DEVELOPMENT; PTX1; EXPRESSION; FAMILY; GLAND; RAT	The pituitary gland has provided unique insight into molecular mechanisms and regulatory factors controling both differentiation and gene transcription. We identified Tpit, a novel T box factor only present in the two pituitary POMC-expressing lineages, the corticotrophs and melanotrophs, and apparently in no other tissue, including hypothalamic POMC neurons. In pituitary cells, Tpit activation of POMC gene transcription requires cooperation with Pitx1, the two factors binding to contiguous sites within the same regulatory element. In gain-of-function experiments, Tpit induces POMC expression in undifferentiated pituitary cells, indicating that it can initiate differentiation into POMC-expressing lineages. TPIT gene mutations were found in patients with isolated deficiency of pituitary POMC-derived ACTH, in support of an essential role of Tpit for differentiation of the pituitary POMC lineage.	Inst Rech Clin Montreal, Genet Mol Lab, Montreal, PQ H2W 1R7, Canada; Univ Mediterranee, Lab Interact Cellulaires Neuroendocriniennes, CNRS, UMR 6544, Marseille, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Drouin, J (corresponding author), Inst Rech Clin Montreal, Genet Mol Lab, 110 Pins Ouest, Montreal, PQ H2W 1R7, Canada.		Brue, Thierry/AAI-2328-2019; Brue, Thierry/P-6571-2019	Brue, Thierry/0000-0001-8482-6691; Brue, Thierry/0000-0001-8482-6691; Drouin, Jacques/0000-0001-8226-5691; Pulichino, Anne-Marie/0000-0002-2419-8344; Lamonerie, Thomas/0000-0003-2371-2708				Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Drouin J, 1998, MOL CELL ENDOCRINOL, V140, P31, DOI 10.1016/S0303-7207(98)00026-4; ELKABES S, 1989, DEV BRAIN RES, V46, P85, DOI 10.1016/0165-3806(89)90145-4; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; GEE CE, 1983, NATURE, V306, P374, DOI 10.1038/306374a0; HAMMER GD, 1990, MOL ENDOCRINOL, V4, P1689, DOI 10.1210/mend-4-11-1689; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; Kioussi C, 1999, MECH DEVELOP, V81, P23, DOI 10.1016/S0925-4773(98)00229-9; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Knezevic V, 1997, DEVELOPMENT, V124, P411; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li QY, 1997, NAT GENET, V15, P21; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; LIN SC, 1994, DEVELOPMENT, V120, P515; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 1999, MOL CELL BIOL, V19, P7549; MALPUECH G, 1988, AM J MED GENET, V29, P125, DOI 10.1002/ajmg.1320290115; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; NEMESKERI A, 1988, NEUROENDOCRINOLOGY, V48, P534, DOI 10.1159/000125060; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; RUBINSTEIN M, 1993, NEUROENDOCRINOLOGY, V58, P373, DOI 10.1159/000126566; Sheng HZ, 1999, TRENDS GENET, V15, P236, DOI 10.1016/S0168-9525(99)01742-4; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Tremblay JJ, 1999, EMBO J, V18, P3431, DOI 10.1093/emboj/18.12.3431; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; Young JI, 1998, J NEUROSCI, V18, P6631	53	367	375	2	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					849	859		10.1016/S0092-8674(01)00282-3	http://dx.doi.org/10.1016/S0092-8674(01)00282-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290323	Bronze			2022-12-28	WOS:000167869200008
J	van Weel, C				van Weel, C			The uses of error: The complexity of general practice	LANCET			English	Editorial Material									Univ Nijmegen, Dept Gen Practice, Nijmegen, Netherlands	Radboud University Nijmegen	van Weel, C (corresponding author), Univ Nijmegen, Dept Gen Practice, Nijmegen, Netherlands.		van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					462	462		10.1016/S0140-6736(00)04018-6	http://dx.doi.org/10.1016/S0140-6736(00)04018-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273082				2022-12-28	WOS:000166865600036
J	Schacher, LF				Schacher, LF			Clinical librarianship: Its value in medical care	ANNALS OF INTERNAL MEDICINE			English	News Item													Schacher, laurence/G-1408-2016						0	20	22	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					717	720		10.7326/0003-4819-134-8-200104170-00023	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304118				2022-12-28	WOS:000168177500015
J	Barnett, TP; Pierce, DW; Schnur, R				Barnett, TP; Pierce, DW; Schnur, R			Detection of anthropogenic climate change in the world's oceans	SCIENCE			English	Article							20TH-CENTURY TEMPERATURE; GREENHOUSE-GAS; NORTH PACIFIC; ATTRIBUTION	Large-scale increases in the heat content of the world's oceans have been observed to occur over the Last 45 years. The horizontal and temporal character of these changes has been closely replicated by the state-of-the-art Parallel Climate Model (PCM) forced by observed and estimated anthropogenic gases. Application of optimal detection methodology shows that the model-produced signals are indistinguishable from the observations at the 0.05 confidence Level. Further, the chances of either the anthropogenic or observed signals being produced by the PCM as a result of natural, internal forcing alone are Less than 5%. This suggests that the observed ocean heat-content changes are consistent with those expected from anthropogenic forcing, which broadens the basis for claims that an anthropogenic signal has been detected in the global climate system. Additionally, the requirement that modeled ocean heat uptakes match observations puts a strong, new constraint on anthropogenically forced climate models. It is unknown if the current generation of climate models, other than the PCM, meet this constraint.	Univ Calif San Diego, Scripps Inst Oceanog, Div Climate Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Barnett, TP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Climate Res, La Jolla, CA 92093 USA.	tbarnett@ucsd.edu						Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Barnett TP, 1999, B AM METEOROL SOC, V80, P2631, DOI 10.1175/1520-0477(1999)080<2631:DAAORC>2.0.CO;2; Dai A, 2001, J CLIMATE, V14, P485, DOI 10.1175/1520-0442(2001)014<0485:COTTAT>2.0.CO;2; DAI A, UNPUB B AM METEOROL; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; Hegerl GC, 2000, CLIM DYNAM, V16, P737, DOI 10.1007/s003820000071; Hegerl GC, 1996, J CLIMATE, V9, P2281, DOI 10.1175/1520-0442(1996)009<2281:DGGICC>2.0.CO;2; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; HOUGHTON JT, 2001, IPCC WGI 3 ASSESSMEN; LATIF M, 1994, SCIENCE, V266, P634, DOI 10.1126/science.266.5185.634; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MITCHELL JFB, 2001, IPCC WGI 3 ASSESSMEN, pCH12; Pierce DW, 2000, J CLIMATE, V13, P1173, DOI 10.1175/1520-0442(2000)013<1173:CBTPOT>2.0.CO;2; REICHERT B, UNPUB; Santer BD, 1996, NATURE, V384, P524, DOI 10.1038/384524a0; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; SCHNUR R, 2000, 314 M PLANCK I MET; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; TETT SFB, UNPUB J GEOPHYS RES; VENRICK EL, 1987, SCIENCE, V238, P70, DOI 10.1126/science.238.4823.70; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079	25	278	286	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					270	274		10.1126/science.1058304	http://dx.doi.org/10.1126/science.1058304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303099				2022-12-28	WOS:000168074000042
J	Chen, LX; Jager, WJH; Jennings, G; Gosztola, DJ; Munkholm, A; Hessler, JP				Chen, LX; Jager, WJH; Jennings, G; Gosztola, DJ; Munkholm, A; Hessler, JP			Capturing a photoexcited molecular structure through time-domain X-ray absorption fine structure	SCIENCE			English	Article							NICKEL(II) TETRAPHENYLPORPHYRIN; SYNCHROTRON-RADIATION; EXCITED-STATE; ELECTRON-TRANSFER; LASER PHOTOLYSIS; CONDENSED-PHASE; SPECTROSCOPY; COMPLEXES; DIFFRACTION; PUMP	The determination of the structure of transient molecules, such as photoexcited states, in disordered media (such as in solution) usually requires methods with high temporal resolution. The transient molecular structure of a reaction intermediate produced by photoexcitation of NiTPP-L-2 (NiTPP, nickeltetraphenylporphyrin; L, piperidine) in solution was determined by x-ray absorption fine structure (XAFS) data obtained on a 14-nanosecond time scale from a third-generation synchrotron source. The XAFS measurements confirm that photoexcitation Leads to the rapid removal of both axial Ligands to produce a transient square-planar intermediate, NiTPP, with a lifetime of 28 nanoseconds. The transient structure of the photodissociated intermediate is nearly identical to that of the ground state NiTPP, suggesting that the intermediate adopts the same structure as the ground state in a noncoordinating solvent before it recombines with two Ligands to form the more stable octahedrally coordinated NiTPP-L-2.	Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA; Argonne Natl Lab, Div Sci Mat, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Chen, LX (corresponding author), Argonne Natl Lab, Div Chem, 9700 S Cass Ave, Argonne, IL 60439 USA.		Gosztola, David/D-9320-2011	Gosztola, David/0000-0003-2674-1379				Bressler C, 1998, P SOC PHOTO-OPT INS, V3451, P108, DOI 10.1117/12.331845; CHANCE B, 1983, BIOCHEMISTRY-US, V22, P3820, DOI 10.1021/bi00285a017; Chen LX, 1999, J PHYS CHEM B, V103, P3270, DOI 10.1021/jp990056j; CHEN LX, 1994, J PHYS CHEM-US, V98, P9457, DOI 10.1021/j100089a017; CHEN LX, 1995, J PHYS CHEM-US, V99, P7958, DOI 10.1021/j100020a018; CHEN LX, 1995, CHEM PHYS LETT, V234, P437, DOI 10.1016/0009-2614(95)00038-6; Eom HS, 1997, J PHYS CHEM A, V101, P3661, DOI 10.1021/jp962374d; HOSHINO M, 1986, INORG CHEM, V25, P2476, DOI 10.1021/ic00234a041; Jia SL, 1998, INORG CHEM, V37, P4402, DOI 10.1021/ic980289+; KIM D, 1986, J AM CHEM SOC, V108, P2099, DOI 10.1021/ja00268a065; KIM D, 1983, CHEM PHYS LETT, V98, P584, DOI 10.1016/0009-2614(83)80247-4; KIM D, 1983, CHEM PHYS, V75, P305, DOI 10.1016/0301-0104(83)85199-4; LARSON BC, 1997, OXFORD SER SYNCHROTR, V2, P137; Maclean AL, 1996, AUST J CHEM, V49, P1273, DOI 10.1071/CH9961273; MILLS DM, 1984, SCIENCE, V223, P811, DOI 10.1126/science.223.4638.811; MILLS DM, 1989, REV SCI INSTRUM, V60, P2338, DOI 10.1063/1.1140763; MILLS DM, 1984, PHYS TODAY, V37, P22, DOI 10.1063/1.2916191; Oyanagi H, 1998, J SYNCHROTRON RADIAT, V5, P1001, DOI 10.1107/S0909049597014301; Perman B, 1998, SCIENCE, V279, P1946, DOI 10.1126/science.279.5358.1946; POWERS L, 1984, BIOCHEMISTRY-US, V23, P5519, DOI 10.1021/bi00318a021; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; RODRIGUEZ J, 1990, J CHEM PHYS, V92, P5944, DOI 10.1063/1.458364; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; SAYERS DE, 1971, PHYS REV LETT, V27, P1204, DOI 10.1103/PhysRevLett.27.1204; Scheuring EM, 1996, J PHYS CHEM-US, V100, P3344, DOI 10.1021/jp943066n; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; SMITH TA, 1985, J AM CHEM SOC, V107, P5945, DOI 10.1021/ja00307a020; THIEL DJ, 1993, NATURE, V362, P40, DOI 10.1038/362040a0; Tomov IV, 1999, J PHYS CHEM B, V103, P7081, DOI 10.1021/jp9908449; Wang HX, 1997, J AM CHEM SOC, V119, P4921, DOI 10.1021/ja961446b; Winter B, 1998, P SOC PHOTO-OPT INS, V3451, P62, DOI 10.1117/12.331850	32	238	269	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					262	264		10.1126/science.1057063	http://dx.doi.org/10.1126/science.1057063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303096				2022-12-28	WOS:000168074000039
J	Lean, J; Rind, D				Lean, J; Rind, D			Earth's response to a variable sun	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; UNITED-STATES; VARIABILITY; SOLAR; TEMPERATURE; IRRADIANCE; DROUGHT; SIGNALS; RECORD; OZONE		USN, Res Lab, EO Hulburt Ctr Space Res, Washington, DC 20375 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Lean, J (corresponding author), USN, Res Lab, EO Hulburt Ctr Space Res, Washington, DC 20375 USA.			Lean, Judith/0000-0002-0087-9639				BALDWIN MP, IN PRESS NATURE; Cole JE, 1998, GEOPHYS RES LETT, V25, P4529, DOI 10.1029/1998GL900145; Cook ER, 1997, J CLIMATE, V10, P1343, DOI 10.1175/1520-0442(1997)010<1343:ANAOPS>2.0.CO;2; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; DETTINGER MD, UNPUB; Frohlich C, 1998, GEOPHYS RES LETT, V25, P4377, DOI 10.1029/1998GL900157; Halliwell GR, 1997, J CLIMATE, V10, P2405, DOI 10.1175/1520-0442(1997)010<2405:DAMNAS>2.0.CO;2; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; Houghton J.T, 1995, SCI CLIMATE CHANGE; KERR RA, 1991, SCIENCE, V254, P652, DOI 10.1126/science.254.5032.652; KERR RA, 1995, SCIENCE, V268, P28, DOI 10.1126/science.268.5207.28; Kerr RA, 1996, SCIENCE, V271, P1360, DOI 10.1126/science.271.5254.1360; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; LEAN JL, UNPUB; LOON H, 2000, GEOPHYS RES LETT, V27, P2965; McCormack JP, 1997, GEOPHYS RES LETT, V24, P2729, DOI 10.1029/97GL02900; MEHTA VM, 1995, J CLIMATE, V8, P172, DOI 10.1175/1520-0442(1995)008<0172:DVOTTA>2.0.CO;2; Michaels PJ, 2000, GEOPHYS RES LETT, V27, P2905, DOI 10.1029/2000GL011833; NORTH GR, IN PRESS J CLIM; RIND D, 1995, J CLIMATE, V8, P2080, DOI 10.1175/1520-0442(1995)008<2080:MTEOUV>2.0.CO;2; Rind D, 1999, J GEOPHYS RES-ATMOS, V104, P1973, DOI 10.1029/1998JD200020; Ruzmaikin A, 1999, GEOPHYS RES LETT, V26, P2255, DOI 10.1029/1999GL900535; Shindell D, 1999, SCIENCE, V284, P305, DOI 10.1126/science.284.5412.305; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; White WB, 1998, J GEOPHYS RES-OCEANS, V103, P21335, DOI 10.1029/98JC01706	26	80	91	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					234	236		10.1126/science.1060082	http://dx.doi.org/10.1126/science.1060082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305317				2022-12-28	WOS:000168074000033
J	Schon, JH; Kloc, C; Hwang, HY; Batlogg, B				Schon, JH; Kloc, C; Hwang, HY; Batlogg, B			RETRACTED: Josephson junctions with tunable weak links (Retracted Article. See vol 298, pg 961, 2002)	SCIENCE			English	Article; Retracted Publication							FIELD-EFFECT TRANSISTORS; SUPERCONDUCTIVITY	The electrical properties of organic molecular crystals, such as polyacenes or C-60, can be tuned from insulating to superconducting by application of an electric field. By structuring the gate electrode of such a field-effect switch, the charge carrier density, and therefore also the superfluid density, can be modulated. Hence, weak Links that behave like Josephson junctions can be fabricated between two superconducting regions. The coupling between the superconducting regions can be tuned and controlled over a wide range by the applied gate bias. Such devices might be used in superconducting circuits, and they are a useful scientific tool to study superconducting material parameters, such as the superconducting gap, as a function of carrier concentration or transition temperature.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; ETH Honggerberg, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Alcatel-Lucent; Lucent Technologies; AT&T; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schon, JH (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	hendrik@lucent.com	Kloc, Christian/A-2255-2011					Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; ARNOLD GB, 1987, J LOW TEMP PHYS, V68, P1, DOI 10.1007/BF00682620; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; GLOVER RE, 1960, PHYS REV LETT, V5, P248, DOI 10.1103/PhysRevLett.5.248; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; KLAPWIJK TM, 1989, SUPERCONDUCTING ELEC, P385; KLEINSASSER AW, 1989, APPL PHYS LETT, V55, P1909, DOI 10.1063/1.102166; Kloc C, 1997, J CRYST GROWTH, V182, P416, DOI 10.1016/S0022-0248(97)00370-9; LIKHAREV KK, 1979, REV MOD PHYS, V51, P101, DOI 10.1103/RevModPhys.51.101; Makhlin Y, 1999, NATURE, V398, P305, DOI 10.1038/18613; Mannhart J, 1996, SUPERCOND SCI TECH, V9, P49, DOI 10.1088/0953-2048/9/2/001; Mooij JE, 1999, MICROELECTRON ENG, V47, P3, DOI 10.1016/S0167-9317(99)00131-8; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; NISHINO T, 1985, IEEE ELECTR DEVICE L, V6, P297, DOI 10.1109/EDL.1985.26131; ONNES HK, 1911, LEIDEN COMMUN, V1206, P1226; Parks R., 1969, SUPERCONDUCTIVITY; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2000, SCIENCE, V287, P1022, DOI 10.1126/science.287.5455.1022; Schon JH, 2001, NATURE, V410, P189, DOI 10.1038/35065565; TAKAYANAGI H, 1985, PHYS REV LETT, V54, P2449, DOI 10.1103/PhysRevLett.54.2449	22	22	22	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					252	254		10.1126/science.1058812	http://dx.doi.org/10.1126/science.1058812			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303093				2022-12-28	WOS:000168074000036
J	Browne, TR; Holmes, GL				Browne, TR; Holmes, GL			Primary care: Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MANAGEMENT; SEIZURES; CARBAMAZEPINE; WITHDRAWAL; PHENYTOIN; CHILDREN		Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Dept Vet Affairs Boston Healthcare Syst, Neurol Serv, Boston, MA USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Browne, TR (corresponding author), Boston Univ, Sch Med, Dept Neurol, 315 Albany St,C-314, Boston, MA 02118 USA.	tbrowne@bu.edu						*AM AC NEUR THER T, 1989, NEUROLOGY, V39, P1437; *AM CLIN NEUR SOC, 1998, J CLIN NEUROPHYSIOL, V15, P76; ANNEGERS JF, 1997, TREATMENT EPILEPSY P, P165; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, NEUROLOGY, V39, P1101; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; [Anonymous], 1996, Neurology, V47, P288; Begley Charles E., 1998, Epilepsia, V39, P222; BERKOVIC SF, 1997, TREATMENT EPILEPSY P, P451; Bleck TP, 1999, EPILEPSIA, V40, pS59, DOI 10.1111/j.1528-1157.1999.tb00880.x; BROWNE TR, 1999, HDB EPILEPSY; BROWNE TR, 1998, EPIELPSY COMPREHENSI, V2, P1557; Buna DK, 1998, PHARMACOTHERAPY, V18, P235; Cramer JA, 1999, EPILEPSIA, V40, P590, DOI 10.1111/j.1528-1157.1999.tb05561.x; Delgado-Escueta A. V., 1997, TREATMENT EPILEPSY P, P484; ENGEL J, 1998, EPILEPSY COMPREHENSI, V2; Glauser TA, 1999, EPILEPSIA, V40, pS71, DOI 10.1111/j.1528-1157.1999.tb00922.x; Glauser TA, 2000, EPILEPSIA, V41, pS6, DOI 10.1111/j.1528-1157.2000.tb02950.x; Greenberg MK, 1996, NEUROLOGY, V47, P26, DOI 10.1212/WNL.47.1.26; Greenberg MK, 1996, NEUROLOGY, V47, P600; Hauser W, 1990, EPILEPSY FREQUENCY C; Hirtz D, 2000, NEUROLOGY, V55, P616, DOI 10.1212/WNL.55.5.616; Kramer G, 2000, EPILEPSIA, V41, pS1, DOI 10.1111/j.1528-1157.2000.tb01527.x; Levy R. H., 1995, ANTIEPILEPTIC DRUGS; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Matsuo F, 1999, EPILEPSIA, V40, pS30, DOI 10.1111/j.1528-1157.1999.tb00917.x; Mattson RH, 1998, NEUROLOGY, V51, pS15, DOI 10.1212/WNL.51.5_Suppl_4.S15; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; MATTSON RH, 1986, ANN NEUROL, V20, P119; Morris GL, 1999, EPILEPSIA, V40, pS63, DOI 10.1111/j.1528-1157.1999.tb00921.x; Novotny EJ, 1998, J CLIN NEUROPHYSIOL, V15, P96, DOI 10.1097/00004691-199803000-00002; Pellock JM, 1998, NEUROLOGY, V51, pS8, DOI 10.1212/WNL.51.5_Suppl_4.S8; Plaa Gabriel L., 1995, P51; Porter Roger J., 1995, P137; Prasad AN, 1999, EPILEPSIA, V40, P1329, DOI 10.1111/j.1528-1157.1999.tb02004.x; ROWAN AJ, 1998, EPILEPSY COMPREHENSI, V2, P1599; SATO S, 1982, NEUROLOGY, V32, P157, DOI 10.1212/WNL.32.2.157; Schachter SC, 1999, EPILEPSIA, V40, pS17, DOI 10.1111/j.1528-1157.1999.tb00915.x; SCHUMACHER GE, 1991, THER DRUG MONIT, V13, P318, DOI 10.1097/00007691-199107000-00007; Shields RW, 1997, J CLIN NEUROPHYSIOL, V14, P169, DOI 10.1097/00004691-199705000-00001; Shorvon SD, 1999, EPILEPSIA, V40, P76; SPENCER SS, 1981, EPILEPSIA, V22, P297, DOI 10.1111/j.1528-1157.1981.tb04113.x; Tecoma ES, 1999, EPILEPSIA, V40, pS37, DOI 10.1111/j.1528-1157.1999.tb00918.x; TREIMAN DM, 1995, J CLIN NEUROPHYSIOL, V12, P343; Willmore LJ, 1998, NEUROLOGY, V51, pS34, DOI 10.1212/WNL.51.5_Suppl_4.S34; WYLLIE E, 1997, TREATMENT EPILEPSY P; [No title captured]	48	210	221	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1145	1151		10.1056/NEJM200104123441507	http://dx.doi.org/10.1056/NEJM200104123441507			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297707				2022-12-28	WOS:000167990600007
J	Niederlander, C; Walsh, JJ; Episkopou, V; Jones, CM				Niederlander, C; Walsh, JJ; Episkopou, V; Jones, CM			Arkadia enhances nodal-related signalling to induce mesendoderm	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-4; EARLY XENOPUS DEVELOPMENT; MESODERM INDUCTION; MATERNAL VEGT; EMBRYOS; BMP; GASTRULATION; LEFTY; MOUSE; ACTS	Nodal-related members of the transforming growth factor (TGF)-beta family regulate the induction of mesoderm, endoderm, and mesendoderm, a tissue specific to the Spemann organizer(1-7). How these different tissues form in response to the same signalling molecules is not completely understood. It has been suggested that concentration-dependent effects, mediated by extracellular cofactors and antagonists, are responsible for the differences(1,8-10). Here we show that the nuclear protein Arkadia specifically potentiates the mesendoderm-inducing activity of a subset of TGF-beta family members. The combined activities of Arkadia and Xenopus nodal-related-1 are sufficient to induce mesendoderm and suppress mesoderm. Arkadia dorsalizes ventral tissues, resulting in the induction of organizer-specific gene expression. Blocking nodal signalling extracellularly inhibits these effects. Arkadia influences nodal activity when co-expressed and can function in cells adjacent to those producing the nodal signal. Our findings, together with the observation that Arkadia mutant mice lack a node and node-derived mesendoderm, identify Arkadia as an essential modulator of the nodal signalling cascade that leads to induction of Spemann's organizer.	Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, London SW3 6JB, England; Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr,Mammalian Neurogenesis Grp, London W12 0NN, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London	Jones, CM (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, 237 Fulham Rd, London SW3 6JB, England.		Episkopou, Vasso/E-2952-2010		MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agius E, 2000, DEVELOPMENT, V127, P1173; Armes NA, 1997, DEVELOPMENT, V124, P3797; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Clements D, 1999, DEVELOPMENT, V126, P4903; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Jones CM, 1996, DEVELOPMENT, V122, P1545; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kofron M, 1999, DEVELOPMENT, V126, P5759; Massague J, 2000, GENE DEV, V14, P627; Osada SI, 1999, DEVELOPMENT, V126, P3229; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Sampath K, 1997, DEVELOPMENT, V124, P3293; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Sun BI, 1999, DEVELOPMENT, V126, P1467; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Yasuo H, 1999, CURR BIOL, V9, P869, DOI 10.1016/S0960-9822(99)80391-1; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	29	60	63	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					830	834		10.1038/35071103	http://dx.doi.org/10.1038/35071103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298453				2022-12-28	WOS:000168021900059
J	Zewail, AH				Zewail, AH			Science for the have-nots - Developed and developing nations can build better partnerships.	NATURE			English	Editorial Material									CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.			gaber, sarah/0000-0002-5995-7291					0	4	4	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					741	741		10.1038/35071136	http://dx.doi.org/10.1038/35071136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298410	Bronze			2022-12-28	WOS:000168021900017
J	Murch, SH				Murch, SH			Toll of allergy reduced by probiotics	LANCET			English	Editorial Material							IMMUNE-RESPONSE; INFANTS; MICROFLORA; FLORA		UCL Royal Free & Univ Coll Sch Med, Ctr Paediat Gastroenterol, London NW3 2PF, England	University of London; University College London	Murch, SH (corresponding author), UCL Royal Free & Univ Coll Sch Med, Ctr Paediat Gastroenterol, London NW3 2PF, England.	s.murch@rfc.ucl.ac.uk						Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Escherich T, 1885, FORTSCHR MED, V3, P515; GIBSON CE, 1991, IMMUNOL CELL BIOL, V69, P387, DOI 10.1038/icb.1991.55; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Montgomery SM, 2000, ALLERGY, V55, P916, DOI 10.1034/j.1398-9995.2000.00480.x; Murch SH, 2000, CURR OPIN GASTROEN, V16, P552, DOI 10.1097/00001574-200011000-00016; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; SIMHON A, 1982, ARCH DIS CHILD, V57, P54; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Wagner RD, 1997, INFECT IMMUN, V65, P3345, DOI 10.1128/IAI.65.8.3345-3351.1997	15	75	92	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1057	1059		10.1016/S0140-6736(00)04305-1	http://dx.doi.org/10.1016/S0140-6736(00)04305-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297952				2022-12-28	WOS:000167996200003
J	Hart-Davis, A				Hart-Davis, A			James Watt and the lunaticks of Birmingham	SCIENCE			English	Article											Hart-Davis, A (corresponding author), 31 Berkely Rd, Bristol BS7 8HF, Avon, England.								0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					55	56		10.1126/science.1060460	http://dx.doi.org/10.1126/science.1060460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294215				2022-12-28	WOS:000167995200028
J	Tolbert, MA; Toon, OB				Tolbert, MA; Toon, OB			Atmospheric science - Solving the PSC mystery	SCIENCE			English	Editorial Material							POLAR STRATOSPHERIC CLOUDS; NITRIC-ACID TRIHYDRATE; ANTARCTIC STRATOSPHERE; OZONE DEPLETION; DENITRIFICATION; PARTICLES; AEROSOLS		Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Tolbert, MA (corresponding author), Univ Colorado, Boulder, CO 80309 USA.							BARTON N, 1993, J PHYS CHEM-US, V97, P5848, DOI 10.1021/j100124a011; Carslaw KS, 1998, J GEOPHYS RES-ATMOS, V103, P5785, DOI 10.1029/97JD03626; CRUTZEN PJ, 1986, NATURE, V324, P651, DOI 10.1038/324651a0; FAHEY DW, 1989, J GEOPHYS RES-ATMOS, V94, P11299, DOI 10.1029/JD094iD09p11299; Fahey DW, 2001, SCIENCE, V291, P1026, DOI 10.1126/science.1057265; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; HANSON D, 1988, GEOPHYS RES LETT, V15, P855, DOI 10.1029/GL015i008p00855; HESSTVEDT E, 1962, TELLUS, V14, P297, DOI 10.1111/j.2153-3490.1962.tb01340.x; Iraci LT, 1998, J GEOPHYS RES-ATMOS, V103, P8491, DOI 10.1029/98JD00281; Koop T, 1996, SCIENCE, V272, P1638, DOI 10.1126/science.272.5268.1638; MCCORMICK MP, 1981, SCIENCE, V214, P328, DOI 10.1126/science.214.4518.328; Portmann RW, 1996, J GEOPHYS RES-ATMOS, V101, P22991, DOI 10.1029/96JD02608; Prenni AJ, 1998, J GEOPHYS RES-ATMOS, V103, P28439, DOI 10.1029/98JD02851; PUESCHEL RF, 1989, J GEOPHYS RES-ATMOS, V94, P11271, DOI 10.1029/JD094iD09p11271; SALAWITCH RJ, 1989, NATURE, V339, P525, DOI 10.1038/339525a0; Salcedo D, 2001, J PHYS CHEM A, V105, P1433, DOI 10.1021/jp001639s; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STORMER C, 1940, GEOFYS PUBL, V12, P3; Tabazadeh A, 2000, SCIENCE, V288, P1407, DOI 10.1126/science.288.5470.1407; Tabazadeh A, 2001, SCIENCE, V291, P2591, DOI 10.1126/science.1057228; TOON OB, 1986, GEOPHYS RES LETT, V13, P1284, DOI 10.1029/GL013i012p01284; TOON OB, 1990, GEOPHYS RES LETT, V17, P445, DOI 10.1029/GL017i004p00445; Voigt C, 2000, SCIENCE, V290, P1756, DOI 10.1126/science.290.5497.1756; Waibel AE, 1999, SCIENCE, V283, P2064, DOI 10.1126/science.283.5410.2064; WILSON E, 1967, DIARY DISCOVERY EXPE, P1901; WORSNOP DR, 1993, SCIENCE, V259, P71, DOI 10.1126/science.259.5091.71	27	58	58	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					61	63		10.1126/science.1060083	http://dx.doi.org/10.1126/science.1060083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294218				2022-12-28	WOS:000167995200033
J	Falk, RH				Falk, RH			Medical progress: Atrial fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; CATHETER ABLATION; SINUS RHYTHM; IMPLANTABLE ATRIAL; ELECTRICAL CARDIOVERSION; STROKE PREVENTION; FOLLOW-UP; THROMBOEMBOLIC COMPLICATIONS; SUPRAVENTRICULAR TACHYCARDIA		Boston Univ, Med Ctr, Cardiol Sect, Boston, MA 02118 USA	Boston University	Falk, RH (corresponding author), Boston Univ, Med Ctr, Cardiol Sect, 88 E Newton St, Boston, MA 02118 USA.	rfalk@bu.edu						Allessie M, 1985, CARDIAC ELECTROPHYSI, P265, DOI DOI 10.1016/J.HRTHM.2012.03.008; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; ANDERSON JL, 1989, CIRCULATION, V80, P1557, DOI 10.1161/01.CIR.80.6.1557; [Anonymous], 1997, Eur Heart J, V18, P649; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Blackshear JL, 1996, LANCET, V348, P633; Boriani G, 1998, PACE, V21, P2470, DOI 10.1111/j.1540-8159.1998.tb01203.x; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen YJ, 1998, J AM COLL CARDIOL, V32, P732, DOI 10.1016/S0735-1097(98)00305-2; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; COBBE SM, 1995, CIRCULATION, V92, P2550; Coumel P, 1996, J CARDIOVASC ELECTR, V7, P999, DOI 10.1111/j.1540-8167.1996.tb00474.x; COX JL, 1991, J THORAC CARDIOV SUR, V101, P569, DOI 10.1016/s0022-5223(19)36684-x; COX JL, 1999, CIRCULATION S1, V100, P1; Danias PG, 1998, J AM COLL CARDIOL, V31, P588, DOI 10.1016/S0735-1097(97)00534-2; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; De Simone A, 1999, J AM COLL CARDIOL, V34, P810, DOI 10.1016/S0735-1097(99)00256-9; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Falk RH, 1998, AM J CARDIOL, V82, p10N, DOI 10.1016/S0002-9149(98)00735-8; FALK RH, 1987, ANN INTERN MED, V106, P503, DOI 10.7326/0003-4819-106-4-503; FALK RH, 1992, ANN INTERN MED, V117, P446, DOI 10.7326/0003-4819-117-5-446; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; Fitzpatrick AP, 1996, AM HEART J, V131, P499, DOI 10.1016/S0002-8703(96)90528-1; FRIEDMAN HZ, 1987, AM J CARDIOL, V59, P866, DOI 10.1016/0002-9149(87)91108-8; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Furlanello F, 1998, J CARDIOVASC ELECTR, V9, pS63; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Hobbs WJC, 2000, CIRCULATION, V101, P1145, DOI 10.1161/01.CIR.101.10.1145; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Huang DT, 1998, J CARDIOVASC ELECTR, V9, P462, DOI 10.1111/j.1540-8167.1998.tb01837.x; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Izumoto H, 2000, EUR J CARDIO-THORAC, V17, P25, DOI 10.1016/S1010-7940(99)00346-2; Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572; Jouven X, 1999, EUR HEART J, V20, P896, DOI 10.1053/euhj.1998.1397; Jung W, 2000, J INTERV CARD ELECTR, V4, P185, DOI 10.1023/A:1009819707643; Jung W, 1998, J CARDIOVASC ELECTR, V9, pS177; JUULMOLLER S, 1990, CIRCULATION, V82, P1932, DOI 10.1161/01.CIR.82.6.1932; Kerr C, 1996, EUR HEART J, V17, P48, DOI 10.1093/eurheartj/17.suppl_C.48; KONINGS KTS, 1994, CIRCULATION, V89, P1665, DOI 10.1161/01.CIR.89.4.1665; Kopecky SL, 1999, ARCH INTERN MED, V159, P1118, DOI 10.1001/archinte.159.10.1118; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P2254; Lee R, 1999, ANN THORAC SURG, V67, P1696, DOI 10.1016/S0003-4975(99)00268-4; Lee SH, 1997, AM J CARDIOL, V79, P905, DOI 10.1016/S0002-9149(97)00025-8; MANNING WJ, 1994, J AM COLL CARDIOL, V23, P1535, DOI 10.1016/0735-1097(94)90652-1; MANNING WJ, 1995, J AM COLL CARDIOL, V25, P1354, DOI 10.1016/0735-1097(94)00560-D; MANNING WJ, 1989, J AM COLL CARDIOL, V13, P617, DOI 10.1016/0735-1097(89)90602-5; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Mittal S, 2000, CIRCULATION, V101, P1282, DOI 10.1161/01.CIR.101.11.1282; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Natale A, 2000, PACE, V23, P224, DOI 10.1111/j.1540-8159.2000.tb00804.x; Nattel S, 1999, J CARDIOVASC ELECTR, V10, P1553, DOI 10.1111/j.1540-8167.1999.tb00214.x; Ommen SR, 1997, NEW ENGL J MED, V337, P209; Oral H, 1999, NEW ENGL J MED, V340, P1849, DOI 10.1056/NEJM199906173402401; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; PANIDIS IP, 1983, AM J CARDIOL, V52, P1197, DOI 10.1016/0002-9149(83)90573-8; Pappone C, 1999, CIRCULATION, V100, P1203, DOI 10.1161/01.CIR.100.11.1203; Pappone C, 2000, CIRCULATION, V102, P2619; PETERSEN P, 1989, LANCET, V1, P175; Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790; Reisinger J, 1998, AM J CARDIOL, V81, P1450, DOI 10.1016/S0002-9149(98)00223-9; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; ROBERTS SA, 1993, AM J CARDIOL, V72, P567, DOI 10.1016/0002-9149(93)90353-E; RODRIGUEZ LM, 1993, AM J CARDIOL, V72, P1137, DOI 10.1016/0002-9149(93)90982-I; ROTH A, 1986, CIRCULATION, V73, P316, DOI 10.1161/01.CIR.73.2.316; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Sabatini T, 2000, J AM GERIATR SOC, V48, P387, DOI 10.1111/j.1532-5415.2000.tb04695.x; Saksena S, 1996, J AM COLL CARDIOL, V28, P687, DOI 10.1016/0735-1097(96)00232-X; Saksena S, 1998, J CARDIOVASC ELECTR, V9, pS155; Satoh T, 1996, J CARDIOVASC ELECTR, V7, P833, DOI 10.1111/j.1540-8167.1996.tb00596.x; Schmit C, 1996, J AM COLL CARDIOL, V28, P994, DOI 10.1016/S0735-1097(96)00274-4; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Singh S, 2000, CIRCULATION, V102, P2385, DOI 10.1161/01.CIR.102.19.2385; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; Stambler BS, 1996, CIRCULATION, V94, P1613, DOI 10.1161/01.CIR.94.7.1613; Swerdlow CD, 2000, CIRCULATION, V101, P878, DOI 10.1161/01.CIR.101.8.878; Tieleman RG, 1998, J AM COLL CARDIOL, V31, P167, DOI 10.1016/S0735-1097(97)00455-5; Timmermans C, 1999, CIRCULATION, V100, P1499, DOI 10.1161/01.CIR.100.14.1499; Timmermans C, 2000, J AM COLL CARDIOL, V35, P1428, DOI 10.1016/S0735-1097(00)00579-9; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Tse HF, 1999, J CARDIOVASC ELECTR, V10, P1200, DOI 10.1111/j.1540-8167.1999.tb00296.x; Tse HF, 1999, J AM COLL CARDIOL, V33, P1974, DOI 10.1016/S0735-1097(99)00138-2; Upshaw CB, 1997, ARCH INTERN MED, V157, P1070; VANGELDER IC, 1991, AM J CARDIOL, V68, P41, DOI 10.1016/0002-9149(91)90707-R; WELLENS HJJ, 1994, NEW ENGL J MED, V331, P944, DOI 10.1056/NEJM199410063311413; Wellens HJJ, 1998, CIRCULATION, V98, P1651, DOI 10.1161/01.CIR.98.16.1651; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 1997, AM J CARDIOL, V79, P1198; Zhou L, 1999, J CARDIOVASC ELECTR, V10, P611, DOI 10.1111/j.1540-8167.1999.tb00719.x; Zipes DP, 1997, CIRCULATION, V95, P1745	99	350	384	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1067	1078		10.1056/NEJM200104053441407	http://dx.doi.org/10.1056/NEJM200104053441407			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287978				2022-12-28	WOS:000167860400007
J	Rapin, I				Rapin, I			An 8-year-old boy with autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; INFANTILE-AUTISM; BEHAVIORAL TREATMENT; YOUNG-CHILDREN; CONGENITAL CYTOMEGALOVIRUS; TUBEROUS SCLEROSIS; DYSPHASIC CHILDREN; PREVALENCE; POPULATION; COMMUNICATION		Albert Einstein Coll Med, Kennedy Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rapin, I (corresponding author), Albert Einstein Coll Med, Kennedy Ctr, Room 807,1410 Pelham Pkwy S, Bronx, NY 10461 USA.	rapin@aecom.yu.edu						Allen DA, 2000, PSYCHOANAL INQ, V20, P704, DOI 10.1080/07351692009348917; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; [Anonymous], 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596.744053]; BAILEY A, 1993, J CHILD PSYCHOL PSYC, V34, P673, DOI 10.1111/j.1469-7610.1993.tb01064.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron-Cohen S, 1997, HDB AUTISM PERVASIVE, P880; Baron-Cohen Simon, 1996, British Journal of Psychiatry, V168, P158, DOI 10.1192/bjp.168.2.158; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bauman M. L., 1992, MOVEMENT DISORDERS N, P660; Berney TP, 1999, ARCH DIS CHILD, V81, P333, DOI 10.1136/adc.81.4.333; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; BISHOP DVM, 1983, J CHILD PSYCHOL PSYC, V24, P415, DOI 10.1111/j.1469-7610.1983.tb00118.x; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Bondy Andrew S., 1998, Seminars in Speech and Language, V19, P373, DOI 10.1055/s-2008-1064055; BRYSON SE, 1988, J CHILD PSYCHOL PSYC, V29, P433, DOI 10.1111/j.1469-7610.1988.tb00735.x; Bryson SE, 1998, MENT RETARD DEV D R, V4, P97, DOI 10.1002/(SICI)1098-2779(1998)4:2<97::AID-MRDD6>3.0.CO;2-U; BURD L, 1987, J AM ACAD CHILD PSY, V26, P407, DOI 10.1097/00004583-198705000-00022; Burger RA, 1998, MENT RETARD DEV D R, V4, P137, DOI 10.1002/(SICI)1098-2779(1998)4:2<137::AID-MRDD11>3.0.CO;2-W; CHASE JB, 1972, RETROLENTAL FIBROPLA; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Chess S, 1971, PSYCHIAT DISORDERS C; Chugani HT, 1996, ANN NEUROL, V39, P643, DOI 10.1002/ana.410390514; COHEN S, 1998, TARGETING AUTISM WHA; Cook EH, 1998, MENT RETARD DEV D R, V4, P113, DOI 10.1002/(SICI)1098-2779(1998)4:2<113::AID-MRDD8>3.0.CO;2-Q; COPLAN J, 1990, PEDIATRICS, V86, P963; DeLong GR, 1997, ANN NEUROL, V42, P11, DOI 10.1002/ana.410420105; DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911; Deonna T, 1999, CURR PROB E, V14, P113; EBERLIN M, 1993, J AUTISM DEV DISORD, V23, P507, DOI 10.1007/BF01046053; Fenson L., 1993, MACARTHUR COMMUNICAT; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Findling RL, 1997, J AUTISM DEV DISORD, V27, P467, DOI 10.1023/A:1025861522935; GAVEL JS, 1994, AM J SPEECH LANG MAY, P25; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Greenspan S.I., 1998, CHILD SPECIAL NEEDS; GREWE TSD, 1994, INT J PEDIATR OTORHI, V30, P123, DOI 10.1016/0165-5876(94)90195-3; Halsey CL, 1996, ARCH PEDIAT ADOL MED, V150, P790, DOI 10.1001/archpedi.1996.02170330016003; HOLMES GL, 1981, EPILEPSIA, V22, P631; IVARSSON SA, 1990, NEUROPEDIATRICS, V21, P102, DOI 10.1055/s-2008-1071471; Kanner L, 1943, NERV CHILD, V2, P217; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kientz MA, 1997, AM J OCCUP THER, V51, P530, DOI 10.5014/ajot.51.7.530; KURITA H, 1992, J AUTISM DEV DISORD, V22, P175, DOI 10.1007/BF01058149; LANDAU WM, 1957, NEUROLOGY, V7, P523, DOI 10.1212/WNL.7.8.523; Laxova R, 1994, Adv Pediatr, V41, P305; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; LOWE TL, 1980, JAMA-J AM MED ASSOC, V243, P126, DOI 10.1001/jama.243.2.126; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; NANSON JL, 1992, ALCOHOL CLIN EXP RES, V16, P558, DOI 10.1111/j.1530-0277.1992.tb01417.x; *NY STAT DEP HLTH, 1999, CLIN PRACT GUID AUT; PFEIFFER SI, 1995, J AUTISM DEV DISORD, V25, P481, DOI 10.1007/BF02178295; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; RAPIN I, 1977, DEV MED CHILD NEUROL, V19, P192; RAPIN I, 2001, TOURETTE SYNDROME, P89; RAPIN I, 1996, PRESCHOOL CHILDREN I, P98; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Rodier PM, 1998, MENT RETARD DEV D R, V4, P121, DOI 10.1002/(SICI)1098-2779(1998)4:2<121::AID-MRDD9>3.0.CO;2-S; Rodier PM, 1997, REPROD TOXICOL, V11, P417, DOI 10.1016/S0890-6238(97)80001-U; Rogers SJ, 1998, J CLIN CHILD PSYCHOL, V27, P168, DOI 10.1207/s15374424jccp2702_4; Rogers SJ, 1998, MENT RETARD DEV D R, V4, P104; RUTTER M, 1994, J CHILD PSYCHOL PSYC, V35, P311, DOI 10.1111/j.1469-7610.1994.tb01164.x; RUTTER M, 1997, HDB AUTISM PERVASIVE, P370; Sandler AD, 1999, NEW ENGL J MED, V341, P1801, DOI 10.1056/NEJM199912093412404; Schopler E., 1986, CHILDHOOD AUTISM RAT; SCHOPLER E, 1997, HDB AUTISM PERVASIVE, P767; Sheinkopf SJ, 1998, J AUTISM DEV DISORD, V28, P15, DOI 10.1023/A:1026054701472; SHINNAR S, IN PRESS PEDIAT NEUR; SMALLEY SL, 1992, J AUTISM DEV DISORD, V22, P339, DOI 10.1007/BF01048239; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; Stapells DR, 1997, AUDIOL NEURO-OTOL, V2, P257, DOI 10.1159/000259252; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; STUBBS EG, 1984, J AUTISM DEV DISORD, V14, P183, DOI 10.1007/BF02409660; SUGIYAMA T, 1989, J AUTISM DEV DISORD, V19, P87, DOI 10.1007/BF02212720; TANOUE Y, 1989, J AUTISM DEV DISORD, V19, P425, DOI 10.1007/BF02212940; Trottier G, 1999, J PSYCHIATR NEUROSCI, V24, P103; Tuchman RF, 1997, PEDIATRICS, V99, P560, DOI 10.1542/peds.99.4.560; TUCHMAN RF, 1991, PEDIATRICS, V88, P1219; TUCHMAN RF, 1991, PEDIATRICS, V88, P1211; Van Bourgondien M.E., 1992, HIGH FUNCTIONING IND, P227, DOI [10.1007/978-1-4899-2456-8_12, DOI 10.1007/978-1-4899-2456-8_12]; vanGent T, 1997, J CHILD PSYCHOL PSYC, V38, P337; Volkmar F, 1999, J AM ACAD CHILD PSY, V38, P1611; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361; VOLKMAR FR, 1997, HDB AUTISM PERVASIVE, P47; Volkmar Fred, 1999, Journal of the American Academy of Child and Adolescent Psychiatry, V38, p32S; Wahlstrom, 1993, RETT SYNDROME CLIN B; WEINBERG WA, 1998, TXB PEDIAT NEUROPSYC, P1287; Woodhouse W, 1996, J CHILD PSYCHOL PSYC, V37, P665, DOI 10.1111/j.1469-7610.1996.tb01458.x; World Health Organization, 1993, ICD 10 CLASS MENT BE, P147; [No title captured]	97	5	6	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1749	1757		10.1001/jama.285.13.1749	http://dx.doi.org/10.1001/jama.285.13.1749			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415FR	11277830				2022-12-28	WOS:000167710600029
J	Hooper, L; Summerbell, CD; Higgins, JPT; Thompson, RL; Capps, NE; Smith, GD; Riemersma, RA; Ebrahim, S				Hooper, L; Summerbell, CD; Higgins, JPT; Thompson, RL; Capps, NE; Smith, GD; Riemersma, RA; Ebrahim, S			Dietary fat intake and prevention of cardiovascular disease: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; LONG-TERM; HIGH-CARBOHYDRATE; RANDOMIZED-TRIAL; RISK-FACTORS; METAANALYSIS; CHOLESTEROL; INTERVENTION; ADVICE; LIPIDS	Objective To assess the effect of reduction or modification of dietary fat intake on total and cardiovascular mortality and cardiovascular morbidity. Design Systematic review, Data sources Cochrane Library Medline, Embase, CAB abstracts, SIGLE, CVRCT registry and biographies were searched; trials known to experts were included. Included studies Randomised controlled trials stating intention to reduce or modify fat or cholesterol intake in healthy adult participants over at least six months. inclusion decisions, validity, and data extraction were duplicated. Meta-analysis (random effects methodology), meta-regression, and funnel plots were performed. Results 27 studies (30 902 person years of observation) were included. Alteration of dietary fat intake had small effects on total mortality (rate ratio 0.98; 95% confidence interval 0.86 to 1.12). Cardiovascular mortality was reduced by 9% (0.91; 0.77 to 1.07) auld cardiovascular events by 16% (0.84; 0.72 to 0.99), which was attenuated (0.86; 0.72 to 1.03) in a sensitivity analysis that excluded a trial using oily fish. Trials with at least two years' follow up provided stronger evidence of protection from cardiovascular events (0.76; 0.65 to 0.90). Conclusions There is a small but potentially important reduction in cardiovascular risk with reduction or modification of dietary fat intake, seen particularly in trials of longer duration.	Univ Manchester, Dent Hosp, Manchester Dent & Educ Ctr, Manchester M15 6FH, Lancs, England; Univ Teesside, Sch Hlth, Middlesbrough TS1 3BA, Cleveland, England; Inst Child Hlth, Systemat Reviews Training Unit, London WC1N 1EH, England; Southampton Gen Hosp, Inst Human Nutr, Southampton SO16 6YD, Hants, England; Princess Royal Hosp NHS Trust, Dept Clin Biochem, Telford TF6 6TF, Shrops, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Edinburgh, Edinburgh EH8 9XF, Midlothian, Scotland	University of Manchester; University of Teesside; University of London; University College London; University of Southampton; University of Bristol; University of Edinburgh	Hooper, L (corresponding author), Univ Manchester, Dent Hosp, Manchester Dent & Educ Ctr, Manchester M15 6FH, Lancs, England.	lee.hooper@man.ac.uk	Hooper, Lee/D-2795-2009; Summerbell, Carolyn/AAC-3159-2019; Higgins, Julian PT/H-4008-2011; Davey Smith, George/A-7407-2013	Hooper, Lee/0000-0002-7904-3331; Summerbell, Carolyn/0000-0003-1910-9383; Higgins, Julian PT/0000-0002-8323-2514; Davey Smith, George/0000-0002-1407-8314				Altman D.G., 1991, PRACTICAL STAT MED R; ANDERSON JW, 1992, AM J CLIN NUTR, V56, P887, DOI 10.1093/ajcn/56.5.887; [Anonymous], 1965, LANCET, V2, P501; [Anonymous], 1968, LANCET, V2, P693; BAKER BM, 1968, CIRCULATION, V37, P1; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; BLACK HS, 1994, NEW ENGL J MED, V330, P1272, DOI 10.1056/NEJM199405053301804; Boyd NF, 1996, CANCER EPIDEM BIOMAR, V5, P217; BOYD NF, 1988, LANCET, V2, P128, DOI 10.1016/S0140-6736(88)90684-8; Brunner E, 1997, AM J PUBLIC HEALTH, V87, P1415, DOI 10.2105/AJPH.87.9.1415; BURR ML, 1989, LANCET, V2, P757; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; CURZIO JL, 1989, J HYPERTENS, V7, pS254, DOI 10.1097/00004872-198900076-00123; DAVEYSMITH G, 1993, BRIT MED J, V306, P1367; DAYTON S, 1969, CIRCULATION       S2, V40, P1; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DULLAART RPF, 1992, DIABETOLOGIA, V35, P165, DOI 10.1007/BF00402550; Ebrahim S, 1998, QUAL HEALTH CARE, V7, P232, DOI 10.1136/qshc.7.4.232; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; FRENKIEL PG, 1986, AM J CLIN NUTR, V43, P239, DOI 10.1093/ajcn/43.2.239; HASSELBLAD VIC, 1995, MED DECIS MAKING, V15, P81, DOI 10.1177/0272989X9501500112; Hellenius ML, 1997, NUTR METAB CARDIOVAS, V7, P293; Higgins JPT, 1999, CIPLOT CONFIDENCE IN; HOCKADAY TDR, 1978, BRIT J NUTR, V39, P357, DOI 10.1079/BJN19780045; Hooper L, 1999, LANCET, V354, P1557, DOI 10.1016/S0140-6736(05)76587-9; HOOPER L, 2000, REDUCED MODIFIED DIE; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Lean MEJ, 1997, EUR J CLIN NUTR, V51, P243, DOI 10.1038/sj.ejcn.1600391; Leren P, 1966, Acta Med Scand Suppl, V466, P1; MARNIEMI J, 1990, INT J OBESITY, V14, P113; MCKEOWNEYSSEN GE, 1994, J CLIN EPIDEMIOL, V47, P525, DOI 10.1016/0895-4356(94)90299-2; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; MIETTINEN M, 1983, INT J EPIDEMIOL, V12, P17, DOI 10.1093/ije/12.1.17; MORRISON LM, 1950, CIRCULATION, V2, P475; PEDERSEN TR, 1994, LANCET, V344, P1383; ROSE GA, 1965, BMJ-BRIT MED J, V1, P1531, DOI 10.1136/bmj.1.5449.1531; SARKKINEN ES, 1994, ATHEROSCLEROSIS, V105, P9, DOI 10.1016/0021-9150(94)90003-5; Seppelt B, 1996, Z ERNAHRUNGSWISS, V35, P369, DOI 10.1007/BF01610555; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Simon MS, 1997, NUTR CANCER, V27, P136, DOI 10.1080/01635589709514515; Tang JL, 1998, BMJ-BRIT MED J, V316, P1213, DOI 10.1136/bmj.316.7139.1213; vanhetHof KH, 1997, INT J FOOD SCI NUTR, V48, P19, DOI 10.3109/09637489709006960; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; WILLIAMS PT, 1994, METABOLISM, V43, P655, DOI 10.1016/0026-0495(94)90210-0; Woodhill J M, 1978, Adv Exp Med Biol, V109, P317; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632	50	227	243	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2001	322	7289					757	763		10.1136/bmj.322.7289.757	http://dx.doi.org/10.1136/bmj.322.7289.757			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282859	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167943200023
J	Diamond, J				Diamond, J			Unwritten knowledge	NATURE			English	Article									Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Diamond, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.								0	19	19	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					521	521		10.1038/35069154	http://dx.doi.org/10.1038/35069154			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279469	Bronze			2022-12-28	WOS:000167859300023
J	Moseley, M; Fielder, A				Moseley, M; Fielder, A			Improvement in amblyopic eye function and contralateral eye disease: evidence of residual plasticity	LANCET			English	Editorial Material									Western Eye Hosp, Imperial Coll Sch Med, Dept Ophthalmol, London NW1 5QH, England	Imperial College London	Moseley, M (corresponding author), Western Eye Hosp, Imperial Coll Sch Med, Dept Ophthalmol, London NW1 5QH, England.							ALLEN HF, 1967, ARCH OPHTHALMOL-CHIC, V77, P1; BIELSCHOWSDKY A, UEBER MONOCULARE DIP; BURIAN HM, 1969, AM J OPHTHALMOL, V67, P1; *DEP HLTH, 2000, REP CHILDR SUB GROUP; El Mallah MK, 2000, BRIT J OPHTHALMOL, V84, P952, DOI 10.1136/bjo.84.9.952; HAMED LM, 1991, BINOC VIS, V6, P97; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; MINTZHITTNER HA, 1908, ARCH OPHTHALMOL-CHIC, V118, P1535; Moseley M. J., 1998, IOVS, V39, pS332; RABIN J, 1984, AM J OPTOM PHYS OPT, V61, P334; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, pS296; Simmers AJ, 1999, OPTOMETRY VISION SCI, V76, P82, DOI 10.1097/00006324-199902000-00014; SNOWDON SH, 9 CRD NHS CTR REV DI; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; VONNOORDEN GK, 1979, T OPHTHAL SOC UK, V99, P442	15	13	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					902	904		10.1016/S0140-6736(00)04231-8	http://dx.doi.org/10.1016/S0140-6736(00)04231-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289343				2022-12-28	WOS:000167625300005
J	Suh, I; Jee, SH; Kim, HC; Nam, CM; Kim, IS; Appel, LJ				Suh, I; Jee, SH; Kim, HC; Nam, CM; Kim, IS; Appel, LJ			Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study	LANCET			English	Article							FACTOR INTERVENTION TRIAL; CEREBRAL-HEMORRHAGE; RISK; MORTALITY; PROGRAM	Background In some prospective studies. haemorrhagic stroke occurs more frequently in individuals with low serum cholesterol than in those with higher concentrations. We aimed to determine whether low total serum cholesterol is an independent risk factor for haemorrhagic stroke (intracerebral haemorrhage and subarachnoid haemorrhage) in South Korea. a country that has a population with relatively low concentrations of total serum cholesterol. Methods We measured total serum cholesterol and other cardiovascular risk factors in 114793 Korean men, aged between 35-59 years in 1990 and 1992, in a prospective observational study. We used data obtained in 1992 for smoking and alcohol consumption. We divided total serum cholesterol into quintiles (<4.31 mmol/L, 4.31-<4.74, 4.74-<5.16, 5.16-<5.69 and greater than or equal to5.69). Our primary outcomes were hospital admissions and deaths from intracerebral and subarachnoid haemorrhage in a 6 year follow-up between 1993 and 1998. Findings 528 men had a haemorrhagic stroke-372 intracerebral and 98 subarachnoid haemorrhage-and 58 were unspecified strokes. The relative risks of intracerebral haemorrhage in each quintile of total serum cholesterol (lowest to highest were: 1.22 (95% CI 0.88-1.69); 0.86 (0.60-1.21); 1.08 (0.78-1.48): and 1.03 (0.75-1.41). The corresponding relative risks for subarachnoid haemorrhage were: 1.44 (0.76-2.73); 1.13 (0.59-2.20): 1.21 (0.64-2.29): and 1.12 (0.59-2.14). Interpretation Low total serum cholesterol Is not independent risk factor for either intracerebral subarachnoid haemorrhagic stroke in Korean men.	Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul 120752, South Korea; Yonsei Univ, Grad Sch Hlth Sci & Management, Dept Epidemiol & Dis Control, Seoul 120752, South Korea; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Yonsei University; Yonsei University Health System; Yonsei University; Johns Hopkins University; Johns Hopkins Medicine	Suh, I (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul 120752, South Korea.		Appel, Larry/GLT-2608-2022; Kim, Hyeon Chang/F-8796-2019	Jee, Sun Ha/0000-0001-9519-3068; Suh, Il/0000-0002-9689-7849; Nam, Chung Mo/0000-0003-0985-0928; Kim, Hyeon Chang/0000-0001-7867-1240				[Anonymous], 1996, GLOBAL BURDEN DIS CO; CHUNG WS, 1991, J CLIN PATHOL QUAL C, V13, P1; Gavin JR, 1997, DIABETES CARE, V20, P1183; IRIBARREN C, 1995, JAMA-J AM MED ASSOC, V273, P1926, DOI 10.1001/jama.273.24.1926; Iribarren C, 1996, STROKE, V27, P1993, DOI 10.1161/01.STR.27.11.1993; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kim YK, 1993, J CLIN PATHOL QUAL C, V15, P1; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; *NIH, 1997, NIH PUBL; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Puddey IB, 1996, ATHEROSCLEROSIS, V119, P1, DOI 10.1016/0021-9150(95)05634-3; Rodgers A, 1998, LANCET, V352, P1801; Ross SD, 1999, ARCH INTERN MED, V159, P1793, DOI 10.1001/archinte.159.15.1793; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; Whitehead TP, 1977, QUALITY CONTROL CLIN; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460	16	107	116	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					922	925		10.1016/S0140-6736(00)04213-6	http://dx.doi.org/10.1016/S0140-6736(00)04213-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289349				2022-12-28	WOS:000167625300011
J	Yarosh, D; Klein, J; O'Connor, A; Hawk, J; Rafal, E; Wolf, P				Yarosh, D; Klein, J; O'Connor, A; Hawk, J; Rafal, E; Wolf, P		Xeroderma Pigmentosum Study Grp	Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study	LANCET			English	Article							DNA-REPAIR ENZYME; SOLAR KERATOSES	Background In patients with xeroderma pigmentosum the frequency of all forms of skin cancer is higher than in the general population, owing to a genetic defect in DNA repair. The bacterial DNA repair enzyme, T4 endonuclease V, delivered intracellularly, increases the rate of repair of sunlight-induced DNA damage in human cells. We tested the ability of this enzyme in a liposomal delivery vehicle applied topically (T4N5 liposome lotion) to lower the rate of new skin cancers in patients with xeroderma pigmentosum. Methods 30 patients were enrolled in this prospective, multicentre. double-blind study. Patients were randomly assigned T4N5 liposome lotion or a placebo liposome lotion, to be applied daily for 1 year. At 3-monthly visits, new actinic keratoses and basal-cell carcinomas were identified and removed. Analyses were by intention to treat. Findings 20 patients were assigned T4N5 liposome lotion and ten placebo lotion; one placebo-group patient withdrew before treatment and one withdrew with progressive disease at 9 months. The annualised rate of new actinic keratoses was 8.2 among the patients assigned T4N5 liposome lotion and 25.9 among those assigned placebo (difference 17.7 [95% CI 11.8-26.5]; p=0.004 by Poisson modelling). For basal-cell carcinoma, the annualised rates of new lesions were 3.8 in the treatment group and 5.4 in the placebo group (difference 1.6 [0.38-2.82]). No significant adverse effects were found among any of the patients. Interpretation DNA damage has an important role in the development of skin cancer and precancerous skin lesions. The topical application of DNA repair enzymes to sun-damaged shin of patients with xeroderma pigmentosum lowered the rate of development of two forms of these lesions during a year of treatment.	Appl Genet Inc Dermat, Freeport, NY 11520 USA; St Thomas Hosp, Kings Coll London, St Johns Inst Dermatol, London, England; New York Inc, Derm Res Ctr, Stony Brook, NY USA; Cornell Univ, Coll Med, New York, NY USA; Graz Univ, Dept Dermatol, Graz, Austria	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cornell University; University of Graz	Yarosh, D (corresponding author), Appl Genet Inc Dermat, 205 Buffalo Ave, Freeport, NY 11520 USA.				FDA HHS [FD-R-001505] Funding Source: Medline	FDA HHS		Brash DE, 1998, CANCER SURV, V32, P69; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; DAHL E, 1992, CANCER, V70, P104, DOI 10.1002/1097-0142(19920701)70:1<104::AID-CNCR2820700117>3.0.CO;2-0; Feldman SR, 1999, J AM ACAD DERMATOL, V40, P43, DOI 10.1016/S0190-9622(99)70526-8; FROST CA, 1994, BRIT J DERMATOL, V131, P455; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Jemal A, 2000, JNCI-J NATL CANCER I, V92, P811, DOI 10.1093/jnci/92.10.811; Kraemer K H, 1985, Clin Dermatol, V3, P33, DOI 10.1016/0738-081X(85)90096-3; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; KRAMER KH, 1987, ARCH DERMATOL, V123, P241; KRAMER KH, 1988, NEW ENGL J MED, V318, P1633; NAYLOR MF, 1995, ARCH DERMATOL, V131, P170, DOI 10.1001/archderm.131.2.170; TANAKA K, 1975, P NATL ACAD SCI USA, V72, P4071, DOI 10.1073/pnas.72.10.4071; Thissen MRTM, 1999, ARCH DERMATOL, V135, P1177, DOI 10.1001/archderm.135.10.1177; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; Wolf P, 2000, J INVEST DERMATOL, V114, P149, DOI 10.1046/j.1523-1747.2000.00839.x; YAROSH D, 1994, J INVEST DERMATOL, V103, P461, DOI 10.1111/1523-1747.ep12395551; Yarosh D, 1996, PHOTODERMATOL PHOTO, V12, P122, DOI 10.1111/j.1600-0781.1996.tb00188.x; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	19	260	269	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					926	929		10.1016/S0140-6736(00)04214-8	http://dx.doi.org/10.1016/S0140-6736(00)04214-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289350				2022-12-28	WOS:000167625300012
J	Tomlinson, JW; Holden, N; Hills, RK; Wheatley, K; Clayton, RN; Bates, AS; Sheppard, MC; Stewart, PM				Tomlinson, JW; Holden, N; Hills, RK; Wheatley, K; Clayton, RN; Bates, AS; Sheppard, MC; Stewart, PM		W Midlands Prospective Hypopituita	Association between premature mortality and hypopituitarism	LANCET			English	Article							GROWTH-HORMONE DEFICIENCY; CARDIOVASCULAR RISK-FACTORS; PITUITARY-TUMORS; LIFE EXPECTANCY; ADULTS; DISEASE; REPLACEMENT; RADIATION; THERAPY	Background Four retrospective studies have reported premature mortality in patients with hypopituitarism with standard mortality ratios (SMRs) varying between 1.20 and 2.17. Patients with hypopituitarism have complex endocrine deficiencies, and the mechanisms underpinning any excess mortality are unknown. Furthermore, the suggestion has emerged that endogenous growth-hormone deficiency might account for any excess mortality. We aimed to clarify these issues by doing a large prospective study of total, and specific-cause mortality in patients with hypopituitarism. Methods We followed up 1014 UK patients (514 men, 500 women) with hypopituitarism from January, 1992, to January, 2000, 573 (57%) patients had non-functioning adenomas, 118 (12%) craniopharyngiomas, and 93 (9%) prolactinomas. SMRs were calculated as the ratio of observed deaths to the number of deaths in an age-matched and sex-matched UK population. Findings The number of observed deaths was 181 compared with the 96.7 expected (SMR 1.87 [99% CI 1.62-2.16], p<0.0001). Univariate analysis indicated that mortality was higher in women (2.29 [1.86-2.82]) than men (1.57 [1.28-1.93], p=0.002), in younger patients, in patients with an underlying diagnosis of craniopharyngioma (9.28 [5.84-14.75] vs 1.61 [1.30-1.99], p<0.0001), and in the 353 patients treated with radiotherapy (2.32 [1.71-3.14] vs 1.66 [1.30-2.13], p=0.004). Excess mortality was attributed to cardiovascular (1.82 [1.30-2.54], p<0.0001), respiratory (2.66 [1.72-4.11], p<0.0001), and cerebrovascular (2.44 [1.58-4.18], p<0.0001) causes. There was no effect of hormonal deficiency on mortality, except for gonadotropin deficiency, which, if untreated was associated with excess mortality (untreated 2.97 [2.13-4.13] vs treated 1.42 [0.97-2.07], p<0.0001). Multiple regression analyses identified age at diagnosis, sex, a diagnosis of craniopharyngioma, and untreated gonadotropin deficiency as independent significant factors affecting mortality. Interpretation Patients with hypopituitarism have excess mortality, predominantly from vascular and respiratory disease. Age at diagnosis, female sex, and above all, craniopharyngioma were significant independent risk factors. Specific endocrine-axis deficiency, with the exception of untreated gonadotropin deficiency, does not seem to have a role.	Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Univ Birmingham, Clin Trials Unit, Birmingham, W Midlands, England; N Staffordshire Hosp, Postgrad Med Sch, Dept Med, Stoke On Trent, Staffs, England; Sollhill Hosp, Dept Med, Solihull, W Midlands, England	University of Birmingham; University of Birmingham; Keele University; University Hospital of North Staffordshire NHS Trust	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.			Tomlinson, Jeremy/0000-0002-3170-8533; Hills, Robert/0000-0003-0166-0062				Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; BATES AS, 1993, Q J MED, V86, P293; BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BITZER M, 1995, STROKE, V26, P131, DOI 10.1161/01.STR.26.1.131; BOWEN J, 1992, STROKE, V23, P908, DOI 10.1161/01.STR.23.6.908; Brada M, 1999, INT J RADIAT ONCOL, V45, P693, DOI 10.1016/S0360-3016(99)00159-5; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Erfurth EM, 1999, GROWTH HORM IGF RES, V9, P21, DOI 10.1016/S1096-6374(99)80005-7; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; FLICKINGER JC, 1989, CANCER, V63, P2404, DOI 10.1002/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; FREY H, 1987, ACATA MED SCAND, V272, P163; Gelding SV, 1998, CLIN ENDOCRINOL, V48, P153, DOI 10.1046/j.1365-2265.1998.3641180.x; Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331; Maison P, 1998, BRIT MED J, V316, P1132, DOI 10.1136/bmj.316.7138.1132; MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; POLTZ CM, 1952, AM J MED, V13, P597; Rodriguez-Arnao J, 1999, CLIN ENDOCRINOL, V51, P53, DOI 10.1046/j.1365-2265.1999.00737.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Stewart PM, 1999, GROWTH HORM IGF RES, V9, P15, DOI 10.1016/S1096-6374(99)80004-5; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Vahl N, 1998, INT J OBESITY, V22, P529, DOI 10.1038/sj.ijo.0800618	30	759	784	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					425	431		10.1016/S0140-6736(00)04006-X	http://dx.doi.org/10.1016/S0140-6736(00)04006-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273062				2022-12-28	WOS:000166865600011
J	Fabrizio, P; Pozza, F; Pletcher, SD; Gendron, CM; Longo, VD				Fabrizio, P; Pozza, F; Pletcher, SD; Gendron, CM; Longo, VD			Regulation of longevity and stress resistance by Sch9 in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; STATIONARY-PHASE; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; IN-VIVO; EXTENSION; SURVIVAL; ACONITASE	The protein kinase Akt/protein kinase B (PKB) is implicated in insulin signaling in mammals and functions in a pathway that regulates Longevity and stress resistance in Caenorhabditis elegans. We screened for Long-Lived mutants in nondividing yeast Saccharomyces cerevisiae and identified mutations in adenylate cyclase and SCH9, which is homologous to Akt/PKB, that increase resistance to oxidants and extend Life-span by up to threefold. Stress-resistance transcription factors Msn2/Msn4 and protein kinase Rim15 were required for this life-span extension. These results indicate that Longevity is associated with increased investment in maintenance and show that highly conserved genes play similar roles in Life-span regulation in S. cerevisiae and higher eukaryotes.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Biogerontol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Max Planck Inst Demog Res, D-18057 Rostock, Germany	University of Southern California; University of Southern California; Max Planck Society	Longo, VD (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Biogerontol, Los Angeles, CA 90089 USA.			fabrizio, paola/0000-0002-1144-7727	NATIONAL INSTITUTE ON AGING [P01AG009793, P01AG008761] Funding Source: NIH RePORTER; NIA NIH HHS [AG09793, AG 08761-10] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; Finch CE, 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LIOU LL, 1999, THESIS U CALIFORNIA; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morano KA, 1999, EMBO J, V18, P5953, DOI 10.1093/emboj/18.21.5953; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Ross-Macdonald P, 1999, METHOD ENZYMOL, V303, P512; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sun JT, 1999, MOL CELL BIOL, V19, P216; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	28	654	686	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					288	290		10.1126/science.1059497	http://dx.doi.org/10.1126/science.1059497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11292860				2022-12-28	WOS:000168074000047
J	Agovino, T				Agovino, T			Democracy and health care in Serbia	LANCET			English	Article											Agovino, T (corresponding author), 230 Garth Rd, Scarsdale, NY 10583 USA.								0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1121	1122		10.1016/S0140-6736(00)04265-3	http://dx.doi.org/10.1016/S0140-6736(00)04265-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297983				2022-12-28	WOS:000167996200033
J	de Wildt, G; Rowson, M; Stoffers, M; Koivusalo, M				de Wildt, G; Rowson, M; Stoffers, M; Koivusalo, M			Which comes first - health or wealth?	LANCET			English	Editorial Material							USER FEES		Medact, London N19 4DJ, England; Phys Social Responsibil, Helsinki 00531, Finland; Wemos, NL-1000 BR Amsterdam, Netherlands		de Wildt, G (corresponding author), 17 Jiggins Lane Med Ctr, Birmingham, W Midlands, England.							Creese A, 1997, BRIT MED J, V315, P202, DOI 10.1136/bmj.315.7102.202; MOSES S, 1992, LANCET, V340, P463, DOI 10.1016/0140-6736(92)91778-7; *UN COMM EC SOC CU, 2000, EC1220004 UN COMM EC	3	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1123	1124		10.1016/S0140-6736(00)04267-7	http://dx.doi.org/10.1016/S0140-6736(00)04267-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297985				2022-12-28	WOS:000167996200035
J	Schmidt, WA				Schmidt, WA			Value of sonography in diagnosis of rheumatoid arthritis	LANCET			English	Editorial Material							FINGER JOINTS; SCINTIGRAPHY; RADIOGRAPHY		Med Ctr Rheumatol, D-13125 Berlin, Germany		Schmidt, WA (corresponding author), Med Ctr Rheumatol, D-13125 Berlin, Germany.		Schmidt, Wolfgang/W-5599-2019	Schmidt, Wolfgang/0000-0001-7831-8738				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Goupille P, 2001, J RHEUMATOL, V28, P35; Grassi W, 2001, ANN RHEUM DIS, V60, P98, DOI 10.1136/ard.60.2.98; Klarlund M, 2000, ANN RHEUM DIS, V59, P521, DOI 10.1136/ard.59.7.521; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Wakefield RJ, 2000, ARTHRITIS RHEUM-US, V43, P2762, DOI 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	9	73	76	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1056	1057		10.1016/S0140-6736(00)04304-X	http://dx.doi.org/10.1016/S0140-6736(00)04304-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297951				2022-12-28	WOS:000167996200002
J	Klironomos, JN; Hart, MM				Klironomos, JN; Hart, MM			Food-web dynamics - Animal nitrogen swap for plant carbon	NATURE			English	Article									Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada	University of Guelph	Klironomos, JN (corresponding author), Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada.		Hart, Miranda m/D-1562-2011					BARRON GL, 1987, CAN J BOT, V65, P774, DOI 10.1139/b87-103; Fitter A. H., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P333; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn	6	98	101	4	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					651	652		10.1038/35070643	http://dx.doi.org/10.1038/35070643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287942				2022-12-28	WOS:000167875400034
J	Gao, KQ; Shubin, NH				Gao, KQ; Shubin, NH			Late Jurassic salamanders from northern China	NATURE			English	Article							EVOLUTIONARY; PHYLOGENY; CAUDATA	With ten extant families, salamanders (urodeles) are one of the three major groups of modern amphibians (lissamphibians)(1-6) Extant salamanders are often used as a model system to assess fundamental issues of developmental, morphological and biogeographical evolution(6-11). Unfortunately, our understanding of these issues has been hampered by the paucity of fossil evidence available to assess the early history of the group(5,6,12). Here we report the discovery of an extraordinary sample of salamander fossils, some with rare soft-tissue impressions, from the Upper Jurassic of China(13-16). With over 500 articulated specimens, this assemblage documents the morphological diversity of early urodeles and includes larvae and adults of both neotenic and metamorphosed taxa. Phylogenetic analysis confirms that these salamanders are primitive, and reveals that all basal salamander clades have Asian distributions. This is compelling evidence for an Asian origin of Recent salamanders, as well as for an extensive and early radiation of several major lineages, These discoveries show that the evolution of salamanders has involved phylogenetic and ecological diversification around a body plan that has remained fundamentally stable for over 150 million years.	Amer Museum Nat Hist, New York, NY 10024 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	American Museum of Natural History (AMNH); University of Chicago	Gao, KQ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	kgao@amnh.org						Cannatella David C., 1993, Herpetological Monographs, V7, P1, DOI 10.2307/1466947; Chen Pei-ji, 1996, Museum of Northern Arizona Bulletin, V60, P395; DONG Z, 1998, VERTEBRAT PALASIATIC, V56, P159; Duellman W. E., 1986, BIOL AMPHIBIANS; Estes R., 1981, HDB PALAOHERPETOLO 2; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Evans SE, 1996, PHILOS T R SOC B, V351, P627, DOI 10.1098/rstb.1996.0061; EVANS SE, 1988, GEOBIOS-LYON, V21, P539, DOI 10.1016/S0016-6995(88)80069-X; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Gao K.-Q., 1998, CHINESE GEOLOGY, V248, P40; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; LARSON A, 1991, EVOL BIOL, V25, P211; Larson Allan, 1993, Herpetological Monographs, V7, P77, DOI 10.2307/1466953; LUO X, 1997, ACTA GEOSCIENTIA SIN, V18, P242; Milner A. R., 1983, EVOLUTION TIME SPACE, P431; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; Ren D., 1999, GEOLOGICAL SCI TECHN, V18, P39; SEVER DM, 1991, HERPETOLOGICA, V47, P165; SHUBIN N, 1995, EVOLUTION, V49, P874, DOI 10.1111/j.1558-5646.1995.tb02323.x; Shubin N, 1996, AM ZOOL, V36, P51; Trueb L., 1991, P223; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Wang S.E., 1998, ACTA GEOL SINICA, V72, P11; Wang Yuan, 2000, Vertebrata Palasiatica, V38, P100; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	26	114	131	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					574	577		10.1038/35069051	http://dx.doi.org/10.1038/35069051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279493				2022-12-28	WOS:000167859300045
J	McNamara, PS; Mallucci, CL; Appleton, RT				McNamara, PS; Mallucci, CL; Appleton, RT			Headache and abdominal pain	LANCET			English	Editorial Material							BRAIN ABSCESSES		Alder Hey Childrens Hosp, Inst Child Hlth, Liverpool L12 2AP, Merseyside, England; Alder Hey Childrens Hosp, Dept Neurosurg, Liverpool L12 2AP, Merseyside, England; Alder Hey Childrens Hosp, EEG Dept, Liverpool L12 2AP, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	McNamara, PS (corresponding author), Alder Hey Childrens Hosp, Inst Child Hlth, Eaton Rd, Liverpool L12 2AP, Merseyside, England.			McNamara, Paul/0000-0002-7055-6034; Mallucci, Conor/0000-0002-5509-0547				ANTHONY SJ, 2000, PRINCIPLES PRACTICE, P2183; Ciurea AV, 1999, CHILD NERV SYST, V15, P309, DOI 10.1007/s003810050400; LIBERTIN CR, 1985, REV INFECT DIS, V7, P498; MUTLUER S, 1999, PEDIAT NEUROSURGERY, P624; Schops M, 1996, ARQ NEURO-PSIQUIAT, V54, P328, DOI 10.1590/S0004-282X1996000200025	5	3	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					930	930		10.1016/S0140-6736(00)04215-X	http://dx.doi.org/10.1016/S0140-6736(00)04215-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289351				2022-12-28	WOS:000167625300013
J	Akhmanova, A; Hoogenraad, CC; Drabek, K; Stepanova, T; Dortland, B; Verkerk, T; Vermeulen, W; Burgering, BM; De Zeeuw, CI; Grosveld, F; Galjart, N				Akhmanova, A; Hoogenraad, CC; Drabek, K; Stepanova, T; Dortland, B; Verkerk, T; Vermeulen, W; Burgering, BM; De Zeeuw, CI; Grosveld, F; Galjart, N			CLASPs are CLIP-115 and-170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts	CELL			English	Article							MITOTIC SPINDLE; DISTAL ENDS; LOCALIZATION; YEAST; COLOCALIZATION; STABILIZATION; MORPHOGENESIS; ORGANIZATION; DROSOPHILA; DYNACTIN	CLIP-170 and CLIP-115 are cytoplasmic linker proteins that associate specifically with the ends of growing microtubules and may act as anti-catastrophe factors. Here, we have isolated two CLIP-associated proteins (CLASPs), which are homologous to the Drosophila Orbit/Mast microtubule-associated protein. CLASPs bind CLIPs and microtubules, colocalize with the CLIPs at microtubule distal ends, and have microtubule-stabilizing effects in transfected cells. After serum induction, CLASPs relocalize to distal segments of microtubules at the leading edge of motile fibroblasts. We provide evidence that this asymmetric CLASP distribution is mediated by PI3-kinase and GSK-3 beta. Antibody injections suggest that CLASP2 is required for the orientation of stabilized microtubules toward the leading edge. We propose that CLASPs are involved in the local regulation of microtubule dynamics in response to positional cues.	Erasmus Univ, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, MGC Dept Anat, NL-3000 DR Rotterdam, Netherlands; Univ Utrecht, Physiol Chem Lab, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Utrecht University; Utrecht University	Galjart, N (corresponding author), Erasmus Univ, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Galjart, Niels/D-1146-2010; Vermeulen, Wim/W-8708-2019; Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011	Galjart, Niels/0000-0003-1964-3607; Vermeulen, Wim/0000-0003-3616-734X; Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758				Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Gavet O, 1998, J CELL SCI, V111, P3333; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Liao GJ, 1999, FASEB J, V13, pS257, DOI 10.1096/fasebj.13.9002.S257; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Sambrook J., 2002, MOL CLONING LAB MANU; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; Vaughan KT, 1999, J CELL SCI, V112, P1437; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wolthuis RMF, 1996, ONCOGENE, V13, P353	36	363	383	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					923	935		10.1016/S0092-8674(01)00288-4	http://dx.doi.org/10.1016/S0092-8674(01)00288-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290329	Bronze			2022-12-28	WOS:000167869200014
J	Pasvol, G				Pasvol, G			Targeting voracious appetite of malaria-infected red-blood cell	LANCET			English	Editorial Material							TRANSPORT; PATHWAYS; MEMBRANE; CHANNEL		Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Wellcome Ctr Clin Trop Med,Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England	Imperial College London	Pasvol, G (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Wellcome Ctr Clin Trop Med,Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England.	g.pasvol@ic.ac.uk						Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1994, BIOCHEM PHARMACOL, V48, P1847, DOI 10.1016/0006-2952(94)90582-7; Kaestner L, 1999, BBA-BIOMEMBRANES, V1417, P9, DOI 10.1016/S0005-2736(98)00240-5; Kirk K, 1999, Novartis Found Symp, V226, P55; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K., 1999, NOVART FDN SYMP, V226, P66; Taraschi T F, 1999, Novartis Found Symp, V226, P114; Taraschi TF, 1999, NOVART FDN SYMP, V226, P121; 2000, DRUGD DAT	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					408	410		10.1016/S0140-6736(00)04023-X	http://dx.doi.org/10.1016/S0140-6736(00)04023-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273055				2022-12-28	WOS:000166865600004
J	Rubery, E				Rubery, E			A year of opportunity - Now is the time for the UK Food Standards Agency to flex its muscles.	NATURE			English	Editorial Material									Univ Cambridge, Sch Business, Judge Inst Management Studies, Cambridge Univ Hlth, Cambridge CB2 1AG, England	University of Cambridge	Rubery, E (corresponding author), Univ Cambridge, Sch Business, Judge Inst Management Studies, Cambridge Univ Hlth, Cambridge CB2 1AG, England.							Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; 2001, NATURE, V410, P501	2	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					867	868		10.1038/35073692	http://dx.doi.org/10.1038/35073692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309587				2022-12-28	WOS:000168152300020
J	Devereaux, PJ; Manns, BJ; Ghali, WA; Quan, H; Lacchetti, C; Montori, VM; Bhandari, M; Guyatt, GH				Devereaux, PJ; Manns, BJ; Ghali, WA; Quan, H; Lacchetti, C; Montori, VM; Bhandari, M; Guyatt, GH			Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY; BIAS; THERAPY	Context When clinicians assess the validity of randomized controlled trials (RCTs), they commonly evaluate the blinding status of individuals in the RCT. The terminology authors often use to convey blinding status (single, double, and triple blinding) may be open to various interpretations. Objective To determine physician interpretations and textbook definitions of RCT blinding terms. Design and Setting Observational study undertaken at 3 Canadian university tertiary care centers between February and May 1999. Participants Ninety-one internal medicine physicians who responded to a survey. Main Outcome Measures Respondents identified which of the following groups they thought were blinded in single-, double-, and triple-blinded RCTs: participants, health care providers, data collectors, judicial assessors of outcomes, data analysts, and personnel who write the article. Definitions from 25 systematically identified textbooks published since 1990 providing definitions for single, double, or triple blinding. Results Physician respondents identified 10, 17, and 15 unique interpretations of single, double, and triple blinding, respectively, and textbooks provided 5, 9, and 7 different definitions of each. The frequencies of the most common physician interpretation and textbook definition were 75% (95% confidence interval [CI], 65%-83%) and 74% (95% CI, 52%-90%) for single blinding, 38% (95% CI, 28%-49%) and 43% (95% CI, 24%-63%) for double blinding, and 18% (95% CI, 10%-28%) and 14% (95% CI, 0%-58%) for triple blinding, respectively. Conclusions Our study suggests that both physicians and textbooks vary greatly in their interpretations and definitions of single, double, and triple blinding. Explicit statements about the blinding status of specific groups involved in RCTs should replace the current ambiguous terminology.	McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Dalhousie Univ, Dept Med, Halifax, NS, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Surg, Hamilton, ON L8N 3Z5, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Mayo Clin & Mayo Fdn, Dept Med, Rochester, MN 55905 USA	McMaster University; Dalhousie University; McMaster University; McMaster University; University of Calgary; University of Calgary; Mayo Clinic	Devereaux, PJ (corresponding author), McMaster Univ, Dept Med, 1200 Main St W,Room 2C12, Hamilton, ON L8N 3Z5, Canada.		Bhandari, Mohit/AAQ-1675-2021; Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019; Manns, Braden J/I-8942-2012	Devereaux, PJ/0000-0003-2935-637X; Montori, Victor/0000-0003-0595-2898				Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; BENSON H, 1979, NEW ENGL J MED, V300, P1424; BOWLING A, 1998, RES METHODS HLTH, P197; CHRISTIE D, 1997, EPIDEMIOLOGY INTRO T, P91; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; CROMBIE IK, 1996, POCKET GUIDE CRITICA, P43; DIXON RA, 1997, EVIDENCE BASED MED W, P5; DUNN G, 1995, CLIN BIOSTATISTICS I, P120; ELWOOD M, 1998, CRITICAL APPRAISAL E, P8; FLETCHER RH, 1996, CLIN EPIDEMIOLOGY ES, P148; FRIEDLAND DJ, 1998, EVIDENCE BASED MED F, P163; FRIEDMAN G, 1994, PHARM APPROACH GASTR, P163; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Gray J. A. M, 1997, EVIDENCE BASED HEALT, P78; GREENBERG RS, 1996, MED EPIDEMIOLOGY, P93; GREENHALGH T, 1997, READ PAPER BASICS EV, P39; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; HASSARD TH, 1991, UNDERSTANDING BIOSTA, P156; INGELFINGER JA, 1994, BIOSTATISTICS CLIN M, P265; JADAD A, 1998, RANDOMISED CONTROLLE, P20; JONES R, 1995, CRITICAL READING PRI, P221; KARLOWSKI TR, 1975, JAMA-J AM MED ASSOC, V231, P1038, DOI 10.1001/jama.231.10.1038; Knapp RG, 1992, CLIN EPIDEMIOLOGY BI, P136; MAY GS, 1981, CIRCULATION, V64, P669, DOI 10.1161/01.CIR.64.4.669; McKibbon A, 1999, PDQ EVIDENCE BASED P, P33; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; NORELL SE, 1995, WORKBOOK EPIDEMIOLOG, P151; RIEGELMAN RK, 1996, STUDYING STUDY TESTI, P8; RIFFENBURGH RH, 1999, STAT MED, P18; ROSSER WW, 1998, EVIDENCE BASED FAMIL, P15; SACKETT DL, 1997, EVIDENCE BASED MED, P91; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SPILKER B, 1991, GUIDE CLIN TRIALS, P15; VALANIS B, 1999, EPIDEMIOLOGY HLTH CA, P361; WASSERTHEILSMOL.S, 1995, BIOSTATISTICS EPIDEM, P130; WHISNANT JP, 1993, STROKE POPULATIONS C, P26	39	172	174	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					2000	2003		10.1001/jama.285.15.2000	http://dx.doi.org/10.1001/jama.285.15.2000			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308438	Bronze			2022-12-28	WOS:000167995900030
J	Wu, L; Hickson, ID				Wu, L; Hickson, ID			DNA ends RecQ-uire attention	SCIENCE			English	Editorial Material							WERNER-SYNDROME PROTEIN; FUNCTIONAL INTERACTION; SYNDROME GENE; HELICASE; KU; RECOMBINATION; REPLICATION; SGS1		Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Imperial Canc Res Fund Labs, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford	Wu, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Imperial Canc Res Fund Labs, Oxford OX3 9DS, England.		Hickson, Ian/AAJ-7548-2020	Hickson, Ian/0000-0002-0583-566X				Chakraverty RK, 1999, BIOESSAYS, V21, P286; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Cooper MP, 2000, GENE DEV, V14, P907; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Frei C, 2000, GENE DEV, V14, P81; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nehlin JO, 2000, ANN NY ACAD SCI, V908, P167; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WU L, IN PRESS COLD SPRING; WU L, IN PRESS J BIOL CHEM; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	22	14	16	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					229	230		10.1126/science.1060832	http://dx.doi.org/10.1126/science.1060832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305313				2022-12-28	WOS:000168074000029
J	Zachos, JC; Shackleton, NJ; Revenaugh, JS; Palike, H; Flower, BP				Zachos, JC; Shackleton, NJ; Revenaugh, JS; Palike, H; Flower, BP			Climate response to orbital forcing across the Oligocene-Miocene boundary	SCIENCE			English	Article							NORTHERN-HEMISPHERE GLACIATION; ATMOSPHERIC CARBON-DIOXIDE; ASTRONOMICAL CALIBRATION; ROSS-SEA; RECORD; PALEOCLIMATE; CYCLES; TIME; TEMPERATURE; CIRCULATION	Spectral analyses of an uninterrupted 5.5-million-year (My)-long chronology of late Oligocene-early Miocene climate and ocean carbon chemistry from two deep-sea cores recovered in the western equatorial Atlantic reveal variance concentrated at all Milankovitch frequencies. Exceptional spectral power in climate is recorded at the 406-thousand-year (ky) period eccentricity band over a 3.4-million-year period [20 to 23.4 My ago (Ma)] as well as in the 125- and 95-ky bands over a 1.3-million-year period (21.7 to 23.0 Ma) of suspected Low greenhouse gas Levels. Moreover, a major transient glaciation at the epoch boundary (similar to 23 Ma), Mi-1, corresponds with a rare orbital congruence involving obliquity and eccentricity. The anomaly, which consists of Low-amplitude variance in obliquity (a node) and a minimum in eccentricity, results in an extended period (similar to 200 ky) of low seasonality orbits favorable to ice-sheet expansion on Antarctica.	Univ Calif Santa Cruz, Dept Earth Sci, Ctr Dynam & Evolut Land Sea Interface, Santa Cruz, CA 95064 USA; Univ Cambridge, Godwin Lab Quaternary Studies, Cambridge CB2 3SA, England; Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	University of California System; University of California Santa Cruz; University of Cambridge; State University System of Florida; University of South Florida	Zachos, JC (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Ctr Dynam & Evolut Land Sea Interface, Santa Cruz, CA 95064 USA.		Revenaugh, Justin/GVR-8368-2022; Palike, Heiko/A-6560-2008; Zachos, James C/A-7674-2008	Revenaugh, Justin/0000-0002-7855-5159; Palike, Heiko/0000-0003-3386-0923; Zachos, James C/0000-0001-8439-1886				Clemens SC, 1997, NATURE, V385, P801, DOI 10.1038/385801a0; CURRY WB, 1995, INIT REP P OCEAN DRI, V154; EDINGER EN, 1994, PALAIOS, V9, P576, DOI 10.2307/3515129; Ehrmann W, 1998, PALAEOGEOGR PALAEOCL, V139, P213, DOI 10.1016/S0031-0182(97)00138-7; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Herbert TD, 1997, P NATL ACAD SCI USA, V94, P8362, DOI 10.1073/pnas.94.16.8362; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; LECKIE RM, 1983, GEOLOGY, V11, P578, DOI 10.1130/0091-7613(1983)11<578:LOMGRO>2.0.CO;2; Lourens LJ, 1997, QUATERN INT, V40, P43, DOI 10.1016/S1040-6182(96)00060-2; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Nong GT, 2000, GEOPHYS RES LETT, V27, P2689, DOI 10.1029/1999GL011072; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Palike H, 2000, EARTH PLANET SC LETT, V182, P1, DOI 10.1016/S0012-821X(00)00229-6; PARK J, 1993, J GEOPHYS RES-SOL EA, V98, P447, DOI 10.1029/92JB01815; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; Sagnotti L, 1998, GEOPHYS J INT, V134, P653, DOI 10.1046/j.1365-246x.1998.00559.x; Shackleton NJ, 1999, PHILOS T R SOC A, V357, P1907, DOI 10.1098/rsta.1999.0407; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216	29	317	346	3	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					274	278		10.1126/science.1058288	http://dx.doi.org/10.1126/science.1058288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303100	Green Submitted			2022-12-28	WOS:000168074000043
J	Young, MA; Gonfloni, S; Superti-Furga, G; Roux, B; Kuriyan, J				Young, MA; Gonfloni, S; Superti-Furga, G; Roux, B; Kuriyan, J			Dynamic coupling between the SH2 and SH3 domains of c-Src and hck underlies their inactivation by C-terminal tyrosine phosphorylation	CELL			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; KINASE HCK; REGULATORY INTERACTIONS; PROTEIN; ACTIVATION; AFFINITY; BINDING; DNA; SIMULATIONS	The effect of C-terminal tyrosine phosphorylation on molecular motions in the Src kinases Hck and c-Src is investigated by molecular dynamics simulations. The SH2 and SH3 domains of the inactive kinases are seen to be tightly coupled by the connector between them, impeding activation. Dephosphorylation of the tail reduces the coupling between the SH2 and SH3 domains in the simulations, as does replacement of connector residues with glycine. A mutational analysis of c-Src expressed in Schizosaccharomyces pombe demonstrates that replacement of residues in the SH2-SH3 connector with glycine activates c-Src. The SH2-SH3 connector appears to be an inducible "snap lock" that clamps the SH2 and SH3 domains upon tail phosphorylation, but which allows flexibility when the tail is released.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; European Molecular Biology Laboratory (EMBL); Cornell University	Kuriyan, J (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.		Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Superti-Furga, Giulio/0000-0002-0570-1768; GONFLONI, STEFANIA/0000-0002-9392-4258				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; AROLD ST, 2001, IN PRESS J BIOL CHEM; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; BRASHER BB, 2001, IN PRESS ONCOGENE; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1995, CURR OPIN STRUC BIOL, V5, P211, DOI 10.1016/0959-440X(95)80078-6; CASE D, 1997, AMBER 5 0; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Engen JR, 1999, J MOL BIOL, V287, P645, DOI 10.1006/jmbi.1999.2619; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; GUILBERT C, 1995, COMPUT PHYS COMMUN, V91, P263, DOI 10.1016/0010-4655(95)00052-H; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LIU XQ, 1993, ONCOGENE, V8, P1119; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tong L, 1996, J MOL BIOL, V256, P601, DOI 10.1006/jmbi.1996.0112; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	40	319	326	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					115	126		10.1016/S0092-8674(01)00301-4	http://dx.doi.org/10.1016/S0092-8674(01)00301-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301007	Bronze			2022-12-28	WOS:000168063300012
J	Spurgeon, D				Spurgeon, D			Farmer fined for growing GM seed	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					615	615		10.1038/35070736	http://dx.doi.org/10.1038/35070736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287907	Bronze			2022-12-28	WOS:000167875400004
J	Bach, PB; Brown, C; Gelfand, SE; McCrory, DC				Bach, PB; Brown, C; Gelfand, SE; McCrory, DC			Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence	ANNALS OF INTERNAL MEDICINE			English	Review							POSITIVE-PRESSURE VENTILATION; ACUTE RESPIRATORY-FAILURE; METERED-DOSE INHALER; BRONCHODILATOR DELIVERY METHODS; RANDOMIZED CONTROLLED-TRIAL; PEAK EXPIRATORY FLOW; CHRONIC-BRONCHITIS; IPRATROPIUM BROMIDE; MECHANICAL VENTILATION; NEBULIZED SALBUTAMOL	Purpose: To review critically the available data on diagnostic evaluation, risk stratification, and therapeutic management of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). Data Sources: English-language articles were identified by searching MEDLINE (1966 to 2000, week 5), EMBASE (1974 to 2000, week 18), HealthStar (1975 to June 2000), and the Cochrane Controlled Trials Register (2000, Issue 1). Study Selection: The best available evidence on each subtopic was selected for analysis. Randomized trials, sometimes buttressed by cohort studies, were used to evaluate therapeutic interventions. Cohort studies were used to evaluate diagnostic tests and risk stratification. Data Extraction: study design and results were summarized in evidence tables. Individual studies were rated by internal validity, external validity, and quality of design. Statistical analyses of combined data were not performed, Data Synthesis: Data on the utility of most diagnostic tests are limited. However, chest radiography and arterial blood gas sampling seem useful while acute spirometry does not. Identifiable clinical variables are associated with risk for relapse and risk for death after hospitalization for an acute exacerbation. Evidence of efficacy was found for bronchodilators, corticosteroids, and noninvasive positive-pressure ventilation. There is also support for the use of antibiotics in patients with more severe exacerbations, On the basis of limited data, mucolytics and chest physiotherapy do not seem to be of benefit, and oxygen supplementation seems to increase the risk for respiratory failure only in an identifiable subgroup of patients. Conclusions: Although suggestions for appropriate management can be made on the basis of available evidence, the supporting literature is scarce and further high-quality research is necessary. Such research will require an improved, generally acceptable, and transportable definition of acute exacerbation of COPD, as well as improved methods for observing and measuring outcomes.	Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; Duke Evidence Based Practice Ctr, Ctr Clin Hlth Policy Res, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA	Memorial Sloan Kettering Cancer Center; Duke University; Duke University	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave,Box 221, New York, NY 10021 USA.				PHS HHS [290-97-0014] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams SG, 2000, CHEST, V117, P1345, DOI 10.1378/chest.117.5.1345; AHMED AH, 1992, THORAX, V47, P858; *AHRQ, AHRQ PUBL; ALBERT RK, 1980, ANN INTERN MED, V92, P753, DOI 10.7326/0003-4819-92-6-753; AMBROSINO N, 1995, THORAX, V50, P755, DOI 10.1136/thx.50.7.755; Angus RM, 1996, THORAX, V51, P1048, DOI 10.1136/thx.51.10.1048; [Anonymous], 1980, Ann Intern Med, V93, P391; [Anonymous], [No title captured]; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Aylward M, 1973, Curr Med Res Opin, V1, P219, DOI 10.1185/03007997309111671; BACKMAN R, 1985, CURR THER RES CLIN E, V38, P135; BALL P, 1995, CHEST, V108, pS43, DOI 10.1378/chest.108.2_Supplement.43S; BALL P, 1995, QJM-INT J MED, V88, P61; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BEATY CD, 1991, AM REV RESPIR DIS, V144, P1408, DOI 10.1164/ajrccm/144.6.1408; BEDON GA, 1970, ARCH INTERN MED, V125, P106, DOI 10.1001/archinte.125.1.106; BERRY DG, 1960, LANCET, V1, P137; BERRY RB, 1989, CHEST, V96, P1241, DOI 10.1378/chest.96.6.1241; BOIX JH, 1996, RESP CARE, V41, P187; BONE RC, 1978, AM J MED, V65, P896, DOI 10.1016/0002-9343(78)90740-4; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BOYTER AC, 1995, J ANTIMICROB CHEMOTH, V36, P403, DOI 10.1093/jac/36.2.403; Braunwald E, 1992, BRAUNWALD HEART DIS, V4th; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Bullard MJ, 1996, AM J EMERG MED, V14, P139, DOI 10.1016/S0735-6757(96)90120-5; BURK RH, 1973, ARCH INTERN MED, V132, P865, DOI 10.1001/archinte.132.6.865; CAMPBELL AH, 1975, MED J AUSTRALIA, V1, P33, DOI 10.5694/j.1326-5377.1975.tb111210.x; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; CONNORS AF, 1981, AM REV RESPIR DIS, V124, P537; Corbetta L, 1997, Monaldi Arch Chest Dis, V52, P421; *CTR EV BAS MED, 1999, LEV EV GRAD REC; CYDULKA RK, 1995, ANN EMERG MED, V25, P470; DARDES N, 1986, EUR J RESPIR DIS, V69, P377; Daskalopoulou E, 1993, CHEST, V103, p271S; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Dewan NA, 2000, CHEST, V117, P662, DOI 10.1378/chest.117.3.662; ELDRIDGE F, 1968, ANN INTERN MED, V68, P569, DOI 10.7326/0003-4819-68-3-569; Elmes P C, 1965, Br Med J, V2, P904; ELMES PC, 1957, BRIT MED J, V2, P1272, DOI 10.1136/bmj.2.5056.1272; EMERMAN CL, 1989, CHEST, V95, P563, DOI 10.1378/chest.95.3.563; EMERMAN CL, 1989, ANN EMERG MED, V18, P523, DOI 10.1016/S0196-0644(89)80837-6; Emerman CL, 1996, ANN EMERG MED, V27, P159, DOI 10.1016/S0196-0644(96)70317-7; EMERMAN CL, 1990, ANN EMERG MED, V19, P643, DOI 10.1016/S0196-0644(05)82468-0; Emerman CL, 1997, ANN EMERG MED, V29, P474, DOI 10.1016/S0196-0644(97)70219-1; EMERMAN CL, 1993, ANN EMERG MED, V22, P680, DOI 10.1016/S0196-0644(05)81847-5; EMERMAN CL, 1991, CHEST, V99, P595, DOI 10.1378/chest.99.3.595; FEAR EC, 1962, BRIT J DIS CHEST, V56, P153, DOI 10.1016/S0007-0971(62)80012-6; FEDULLO AJ, 1986, NEW YORK STATE J MED, V86, P4; FINIGUERRA M, 1982, CURR THER RES CLIN E, V31, P895; FOGLIO C, 1992, CHEST, V101, P1533, DOI 10.1378/chest.101.6.1533; FUSO L, 1995, AM J MED, V98, P272, DOI 10.1016/S0002-9343(99)80374-X; Girault C, 1997, THORAX, V52, P690, DOI 10.1136/thx.52.8.690; GREENE AB, 1988, J NATL MED ASSOC, V80, P393; GUMP DW, 1976, AM REV RESPIR DIS, V113, P465; *HEALTHC COST UT P, 1997, NAT INP SAMPL; HEUSER MD, 1992, ARCH INTERN MED, V152, P1683, DOI 10.1001/archinte.152.8.1683; HIGGINS RM, 1987, B EUR PHYSIOPATH RES, V23, P261; Hilbert G, 1997, INTENS CARE MED, V23, P955, DOI 10.1007/s001340050438; Hillberg RE, 1997, NEW ENGL J MED, V337, P1746, DOI 10.1056/NEJM199712113372407; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JASPER AC, 1987, CHEST, V91, P614, DOI 10.1378/chest.91.4.614; JEFFREY AA, 1992, THORAX, V47, P34, DOI 10.1136/thx.47.1.34; JONES DJM, 1994, THORAX, V49, P1222, DOI 10.1136/thx.49.12.1222; JORGENSEN A F, 1992, Scandinavian Journal of Primary Health Care, V10, P7, DOI 10.3109/02813439209014027; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KARPEL JP, 1990, CHEST, V98, P835, DOI 10.1378/chest.98.4.835; Keenan SP, 1997, CRIT CARE MED, V25, P1685, DOI 10.1097/00003246-199710000-00018; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; LANGLANDS JH, 1970, LANCET, V1, P448; MAGUIRE GP, 1991, CHEST, V100, P1300, DOI 10.1378/chest.100.5.1300; MARTIN TJ, 1994, CRIT CARE MED, V23, pA219; Meduri GU, 1996, CHEST, V109, P179, DOI 10.1378/chest.109.1.179; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; MOAYYEDI P, 1995, THORAX, V50, P834, DOI 10.1136/thx.50.8.834; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; MOSS K, 1985, CHEST, V88, pS53; MURATA GH, 1992, ARCH INTERN MED, V152, P73, DOI 10.1001/archinte.152.1.73; MURATA GH, 1992, ARCH INTERN MED, V152, P82, DOI 10.1001/archinte.152.1.82; MURATA GH, 1989, ANN EMERG MED, V18, P501, DOI 10.1016/S0196-0644(89)80833-9; MURATA GH, 1991, ANN EMERG MED, V20, P125, DOI 10.1016/S0196-0644(05)81207-7; MUSHLIN AI, 1991, JAMA-J AM MED ASSOC, V266, P80; NEWTON DAG, 1978, BMJ-BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6151.1525; NICOTRA MB, 1982, ANN INTERN MED, V97, P18, DOI 10.7326/0003-4819-97-1-18; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Niewoehner DE, 2000, AM J RESP CRIT CARE, V161, P1201, DOI 10.1164/ajrccm.161.4.9907143; ODRISCOLL BR, 1989, LANCET, V1, P1418; Parshall MB, 1999, NURS RES, V48, P62, DOI 10.1097/00006199-199903000-00004; PATRICK DM, 1990, CHEST, V98, P295, DOI 10.1378/chest.98.2.295; PEACH H, 1981, THORAX, V36, P585, DOI 10.1136/thx.36.8.585; Pearson MG, 1997, THORAX, V52, pS1; PERALTA J, 1987, ARZNEIMITTEL-FORSCH, V37-2, P969; PETERSEN ES, 1967, ACTA MED SCAND, V182, P293; Petty TL, 1997, JAMA-J AM MED ASSOC, V277, P246, DOI 10.1001/jama.277.3.246; PINES A, 1968, BMJ-BRIT MED J, V2, P735, DOI 10.1136/bmj.2.5607.735; PINES A, 1972, British Journal of Diseases of the Chest, V66, P107, DOI 10.1016/S0007-0971(72)80032-9; PORTIER F, 1992, CHEST, V101, P204, DOI 10.1378/chest.101.1.204; REBUCK AS, 1987, AM J MED, V82, P59, DOI 10.1016/0002-9343(87)90378-0; RICE KL, 1987, ANN INTERN MED, V107, P305, DOI 10.7326/0003-4819-107-2-305; SACHS APE, 1995, THORAX, V50, P758, DOI 10.1136/thx.50.7.758; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Schaberg T, 1996, THORAX, V51, P1017, DOI 10.1136/thx.51.10.1017; SCHWARTZ J, 1994, AM J RESP CRIT CARE, V150, P648, DOI 10.1164/ajrccm.150.3.8087333; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; SEIDENFELD JJ, 1984, ANN EMERG MED, V13, P248, DOI 10.1016/S0196-0644(84)80472-2; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; SERVERA E, 1995, CHEST, V108, P1572, DOI 10.1378/chest.108.6.1572; SHERMAN S, 1989, ARCH INTERN MED, V149, P2493, DOI 10.1001/archinte.149.11.2493; SHRESTHA M, 1991, ANN EMERG MED, V20, P1206, DOI 10.1016/S0196-0644(05)81472-6; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; SMITH CB, 1976, J INFECT DIS, V134, P552, DOI 10.1093/infdis/134.6.552; SUMMER W, 1989, ARCH INTERN MED, V149, P618, DOI 10.1001/archinte.149.3.618; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; TSAI TW, 1993, ANN EMERG MED, V22, P1854; TURNER JR, 1988, CHEST, V93, P476, DOI 10.1378/chest.93.3.476; Turner MO, 1997, ARCH INTERN MED, V157, P1736, DOI 10.1001/archinte.157.15.1736; *US DEP COMM, 1997, STAT ABSTR US 1997; VITACCA M, 1993, INTENS CARE MED, V19, P450, DOI 10.1007/BF01711086; WARRELL DA, 1970, BMJ-BRIT MED J, V2, P452, DOI 10.1136/bmj.2.5707.452; WARREN PM, 1980, LANCET, V1, P467; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WOLLMER P, 1985, EUR J RESPIR DIS, V66, P233; WRENN K, 1991, ANN INTERN MED, V115, P241, DOI 10.7326/0003-4819-115-4-241; WU AW, 1995, ANN INTERN MED, V122, P342, DOI 10.7326/0003-4819-122-5-199503010-00004; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761; ZEHNER WJ, 1995, ACAD EMERG MED, V2, P686, DOI 10.1111/j.1553-2712.1995.tb03619.x	129	169	186	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					600	620		10.7326/0003-4819-134-7-200104030-00016	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00016			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281745				2022-12-28	WOS:000167931200009
J	Ruderman, N; Flier, JS				Ruderman, N; Flier, JS			Cell biology - Chewing the fat - ACC and energy balance	SCIENCE			English	Editorial Material							SKELETAL-MUSCLE		BioSquare 2, Diabet Unit, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Ruderman, N (corresponding author), BioSquare 2, Diabet Unit, Boston, MA 02118 USA.		Flier, jeffrey/AAG-6223-2019	Ruderman, Neil/0000-0002-6589-6587				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE622, DOI 10.1152/ajpendo.2000.279.3.E622	12	24	25	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2558	2559		10.1126/science.1060277	http://dx.doi.org/10.1126/science.1060277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286278				2022-12-28	WOS:000167861000027
J	Campbell, EA; Korzheva, N; Mustaev, A; Murakami, K; Nair, S; Goldfarb, A; Darst, SA				Campbell, EA; Korzheva, N; Mustaev, A; Murakami, K; Nair, S; Goldfarb, A; Darst, SA			Structural mechanism for rifampicin inhibition of bacterial RNA polymerase	CELL			English	Article							ESCHERICHIA-COLI; RPOB GENE; BETA-SUBUNIT; MOLECULAR-STRUCTURE; RESISTANT MUTANTS; MUTATIONS; RIFAMYCIN; DNA; ANSAMYCINS; SEQUENCE	Rifampicin (Rif) is one of the most potent and broad spectrum antibiotics against bacterial pathogens and is a key component of anti-tuberculosis therapy, stemming from its inhibition of the bacterial RNA polymerase (RNAP). We determined the crystal structure of Thermus aquaticus core RNAP complexed with Rif. The inhibitor binds in a pocket of the RNAP beta subunit deep within the DNA/RNA channel, but more than 12 Angstrom away from the active site. The structure, combined with biochemical results, explains the effects of Rif on RNAP function and indicates that the inhibitor acts by directly blocking the path of the elongating RNA when the transcript becomes 2 to 3 nt in length.	Rockefeller Univ, New York, NY 10021 USA; Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu	Nair, Satish/AAY-2510-2021	Campbell, Elizabeth/0000-0002-1332-128X; Murakami, Katsuhiko/0000-0003-2244-0501	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049242, R01GM061898, R01GM030717] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49242, GM20470, GM61898, GM35759, GM30717] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; ARORA SK, 1983, MOL PHARMACOL, V23, P133; ARORA SK, 1985, J MED CHEM, V28, P1099, DOI 10.1021/jm00146a021; ARORA SK, 1981, ACTA CRYSTALLOGR B, V37, P152, DOI 10.1107/S0567740881002380; ARORA SK, 1984, J ANTIBIOT, V37, P178, DOI 10.7164/antibiotics.37.178; BRUFANI M, 1974, J MOL BIOL, V87, P409, DOI 10.1016/0022-2836(74)90094-1; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHAMBERLIN MJ, 1993, HARVEY LECT, V88, P1; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Drancourt M, 1999, ANTIMICROB AGENTS CH, V43, P2400, DOI 10.1128/AAC.43.10.2400; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; HARTMANN G, 1967, BIOCHIM BIOPHYS ACTA, V145, P843, DOI 10.1016/0005-2787(67)90147-5; Heep M, 1999, ANTIMICROB AGENTS CH, V43, P1497, DOI 10.1128/AAC.43.6.1497; Heep M, 2000, ANTIMICROB AGENTS CH, V44, P1075, DOI 10.1128/AAC.44.4.1075-1077.2000; HEIL A, 1970, FEBS LETT, V11, P165, DOI 10.1016/0014-5793(70)80519-1; HINKLE DC, 1972, J MOL BIOL, V70, P209, DOI 10.1016/0022-2836(72)90534-7; HONORE N, 1993, MOL MICROBIOL, V7, P207, DOI 10.1111/j.1365-2958.1993.tb01112.x; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; JIN DJ, 1991, J BIOL CHEM, V266, P14478; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Lancini G, 1977, STRUCTURE ACTIVITY R, P531; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LISITSYN NA, 1984, MOL GEN GENET, V196, P173, DOI 10.1007/BF00334112; LISITSYN NA, 1984, BIOORG KHIM+, V10, P127; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Minakhin L, 2001, J BACTERIOL, V183, P71, DOI 10.1128/JB.183.1.71-76.2001; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; Morse R, 1999, J CLIN MICROBIOL, V37, P2913, DOI 10.1128/JCM.37.9.2913-2919.1999; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; MUSTAEV A, 1994, P NATL ACAD SCI USA, V91, P12036, DOI 10.1073/pnas.91.25.12036; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte O, 1997, J ANTIMICROB CHEMOTH, V39, P747, DOI 10.1093/jac/39.6.747; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; OVCHINNIKOV YA, 1983, MOL GEN GENET, V190, P344, DOI 10.1007/BF00330662; Padayachee T, 1999, ANTIMICROB AGENTS CH, V43, P2361, DOI 10.1128/AAC.43.10.2361; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; SCHULZ W, 1981, NUCLEIC ACIDS RES, V9, P6889, DOI 10.1093/nar/9.24.6889; SENSI P, 1983, REV INFECT DIS, V5, pS402; Sensi P, 1960, ANTIBIOT ANNU, P262; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; SEVERINOV K, 1994, MOL GEN GENET, V244, P120, DOI 10.1007/BF00283512; Shinnick T. M., 1996, CURR TOP MICROBIOL; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEHRLI W, 1968, BIOCHEM BIOPH RES CO, V32, P284, DOI 10.1016/0006-291X(68)90382-3; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	56	925	966	5	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					901	912		10.1016/S0092-8674(01)00286-0	http://dx.doi.org/10.1016/S0092-8674(01)00286-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290327	Bronze			2022-12-28	WOS:000167869200012
J	Smith, CI; Chamberlain, AT; Riley, MS; Cooper, A; Stringer, CB; Collins, MJ				Smith, CI; Chamberlain, AT; Riley, MS; Cooper, A; Stringer, CB; Collins, MJ			Not just old but old and cold?	NATURE			English	Article							NEANDERTHAL DNA; CLIMATE; WESTERN; EUROPE		Newcastle Univ, Fossil Fuel & Environm Geochem Postgrad Inst, NRG, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Univ Birmingham, Sch Earth Sci, Birmingham B15 2TT, W Midlands, England; Univ Oxford, Dept Biol Anthropol, Oxford OX2 6QS, England; Univ Oxford, Dept Zool, Oxford OX2 6QS, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Newcastle University - UK; University of Sheffield; University of Birmingham; University of Oxford; University of Oxford; Natural History Museum London	Collins, MJ (corresponding author), Newcastle Univ, Fossil Fuel & Environm Geochem Postgrad Inst, NRG, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.collins@ncl.ac.uk	Riley, Michael S/G-2295-2014; Chamberlain, Andrew T/F-2118-2018; Cooper, Alan/E-8171-2012; Smith, Colin/A-9150-2008	Cooper, Alan/0000-0002-7738-7851; Collins, Matthew/0000-0003-4226-5501; Smith, Colin/0000-0001-5901-8780				Cooper A, 1996, NATURE, V381, P484, DOI 10.1038/381484a0; Cooper A, 1997, SCIENCE, V277, P1021; Elias SA, 2000, QUATERNARY RES, V53, P229, DOI 10.1006/qres.1999.2093; Fleischer RC, 2000, AUK, V117, P1051, DOI 10.1642/0004-8038(2000)117[1051:IOTEHE]2.0.CO;2; GUIOT J, 1993, PALAEOGEOGR PALAEOCL, V103, P73, DOI 10.1016/0031-0182(93)90053-L; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Osborne MR, 2000, CHEM RES TOXICOL, V13, P257, DOI 10.1021/tx990182e; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Vandenberghe J, 1998, J QUATERNARY SCI, V13, P361, DOI 10.1002/(SICI)1099-1417(1998090)13:5<361::AID-JQS404>3.0.CO;2-O; Vercauteren M., 1997, ANC BIOMOL, V1, P109; Zhang T, 1997, PERMAFROST PERIGLAC, V8, P45, DOI 10.1002/(SICI)1099-1530(199701)8:1&lt;45::AID-PPP240&gt;3.0.CO;2-K	14	117	120	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					771	772		10.1038/35071177	http://dx.doi.org/10.1038/35071177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298436	Green Accepted, Green Published			2022-12-28	WOS:000168021900042
J	Cantor, SB; Bell, DW; Ganesan, S; Kass, EM; Drapkin, R; Grossman, S; Wahrer, DCR; Sgroi, DC; Lane, WS; Haber, DA; Livingston, DM				Cantor, SB; Bell, DW; Ganesan, S; Kass, EM; Drapkin, R; Grossman, S; Wahrer, DCR; Sgroi, DC; Lane, WS; Haber, DA; Livingston, DM			BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA-POLYMERASE-II; DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; TRANSCRIPTIONAL ACTIVATION; BASAL TRANSCRIPTION; DAMAGE RESPONSE; MEIOTIC CELLS; YEAST RAD3; TFIIH	BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1.A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc Risk Anal, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu	Sgroi, Dennis/AAV-2487-2021; Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977	NCI NIH HHS [P50 CA89393] Funding Source: Medline; NHLBI NIH HHS [T32 HL07627-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; BADIE C, 1995, RADIAT RES, V144, P26, DOI 10.2307/3579232; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Deng CX, 2000, BIOESSAYS, V22, P728; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Kiltie AE, 1997, NUCLEIC ACIDS RES, V25, P2945, DOI 10.1093/nar/25.14.2945; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; MA LB, 1994, MOL CELL BIOL, V14, P4126, DOI 10.1128/MCB.14.6.4126; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Prakash L, 1989, Ann Ist Super Sanita, V25, P99; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; SERIZAWA H, 1994, J BIOL CHEM, V269, P20750; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Tomlinson GE, 1998, CANCER RES, V58, P3237; Vermeulen W, 1997, BIOCHEM SOC T, V25, P309, DOI 10.1042/bst0250309; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang Y, 2000, GENE DEV, V14, P927; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; WU X, 2000, SCIENCE, V289, pA11; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zabludoff SD, 1996, ONCOGENE, V13, P649; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	58	512	531	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					149	160		10.1016/S0092-8674(01)00304-X	http://dx.doi.org/10.1016/S0092-8674(01)00304-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301010	Bronze			2022-12-28	WOS:000168063300015
J	Ernest, SKM; Brown, JH				Ernest, SKM; Brown, JH			Delayed compensation for missing keystone species by colonization	SCIENCE			English	Article							DESERT RODENT COMMUNITY; PLANT-COMMUNITIES; LONG-TERM; ECOSYSTEM; BIODIVERSITY; DIVERSITY; COMPETITION; GRASSLANDS; EXTINCTION; STABILITY	Because individual species can play key roles, the Loss of species through extinction OF their gain through colonization can cause major changes in ecosystems. For almost 20 years after kangaroo rats were experimentally removed from a Chihuahuan desert ecosystem in the United States, other rodent species were unable to compensate and use the available resources. This changed abruptly in 1995, when an alien species of pocket mouse colonized the ecosystem, used most of the available resources, and compensated almost completely for the missing kangaroo rats. These results demonstrate the importance of individual species and of colonization and extinction events in the structure and dynamics of ecosystems.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Ernest, SKM (corresponding author), Texas Tech Univ, Dept Biol Sci, Program Ecol, Lubbock, TX 79409 USA.	morgan.ernest@ttu.edu	Ernest, S.K. Morgan/O-2532-2015; Ernest, Morgan/A-4355-2008	Ernest, S.K. Morgan/0000-0002-6026-8530; Ernest, Morgan/0000-0002-6026-8530				[Anonymous], COMMUNITY ECOLOGY; Bond WJ, 1994, BIODIVERSITY ECOSYST, P237, DOI [DOI 10.1890/0012-9658(1997)0781531:EOROSO2.0.CO;2, 10.1007/978-3-642-58001-7_11, DOI 10.1007/978-3-642-58001-7_11]; BROWN JH, 1985, ECOLOGY, V66, P1545, DOI 10.2307/1938017; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; Calder WA., 1984, SIZE FUNCTION LIFE H; Davis M.B., 1986, COMMUNITY ECOL, P269; FRANK DA, 1991, OIKOS, V62, P360, DOI 10.2307/3545501; GELUSO K, UNPUB; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Guo QF, 1996, OECOLOGIA, V107, P568, DOI 10.1007/BF00333950; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; Hoffmeister D. F., 1986, MAMMALS ARIZONA; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MITTELBACH GG, 1995, ECOLOGY, V76, P2347, DOI 10.2307/2265812; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; PULLIAM HR, 1975, ECOLOGY, V56, P1158, DOI 10.2307/1936155; REICHMAN OJ, 1975, J MAMMAL, V56, P731, DOI 10.2307/1379649; ROSENZWEIG ML, 1969, ECOLOGY, V50, P558, DOI 10.2307/1936246; Schmidt-Neilsen K, 1984, SCALING WHY IS ANIMA; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; VALONE TJ, 1995, SCIENCE, V267, P880, DOI 10.1126/science.7846530; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731	30	70	72	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					101	104						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292873				2022-12-28	WOS:000167995200047
J	O'Hara, KM; Thomas, JE				O'Hara, KM; Thomas, JE			Quantum physics - Standing room only at the quantum scale	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; LITHIUM FERMIONS; ATOMIC GAS		Duke Univ, Dept Phys, Durham, NC 27706 USA	Duke University	O'Hara, KM (corresponding author), Duke Univ, Dept Phys, Durham, NC 27706 USA.							Abraham ERI, 1997, PHYS REV A, V55, pR3299, DOI 10.1103/PhysRevA.55.R3299; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bohn JL, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053409; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; O'Hara KM, 2000, PHYS REV LETT, V85, P2092, DOI 10.1103/PhysRevLett.85.2092; O'Hara KM, 1999, PHYS REV LETT, V82, P4204, DOI 10.1103/PhysRevLett.82.4204; SCHRECK F, UNPUB; Stoof HTC, 1996, PHYS REV LETT, V76, P10, DOI 10.1103/PhysRevLett.76.10; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318	11	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2556	2557		10.1126/science.1060025	http://dx.doi.org/10.1126/science.1060025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286277				2022-12-28	WOS:000167861000026
J	Chan, FKL; Chung, SCS; Suen, BY; Lee, YT; Leung, WK; Leung, VKS; Wu, JCY; Lau, JYW; Hui, Y; Lai, MS; Chan, HLY; Sung, JJY				Chan, FKL; Chung, SCS; Suen, BY; Lee, YT; Leung, WK; Leung, VKS; Wu, JCY; Lau, JYW; Hui, Y; Lai, MS; Chan, HLY; Sung, JJY			Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTRIC-ULCERS; RISK; OMEPRAZOLE; ERADICATION; THERAPY; USERS; TRIAL	Background: Many patients who have had upper gastrointestinal bleeding continue to take low-dose aspirin for cardiovascular prophylaxis or other nonsteroidal antiinflammatory drugs (NSAIDs) for musculoskeletal pain. It is uncertain whether infection with Helicobacter pylori is a risk factor for bleeding in such patients. Methods: We studied patients with a history of upper gastrointestinal bleeding who were infected with H. pylori and who were taking low-dose aspirin or other NSAIDs. We evaluated whether eradication of the infection or omeprazole treatment was more effective in preventing recurrent bleeding. We recruited patients who presented with upper gastrointestinal bleeding that was confirmed by endoscopy. Their ulcers were healed by daily treatment with 20 mg of omeprazole for eight weeks or longer. Then, those who had been taking aspirin were given 80 mg of aspirin daily, and those who had been taking other NSAIDs were given 500 mg of naproxen twice daily for six months. The patients in each group were then randomly assigned separately to receive 20 mg of omeprazole daily for six months or one week of eradication therapy, consisting of 120 mg of bismuth subcitrate, 500 mg of tetracycline, and 400 mg of metronidazole, all given four times daily, followed by placebo for six months. Results: We enrolled 400 patients (250 of whom were taking aspirin and 150 of whom were taking other NSAIDs). Among those taking aspirin, the probability of recurrent bleeding during the six-month period was 1.9 percent for patients who received eradication therapy and 0.9 percent for patients who received omeprazole (absolute difference, 1.0 percent; 95 percent confidence interval for the difference, -1.9 to 3.9 percent). Among users of other NSAIDs, the probability of recurrent bleeding was 18.8 percent for patients receiving eradication therapy and 4.4 percent for those treated with omeprazole (absolute difference, 14.4 percent; 95 percent confidence interval for the difference, 4.4 to 24.4 percent; P=0.005). Conclusions: Among patients with H. pylori infection and a history of upper gastrointestinal bleeding who are taking low-dose aspirin, the eradication of H. pylori is equivalent to treatment with omeprazole in preventing recurrent bleeding. Omeprazole is superior to the eradication of H. pylori in preventing recurrent bleeding in patients who are taking other NSAIDs, such as naproxen. (N Engl J Med 2001;344:967-73.) Copyright (C) 2001 Massachusetts Medical Society.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; Alice Ho Miu Ling Nethersole Hosp, Med Unit, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Alice Ho Miu Ling Nethersole Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.		Leung, Wai Keung/B-8140-2011; Chan, Francis K. L./F-4851-2010; Wu, Justin/N-6916-2015; Lau, James Y. W./O-2612-2016; Sung, Joseph J. Y./R-3203-2018; Chan, Henry Lik-Yuen/B-9636-2008; Lee, Yeong Yeh/G-2470-2010	Leung, Wai Keung/0000-0002-5993-1059; Chan, Francis K. L./0000-0001-7388-2436; Lau, James Y. W./0000-0003-0122-4068; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Lee, Yeong Yeh/0000-0002-6486-7717				Aalykke C, 1999, GASTROENTEROLOGY, V116, P1305, DOI 10.1016/S0016-5085(99)70494-4; Chan FKL, 1998, GASTROENTEROLOGY, V114, pA87, DOI 10.1016/S0016-5085(98)80353-3; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; COX DR, 1972, J R STAT SOC B, V34, P187; Cullen DJE, 1997, GUT, V41, P459, DOI 10.1136/gut.41.4.459; Gillen D, 1999, GUT, V44, P468, DOI 10.1136/gut.44.4.468; Graham DY, 1996, AM J GASTROENTEROL, V91, P2080; Hawkey CJ, 1998, LANCET, V352, P1634; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; HENRY D, 1996, BRIT MED J, V312, P563; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Konturek JW, 1998, GASTROENTEROLOGY, V114, P245, DOI 10.1016/S0016-5085(98)70474-3; Labenz J, 1996, GASTROENTEROLOGY, V110, P725, DOI 10.1053/gast.1996.v110.pm8608881; Labenz J, 1999, ITAL J GASTROENTEROL, V31, P110; LAINE L, 1992, AM J GASTROENTEROL, V87, P1398; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; McCarthy DM, 1998, YALE J BIOL MED, V71, P101; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; RODRIGUEZ LAG, 1994, LANCET, V343, P1048; Rodriguez LAG, 1999, EPIDEMIOLOGY, V10, P228, DOI 10.1097/00001648-199905000-00006; Russell RI, 1999, ITAL J GASTROENTEROL, V31, P116; Santolaria S, 1999, ALIMENT PHARM THERAP, V13, P1511; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	26	460	481	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					967	973		10.1056/NEJM200103293441304	http://dx.doi.org/10.1056/NEJM200103293441304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274623				2022-12-28	WOS:000167716600004
J	De Moraes, CM; Mescher, MC; Tumlinson, JH				De Moraes, CM; Mescher, MC; Tumlinson, JH			Caterpillar-induced nocturnal plant volatiles repel conspecific females	NATURE			English	Article							COLORADO POTATO BEETLE; HOST-PLANT; PARASITIC WASPS; DAMAGE; ATTRACTION; COLEOPTERA; KAIROMONE; PHEROMONE; RESPONSES; LARVAE	Plants respond to insect herbivory by synthesizing and releasing complex blends of volatile compounds, which provide important host-location cues for insects that are natural enemies of herbivores(1-3). The effects of these volatile blends on herbivore behaviour have been investigated to only a limited extent(4,5), in part because of the assumption that herbivore-induced volatile emissions occur mainly during the light phase of the photoperiod(6,7). Because many moths-whose larvae are some of the most important insect herbivores-are nocturnal, herbivore-induced plant volatiles have not hitherto been considered to be temporally available as host-location cues for ovipositing females. Here we present chemical and behavioural assays showing that tobacco plants (Nicotiana tabacum) release herbivore-induced volatiles during both night and day. Moreover, several volatile compounds are released exclusively at night and are highly repellent to female moths (Heliothis virescens). The demonstration that tobacco plants release temporally different volatile blends and that lepidopteran herbivores use induced plant signals released during the dark phase to choose sites for oviposition adds a new dimension to our understanding of the role of chemical cues in mediating tritrophic interactions.	USDA ARS, CMAVE, Gainesville, FL 32604 USA; Univ Georgia, Dept Entomol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Tumlinson, JH (corresponding author), USDA ARS, CMAVE, POB 14565, Gainesville, FL 32604 USA.	jtumlinson@gainesville.usda.ufl.edu	Tumlinson, James H/G-8358-2011					Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; DICKE M, 1986, PHYSIOL ENTOMOL, V11, P251, DOI 10.1111/j.1365-3032.1986.tb00412.x; HARARI AR, 1994, J CHEM ECOL, V20, P361, DOI 10.1007/BF02064443; HEATH RR, 1994, J CHEM ECOL, V20, P593, DOI 10.1007/BF02059600; HEATH RR, 1986, J CHEM ECOL, V12, P2133, DOI 10.1007/BF01020315; HEATH RR, 1986, J CHEM ECOL, V12, P2081, DOI 10.1007/BF01041998; KARBAN R, 1985, ENTOMOL EXP APPL, V37, P137, DOI 10.1111/j.1570-7458.1985.tb03464.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; LANDOLT PJ, 1993, ENTOMOL EXP APPL, V67, P79, DOI 10.1007/BF02382720; Landolt PJ, 1999, ENVIRON ENTOMOL, V28, P973, DOI 10.1093/ee/28.6.973; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; MATTIACCI L, 1994, J CHEM ECOL, V20, P2229, DOI 10.1007/BF02033199; MCCALL PJ, 1993, J INSECT BEHAV, V6, P625, DOI 10.1007/BF01048128; Pallini A, 1997, OECOLOGIA, V110, P179, DOI 10.1007/s004420050147; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251	24	712	748	9	224	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					577	580		10.1038/35069058	http://dx.doi.org/10.1038/35069058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279494				2022-12-28	WOS:000167859300046
J	Cox, E; Bonner, J				Cox, E; Bonner, J			Ecology - The advantages of togetherness	SCIENCE			English	Editorial Material									Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Cox, E (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							Bonner JT., 2000, 1 SIGNALS EVOLUTION; DWORKIN M, 1972, CRIT REV MICROBIOL, V2, P435, DOI DOI 10.3109/10408417209103873; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079	3	12	14	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					448	449		10.1126/science.1060456	http://dx.doi.org/10.1126/science.1060456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11283359				2022-12-28	WOS:000168187300029
J	Beevers, G; Lip, GYH; O'Brien, E				Beevers, G; Lip, GYH; O'Brien, E			ABC of hypertension - The pathophysiology of hypertension	BRITISH MEDICAL JOURNAL			English	Review																		BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; DZAU VJ, 1988, CIRCULATION, V77, P4; HARRAP SB, 1994, LANCET, V344, P169, DOI 10.1016/S0140-6736(94)92762-6; HUGHES AD, 1994, BRIT MED BULL, V50, P356, DOI 10.1093/oxfordjournals.bmb.a072896; KURTZ TW, 1994, LANCET, V344, P167, DOI 10.1016/S0140-6736(94)92761-8; Lip GYH, 1998, J HYPERTENS, V16, P913, DOI 10.1097/00004872-199816070-00003; MATHIAS CJ, 1991, HYPERTENSION S3, V18, P22; SAGNELLA GA, 1990, Q J MED, V77, P1001, DOI 10.1093/qjmed/77.1.1001	8	222	239	0	34	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					912	916		10.1136/bmj.322.7291.912	http://dx.doi.org/10.1136/bmj.322.7291.912			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302910	Green Published			2022-12-28	WOS:000168311300027
J	Moran, CG; Tourret, LJ				Moran, CG; Tourret, LJ			Recent advances - Orthopaedics	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UNSTABLE FOREARM FRACTURES; BOTULINUM-TOXIN-A; METAL-ON-METAL; CEREBRAL-PALSY; WEAR DEBRIS; CHILDREN; CARTILAGE; FIXATION; BEARING; DAMAGE		Univ Nottingham Hosp, Queens Med Ctr, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England	University of Nottingham	Moran, CG (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England.	crazvorthopod@netlineuk.net						Anissian HL, 1999, ACTA ORTHOP SCAND, V70, P578, DOI 10.3109/17453679908997845; Baltzer AWA, 1999, KNEE SURG SPORT TR A, V7, P197, DOI 10.1007/s001670050147; BarOn E, 1997, J BONE JOINT SURG BR, V79B, P975, DOI 10.1302/0301-620X.79B6.7740; Bentley G, 2000, BRIT MED J, V320, P1585, DOI 10.1136/bmj.320.7249.1585; Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS124, DOI 10.1097/00003086-199810001-00014; Boyd RN, 2000, DEV MED CHILD NEUROL, V42, P32, DOI 10.1017/S0012162200000074; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Corry IS, 1998, J PEDIATR ORTHOPED, V18, P304, DOI 10.1097/00004694-199805000-00006; Goldsmith AAJ, 2000, P I MECH ENG H, V214, P39, DOI 10.1243/0954411001535228; Goldstein SA, 1998, CLIN ORTHOP RELAT R, pS154; Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5; Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219; Koman LA, 2000, J PEDIATR ORTHOPED, V20, P108, DOI 10.1097/00004694-200001000-00022; Luhmann SJ, 1998, J PEDIATR ORTHOPED, V18, P451, DOI 10.1097/00004694-199807000-00009; Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664; Minas T, 1997, ORTHOPEDICS, V20, P525; Niyibizi C, 1998, CLIN ORTHOP RELAT R, pS148; Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6; Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66; Richter D, 1998, J PEDIATR ORTHOPED, V18, P457, DOI 10.1097/00004694-199807000-00010; Sieber HP, 1999, J BONE JOINT SURG BR, V81B, P46, DOI 10.1302/0301-620X.81B1.9047; Van der Reis WL, 1998, J PEDIATR ORTHOPED, V18, P9, DOI 10.1097/00004694-199801000-00003; VRANSKY P, 2000, J PEDIATR ORTHOPED, V20, P23; WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95	24	8	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					902	905		10.1136/bmj.322.7291.902	http://dx.doi.org/10.1136/bmj.322.7291.902			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302907	Green Published			2022-12-28	WOS:000168311300024
J	Deschenes, LA; Vanden Bout, DA				Deschenes, LA; Vanden Bout, DA			RETRACTED: Single-molecule studies of heterogeneous dynamics in polymer melts near the class transition (Retracted article. See vol 312, pg 195, 2006)	SCIENCE			English	Article; Retracted Publication							GLASS-TRANSITION; SUPERCOOLED LIQUIDS; TRANSLATIONAL DIFFUSION; TEMPERATURE-DEPENDENCE; ROTATIONAL DIFFUSION; RELAXATION; SPECTROSCOPY; JUMPS; SOLIDS; MOTION	Single-molecule spectroscopy was used to follow the orientation of a single probe molecule in a polymer film in real time. Broad spatially heterogeneous dynamics were observed on Long time scales, which result from simple diffusive rotational motions on short time scales. This diffusive behavior persists for many rotations before the molecule's local environment changes to one characterized by a new time scale. This environmental exchange occurs instantaneously on the time scale of the experiment and may arise from large-scale collective motions. The distribution of exchange times for these environments was measured for several temperatures near the glass transition.	Univ Texas, Dept Chem, Ctr Nano & Mol Mat Sci & Technol, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Vanden Bout, DA (corresponding author), Univ Texas, Dept Chem, Ctr Nano & Mol Mat Sci & Technol, Austin, TX 78712 USA.	davandenbout@mail.utexas.edu						ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; [Anonymous], 1976, TIME SERIES ANAL; Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; BASCHE T, 1995, NATURE, V373, P132, DOI 10.1038/373132a0; Bennemann C, 1999, NATURE, V399, P246, DOI 10.1038/20406; Chang I, 1997, J PHYS CHEM B, V101, P8794, DOI 10.1021/jp9640989; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Fourkas J.T., 1997, ACS S SERIES, V676; Gleim T, 1998, PHYS REV LETT, V81, P4404, DOI 10.1103/PhysRevLett.81.4404; Ha T, 1999, J PHYS CHEM B, V103, P6839, DOI 10.1021/jp990948j; Ha T, 1998, PHYS REV LETT, V80, P2093, DOI 10.1103/PhysRevLett.80.2093; Hall DB, 1997, PHYS REV LETT, V79, P103, DOI 10.1103/PhysRevLett.79.103; Harrison G, 1976, DYNAMIC PROPERTIES S; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; MOERNER WE, 1994, SCIENCE, V265, P46, DOI 10.1126/science.265.5168.46; Moerner WE, 1996, ACCOUNTS CHEM RES, V29, P561; Ngai KL, 1999, J PHYS CHEM B, V103, P10684, DOI 10.1021/jp990554s; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Richert R, 1997, J PHYS CHEM B, V101, P6323, DOI 10.1021/jp9713219; Russell EV, 2000, NATURE, V408, P695; Sillescu H, 1999, J NON-CRYST SOLIDS, V243, P81, DOI 10.1016/S0022-3093(98)00831-X; VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074; Veerman JA, 1999, PHYS REV LETT, V83, P2155, DOI 10.1103/PhysRevLett.83.2155; Wang CY, 2000, J PHYS CHEM B, V104, P1724, DOI 10.1021/jp993420n; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wendt H, 2000, PHYS REV E, V61, P1722, DOI 10.1103/PhysRevE.61.1722	31	202	204	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					255	258		10.1126/science.1056430	http://dx.doi.org/10.1126/science.1056430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303094				2022-12-28	WOS:000168074000037
J	Sutherland, D; Block, PC				Sutherland, D; Block, PC			Aneurysm of a saphenous-vein bypass graft.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Providence St Vincent Med Ctr, Portland, OR 97225 USA		Sutherland, D (corresponding author), Providence St Vincent Med Ctr, Portland, OR 97225 USA.								0	6	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2001	344	15					1139	1139		10.1056/NEJM200104123441505	http://dx.doi.org/10.1056/NEJM200104123441505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420EC	11297705				2022-12-28	WOS:000167990600005
J	Philip, P; Vervialle, F; Le Breton, P; Taillard, J; Horne, JA				Philip, P; Vervialle, F; Le Breton, P; Taillard, J; Horne, JA			Fatigue, alcohol, and serious road crashes in France: factorial study of national data	BRITISH MEDICAL JOURNAL			English	Article							AUTOMOBILE DRIVERS		Ctr Hosp Univ, Clin Sommeil, F-33076 Bordeaux, France; Serv Etud Tech Routes & Autoroutes, Bagneux, France; Univ Loughborough, Sleep Res Lab, Loughborough LE11 3TU, Leics, England	CHU Bordeaux; Loughborough University	Philip, P (corresponding author), Ctr Hosp Univ, Clin Sommeil, F-33076 Bordeaux, France.		Taillard, Jacques/H-5063-2018; PHILIP, Pierre/AAS-8889-2020	Taillard, Jacques/0000-0001-9067-8189; PHILIP, Pierre/0000-0003-3267-634X				BIECHELEN MB, 1995, CONDUITE AUTOMOBILE; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; *OBS NAT INT SEC R, 1999, BIL ANN STAT COMM; Philip P, 1996, J PSYCHOSOM RES, V41, P279, DOI 10.1016/0022-3999(96)00127-4; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475	5	125	129	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					829	830		10.1136/bmj.322.7290.829	http://dx.doi.org/10.1136/bmj.322.7290.829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290636	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000168063000023
J	Truswell, AS				Truswell, AS			Levels and kinds of evidence for public-health nutrition	LANCET			English	Editorial Material							METAANALYSIS; CHOLESTEROL		Univ Sydney, Dept Biochem, Human Nutr Unit, Sydney, NSW 2006, Australia	University of Sydney	Truswell, AS (corresponding author), Univ Sydney, Dept Biochem, Human Nutr Unit, Sydney, NSW 2006, Australia.							*AUSTR NZ FOOD AUT, 2000, PIL MAN FRAM HLTH CL, P170; Cardiovascular Review Group of the Committee on Medical Aspects of Food Policy, 1994, NUTR ASP CARD DIS; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; *NAT HLTH MED RES, 1999, GUID DEV IMPL EV CLI; PAPAS AM, 1991, XEROPHTHALMIA CLUB B, V70, P1; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Truswell AS, 1999, AM J CLIN NUTR, V70, P942; TRUSWELL S, 2000, AUSTR ACAD SCI NEWSL, V48, P5; *US FDA, 1999, FOOD ADV COMM M JUN; Willett W., 1990, NUTR EPIDEMIOLOGY	12	36	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1061	1062		10.1016/S0140-6736(00)04308-7	http://dx.doi.org/10.1016/S0140-6736(00)04308-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297955				2022-12-28	WOS:000167996200006
J	Lipsitch, M				Lipsitch, M			Microbiology - Bacterial population genetics and disease	SCIENCE			English	Editorial Material							VIRULENCE; EVOLUTION; MALARIA		Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.							Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; Booth MC, 2001, INFECT IMMUN, V69, P345, DOI 10.1128/IAI.69.1.345-352.2001; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571	11	7	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					59	60		10.1126/science.1060498	http://dx.doi.org/10.1126/science.1060498			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294216				2022-12-28	WOS:000167995200031
J	Pletnev, SV; Zhang, W; Mukhopadhyay, S; Fisher, BR; Hernandez, R; Brown, DT; Baker, TS; Rossmann, MG; Kuhn, RJ				Pletnev, SV; Zhang, W; Mukhopadhyay, S; Fisher, BR; Hernandez, R; Brown, DT; Baker, TS; Rossmann, MG; Kuhn, RJ			Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold	CELL			English	Article							SEMLIKI-FOREST-VIRUS; INFECTIOUS RNA TRANSCRIPTS; BORNE ENCEPHALITIS-VIRUS; SINDBIS VIRUS; SPIKE-PROTEIN; CRYOELECTRON MICROSCOPY; MEMBRANE-GLYCOPROTEINS; 3-DIMENSIONAL RECONSTRUCTION; NUCLEOTIDE-SEQUENCE; ENVELOPED VIRUS	There are 80 spikes on the surface of Sindbis virus arranged as an icosahedral surface lattice. Each spike consists of three copies of each of the glycoproteins E1 and E2. There are two glycosylation sites on E1 and two on E2. These four sites have been located by removal of the glycosylation recognition motifs using site-specific mutagenesis, followed by cryoelectron microscopy. The positions of these sites have demonstrated that E2 forms the protruding spikes and that E1 must be long and narrow, lying flat on the viral surface, forming an icosahedral scaffold analogous to the arrangement of the E glycoprotein in flaviviruses. This arrangement of E1 leads to both dimeric and trimeric intermolecular contacts, consistent with the observed structural changes that occur on fusion with host cell membranes, suggesting a similar fusion mechanism for alpha- and flaviviruses.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; , Timothy/0000-0001-6543-8968	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050, R01GM056279] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI045976, AI45976] Funding Source: Medline; NIGMS NIH HHS [R37 GM033050, R01 GM056279, GM56279] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BONATTI S, 1979, J CELL BIOL, V80, P219, DOI 10.1083/jcb.80.1.219; CANCEDDA R, 1975, CELL, V6, P215, DOI 10.1016/0092-8674(75)90012-4; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHENG RH, 1995, CELL, V80, P621; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; DUBUISSON J, 1993, J VIROL, V67, P3363, DOI 10.1128/JVI.67.6.3363-3374.1993; EKSTROM M, 1994, EMBO J, V13, P1058, DOI 10.1002/j.1460-2075.1994.tb06354.x; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; GAROFF H, 1980, NATURE, V288, P236, DOI 10.1038/288236a0; GAROFF H, 1978, J MOL BIOL, V124, P587, DOI 10.1016/0022-2836(78)90173-0; HARRISON SC, 1992, CURR OPIN STRUC BIOL, V2, P293; HELENIUS A, 1980, EUR J BIOCHEM, V106, P613, DOI 10.1111/j.1432-1033.1980.tb04609.x; KENNEY JM, 1994, STRUCTURE, V2, P823, DOI 10.1016/S0969-2126(94)00083-2; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X; Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MAYNE JT, 1985, VIROLOGY, V142, P121, DOI 10.1016/0042-6822(85)90427-1; MURPHY FA, 1980, TOGAVIRUSES BIOL STR, P241; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RICE CM, 1981, P NATL ACAD SCI-BIOL, V78, P2062, DOI 10.1073/pnas.78.4.2062; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; ROBBINS PW, 1977, CELL, V12, P893, DOI 10.1016/0092-8674(77)90153-2; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; ROSSMMANN M G, 1983, Journal of Molecular Biology, V166, P37, DOI 10.1016/S0022-2836(83)80049-7; SCHACHTER H, 1980, BIOCH GLYCOPROTEINS, P85; SCHLESINGER RW, 1980, TOGAVIRUSES BIOL STR; Schlesinger S., 1986, TOGAVIRIDAE FLAVIVIR, P121, DOI [10.1007/978-1-4757-0785-4_5, DOI 10.1007/978-1-4757-0785-4_5]; SCHMALJOHN AL, 1983, VIROLOGY, V130, P144, DOI 10.1016/0042-6822(83)90124-1; SEFTON BM, 1977, CELL, V10, P659, DOI 10.1016/0092-8674(77)90099-X; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; VONBONSDORFF CH, 1978, J VIROL, V28, P578, DOI 10.1128/JVI.28.2.578-583.1978; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WILEY DC, 1978, J MOL BIOL, V120, P375, DOI 10.1016/0022-2836(78)90425-4	55	160	164	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					127	136		10.1016/S0092-8674(01)00302-6	http://dx.doi.org/10.1016/S0092-8674(01)00302-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301008	Bronze, Green Accepted			2022-12-28	WOS:000168063300013
J	Annas, GJ				Annas, GJ			Conjoined twins - The limits of law at the limits of life.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				ANNAS GJ, 1987, HASTINGS CENT REP, V17, P27, DOI 10.2307/3562040; Bleich JD, 1996, TRADITION, V31, P92; BUNYAN N, 2000, DAILY TELEGRAPH 1216, P9; CRAMB A, 2001, DAILY TELEGRAPH 0120, P3; CULLEN K, 2000, BOSTON GLOBE    0911, pA1; DRAKE DC, 1977, PHILADELPHIA IN 1016; Fuller LL, 1949, HARVARD LAW REV, V62, P616, DOI 10.2307/1336025; LAVILLE S, 2000, DAILY TELEGRAPH 1207, P1; Norwitz ER, 2000, NEW ENGL J MED, V343, P399, DOI 10.1056/NEJM200008103430604; ONEILL JA, 1998, PEDIAT SURG, P1925; Rosato J L, 2000, Temple Law Rev, V73, P1; Simpson A.W. Brian, 1984, CANNIBALISM COMMON L; Smith AM, 2000, BRIT MED J, V321, P782, DOI 10.1136/bmj.321.7264.782; Spitz L, 2000, LANCET, V356, P1765, DOI 10.1016/S0140-6736(00)03220-7; Styron W, 1979, SOPHIES CHOICE; Thomasma DC, 1996, HASTINGS CENT REP, V26, P4, DOI 10.2307/3527600; WELLS M, 2000, GUARDIAN LONDON 1208, P13; 2001, TORONTO STAR    0107, P1	18	15	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1104	1108		10.1056/NEJM200104053441419	http://dx.doi.org/10.1056/NEJM200104053441419			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287982	Green Published			2022-12-28	WOS:000167860400027
J	Loveday, JS; Nelmes, RJ; Guthrie, M; Belmonte, SA; Allan, DR; Klug, DD; Tse, JS; Handa, YP				Loveday, JS; Nelmes, RJ; Guthrie, M; Belmonte, SA; Allan, DR; Klug, DD; Tse, JS; Handa, YP			Stable methane hydrate above 2 GPa and the source of Titan's atmospheric methane	NATURE			English	Article							HIGH-PRESSURE; CLATHRATE; DIFFRACTION; SYSTEM	Methane hydrate is thought to have been the dominant methane-containing phase in the nebula from which Saturn, Uranus, Neptune and their major moons formed(1). It accordingly plays an important role in formation models of Titan, Saturn's largest moon. Current understanding(1,2) assumes that methane hydrate dissociates into ice and free methane in the pressure range 1-2 GPa (10-20 kbar), consistent with some theoretical(3) and experimental(4,5) studies. But such pressure-induced dissociation would have led to the early loss of methane from Titan's interior to its atmosphere, where it would rapidly have been destroyed by photochemical processes(6,7). This is difficult to reconcile with the observed presence of significant amounts of methane in Titan's present atmosphere. Here we report neutron and synchrotron X-ray diffraction studies that determine the thermodynamic behaviour of methane hydrate at pressures up to 10 GPa. We rnd structural transitions at about 1 and 2 GPa to new hydrate phases which remain stable to at least 10 GPa. This implies that the methane in the primordial core of Titan remained in stable hydrate phases throughout differentiation, eventually forming a layer of methane clathrate approximately 100 km thick within the ice mantle. This layer is a plausible source for the continuing replenishment of Titan's atmospheric methane.	Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada	University of Edinburgh; National Research Council Canada	Loveday, JS (corresponding author), Univ Edinburgh, Dept Phys & Astron, Mayfield Rd, Edinburgh EH9 3JZ, Midlothian, Scotland.		Guthrie, Malcolm/AAZ-5995-2021; Guthrie, Malcolm/K-3099-2012	Guthrie, Malcolm/0000-0002-9888-7468; 				Chou IM, 2000, P NATL ACAD SCI USA, V97, P13484, DOI 10.1073/pnas.250466497; Dyadin YA, 1997, MENDELEEV COMMUN, P34; Dyadin YA, 1999, MENDELEEV COMMUN, P209; Dyadin YA, 1997, MENDELEEV COMMUN, P32; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; Grasset O, 1996, ICARUS, V123, P101, DOI 10.1006/icar.1996.0144; Gutt C, 2000, J CHEM PHYS, V113, P4713, DOI 10.1063/1.1288789; HANDA YP, 1986, J CHEM THERMODYN, V18, P915, DOI 10.1016/0021-9614(86)90149-7; Hirai H, 2000, J PHYS CHEM B, V104, P1429, DOI 10.1021/jp9926490; Hirai H, 2000, CHEM PHYS LETT, V325, P490, DOI 10.1016/S0009-2614(00)00694-1; Lorenz RD, 2000, SCIENCE, V290, P467, DOI 10.1126/science.290.5491.467; Lotz HT, 1999, J CHEM PHYS, V111, P10242, DOI 10.1063/1.480342; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; NELMES RJ, 1994, J SYNCHROTRON RADIAT, V1, P69, DOI 10.1107/S0909049594006679; PISTORIUS CWF, 1963, J CHEM PHYS, V38, P600, DOI 10.1063/1.1733711; *RUTH APPL LAB, 1997, RALTR97050; STEVENSON DJ, 1992, ESASP338, P29; Udachin KA, 1997, SUPRAMOL CHEM, V8, P173, DOI 10.1080/10610279708034933; VANDERWAALS JH, 1956, T FARADAY SOC, V52, P184, DOI 10.1039/tf9565200184; VANDERWAALS JH, 1959, ADV CHEM PHYS, V2, P1; VANHINSBERG MGE, 1993, J CHEM PHYS, V99, P752, DOI 10.1063/1.465751; [No title captured]	24	261	265	1	79	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					661	663		10.1038/35070513	http://dx.doi.org/10.1038/35070513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287946				2022-12-28	WOS:000167875400038
J	Withers, P; Neumann, GA				Withers, P; Neumann, GA			Enigmatic northern plains of Mars - A network of ridges in this region opens a new tectonic window onto this planet.	NATURE			English	Article									Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NASA, Goddard Space Flight Ctr, Terr Phys Lab, Greenbelt, MD 20771 USA	University of Arizona; Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Withers, P (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	withers@lpl.arizona.edu	Withers, Paul/H-2241-2014; Neumann, Gregory A/I-5591-2013	Neumann, Gregory A/0000-0003-0644-9944				BANERDT WB, 1992, MARS, P249; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Schultz RA, 2000, J GEOPHYS RES-PLANET, V105, P12035, DOI 10.1029/1999JE001212; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495	4	29	29	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					651	651		10.1038/35070640	http://dx.doi.org/10.1038/35070640			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287941				2022-12-28	WOS:000167875400033
J	Hannah, M				Hannah, M			Antibiotics for preterm prelabour rupture of membranes and preterm labour?	LANCET			English	Editorial Material									Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Obstet & Gynaecol, Toronto, ON M5G 1N8, Canada; Univ Toronto, Ctr Res Womens Hlth, Maternal Infant & Reprod Hlth Res Unit, Toronto, ON M5G 1N8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Hannah, M (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Obstet & Gynaecol, Toronto, ON M5G 1N8, Canada.							Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; KENYON S, 2001, COCHRANE LIB; KING J, 2001, COCHRANE LIB	3	14	14	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					973	974		10.1016/S0140-6736(00)04253-7	http://dx.doi.org/10.1016/S0140-6736(00)04253-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293636				2022-12-28	WOS:000167791500003
J	Lantz, MA; Hug, HJ; Hoffmann, R; van Schendel, PJA; Kappenberger, P; Martin, S; Baratoff, A; Guntherodt, HJ				Lantz, MA; Hug, HJ; Hoffmann, R; van Schendel, PJA; Kappenberger, P; Martin, S; Baratoff, A; Guntherodt, HJ			Quantitative measurement of short-range chemical bonding forces	SCIENCE			English	Article							SILICON (111)-(7X7) SURFACE; ATOMIC-RESOLUTION; FREQUENCY-SHIFTS; MICROSCOPY; RECONSTRUCTION; SI(111)-7X7	We report direct force measurements of the formation of a chemical bond. The experiments were performed using a Low-temperature atomic force microscope, a silicon tip, and a silicon (111) 7x7 surface. The measured site-dependent attractive short-range force, which attains a maximum value of 2.1 nanonewtons, is in good agreement with first-principles calculations of an incipient covalent bond in an analogous model system. The resolution was sufficient to distinguish differences in the interaction potential between inequivalent adatoms, demonstrating the ability of atomic force microscopy to provide quantitative, atomic-scale information on surface chemical reactivity.	Univ Basel, Inst Phys, CH-4056 Basel, Switzerland	University of Basel	Lantz, MA (corresponding author), Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	mark.lantz@unibas.ch	Hoffmann-Vogel, Regina C/A-6385-2008	Hoffmann-Vogel, Regina/0000-0002-5771-7956				ABDURIXIT A, UNPUB; [Anonymous], 1992, INTERMOLECULAR SURFA; Argento C, 1996, J APPL PHYS, V80, P6081, DOI 10.1063/1.363680; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BROMMER KD, 1992, PHYS REV LETT, V68, P1355, DOI 10.1103/PhysRevLett.68.1355; BROMMER KD, 1994, SURF SCI, V314, P57, DOI 10.1016/0039-6028(94)90212-7; Durig U, 2000, APPL PHYS LETT, V76, P1203, DOI 10.1063/1.125983; Erlandsson R, 1996, PHYS REV B, V54, pR8309, DOI 10.1103/PhysRevB.54.R8309; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Giessibl FJ, 2001, APPL PHYS LETT, V78, P123, DOI 10.1063/1.1335546; Gotsmann B, 1999, APPL SURF SCI, V140, P314, DOI 10.1016/S0169-4332(98)00547-9; Guggisberg M, 2000, PHYS REV B, V61, P11151, DOI 10.1103/PhysRevB.61.11151; Hug HJ, 1999, REV SCI INSTRUM, V70, P3625, DOI 10.1063/1.1149970; Jarvis SP, 1996, NATURE, V384, P247, DOI 10.1038/384247a0; KITAMURA S, 1995, JPN J APPL PHYS 2, V34, pL145, DOI 10.1143/JJAP.34.L145; Lantz MA, 2000, PHYS REV LETT, V84, P2642, DOI 10.1103/PhysRevLett.84.2642; Luthi R, 1997, SURF REV LETT, V4, P1025, DOI 10.1142/S0218625X9700122X; Morita S, 2000, NANOTECHNOLOGY, V11, P120, DOI 10.1088/0957-4484/11/2/313; Nakagiri N, 1997, SURF SCI, V373, pL329, DOI 10.1016/S0039-6028(96)01276-9; OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451; Perez R, 1998, PHYS REV B, V58, P10835, DOI 10.1103/PhysRevB.58.10835; SENDEN TJ, 1995, COLLOID SURFACE A, V94, P29, DOI 10.1016/0927-7757(94)02954-Q; STICH I, 1992, PHYS REV LETT, V68, P1351, DOI 10.1103/PhysRevLett.68.1351; TAKAYANAGI K, 1985, J VAC SCI TECHNOL A, V3, P1502, DOI 10.1116/1.573160; Uchihashi T, 1997, PHYS REV B, V56, P9834, DOI 10.1103/PhysRevB.56.9834; Yokoyama K, 1999, PHYS REV LETT, V83, P5023, DOI 10.1103/PhysRevLett.83.5023	28	333	340	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2580	2583		10.1126/science.1057824	http://dx.doi.org/10.1126/science.1057824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283365				2022-12-28	WOS:000167861000035
J	Lok, C				Lok, C			Plans to reduce acceptable arsenic limit put on hold	NATURE			English	News Item																		Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411	1	3	3	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					503	503		10.1038/35069212	http://dx.doi.org/10.1038/35069212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279452	Bronze			2022-12-28	WOS:000167859300008
J	Cuthbertson, DJR; Vinjamuri, S; Bowen-Jones, D				Cuthbertson, DJR; Vinjamuri, S; Bowen-Jones, D			Clinical picture: occult ectopic ACTH syndrome	LANCET			English	Article									Royal Liverpool Univ Hosp, Dept Nucl Med, Liverpool, Merseyside, England; Arrow Pk Hosp, Dept Endocrinol & Diabet, Wirral, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Cuthbertson, DJR (corresponding author), Royal Liverpool Univ Hosp, Dept Nucl Med, Liverpool, Merseyside, England.			Cuthbertson, Daniel/0000-0002-6128-0822					0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					419	419		10.1016/S0140-6736(00)04016-2	http://dx.doi.org/10.1016/S0140-6736(00)04016-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273060				2022-12-28	WOS:000166865600009
J	MacMahon, S; Collins, R				MacMahon, S; Collins, R			Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies	LANCET			English	Review							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; CAROTID-ENDARTERECTOMY; REGRESSION DILUTION; REPLACEMENT THERAPY; CONTROLLED-TRIALS; BETA-CAROTENE; RISK; BIAS	Observational studies and randomised trials can contribute complementary evidence about the effects of treatment on mortality and on major non-fatal outcomes. In particular, observational studies have an important role in the identification of large adverse effects of treatment on infrequent outcomes (ie, rare, but serious, side-effects) that are not likely to be related to the indications for (or contraindications to) the treatment of interest. Such studies can also provide useful Information about the risks of death and disability in particular circumstances that can help to generalise from clinical trials to clinical practice. But, due to their Inherent potential for moderate or large biases, observational studies have little role in the direct assessment of any moderate effects of treatment on major outcomes that might exist. Instead, sufficiently large-scale evidence from randomised trials is needed to assess such treatment effects appropriately reliably. Wider appreciation of the different strengths and weaknesses of these two types of epidemiological study should increase the likelihood that the most reliable evidence available informs decisions about the treatments doctors use-and patients receive-for the management of a wide range of life-threatening conditions.	Univ Sydney, Inst Int Hlth, Sydney, NSW 2042, Australia; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Sydney; University of Oxford; University of Oxford	MacMahon, S (corresponding author), Univ Sydney, Inst Int Hlth, POB 576, Sydney, NSW 2042, Australia.	s.macmahon@iih.usyd.edu.au		MacMahon, Stephen/0000-0003-2064-7699				Alderman M, 1997, J HYPERTENS, V15, P105; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1974, LANCET, V2, P669; Bar-Oz B, 1999, LANCET, V354, P1700, DOI 10.1016/S0140-6736(99)04411-6; Barbone F, 1998, LANCET, V352, P1331, DOI 10.1016/S0140-6736(98)04087-2; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; Black N, 1996, BRIT MED J, V312, P1215; BURING J, 1993, CANC PRINCIPLES PRAC; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Doughty RN, 1997, EUR HEART J, V18, P560; Florey ME, 1943, LANCET, V1, P387; Gargiullo PM, 1999, LANCET, V353, P501, DOI 10.1016/S0140-6736(05)75177-1; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; HARINGTON M, 1959, BRIT MED J, V2, P969, DOI 10.1136/bmj.2.5158.969; HEINONEN OP, 1974, LANCET, V2, P675; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1993, ANN NY ACAD SCI, V703, P18, DOI 10.1111/j.1749-6632.1993.tb26330.x; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; HORWITZ RI, 1985, ARCH INTERN MED, V145, P1873, DOI 10.1001/archinte.145.10.1873; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; KHOURY MJ, 1994, TERATOLOGY, V49, P273, DOI 10.1002/tera.1420490407; Larkin M, 2000, LANCET, V355, P1338, DOI 10.1016/S0140-6736(05)72573-3; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lechat P, 1999, LANCET, V353, P9; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lindsay SJ, 1999, LANCET, V354, P1003, DOI 10.1016/S0140-6736(99)03815-5; MacDonald TM, 1999, LANCET, V353, P501, DOI 10.1016/S0140-6736(05)75178-3; MACMAHON B, 1964, INT J CANCER, V20, P1172; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; MELLIN G W, 1962, N Engl J Med, V267, P1184, DOI 10.1056/NEJM196212062672305; MOSS AJ, 1981, CIRCULATION, V64, P1150, DOI 10.1161/01.CIR.64.6.1150; Neal B, 2000, LANCET, V356, P1955; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Perry G, 1997, NEW ENGL J MED, V336, P525; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Spargias KS, 1999, LANCET, V354, P391, DOI 10.1016/S0140-6736(99)01429-4; STEWART A, 1958, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.5086.1495; SWAN SH, 1992, EPIDEMIOLOGY, V3, P356, DOI 10.1097/00001648-199207000-00011; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; THURMER HL, 1994, J HYPERTENS, V12, P481; *WHO, 1996, WHO HLTH STAT ANN; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145	72	186	191	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					455	462		10.1016/S0140-6736(00)04017-4	http://dx.doi.org/10.1016/S0140-6736(00)04017-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273081				2022-12-28	WOS:000166865600035
J	Petsch, ST; Eglinton, TI; Edwards, KJ				Petsch, ST; Eglinton, TI; Edwards, KJ			C-14-dead living biomass: Evidence for microbial assimilation of ancient organic carbon during share weathering	SCIENCE			English	Article							FATTY-ACID PROFILES; ATMOSPHERIC OXYGEN; FRACTIONATION; COMMUNITIES; SEDIMENTS; SOILS; DEEP; OIL; O-2	Prokaryotes have been cultured from a modern weathering profile developed on a similar to 365-million-year-old black share that use macromolecular share organic matter as their sole organic carbon source. Using natural-abundance carbon-14 analysis of membrane Lipids, we show that 74 to 94% of Lipid carbon in these cultures derives from assimilation of carbon-14-free organic carbon from the share. These results reveal that microorganisms enriched from share weathering profiles are able to use a macromolecular and putatively refractory pool of ancient organic matter. This activity may facilitate the oxidation of sedimentary organic matter to inorganic carbon when sedimentary rocks are exposed by erosion. Thus, microorganisms may play a more active role in the geochemical carbon cycle than previously recognized, with profound implications for controls on the abundance of oxygen and carbon dioxide in Earth's atmosphere over geologic time.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Petsch, ST (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	spetsch@whoi.edu		Eglinton, Timothy/0000-0001-5060-2155				BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; BERNER RA, 1989, PALAEOGEOGR PALAEOCL, V75, P97, DOI DOI 10.1016/0031-0182(89)90186-7; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; CLAYTON JL, 1978, GEOCHIM COSMOCHIM AC, V42, P305, DOI 10.1016/0016-7037(78)90183-7; Colwell FS, 1997, FEMS MICROBIOL REV, V20, P425, DOI 10.1016/S0168-6445(97)00024-7; COWIE G, 1998, P OC DRILL PROGR SCI, P581, DOI DOI 10.2973/ODP.PROC.SR.157.150.1998; DOWLING NJE, 1986, J GEN MICROBIOL, V132, P1815; Eglinton TI, 1997, SCIENCE, V277, P796, DOI 10.1126/science.277.5327.796; Fang JS, 2000, APPL GEOCHEM, V15, P157, DOI 10.1016/S0883-2927(99)00037-2; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hoefs M. J. L., 1998, P OCEAN DRILL PROG S, V157, P591; Keller CK, 1998, GLOBAL BIOGEOCHEM CY, V12, P361, DOI 10.1029/98GB00742; Krumholz LR, 1997, NATURE, V386, P64, DOI 10.1038/386064a0; LEYTHAUSER D, 1973, COSMOCHIM ACTA, V37, P133; Lichtfouse E, 1997, ORG GEOCHEM, V26, P353, DOI 10.1016/S0146-6380(97)00009-0; Macnaughton SJ, 1999, APPL ENVIRON MICROB, V65, P3566; Nielsen P, 2000, SOIL BIOL BIOCHEM, V32, P1241, DOI 10.1016/S0038-0717(00)00041-9; PARKES RJ, 1983, ESTUAR COAST SHELF S, V16, P173, DOI 10.1016/0272-7714(83)90139-7; PEARSON A, 2001, IN PRESS GEOCHIM COS; Petsch ST, 1998, AM J SCI, V298, P246, DOI 10.2475/ajs.298.3.246; Petsch ST, 2000, ORG GEOCHEM, V31, P475, DOI 10.1016/S0146-6380(00)00014-0; Ringelberg DB, 1997, FEMS MICROBIOL REV, V20, P371, DOI 10.1016/S0168-6445(97)00019-3; Wilkes H, 2000, ORG GEOCHEM, V31, P101, DOI 10.1016/S0146-6380(99)00147-3	26	193	202	6	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1127	1131		10.1126/science.1058332	http://dx.doi.org/10.1126/science.1058332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11283356				2022-12-28	WOS:000168609200048
J	Yusupov, MM; Yusupova, GZ; Baucom, A; Lieberman, K; Earnest, TN; Cate, JHD; Noller, HF				Yusupov, MM; Yusupova, GZ; Baucom, A; Lieberman, K; Earnest, TN; Cate, JHD; Noller, HF			Crystal structure of the ribosome at 5.5 angstrom resolution	SCIENCE			English	Article							ESCHERICHIA-COLI RIBOSOME; PEPTIDYL TRANSFERASE CENTER; SECONDARY STRUCTURE MODEL; TRANSFER-RNA; A-SITE; 70S RIBOSOME; P-SITE; CRYOELECTRON MICROSCOPY; CONFORMATIONAL SWITCH; THERMUS-THERMOPHILUS	We describe the crystal structure of the complete Thermus thermophilus 70S ribosome containing bound messenger RNA and transfer RNAs (tRNAs) at 5.5 angstrom resolution. All of the 16S, 23S, and 5S ribosomal RNA (rRNA) chains, the A-, P-, and E-site tRNAs, and most of the ribosomal proteins can be fitted to the electron density map. The core of the interface between the 30S small subunit and the 50S large subunit, where the tRNA substrates are bound, is dominated by RNA, with proteins located mainly at the periphery, consistent with ribosomal function being based on rRNA. In each of the three tRNA binding sites, the ribosome contacts all of the major elements of tRNA, providing an explanation for the conservation of tRNA structure. The tRNAs are closely juxtaposed with the intersubunit bridges, in a way that suggests coupling of the 20 to 50 angstrom movements associated with tRNA translocation with intersubunit movement.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Sinsheimer Labs, Santa Cruz, CA 95064 USA; Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Phys Biosci Div, Berkeley, CA 94720 USA; Whitehead Inst, Cambridge, MA 01242 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute	Noller, HF (corresponding author), IGBMC, CNRS, UPR Biol & Genom Struct 9004, BP 163,1 Rue L Fries, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.		Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013	Yusupov, Marat/0000-0001-5544-0597				Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; DORING T, 1994, EMBO J, V13, P2677, DOI 10.1002/j.1460-2075.1994.tb06558.x; FEINBERG JS, COMMUNICATION; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; GARRETT RA, 2000, RIBOSOME; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1994, NUCLEIC ACIDS RES, V22, P3502, DOI 10.1093/nar/22.17.3502; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; HERR W, 1979, J MOL BIOL, V130, P433, DOI 10.1016/0022-2836(79)90433-9; Hill WE., 1990, RIBOSOME STRUCTURE F; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph S, 1996, EMBO J, V15, P910, DOI 10.1002/j.1460-2075.1996.tb00425.x; Joseph S, 1997, SCIENCE, V278, P1093, DOI 10.1126/science.278.5340.1093; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; KURLAND CG, 1990, RIBOSOME, P513; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MAKOWSKI I, 1987, J MOL BIOL, V193, P819, DOI 10.1016/0022-2836(87)90362-7; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; MATHESON AT, 1995, BIOCH CELL BIOL, V73; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; Merryman C, 1999, J MOL BIOL, V285, P107, DOI 10.1006/jmbi.1998.2243; MITCHELL P, 1992, BIOCHEMISTRY-US, V31, P3004, DOI 10.1021/bi00126a023; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MOUGEL M, 1987, J MOL BIOL, V198, P91, DOI 10.1016/0022-2836(87)90460-8; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NISSEN P, 2001, PNATL ACAD SCI  0410; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1972, P NATL ACAD SCI USA, V69, P3115, DOI 10.1073/pnas.69.11.3115; OAKES MI, 1990, RIBOSOME, P180; OCONNOR M, 1995, J MOL BIOL, V254, P838, DOI 10.1006/jmbi.1995.0659; OFENGAND J, 1986, STRUCTURE FUNCTION G, P473; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schnitzer W, 1997, P NATL ACAD SCI USA, V94, P12823, DOI 10.1073/pnas.94.24.12823; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STOFFLERMEILICKE M, 1990, RIBOSOME, P123; TRAKHANOV S, 1989, J MOL BIOL, V209, P327, DOI 10.1016/0022-2836(89)90282-9; Uhlein M, 1998, BIOCHEM J, V331, P423; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WEISER B, UNPUB; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; YUSUPOV MM, 1991, BIOCHIMIE, V73, P887, DOI 10.1016/0300-9084(91)90130-S	86	1601	1707	5	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					883	896		10.1126/science.1060089	http://dx.doi.org/10.1126/science.1060089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11283358				2022-12-28	WOS:000168514900033
J	Groisman, A; Steinberg, V				Groisman, A; Steinberg, V			Efficient mixing at low Reynolds numbers using polymer additives	NATURE			English	Article							PASSIVE SCALAR; TURBULENT FLOWS; INSTABILITIES; STATISTICS	Mixing in fluids is a rapidly developing area in fluid mechanics(1-3), being an important industrial and environmental problem. The mixing of liquids at low Reynolds numbers is usually quite weak in simple flows, and it requires special devices to be efficient. Recently, the problem of mixing was solved analytically for a simple case of random flow, known as the Batchelor regime(4-8). Here we demonstrate experimentally that very viscous liquids containing a small amount of high-molecular-weight polymers can be mixed quite efficiently at very low Reynolds numbers, for a simple flow in a curved channel. A polymer concentration of only 0.001% suffices. The presence of the polymers leads to an elastic instability(9) and to irregular flow(10), with velocity spectra corresponding to the Batchelor regime(4-8). Our detailed observations of the mixing in this regime enable us to confirm several important theoretical predictions: the probability distributions of the concentration exhibit exponential tails(6,8), moments of the distribution decay exponentially along the flow 8, and the spatial correlation function of concentration decays logarithmically.	Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Steinberg, V (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.		Groisman, Alexander/AAU-7843-2021; Steinberg, Victor/B-3205-2009					Balkovsky E, 1999, PHYS REV E, V60, P4164, DOI 10.1103/PhysRevE.60.4164; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Bird R.B., 1987, FLUID MECH-SOV RES, V1; BYARS JA, 1994, J FLUID MECH, V271, P173, DOI 10.1017/S0022112094001734; CHERTKOV M, 1995, PHYS REV E, V51, P5609, DOI 10.1103/PhysRevE.51.5609; Groisman A, 2000, NATURE, V405, P53, DOI 10.1038/35011019; JOO JL, 1994, J FLUID MECH, V262, P27; Kraichnan R. H., 1974, Journal of Fluid Mechanics, V64, P737, DOI 10.1017/S0022112074001881; LARSON RG, 1990, J FLUID MECH, V218, P573, DOI 10.1017/S0022112090001124; Miller PL, 1996, J FLUID MECH, V308, P129, DOI 10.1017/S0022112096001425; SHRAIMAN BI, 1994, PHYS REV E, V49, P2912, DOI 10.1103/PhysRevE.49.2912; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Warhaft Z, 2000, ANNU REV FLUID MECH, V32, P203, DOI 10.1146/annurev.fluid.32.1.203; Williams BS, 1997, PHYS FLUIDS, V9, P2061, DOI 10.1063/1.869326	15	278	282	1	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					905	908		10.1038/35073524	http://dx.doi.org/10.1038/35073524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309609	Green Submitted			2022-12-28	WOS:000168152300038
J	Kremer, JM				Kremer, JM			Rational use of new and existing disease-modifying agents in rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; LOW-DOSE METHOTREXATE; CARTILAGE PANNUS JUNCTION; ALPHA MONOCLONAL-ANTIBODY; FACTOR-BINDING-PROTEIN; LONG-TERM OUTCOMES; WORK DISABILITY; DOUBLE-BLIND; FUSION PROTEIN; RECEIVING METHOTREXATE	Because of radiographic evidence of progressive bone loss and the inability to eliminate synovial proliferation with methotrexate, it became apparent that therapy for rheumatoid arthritis needed further advancement. Methotrexate is not a remission-inducing drug and may have dose-limiting toxicity. In the past 2 years, three new disease-modifying antirheumatic drugs (DMARDs) have been approved: leflunomide, etanercept, and infliximab. Each of these agents has demonstrated efficacy compared with placebo in randomized, controlled studies. Because methotrexate had a dominant therapeutic role, the new drugs were also studied in combination with it. Other established DMARDs, such as sulfasalazine and hydroxychloroquine, have also demonstrated efficacy when used together with methotrexate. The results of these combination studies clearly demonstrate that clinical responses can be meaningfully improved when new and existing DMARDs are added to methotrexate. Although toxicity remains a serious concern when powerful immune modulators and antimetabolites are used in combination, relatively few serious adverse events have been reported during 2-year treatment periods. It has also become apparent that combinations of new DMARDs and methotrexate virtually halt radiographic progression over 2 years. The new agents are expensive, but annual costs must be weighed against the personal and societal expense of joint arthroplasty, hospitalizations, disability, and diminished quality of life that accompanies poorly controlled rheumatoid arthritis. The ultimate value of combination DMARD therapy with methotrexate will be determined by longterm data on safety, efficacy, and effects on radiographic deterioration of bone. Additional long-term observational data on the incidence of joint arthroplasty and disability will help to place the issue of societal costs in a better perspective. This will allow the value of aggressive treatment to be established with certainty.	Ctr Rheumatol, Albany, NY 12206 USA		Kremer, JM (corresponding author), Ctr Rheumatol, 1367 Washington Ave, Albany, NY 12206 USA.	jkremer@rheum-docs.com						AHMADZADEH N, 1990, CLIN EXP RHEUMATOL, V8, P387; Alarcon GS, 1997, ANN INTERN MED, V127, P356, DOI 10.7326/0003-4819-127-5-199709010-00003; ALARCON GS, 1997, ARTHRITIS ALLIED CON, P679; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; BENSEN WG, 1990, J RHEUMATOL, V17, P987; BRENNAN FM, 1992, CURR OPIN IMMUNOL, V4, P754, DOI 10.1016/0952-7915(92)90057-L; Brion PH, 1999, ANN INTERN MED, V131, P634, DOI 10.7326/0003-4819-131-8-199910190-00031; BROOK A, 1977, ANN RHEUM DIS, V36, P71, DOI 10.1136/ard.36.1.71; *CENT, 2000, REM INFL ALT PACK IN; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Cronstein BN, 1996, ARTHRITIS RHEUM-US, V39, P1951, DOI 10.1002/art.1780391203; DELEURAN BW, 1992, ARTHRITIS RHEUM, V35, P1170, DOI 10.1002/art.1780351009; DIGEL W, 1992, J CLIN INVEST, V89, P1690, DOI 10.1172/JCI115769; ELSASSERBEILE U, 1994, TUMOR BIOL, V15, P17, DOI 10.1159/000217869; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; EMERY P, 1999, ANN RHEUM DIS, V58, pS133; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; ERICKSON AR, 1995, ARTHRITIS RHEUM, V38, P1115, DOI 10.1002/art.1780380814; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Fox R, 1998, ARTHRITIS RHEUM, V41, pS138; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Fox RI, 1999, BIODRUGS, V12, P301, DOI 10.2165/00063030-199912040-00007; FUCHS HA, 1989, J RHEUMATOL, V16, P585; Hamilton RA, 1997, BRIT J RHEUMATOL, V36, P86; *IMM, 1999, ENBR ET ALT PACK INS; Jantti J, 1999, RHEUMATOLOGY, V38, P1138, DOI 10.1093/rheumatology/38.11.1138; KREMER JM, 1995, ARTHRITIS RHEUM, V38, P1194, DOI 10.1002/art.1780380904; Kremer JM, 2000, ARTHRITIS RHEUM, V43, pS229; Kremer JM, 2000, ARTHRITIS RHEUM, V43, pS224; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P1829, DOI 10.1002/art.1780401016; KREMER JM, 1992, ARTHRITIS RHEUM, V35, P138, DOI 10.1002/art.1780350203; KREMER JM, 1994, ARTHRITIS RHEUM-US, V37, P316, DOI 10.1002/art.1780370304; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P822, DOI 10.1002/art.1780290702; Kremer JM, 1998, ARTHRITIS RHEUM, V41, pS158; KREMER JM, 1987, AM J MED, V82, P781, DOI 10.1016/0002-9343(87)90015-5; Kremer JM, 1997, SEMIN ARTHRITIS RHEU, V26, P785, DOI 10.1016/S0049-0172(97)80021-2; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P984, DOI 10.1002/art.1780400533; KREMER JM, 2000, ARTHRITIS ALLIED CON; KUSHNER I, 1989, J RHEUMATOL, V16, P1; Lipsky P, 1999, ARTHRITIS RHEUM, V42, pS401; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Manna SK, 1999, J IMMUNOL, V162, P2095; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111; Mohan N, 2000, ARTHRITIS RHEUM, V43, pS228; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Moreland LM, 1999, ARTHRITIS RHEUM, V42, pS401; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; MORGAN SL, 1990, ARTHRITIS RHEUM-US, V33, P9, DOI 10.1002/art.1780330102; MORGAN SL, 1994, ANN INTERN MED, V121, P833, DOI 10.7326/0003-4819-121-11-199412010-00002; O'Dell J, 1998, ARTHRITIS RHEUM, V41, pS132; O'Dell J, 1999, ARTHRITIS RHEUM, V42, pS117; ODELL J, 1997, ARTHRITIS RHEUM, V40, P550; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; OLSSON I, 1989, EUR J HAEMATOL, V42, P270, DOI 10.1111/j.1600-0609.1989.tb00111.x; Panayi G. S., 1993, British Journal of Rheumatology, V32, P1; PASTERNAK RD, 1987, AGENTS ACTIONS, V21, P241, DOI 10.1007/BF01966478; PAULUS HE, 1990, ARTHRITIS RHEUM, V33, P113, DOI 10.1002/art.1780330116; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Pincus T, 1998, J RHEUMATOL, V25, P636; PINCUS T, 1986, J RHEUMATOL, V13, P841; POPOVIC S, 1986, AGENTS ACTIONS, V19, P313, DOI 10.1007/BF01971235; Pugner KM, 2000, SEMIN ARTHRITIS RHEU, V29, P305, DOI 10.1016/S0049-0172(00)80017-7; SCOTT DL, 1987, LANCET, V1, P1108; SHINGU M, 1993, CLIN EXP IMMUNOL, V94, P145; Siemasko K, 1998, J IMMUNOL, V160, P1581; Sokka T, 1999, J RHEUMATOL, V26, P1681; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; Van Ede A, 1999, ARTHRITIS RHEUM, V42, pS380; WEINBLATT ME, 1992, ARTHRITIS RHEUM, V35, P129, DOI 10.1002/art.1780350202; Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P; WEINBLATT ME, 1988, ARTHRITIS RHEUM, V31, P167, DOI 10.1002/art.1780310203; Weinblatt ME, 1998, J RHEUMATOL, V25, P238; WEINBLATT ME, 1985, NEW ENGL J MED, V312, P818, DOI 10.1056/NEJM198503283121303; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 1996, ANN INTERN MED, V124, P773, DOI 10.7326/0003-4819-124-8-199604150-00012; WEINBLATT ME, 1997, TXB RHEUMATOLOGY, P771; WILLIAMS HJ, 1985, ARTHRITIS RHEUM-US, V28, P721, DOI 10.1002/art.1780280702; Wolfe F, 1998, J RHEUMATOL, V25, P2108; Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1571, DOI 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R; Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1072, DOI 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G; Wolfe F., 1997, Arthritis and Rheumatism, V40, pS218; YELIN E, 1980, ANN INTERN MED, V93, P551, DOI 10.7326/0003-4819-93-4-551; Yocum DE, 1998, ARTHRITIS RHEUM, V41, pS364	86	152	168	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					695	706		10.7326/0003-4819-134-8-200104170-00013	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00013			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304108				2022-12-28	WOS:000168177500007
J	Ibn-Elhaj, M; Schadt, M				Ibn-Elhaj, M; Schadt, M			Optical polymer thin films with isotropic and anisotropic nano-corrugated surface topologies	NATURE			English	Article							LIQUID-CRYSTALS; ALIGNMENT; GRATINGS	Light reflection from computer monitors, car dashboards and any other optical surface can impair the legibility of displays, degrade transmission of optical components and in some cases may even pose safety hazards. Antireflective coatings are therefore widely used, but existing antireflection technologies often perform suboptimally or are expensive to implement. Here we present an alternative approach to antireflection coatings, based on an extension of our photo-aligning and photo-patterning technology for liquid-crystal displays(1,2) (LCDs) and liquid-crystal polymer films with smooth surfaces(3,4) to optical polymer films with controlled surface topologies. Nano- and micro-corrugated topologies are shown to result from optically induced monomer phase-separation on the polymer surfaces. The properties of the resulting films make them suitable high-performance and low-cost antireflection coatings for optical components of virtually any size, shape and material. Moreover, the approach can be used to form a wide range of other functional polymer thin films with isotropic as well as anisotropic topologies. For example, films can be produced whose optical birefringence exceeds that of the birefringence of the polymer material itself. These new films can also be used as diffractive thin films, diffusers, and directional reflectors which preserve light polarization, or as substrates for aligning liquid crystals to produce bright, low-power-consumption LCDs with integrated optical functions and memory.	ROLIC Res Ltd, CH-4123 Allschwil, Switzerland		Schadt, M (corresponding author), ROLIC Res Ltd, Gewerbestr 18, CH-4123 Allschwil, Switzerland.	martin.schadt@rolic.ch						Benecke C, 2000, JPN J APPL PHYS 1, V39, P525, DOI 10.1143/JJAP.39.525; BERREMAN DW, 1972, PHYS REV LETT, V28, P1683, DOI 10.1103/PhysRevLett.28.1683; Burns SA, 1995, HDB OPTICS, VI; CHEN K, 1999, P SOC INF DISPL SID9, P1054; CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0; COGNARD J, 1981, MOL CRYST LIQ CRY S1, V78; FLANDERS DC, 1983, APPL PHYS LETT, V42, P492, DOI 10.1063/1.93979; FRAUNHOFER J, 1888, VERSUCHE URSACHEN AN; GIBBONS WM, 1991, NATURE, V351, P49, DOI 10.1038/351049a0; HEINE C, 1995, APPL OPTICS, V34, P2476, DOI 10.1364/AO.34.002476; Hodgkinson IJ, 1999, P SOC PHOTO-OPT INS, V3790, P119, DOI 10.1117/12.351259; JONES JC, 2000, P 7 INT DISPL WORKSH, P301; MOIA E, 2000, P SOC PHOTO-OPT INS, V3973, P196; MOULTON HM, 1951, Patent No. 2536764; REITER G, 1993, LANGMUIR, V9, P1344, DOI 10.1021/la00029a031; RUETSCHI M, 1994, SCIENCE, V265, P512, DOI 10.1126/science.265.5171.512; SCAHDT M, 1994, Patent No. 6160597; SCHADT M, 1995, JPN J APPL PHYS 1, V34, P3240, DOI 10.1143/JJAP.34.3240; Schadt M, 1997, MOL CRYST LIQ CRYS A, V292, P235, DOI 10.1080/10587259708031934; SCHADT M, 1992, JPN J APPL PHYS 1, V31, P2155, DOI 10.1143/JJAP.31.2155; Schadt M, 1996, NATURE, V381, P212, DOI 10.1038/381212a0; SCHADT M, IN PRESS P INT LIQ C; SCHADT M, 1997, P SOC INF DISP SID97, P397; SCHMITT K, 1999, P INT DISPL RES C ID, P437; SEIBERLE H, 1998, Patent No. 9901001; THOMAS IM, 1992, APPL OPTICS, V31, P6145, DOI 10.1364/AO.31.006145; Virga EG, 1997, PHILOS T R SOC A, V355, P2035, DOI 10.1098/rsta.1997.0105; Virga EG, 2000, JPN J APPL PHYS 1, V39, P6637, DOI 10.1143/JJAP.39.6637; Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520	29	246	271	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					796	799		10.1038/35071039	http://dx.doi.org/10.1038/35071039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298443				2022-12-28	WOS:000168021900049
J	Marder, E				Marder, E			Moving rhythms	NATURE			English	Article									Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.							Delcomyn F., 1998, FDN NEUROBIOLOGY, P648; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Stein P. S. G., 1997, NEURONS NETWORKS MOT	3	22	22	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					755	755		10.1038/35071196	http://dx.doi.org/10.1038/35071196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298422				2022-12-28	WOS:000168021900031
J	Kanzler, MH; Mraz-Gernhard, S				Kanzler, MH; Mraz-Gernhard, S			Treatment of primary cutaneous melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LYMPH-NODE DISSECTION; MALIGNANT-MELANOMA; STAGE-1 MELANOMA; SURGICAL MARGINS; 4 MM; EXCISION; INTERFERON-ALPHA-2B; EFFICACY		Santa Clara Valley Med Ctr, Div Dermatol, San Jose, CA 95128 USA; Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA USA	Santa Clara Valley Medical Center; Stanford University	Kanzler, MH (corresponding author), Santa Clara Valley Med Ctr, Div Dermatol, 751 S Bascom Ave, San Jose, CA 95128 USA.	kanzlerm@yahoo.com						Albertini JJ, 1996, ANN SURG, V223, P217, DOI 10.1097/00000658-199602000-00016; Balch CM, 1996, ANN SURG, V224, P255, DOI 10.1097/00000658-199609000-00002; BALCH CM, 1993, ANN SURG, V218, P262, DOI 10.1097/00000658-199309000-00005; Buzaid AC, 1997, J CLIN ONCOL, V15, P1039, DOI 10.1200/JCO.1997.15.3.1039; COHEN MH, 1977, ANN SURG, V186, P635; *DEP HHS PHS, 1992, JAMA-J AM MED ASSOC, V268, P1314; Handley WS, 1907, LANCET, V1, P927; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654; LEONG SL, 2000, 36 ANN M AM SOC CLIN; Leong SPL, 1997, ARCH SURG-CHICAGO, V132, P666; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Mraz-Gernhard S, 1998, ARCH DERMATOL, V134, P983, DOI 10.1001/archderm.134.8.983; MUNDUN A, 1996, RADIOLOGY, V199, P171; REINTGEN D, 1994, ANN SURG, V220, P759, DOI 10.1097/00000658-199412000-00009; REINTGEN DS, 1987, ARCH SURG-CHICAGO, V122, P1338; SIM FH, 1986, MAYO CLIN PROC, V61, P697, DOI 10.1016/S0025-6196(12)62768-2; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; SWETTER SM, 1995, CLIN ONCOLOGY, P1023; VANDERVEEN H, 1994, BRIT J SURG, V81, P1769, DOI 10.1002/bjs.1800811220; VERONESI U, 1982, CANCER-AM CANCER SOC, V49, P2420, DOI 10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2; VERONESI U, 1977, NEW ENGL J MED, V297, P627, DOI 10.1056/NEJM197709222971202; VERONESI U, 1991, ARCH SURG-CHICAGO, V126, P438; VERONESI U, 1988, NEW ENGL J MED, V318, P1159, DOI 10.1056/NEJM198805053181804; Zitelli JA, 1997, J AM ACAD DERMATOL, V37, P422, DOI 10.1016/S0190-9622(97)70144-0	26	9	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1819	1821		10.1001/jama.285.14.1819	http://dx.doi.org/10.1001/jama.285.14.1819			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308377				2022-12-28	WOS:000167876700001
J	Schatz, IJ				Schatz, IJ			Treatment of severe autonomic orthostatic hypotension	LANCET			English	Editorial Material									Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA	University of Hawaii System	Schatz, IJ (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA.							Bradbury S, 1925, AM HEART J, V1, P75; DANIEL SE, 2000, AUTONOMIC FAILURE, pCH33; Oldenburg O, 2001, J AM COLL CARDIOL, V37, P219, DOI 10.1016/S0735-1097(00)01062-7; POLINSKY RJ, 1983, LANCET, V1, P901; Schatz IJ, 1996, ANN INTERN MED, V125, P74, DOI 10.7326/0003-4819-125-1-199607010-00012; SCHATZ IJ, 1996, CLIN AUTON RES, V6, P125; SHY GM, 1960, ARCH NEUROL-CHICAGO, V2, P511, DOI 10.1001/archneur.1960.03840110025004	7	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1060	1061		10.1016/S0140-6736(00)04307-5	http://dx.doi.org/10.1016/S0140-6736(00)04307-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297954				2022-12-28	WOS:000167996200005
J	Whalley, LJ; Deary, IJ				Whalley, LJ; Deary, IJ			Longitudinal cohort study of childhood IQ and survival up to age 76	BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL FACTORS; COGNITIVE FUNCTION; EDUCATIONAL-LEVEL; ADULT MORTALITY; SOCIAL-CLASS; DISEASE; DEPRIVATION; PREDICTORS; ABILITY; HEALTH	Objectives To test the association between childhood IQ and mortality over the normal human lifespan. Design Longitudinal cohort study. Setting Aberdeen. Subjects All 2792 children in Aberdeen born in 1921 and attending school on 1 June 1932 who sat a mental ability test as part of the Scottish mental survey 1932. Main outcome measure Survival at 1 January 1997. Results 79.9% (2230) of the sample was traced. Childhood mental ability was positively related to survival to age 76 years in women (0.978 (0.971 to 0.984), P < 0.0001) and men (0.989 (0.984 to 0.994), P< 0.0001). A 15 point disadvantage in mental ability at age 11 conferred a relative risk of 0.79 of being alive 65 years later (95% confidence interval 0.75 to 0.84); a 30 point disadvantage reduced this to 0.63 (0.56 to 0.71. However, men who died during active service in the second world war had a relatively high IQ. Overcrowding in the school catchment area was weakly related to death. Controlling for this factor did not alter the association between mental ability and mortality. Conclusion Childhood mental ability is a significant factor among the variables that predict age at death.	Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Aberdeen, Cornhill Hosp, Clin Res Ctr, Dept Mental Hlth, Aberdeen AB24 2ZD, Scotland	University of Edinburgh; University of Aberdeen	Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Deary, Ian J/C-6297-2009; whalley, lawrence j/E-9019-2011	Deary, Ian J/0000-0002-1733-263X; 				BARKER DJP, 1989, LANCET, V2, P577; BENTHAM G, 1988, SOC SCI MED, V26, P49, DOI 10.1016/0277-9536(88)90044-5; Black D, 1980, INEQUALITIES HLTH RE; Bosma H, 1999, BRIT MED J, V318, P18; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Deary I. J., 2000, LOOKING HUMAN INTELL; DEEG DJH, 1990, AM J EPIDEMIOL, V132, P973, DOI 10.1093/oxfordjournals.aje.a115740; DOORNBOS G, 1990, INT J EPIDEMIOL, V19, P374, DOI 10.1093/ije/19.2.374; DUIJKERS TJ, 1989, INT J EPIDEMIOL, V18, P658, DOI 10.1093/ije/18.3.658; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Fischer Claude, 1996, INEQUALITY DESIGN CR; FOX AJ, 1985, J EPIDEMIOL COMMUN H, V39, P1, DOI 10.1136/jech.39.1.1; Hernstein R.J., 1994, BELL CURVE INTELLIGE; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; Korten AE, 1999, J EPIDEMIOL COMMUN H, V53, P83, DOI 10.1136/jech.53.2.83; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; Maxwell J., 1961, LEVEL TREND NATL INT; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; *OFF POP CENS SURV, 1986, OCC MORT SER; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; SCHWARTZ JE, 1995, AM J PUBLIC HEALTH, V85, P1237, DOI 10.2105/AJPH.85.9.1237; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; VALKONEN T, 1989, HLTH INEQUALITIES EU, P942; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455	28	257	259	0	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					819	822		10.1136/bmj.322.7290.819	http://dx.doi.org/10.1136/bmj.322.7290.819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290633	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000168063000020
J	Low-Zeddies, SS; Takahashi, JS				Low-Zeddies, SS; Takahashi, JS			Chimera analysis of the Clock mutation in mice shows that complex cellular integration determines circadian behavior	CELL			English	Article							RAT SUPRACHIASMATIC NUCLEUS; BETA-GALACTOSIDASE; NEURAL TRANSPLANT; LOCOMOTOR RHYTHMS; ENU-MUTAGENESIS; MOUSE CHIMERAS; MUTANT MICE; IN-VITRO; NEURONS; GENE	The Clock mutation lengthens periodicity and reduces amplitude of circadian rhythms in mice. The effects of Clock are cell intrinsic and can be observed at the level of single neurons in the suprachiasmatic nucleus. To address how cells of contrasting genotype functionally interact in vivo to control circadian behavior, we have analyzed a series of Clock mutant mouse aggregation chimeras. Circadian behavior in Clock! Clock - wild-type chimeric individuals was determined by the proportion of mutant versus normal cells. Significantly, a number of intermediate phenotypes, including Clock/+ phenocopies and novel combinations of the parental behavioral characteristics, were seen in balanced chimeras. Multivariate statistical techniques were used to quantitatively analyze relationships among circadian period, amplitude, and suprachiasmatic nucleus composition. Together, our results demonstrate that complex integration of cellular phenotypes determines the generation and expression of coherent circadian rhythms at the organismal level.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Low-Zeddies, SS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.		Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Jansen, Heiko T./A-5770-2008	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Jansen, Heiko T./0000-0003-0178-396X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AGUILARROBLERO R, 1994, EXP NEUROL, V130, P250, DOI 10.1006/exnr.1994.1203; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balling R, 2000, MAMM GENOME, V11, P471, DOI 10.1007/s003350010091; BOUSKILA Y, 1995, BRAIN RES, V670, P333, DOI 10.1016/0006-8993(94)01356-M; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Challet E, 2000, BRAIN RES, V859, P398, DOI 10.1016/S0006-8993(00)02040-0; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; DECOURSEY PJ, 1989, BRAIN RES, V500, P263, DOI 10.1016/0006-8993(89)90322-3; DEWEY MJ, 1976, DEV BIOL, V50, P68, DOI 10.1016/0012-1606(76)90068-3; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; EWER J, 1992, J NEUROSCI, V12, P3321; FALCONER DS, 1978, J EMBRYOL EXP MORPH, V43, P195; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FRIEDRICH VL, 1993, J NEUROSCI RES, V36, P88, DOI 10.1002/jnr.490360110; GARDNER RL, 1984, CHIMAERAS DEV BIOL, P431; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GOLDOWITZ D, 1987, DEV BRAIN RES, V35, P1, DOI 10.1016/0165-3806(87)90002-2; GRUVAEUS G, 1972, BRIT J MATH STAT PSY, V25, P200, DOI 10.1111/j.2044-8317.1972.tb00491.x; HARRINGTON ME, 1993, BRAIN RES BULL, V30, P655, DOI 10.1016/0361-9230(93)90097-U; HARTIGANS JA, 1975, CLUSTERING ALGORITHM; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2000, J COMP NEUROL, V424, P86, DOI 10.1002/1096-9861(20000814)424:1<86::AID-CNE7>3.0.CO;2-W; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hogan B, 1994, MANIPULATING MOUSE E; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; HURD MW, 1995, AM J PHYSIOL-REG I, V269, pR958, DOI 10.1152/ajpregu.1995.269.5.R958; Ingram CD, 1998, PROG BRAIN RES, V119, P351; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; King DP, 1997, GENETICS, V146, P1049; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Leak RK, 1999, BRAIN RES, V819, P23, DOI 10.1016/S0006-8993(98)01317-1; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; LeSauter J, 1999, J NEUROSCI, V19, P5574; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; LIU X, 1991, NEURON, V6, P753, DOI 10.1016/0896-6273(91)90172-V; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MINTZ B, 1962, AM J ZOOL, V4, P432; Moore RY, 1996, PROG BRAIN RES, V111, P103, DOI 10.1016/S0079-6123(08)60403-3; MULLEN RJ, 1971, J EXP ZOOL, V178, P165, DOI 10.1002/jez.1401780203; MULLEN RJ, 1979, NEUROGENETICS GENETI, P173; MUSCI TS, 1992, DEV BIOL, V152, P133, DOI 10.1016/0012-1606(92)90163-B; NONAN PM, 2000, NAT GENET, V25, P440; OSTERGRANITE ML, 1981, DEV BIOL, V85, P199, DOI 10.1016/0012-1606(81)90251-7; PAGE TL, 1983, J COMP PHYSIOL, V153, P353, DOI 10.1007/BF00612589; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SIDMAN RL, 1982, MOL GENETIC NEUROSCI, P389; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; SILVER R, 1990, BRAIN RES, V525, P45, DOI 10.1016/0006-8993(90)91319-C; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; TAKAHASHI JS, 1982, J NEUROSCI, V2, P815; VANDENPOL AN, 1979, BRAIN RES, V160, P307, DOI 10.1016/0006-8993(79)90427-X; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; ZHANG LM, 1995, NEUROREPORT, V6, P537, DOI 10.1097/00001756-199502000-00032	72	119	124	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					25	42		10.1016/S0092-8674(01)00294-X	http://dx.doi.org/10.1016/S0092-8674(01)00294-X			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301000	Green Accepted, Bronze			2022-12-28	WOS:000168063300005
J	Lu, Q; Sun, EE; Klein, RS; Flanagan, JG				Lu, Q; Sun, EE; Klein, RS; Flanagan, JG			Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction	CELL			English	Article							RECEPTOR TYROSINE KINASES; DOMAIN-CONTAINING PROTEIN; CENTRAL-NERVOUS-SYSTEM; CELL-MIGRATION; CARDIOVASCULAR DEVELOPMENT; CAENORHABDITIS-ELEGANS; CEREBELLAR DEVELOPMENT; TRANSMEMBRANE LIGANDS; CYTOPLASMIC DOMAIN; AXON GUIDANCE	Transmembrane B ephrins and their Eph receptors signal bidirectionally. However, neither the cell biological effects nor signal transduction mechanisms of the reverse signal are well understood. We describe a cytoplasmic protein, PDZ-RGS3, which binds B ephrins through a PDZ domain, and has a regulator of heterotrimeric G protein signaling (RGS) domain. PDZ-RGS3 can mediate signaling from the ephrin-B cytoplasmic tail. SDF-1, a chemokine with a G protein-coupled receptor, or BDNF, act as chemoattractants for cerebellar granule cells, with SDF-1 action being selectively inhibited by soluble EphB receptor. This study reveals a pathway that links reverse signaling to cellular guidance, uncovers a novel mode of control for G proteins, and demonstrates a mechanism for selective regulation of responsiveness to neuronal guidance cues.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029417, R37HD029417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29417] Funding Source: Medline; NINDS NIH HHS [NS40043] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cai HB, 1999, J NEUROSCI, V19, P6519; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Karam SD, 2000, J NEUROSCI, V20, P6488, DOI 10.1523/JNEUROSCI.20-17-06488.2000; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PFEFFER S, 1985, NATURE, V313, P184, DOI 10.1038/313184a0; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Suzuki G, 1999, J IMMUNOL, V162, P5981; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Vancura KL, 1998, SEMIN NEUROSCI, V9, P209, DOI 10.1006/smns.1997.0118; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Watson S., 1994, G PROTEIN LINKED REC; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	63	317	323	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					69	79		10.1016/S0092-8674(01)00297-5	http://dx.doi.org/10.1016/S0092-8674(01)00297-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301003	Bronze			2022-12-28	WOS:000168063300008
J	Sacco, RL; DeRosa, JT; Haley, EC; Levin, B; Ordronneau, P; Phillips, SJ; Rundek, T; Snipes, RG; Thompson, JLP				Sacco, RL; DeRosa, JT; Haley, EC; Levin, B; Ordronneau, P; Phillips, SJ; Rundek, T; Snipes, RG; Thompson, JLP		GAIN Amer Investigators	Glycine antagonist in neuroprotection for patients with acute stroke - GAIN Americas: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC STROKE; CEREBRAL INFARCTION; FOCAL ISCHEMIA; BARTHEL INDEX; SCALE; CLASSIFICATION; RELIABILITY; THRESHOLDS; LUBELUZOLE; PENUMBRA	Context Elucidation of the ischemic cascade has helped stimulate development of neuroprotective drugs aimed at limiting brain injury in the hours following an ischemic stroke. To date, none of these drugs has shown clinical efficacy. Objective To examine the efficacy of gavestinel (GV150526), an antagonist of the glycine site of the N-methyl-D-aspartate receptor, as a neuroprotective therapy for acute ischemic stroke when administered within 6 hours of symptom onset. Design The Glycine Antagonist in Neuroprotection (GAIN) Americas trial, a randomized, double-blind placebo-controlled trial with enrollment from April 1998 to October 1999. Setting One hundred thirty-two hospital centers across the United States and Canada. Patients The primary efficacy population consisted of 1367 ischemic stroke patients with a predefined level of limb weakness and functional independence prior to stroke, stratified at randomization by age (less than or equal to 75 vs > 75 years) and initial stroke severity (National Institutes of Health [NIH] Stroke Scale scores of 2-5, 6-13, or greater than or equal to 14). Intervention Patients were randomly assigned to receive an intravenous loading dose (800 mg) plus 5 maintenance doses (200 mg every 12 hours) of gavestinel (n = 701) or placebo (n = 666) for 3 days, Main Outcome Measure Functional capability at 3 months, measured by the Barthel Index (BI), with scores trichotomized as dead/0-55, 60-90, and 95-100, compared between the gavestinel and placebo groups. Results Treatment groups were well matched for baseline characteristics. For each group, median NIH Stroke Scale was 12, median age was 72 years, and median time to treatment was 5.2 hours. No statistically significant improvement on the 3-month BI trichotomy was demonstrated for gavestinel (P = .79). The proportion who were functionally independent (BI score = 95-100) was 39% in the gavestinel group and 37% in the placebo group, No statistically significant difference in 3-month survival was observed using Kaplan-Meier curves (P = 11). No other secondary end point suggested an advantage for gavestinel. Among the 333 patients (24%) who received recombinant tissue-type plasminogen activator, there was also no benefit for gavestinel (P = .53). There were no serious safety issues. Conclusion In this study, gavestinel administered up to 6 hours after an acute ischemic stroke did not improve functional outcome at 3 months.	Columbia Univ, Neurol Inst, New York, NY 10032 USA; New York Presbyterian Hosp, New York, NY USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Dalhousie Univ, Halifax, NS, Canada	Columbia University; NewYork-Presbyterian Hospital; University of Virginia; GlaxoSmithKline; Dalhousie University	Sacco, RL (corresponding author), Columbia Univ, Neurol Inst, 710 W 168th St,Room 547, New York, NY 10032 USA.		Buchan, Alastair M/B-9095-2009; Sacco, Ralph/Y-9278-2019	Buchan, Alastair M/0000-0002-2918-5200; 				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Babikian V, 2000, STROKE, V31, P358; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bordi F, 1997, EXP NEUROL, V145, P425, DOI 10.1006/exnr.1997.6442; Clark W, 1999, J Stroke Cerebrovasc Dis, V8, P224, DOI 10.1016/S1052-3057(99)80071-8; Clark WM, 1999, STROKE, V30, P2592, DOI 10.1161/01.STR.30.12.2592; Clark WM, 2000, STROKE, V31, P1234, DOI 10.1161/01.STR.31.6.1234; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; DeDeyn PP, 1997, STROKE, V28, P2347, DOI 10.1161/01.STR.28.12.2347; Di Fabio Romano, 1998, Drugs of the Future, V23, P61, DOI 10.1358/dof.1998.023.01.442870; Diener HC, 1998, CEREBROVASC DIS, V8, P172, DOI 10.1159/000015847; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Dyker AG, 1999, STROKE, V30, P986, DOI 10.1161/01.STR.30.5.986; Eliasziw M, 1998, CEREBROVASC DIS, V8, P20, DOI 10.1159/000015819; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; GRIZZLE JE, 1969, BIOMETRICS, V25, P489, DOI 10.2307/2528901; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; Grotta JC, 2000, STROKE, V31, P278; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; MAHONEY F I, 1965, Md State Med J, V14, P61; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Sacco RL, 1998, NEUROLOGY, V50, pA327; Scott P, 1996, STROKE, V27, P1453; Squire IB, 1996, CEREBROVASC DIS, V6, P156, DOI 10.1159/000108016; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren NG, 1999, STROKE, V30, P21, DOI 10.1161/01.STR.30.1.21; WAHLGREN NG, 1994, CEREBROVASC DIS, V4, P204, DOI 10.1159/000108483; Warach S, 2000, NEUROLOGY, V54, pA87; WESTER P, 2000, CEREBROVASC DIS, V10, P76	37	198	207	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1719	1728		10.1001/jama.285.13.1719	http://dx.doi.org/10.1001/jama.285.13.1719			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277826	Bronze			2022-12-28	WOS:000167710600025
J	Vadas, P; Wai, Y; Burks, W; Perelman, B				Vadas, P; Wai, Y; Burks, W; Perelman, B			Detection of peanut allergens in breast milk of lactating women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BOVINE BETA-LACTOGLOBULIN; COWS MILK; MATERNAL DIET; NUT ALLERGY; FED INFANTS; FOOD; CHILDREN; MOTHERS; EGG; HYPERSENSITIVITY	Context Most individuals who react to peanuts do so on their first known exposure. A potential but unproven route of occult exposure resulting in sensitization to peanut is via breast milk during lactation. Objective To investigate the ability of maternal dietary peanut protein to pass into breast milk during lactation, Design and Setting Clinical investigation conducted at 2 North American hospitals from March 1999 to October 2000, Patients Twenty-three healthy, lactating women aged 21 to 35 years. Intervention Each woman consumed 50 g of dry roasted peanuts, after which breast milk samples were collected at hourly intervals. Main Outcome Measures Presence in breast milk of total peanut protein, analyzed by a sandwich enzyme-linked immunosorbent assay, and 2 major peanut allergens, Ara h 1 and Ara h 2, detected by immunoblot analysis. Results Peanut protein was detected in 11 of 23 subjects, It was detected in 10 subjects within 2 hours of ingestion and in 1 subject within 6 hours. The median peak peanut protein concentration in breast milk was 200 ng/mL (mean, 222 ng/mL; range, 120-430 ng/mL). Both major peanut allergens Ara h 1 and Ara h 2 were detected. Conclusions Peanut protein is secreted into breast milk of lactating women following maternal dietary ingestion, Exposure to peanut protein during breastfeeding is a route of occult exposure that may result in sensitization of at-risk infants.	Univ Toronto, St Michaels Hosp, Div Clin Immunol & Allergy, Toronto, ON M5B 1W8, Canada; Univ Arkansas Med Sci, Arkansas Childrens Hosp, Little Rock, AR 72205 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Vadas, P (corresponding author), Univ Toronto, St Michaels Hosp, Div Clin Immunol & Allergy, Room 8-161,Victoria Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.							ASSEM ESK, 1990, BRIT MED J, V300, P1377, DOI 10.1136/bmj.300.6736.1377; AXELSSON I, 1986, ACTA PAEDIATR SCAND, V75, P702, DOI 10.1111/j.1651-2227.1986.tb10277.x; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; CANT A, 1985, BRIT MED J, V291, P932, DOI 10.1136/bmj.291.6500.932; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Duchen K, 1991, Adv Exp Med Biol, V310, P427; Ewan PW, 1996, BRIT MED J, V312, P1074; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Fukushima Y, 1997, AM J CLIN NUTR, V65, P30, DOI 10.1093/ajcn/65.1.30; GERRARD JW, 1986, ANN ALLERGY, V56, P351; HOST A, 1990, CLIN EXP ALLERGY, V20, P383, DOI 10.1111/j.1365-2222.1990.tb02798.x; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P1240, DOI [10.1111/j.1365-2222.1997.tb01167.x, 10.1046/j.1365-2222.1997.1520954.x]; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; KILSHAW PJ, 1984, INT ARCH ALLER A IMM, V75, P8, DOI 10.1159/000233582; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; SORVA R, 1994, J ALLERGY CLIN IMMUN, V93, P787, DOI 10.1016/0091-6749(94)90259-3; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; TRONCONE R, 1987, ACTA PAEDIATR SCAND, V76, P453, DOI 10.1111/j.1651-2227.1987.tb10498.x; VANASPEREN PP, 1983, ARCH DIS CHILD, V58, P253, DOI 10.1136/adc.58.4.253; WARNER JO, 1980, CLIN ALLERGY, V10, P133, DOI 10.1111/j.1365-2222.1980.tb02090.x	23	150	155	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1746	1748		10.1001/jama.285.13.1746	http://dx.doi.org/10.1001/jama.285.13.1746			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277829	Bronze			2022-12-28	WOS:000167710600028
J	Tchernichovski, O; Mitra, PP; Lints, T; Nottebohm, F				Tchernichovski, O; Mitra, PP; Lints, T; Nottebohm, F			Dynamics of the vocal imitation process: How a zebra finch learns its song	SCIENCE			English	Editorial Material							MODEL; BIRDSONG	Song imitation in birds provides good material for studying the basic biology of vocal learning. Techniques were developed for inducing the rapid onset of song imitation in young zebra finches and for tracking trajectories of vocal change over a 7-week period until a match to a model song was achieved. Exposure to a model song induced the prompt generation of repeated structured sounds (prototypes) followed by a slow transition from repetitive to serial delivery of syllables. Tracking this transition revealed two phenomena: (i) imitations of dissimilar sounds can emerge from successive renditions of the same prototype, and (ii) developmental trajectories for some sounds followed paths of increasing acoustic mismatch until an abrupt correction occurred by period doubling. These dynamics are Likely to reflect underlying neural and articulatory constraints on the production and imitation of sounds.	Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Rockefeller University; Alcatel-Lucent; Lucent Technologies; AT&T	Tchernichovski, O (corresponding author), Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA.	tcherno@mail.rockefeller.edu	Lints, Thierry/K-4408-2012; Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	NIDCD NIH HHS [DC04722-01] Funding Source: Medline; NIMH NIH HHS [MH18343] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRET P, 1993, ANIM BEHAV, V46, P149, DOI 10.1006/anbe.1993.1170; CLARK CW, 1987, ETHOLOGY, V76, P101; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; HULTSCH H, 1992, ANIM BEHAV, V44, P590, DOI 10.1016/0003-3472(92)90074-J; Immelmann K., 1969, P61; Jones AE, 1996, J COMP PSYCHOL, V110, P354; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [10.1016/B978-0-12-770601-6.50011-5, DOI 10.1016/B978-0-12-770601-6.50011-5]; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; ROUG L, 1989, J CHILD LANG, V16, P19, DOI 10.1017/S0305000900013416; Stark R. E., 1980, CHILD PHONOLOGY, V1, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; VIHMAN MM, 1993, NATO ADV SCI INST SE, V69, P411; Zann RA., 1996, ZEBRA FINCH SYNTHESI	22	348	351	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2564	2569		10.1126/science.1058522	http://dx.doi.org/10.1126/science.1058522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283361				2022-12-28	WOS:000167861000031
J	Howell, CY; Bestor, TH; Ding, F; Latham, KE; Mertineit, C; Trasler, JM; Chaillet, JR				Howell, CY; Bestor, TH; Ding, F; Latham, KE; Mertineit, C; Trasler, JM; Chaillet, JR			Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene	CELL			English	Article							PARENTAL-SPECIFIC METHYLATION; DNA METHYLTRANSFERASE; PARTHENOGENETIC DEVELOPMENT; PREIMPLANTATION DEVELOPMENT; EPIGENETIC MODIFICATIONS; PATERNAL METHYLATION; OOCYTE GROWTH; MOUSE EMBRYOS; ANNEXIN-V; DE-NOVO	Maintenance of genomic methylation patterns in mammalian somatic cells depends on DNA methyltransferase-1 (Dnmt1). Mouse oocytes and preimplantation embryos lack Dnmt1 but express a variant of this protein called Dnmt1o. We eliminated Dnmt1o by deletion of the oocyte-specific promoter and first exon from the Dnmt1 locus. Homozygous animals were normal, but most heterozygous fetuses of homozygous females died during the last third of gestation. Although genomic methylation patterns were established normally in Dnmt1o-deficient oocytes, embryos derived from such oocytes showed a loss of allele-specific expression and methylation at certain imprinted loci. Transient nuclear localization of Dnmt1o in 8-cell embryos suggests that this variant of Dnmt1 provides maintenance methyltransferase activity specifically at imprinted loci during the fourth embryonic S phase.	Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Temple Univ, Sch Med, Dept Biochem, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Pediat, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Therapeut, Montreal, PQ H3H 1P3, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; McGill University; McGill University; McGill University; McGill University	Chaillet, JR (corresponding author), Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA.	chaillet@pitt.edu	Ding, Feng/AAH-7335-2019; Ding, Feng/E-5112-2012					Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barwise JL, 1996, FEBS LETT, V394, P213, DOI 10.1016/0014-5793(96)00950-7; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hogan B, 1994, MANIPULATING MOUSE E; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Latham KE, 2000, METH MOL B, V136, P405; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li LL, 2000, GENOMICS, V63, P333, DOI 10.1006/geno.1999.6103; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Ohsawa K, 1996, J NEUROCHEM, V67, P89, DOI 10.1046/j.1471-4159.1996.67010089.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Patkin EL, 1998, ZYGOTE, V6, P351, DOI 10.1017/S0967199498000318; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Trasler JM, 1996, DEV DYNAM, V206, P239, DOI 10.1002/(SICI)1097-0177(199607)206:3<239::AID-AJA2>3.3.CO;2-M; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	49	518	550	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					829	838		10.1016/S0092-8674(01)00280-X	http://dx.doi.org/10.1016/S0092-8674(01)00280-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290321	Bronze			2022-12-28	WOS:000167869200006
J	Grace, AA; Brady, PA; Shapiro, LM				Grace, AA; Brady, PA; Shapiro, LM			Risk management in hypertrophic cardiomyopathy	LANCET			English	Editorial Material							BLOOD-PRESSURE RESPONSE; NONSUSTAINED VENTRICULAR-TACHYCARDIA; EXERCISE; POPULATION; PROGNOSIS		Papworth Hosp, Cardiac Unit, Cambridge CB3 8RE, England	Papworth Hospital	Grace, AA (corresponding author), Papworth Hosp, Cardiac Unit, Cambridge CB3 8RE, England.							CANNAN CR, 1995, CIRCULATION, V92, P2488, DOI 10.1161/01.CIR.92.9.2488; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Elliott PM, 1999, J AM COLL CARDIOL, V33, P1596, DOI 10.1016/S0735-1097(99)00056-X; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; FANANAPAZIR L, 1992, CIRCULATION, V86, P730, DOI 10.1161/01.CIR.86.3.730; FRENNEAUX MP, 1990, CIRCULATION, V82, P1995, DOI 10.1161/01.CIR.82.6.1995; Kuck KH, 1997, PACE, V20, P2706, DOI 10.1111/j.1540-8159.1997.tb06120.x; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MCKENNA WJ, 1994, CIRCULATION, V90, P3115, DOI 10.1161/01.CIR.90.6.3115; Olivotto I, 1999, J AM COLL CARDIOL, V33, P2044, DOI 10.1016/S0735-1097(99)00094-7; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SAUMAREZ RC, 1995, CIRCULATION, V91, P2762, DOI 10.1161/01.CIR.91.11.2762; Saumarez RC, 2000, CARDIOVASC RES, V47, P11, DOI 10.1016/S0008-6363(00)00096-1; SHAPIRO LM, 1983, BRIT HEART J, V50, P530; SPIRITO P, 1994, CIRCULATION, V90, P2743, DOI 10.1161/01.CIR.90.6.2743; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476	19	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					407	408		10.1016/S0140-6736(00)04022-8	http://dx.doi.org/10.1016/S0140-6736(00)04022-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273054				2022-12-28	WOS:000166865600003
J	Sizemore, J; Mitre, E				Sizemore, J; Mitre, E			Leg pain in a patient with chronic hepatitis C	LANCET			English	Editorial Material							VIBRIO-VULNIFICUS		Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; NIAID, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mitre, E (corresponding author), NIH, Bldg 4 Room B1-09, Bethesda, MD 20892 USA.							CHART H, 1985, FEMS MICROBIOL LETT, V26, P227, DOI 10.1111/j.1574-6968.1985.tb01596.x; KUMAMOTO KS, 1998, J EMERGENCY MED, V16, P6; Vollberg CM, 1997, SOUTHERN MED J, V90, P1040, DOI 10.1097/00007611-199710000-00014; Wright AC, 1996, APPL ENVIRON MICROB, V62, P717, DOI 10.1128/AEM.62.2.717-724.1996	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					440	440		10.1016/S0140-6736(00)04009-5	http://dx.doi.org/10.1016/S0140-6736(00)04009-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273065				2022-12-28	WOS:000166865600014
J	Coyte, PC; Croxford, R; McIsaac, W; Feldman, W; Friedberg, J				Coyte, PC; Croxford, R; McIsaac, W; Feldman, W; Friedberg, J			The role of adjuvant adenoidectomy and tonsillectomy in the outcome of the insertion of tympanostomy tubes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC OTITIS-MEDIA; ICD-9-CM ADMINISTRATIVE DATA; CLINICAL COMORBIDITY INDEX; GLUE EAR; CHILDREN; EFFUSION; ADENOTONSILLECTOMY; SURGERY; TRIALS	Background: Otitis media is the most common medical problem in young children. The usual surgical treatment is myringotomy with insertion of tympanostomy tubes. There is debate about the usefulness of concomitant adenoidectomy or adenotonsillectomy. We examined the effects of these adjuvant procedures on the rates of reinsertion of tympanostomy tubes and rehospitalization for conditions related to otitis media. Methods: Using hospital discharge records for the period 1995 through 1997, we examined the results of surgery for all 37,316 children (defined as persons 19 years of age or younger) in Ontario, Canada, who received tympanostomy tubes as their first surgical treatment for otitis media. We determined the time to the first readmission for conditions related to otitis media and the time to the first reinsertion of tympanostomy tubes. Results: As compared with treatment involving the insertion of tympanostomy tubes alone, adjuvant adenoidectomy was associated with a reduction in the likelihood of reinsertion of tympanostomy tubes (relative risk, 0.5; 95 percent confidence interval, 0.5 to 0.6; P<0.001) and the likelihood of readmission for conditions related to otitis media (relative risk, 0.5; 95 percent confidence interval, 0.5 to 0.6; P<0.001). The risk of these outcomes was further reduced if an adjuvant adenotonsillectomy was performed. The effect was age-related. Children as young as one year appeared to benefit from adjuvant adenotonsillectomy; the benefit of an adjuvant adenoidectomy was apparent in two-year-olds and was greatest for children three years of age or older. Conclusions: Performing adenoidectomy or adenotonsillectomy at the time of the initial insertion of tympanostomy tubes substantially reduces the likelihood of additional hospitalizations and operations related to otitis media among children two years of age or older. (N Engl J Med 2001;344:1188-95.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Toronto, Fac Med, Dept Hlth Adm, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Home Care Evaluat & Res Ctr, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON, Canada; Mt Sinai Hosp, Dept Otolaryngol, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Family Med, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Div Gen Practice, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Otolaryngol, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Coyte, PC (corresponding author), Univ Toronto, Fac Med, Dept Hlth Adm, 2nd Fl,McMurrich Bldg, Toronto, ON M5S 1A8, Canada.							*AM AC OT HEAD NEC, 1998, B AM AC OT HEAD NECK; BLACK N, 1984, LANCET, V1, P835; Bluestone CD, 1998, PEDIATR INFECT DIS J, V17, P1090, DOI 10.1097/00006454-199811000-00040; BLUESTONE CD, 1989, PEDIATR CLIN N AM, V36, P1371; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1399, DOI 10.1056/NEJM198206103062305; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collett D, 1994, MODELLING SURVIVAL D; CRYSDALE WS, 1986, CAN MED ASSOC J, V135, P1139; GATES GA, 1988, LARYNGOSCOPE, V98, P58; GATES GA, 1987, NEW ENGL J MED, V317, P1444, DOI 10.1056/NEJM198712033172305; Gates GA, 1996, ARCH OTOLARYNGOL, V122, P239; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; MAW AR, 1986, LANCET, V1, P1399; MAW AR, 1983, BRIT MED J, V287, P1586, DOI 10.1136/bmj.287.6405.1586; MAW AR, 1985, AM J OTOLARYNG, V6, P245; MAW R, 1993, BMJ-BRIT MED J, V306, P756, DOI 10.1136/bmj.306.6880.756; OLUWOLE M, 1995, INT J PEDIATR OTORHI, V32, P129, DOI 10.1016/0165-5876(94)01124-G; PARADISE JL, 1977, PEDIATRICS, V60, P86; Paradise JL, 1999, JAMA-J AM MED ASSOC, V282, P945, DOI 10.1001/jama.282.10.945; PARADISE JL, 1990, JAMA-J AM MED ASSOC, V263, P2066, DOI 10.1001/jama.263.15.2066; Pransky SM, 1998, J OTOLARYNGOL, V27, P37; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; *SAS I, 1996, SAS VERS 6 12; STOOL SE, 1994, AHCPR PUBLICATION; TO T, 1996, PATTERNS HLTH CARE O, P297; WEN SW, 1995, JAMA-J AM MED ASSOC, V274, P1687, DOI 10.1001/jama.274.21.1687; Wright ED, 1998, INT J PEDIATR OTORHI, V45, P207, DOI 10.1016/S0165-5876(98)00113-X	28	77	83	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1188	1195		10.1056/NEJM200104193441602	http://dx.doi.org/10.1056/NEJM200104193441602			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309633				2022-12-28	WOS:000168127600002
J	Rao, H; Uhlmann, F; Nasmyth, K; Varshavsky, A				Rao, H; Uhlmann, F; Nasmyth, K; Varshavsky, A			Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability	NATURE			English	Article							SISTER-CHROMATID SEPARATION; PROTEIN; CENTROMERES; PROTEOLYSIS; CLEAVAGE	Cohesion between sister chromatids is established during DNA replication and depends on a protein complex called cohesin(1-7). At the metaphase-anaphase transition in the yeast Saccharomyces cerevisiae, the ESP1-encoded protease separin cleaves SCC1, a subunit of cohesin with a relative molecular mass of 63,000 (M-r 63K)(8). The resulting 33K carboxy-terminal fragment of SCC1 bears an amino-terminal arginine-a destabilizing residue in the N-end rule(9). Here we show that the SCC1 fragment is short-lived (t(1/2) approximate to 2 min), being degraded by the ubiquitin/proteasome-dependent N-end rule pathway. Overexpression of a long-lived derivative of the SCC1 fragment is lethal. In ubr1 Delta cells, which lack the N-end rule pathway(9), we found a highly increased frequency of chromosome loss. The bulk of increased chromosome loss in ubr1 Delta cells is caused by metabolic stabilization of the ESP1-produced SCC1 fragment. This fragment is the first physiological substrate of the N-end rule pathway that is targeted through its N-terminal residue. A number of yeast proteins bear putative cleavage sites for the ESP1 separin, suggesting other physiological substrates and functions of the N-end rule pathway.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Imperial Canc Res Fund, London WC2A 3PX, England; Res Inst Mol Pathol, A-1030 Vienna, Austria	California Institute of Technology; Cancer Research UK; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Nasmyth, Kim/0000-0001-7030-4403; RAO, HAI/0000-0002-4235-2210; Uhlmann, Frank/0000-0002-3527-6619				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Biggins S, 1999, CURR OPIN GENET DEV, V9, P230, DOI 10.1016/S0959-437X(99)80034-3; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Dej KJ, 2000, TRENDS CELL BIOL, V10, P392, DOI 10.1016/S0962-8924(00)01821-3; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; Sijts AJAM, 1997, J BIOL CHEM, V272, P19261, DOI 10.1074/jbc.272.31.19261; SPENCER F, 1990, GENETICS, V124, P237; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x	26	222	229	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					955	959		10.1038/35073627	http://dx.doi.org/10.1038/35073627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309624				2022-12-28	WOS:000168152300053
J	Gasser, U; Weeks, ER; Schofield, A; Pusey, PN; Weitz, DA				Gasser, U; Weeks, ER; Schofield, A; Pusey, PN; Weitz, DA			Real-space imaging of nucleation and growth in colloidal crystallization	SCIENCE			English	Article							HARD-SPHERE COLLOIDS; CRYSTAL-NUCLEATION; DENSITY-FLUCTUATIONS; SUSPENSIONS; GLASSES; LIQUIDS; TRANSITION; DYNAMICS; EQUATION; KINETICS	Crystallization of concentrated colloidal suspensions was studied in real space with laser scanning confocal microscopy. Direct imaging in three dimensions allowed identification and observation of both nucleation and growth of crystalline regions, providing an experimental measure of properties of the nucleating crystallites. By following their evolution, we identified critical nuclei, determined nucleation rates, and measured the average surface tension of the crystal-liquid interface. The structure of the nuclei was the same as the bulk solid phase, random hexagonal close-packed, and their average shape was rather nonspherical, with rough rather than faceted surfaces.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	Harvard University; Harvard University; University of Edinburgh	Gasser, U (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	gasser@deas.harvard.edu	Schofield, Andrew Bruce/AAV-4862-2020; Weeks, Eric R/I-8960-2019	Schofield, Andrew Bruce/0000-0002-8741-856X; Weeks, Eric R/0000-0003-1503-3633; Gasser, Urs/0000-0001-8137-1249				ACKERSON BJ, 1995, PHYS REV E, V52, P6448, DOI 10.1103/PhysRevE.52.6448; ALDER BJ, 1968, J CHEM PHYS, V49, P3688, DOI 10.1063/1.1670653; ALEXANDER S, 1978, PHYS REV LETT, V41, P702, DOI 10.1103/PhysRevLett.41.702; ANTL L, 1986, COLLOID SURFACE, V17, P67, DOI 10.1016/0166-6622(86)80187-1; Auer S, 2001, NATURE, V409, P1020, DOI 10.1038/35059035; BARTLETT P, 1992, PHYS REV LETT, V68, P3801, DOI 10.1103/PhysRevLett.68.3801; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Davidchack RL, 2000, PHYS REV LETT, V85, P4751, DOI 10.1103/PhysRevLett.85.4751; Harland JL, 1997, PHYS REV E, V55, P3054, DOI 10.1103/PhysRevE.55.3054; He YM, 1996, PHYS REV E, V54, P5286, DOI 10.1103/PhysRevE.54.5286; KELTON KF, 1991, SOLID STATE PHYS, V45, P75; MARR DW, 1993, PHYS REV E, V47, P1212, DOI 10.1103/PhysRevE.47.1212; OHNESORGE R, 1994, PHYS REV E, V50, P4801, DOI 10.1103/PhysRevE.50.4801; Ostwald W., 1897, Z PHYS CHEM, V22, P289, DOI [DOI 10.1515/ZPCH-1897-2233, 10.1515/zpch-1897-2233]; Palberg T, 1999, J PHYS-CONDENS MAT, V11, pR323, DOI 10.1088/0953-8984/11/28/201; Phan SE, 1996, PHYS REV E, V54, P6633, DOI 10.1103/PhysRevE.54.6633; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; PUSEY PN, 1989, PHYS REV LETT, V63, P2753, DOI 10.1103/PhysRevLett.63.2753; PUSEY PN, 1991, LES HOUCH S, V51, P763; SCHATZEL K, 1993, PHYS REV E, V48, P3766, DOI 10.1103/PhysRevE.48.3766; SCHATZEL K, 1992, PHYS REV LETT, V68, P337, DOI 10.1103/PhysRevLett.68.337; SOOD AK, 1991, SOLID STATE PHYS, V45, P1; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; tenWolde PR, 1996, J CHEM PHYS, V104, P9932, DOI 10.1063/1.471721; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Yau ST, 2000, NATURE, V406, P494, DOI 10.1038/35020035; Zhu JX, 1997, NATURE, V387, P883, DOI 10.1038/43141	28	829	838	9	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					258	262		10.1126/science.1058457	http://dx.doi.org/10.1126/science.1058457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303095				2022-12-28	WOS:000168074000038
J	Haran, M; Ni, S				Haran, M; Ni, S			Recurrent reversible paraplegia	LANCET			English	Editorial Material							SPINAL-CORD COMPRESSION; EXTRAMEDULLARY HEMATOPOIESIS; THALASSEMIA; MRI		Royal N Shore Hosp, Dept Aged Care & Rehabil Med, St Leonards, NSW 2065, Australia	Royal North Shore Hospital	Haran, M (corresponding author), Royal N Shore Hosp, Dept Aged Care & Rehabil Med, St Leonards, NSW 2065, Australia.							CHALJUB G, 1991, SPINE, V16, P583, DOI 10.1097/00007632-199105000-00019; GATTO I, 1954, Haematologica, V38, P61; HEFFEZ DS, 1982, J NEUROSURG, V57, P399, DOI 10.3171/jns.1982.57.3.0399; PAPAVASILIOU C, 1990, CLIN RADIOL, V42, P91, DOI 10.1016/S0009-9260(05)82074-4; SINGHAL S, 1992, J NEUROL NEUROSUR PS, V55, P310, DOI 10.1136/jnnp.55.4.310	5	14	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1092	1092		10.1016/S0140-6736(00)04262-8	http://dx.doi.org/10.1016/S0140-6736(00)04262-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297961				2022-12-28	WOS:000167996200012
J	Campbell, AM				Campbell, AM			Superconductivity - How could we miss it?	SCIENCE			English	Editorial Material									Univ Cambridge, Interdisciplinary Res Ctr Superconduct, Cambridge, England	University of Cambridge	Campbell, AM (corresponding author), Univ Cambridge, Interdisciplinary Res Ctr Superconduct, Cambridge, England.							Kambara M, 2001, SUPERCOND SCI TECH, V14, pL5, DOI 10.1088/0953-2048/14/4/101; MATHIAS BT, 1963, REV MOD PHYS, V35, P1; Monteverde M, 2001, SCIENCE, V292, P75, DOI 10.1126/science.1059775; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039	4	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					65	66		10.1126/science.1060380	http://dx.doi.org/10.1126/science.1060380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294221				2022-12-28	WOS:000167995200036
J	Dubrovinsky, LS; Dubrovinskaia, NA; Swamy, V; Muscat, J; Harrison, NM; Ahuja, R; Holm, B; Johansson, B				Dubrovinsky, LS; Dubrovinskaia, NA; Swamy, V; Muscat, J; Harrison, NM; Ahuja, R; Holm, B; Johansson, B			Materials science - The hardest known oxide	NATURE			English	Article									Uppsala Univ, Inst Earth Sci, S-75236 Uppsala, Sweden; CSIRO Minerals, Clayton, Vic 3169, Australia; SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England; Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; Uppsala Univ, Dept Phys, Condensed Matter Theory Grp, S-75121 Uppsala, Sweden; Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden	Uppsala University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); STFC Daresbury Laboratory; Imperial College London; Uppsala University; Royal Institute of Technology	Dubrovinsky, LS (corresponding author), Uppsala Univ, Inst Earth Sci, S-75236 Uppsala, Sweden.	leonid.dubrovinsky@geo.uu.se	Harrison, Nicholas/H-3198-2013; Harrison, Nicholas/ABC-3456-2020; Swamy, Varghese/C-2851-2013; Dubrovinskaia, Natalia/A-8013-2015	Harrison, Nicholas/0000-0001-7498-8144; Harrison, Nicholas/0000-0001-7498-8144; Swamy, Varghese/0000-0002-9006-386X; Dubrovinskaia, Natalia/0000-0002-8256-5675				COHEN ML, 1994, SOLID STATE COMMUN, V92, P45, DOI 10.1016/0038-1098(94)90857-5; Desgreniers S, 1999, PHYS REV B, V59, P8467, DOI 10.1103/PhysRevB.59.8467; HAINES J, 1993, PHYSICA B, V192, P233, DOI 10.1016/0921-4526(93)90025-2; Jhi SH, 1999, NATURE, V399, P132, DOI 10.1038/20148; Larson A. C., 1994, 86 LAUR LOS AL NAT L; Leger JM, 1996, NATURE, V383, P401, DOI 10.1038/383401a0; LEGER JM, 1994, J MATER SCI LETT, V13, P1688, DOI 10.1007/BF00451741; Leinenweber K, 1998, GEOPH MONOG SERIES, V101, P97; Lundin U, 1998, PHYS REV B, V57, P4979, DOI 10.1103/PhysRevB.57.4979; Olsen JS, 1999, J PHYS CHEM SOLIDS, V60, P229, DOI 10.1016/S0022-3697(98)00274-1; RIEDEL R, 1994, ADV MATER, V6, P549, DOI 10.1002/adma.19940060705; Sung CM, 1996, MATER CHEM PHYS, V43, P1, DOI 10.1016/0254-0584(95)01607-V; Teter DM, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400031420	13	289	302	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					653	654		10.1038/35070650	http://dx.doi.org/10.1038/35070650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287944	Green Accepted			2022-12-28	WOS:000167875400036
J	Triendl, R				Triendl, R			Staffing shortage threatens Japan's structural genomics	NATURE			English	Article																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					724	724		10.1038/35070725	http://dx.doi.org/10.1038/35070725			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287970	Bronze			2022-12-28	WOS:000167875400058
J	DeFalco, J; Tomishima, M; Liu, HY; Zhao, C; Cai, XL; Marth, JD; Enquist, L; Friedman, JM				DeFalco, J; Tomishima, M; Liu, HY; Zhao, C; Cai, XL; Marth, JD; Enquist, L; Friedman, JM			Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus	SCIENCE			English	Article							PSEUDORABIES VIRUS; AFFERENT CONNECTIONS; GENE-EXPRESSION; MOUSE-BRAIN; LEPTIN; RAT; PROJECTIONS; NEURONS; TYPE-1; LOCALIZATION	We report the development of a pseudorabies virus that can be used for retrograde tracing from selected neurons. This virus encodes a green fluorescent protein marker and replicates only in neurons that express the Cre recombinase and in neurons in synaptic contact with the originally infected cells. The virus was injected into the arcuate nucleus of mice that express Cre only in those neurons that express neuropeptide Y or the leptin receptor. Sectioning of the brains revealed that these neurons receive inputs from neurons in other regions of the hypothalamus, as well as the amygdala, cortex, and other brain regions. These data suggest that higher cortical centers modulate leptin signaling in the hypothalamus. This method of neural tracing may prove useful in studies of other complex neural circuits.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Rockefeller University; Princeton University; Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	friedj@mail.rockefeller.edu	Friedman, Jeffrey M/E-5784-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096, R01DK048247] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48247, R01DK41096] Funding Source: Medline; PHS HHS [R01133506] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARONE FC, 1981, BRAIN RES BULL, V7, P75, DOI 10.1016/0361-9230(81)90101-5; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; CARD JP, 1990, J NEUROSCI, V10, P1974; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; DEFALCO J, UNPUB; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GEHLERT DR, 1987, SYNAPSE, V1, P25, DOI 10.1002/syn.890010106; GORDON Y, 1983, ARCH VIROL, V76, P39, DOI 10.1007/BF01315702; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HEFFNER S, 1993, J VIROL, V67, P1529, DOI 10.1128/JVI.67.3.1529-1537.1993; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; HIGUCHI H, 1988, J BIOL CHEM, V263, P6288; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Knapp AC, 1997, J VIROL, V71, P2731, DOI 10.1128/JVI.71.4.2731-2739.1997; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Loewy AD, 1998, NEUROSCI BIOBEHAV R, V22, P679, DOI 10.1016/S0149-7634(98)00006-2; Logvinoff C, 2000, J VIROL, V74, P8402, DOI 10.1128/JVI.74.18.8402-8412.2000; Petrovich GD, 1996, J COMP NEUROL, V374, P387, DOI 10.1002/(SICI)1096-9861(19961021)374:3<387::AID-CNE6>3.0.CO;2-Y; ROBBINS AK, 1986, J VIROL, V58, P339, DOI 10.1128/JVI.58.2.339-347.1986; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Standish A, 1995, J NEUROVIROL, V1, P359, DOI 10.3109/13550289509111025; Yang M, 1999, J VIROL, V73, P4350, DOI 10.1128/JVI.73.5.4350-4359.1999; ZABORSZKY L, 1982, ADV ANAT EMBRYOL CEL, V69, P1; ZHU Y, COMMUNICATION	29	296	317	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2608	2613		10.1126/science.1056602	http://dx.doi.org/10.1126/science.1056602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283374				2022-12-28	WOS:000167861000044
J	Khodri, M; Leclainche, Y; Ramstein, G; Braconnot, P; Marti, O; Cortijo, E				Khodri, M; Leclainche, Y; Ramstein, G; Braconnot, P; Marti, O; Cortijo, E			Simulating the amplification of orbital forcing by ocean feedbacks in the last glaciation	NATURE			English	Article							NORTH-ATLANTIC OCEAN; GENERAL-CIRCULATION MODEL; LAURENTIDE ICE-SHEET; THERMOHALINE CIRCULATION; INTERGLACIAL PERIOD; GROWTH; SEA; SENSITIVITY; INCEPTION; RECORD	According to Milankovitch theory, the lower summer insolation at high latitudes about 115,000 years ago allowed winter snow to persist throughout summer, leading to ice-sheet build-up and glaciation(1), But attempts to simulate the last glaciation using global atmospheric models have failed to produce this outcome when forced by insolation changes only(2-5). These results point towards the importance of feedback effects-for example, through changes in vegetation or the ocean circulation-for the amplification of solar forcing(6-9). Here we present a fully coupled ocean-atmosphere model of the last glaciation that produces a build-up of perennial snow cover at known locations of ice sheets during this period. We show that ocean feedbacks lead to a cooling of the high northern latitudes, along with an increase in atmospheric moisture transport from the Equator to the poles. These changes agree with available geological data(10-15) and, together, they lead to an increased delivery of snow to high northern latitudes, The mechanism we present explains the onset of glaciation-which would be amplified by changes in vegetation-in response to weak orbital forcing.	Ctr Etud Saclay, LSCE, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Khodri, M (corresponding author), Ctr Etud Saclay, LSCE, F-91191 Gif Sur Yvette, France.		Ramstein, Gilles/L-3328-2014; Le Clainche, Yvonnick/G-2933-2010; Marti, Olivier/B-2378-2009; Khodri, Myriam/K-1399-2016	Ramstein, Gilles/0000-0002-1522-917X; Marti, Olivier/0000-0002-8246-5578; Khodri, Myriam/0000-0003-1941-1646				Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; ANDREWS JT, 1976, QUATERNARY RES, V6, P167, DOI 10.1016/0033-5894(76)90048-X; [Anonymous], [No title captured]; BALBON E, 2000, THESIS ORSAY U; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Braconnot P, 2000, J CLIMATE, V13, P1537, DOI 10.1175/1520-0442(2000)013<1537:OFIRTK>2.0.CO;2; CORTIJO E, 1994, NATURE, V372, P446, DOI 10.1038/372446a0; Cortijo E, 1999, PALEOCEANOGRAPHY, V14, P23, DOI 10.1029/1998PA900004; deNoblet NI, 1996, GEOPHYS RES LETT, V23, P3191, DOI 10.1029/96GL03004; DONG BW, 1995, J CLIMATE, V8, P2471, DOI 10.1175/1520-0442(1995)008<2471:SSONHG>2.0.CO;2; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; DUPLESSY JC, 1985, NATURE, V316, P500, DOI 10.1038/316500a0; Gallimore RG, 1996, NATURE, V381, P503, DOI 10.1038/381503a0; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P669; IVES JD, 1975, NATURWISSENSCHAFTEN, V62, P118, DOI 10.1007/BF00623272; LECLAINCHE Y, UNPUB CLIM DYN; Mangerud J., 1991, KLIMAGESCHICHTLICHE, P307; Marshall SJ, 1999, CLIM DYNAM, V15, P533, DOI 10.1007/s003820050298; Members L.I.G.A., 1991, QUATERN INT, V10-12, P9, DOI DOI 10.1016/1040-6182(91)90038-P; MITCHELL JFB, 1993, PHILOS T R SOC B, V341, P267, DOI 10.1098/rstb.1993.0112; OGLESBY RJ, 1990, CLIM DYNAM, V4, P219; PHILLIPPS PJ, 1994, J CLIMATE, V7, P767, DOI 10.1175/1520-0442(1994)007<0767:TRTOPI>2.0.CO;2; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; RAYNAUD D, 1993, SCIENCE, V259, P926, DOI 10.1126/science.259.5097.926; RIND D, 1989, J GEOPHYS RES-ATMOS, V94, P12851, DOI 10.1029/JD094iD10p12851; ROYER JF, 1983, NATURE, V304, P43, DOI 10.1038/304043a0; RUDDIMAN WF, 1979, SCIENCE, V204, P173, DOI 10.1126/science.204.4389.173; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583	30	136	138	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					570	574		10.1038/35069044	http://dx.doi.org/10.1038/35069044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279492				2022-12-28	WOS:000167859300044
J	Wang, SQ; Song, LS; Lakatta, EG; Cheng, HP				Wang, SQ; Song, LS; Lakatta, EG; Cheng, HP			Ca2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells	NATURE			English	Article							FROG SKELETAL-MUSCLE; CARDIAC MYOCYTES; CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; SPARKS; INACTIVATION	Ca2+-induced Ca2+ release is a general mechanism that most cells use to amplify Ca2+ signals(1-5). In heart cells, this mechanism is operated between voltage-gated L-type Ca2+ channels (LCCs) in the plasma membrane and Ca2+ release channels, commonly known as ryanodine receptors, in the sarcoplasmic reticulum(3-5) The Ca2+ influx through LCCs traverses a deft of roughly 12 nm formed by the cell surface and the sarcoplasmic reticulum membrane, and activates adjacent ryanodine receptors to release Ca2+ in the form of Ca2+ sparks(6). Here we determine the kinetics, fidelity and stoichiometry of coupling between LCCs and ryanodine receptors. We show that the local Ca2+ signal produced by a single opening of an LCC named a 'Ca2+ sparklet: can trigger about 4-6 ryanodine receptors to generate a Ca2+ spark. The coupling between LCCs and ryanodine receptors is stochastic, as judged by the exponential distribution of the coupling latency. The fraction of sparklets that successfully triggers a spark is less than unity and declines in a use-dependent manner. This optical analysis of single-channel communication affords a powerful means for elucidating Ca2+-signalling mechanisms at the molecular level.	NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University	Cheng, HP (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.		cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019; Lakatta, Edward G/AAL-1447-2020; Song, Long-Sheng/D-5899-2012	Heping, Cheng/0000-0002-9604-6702; Wang, Shi-Qiang/0000-0001-7784-4461; Song, Long-Sheng/0000-0002-6035-8106; Lakatta, Edward/0000-0002-4772-0035	NATIONAL INSTITUTE ON AGING [Z01AG000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Blatter LA, 1997, P NATL ACAD SCI USA, V94, P4176, DOI 10.1073/pnas.94.8.4176; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Bridge JHB, 1999, J PHYSIOL-LONDON, V518, P469, DOI 10.1111/j.1469-7793.1999.0469p.x; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CARL SL, 1995, J CELL BIOL, V129, P672; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Gonzalez A, 2000, P NATL ACAD SCI USA, V97, P4380, DOI 10.1073/pnas.070056497; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARKINS AB, 1993, BIOPHYS J, V65, P865, DOI 10.1016/S0006-3495(93)81112-3; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; Lipp P, 1998, J PHYSIOL-LONDON, V508, P801, DOI 10.1111/j.1469-7793.1998.801bp.x; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Mejia-Alvarez R, 1999, J GEN PHYSIOL, V113, P177, DOI 10.1085/jgp.113.2.177; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Santana LF, 1996, CIRC RES, V78, P166, DOI 10.1161/01.RES.78.1.166; Schneider MF, 1999, J GEN PHYSIOL, V113, P365, DOI 10.1085/jgp.113.3.365; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Shorofsky SR, 1998, CIRC RES, V82, P424, DOI 10.1161/01.RES.82.4.424; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559	29	325	346	4	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					592	596		10.1038/35069083	http://dx.doi.org/10.1038/35069083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279498				2022-12-28	WOS:000167859300050
J	Tsai, B; Rodighiero, C; Lencer, WI; Rapoport, TA				Tsai, B; Rodighiero, C; Lencer, WI; Rapoport, TA			Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin	CELL			English	Article							ENDOPLASMIC-RETICULUM; DEGRADATION PATHWAY; SECRETORY PROTEIN; MAMMALIAN-CELLS; QUALITY-CONTROL; BOND FORMATION; LABILE TOXIN; HSP70; TRANSLOCATION; REDUCTION	Cholera toxin is assembled from two subunits in the periplasm of Vibrio cholerae and disassembled in the analogous compartment of target cells, the lumen of the endoplasmic reticulum (ER), before a fragment of it, the Al chain, is transported into the cytosol. We show that protein disulfide isomerase (PDI) in the ER lumen functions to disassemble and unfold the toxin once its A chain has been cleaved. PDI acts as a redox-driven chaperone; in the reduced state, it binds to the A chain and in the oxidized state it releases it. Our results explain the pathway of cholera toxin, suggest a role for PDI in retrograde protein transport into the cytosol, and indicate that PDI can act as a novel type of chaperone, whose binding and release of substrates is regulated by a redox, rather than an ATPase, cycle.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Combined Program Pediat Gastroenterol & Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.			Lencer, Wayne/0000-0001-7346-2730	NIDDK NIH HHS [DK34854, DK48106] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048106, P30DK034854, R01DK048106] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER S, 1983, J BIOL CHEM, V258, P6956; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Courageot J, 1999, EUR J BIOCHEM, V260, P482, DOI 10.1046/j.1432-1327.1999.00193.x; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HIRSCH PM, 1995, IEEE COMPUT APPL POW, V8, P8; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rodighiero C, 1999, J BIOL CHEM, V274, P3962, DOI 10.1074/jbc.274.7.3962; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Thyberg J, 2000, LAB INVEST, V80, P915, DOI 10.1038/labinvest.3780095; Wainwright LJ, 1997, BIOCHEM J, V321, P655, DOI 10.1042/bj3210655; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; YOUNG J, 1993, J BIOL CHEM, V268, P19810; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	34	387	400	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					937	948		10.1016/S0092-8674(01)00289-6	http://dx.doi.org/10.1016/S0092-8674(01)00289-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290330	Bronze			2022-12-28	WOS:000167869200015
J	Ferguson, NM; Donnelly, CA; Anderson, RM				Ferguson, NM; Donnelly, CA; Anderson, RM			The foot-and-mouth epidemic in Great Britain: Pattern of spread and impact of interventions	SCIENCE			English	Article							EMERGENCY VACCINATION; DISEASE; PROTECTION; REDUCTION	We present an analysis of the current foot-and-mouth disease epidemic in Great Britain over the first 2 months of the spread of the virus. The net transmission potential of the pathogen and the increasing impact of control measures are estimated over the course of the epidemic to date. These results are used to parameterize a,mathematical model of disease transmission that captures the differing spatial contact patterns between farms before and after the imposition of movement restrictions. The model is used to make predictions of future incidence and to simulate the impact of additional control strategies. Hastening the slaughter of animals with suspected infection is predicted to slow the epidemic, but more drastic action, such as "ring" culling or vaccination around;infection foci, is necessary for more rapid control. Culling is predicted to be more effective than vaccination.	Imperial Coll Sch Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Imperial Coll Sch Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	Neil.Ferguson@ic.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175				ANDERSON R M, 1991; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; DONALDSON AI, 1992, VET REC, V131, P114, DOI 10.1136/vr.131.6.114; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; HMSO (Her Majesty's Stationery Office), 1968, NORTHUMBERLAND REPOR; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; HUGHJONES ME, 1970, J HYG-CAMB, V68, P253, DOI 10.1017/S0022172400028722; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; *MIN AGR FISH FOOD, 2001, JUN 2000 AGR HORT CE; Salt JS, 1998, VACCINE, V16, P746, DOI 10.1016/S0264-410X(97)86180-4; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250	13	501	512	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1155	1160		10.1126/science.1061020	http://dx.doi.org/10.1126/science.1061020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11303090				2022-12-28	WOS:000168609200058
J	Davies, R; Cartwright, J; Pike, J; Line, C				Davies, R; Cartwright, J; Pike, J; Line, C			Early Oligocene initiation of North Atlantic Deep Water formation	NATURE			English	Article								Dating the onset of deep-water flow between the Arctic and North Atlantic oceans is critical for modelling climate change in the Northern Hemisphere(1,2) and for explaining changes in global ocean circulation throughout the Cenozoic era(3) (from about 65 million years ago to the present). In the early Cenozoic era, exchange between these two ocean basins was inhibited by the Greenland-Scotland ridge(3,4), but a gateway through the Faeroe-Shetland basin has been hypothesized(3,5). Previous estimates of the date marking the onset of deep-water circulation through this basin-on the basis of circumstantial evidence from neighbouring basins-have been contradictory(5-9), ranging from about 35 to 15 million years ago. Here we describe the newly discovered Southeast Faeroes drift, which extends for 120 km parallel to the basin axis. The onset of deposition in this drift has been dated to the early Oligocene epoch (similar to 35 million years ago) from a petroleum exploration borehole. We show that the drift was deposited under a southerly flow regime, and conclude that the initiation of deep-water circulation from the Norwegian Sea into the North Atlantic Ocean took place much earlier than is currently assumed in most numerical models of ancient ocean circulation.	ExxonMobil Int Ltd, London WC2B 6WF, England; Univ Cardiff, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales	Exxon Mobil Corporation; Cardiff University	Davies, R (corresponding author), ExxonMobil Int Ltd, St Catherines House,2 Kingsway,POB 393, London WC2B 6WF, England.	richard_davies@email.mobil.com; cartwrightja@cardiff.ac.uk	Pike, Jennifer/D-2589-2009	Pike, Jennifer/0000-0001-9415-6003				BERGGREN W. A., 1983, STRUCTURE DEV GREENL, P495; Berggren W.A., 1974, SPEC PUBLS SOC ECON, V20, P126; Blow W.H., 1979, CENOZOIC GLOBIGERINI, V3, P1; BOLDREEL IO, 1995, TECTONICS SEDIMENTAT, P145; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Davies R, 1999, GEOLOGY, V27, P907, DOI 10.1130/0091-7613(1999)027<0907:GHIDWM>2.3.CO;2; Dean K., 1999, PETROLEUM GEOLOGY NW, V5, P533, DOI [DOI 10.1144/0050533, 10.1144/0050533]; Eldholm O., 1990, MEM GEOL ITAL, V44, P13; Faugeres JC, 1999, MAR GEOL, V162, P1, DOI 10.1016/S0025-3227(99)00068-7; Harland W.B., 1990, GEOLOGIC TIME SCALE; HEIN JR, 1978, SEDIMENTOLOGY, V25, P155, DOI 10.1111/j.1365-3091.1978.tb00307.x; HEINRICH R, 1989, P OCEAN DRILLING PRO, V104, P75; Hollister C.D., 1972, STUDIES PHYSICAL OCE, V2, P37; KIDD RB, 1987, INITIAL REP DEEP SEA, V94, P1217; Martini E, 1971, 2 P PLANKT C TECN RO, V2, P739; MILLER K. G., 1983, STRUCTURE DEV GREENL, P549, DOI DOI 10.1007/978-1-4613-3485-9_27; MITCHELL SM, 1993, PETROLEUM GEOLOGY OF NORTHWEST EUROPE: PROCEEDINGS OF THE 4TH CONFERENCE, P1011, DOI 10.1144/0041011; NILSEN TH, 1983, STRUCTURE DEV GREENL, P457; SCHNITKER D, 1980, NATURE, V284, P615, DOI 10.1038/284615a0; SCHNITKER D, 1980, EARTH-SCI REV, V16, P1, DOI 10.1016/0012-8252(80)90002-1; SHOR AN, 1907, INIT REP DSDP, V49, P859; Stoker MS, 1998, GEOL SOC SPEC PUBL, V129, P229, DOI 10.1144/GSL.SP.1998.129.01.15; STOW DAV, 1984, INITIAL REP DEEP SEA, V81, P695; Thiede J., 1983, STRUCTURE DEV GREENL, P445; VOGT PR, 1972, NATURE, V239, P79, DOI 10.1038/239079a0; WOLD CN, 1994, PALEOCEANOGRAPHY, V9, P917, DOI 10.1029/94PA01438; WOLD CN, 1995, TECTONICS SEDIMENTAT, P271; Wright JD, 1996, PALEOCEANOGRAPHY, V11, P157, DOI 10.1029/95PA03696	29	107	112	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					917	920		10.1038/35073551	http://dx.doi.org/10.1038/35073551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309613				2022-12-28	WOS:000168152300042
J	Egger, M; Juni, P; Bartlett, C				Egger, M; Juni, P; Bartlett, C		CONSORT Grp	Value of flow diagrams in reports of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSORT STATEMENT; QUALITY	Context Diagrams of the flow of participants through a clinical trial are recommended in the Consolidated Standards for Reporting of Trials (CONSORT) statement, but it is unclear whether such flow diagrams improve the quality of trial reports. Objective To examine the information contributed by flow diagrams and the completeness of reporting overall in reports of randomized controlled trials (RCTs) published in 5 general and internal medicine journals. Design and Setting Analysis of 270 reports of RCTs published in 1998 in the Annals of Internal Medicine (AIM; n = 19), BMJ (n = 42), JAMA (n = 45), The Lancet (n = 81), and The New England Journal of Medicine (NEJM; n = 83). Main Outcome Measures Proportion of reports that included a flow diagram, information provided in flow diagrams, and completeness of reporting about flow of published in 5 general and internal medicine journals. participants overall in flow diagrams or text. Results A total of 139 reports (51.5%) of RCTs included a flow diagram, but this varied widely among journals (AIM, 21.0%; BMJ, 38.1%; JAMA, 80.0%; The Lancet, 93.8%; and NEJM, 8.4%). Diagrams generally provided useful information, but only 73 (52.5%) included the number of participants who received allocated interventions and only 32 (23.0%) included the number of participants included in the analysis. In logistic regression analysis, overall completeness of reporting about flow of study participants was associated with publication of a flow diagram. Conclusions Flow diagrams are associated with improved quality of reporting of randomized controlled trials. However, the structure of current flow diagrams is less than ideal. We propose a revised flow diagram that includes all important counts through participants overall in flow diagrams or text. the stages of parallel group trials.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	University of Bristol; University of Bern	Egger, M (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.		Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Egger, Matthias/0000-0001-7462-5132				Altman DG, 1996, BRIT MED J, V313, P570; Ausejo M, 1998, Aten Primaria, V21, P351; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; *CONSORT, 1998, NED TIJDSCHR GENEESK, V142, P1089; Deeks JJ, 1998, LANCET, V352, P1908, DOI 10.1016/S0140-6736(05)60399-6; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Huston P, 1996, CAN MED ASSOC J, V155, P1277; JUNI P, 2001, SYSTEMATIC REV HLTH; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987	13	241	254	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1996	1999		10.1001/jama.285.15.1996	http://dx.doi.org/10.1001/jama.285.15.1996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308437				2022-12-28	WOS:000167995900029
J	Geleziunas, R; Xu, WD; Takeda, K; Ichijo, H; Greene, WC				Geleziunas, R; Xu, WD; Takeda, K; Ichijo, H; Greene, WC			HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell	NATURE			English	Article							FAS LIGAND EXPRESSION; HUMAN-IMMUNODEFICIENCY-VIRUS; TUMOR-NECROSIS-FACTOR; CD4 DOWN-REGULATION; T-LYMPHOCYTES; DILEUCINE MOTIF; LYMPH-NODES; SH3 DOMAIN; IN-VIVO; APOPTOSIS	In vivo infection of lymphatic tissues by the human immunodeficiency virus type 1 (HIV-1) leads to enhanced apoptosis, which prominently involves uninfected bystander cells(1-3). Increased killing of such bystander cells is mediated in part through Nef induction of Fas ligand (FasL) expression(4-6) on the surface of the virally infected T cells. The subsequent interaction of FasL with Fas (CD95) displayed on neighbouring cells, including HIV-1-specific cytotoxic T lymphocytes, may lead to bystander cell killing and thus forms an important mechanism of immune evasion. As HIV-1 also enhances Fas expression on virally infected cells(7-9), it is unclear how these hosts avoid rapid cell-autonomous apoptosis mediated through cis ligation of Fas by FasL. Here we show that HIV-1 Nef associates with and inhibits apoptosis signal-regulating kinase 1 (ASK1), a serine/threonine kinase that forms a common and key signalling intermediate in the Fas and tumour-necrosis factor-alpha (TNF alpha) death-signalling pathways(10-12). The interaction of Nef with ASK1 inhibits both Fas- and TNF alpha -mediated apoptosis, as well as the activation of the downstream c-Jun amino-terminal kinase. Our findings reveal a strategy by which HIV-1 Nef promotes the killing of bystander cells through the induction of FasL, while simultaneously protecting the HIV-1-infected host cell from these same pro-apoptotic signals through its interference with ASK1 function.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Tokyo Med & Dent Univ, Grad Sch, Lab Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; Japan Sci & Technol, CREST, Chiyoda Ku, Tokyo 1020081, Japan; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.			Takeda, Kohsuke/0000-0002-8359-8399; Ichijo, Hidenori/0000-0002-5005-6438				Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; CHANG CF, 1981, P S QINGHAI XIZANG T, V1, P1; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hodge S, 1998, VIROLOGY, V252, P354, DOI 10.1006/viro.1998.9477; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jaworowski A, 1999, IMMUNOL CELL BIOL, V77, P90, DOI 10.1046/j.1440-1711.1999.00798.x; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Mitra D, 1996, IMMUNOLOGY, V87, P581, DOI 10.1046/j.1365-2567.1996.510589.x; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	30	266	279	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					834	838		10.1038/35071111	http://dx.doi.org/10.1038/35071111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298454				2022-12-28	WOS:000168021900060
J	Little, RF; Gutierrez, M; Jaffe, ES; Pau, A; Horne, M; Wilson, W				Little, RF; Gutierrez, M; Jaffe, ES; Pau, A; Horne, M; Wilson, W			HIV-associated non-Hodgkin lymphoma - Incidence, presentation, and prognosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE-DEFICIENCY SYNDROME; EPSTEIN-BARR-VIRUS; LYMPHOPROLIFERATIVE DISORDERS; INTENSIVE CHEMOTHERAPY; DRUG-INTERACTIONS; AIDS; INFECTION; SURVIVAL; CLASSIFICATION	Patients with acquired immunodeficiency syndrome (AIDS)-associated non-Hodgkin lymphoma often present with multiple poor prognostic features, including significant tumor burden, advanced immunosuppression, and other concurrent morbidities, Strategies to manage such complex multiple-disease cases have often incorporated the assumption that prospects for long-term survival are poor and that intensive therapy cannot be tolerated and so is not justified. Since the advent of highly active antiretroviral therapy-for human immunodeficiency virus infection, life expectancy has improved substantially for patients in whom the virus can be successfully suppressed. Thus, for complicated cases involving AIDS-associated malignancy, a reassess ment of treatment strategies and the potential for long-term survival is warranted. Here, we present the case of a patient with poor prognosis due to AIDS-associated lymphoma with leptomeningeal involvement, advanced immunosuppression, and deep venous thrombosis. The management of this case illustrates that a multidisciplinary approach to complex AIDS cases involving malignancy and concurrent morbidity can result in a return to functional health in affected patients. Successful strategies for achieving favorable outcomes currently exist with available therapies.	NCI, HIV & AIDS Malignancy Branch, Div Clin Sci, Bethesda, MD 20892 USA; NCI, Med Branch, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Pathol Lab, Bethesda, MD 20892 USA; NIH, Ctr Clin, Dept Clin Pathol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Little, RF (corresponding author), NCI, HIV & AIDS Malignancy Branch, Div Clin Sci, Bldg 10,Room 10S255,9000 Rockville Pike, Bethesda, MD 20892 USA.	rlittle@helix.nih.gov	Jaffe, Elaine/G-8981-2014					Aboulafia D M, 1994, Cancer Pract, V2, P297; ANTINORI A, 1999, 6 C RETR OPP INF JAN; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; CARBONE PP, 1971, CANCER RES, V31, P1860; COSTAGLIOLA D, 1998, 12 INT C AIDS JUN 28; Cote TR, 1997, INT J CANCER, V73, P645, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;645::AID-IJC6&gt;3.0.CO;2-X; Davi F, 1998, J CLIN ONCOL, V16, P3788, DOI 10.1200/JCO.1998.16.12.3788; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; ENTING RH, 1994, J NEUROL NEUROSUR PS, V57, P150, DOI 10.1136/jnnp.57.2.150; FAUCI A, 1998, GUIDELINES USE ANTIR; FAUCI AS, 2000, GUIDELINES USE ANTIR; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Freimuth WW, 1996, ADV EXP MED BIOL, V394, P279; Grulich AE, 1999, J ACQ IMMUN DEF SYND, V21, pS27; HAGEMEISTER FB, 1994, ANN ONCOL, V5, pS41, DOI 10.1093/annonc/5.suppl_2.S41; HARRIS NL, 1994, BLOOD, V84, P1361; Irwin David, 1993, Current Opinion in Oncology, V5, P852, DOI 10.1097/00001622-199309000-00013; Jaffe ES, 1997, CANCER SURV, V30, P233; JONES J, 1998, 2 NAT AIDS MAL C APR; Kaplan L D, 1993, AIDS Clin Rev, P145; Kaplan LD, 1997, NEW ENGL J MED, V336, P1641, DOI 10.1056/NEJM199706053362304; Kempf DJ, 1997, ANTIMICROB AGENTS CH, V41, P654, DOI 10.1128/AAC.41.3.654; Kingma DW, 1999, ARCH PATHOL LAB MED, V123, P83; Knowles DM, 1999, MODERN PATHOL, V12, P200; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; LAI GM, 1991, INT J CANCER, V49, P696, DOI 10.1002/ijc.2910490512; Lai R, 1998, MODERN PATHOL, V11, P864; LEVINE AM, 1991, HEMATOL ONCOL CLIN N, V5, P331, DOI 10.1016/S0889-8588(18)30445-3; LEVINE AM, 1987, SEMIN ONCOL, V14, P34; LEVINE AM, 1991, CANCER, V68, P2466, DOI 10.1002/1097-0142(19911201)68:11<2466::AID-CNCR2820681124>3.0.CO;2-G; LEVINE AM, 1994, ANN ONCOL, V5, pS29, DOI 10.1093/annonc/5.suppl_2.S29; LEVINE AM, 1992, MED CLIN N AM, V76, P253, DOI 10.1016/S0025-7125(16)30379-0; LEVINE AM, 1993, JNCI-J NATL CANCER I, V85, P1382, DOI 10.1093/jnci/85.17.1382; LITTLE RF, 1999, 35 ANN M AM SOC CLIN; MACKALL CL, 1994, BLOOD, V84, P2221; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; MORAN CA, 1992, MODERN PATHOL, V5, P85; National Cancer Institute (NCI), 1973, SEER CANC STAT REV; Navarro JT, 1998, HAEMATOLOGICA, V83, P508; PELICCI PG, 1986, J EXP MED, V164, P2049, DOI 10.1084/jem.164.6.2049; RAPHAEL MM, 1994, AM J CLIN PATHOL, V101, P773, DOI 10.1093/ajcp/101.6.773; RATNER L, 1999, 3 NAT AIDS MAL M MAY; ROITHMANN S, 1992, EUR J CANCER, V28A, P1501, DOI 10.1016/0959-8049(92)90553-E; SPARANO J, 1998, 2 NAT AIDS MAL C APR; Sparano JA, 1996, J CLIN ONCOL, V14, P3026, DOI 10.1200/JCO.1996.14.11.3026; Taburet AM, 1996, CLIN PHARMACOKINET, V30, P385, DOI 10.2165/00003088-199630050-00005; Tirelli U, 1995, LEUKEMIA LYMPHOMA, V20, P91, DOI 10.3109/10428199509054758; Tirelli U, 1996, HEMATOL ONCOL, V14, P7, DOI 10.1002/(SICI)1099-1069(199603)14:1<7::AID-HON556>3.0.CO;2-D; Vaccher E, 1996, J CLIN ONCOL, V14, P2217, DOI 10.1200/JCO.1996.14.8.2217; VACCNER E, 1998, 12 INT C AIDS JUN 28; van Besien K, 1998, BLOOD, V91, P1178, DOI 10.1182/blood.V91.4.1178; WILSON WH, 1993, J CLIN ONCOL, V11, P1573, DOI 10.1200/JCO.1993.11.8.1573; WILSON WH, 1998, 34 ANN M AM SOC CLIN; YOUSEM DM, 1990, J COMPUT ASSIST TOMO, V14, P255, DOI 10.1097/00004728-199003000-00018; ZHOUPAN XR, 1993, CANCER RES, V53, P5121; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904; 1985, MMWR MORB MORTAL WKL, V34, P373; 1999, MMWR MORB MORTAL WKL, V48, pSS2	60	54	56	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1880	1885		10.1001/jama.285.14.1880	http://dx.doi.org/10.1001/jama.285.14.1880			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308402				2022-12-28	WOS:000167876700029
J	Macgregor-Morris, R; Ewbank, J; Birmingham, L				Macgregor-Morris, R; Ewbank, J; Birmingham, L			Potential impact of the Human Rights Act on psychiatric practice: the best of British values?	BRITISH MEDICAL JOURNAL			English	Article									Ravenswood House Medium Secure Unit, Knowle PO17 5NA, Fareham, England		Macgregor-Morris, R (corresponding author), Ravenswood House Medium Secure Unit, Knowle PO17 5NA, Fareham, England.								0	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					848	850		10.1136/bmj.322.7290.848	http://dx.doi.org/10.1136/bmj.322.7290.848			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290643	Green Published			2022-12-28	WOS:000168063000029
J	Shaw, C				Shaw, C			External assessment of health care	BRITISH MEDICAL JOURNAL			English	Article							QUALITY IMPROVEMENT; 4 MODELS; ACCREDITATION; ASSURANCE; SERVICE		CASPE Res, London W1M 0AN, England		Shaw, C (corresponding author), CASPE Res, 11-13 Cavendish Sq, London W1M 0AN, England.							*AG NAT ACCR EV SA, 1997, DECR CONS ET 97311 7; Arce HE, 1999, INT J QUAL HEALTH C, V11, P425, DOI 10.1093/intqhc/11.5.425; *AUSTR BUS EXC FRA, 1999, COMP QUAL PROGR; *DEP HLTH, 1989, WORK PAT WHIT PAP; Donahue KT, 2000, INT J QUAL HEALTH C, V12, P243, DOI 10.1093/intqhc/12.3.243; Gibbs Brown J, 1999, EXTERNAL REV HOSP QU; Heidemann EG, 1999, INT J QUAL HEALTH C, V11, P275, DOI 10.1093/intqhc/11.4.275; Huang P, 2000, INT J QUAL HEALTH C, V12, P251, DOI 10.1093/intqhc/12.3.251; Ito H, 1998, INT J QUAL HEALTH C, V10, P361, DOI 10.1093/intqhc/10.4.361; Joint Commission International, 2000, JOINT COMM INT ACCR; Kizer KW, 2000, INT J QUAL HEALTH C, V12, P85, DOI 10.1093/intqhc/12.2.85; Klazinga N, 2000, INT J QUAL HEALTH C, V12, P183, DOI 10.1093/intqhc/12.3.183; Nabitz U, 2000, INT J QUAL HEALTH C, V12, P191, DOI 10.1093/intqhc/12.3.191; *NAT EXP ADV GROUP, 1909, INT REP APR 1998; Oldham J, 1997, BRIT MED J, V315, P896; President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry, 1998, QUAL 1 BETT HLTH CAR; Royal Commission on the National Health Service, 1979, REP ROYAL COMM NAT H; Scottish Office, 1998, AC SERV REV REP; SHAW CD, 1982, BRIT MED J, V284, P217, DOI 10.1136/bmj.284.6310.217; STEELE DR, 2000, HLTH B; Sweeney J, 2000, INT J QUAL HEALTH C, V12, P203, DOI 10.1093/intqhc/12.3.203; *TASKF QUAL AUSTR, 1996, FIN REP TASKF QUAL A; Van Weert C, 2000, INT J QUAL HEALTH C, V12, P239, DOI 10.1093/intqhc/12.3.239; Whittaker S, 1998, INT J QUAL HEALTH C, V10, P263, DOI 10.1093/intqhc/10.3.263	24	58	58	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					851	854		10.1136/bmj.322.7290.851	http://dx.doi.org/10.1136/bmj.322.7290.851			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290644	Green Published			2022-12-28	WOS:000168063000030
J	Wiltshire, MCK				Wiltshire, MCK			Optical materials - Bending light the wrong way	SCIENCE			English	Editorial Material							LOW-FREQUENCY PLASMONS		Marconi Caswell Ltd, Towcester, Northants, England		Wiltshire, MCK (corresponding author), Marconi Caswell Ltd, Towcester, Northants, England.							Landau L. D., 1960, ELECTRODYNAMICS CONT; Pendry JB, 1998, J PHYS-CONDENS MAT, V10, P4785, DOI 10.1088/0953-8984/10/22/007; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shelby RA, 2001, APPL PHYS LETT, V78, P489, DOI 10.1063/1.1343489; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849	10	18	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					60	61		10.1126/science.1060221	http://dx.doi.org/10.1126/science.1060221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294217				2022-12-28	WOS:000167995200032
J	Hellebrand, E; Snow, JE; Dick, HJB; Hofmann, AW				Hellebrand, E; Snow, JE; Dick, HJB; Hofmann, AW			Coupled major and trace elements as indicators of the extent of melting in mid-ocean-ridge peridotites	NATURE			English	Article							ISLANDS OPHIOLITE; ION-MICROPROBE; FRACTURE-ZONE; UPPER-MANTLE; ATLANTIC; BASALT; CLINOPYROXENES; SYSTEM; SOUTH; BAY	Rocks in the Earth's uppermost sub-oceanic mantle, known as abyssal peridotites, have lost variable but generally large amounts of basaltic melt, which subsequently forms the oceanic crust(1,2). This process preferentially removes from the peridotite some major constituents such as aluminium, as well as trace elements that are incompatible in mantle minerals (that is, prefer to enter the basaltic melt), such as the rare-earth elements(3,4). A quantitative understanding of this important differentiation process has been hampered by the lack of correlation generally observed between major- and trace-element depletions in such peridotites. Here we show that the heavy rare-earth elements in abyssal clinopyroxenes that are moderately incompatible are highly correlated with the Cr/(Cr + Al) ratios of coexisting spinels. This correlation deteriorates only for the most highly incompatible elements-probably owing to late metasomatic processes. Using electron- and ion-microprobe data from residual abyssal peridotites collected on the central Indian ridge, along with previously published data, we develop a quantitative melting indicator for mantle residues. This procedure should prove useful for relating partial melting in peridotites to geodynamic variables such as spreading rate and mantle temperature.	Max Planck Inst Chem, D-55020 Mainz, Germany; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Max Planck Society; Woods Hole Oceanographic Institution	Hellebrand, E (corresponding author), Max Planck Inst Chem, Postfach 3060, D-55020 Mainz, Germany.		Snow, Jonathan/E-5591-2011; Hellebrand, Eric/L-2898-2013; Facility, NENIMF/B-8811-2015	Hellebrand, Eric/0000-0003-1909-6279				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BAKER MB, 1994, GEOCHIM COSMOCHIM AC, V58, P2811, DOI 10.1016/0016-7037(94)90116-3; Batanova VG, 1998, GEOCHIM COSMOCHIM AC, V62, P853, DOI 10.1016/S0016-7037(97)00384-0; BENDER JF, 1984, J PETROL, V25, P231; BODINIER JL, 1990, J PETROL, V31, P597, DOI 10.1093/petrology/31.3.597; BONATTI E, 1968, NATURE, V219, P363, DOI 10.1038/219363a0; Dick H.B.J, 1989, GEOL SOC LOND SPEC P, V42, P71, DOI DOI 10.1144/GSL.SP.1989.042.01.06; DICK HJB, 1984, EARTH PLANET SC LETT, V69, P88, DOI 10.1016/0012-821X(84)90076-1; Ghose I, 1996, GEOLOGY, V24, P1139, DOI 10.1130/0091-7613(1996)024<1139:TFEOMM>2.3.CO;2; HART SR, 1993, CONTRIB MINERAL PETR, V113, P1, DOI 10.1007/BF00320827; HELLEBRAND E, IN PRESS CHEM GEOL; HELLEBRAND E, UNPUB J PETROL; Hess H.H., 1962, PETROLOGIC STUDIES V, P500, DOI [DOI 10.1130/PETROLOGIC.1962.599, 10.1130/PETROLOGIC.1962.599]; Jochum KP, 2000, GEOSTANDARD NEWSLETT, V24, P87, DOI 10.1111/j.1751-908X.2000.tb00590.x; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; JOHNSON KTM, 1992, J GEOPHYS RES-SOL EA, V97, P9219, DOI 10.1029/92JB00701; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; MICHAEL PJ, 1985, EARTH PLANET SC LETT, V73, P91, DOI 10.1016/0012-821X(85)90037-8; Natland J.H, 1996, P OCEAN DRILL PROGRA, V147, P103, DOI DOI 10.2973/ODP.PROC.SR.147.007.1996; NATLAND JH, 1980, INIT REPTS DSDP, V54, P705; Niu YL, 1997, NATURE, V385, P326, DOI 10.1038/385326a0; Pearce JA, 2000, CONTRIB MINERAL PETR, V139, P36, DOI 10.1007/s004100050572; Ross K., 1997, P OC DRILL PROGR SCI, V153, P277; Seyler M, 1997, EARTH PLANET SC LETT, V146, P273, DOI 10.1016/S0012-821X(96)00220-8; SHIMIZU N, 1978, GEOCHIM COSMOCHIM AC, V42, P1321, DOI 10.1016/0016-7037(78)90037-6; SOBOLEV AV, 1992, DOKL AKAD NAUK+, V326, P354; Suhr G, 1999, J PETROL, V40, P575, DOI 10.1093/petrology/40.4.575; Suhr G, 1998, CONTRIB MINERAL PETR, V131, P136, DOI 10.1007/s004100050384	29	477	515	4	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					677	681		10.1038/35070546	http://dx.doi.org/10.1038/35070546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287951				2022-12-28	WOS:000167875400043
J	Robinson, KA; Baughman, W; Rothrock, G; Barrett, NL; Pass, M; Lexau, C; Damaske, B; Stefonek, K; Barnes, B; Patterson, J; Zell, ER; Schuchat, A; Whitney, CG				Robinson, KA; Baughman, W; Rothrock, G; Barrett, NL; Pass, M; Lexau, C; Damaske, B; Stefonek, K; Barnes, B; Patterson, J; Zell, ER; Schuchat, A; Whitney, CG		ABCs Emerging Infect Program Netw	Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 - Opportunities for prevention in the conjugate vaccine era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED SURVEILLANCE; PNEUMOCOCCAL DISEASE; RISK-FACTORS; EFFICACY; CHILDREN; BACTEREMIA; COUNTY; SOUTH	Context Pneumococcal polysaccharide Vaccine is recommended for elderly persons and adults with certain chronic illnesses. Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine has been recommended for use in young children and could dramatically change the epidemiology of pneumococcal disease. Objectives To assess pneumococcal disease burden in the United States, estimate the potential impact of new vaccines, and identify gaps in vaccine recommendations, Design and Setting Analysis of data from the Active Bacterial Core Surveillance (ABCs)/Emerging infections Program Network, an active, population-based system in 9 states. Patients A total of 15860 cases of invasive pneumococcal disease occurring between January 1, 1995, and December 31, 1998, Main Outcome Measures Age- and race-specific pneumoccocal disease incidence rates per 100000 persons, case-fatality rates, and vaccine preventability. Results In 1998, overall incidence was 23.2 cases per 100000, corresponding to an estimated 62840 cases in the United States. Incidence was highest among children younger than 2 years (166.9) and adults aged 65 years or older (59.7). Incidence among blacks was 2.6 times higher than among whites (95% confidence interval [CI], 2,4-2.8). Overall, 28.6% of case-patients were at least 65 years old and 85.9% of cases in this age group were due to serotypes included in the 23-valent polysaccharide vaccine; 19.3% of case-patients were younger than 2 years and 82.2% of cases in this age group were due to serotypes included in the 7-valent conjugate vaccine. Among patients aged 2 to 64 years, 50.6% had a vaccine indication as defined by the Advisory Committee on Immunization Practices (ACIP), The case-fatality rate among patients aged 18 to 64 years with an ACIP indication was 12.1% compared with 5.4% for those without an indication (relative risk, 2.2; 95% CI, 1.7-2.9). Conclusions Young children, elderly persons, and black persons of ail ages are disproportionately affected by invasive pneumococcal disease. Current ACIP recommendations do not address a subset of persons aged 18 to 64 years but do include those at highest risk for death from invasive pneumococcal disease.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Georgia Dept Human Resources, Emerging Infect Program, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Calif Dept Hlth Serv, Emerging Infect Program, Berkeley, CA 94704 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Connecticut Dept Publ Hlth, Emerging Infect Program, Hartford, CT USA; Maryland Dept Hlth & Mental Hyg, Emerging Infect Program, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Emerging Infect Program, Minneapolis, MN USA; New York State Dept Hlth, Emerging Infect Program, Albany, NY USA; Oregon Dept Human Resources, Hlth Div, Emerging Infect Program, Portland, OR USA; Tennessee Dept Hlth, Emerging Infect Program, Knoxville, TN USA; Vanderbilt Univ, Med Ctr, Knoxville, TN USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; California Department of Health Care Services; University of California System; University of California Berkeley; Maryland Department of Health & Mental Hygiene; Johns Hopkins University; Minnesota Department of Health (MHD); State University of New York (SUNY) System; Tennessee Department Health; Vanderbilt University; University of Texas System; University of Texas Health San Antonio	Robinson, KA (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, MS D-65,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	kad2@cdc.gov		Patterson, Jan/0000-0002-6459-9783				Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; Butler JC, 1997, MICROB DRUG RESIST, V3, P125, DOI 10.1089/mdr.1997.3.125; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P993; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P961; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; CORTESE MM, 1997, PEDIATR INFECT DIS J, V16, P555; DAVIDSON M, 1999, 39 INT C ANT AG CHEM; ESKOLA J, 1992, JAMA-J AM MED ASSOC, V268, P3323, DOI 10.1001/jama.268.23.3323; GESSNER BD, 1995, PEDIATR INFECT DIS J, V14, P123, DOI 10.1097/00006454-199502000-00008; Harrison LH, 2000, ARCH INTERN MED, V160, P89, DOI 10.1001/archinte.160.1.89; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; OBRIEN KL, 1999, 39 INT C ANT AG CHEM; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Smith MD, 1998, EPIDEMIOL INFECT, V120, P117, DOI 10.1017/S0950268897008522; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752	31	500	541	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1729	1735		10.1001/jama.285.13.1729	http://dx.doi.org/10.1001/jama.285.13.1729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277827	Bronze			2022-12-28	WOS:000167710600026
J	Fujiwara, A; Takahashi, Y				Fujiwara, A; Takahashi, Y			Manipulation of elementary charge in a silicon charge-coupled device	NATURE			English	Article							SINGLE-ELECTRON TRANSISTOR; SMALL TUNNEL-JUNCTIONS; ROOM-TEMPERATURE; COULOMB-BLOCKADE; OSCILLATIONS; MEMORY; PUMP	The ultimate limit in the operation of an electronic device is the manipulation of a single charge, Such a limit has been achieved in single-electron tunnelling devices(1,2). However, these devices are based on multiple tunnel barriers and conductive islands, which are complex structures to fabricate. Here we demonstrate another type of device that can also manipulate elementary charge, but which is more suitable for large-scale integration, The device consists of two closely packed silicon wire-MOSFETs, which are commonly used building blocks of electronic circuits. We have developed a scheme to generate and store holes in the channels of either of these MOSFETs, Subsequently, holes can be transferred between the two MOSFETs at the level of an elementary charge, and their exact position can be monitored. This single-charge transfer device, which is operated at 25 K, is in effect a charge-coupled device(3), This is also the first realization of a silicon-based device that manipulates elementary charge.	NTT, Basic Res Labs, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation	Fujiwara, A (corresponding author), NTT, Basic Res Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.		Fujiwara, Akira/A-6648-2012; Takahashi, Yasuo/H-4799-2011	Takahashi, Yasuo/0000-0003-2745-2181				ALI D, 1994, APPL PHYS LETT, V64, P2119, DOI 10.1063/1.111702; Asahi N, 1997, IEEE T ELECTRON DEV, V44, P1109, DOI 10.1109/16.595938; Averin D., 1991, MESOSCOPIC PHENOMENA, P173, DOI DOI 10.1016/B978-0-444-88454-1.50012-7; AVERIN DV, 1986, J LOW TEMP PHYS, V62, P345, DOI 10.1007/BF00683469; BARBE DF, 1980, CHARGE COUPLED DEVIC; COLINGE JP, 1997, SILICON ON INSULATOR; Cristoloveanu S., 1995, ELECT CHARACTERIZATI, V2nd; DRESSELHAUS PD, 1994, PHYS REV LETT, V72, P3226, DOI 10.1103/PhysRevLett.72.3226; FUJIWARA A, 1995, APPL PHYS LETT, V67, P2957, DOI 10.1063/1.114824; Fujiwara A, 1997, PHYS REV LETT, V78, P1532, DOI 10.1103/PhysRevLett.78.1532; Fujiwara A, 1999, IEEE T ELECTRON DEV, V46, P954, DOI 10.1109/16.760403; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; GEERLIGS LJ, 1990, PHYS REV LETT, V64, P2691, DOI 10.1103/PhysRevLett.64.2691; GRABERT H, 1992, SINGLE CHARGE TUNNEL; Guo LJ, 1997, SCIENCE, V275, P649, DOI 10.1126/science.275.5300.649; Keller MW, 1996, APPL PHYS LETT, V69, P1804, DOI 10.1063/1.117492; KUZMIN LS, 1987, JETP LETT+, V45, P495; Lent C. S., 1993, Nanotechnology, V4, P49, DOI 10.1088/0957-4484/4/1/004; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; LIKHAREV KK, 1987, IEEE T MAGN, V23, P1142, DOI 10.1109/TMAG.1987.1065001; Meriav U., 1995, SEMICOND SCI TECH, V10, P255; MERIAV U, 1990, PHYS REV LETT, V65, P771; POTHIER H, 1991, PHYSICA B, V169, P573, DOI 10.1016/0921-4526(91)90332-9; SCOTTTHOMAS JHF, 1989, PHYS REV LETT, V62, P583, DOI 10.1103/PhysRevLett.62.583; Single C, 1999, SEMICOND SCI TECH, V14, P1165, DOI 10.1088/0268-1242/14/12/327; SU B, 1992, SCIENCE, V255, P313, DOI 10.1126/science.255.5042.313; Takahashi Y, 1999, INT J ELECTRON, V86, P605, DOI 10.1080/002072199133283; TAKAHASHI Y, 1995, ELECTRON LETT, V31, P136, DOI 10.1049/el:19950082; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; YANO K, 1994, IEEE T ELECTRON DEV, V41, P1628, DOI 10.1109/16.310117	30	61	64	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					560	562		10.1038/35069023	http://dx.doi.org/10.1038/35069023			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279488				2022-12-28	WOS:000167859300040
J	Wass, V; Van der Vleuten, C; Shatzer, J; Jones, R				Wass, V; Van der Vleuten, C; Shatzer, J; Jones, R			Assessment of clinical competence	LANCET			English	Article							GENERAL-PRACTITIONERS; ORAL EXAMINATIONS; RELIABILITY; VALIDITY; PERFORMANCE; CHECKLISTS; OSCE	Tests of clinical competence, which allow decisions to be made about medical qualification and fitness to practise, must be designed with respect to key issues including blueprinting, validity, reliability, and standard setting, as well as clarity about their formative or summative function. Multiple choice questions, essays, and oral examinations could be used to test factual recall and applied knowledge, but more sophisticated methods are needed to assess clinical performance, including directly observed long and short cases, objective structured clinical examinations, and the use of standardised patients, The goal of assessment in medical education remains the development of reliable measurements of student performance which, as well as having predictive value for subsequent clinical competence, also have a formative, educational role.	Weston Educ Ctr, Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE5 9RJ, England; Unv Maastricht, Dept Educ Dev & Res, Maastricht, Netherlands; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of London; King's College London; Maastricht University; Johns Hopkins University	Wass, V (corresponding author), Weston Educ Ctr, Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE5 9RJ, England.	valerie.wass@kcl.ac.uk						CASE SM, 1996, CONSTRUCTING WRITTEN; Case SM, 1993, TEACH LEARN MED, V5, P107; Colliver JA, 1998, TEACH LEARN MED, V10, P8, DOI 10.1207/S15328015TLM1001_2; COLLIVER JA, 1989, TEACH LEARN MED, V1, P31; Cusimano MD, 1996, ACAD MED, V71, pS112, DOI 10.1097/00001888-199610000-00062; Dauphinee D., 1994, CERTIFICATION RECERT, P92; Frijns PHAM, 1990, TEACHING ASSESSING C, P466; *GEN MED COUNC ED, 1993, TOM DOCTREC UND MED; Gleeson F, 1994, P 6 OTT C MED ED TOR, P412; HARDEN RM, 1979, MED EDUC, V13, P41; HAYS RB, 1995, MED EDUC, V29, P317, DOI 10.1111/j.1365-2923.1995.tb02855.x; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; NEUFELD VR, 1985, ASSESSING CLIN COMPE, V7; NEWBLE DI, 1991, MED EDUC, V25, P369, DOI 10.1111/j.1365-2923.1991.tb00083.x; NEWBLE DI, 1988, MED EDUC, V22, P325, DOI 10.1111/j.1365-2923.1988.tb00761.x; NORCINI JJ, 1985, MED EDUC, V19, P238, DOI 10.1111/j.1365-2923.1985.tb01314.x; PAGE G, 1995, ACAD MED, V70, P194, DOI 10.1097/00001888-199503000-00009; PRICE J, 1994, MED EDUC, V28, P120, DOI 10.1111/j.1365-2923.1994.tb02530.x; Ram P, 1999, MED EDUC, V33, P447; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Reznick RK, 1998, ACAD MED, V73, pS97, DOI 10.1097/00001888-199810000-00058; Roberts C, 2000, BRIT MED J, V320, P370, DOI 10.1136/bmj.320.7231.370; Schuwirth LWT, 1996, MED TEACH, V18, P294, DOI 10.3109/01421599609034180; SHATZER JH, 1994, TEACH LEARN MED, V6, P54; STALENHOEFHALLI.BF, 1990, TEACHING ASSESSING C, P1020; SWANSON DB, 1987, FURTHER DEV ASSESSIN, P13; Swanson DB., 1995, EDUC RES-UK, V24, P5, DOI [DOI 10.3102/0013189X024005005, 10.3102/0013189X024005005]; Swartz MH, 1999, ACAD MED, V74, P1028, DOI 10.1097/00001888-199909000-00018; van der Vleuten C, 2000, BRIT MED J, V321, P1217, DOI 10.1136/bmj.321.7270.1217; van der Vleuten C.P., 1990, TEACH LEARN MED, V2, P58, DOI [https://doi.org/10.1080/10401339009539432, DOI 10.1080/10401339009539432]; Van der Vleuten CPM, 1996, ADV HEALTH SCI EDUC, V1, P41, DOI 10.1007/BF00596229; WAKEFORD R, 1995, BRIT MED J, V311, P931; WASS V, IN PRESS MED ED; Williams RG, 1999, ACAD MED, V74, P1118, DOI 10.1097/00001888-199910000-00015	34	599	624	3	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2001	357	9260					945	949		10.1016/S0140-6736(00)04221-5	http://dx.doi.org/10.1016/S0140-6736(00)04221-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289364				2022-12-28	WOS:000167625300033
J	Colvin, JS; Green, RP; Schmahl, J; Capel, B; Ornitz, DM				Colvin, JS; Green, RP; Schmahl, J; Capel, B; Ornitz, DM			Male-to-female sex reversal in mice lacking fibroblast growth factor 9	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; ANTI-MULLERIAN HORMONE; TARGETED DISRUPTION; SERTOLI-CELLS; TESTIS DIFFERENTIATION; PERITUBULAR CELLS; MOUSE TESTIS; GENE; EXPRESSION; SRY	Fgfs direct embryogenesis of several organs, including the lung, limb, and anterior pituitary. Here we report male-to-female sex reversal in mice lacking Fibroblast growth factor 9 (Fgf9), demonstrating a novel role for FGF signaling in testicular embryogenesis. Fgf9(/-) mice also exhibit lung hypoplasia and die at birth. Reproductive system phenotypes range from testicular hypoplasia to complete sex reversal, with most Fgf9(-/-) reproductive systems appearing grossly female at birth. Fgf9 appears to act downstream of Sly to stimulate mesenchymal proliferation, mesonephric cell migration, and Sertoli cell differentiation in the embryonic testis. While Sry is found only in some mammals, Fgfs are highly conserved. Thus, Fgfs may function in sex determination and reproductive system development in many species.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Washington University (WUSTL); Duke University	Ornitz, DM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Campus Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	domitz@pcg.wustl.edu		Ornitz, David/0000-0003-1592-7629	NCI NIH HHS [CA60673] Funding Source: Medline; NICHD NIH HHS [HD33688, HD35692] Funding Source: Medline; NIGMS NIH HHS [GM56757, 5-T32-GM07200-25] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035692, P30HD033688] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056757, T32GM007200] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; AGELOPOULOU R, 1984, J EMBRYOL EXP MORPH, V83, P15; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BUEHR M, 1993, DEVELOPMENT, V117, P273; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Colvin JS, 1999, DEV DYNAM, V216, P72; COLVIN JS, 2001, IN PRESS DEVELOPMENT; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; Johnston CM, 1995, PHILOS T R SOC B, V350, P297, DOI 10.1098/rstb.1995.0165; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; MAGRE S, 1991, J ELECTRON MICR TECH, V19, P172, DOI 10.1002/jemt.1060190205; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Mishina Y, 1996, GENE DEV, V10, P2577, DOI 10.1101/gad.10.20.2577; MITTWOCH U, 1992, HUM GENET, V89, P467, DOI 10.1007/BF00219168; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; MULLER J, 1991, HORM RES, V36, P203, DOI 10.1159/000182162; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; Ornitz DM, 2001, GENOME BIOL, V2; Orth JM., 1993, CELL MOL BIOL TESTIS, P3; PALMER SJ, 1991, DEVELOPMENT, V113, P709; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Rey R, 1996, AM J PATHOL, V148, P1689; ROBERTS MM, 1993, NEUROENDOCRINOLOGY, V57, P388, DOI 10.1159/000126384; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Scherer G, 1999, CELL MOL LIFE SCI, V55, P821, DOI 10.1007/s000180050335; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sinclair AH, 1998, J EXP ZOOL, V281, P501, DOI 10.1002/(SICI)1097-010X(19980801)281:5<501::AID-JEZ15>3.0.CO;2-B; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Song JW, 1996, DEV DYNAM, V206, P427, DOI 10.1002/(SICI)1097-0177(199608)206:4<427::AID-AJA8>3.0.CO;2-K; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tilmann C, 1999, DEVELOPMENT, V126, P2883; TUNG PS, 1987, DEV BIOL, V120, P139, DOI 10.1016/0012-1606(87)90112-6; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 1999, MECH DEVELOP, V83, P165, DOI 10.1016/S0925-4773(99)00034-9; Xu XL, 1998, DEVELOPMENT, V125, P753; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	69	435	451	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					875	889		10.1016/S0092-8674(01)00284-7	http://dx.doi.org/10.1016/S0092-8674(01)00284-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290325	Bronze			2022-12-28	WOS:000167869200010
J	Pollock, A				Pollock, A			Scotland the brave: collective responsibility for personal care for the elderly and for the young disabled	LANCET			English	Editorial Material							WORLD-TRADE ORGANIZATION; HEALTH-CARE; PRIVATISATION; SYSTEMS; NHS		UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England	University of London; University College London	Pollock, A (corresponding author), UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England.	allyson.pollock@ucl.ac.uk		pollock, allyson/0000-0002-7388-3110				Buse K, 1998, LANCET, V351, P665, DOI 10.1016/S0140-6736(97)11453-2; *DEP HLTH, 2001, FAIR CHARG POL HOM C; *DEP HLTH, 1999, BED AV OCC; Gaffney D, 1999, BRIT MED J, V319, P249, DOI 10.1136/bmj.319.7204.249; *NHS, 2000, NHS PLAN PLAN INV PL; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1; Pollock AM, 2000, BMJ-BRIT MED J, V321, P393, DOI 10.1136/bmj.321.7258.393; Price D, 1999, LANCET, V354, P1889, DOI 10.1016/S0140-6736(99)11060-2; Qadeer I, 2000, J PUBLIC HEALTH MED, V22, P25, DOI 10.1093/pubmed/22.1.25; Royal Commission on Long Term Care, 1999, RESP OLD AG LONG TER; 2001, SCOTTISH PARLIAMENT, V10	11	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					412	412		10.1016/S0140-6736(00)04026-5	http://dx.doi.org/10.1016/S0140-6736(00)04026-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273058				2022-12-28	WOS:000166865600007
J	Ivan, M; Kondo, K; Yang, HF; Kim, W; Valiando, J; Ohh, M; Salic, A; Asara, JM; Lane, WS; Kaelin, WG				Ivan, M; Kondo, K; Yang, HF; Kim, W; Valiando, J; Ohh, M; Salic, A; Asara, JM; Lane, WS; Kaelin, WG			HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O-2 sensing	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROLYL 4-HYDROXYLASE; HYPOXIA; COMPLEX; UBIQUITINATION; UBIQUITYLATION; ACCUMULATION; INHIBITION; ACTIVATION; SUBUNIT	HIF (hypoxia-inducible factor) is a transcription factor that plays a pivotal role in cellular adaptation to changes in oxygen availability. In the presence of oxygen, HIF is targeted for destruction by an E3 ubiquitin ligase containing the von Hippel-lindau tumor suppressor protein (pVHL). We found that human pVHL binds to a short HIF-derived peptide when a conserved proline residue at the core of this peptide is hydroxylated. Because proline hydroxylation requires molecular oxygen and Fe2+, this protein modification may play a key role in mammalian oxygen sensing.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Ivan, Mircea/A-8109-2012; Salic, Adrian/GXG-1611-2022	Ivan, Mircea/0000-0003-3424-6642				Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Franklin TJ, 2001, BIOCHEM J, V353, P333, DOI 10.1042/bj3530333; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; IVAN M, UNPUB; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; LEVENE CI, 1976, BIOCHIM BIOPHYS ACTA, V444, P446, DOI 10.1016/0304-4165(76)90388-3; LUDLOW JW, 1989, J VIROL, V63, P2881, DOI 10.1128/JVI.63.6.2881-2884.1989; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Wenger RH, 2000, J EXP BIOL, V203, P1253; Zhu H, 1999, RESP PHYSIOL, V115, P239, DOI 10.1016/S0034-5687(99)00024-9	26	3663	3829	11	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					464	468		10.1126/science.1059817	http://dx.doi.org/10.1126/science.1059817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11292862				2022-12-28	WOS:000168187300035
J	Mukamal, KJ; Maclure, M; Muller, JE; Sherwood, JB; Mittleman, MA				Mukamal, KJ; Maclure, M; Muller, JE; Sherwood, JB; Mittleman, MA			Prior alcohol consumption and mortality following acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	23rd Annual Meeting of the Society-for-General-Internal Medicine	MAY 05-06, 2000	BOSTON, MASSACHUSETTS	Soc Gen Internal Med			CORONARY HEART-DISEASE; MIDDLE-AGED MEN; CARDIOVASCULAR MORTALITY; HYPERTENSIVE PATIENTS; FIBRINOLYTIC FACTORS; PHYSICAL EXERTION; CONTROLLED TRIAL; BLOOD-PRESSURE; RISK; ETHANOL	Context Studies have found that individuals who consume 1 alcoholic drink every 1 to 2 days have a lower risk of a first acute myocardial infarction (AMI) than abstainers or heavy drinkers, but the effect of prior drinking on mortality after AMI is uncertain. Objective To determine the effect of prior alcohol consumption on long-term mortality among early survivors of AMI. Design and Setting Prospective inception cohort study conducted at 45 US communi ly and tertiary care hospitals between August 1989 and September 1994, with a median follow-up of 3.8 years. Patients A total of 1913 adults hospitalized with AMI between 1989 and 1994. Main Outcome Measure All-cause mortality, compared by self-reported average weekly consumption of beer, wine, and liquor during the year prior to AMI. Results Of the 1913 patients, 896 (47%) abstained from alcohol, 696 (36%) consumed less than 7 alcoholic drinks/wk, and 321 (17%) consumed 7 or more alcoholic drinks/wk. Compared with abstainers, patients who consumed less than 7 drinks/wk had a lower all-cause mortality rate (3.4 vs 6.3 deaths per 100 person-years; hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.43-0.71) as did those who consumed 7 or more drinks/wk (2.4 vs 6.3 deaths per 100 person-years; HR, 0.38; 95% CI, 0.25-0.55; P<.001 for trend). After adjusting for propensity to drink and other potential confounders, increasing alcohol consumption remained predictive of lower mortality for less than 7 drinks/wk, with an adjusted HR of 0.79 (95% CI, 0.60-1.03), and for 7 or more drinks/wk, with an adjusted HR of 0.68 (95% CI, 0.45 1.05; P=.01 for trend). The association was similar for total and cardiovascular mortality, among both men and women, and among different types of alcoholic beverages. Conclusion Self-reported moderate alcohol consumption in the year prior to AMI is associated with reduced mortality following infarction.	Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Epidemiol,Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Epidemiol,Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Hlth & Social Behav,Div Gen Med & Primary Ca, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Hlth & Social Behav,Div Cardiol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Mukamal, KJ (corresponding author), Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Epidemiol,Div Gen Med & Primary Care, Boston, MA 02215 USA.		Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274	NHLBI NIH HHS [R01HL41016] Funding Source: Medline; NIAAA NIH HHS [K23AA00299] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA000299] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABE H, 1994, CIRCULATION, V89, P2626, DOI 10.1161/01.CIR.89.6.2626; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; BERNAUER W, 1986, EUR J PHARMACOL, V126, P179, DOI 10.1016/0014-2999(86)90047-6; *BUR CENS, 1992, CENS POP HOUS 1990; CHICK J, 1981, DRUG ALCOHOL DEPEN, V7, P265, DOI 10.1016/0376-8716(81)90098-3; Cleophas TJM, 1996, ANGIOLOGY, V47, P789, DOI 10.1177/000331979604700806; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; COX KL, 1993, J HYPERTENS, V11, P191, DOI 10.1097/00004872-199302000-00012; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; GREENBERG BH, 1982, ANN INTERN MED, V97, P171, DOI 10.7326/0003-4819-97-2-171; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; HAYES SN, 1988, CIRCULATION, V78, P165, DOI 10.1161/01.CIR.78.1.165; HENDRIKS HFJ, 1994, BRIT MED J, V308, P1003, DOI 10.1136/bmj.308.6935.1003; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; KELLER JW, 1988, CARDIOVASC RES, V22, P73, DOI 10.1093/cvr/22.1.73; KLATSKY AL, 1990, AM J CARDIOL, V66, P1237, DOI 10.1016/0002-9149(90)91107-H; LINN S, 1993, AM J PUBLIC HEALTH, V83, P811, DOI 10.2105/AJPH.83.6.811; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mukamal KJ, 1999, AM HEART J, V138, P926, DOI 10.1016/S0002-8703(99)70019-0; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X; ORLANDO J, 1976, ANN INTERN MED, V84, P652, DOI 10.7326/0003-4819-84-6-652; PALMER AJ, 1995, J HYPERTENS, V13, P957, DOI 10.1097/00004872-199509000-00004; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; REGAN TJ, 1990, JAMA-J AM MED ASSOC, V264, P377, DOI 10.1001/jama.264.3.377; RENAUD SC, 1992, AM J CLIN NUTR, V55, P1012, DOI 10.1093/ajcn/55.5.1012; Renaud SC, 1999, ARCH INTERN MED, V159, P1865, DOI 10.1001/archinte.159.16.1865; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; SHIFFMAN S, 1995, NIH PUBLICATION; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Valmadrid CT, 1999, JAMA-J AM MED ASSOC, V282, P239, DOI 10.1001/jama.282.3.239; WANNAMETHEE G, 1995, BRIT HEART J, V74, P324; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18	40	120	120	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1965	1970		10.1001/jama.285.15.1965	http://dx.doi.org/10.1001/jama.285.15.1965			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308432	Bronze			2022-12-28	WOS:000167995900024
J	Pena, JL; Konishi, M				Pena, JL; Konishi, M			Auditory spatial receptive fields created by multiplication	SCIENCE			English	Article							PARIETAL CORTEX; DIRECTION SELECTIVITY; INFERIOR COLLICULUS; OWL; COMPUTATION; SYSTEM; SPACE; CELLS; TIME	Examples of multiplication by neurons or neural circuits are scarce, although many computational models use this basic operation. The owl's auditory system computes interaural time (ITD) and Level (ILD) differences to create a two-dimensional map of auditory space. Space-specific neurons are selective for combinations of ITD and ILD, which define, respectively, the horizontal and vertical dimensions of their receptive fields. A multiplication of separate postsynaptic potentials tuned to ITD and ILD, rather than an addition, can account for the subthreshold responses of these neurons to ITD-ILD pairs. Other nonlinear processes improve the spatial tuning of the spike output and reduce the fit to the multiplicative model.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Pena, JL (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.			Pena, Jose/0000-0001-6773-5640	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000134] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00134] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], 1990, ADV NEURAL INFORM PR; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FELDMAN DE, 1994, J NEUROSCI, V14, P5939; FUJITA I, 1991, J NEUROSCI, V11, P722; Golub G. H., 1989, MATRIX COMPUTATIONS; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; Koch C., 1998, BIOPHYSICS COMPUTATI; MOISEFF A, 1983, J NEUROSCI, V3, P2553; Pena JL, 2000, P NATL ACAD SCI USA, V97, P11787, DOI 10.1073/pnas.97.22.11787; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P944; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SULLIVAN WE, 1984, J NEUROSCI, V4, P1786; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347	20	172	172	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					249	252		10.1126/science.1059201	http://dx.doi.org/10.1126/science.1059201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303092				2022-12-28	WOS:000168074000035
J	Tilman, D; Fargione, J; Wolff, B; D'Antonio, C; Dobson, A; Howarth, R; Schindler, D; Schlesinger, WH; Simberloff, D; Swackhamer, D				Tilman, D; Fargione, J; Wolff, B; D'Antonio, C; Dobson, A; Howarth, R; Schindler, D; Schlesinger, WH; Simberloff, D; Swackhamer, D			Forecasting agriculturally driven global environmental change	SCIENCE			English	Article							NITROGEN BUDGETS; INTENSIFICATION; BIODIVERSITY; FOOD	During the next 50 years, which is likely to be the final period of rapid agricultural expansion, demand for food by a wealthier and 50% Larger global population will be a major driver of global environmental change. Should past dependences of the global environmental impacts of agriculture on human population and consumption continue, 10(9) hectares of natural ecosystems would be converted to agriculture by 2050. This would be accompanied by 2.4- to 2.7-fold increases in nitrogen- and phosphorus-driven eutrophication of terrestrial, freshwater, and near-shore marine ecosystems, and comparable increases in pesticide use. This eutrophication and habitat destruction would cause unprecedented ecosystem simplification, Loss of ecosystem services, and species extinctions. Significant scientific advances and regulatory, technological, and policy changes are needed to control the environmental impacts of agricultural expansion.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; Marine Biol Lab, Oceans Program, Woods Hole, MA 02543 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alberta, Edmonton, AB T6G 2E9, Canada; Duke Univ, Durham, NC 27708 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; Princeton University; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; University of Alberta; Duke University; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Schindler, David/A-3752-2014; Tilman, David/ABD-5309-2021	Howarth, Robert/0000-0001-9531-4288				Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; ALEXANDRATOS N., 1995, WORLD AGR 2010; *ARCT MON ASS PROG, 1998, ASS REP ARCT POLL IS; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Bouwman AF, 1997, GLOBAL BIOGEOCHEM CY, V11, P561, DOI 10.1029/97GB02266; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cohen J. E., 1995, MANY PEOPLE CAN EART; Conway G., 1997, DOUBLY GREEN REVOLUT; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; DOWNING JA, 1999, 134 COUNC AGR SCI TE; *FAO UN, 2001, FAOSTAT HOM; GREEN MJB, 1998, PROT AR S ALB W AUST; Groot JJR, 1998, NUTR CYCL AGROECOSYS, V50, P181, DOI 10.1023/A:1009788211315; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; KIDD KA, 1995, SCIENCE, V269, P240, DOI 10.1126/science.269.5221.240; Maddison A., 1995, MONITORING WORLD EC; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; *NAT RES COUNC, 2000, CLEAN COAST WAT UND; National Research Council, 1999, OUR COMM JOURN TRANS; National Research Council (USA), 2000, GLOB CHANG EC RES; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Postel S., 1999, PILLAR SAND CAN IRRI; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Ruttan VW, 1999, P NATL ACAD SCI USA, V96, P5960, DOI 10.1073/pnas.96.11.5960; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler D, 1999, AMBIO, V28, P350; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; UN Department of Economic and Social Affairs, 1999, WORLD POP PROSP 1998; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WALSH J, 1991, PRESERVING OPTIONS F; Woomer P.L., 1994, BIOL MANAG TROP SOIL; *WORLD BANK, 2000, WORLD DEV IND CD ROM; World Health Organization (WHO), 1990, PUBL HLTH IMP PEST U; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	41	2408	2580	53	1968	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					281	284		10.1126/science.1057544	http://dx.doi.org/10.1126/science.1057544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303102				2022-12-28	WOS:000168074000045
J	Wendin, G; Shumeiko, VS				Wendin, G; Shumeiko, VS			Toward tunable superconducting electronics	SCIENCE			English	Editorial Material									Chalmers Univ Technol, Dept Microelect & Nonosci, S-41296 Gothenburg, Sweden; Univ Gothenburg, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Wendin, G (corresponding author), Chalmers Univ Technol, Dept Microelect & Nonosci, S-41296 Gothenburg, Sweden.	wendin@fy.chalmers.se						ANDREEV BD, 1964, PHYS LETT, V19, P1228; Baselmans JJA, 1999, NATURE, V397, P43, DOI 10.1038/16204; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; PETRASHOV VT, 1995, PHYS REV LETT, V74, P5268, DOI 10.1103/PhysRevLett.74.5268; Scheer E, 1998, NATURE, V394, P154, DOI 10.1038/28112; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2001, SCIENCE, V292, P252, DOI 10.1126/science.1058812; TAKAYANAGI H, 1985, PHYS REV LETT, V54, P2449, DOI 10.1103/PhysRevLett.54.2449	9	5	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					231	232		10.1126/science.1060861	http://dx.doi.org/10.1126/science.1060861			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305314				2022-12-28	WOS:000168074000030
J	Butchart, N; Scaife, AA				Butchart, N; Scaife, AA			Removal of chlorofluorocarbons by increased mass exchange between the stratosphere and troposphere in a changing climate	NATURE			English	Article							GENERALIZED ELIASSEN-PALM; MIDDLE ATMOSPHERE; GREENHOUSE GASES; DOWNWARD CONTROL; UNIFIED MODEL; WAVES; CO2	Chlorofluorocarbons (CFCs), along with bromine compounds, have been unequivocally identified as being responsible for most of the anthropogenic destruction of stratospheric ozone(1). With curbs on emissions of these substances, the recovery of the ozone layer will depend on their removal from the atmosphere. As CFCs have no significant tropospheric removal process, but are rapidly photolysed above the lower stratosphere, the timescale for their removal is set mainly by the rate at which air is transported from the troposphere into the stratosphere(2). Using a global climate model we predict that, in response to the projected changes in greenhouse-gas concentrations during the first half of the twenty-first century, this rate of mass exchange will increase by 3% per decade. This increase is due to more vigorous extra-tropical planetary waves emanating from the troposphere. We estimate that this increase in mass exchange will accelerate the removal of CFCs to an extent that recovery to levels currently predicted for 2050 and 2080 will occur 5 and 10 years earlier, respectively.	Meteorol Off, Bracknell RG12 2SZ, Berks, England	Met Office - UK	Butchart, N (corresponding author), Meteorol Off, London Rd, Bracknell RG12 2SZ, Berks, England.							Andrews D.G., 1987, MIDDLE ATMOSPHERE DY; ANDREWS DG, 1978, J ATMOS SCI, V35, P175; ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Austin J, 2000, Q J ROY METEOR SOC, V126, P1533, DOI 10.1256/smsqj.56515; AUSTIN J, IN PRESS Q J R METEO, P2015; Brasseur G., 1984, AERONOMY MIDDLE ATMO; Butchart N, 2000, J CLIMATE, V13, P2142, DOI 10.1175/1520-0442(2000)013<2142:TROTSC>2.0.CO;2; Butchart N, 1998, J ATMOS SCI, V55, P2782, DOI 10.1175/1520-0469(1998)055<2782:MACFTT>2.0.CO;2; CULLEN MJP, 1993, METEOROL MAG, V122, P81; DUNKERTON T, 1981, J ATMOS SCI, V38, P819, DOI 10.1175/1520-0469(1981)038<0819:SEALDF>2.0.CO;2; Gregory D, 1998, Q J ROY METEOR SOC, V124, P463, DOI 10.1002/qj.49712454606; HAYNES PH, 1991, J ATMOS SCI, V48, P651, DOI 10.1175/1520-0469(1991)048<0651:OTCOED>2.0.CO;2; HOFMANN DJ, 1998, SCI ASSESSMENT OZONE, pCH12; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; HOUGHTON JT, 1996, CLIMATE CHANGE 1995, pCH6; KO MKW, 1994, REFERENCE PUBLICATIO, V1339, pCH5; MADRONICH S, 1999, SCI ASSESSMENT OZONE, pCH11; MAHFOUF JF, 1994, CLIM DYNAM, V9, P345, DOI 10.1007/s003820050028; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; MOTE PW, 1998, J GEOPHYS RES, V103, P8561; Pawson S, 2000, B AM METEOROL SOC, V81, P781, DOI 10.1175/1520-0477(2000)081<0781:TGIPFS>2.3.CO;2; PRINN RG, 1999, SCI ASSESSMENT OZONE, pCH1; Rind D, 1998, J CLIMATE, V11, P876, DOI 10.1175/1520-0442(1998)011<0876:CCATMA>2.0.CO;2; ROSENLOF KH, 1993, J GEOPHYS RES-ATMOS, V98, P10465, DOI 10.1029/93JD00392; ROSENLOF KH, 1995, J GEOPHYS RES-ATMOS, V100, P5173, DOI 10.1029/94JD03122; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; *UK STRAT OZ REV G, 1999, 7 UK STRAT OZ REV GR; Waibel AE, 1999, SCIENCE, V283, P2064, DOI 10.1126/science.283.5410.2064; YULAEVA E, 1994, J ATMOS SCI, V51, P169, DOI 10.1175/1520-0469(1994)051<0169:OTCOTA>2.0.CO;2	30	219	221	2	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					799	802		10.1038/35071047	http://dx.doi.org/10.1038/35071047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298444				2022-12-28	WOS:000168021900050
J	Hofstra, L; Dumont, EA; Thimister, PWL; Heidendal, GAK; DeBruine, AP; Elenbaas, TWO; Boersma, HH; van Heerde, WL; Reutelingsperger, CPM				Hofstra, L; Dumont, EA; Thimister, PWL; Heidendal, GAK; DeBruine, AP; Elenbaas, TWO; Boersma, HH; van Heerde, WL; Reutelingsperger, CPM			In vivo detection of apoptosis in an intracardiac tumor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CELL		Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Nucl Med, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Pathol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Cardiac Surg, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; Univ Maastricht, Dept Biochem, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Hofstra, L (corresponding author), Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands.		van Heerde, Waander/L-4357-2015; Boersma, Hendrikus/AAF-8139-2020	van Heerde, Waander/0000-0001-7101-8775; Boersma, Hendrikus/0000-0003-1892-9830				BELHOCINE TZ, 2000, 47 ANN M SOC NUCL ME; Gisbertz IAM, 1998, CANCER, V83, P158, DOI 10.1002/(SICI)1097-0142(19980701)83:1<158::AID-CNCR21>3.0.CO;2-V; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; MARTIN SJ, 1995, J EXP MED, V182, P552; Naresh KN, 2001, CANCER, V91, P578, DOI 10.1002/1097-0142(20010201)91:3<578::AID-CNCR1037>3.3.CO;2-N	5	52	56	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1841	1842		10.1001/jama.285.14.1841	http://dx.doi.org/10.1001/jama.285.14.1841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308396				2022-12-28	WOS:000167876700023
J	Bennett, CC; Johnson, A; Field, DJ; Elbourne, D				Bennett, CC; Johnson, A; Field, DJ; Elbourne, D		UK Collaborative ECMO Trial Grp	UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years	LANCET			English	Article								Extracorporeal membrane oxygenation (ECMO) is a supportive Intensive-care technique used for babies with acute respiratory failure, We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.	Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ Oxford, Oxford, England; Univ Leicester, Leicester, Leics, England; London Sch Hyg & Trop Med, London WC1, England	University of Oxford; University of Oxford; University of Leicester; University of London; London School of Hygiene & Tropical Medicine	Bennett, CC (corresponding author), Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.			Johnson, Anne/0000-0003-1330-7100				Field D, 1996, LANCET, V348, P75; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; *NFER NIELS PUBL C, 1996, BRIT AB SCAL; Roberts TE, 1998, BMJ-BRIT MED J, V317, P911; UK Collaborative ECMO Group, 1998, PEDIATRICS, V101, P690	5	129	130	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1094	1096		10.1016/S0140-6736(00)04310-5	http://dx.doi.org/10.1016/S0140-6736(00)04310-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297963				2022-12-28	WOS:000167996200014
J	Brewster, DH; Thomson, CS; Hole, DJ; Black, RJ; Stroner, PL; Gillis, CR				Brewster, DH; Thomson, CS; Hole, DJ; Black, RJ; Stroner, PL; Gillis, CR		Scottish Canc Therapy Network	Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies	BRITISH MEDICAL JOURNAL			English	Article							DEPRIVATION; WOMEN		Scottish Canc Intelligence Unit, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Univ Glasgow, Dept Publ Hlth, W Scotland Canc Surveillance Unit, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow	Brewster, DH (corresponding author), Scottish Canc Intelligence Unit, Informat & Stat Div, Trin Pk House, Edinburgh EH5 3SQ, Midlothian, Scotland.			Brewster, David/0000-0002-5346-5608				CARNON AG, 1994, BRIT MED J, V309, P1054, DOI 10.1136/bmj.309.6961.1054; Ionescu MV, 1998, LANCET, V352, P1439, DOI 10.1016/S0140-6736(98)00052-X; LAMONT DW, 1993, BRIT J CANCER, V67, P351, DOI 10.1038/bjc.1993.64; Macleod U, 2000, ANN ONCOL, V11, P105, DOI 10.1023/A:1008385321476; McLaren G, 1998, DEPRIVATION HLTH SCO	5	81	81	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					830	831		10.1136/bmj.322.7290.830	http://dx.doi.org/10.1136/bmj.322.7290.830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290637	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168063000024
J	Puertollano, R; Randazzo, PA; Presley, JF; Hartnell, LM; Bonifacino, JS				Puertollano, R; Randazzo, PA; Presley, JF; Hartnell, LM; Bonifacino, JS			The GGAs promote ARF-dependent recruitment of clathrin to the TGN	CELL			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; AP-3 ADAPTER COMPLEX; GOLGI MEMBRANES; GAMMA-ADAPTIN; MEDIATED ENDOCYTOSIS; SYNTHETIC LIPOSOMES; BINDING PROTEIN; TRANS-GOLGI; FACTOR-I	The GGAs constitute a family of modular adaptor-related proteins that bind ADP-ribosylation factors (ARFs) and localize to the trans-Golgi network (TGN) via their GAT domains. Here, we show that binding of the GAT domain stabilizes membrane-bound ARF1 . GTP due to interference with the action of GTPase-activating proteins. We also show that the hinge and ear domains of the GGAs interact with clathrin in vitro, and that the GGAs promote recruitment of clathrin to liposomes in vitro and to TGN membranes in vivo. These observations suggest that the GGAs could function to link clathrin to membrane-bound ARF GTP.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Clabecq A, 2000, J BIOL CHEM, V275, P31786, DOI 10.1074/jbc.M003705200; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723; Ellenberg J, 1999, TRENDS CELL BIOL, V9, P52, DOI 10.1016/S0962-8924(98)01420-2; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; Kuai J, 2000, J BIOL CHEM, V275, P4022, DOI 10.1074/jbc.275.6.4022; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; VIRSHUP DM, 1988, J CELL BIOL, V106, P39, DOI 10.1083/jcb.106.1.39; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu XJ, 2000, J BIOL CHEM, V275, P13465, DOI 10.1074/jbc.275.18.13465; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013; Zhu YX, 1999, MOL BIOL CELL, V10, P537, DOI 10.1091/mbc.10.3.537; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	46	212	221	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					93	102		10.1016/S0092-8674(01)00299-9	http://dx.doi.org/10.1016/S0092-8674(01)00299-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301005	Bronze			2022-12-28	WOS:000168063300010
J	Shelby, RA; Smith, DR; Schultz, S				Shelby, RA; Smith, DR; Schultz, S			Experimental verification of a negative index of refraction	SCIENCE			English	Article							PHOTONIC CRYSTALS	We present experimental scattering data at microwave frequencies on a structured metamaterial that exhibits a frequency band where the effective index of refraction (n) is negative. The material consists of a two-dimensional array of repeated unit cells of copper strips and split ring resonators on interlocking strips of standard circuit board material. By measuring the scattering angle of the transmitted beam through a prism fabricated from this material, we determine the effective n, appropriate to Snell's law. These experiments directly confirm the predictions of Maxwell's equations that n is given by the negative square root of epsilon.mu for the frequencies where both the permittivity (epsilon) and the permeability (mu) are negative. Configurations of geometrical optical designs are now possible that could not be realized by positive index materials.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Shelby, RA (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.		huihui, zhang/M-9283-2014; Smith, David R/E-4710-2012	Sanchez-Fernandez, Gregorio Esteban/0000-0002-6059-7182				Gralak B, 2000, J OPT SOC AM A, V17, P1012, DOI 10.1364/JOSAA.17.001012; Landau L. D., 1984, ELECTRODYNAMICS CONT, P287; Notomi M, 2000, PHYS REV B, V62, P10696, DOI 10.1103/PhysRevB.62.10696; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, APPL PHYS LETT, V78, P489, DOI 10.1063/1.1343489; Smith DR, 2000, PHYS REV LETT, V85, P2933, DOI 10.1103/PhysRevLett.85.2933; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	10	7255	7713	147	2420	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					77	79		10.1126/science.1058847	http://dx.doi.org/10.1126/science.1058847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292865				2022-12-28	WOS:000167995200039
J	Kotiaho, JS; Simmons, LW; Tomkins, JL				Kotiaho, JS; Simmons, LW; Tomkins, JL			Towards a resolution of the lek paradox	NATURE			English	Article							GENETIC-VARIATION; SEXUAL SELECTION; BODY CONDITION; MALE ATTRACTIVENESS; OFFSPRING CONDITION; MATING PREFERENCES; ESTIMATING FITNESS; NATURAL-SELECTION; EVOLUTION; INVESTMENT	Genetic benefits in the shape of 'good genes' have been invoked to explain costly female choice in the absence of direct fitness benefits(1-3). Little genetic variance in fitness traits is expected, however, because directional selection tends to drive beneficial alleles to fixation(4-6). There seems to be little potential, therefore, for female choice to result in genetic benefits, giving rise to the 'lek paradox'(7-9). Nevertheless, evidence shows that genetic variance persists despite directional selection(10,11) and genetic benefits of female choice are frequently reported(12,13). A theoretical solution to the lek paradox has been proposed on the basis of two assumptions(14): that traits are condition-dependent, and that condition shows high genetic variance. The observed genetic variability in sexual traits will be accounted for, because a proportion of the genetic variance in condition will be captured and expressed in the trait(14). Here we report results from experiments showing that male courtship rate in the dung beetle Onthophagus taurus is a condition-dependent trait that is preferred by females. More importantly, male condition has high genetic variance and is genetically correlated with courtship rate. Our results thereby represent a significant step towards a resolution of the lek paradox.	Univ Western Australia, Dept Zool, Evolutionary Biol Res Grp, Nedlands, WA 6907, Australia	University of Western Australia	Kotiaho, JS (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, FIN-40351 Jyvaskyla, Finland.	jkotiaho@cc.jyu.fi	Tomkins, Joseph L/A-8091-2011; Simmons, Leigh W/B-1815-2011	Tomkins, Joseph L/0000-0003-1259-7898; Simmons, Leigh W/0000-0003-0562-1474; Kotiaho, Janne/0000-0002-4732-784X				Alatalo RV, 1998, P ROY SOC B-BIOL SCI, V265, P2297, DOI 10.1098/rspb.1998.0574; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Borgia G., 1979, SEXUAL SELECTION REP, P19; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Falconer D. S., 1989, Introduction to quantitative genetics.; Fisher, 1958, GENETICAL THEORY NAT; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1999, GENET RES, V73, P165, DOI 10.1017/S0016672398003656; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Wilkinson GS, 1999, P ROY SOC B-BIOL SCI, V266, P1685, DOI 10.1098/rspb.1999.0832	30	217	217	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					684	686		10.1038/35070557	http://dx.doi.org/10.1038/35070557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287953				2022-12-28	WOS:000167875400045
J	Smaglik, P				Smaglik, P			US structural genomics effort needs physicists for success	NATURE			English	Article																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					723	724		10.1038/35070720	http://dx.doi.org/10.1038/35070720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287968				2022-12-28	WOS:000167875400057
J	Brophy, JM; Joseph, L; Rouleau, JL				Brophy, JM; Joseph, L; Rouleau, JL			beta-blockers in congestive heart failure - A Bayesian meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; DOUBLE-BLIND; DILATED CARDIOMYOPATHY; ADRENERGIC-BLOCKADE; ELDERLY-PATIENTS; CLINICAL-TRIALS; UNITED-STATES; CARVEDILOL; MORTALITY	Purpose: Congestive heart failure is an important cause of patient morbidity and mortality. Although several randomized clinical trials have compared beta -blockers with placebo for treatment of congestive heart failure, a meta-analysis quantifying the effect on mortality and morbidity has not been performed recently. Data Sources: The MEDLINE, Cochrane, and Web of Science electronic databases were searched from 1966 to July 2000. References were also identified from bibliographies of pertinent articles. Study Selection: All randomized clinical trials of beta -blockers versus placebo in chronic stable congestive heart failure were included. Data Extraction: A specified protocol was followed to extract data on patient characteristics, beta -blocker used, overall mortality, hospitalizations for congestive heart failure, and study quality. Data Synthesis: A hierarchical random-effects model was used to synthesize the results, A total of 22 trials involving 10 135 patients were identified. There were 624 deaths among 4862 patients randomly assigned to placebo and 444 deaths among 5273 patients assigned to beta -blocker therapy. In these groups, 754 and 540 patients, respectively, required hospitalization for congestive heart failure, The probability that beta -blocker therapy reduced total mortality and hospitalizations for congestive heart failure was almost 100%. The best estimates of these advantages are 3.8 lives saved and 4 fewer hospitalizations per 100 patients treated in the first year after therapy. The probability that these benefits are clinically significant (>2 lives saved or >2 fewer hospitalizations per 100 patients treated) is 99%, Both selective and nonselective agents produced these salutary effects. The results are robust to any reasonable publication bias, Conclusions: beta -Blocker therapy is associated with clinically meaningful reductions in mortality and morbidity in patients with stable congestive heart failure and should be routinely offered to all patients similar to those included in trials.	Univ Montreal, Ctr Hosp, Serv Cardiol, Montreal, PQ H2L 4M1, Canada; McGill Univ, Montreal, PQ, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Univ Hlth Network, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON, Canada	Universite de Montreal; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Brophy, JM (corresponding author), Univ Montreal, Ctr Hosp, Serv Cardiol, Pavillon Notre-Dame,1560 Rue Sherbrooke Est, Montreal, PQ H2L 4M1, Canada.	jbroph@po-box.mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				ANDERSON GM, 1989, NEW ENGL J MED, V321, P1443, DOI 10.1056/NEJM198911233212105; ANDERSON JL, 1985, AM J CARDIOL, V55, P471, DOI 10.1016/0002-9149(85)90396-0; [Anonymous], 1990, Lancet, V336, P1; Avezum A, 1998, CAN J CARDIOL, V14, P1045; *BET EV SURV TRIAL, 2001, 72 SCI SESS AM HEART; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1994, CIRCULATION, V89, P1632, DOI 10.1161/01.CIR.89.4.1632; BROPHY JM, 1992, CAN J CARDIOL, V8, P495; CHADDA K, 1986, CIRCULATION, V73, P503, DOI 10.1161/01.CIR.73.3.503; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; Cohn J N, 1997, J Card Fail, V3, P173, DOI 10.1016/S1071-9164(97)90013-0; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Cowie MR, 1997, EUR HEART J, V18, P208; DIAMOND GA, 1983, ANN INTERN MED, V98, P385, DOI 10.7326/0003-4819-98-3-385; Doughty RN, 1997, EUR HEART J, V18, P560; EDDY DM, 1992, SOFTWARE METAANALYSI; Eddy DM, 1992, METAANALYSIS CONFIDE; EICHHORN EJ, 1994, J AM COLL CARDIOL, V24, P1310, DOI 10.1016/0735-1097(94)90114-7; ENGELMEIER RS, 1985, CIRCULATION, V72, P536, DOI 10.1161/01.CIR.72.3.536; FISHER ML, 1994, J AM COLL CARDIOL, V23, P943, DOI 10.1016/0735-1097(94)90641-6; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Gelman Andrew, 1995, BAYESIAN DATA ANAL; GHALI JK, 1990, ARCH INTERN MED, V150, P769, DOI 10.1001/archinte.150.4.769; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Hjalmarson A, 1999, LANCET, V353, P2001; KJALMARSON A, 2000, JAMA-J AM MED ASSOC, V283, P1295; KRUM H, 1995, CIRCULATION, V92, P1499, DOI 10.1161/01.CIR.92.6.1499; Krumholz HM, 1996, ANN INTERN MED, V124, P292, DOI 10.7326/0003-4819-124-3-199602010-00002; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; LAMAS GA, 1992, NEW ENGL J MED, V327, P241, DOI 10.1056/NEJM199207233270405; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; MacMahon S, 1997, LANCET, V349, P375; METRA M, 1994, J AM COLL CARDIOL, V24, P1678, DOI 10.1016/0735-1097(94)90174-0; OLSEN SL, 1995, J AM COLL CARDIOL, V25, P1225, DOI 10.1016/0735-1097(95)00012-S; PACKER M, 1993, CIRCULATION, V88, P301; Packer M, 1996, CIRCULATION, V94, P2793, DOI 10.1161/01.CIR.94.11.2793; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; PAOLISSO G, 1992, AM HEART J, V123, P103, DOI 10.1016/0002-8703(92)90753-I; Perry G, 1997, NEW ENGL J MED, V336, P525; Pfeffer MA, 1996, NEW ENGL J MED, V334, P1396, DOI 10.1056/NEJM199605233342109; POLLOCK SG, 1990, AM J CARDIOL, V66, P603, DOI 10.1016/0002-9149(90)90488-M; SMITH WM, 1985, AM J CARDIOL, V55, pA3, DOI 10.1016/0002-9149(85)90789-1; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; WAAGSTEIN F, 1975, BRIT HEART J, V37, P1022; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; WISENBAUGH T, 1993, J AM COLL CARDIOL, V21, P1094, DOI 10.1016/0735-1097(93)90230-X; WOODLEY SL, 1991, CIRCULATION, V84, P2426, DOI 10.1161/01.CIR.84.6.2426	53	281	293	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					550	560		10.7326/0003-4819-134-7-200104030-00008	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281737				2022-12-28	WOS:000167931200002
J	Kusano, K; Johnson-Schlitz, DM; Engels, WR				Kusano, K; Johnson-Schlitz, DM; Engels, WR			Sterility of Drosophila with mutations in the bloom syndrome gene - Complementation by Ku70	SCIENCE			English	Article							STRAND BREAK REPAIR; P-ELEMENT EXCISION; MELANOGASTER; PROTEIN; RECOMBINATION; HELICASES; JUNCTIONS; PRODUCT; HOMOLOG; DAMAGE	The Drosophila Dmblm locus is a homolog of the human Bloom syndrome gene, which encodes a helicase of the RECQ family. We show that Dmblm is identical to mus309, a locus originally identified in a mutagen-sensitivity screen. One mus309 allele, which carries a stop codon between two of the helicase motifs, causes partial male sterility and complete female sterility. Mutant males produce an excess of XY sperm and nullo sperm, consistent with a high frequency of nondisjunction and/or chromosome loss. These phenotypes of mus309 suggest that Dmblm functions in DNA double-strand break repair. The mutant Dmblm phenotypes were partially rescued by an extra copy of the DNA repair gene Ku70, indicating that the two genes functionally interact in vivo.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Engels, WR (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030948, R56GM030948] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANGA SS, 1991, MUTAT RES, V255, P79, DOI 10.1016/0921-8777(91)90020-P; Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; BOYD JB, 1981, GENETICS, V97, P607; Brodsky MH, 2000, GENE DEV, V14, P666; Cooper MP, 2000, GENE DEV, V14, P907; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GAUSZ J, 1981, GENETICS, V98, P775; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kooistra R, 1999, MOL CELL BIOL, V19, P6269; Kusano K, 1999, GENETICS, V151, P1027; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Ochem AE, 1997, J BIOL CHEM, V272, P29919, DOI 10.1074/jbc.272.47.29919; PASTINK A, 1991, MOL GEN GENET, V229, P213, DOI 10.1007/BF00272158; Preston CR, 1996, GENETICS, V144, P1623; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; YU EE, 1996, SCIENCE, V272, P258	22	92	94	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2600	2602		10.1126/science.291.5513.2600	http://dx.doi.org/10.1126/science.291.5513.2600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283371				2022-12-28	WOS:000167861000041
J	Lee, BW; Clark, NA				Lee, BW; Clark, NA			Alignment of liquid crystals with patterned isotropic surfaces	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; PLANAR	The molecules of a nematic liquid crystal exposed to an isotropic surface adopt a mean tilt relative to the normal but have no in-plane alignment-that is, they are free to have any azimuthal orientation in the surface plane. Pursuing the theoretical suggestion by Meyer that, in spite of this azimuthal degeneracy, spatially inhomogeneous isotropic surfaces combine with liquid crystal elastic anisotropy to produce alignment, we show that a boundary line between two isotropic regions that differ in mean tilt does indeed align the liquid crystal. The boundaries on a patterned surface of distinct isotropic regions thus act as a system of lines that the molecular orientation locally follows. This enables the development of liquid crystal alignment surfaces based on printing or lithographic patterning.	Univ Colorado, Dept Phys, Ferroelect Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Clark, NA (corresponding author), Univ Colorado, Dept Phys, Ferroelect Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA.		Clark, Noel A./E-9011-2010; Clark, Noel A/AAP-9116-2020	Clark, Noel A./0000-0001-9301-5540; 				BARBERI R, 1994, NUOVO CIMENTO D, V16, P895, DOI 10.1007/BF02456740; BERREMAN DW, 1972, PHYS REV LETT, V28, P1983; COGNARD J, 1982, MOL CRYST LIQ CRYS S, V1, P1; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; FAETTI S, 1987, PHYS REV A, V36, P408, DOI 10.1103/PhysRevA.36.408; FLANDERS DC, 1978, APPL PHYS LETT, V32, P597, DOI 10.1063/1.89864; GEARY JM, 1987, J APPL PHYS, V62, P4100, DOI 10.1063/1.339124; Gupta VK, 1997, SCIENCE, V276, P1533, DOI 10.1126/science.276.5318.1533; ICHIMURA K, 1996, SUPRAMOL SCI, V3, P67; JANNING JL, 1972, APPL PHYS LETT, V21, P173, DOI 10.1063/1.1654331; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; Komitov L, 1999, J APPL PHYS, V86, P3508, DOI 10.1063/1.371249; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; KUMAR S, 1996, PHYS REV E, V53, P3777; Lee BW, 1998, LANGMUIR, V14, P5495, DOI 10.1021/la970217f; LEE BW, 1998, THESIS U COLORADO; MEYER RB, 1979, J PHYS, V40, P58; Mooney JF, 1996, P NATL ACAD SCI USA, V93, P12287, DOI 10.1073/pnas.93.22.12287; ONG HL, 1985, J APPL PHYS, V57, P186, DOI 10.1063/1.334841; Qian TZ, 1997, PHYS REV E, V55, P7111, DOI 10.1103/PhysRevE.55.7111; Qian TZ, 1996, PHYS REV LETT, V77, P4564; SCHADT M, 1971, APPL PHYS LETT, V18, P127, DOI 10.1063/1.1653593; STANNARIUS R, 1998, HDB LIQUID CRYSTALS; 1994, ORIEL CATALOGUE, V2, P1	24	131	137	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2576	2580		10.1126/science.291.5513.2576	http://dx.doi.org/10.1126/science.291.5513.2576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283364				2022-12-28	WOS:000167861000034
J	Wood, M				Wood, M			When stool cultures from adult inpatients are appropriate	LANCET			English	Editorial Material							ENTERIC PATHOGENS; DIARRHEA; COST		Birmingham Heartlands Hosp, Dept Infect, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham	Wood, M (corresponding author), Birmingham Heartlands Hosp, Dept Infect, Birmingham B9 5SS, W Midlands, England.							BARBUT F, 1995, EUR J CLIN MICROBIOL, V14, P346, DOI 10.1007/BF02116530; Bauer TH, 2001, JAMA-J AM MED ASSOC, V285, P313, DOI 10.1001/jama.285.3.313; Chitkara YK, 1996, ARCH INTERN MED, V156, P1445, DOI 10.1001/archinte.156.13.1445; Craven D, 1998, PEDIATR INFECT DIS J, V17, P1040, DOI 10.1097/00006454-199811000-00015; FAN K, 1993, J CLIN MICROBIOL, V31, P2233, DOI 10.1128/JCM.31.8.2233-2235.1993; GROSS PA, 1988, INFECT CONT HOSP EP, V9, P497, DOI 10.2307/30146545; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; KOPLAN JP, 1980, LANCET, V2, P413; MCFARLAND LV, 1993, GASTROENTEROL CLIN N, V22, P563; Morris AJ, 1996, J CLIN MICROBIOL, V34, P1776, DOI 10.1128/JCM.34.7.1776-1778.1996; Ozerek AE, 1999, J HOSP INFECT, V41, P159, DOI 10.1016/S0195-6701(99)90055-5; Rohner P, 1997, J CLIN MICROBIOL, V35, P1427, DOI 10.1128/JCM.35.6.1427-1432.1997; SIEGEL DL, 1990, JAMA-J AM MED ASSOC, V263, P979, DOI 10.1001/jama.263.7.979; Valenstein P, 1996, ARCH PATHOL LAB MED, V120, P206	14	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					901	902		10.1016/S0140-6736(00)04230-6	http://dx.doi.org/10.1016/S0140-6736(00)04230-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289342				2022-12-28	WOS:000167625300004
J	Zollner, B; Petersen, J; Schroter, M; Laufs, R; Schoder, V; Feucht, HH				Zollner, B; Petersen, J; Schroter, M; Laufs, R; Schoder, V; Feucht, HH			20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw	LANCET			English	Article								We investigated subtype-dependent development of lamivudine resistance In hepatitis B virus (HBV) longitudinally In 26 consecutive patients (13 adw and 13 ayw carriers) during antiviral treatment of chronic hepatitis B, Lamivudine resistance developed in seven adw carriers and one ayw carrier. Risk of lamivudine resistance was significantly higher for adw carriers than for ayw carriers (p=0.03). We believe that the adw subtype of HBV Is associated with a high risk of lamivudine resistance, which might be linked to simultaneous changes of the HBsAg that occurs with the emergence of resistance.	Univ Hamburg, Hosp Eppendorf, Inst Med Microbiol & Immunol, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Internal Med, Heinrich Pette Inst Expt Virol & Immunol, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Inst Math & Data Sci Med, D-20246 Hamburg, Germany	University of Hamburg; Heinrich Pette Institute; University of Hamburg; University of Hamburg	Zollner, B (corresponding author), Univ Hamburg, Hosp Eppendorf, Inst Med Microbiol & Immunol, Martinistr 52, D-20246 Hamburg, Germany.			Zollner, Bernhard/0000-0001-6330-558X				Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Dandri M, 2000, HEPATOLOGY, V32, P139, DOI 10.1053/jhep.2000.8701; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201; Zollner B, 2000, J CLIN VIROL, V17, P183, DOI 10.1016/S1386-6532(00)00092-5	5	100	107	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					934	935		10.1016/S0140-6736(00)04219-7	http://dx.doi.org/10.1016/S0140-6736(00)04219-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289355				2022-12-28	WOS:000167625300017
J	Schlittler, RR; Seo, JW; Gimzewski, JK; Durkan, C; Saifullah, MSM; Welland, ME				Schlittler, RR; Seo, JW; Gimzewski, JK; Durkan, C; Saifullah, MSM; Welland, ME			Single crystals of single-walled carbon nanotubes formed by self-assembly	SCIENCE			English	Article							ARRAYS	We report the self-assembly of single crystals of single-walled carbon nanotubes (SWCNTs) using thermolysis of nano-patterned precursors. The synthesis of these perfectly ordered, single crystals of SWCNTs results in extended structures with dimension on the micrometer scale. Each crystal is composed of an ordered array of tubes with identical diameters and chirality, although these properties vary between crystals. The results show that SWCNTs can be produced as a perfect bulk material on the micrometer scale and point toward the synthesis of bulk macroscopic crystalline material.	IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; Univ Neuchatel, Inst Phys, CH-2000 Neuchatel, Switzerland; Univ Cambridge, Dept Engn, Nanoscale Sci Lab, Cambridge CB2 1PZ, England	International Business Machines (IBM); University of Neuchatel; University of Cambridge	Gimzewski, JK (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 951569, Los Angeles, CA 90095 USA.	gim@chem.ucla.edu	Saifullah, M. S. M./B-8149-2011; Idris, Saifullah/M-4993-2019; Seo, Jin Won/J-3980-2013; Seo, Maria/L-9960-2018; Durkan, Colm/F-1950-2011	Saifullah, M. S. M./0000-0002-3172-041X; Idris, Saifullah/0000-0002-9255-4814; Seo, Jin Won/0000-0003-4937-0769; Seo, Maria/0000-0003-4937-0769; gimzewski, james/0000-0003-4333-6957; Durkan, Colm/0000-0001-9398-2813				BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; Brugger J, 2000, MICROELECTRON ENG, V53, P403, DOI 10.1016/S0167-9317(00)00343-9; Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Henrard L, 2000, EUR PHYS J B, V13, P661, DOI 10.1007/s100510050083; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kiang CH, 1998, PHYS REV LETT, V81, P1869, DOI 10.1103/PhysRevLett.81.1869; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; KUZUO R, 1992, JPN J APPL PHYS 2, V31, pL1484, DOI 10.1143/JJAP.31.L1484; Lee CJ, 1999, APPL PHYS LETT, V75, P1721, DOI 10.1063/1.124837; Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377; Luthi R, 1999, APPL PHYS LETT, V75, P1314, DOI 10.1063/1.124679; Meyer RR, 2000, SCIENCE, V289, P1324, DOI 10.1126/science.289.5483.1324; MOORE G, 1965, EVERY 18 MONTHS PROC; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Saito R., 1998, PHYS PROPERTIES CARB; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Wang QH, 1998, APPL PHYS LETT, V72, P2912, DOI 10.1063/1.121493; ZHANG XF, 1993, J CRYST GROWTH, V130, P368, DOI 10.1016/0022-0248(93)90522-X	27	177	192	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1136	1139		10.1126/science.1057823	http://dx.doi.org/10.1126/science.1057823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11292859				2022-12-28	WOS:000168609200051
J	Levis, RJ; Menkir, GM; Rabitz, H				Levis, RJ; Menkir, GM; Rabitz, H			Selective bond dissociation and rearrangement with optimally tailored, strong-field laser pulses	SCIENCE			English	Article							POLYATOMIC-MOLECULES; QUANTUM CONTROL; IONIZATION; IMPLEMENTATION; CHEMISTRY	We used strong-field laser pulses that were tailored with closed-loop optimal control to govern specified chemical dissociation and reactivity channels in a series of organic molecules. Selective cleavage and rearrangement of chemical bonds having dissociation energies up to approximately 100 kilocalories per mole (about 4 electron volts) are reported for polyatomic molecules, including (CH3)(2)CO (acetone), CH3COCF3 (trifluoroacetone), and C6H5COCH3 (acetophenone). Control over the formation of CH,CO from (CH3)(2)CO, CF3 (or CH3) from CH3COCF3, and C6H5CH3 (toluene) from C6H5COCH3 was observed with high selectivity. Strong-field control appears to have generic applicability for manipulating molecular reactivity because the tailored intense laser fields (about 10(13) watts per square centimeter) can dynamically Stark shift many excited states into resonance, and consequently, the method is not confined by resonant spectral restrictions found in the perturbative (weak-field) regime.	Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; Princeton Univ, Dept Chem, Princeton, NJ 08540 USA	Wayne State University; Princeton University	Levis, RJ (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.							Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; BERKOWITZ J, 1994, J PHYS CHEM-US, V98, P2744, DOI 10.1021/j100062a009; DEMIRALP M, 1993, PHYS REV A, V47, P809, DOI 10.1103/PhysRevA.47.809; DeWitt MJ, 1998, PHYS REV LETT, V81, P5101, DOI 10.1103/PhysRevLett.81.5101; DeWitt MJ, 1999, J CHEM PHYS, V110, P11368, DOI 10.1063/1.479077; Geremia JM, 2000, J CHEM PHYS, V113, P10841, DOI 10.1063/1.1326905; Goldberg D.E., 1989, GENETIC ALGORITHMS S; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kunde J, 2000, APPL PHYS LETT, V77, P924, DOI 10.1063/1.1288603; Levis RJ, 1999, J PHYS CHEM A, V103, P6493, DOI 10.1021/jp984543v; MARKEVITCH AN, IN PRESS CHEM PHYS; Moore NP, 2000, J CHEM PHYS, V112, P1316, DOI 10.1063/1.480683; OMENETTO F, IN PRESS OPT LETT; Rabitz H, 2000, ACCOUNTS CHEM RES, V33, P572, DOI 10.1021/ar990054h; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Sundermann E, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.013409; VAJDA S, IN PRESS CHEM PHYS; WEFERS MM, 1995, J OPT SOC AM B, V12, P1343, DOI 10.1364/JOSAB.12.001343; Weinacht TC, 1999, J PHYS CHEM A, V103, P10166, DOI 10.1021/jp991977x; WEINER AM, 1995, PROG QUANT ELECTRON, V19, P161, DOI 10.1016/0079-6727(94)00013-O	22	764	792	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					709	713		10.1126/science.1059133	http://dx.doi.org/10.1126/science.1059133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11283357				2022-12-28	WOS:000168478300046
J	Mann, JFE; Gerstein, HC; Pogue, J; Bosch, J; Yusuf, S				Mann, JFE; Gerstein, HC; Pogue, J; Bosch, J; Yusuf, S		HOPE Investigators	Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM CREATININE; BLOOD-PRESSURE; DISEASE; MORTALITY; MILD	Background: The cardiovascular risk associated with early renal insufficiency is unknown. Clinicians are often reluctant to use angiotensin-converting enzyme inhibitors in patients with renal insufficiency. Objective: To determine whether mild renal insufficiency increases cardiovascular risk and whether ramipril decreases that risk. Design: Post hoc analysis. Setting: The Heart Outcomes and Prevention Evaluation (HOPE) study, a randomized, double-blind, multinational trial involving 267 study centers. Patients: 980 patients with mild renal insufficiency (serum creatinine concentration greater than or equal to 124 mu mol/L [greater than or equal to 1.4 mg/dL]) and 8307 patients with normal renal function (serum creatinine concentration < 124 mu mol/L [<1.4 mg/dl]) Patients with a baseline serum creatinine concentration greater than 200 mu mol/L (2.3 mg/dL) were excluded. Measurements: The primary outcome measure was incidence of cardiovascular death, myocardial infarction, or stroke. Results: Cumulative incidence of the primary outcome was higher in patients with renal insufficiency than in those without (22.2% vs. 15.1%; P < 0.001) and increased with serum creatinine concentration. Patients with renal insufficiency had a substantially increased risk for cardiovascular death (11.4% vs. 6.6%) and total mortality (17.8% vs. 10.6%) (P < 0.001 for both comparisons). The effect of renal insufficiency on the primary outcome (adjusted hazard ratio, 1.40 [95% Cl, 1.16 to 1.69]) was independent of known cardiovascular risks and treatment. Ramipril reduced the incidence of the primary outcome in patients with and those without renal insufficiency (hazard ratio, 0.80 vs. 0.79; P > 0.2 for the difference). Conclusions: In patients who had preexisting vascular disease or diabetes combined with an additional cardiovascular risk factor, mild renal insufficiency significantly increased the risk for subsequent cardiovascular events. Ramipril reduced cardiovascular risk without increasing adverse effects.	McMaster Univ, Hamilton, ON, Canada; Univ Munich, Schwabing Gen Hosp, Munich, Germany; German Inst High Blood Pressure Res, Heidelberg, Germany	McMaster University; University of Munich	Mann, JFE (corresponding author), McMaster Univ, Hamilton Gen Hosp, HOPE Off, 527 Barton St E, Hamilton, ON L8L 2X2, Canada.		Mann, Johannes/AAI-8803-2020; Gerstein, Hertzel C/B-1235-2013; Gerstein, Hertzel/ABB-8781-2020; Bosch, Jacqueline/AAP-6910-2021	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Bosch, Jacqueline/0000-0001-6292-4207; Yusuf, Salim/0000-0003-4776-5601				Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; Hall WD, 1999, AM J MED SCI, V317, P176, DOI 10.1097/00000441-199903000-00007; Jungers P, 1999, NEPHROL DIAL TRANSPL, V14, P2903, DOI 10.1093/ndt/14.12.2903; KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Stefanski A, 1996, KIDNEY INT, V50, P1321, DOI 10.1038/ki.1996.444; TRACY RE, 1994, MODERN PATHOL, V7, P301; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2000, NEW ENGL J MED, V342, P145	20	1047	1105	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					629	636		10.7326/0003-4819-134-8-200104170-00007	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304102				2022-12-28	WOS:000168177500001
J	Dettmer, K; Saunders, B; Strang, J				Dettmer, K; Saunders, B; Strang, J			Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes	BRITISH MEDICAL JOURNAL			English	Article							HEROIN		Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; Maudsley Hosp, London SE5 8AF, England; Alcohol & Drug Serv, St Saviour JE2 7LB, Jersey, England; Fixpunkt eV Mobilix, D-10967 Berlin, Germany	University of London; King's College London; South London & Maudsley NHS Trust	Strang, J (corresponding author), Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				Darke S, 1997, ADDICTION, V92, P1195; Strang J, 1996, BRIT MED J, V312, P1435, DOI 10.1136/bmj.312.7044.1435; Strang J, 1999, ADDICTION, V94, P199, DOI 10.1046/j.1360-0443.1999.9421993.x; Wanger K, 1998, ACAD EMERG MED, V5, P293, DOI 10.1111/j.1553-2712.1998.tb02707.x	4	109	113	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					895	896		10.1136/bmj.322.7291.895	http://dx.doi.org/10.1136/bmj.322.7291.895			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302902	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168311300020
J	Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W				Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W			Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition	NATURE			English	Article							CARBON-DIOXIDE ENRICHMENT; ATMOSPHERIC CO2; LONG-TERM; CALCAREOUS GRASSLAND; SPECIES COMPOSITION; BIOMASS; MONOCULTURES; PRODUCTIVITY; BIODIVERSITY; COMPETITION	Human actions are causing declines in plant biodiversity, increases in atmospheric CO2 concentrations and increases in nitrogen deposition; however, the interactive effects of these factors on ecosystem processes are unknown(1,2). Reduced biodiversity has raised numerous concerns, including the possibility that ecosystem functioning may be affected negatively(1-4), which might be particularly important in the face of other global changes(5,6). Here we present results of a grassland field experiment in Minnesota, USA, that tests the hypothesis that plant diversity and composition influence the enhancement of biomass and carbon acquisition in ecosystems subjected to elevated atmospheric CO2 concentrations and nitrogen deposition. The study experimentally controlled plant diversity (1, 4, 9 or 16 species), soil nitrogen (unamended versus deposition of 4 g of nitrogen per m(2) per yr) and atmospheric CO2 concentrations using free-air CO2 enrichment (ambient, 368 mu mol mol(-1), versus elevated, 560 mu mol mol(-1)). We found that the enhanced biomass accumulation in response to elevated levels of CO2 or nitrogen, or their combination, is less in species-poor than in species-rich assemblages.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Brookhaven Natl Lab, Div Environm Biol, Upton, NY 11973 USA; Univ Nebraska, Sch Nat Resource Sci, Lincoln, NE 68583 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Nebraska System; University of Nebraska Lincoln	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.		Knops, Johannes/AAA-8546-2020; Tilman, David/ABD-5309-2021; Wedin, David A/K-4093-2012; Tjoelker, Mark G/M-2413-2016; Craine, Joseph/D-4569-2009	Tjoelker, Mark G/0000-0003-4607-5238; Craine, Joseph/0000-0001-6561-3244; Ellsworth, David/0000-0002-9699-2272; Reich, Peter/0000-0003-4424-662X; Lee, Tali/0000-0002-3933-6607				BOLKER BM, 1995, GLOB CHANGE BIOL, V1, P373, DOI 10.1111/j.1365-2486.1995.tb00035.x; Cannell MGR, 1998, GLOBAL CHANGE BIOL, V4, P431, DOI 10.1046/j.1365-2486.1998.00167.x; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KORNER C, 1996, CARBON DIOXIDE POPUL; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LEWIN KF, 1994, AGR FOREST METEOROL, V70, P15, DOI 10.1016/0168-1923(94)90045-0; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; Navas ML, 1999, NEW PHYTOL, V143, P323, DOI 10.1046/j.1469-8137.1999.00443.x; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schenk U, 1997, NEW PHYTOL, V135, P67, DOI 10.1046/j.1469-8137.1997.00615.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHMID B, IN PRESS FUNCTIONAL; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Warwick KR, 1998, GLOB CHANGE BIOL, V4, P375, DOI 10.1046/j.1365-2486.1998.00159.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.1890/1051-0761(2000)010[0034:ACSNAA]2.0.CO;2; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	29	436	476	7	317	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					809	812		10.1038/35071062	http://dx.doi.org/10.1038/35071062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298447	Green Published			2022-12-28	WOS:000168021900053
J	Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS				Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS			Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; INTERNATIONAL TRIAL; ACC/AHA GUIDELINES; UNSTABLE ANGINA; HEART-DISEASE; CHOLESTEROL; PREVENTION; STATINS; MEN; ENDOTHELIUM	Background Lipid-lowering agents are known to reduce longterm mortality in patients with stable coronary disease or significant risk factors. However, the effect of lipid-lowering therapy on short-term mortality immediately after an acute coronary syndrome has not been determined. We did an observational study using data from two randomised trials to investigate this issue. Methods We used data from the GUSTO IIb and PURSUIT trials to compare ail-cause mortality among patients with acute coronary syndromes who were discharged on lipid-lowering agents (n=3653) with those who were not (n=17 156). A propensity analysis was done to adjust for presumed selection biases in the prescription of lipid-lowering agents. Findings Lipid-lowering therapy was associated with a smaller proportion of deaths at 30 days (17 [0.5%] vs 179 [1.0%], hazard ratio 0.44 [95% CI 0.27-0.73], p=0.001) and at 6 months (63 [1.7%] vs 605 [3.5%], 0.48 [0.37-0.63], p<0.0001). After adjustment for the propensity to be prescribed lipid-lowering agents and other potential confounders, prescription of a lipid-lowering agent at discharge remained associated with a reduced risk of death at 6 months (0.67 [0.48-0.95], p=0.023). Interpretation Prescription of a lipid-lowering drug at hospital discharge was independently associated with reduced short-term mortality among patients after an acute coronary syndrome.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Duke Clin Res Inst, Durham, NC USA; Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Hungarian Inst Cardiol, Budapest, Hungary; Univ Nottingham Hosp, Queens Med Ctr, Nottingham NG7 2UH, England; Hop Bichat Claude Bernard, Serv Cardiol, F-75877 Paris, France; Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada	Cleveland Clinic Foundation; Duke University; Baylor College of Medicine; University of Nottingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Alberta	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Topol, Eric/0000-0002-1478-4729; Armstrong, Paul/0000-0002-0460-3445				Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Harrington RA, 1997, AM J CARDIOL, V80, pB34, DOI 10.1016/S0002-9149(97)00575-4; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kalblleisch JD, 1980, COMPETING RISKS STAT, P163; Kluft C, 1999, LANCET, V353, P1274, DOI 10.1016/S0140-6736(05)66951-6; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Krumholz HM, 1999, ANN INTERN MED, V131, P648, DOI 10.7326/0003-4819-131-9-199911020-00003; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; NOTARBARTOLO A, 1995, ARTERIOSCL THROM VAS, V15, P247, DOI 10.1161/01.ATV.15.2.247; PEDERSEN TR, 1994, LANCET, V344, P1383; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 1998, AM J CARDIOL, V81, P578, DOI 10.1016/S0002-9149(97)00963-6; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Siegel D, 2000, AM J MED, V108, P496, DOI 10.1016/S0002-9343(00)00319-3; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7; STROES ESG, 1995, LANCET, V346, P467, DOI 10.1016/S0140-6736(95)91322-X; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0	33	232	242	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1063	1068		10.1016/S0140-6736(00)04257-4	http://dx.doi.org/10.1016/S0140-6736(00)04257-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297956				2022-12-28	WOS:000167996200007
J	Bond, W				Bond, W			Ecology - Keystone species - Hunting the snark?	SCIENCE			English	Editorial Material									Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa	University of Cape Town	Bond, W (corresponding author), Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa.	bond@botzoo.uct.ac.za	Bond, William/AAY-7631-2020	Bond, William/0000-0002-3441-2084				Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; Brown J.H., 1986, COMMUNITY ECOL, P41; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Ernest SKM, 2001, SCIENCE, V292, P101; Hurlbert SH, 1997, AUST J ECOL, V22, P369, DOI 10.1111/j.1442-9993.1997.tb00687.x; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Mooney H.A., 2000, INVASIVE SPECIES CHA; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990	10	26	28	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					63	64		10.1126/science.1060793	http://dx.doi.org/10.1126/science.1060793			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11294219				2022-12-28	WOS:000167995200034
J	Day, NPJ; Moore, CE; Enright, MC; Berendt, AR; Smith, JM; Murphy, MF; Peacock, SJ; Spratt, BG; Feil, EJ				Day, NPJ; Moore, CE; Enright, MC; Berendt, AR; Smith, JM; Murphy, MF; Peacock, SJ; Spratt, BG; Feil, EJ			RETRACTED: A link between virulence and ecological abundance in natural populations of Staphylococcus aureus (Retracted article. See vol 295, pg 971, 2002)	SCIENCE			English	Article; Retracted Publication							CLONES; RESISTANCE	Staphylococcus aureus is a major cause of severe infection in humans and yet is carried without symptoms by a Large proportion of the population. We used multilocus sequence typing to characterize isolates of S. aureus recovered from asymptomatic nasal carriage and from episodes of severe disease within a defined population. We identified a number of frequently carried genotypes that were disproportionately common as causes of disease. even taking into account their relative abundance among carriage isolates, The existence of these ecologically abundant hypervirulent clones suggests that factors promoting the ecological fitness of this important pathogen also increase its virulence.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; John Radcliffe Hosp, Natl Blood Serv, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Sussex; University of Oxford; University of Oxford	Day, NPJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England.		Peacock, Sharon J/ABE-6331-2020; Moore, Catrin/K-1980-2017; Spratt, Brian G/A-1676-2009	Moore, Catrin/0000-0002-8639-9846; Enright, Mark/0000-0001-5273-8750				Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ENRIGHT MC, UNPUB; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; KUSTERS JG, 1994, FIMBRIAE ADHESION GE, P179; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Musser J. M., 1990, MOL BIOL STAPHYLOCOC, P59; MUSSER JM, 1990, P NATL ACAD SCI USA, V87, P225, DOI 10.1073/pnas.87.1.225; *PUBL HLTH LAB SER, 2000, COMMUNICAB DIS REP, V10, P23; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255	16	85	89	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					114	116		10.1126/science.1056495	http://dx.doi.org/10.1126/science.1056495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292876				2022-12-28	WOS:000167995200051
J	Liu, JG; Linderman, M; Ouyang, ZY; An, L; Yang, J; Zhang, HM				Liu, JG; Linderman, M; Ouyang, ZY; An, L; Yang, J; Zhang, HM			Ecological degradation in protected areas: The case of Wolong Nature Reserve for giant pandas	SCIENCE			English	Article							CONSERVATION TARGETS; BIODIVERSITY; HURRICANE	It is generally perceived that biodiversity is better protected from human activities after an area is designated as a protected area. However, we found that this common perception was not true in Wolong Nature Reserve (southwestern China), which was established in 1975 as a "flagship" protected area for the world-renowned endangered giant pandas. Analyses of remote sensing data from pre- and post-establishment periods indicate that the reserve has become more fragmented and less suitable for giant panda habitation. The rate of Loss of high-quality habitat after the reserve's establishment was much higher than before the reserve was created, and the fragmentation of high-quality habitat became far more severe. After the creation of the reserve, rates of habitat loss and fragmentation inside the reserve unexpectedly increased to levels that were;similar to or higher than those outside the reserve, in contrast to the situation before the reserve was created.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Dept Syst Ecol, Beijing, Peoples R China; Chinas Ctr Giant Panda Res & Conservat, Wolong Nat Reserve, Wenchuan Cty, Sichuan Provinc, Peoples R China	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, 13 Nat Resources Bldg, E Lansing, MI 48824 USA.		Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; BASNET K, 1992, J TROP ECOL, V8, P47, DOI 10.1017/S0266467400006076; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Caro TM, 1998, AFR J ECOL, V36, P303, DOI 10.1046/j.1365-2028.1998.00147.x; *CHIN MIN FOR WWF, 1989, CONS MAN PLAN GIANT; Dompka V, 1996, HUMAN POPULATION BIO; Forman RT., 1995, LAND MOSAICS ECOLOGY; Giant Panda Expedition of the Wanglang Nature Reserve, 1974, ACTA ZOOL SINICA, V20, P162; *INT UN CONS NAT N, 1998, UN LIST PROT AR; Jensen J.R., 2015, INTRO DIGITAL IMAGE; Lillesand T., 1994, REMOTE SENSING IMAGE; LIU J, IN PRESS ECOL MODEL; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; McGarigal Kevin, 1994, FRAGSTATS SPATIAL PA; Morrison ML, 2007, WILDLIFE HABITAT REL; Noss Reed F., 1996, P91; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Sanchez-Azofeifa GA, 1999, CONSERV BIOL, V13, P407, DOI 10.1046/j.1523-1739.1999.013002407.x; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller GB, 1994, LAST PANDA; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; STOW D, 1990, GEOCARTO INT, V3, P3; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; van Schaik Carel P., 1997, P64; van Schaik Carel P., 1997, P212	26	505	598	22	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					98	101		10.1126/science.1058104	http://dx.doi.org/10.1126/science.1058104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292872				2022-12-28	WOS:000167995200046
J	Pichaud, F; Treisman, J; Desplan, C				Pichaud, F; Treisman, J; Desplan, C			Reinventing a common strategy for patterning the eye	CELL			English	Review							VERTEBRATE; APPENDAGES; DROSOPHILA; EVOLUTION; RETINA; NOTCH; PAX-6		NYU, Dept Biol, Mol Genet Lab, New York, NY 10003 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University	Pichaud, F (corresponding author), NYU, Dept Biol, Mol Genet Lab, 1009 Main Bldg,100 Washington Sq E, New York, NY 10003 USA.			Treisman, Jessica/0000-0002-7453-107X; Desplan, Claude/0000-0002-6914-1413; Pichaud, Franck/0000-0002-8393-716X				Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chow RL, 1999, DEVELOPMENT, V126, P4213; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Crowe R, 1998, DEVELOPMENT, V125, P767; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Pichaud F, 2001, DEVELOPMENT, V128, P815; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Xu PX, 1999, DEVELOPMENT, V126, P383	20	50	50	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					9	12		10.1016/S0092-8674(01)00292-6	http://dx.doi.org/10.1016/S0092-8674(01)00292-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11300998	Bronze			2022-12-28	WOS:000168063300003
J	Hu, YL; Baud, V; Oga, T; Kim, KII; Yoshida, K; Karin, M				Hu, YL; Baud, V; Oga, T; Kim, KII; Yoshida, K; Karin, M			IKK alpha controls formation of the epidermis independently of NF-kappa B	NATURE			English	Article							DEFICIENT MICE; KINASE COMPLEX; INCONTINENTIA PIGMENTI; SIGNAL-TRANSDUCTION; BETA SUBUNIT; ACTIVATION; SKIN; PHOSPHORYLATION; DIFFERENTIATION; APOPTOSIS	The IKK alpha and IKK beta catalytic subunits of I kappaB kinase (IKK) share 51% amino-acid identity and similar biochemical activities: they both phosphorylate I kappaB proteins at serines that trigger their degradation(1-4). IKK alpha and IKK beta differ, however, in their physiological functions. IKK beta and the IKK gamma /NEMO regulatory subunit are required for activating NF-kappaB by pro-inflammatory stimuli and preventing apoptosis induced by tumour necrosis factor-alpha (refs 5-11). IKK alpha is dispensable for these functions, but is essential for developing the epidermis and its derivatives(12-15). The mammalian epidermis is composed of the basal, spinous, granular and cornified layers(16). Only basal keratinocytes can proliferate and give rise to differentiated derivatives, which on full maturation undergo enucleation to generate the cornified layer. Curiously, keratinocyte-specific inhibition of NF-kappaB, as in Ikk alpha (-/-) mice(12-15), results in epidermal thickening but does not block terminal differentiation(17,18). It has been proposed(19,20) that the epidermal defect in Ikk alpha (-/-) mice may be due to the failed activation of NF-kappaB. Here we show that the unique function of IKK alpha in control of keratinocyte differentiation is not exerted through its I kappaB kinase activity or through NF-kappaB. Instead, IKK alpha controls production of a soluble factor that induces keratinocyte differentiation.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Baud, Veronique/AAL-3950-2020; KIM, KEUN IL/D-2959-2011; Baud, Veronique/F-7699-2013; Hu, Yinling/G-5682-2015	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Hu, Yinling/0000-0002-4795-8537				Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FISHER C, 1987, J CELL BIOL, V105, P1807, DOI 10.1083/jcb.105.4.1807; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; KNUCHEL R, 1990, VERH DEUT G, V74, P275; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; May MJ, 1999, SCIENCE, V284, P271, DOI 10.1126/science.284.5412.271; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MOCK BA, 1995, GENOMICS, V27, P348, DOI 10.1006/geno.1995.1054; OETTINGER MA, 1992, TRENDS GENET, V8, P413, DOI 10.1016/0168-9525(92)90323-V; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; ROTHWARF DM, 1999, SCI STKE        1026; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoshida K, 2000, INVEST OPHTH VIS SCI, V41, P3665; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	30	292	308	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					710	714		10.1038/35070605	http://dx.doi.org/10.1038/35070605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287960				2022-12-28	WOS:000167875400052
J	Schiermeier, Q				Schiermeier, Q			Network boost for southeast Europe	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					619	619		10.1038/35070760	http://dx.doi.org/10.1038/35070760			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287915	Bronze			2022-12-28	WOS:000167875400012
J	Yue, LX; Peng, JB; Hediger, MA; Clapham, DE				Yue, LX; Peng, JB; Hediger, MA; Clapham, DE			CaT1 manifests the pore properties of the calcium-release-activated calcium channel	NATURE			English	Article							INTRACELLULAR CA2+ STORES; JURKAT T-LYMPHOCYTES; MAST-CELLS; I-CRAC; DEPLETION; TRANSPORTER; PERMEATION; INFLUX	The calcium-release-activated Ca2+ channel, I-CRAC(1-3), is a highly Ca2+-selective ion channel that is activated on depletion of either intracellular Ca2+ levels or intracellular Ca2+ stores. The unique gating of I-CRAC has made it a favourite target of investigation for new signal transduction mechanisms; however, without molecular identification of the channel protein, such studies have been inconclusive. Here we show that the protein CaT1 (ref. 4), which has six membrane-spanning domains, exhibits the unique biophysical properties of I-CRAC when expressed in mammalian cells. Like I-CRAC, expressed CaT1 protein is Ca2+ selective, activated by a reduction in intracellular Ca2+ concentration, and inactivated by higher intracellular concentrations of Ca2+. The channel is indistinguishable from I-CRAC in the following features: sequence of selectivity to divalent cations; an anomalous mole fraction effect; whole-cell current kinetics; block by lanthanum; loss of selectivity in the absence of divalent cations; and single-channel conductance to Na+ in divalent-ion-free conditions. CaT1 is activated by both passive and active depletion of calcium stores. We propose that CaT1 comprises all or part of the I-CRAC pore.	Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Membrane Biol Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Hediger, Matthias/0000-0003-1946-027X				CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Fasolato C, 1998, PFLUG ARCH EUR J PHY, V436, P69, DOI 10.1007/s004240050605; Fierro L, 2000, J PHYSIOL-LONDON, V522, P247, DOI 10.1111/j.1469-7793.2000.t01-1-00247.x; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Hille B., 1992, IONIC CHANNELS EXCIT; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kerschbaum HH, 1998, J GEN PHYSIOL, V111, P521, DOI 10.1085/jgp.111.4.521; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; LEWIS RR, 1989, WETLAND CREATION RES, V2, P1; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; MONTERO M, 1990, BIOCHEM J, V271, P535, DOI 10.1042/bj2710535; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2000, J BIOL CHEM, V275, P28186; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PUTNEY JW, 1977, J PHYSIOL-LONDON, V268, P139, DOI 10.1113/jphysiol.1977.sp011851; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	22	271	295	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					705	709		10.1038/35070596	http://dx.doi.org/10.1038/35070596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287959				2022-12-28	WOS:000167875400051
J	Felson, DT; Chaisson, CE; Hill, CL; Totterman, SMS; Gale, ME; Skinner, KM; Kazis, L; Gale, DR				Felson, DT; Chaisson, CE; Hill, CL; Totterman, SMS; Gale, ME; Skinner, KM; Kazis, L; Gale, DR			The association of bone marrow lesions with pain in knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							HIP; SCINTIGRAPHY; EDEMA	Background: The cause of pain in osteoarthritis is unknown. Bone has pain fibers, and marrow lesions, which are thought to represent edema, have been noted in osteoarthritis. Objective: To determine whether bone marrow lesions on magnetic resonance imaging (MRI) are associated with pain in knee osteoarthritis. Design: Cross-sectional observational study. Setting: Veterans Affairs Medical Center. Patients: 401 persons (mean age, 66.8 years) with knee osteoarthritis on radiography who were drawn from clinics in the Veterans Administration health care system and from the community. Of these persons, 351 had knee pain and 50 had no knee pain. Measurements: Knee radiography and MRI of one knee were performed in all participants. Those with knee pain quantified the severity of their pain. On MRI, coronal T-2-weighted fat-saturated images were used to score the size of bone marrow lesions, and each knee was characterized as having any lesion or any large lesion, The prevalence of lesions acid large lesions in persons with and without knee pain was compared; in participants with knee pain, the presence of lesions was correlated with severity of pain. Results: Bone marrow lesions were found in 272 of 351 (77.5%) persons with painful knees compared with 15 of 50 (30%) persons with no knee pain (P < 0.001). Large lesions were present almost exclusively in persons with knee pain (35.9% vs. 2%; P < 0.001). After adjustment for severity of radiographic disease, effusion, age, and sex, lesions and large lesions remained associated with the occurrence of knee pain. Among persons with knee pain, bone marrow lesions were not associated with pain severity. Conclusions: Bone marrow lesions on MRI are strongly associated with the presence of pain in knee osteoarthritis.	Boston Univ, Arthrit Ctr, Boston Med Ctr, Vet Affairs Boston Healthcare Syst, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Vet Affairs Hlth Serv Res & Dev Field Program, Ctr Hlth Qual Outcomes & Econ Res, Boston, MA USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Bedford Vet Affairs Med Ctr, Bedford, MA USA	Boston Medical Center; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Rochester	Felson, DT (corresponding author), Boston Univ, Sch Med, 715 Albany St,A203, Boston, MA 02118 USA.		Hill, Catherine L/AAE-7152-2019	Hill, Catherine L/0000-0001-8289-4922; Felson, David/0000-0002-2668-2447; Kazis, Lewis/0000-0003-1800-5849; Chaisson, Christine/0000-0002-3207-9257	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020613] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR20613] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNOLDI CC, 1980, ACTA ORTHOP SCAND, V51, P19, DOI 10.3109/17453678008990764; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Boegard T, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.1.20; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; Chaisson CE, 2000, RHEUMATOLOGY, V39, P1218, DOI 10.1093/rheumatology/39.11.1218; Creamer P, 1996, J RHEUMATOL, V23, P1031; Felson DT, 1997, OSTEOARTHR CARTILAGE, V5, P241, DOI 10.1016/S1063-4584(97)80020-9; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Fleiss JL, 1981, STATISTICAL METHODS, P217; HADLER NM, 1992, ANN INTERN MED, V116, P598, DOI 10.7326/0003-4819-116-7-598; Hill CL, 1999, ARTHRITIS RHEUM, V42, pS294; HUTTON CW, 1986, ANN RHEUM DIS, V45, P622, DOI 10.1136/ard.45.8.622; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Koo KH, 1999, RADIOLOGY, V213, P715, DOI 10.1148/radiology.213.3.r99dc06715; McAlindon T, 1996, J RHEUMATOL, V23, P332; McNicholas MJ, 1999, J ROY COLL SURG EDIN, V44, P31; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; SPEER KP, 1992, AM J SPORT MED, V20, P382, DOI 10.1177/036354659202000403; WILSON AJ, 1988, RADIOLOGY, V167, P757, DOI 10.1148/radiology.167.3.3363136; WOJTYS E M, 1990, Arthroscopy, V6, P254, DOI 10.1016/0749-8063(90)90054-H; WYKE B, 1981, CLIN RHEUM DIS, V7, P223	22	679	709	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					541	549		10.7326/0003-4819-134-7-200104030-00007	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281736				2022-12-28	WOS:000167931200001
J	Beckingham, IJ; Krige, JEJ				Beckingham, IJ; Krige, JEJ			ABC of diseases of liver, pancreas, and biliary system	BRITISH MEDICAL JOURNAL			English	Review									Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa	University of Nottingham; University of Cape Town	Beckingham, IJ (corresponding author), Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England.		Krige, Jake E/G-3496-2015	Krige, Jake E/0000-0002-7057-9156				FELICIANO DV, 1994, HEPATOBILIARY PANCRE, P107; KRIGE JEJ, 1994, HEPATOBILIARY PANCRE, P421; PACHTER HL, 1995, AM J SURG, V169, P442	3	29	34	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					783	785		10.1136/bmj.322.7289.783	http://dx.doi.org/10.1136/bmj.322.7289.783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282870	Green Published			2022-12-28	WOS:000167943200032
J	Cousens, S; Smith, PG; Ward, H; Everington, D; Knight, RSG; Zeidler, M; Stewart, G; Smith-Bathgate, EAB; Macleod, MA; Mackenzie, J; Will, RG				Cousens, S; Smith, PG; Ward, H; Everington, D; Knight, RSG; Zeidler, M; Stewart, G; Smith-Bathgate, EAB; Macleod, MA; Mackenzie, J; Will, RG			Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000	LANCET			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; BSE; CJD; TRANSMISSION; CLUSTERS; HUMANS; UK	Background Geographical variation in the distribution of variant Creutzfeldt-Jakob disease (vCJD) might indicate the transmission route of the infectious agent to man. We investigated whether regional incidences of vCJD were correlated with regional dietary data. Methods The National CJD Surveillance Unit prospectively identified 84 people with vCJD up to Nov 10, 2000, in Great Britain. Their lifetime residential histories were obtained by interviews with a close relative. Cumulative incidences of vCJD by standard region were calculated. Grid references for places of residence in 1991 were identified and evidence of geographical clusters were sought. Data on diet in the 1980s were analysed for regional correlations with vCJD incidence. The socioeconomic status of the places of residence of people with vCJD was compared with that of the general population. Findings vCJD incidence was higher in the north of Great Britain than the south. The rate ratio (north vs south) was 1.94 (95% CI 1.27-2.98). The mean Carstairs' deprivation score for areas of residence of people with vCJD was -0.09 (-0.73 to 0.55), which is close to the national average of zero. Regional rates of vCJD were correlated with consumption of other meat or meat products as classified and recorded by the Household Food Consumption and Expenditure Survey (r=0.72), but not with data from the Dietary and Nutritional Survey of British Adults. Five people with vCJD in Leicestershire formed a cluster (p=0.004). Interpretation Regional differences in vCJD incidence are unlikely to be due to ascertainment bias. We had difficulty determining whether regional variations in diet might cause these differences, since the results of dietary analyses were inconsistent.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh	Cousens, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRYANT G, 2001, SUMMARY FINAL REPORT; Carstairs V., 1991, DEPRIVATION HLTH SCO; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cousens SN, 1999, LANCET, V353, P18, DOI 10.1016/S0140-6736(98)08062-3; *DEP HLTH, 2001, MONTHL CREUTZF JAK D; Gregory J., 1990, DIETARY NUTR SURVEY; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; *NAT CJD SURV UN L, 2000, CREUTZF JAK DIS SURV; *NAT FOOD SURV COM, 1989, HOUS FOOD CONS EXP 1; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; WILESMITH JW, 1988, VET REC, V123, P638; WILESMITH JW, 1993, VET REC, V132, P300, DOI 10.1136/vr.132.12.300; Will RG, 2000, ANN NEUROL, V47, P575; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will Robert G., 1996, P119	19	87	90	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1002	1007		10.1016/S0140-6736(00)04236-7	http://dx.doi.org/10.1016/S0140-6736(00)04236-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293592				2022-12-28	WOS:000167791500010
J	Alam, M; Ratner, D				Alam, M; Ratner, D			Primary care: Cutaneous squamous-cell carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NONMELANOMA SKIN-CANCER; POPULATION-BASED INCIDENCE; MOHS MICROGRAPHIC SURGERY; ACTINIC KERATOSES; RISK-FACTORS; TRANSPLANT RECIPIENTS; ULTRAVIOLET-RADIATION; SURGICAL MARGINS; LOCAL RECURRENCE; BASAL		Columbia Presbyterian Med Ctr, Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital	Ratner, D (corresponding author), Columbia Presbyterian Med Ctr, Coll Phys & Surg, Dept Dermatol, 161 Ft Washington Ave,12th Fl, New York, NY 10032 USA.	dr221@columbia.edu		Ratner, Desiree/0000-0002-1217-1929				ABIDE JM, 1984, PLAST RECONSTR SURG, V73, P492, DOI 10.1097/00006534-198403000-00030; Baron JM, 1999, J AM ACAD DERMATOL, V40, P633, DOI 10.1016/S0190-9622(99)70451-2; Bastin KT, 1997, AM J CLIN ONCOL-CANC, V20, P55, DOI 10.1097/00000421-199702000-00012; BRODLAND DG, 1992, J AM ACAD DERMATOL, V27, P1, DOI 10.1016/0190-9622(92)70146-7; BRODLAND DG, 1992, J AM ACAD DERMATOL, V27, P241, DOI 10.1016/0190-9622(92)70178-I; Callen JP, 1997, J AM ACAD DERMATOL, V36, P650, DOI 10.1016/S0190-9622(97)70265-2; CHERNOSKY ME, 1978, SOUTH MED J, V71, P802, DOI 10.1097/00007611-197807000-00019; CHERNOSKY ME, 1987, SOUTH MED J, V71, P806; Cohn BA, 1998, J AM ACAD DERMATOL, V39, P134, DOI 10.1016/S0190-9622(98)70419-0; Cook J, 1998, J AM ACAD DERMATOL, V39, P698, DOI 10.1016/S0190-9622(98)70041-6; Cowen EW, 1999, J AM ACAD DERMATOL, V40, P697, DOI 10.1016/S0190-9622(99)70149-0; Cribier B, 1999, DERMATOLOGY, V199, P208, DOI 10.1159/000018276; CZARNECKI D, 1994, DERMATOLOGY, V189, P52, DOI 10.1159/000246783; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; DAVIS MM, 1989, J AM ACAD DERMATOL, V20, P608, DOI 10.1016/S0190-9622(89)70072-4; Denic S, 1999, AM J CLIN ONCOL-CANC, V22, P32, DOI 10.1097/00000421-199902000-00008; DINEHART SM, 1989, J AM ACAD DERMATOL, V21, P241, DOI 10.1016/S0190-9622(89)70168-7; Dinehart SM, 1997, CANCER, V79, P920, DOI 10.1002/(SICI)1097-0142(19970301)79:5<920::AID-CNCR8>3.0.CO;2-F; DRAKE LA, 1993, J AM ACAD DERMATOL, V28, P628, DOI 10.1016/S0190-9622(08)81782-3; DZUBOW LM, 1982, ARCH DERMATOL, V118, P900, DOI 10.1001/archderm.118.11.900; English DR, 1998, INT J CANCER, V76, P628, DOI 10.1002/(SICI)1097-0215(19980529)76:5<628::AID-IJC3>3.0.CO;2-S; EPSTEIN E, 1968, ARCH DERMATOL, V97, P245, DOI 10.1001/archderm.97.3.245; EUVRARD S, 1995, TRANSPLANT P, V27, P1767; FEARS TR, 1983, CANCER INVEST, V1, P119; FITZPATRICK PJ, 1985, AM J CLIN ONCOL-CANC, V8, P468, DOI 10.1097/00000421-198512000-00004; FLEMING ID, 1995, CANCER, V75, P699, DOI 10.1002/1097-0142(19950115)75:2+<699::AID-CNCR2820751413>3.0.CO;2-Q; FORMAN AB, 1989, ARCH DERMATOL, V125, P515, DOI 10.1001/archderm.125.4.515; FRANKEL DH, 1992, J AM ACAD DERMATOL, V26, P720, DOI 10.1016/0190-9622(92)70100-T; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P164, DOI 10.1001/archderm.131.2.164; GALLAGHER RP, 1990, J AM ACAD DERMATOL, V23, P413, DOI 10.1016/0190-9622(90)70234-9; GLASS AG, 1989, JAMA-J AM MED ASSOC, V262, P2097, DOI 10.1001/jama.262.15.2097; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; GRAHAM GF, 1990, CLIN DERMATOL, V8, P101, DOI 10.1016/0738-081X(90)90072-9; Gray DT, 1997, ARCH DERMATOL, V133, P735, DOI 10.1001/archderm.133.6.735; GREEN A, 1990, INT J CANCER, V46, P356, DOI 10.1002/ijc.2910460303; Grekin RC, 1998, CUTANEOUS ONCOLOGY P, P506; Grossman D, 1997, ARCH DERMATOL, V133, P1263, DOI 10.1001/archderm.133.10.1263; Guenthner ST, 1999, J AM ACAD DERMATOL, V41, P443, DOI 10.1016/S0190-9622(99)70119-2; HACKER SM, 1993, POSTGRAD MED, V93, P115; Hacker SM, 1993, POSTGRAD MED, V93, P125; Holmkvist KA, 1998, J AM ACAD DERMATOL, V38, P960, DOI 10.1016/S0190-9622(98)70160-4; HONEYCUTT WM, 1973, ARCH DERMATOL, V108, P670, DOI 10.1001/archderm.108.5.670; Hoy WE, 1996, CANCER, V77, P2489, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2489::AID-CNCR11>3.0.CO;2-O; HURWITZ RM, 1995, DERMATOL SURG, V21, P184, DOI 10.1111/j.1524-4725.1995.tb00141.x; JACKSON A, 1995, BRIT J GEN PRACT, V45, P97; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; JOHNSON TM, 1992, J AM ACAD DERMATOL, V26, P467, DOI 10.1016/0190-9622(92)70074-P; KEELER CLYDE E., 1963, NATL CANCER INST MONOGR, V10, P349; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; KWA RE, 1992, J AM ACAD DERMATOL, V26, P1, DOI 10.1016/0190-9622(92)70001-V; LAWRENCE N, 1994, J AM ACAD DERMATOL, V31, P30, DOI 10.1016/S0190-9622(94)70131-8; Liang SB, 1999, VIRCHOWS ARCH, V434, P193, DOI 10.1007/s004280050327; Lippman SM, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P219; McGregor JM, 1996, CANCER SURV, V26, P219; MERIMSKY O, 1992, ANTI-CANCER DRUG, V3, P481, DOI 10.1097/00001813-199210000-00006; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; NOVICK M, 1977, J TRAUMA, V17, P809, DOI 10.1097/00005373-197710000-00010; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; REIZNER GT, 1994, J AM ACAD DERMATOL, V31, P596, DOI 10.1016/S0190-9622(94)70222-5; RHODES AR, 1995, CANCER, V75, P613, DOI 10.1002/1097-0142(19950115)75:2+<613::AID-CNCR2820751403>3.0.CO;2-G; ROBINS P, 1981, J DERMATOL SURG ONC, V7, P800, DOI 10.1111/j.1524-4725.1981.tb00168.x; Rosenblatt L, 1996, Australas J Dermatol, V37, P26, DOI 10.1111/j.1440-0960.1996.tb00990.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; RUNDEL RD, 1983, PHOTOCHEM PHOTOBIOL, V38, P569, DOI 10.1111/j.1751-1097.1983.tb03385.x; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; SCHWARTZ RA, 1994, J AM ACAD DERMATOL, V30, P1, DOI 10.1016/S0190-9622(94)70001-X; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805; Suchniak JM, 1997, J AM ACAD DERMATOL, V37, P392, DOI 10.1016/S0190-9622(97)70137-3; Veness MJ, 1999, CANCER, V85, P1758, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F; WEINSTOCK MA, 1991, ARCH DERMATOL, V127, P1194, DOI 10.1001/archderm.127.8.1194; Weinstock MA, 1997, ARCH DERMATOL, V133, P1207, DOI 10.1001/archderm.133.10.1207; Yantsos VA, 1999, SEMIN CUTAN MED SURG, V18, P3, DOI 10.1016/S1085-5629(99)80003-0; ZACKHEIM HS, 1964, J INVEST DERMATOL, V43, P519, DOI 10.1038/jid.1964.194	73	838	872	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					975	983		10.1056/NEJM200103293441306	http://dx.doi.org/10.1056/NEJM200103293441306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415HY	11274625				2022-12-28	WOS:000167716600006
J	Iglehart, JK				Iglehart, JK			Medicare and prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HMO											ALLEN M, 2001, WASH POST       0321, pA6; Berndt ER, 2001, HEALTH AFFAIR, V20, P100, DOI 10.1377/hlthaff.20.2.100; BUSH GW, 2000, MODERNIZING MED OFFE; *C BUDG OFF, 1996, MED REB PRESCR DRUGS; Cook A, 2000, ROLE PBMS MANAGING D; DAO J, 2000, NY TIMES        0908, pA17; *DEP HLTH HUM SERV, 2000, PRESCR DRUG COV SPEN; *DEP VET AFF, 2000, FED SUPPL SCHED; Dubois RW, 2000, HEALTH AFFAIR, V19, P231, DOI 10.1377/hlthaff.19.2.231; Etheredge L, 1999, HEALTH AFFAIR, V18, P7, DOI 10.1377/hlthaff.18.4.7; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; FREUDENHEIM M, 2000, NY TIMES        1231, pC8; *GEN ACC OFF, 2000, PRESCR DRUGS EXP ACC; *GEN ACC OFF, 2000, MED PLUS CHOIC PAYM; *GEN ACC OFF, 1997, MED HMOS HCFA CAN PR; HAMBURGER T, 2000, WALL STREE J    1109, pB1; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; *HJ KAIS FAM FDN, 2000, NEWSH J LEHR KAIS FA; Huskamp HA, 2000, HEALTH AFFAIR, V19, P8, DOI 10.1377/hlthaff.19.2.8; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; *IMS HLTH, 2000, PHARM IND PROF 2000; KEITH A, 2000, PHARM PRICES WHATS M, V1, P3; Kleinke JD, 2000, HEALTH AFFAIR, V19, P78, DOI 10.1377/hlthaff.19.2.78; MCARDLE F, 2000, IMPLICATIONS MED PRE; *MED EC, 2000, RED BOOK UPD; MOON M, 1993, MED NOW FUTURE; PEAR R, 2001, NY TIMES        0224, pA7; Pear Robert, 1999, N Y Times Web, pA20; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; REINHARDT UE, 2001, NY TIMES        0102, pA19; Riley G, 1996, HEALTH CARE FINANC R, V17, P65; Steinberg EP, 2000, HEALTH AFFAIR, V19, P198, DOI 10.1377/hlthaff.19.2.198; Thomas J, 2000, NY TIMES        1231, pA14; Vladeck BC, 1999, NEW ENGL J MED, V340, P1503, DOI 10.1056/NEJM199905133401911; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; *WM MERC CO, 1998, MERC FOST HIGG NAT S	36	30	31	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2001	344	13					1010	1015		10.1056/NEJM200103293441311	http://dx.doi.org/10.1056/NEJM200103293441311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415HY	11274630				2022-12-28	WOS:000167716600011
J	Muhr, J; Andersson, E; Persson, M; Jessell, TM; Ericson, J				Muhr, J; Andersson, E; Persson, M; Jessell, TM; Ericson, J			Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube	CELL			English	Article							SONIC HEDGEHOG; DROSOPHILA-ENHANCER; GENE-EXPRESSION; NERVOUS-SYSTEM; DEVELOPING CNS; HOMEODOMAIN; IDENTITY; SPECIFICATION; CLONING; MOUSE	The pattern of neuronal specification in the ventral neural tube is controlled by homeodomain transcription factors expressed by neural progenitor cells, but no general logic has emerged to explain how these proteins determine neuronal fate. We show that most of these homeodomain proteins possess a conserved ehl motif that mediates the recruitment of Gro/TLE corepressors. The ehl motif underlies the function of these proteins as repressors during neural patterning in vivo. Inhibition of Gro/TLE-mediated repression in vivo results in a deregulation of cell pattern in the neural tube. These results imply that the pattern of neurogenesis in the neural tube is achieved through the spatially controlled repression of transcriptional repressors-a derepression strategy of neuronal fate specification.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Karolinska Institutet; Columbia University; Howard Hughes Medical Institute	Ericson, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@cmb.ki.se	Lek, Madelen/AGZ-3906-2022	Ericson, Johan/0000-0002-8019-7127; andersson, elisabet/0000-0003-3095-465X				Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Ma QF, 1997, J NEUROSCI, V17, P3644; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smith ST, 1996, DEVELOPMENT, V122, P3141; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764	46	314	317	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					861	873		10.1016/S0092-8674(01)00283-5	http://dx.doi.org/10.1016/S0092-8674(01)00283-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290324	Bronze			2022-12-28	WOS:000167869200009
J	McCune, JM				McCune, JM			The dynamics of CD4(+) T-cell depletion in HIV disease	NATURE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; VIRAL DYNAMICS; RAPID TURNOVER; INFECTION; LYMPHOCYTES; KINETICS; HOMEOSTASIS	The size and composition of the CD4(+) T-cell population is regulated by balanced proliferation of progenitor cells and death of mature progeny. After infection with the human immunodeficiency virus, this homeostasis is often disturbed and CD4(+) T cells are instead depleted. Such depletion cannot result simply from accelerated destruction of mature CD4(+) T cells - sources of T-cell production must also fail. Ironically, this failure may be precipitated by physiological mechanisms designed to maintain homeostasis in the face of accelerated T-cell loss.	Univ Calif San Francisco, Dept Med, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.	mmccune@gladstone.ucsf.edu						Ahsan N, 1998, SEMIN NEPHROL, V18, P422; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Anderson RW, 1998, J ACQ IMMUN DEF SYND, V17, P245, DOI 10.1097/00042560-199803010-00010; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Belanger F, 1997, INT J EPIDEMIOL, V26, P1340, DOI 10.1093/ije/26.6.1340; Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; BISHOP DK, 1990, J IMMUNOL, V144, P1153; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; BUJDOSO R, 1989, EUR J IMMUNOL, V19, P1779, DOI 10.1002/eji.1830191003; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cao J, 1996, J VIROL, V70, P1340, DOI 10.1128/JVI.70.3.1340-1354.1996; Casella C R, 1997, Curr Opin Hematol, V4, P24; Chene L, 1999, J VIROL, V73, P7533; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Crowe SM, 1995, AUST NZ J MED, V25, P777, DOI 10.1111/j.1445-5994.1995.tb02881.x; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; DEEKS SG, UNPUB P NATL ACAD SC; DIMITROV DS, 1995, NATURE, V375, P194, DOI 10.1038/375194b0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; DSOUZA MP, 1999, TXB AIDS MED, P59; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; Fleury S, 1998, NAT MED, V4, P794, DOI 10.1038/nm0798-794; FRY TJ, IN PRESS BLOOD; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Globerson A, 2000, IMMUNOL TODAY, V21, P515, DOI 10.1016/S0167-5699(00)01714-X; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; Grossman Z, 1997, NAT MED, V3, P486, DOI 10.1038/nm0597-486; GROSSMAN Z, 1993, CLIN IMMUNOL IMMUNOP, V69, P123, DOI 10.1006/clin.1993.1160; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hellerstein MK, 1999, IMMUNOL TODAY, V20, P438, DOI 10.1016/S0167-5699(99)01529-7; Hengel RL, 1999, J IMMUNOL, V163, P3539; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang SS, 2000, CLIN INFECT DIS, V30, P504, DOI 10.1086/313714; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kirschner D, 2000, J ACQ IMMUN DEF SYND, V24, P352; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; McCune J M, 1997, Semin Immunol, V9, P397, DOI 10.1006/smim.1997.0098; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; MCCUNE JM, 1991, CELL, V64, P351, DOI 10.1016/0092-8674(91)90644-E; MCCUNE JM, 1995, HUMAN HEMATOPOIESIS, P129; Mitra DK, 1999, INT IMMUNOL, V11, P1801, DOI 10.1093/intimm/11.11.1801; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; MOSLER DE, 1995, NATURE, V375, P193, DOI 10.1038/375193b0; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg YJ, 1999, SEMIN IMMUNOL, V11, P139, DOI 10.1006/smim.1999.0169; ROSENBERG YJ, 1993, AIDS RES HUM RETROV, V9, P639, DOI 10.1089/aid.1993.9.639; Rosok BI, 1996, AIDS, V10, pF35, DOI 10.1097/00002030-199609000-00001; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Smith KY, 2000, J INFECT DIS, V181, P141, DOI 10.1086/315169; SPRENT J, 1995, NATURE, V375, P194, DOI 10.1038/375194a0; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; STODDART CA, IN PRESS NATURE MED; SU L, 1995, IMMUNITY, V2, P25, DOI 10.1016/1074-7613(95)90076-4; WAINHOBSON S, 1995, NATURE, V373, P102, DOI 10.1038/373102a0; Wang LQ, 1999, J IMMUNOL, V162, P268; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WESTERMANN J, 1990, IMMUNOL TODAY, V9, P43; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zhang ZQ, 1998, P NATL ACAD SCI USA, V95, P1154, DOI 10.1073/pnas.95.3.1154; ZINKERNAGEL RM, 1995, CURR OPIN IMMUNOL, V7, P462, DOI 10.1016/0952-7915(95)80089-1	81	402	415	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					974	979		10.1038/35073648	http://dx.doi.org/10.1038/35073648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309627				2022-12-28	WOS:000168152300057
J	Katz, SL; Syme, DA; Shadwick, RE				Katz, SL; Syme, DA; Shadwick, RE			Enhanced power in yellowfin tuna	NATURE			English	Article							RED MUSCLE; SCOMBRID FISHES; STEADY; LOCOMOTION; ACTIVATION; OUTPUT		Biol Lab Open Water Mech Engn, Oxnard, CA 93035 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92039 USA	University of Calgary; University of California System; University of California San Diego; Scripps Institution of Oceanography	Katz, SL (corresponding author), Biol Lab Open Water Mech Engn, 3241 Ocean Dr, Oxnard, CA 93035 USA.							ALTRINGHAM JD, 1990, J EXP BIOL, V148, P395; Fierstine H.L., 1968, MEM STH CALIF ACAD S, V6, P1, DOI DOI 10.5962/BHL.TITLE.146943; GRAHAM JB, 1983, CAN J ZOOL, V61, P2087, DOI 10.1139/z83-274; JOSEPHSON RK, 1985, J EXP BIOL, V114, P493; Katz SL, 1999, J EXP BIOL, V202, P529; Knower T, 1999, J EXP BIOL, V202, P2127; Korsmeyer KE, 1996, COMP BIOCHEM PHYS B, V113, P45, DOI 10.1016/0305-0491(95)02044-6; Magnuson J.J., 1979, FISH PHYSIOL, V7, P239, DOI DOI 10.1016/S1546-5098(08)60166-1; Shadwick RE, 1999, J EXP BIOL, V202, P2139; WESTNEAT MW, 1993, J MORPHOL, V217, P183, DOI 10.1002/jmor.1052170207	10	41	44	3	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					770	771		10.1038/35071170	http://dx.doi.org/10.1038/35071170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298434				2022-12-28	WOS:000168021900040
J	Glikson, M; Friedman, PA				Glikson, M; Friedman, PA			The implantable cardioverter defibrillator	LANCET			English	Review							AMERICAN-HEART-ASSOCIATION; VENTRICULAR-TACHYCARDIA; ATRIAL-FIBRILLATION; TIERED-THERAPY; ANTIARRHYTHMIC-DRUGS; CLINICAL-EXPERIENCE; SUDDEN-DEATH; INTERFERENCE; MANAGEMENT; PACEMAKER	Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are symptomless, Use of an ICD will affect the patient's quality of life, Some drugs can substantially affect defibrillator function and efficacy, and possible drug-device interactions should be considered. Patients with ICDs may encounter cell phones, antitheft detectors, and many other sources of potential electromagnetic interference, In addition to treating ventricular tachyarrhythmias, new defibrillators provide full featured dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means of biventricular pacing.	Mayo Clin & Mayo Fdn, Div Cardiovasc Med, Rochester, MN 55905 USA; Tel Aviv Univ, Chaim Sheba Med Ctr, Inst Heart, Tel Hashomer, Israel	Mayo Clinic; Chaim Sheba Medical Center; Tel Aviv University	Friedman, PA (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Med, 200 1st St SW, Rochester, MN 55905 USA.	pfriedman@mayo.edu						BARDY GH, 1992, CIRCULATION, V85, P1689, DOI 10.1161/01.CIR.85.5.1689; Bardy GH, 1996, J AM COLL CARDIOL, V28, P400, DOI 10.1016/0735-1097(96)00157-X; BARDY GH, 1993, CIRCULATION, V87, P1152, DOI 10.1161/01.CIR.87.4.1152; Belhassen B, 1999, J CARDIOVASC ELECTR, V10, P1301, DOI 10.1111/j.1540-8167.1999.tb00183.x; Best PJM, 1999, PACE, V22, P79, DOI 10.1111/j.1540-8159.1999.tb00303.x; Blanc JJ, 1997, CIRCULATION, V96, P3273; BLOCK M, 1995, CARDIAC ELECTROPHYSI; Brady PA, 1998, J AM COLL CARDIOL, V31, P616, DOI 10.1016/S0735-1097(97)00529-9; BRADY PA, 1995, AM J CARDIOL, V76, P580, DOI 10.1016/S0002-9149(99)80159-3; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Delfaut P, 1998, J AM COLL CARDIOL, V32, P1900, DOI 10.1016/S0735-1097(98)00489-6; Domanski MJ, 1999, J AM COLL CARDIOL, V34, P1090, DOI 10.1016/S0735-1097(99)00327-7; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Fetter JG, 1996, J AM COLL CARDIOL, V28, P423, DOI 10.1016/0735-1097(96)00147-7; Fetter JG, 1998, J AM COLL CARDIOL, V31, P623, DOI 10.1016/S0735-1097(97)00546-9; Fotuhi PC, 1999, AM J CARDIOL, V83, p24D; FRIEDMAN PA, 1995, J CARDIOVASC ELECTR, V6, P48, DOI 10.1111/j.1540-8167.1995.tb00757.x; Friedman PA, 1999, PACE, V22, P1186, DOI 10.1111/j.1540-8159.1999.tb00599.x; Friedman PA, 1999, CIRCULATION, V100, P69; Glikson M, 2000, J CARDIOVASC ELECTR, V11, P127, DOI 10.1111/j.1540-8167.2000.tb00311.x; GOLDSCHLAGER N, IN PRESS ARCH INTERN; Gras D, 1998, PACE, V21, P2249, DOI 10.1111/j.1540-8159.1998.tb01162.x; Gregoratos G, 1998, CIRCULATION, V97, P1325, DOI 10.1161/01.CIR.97.13.1325; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; HAMMILL SC, 1995, PACE, V18, P3, DOI 10.1111/j.1540-8159.1995.tb02469.x; Harthorne JW, 1999, NEW ENGL J MED, V340, P1117; Hayes DL, 1996, PACE, V19, P1419, DOI 10.1111/j.1540-8159.1996.tb03154.x; Higgins SL, 2000, PACE, V23, P18, DOI 10.1111/j.1540-8159.2000.tb00645.x; HOOK BG, 1993, CIRCULATION, V87, P1897, DOI 10.1161/01.CIR.87.6.1897; KELLY PA, 1988, J AM COLL CARDIOL, V11, P1278, DOI 10.1016/0735-1097(88)90292-6; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; LEHMANN MH, 1991, PACE, V14, P969, DOI 10.1111/j.1540-8159.1991.tb04143.x; Link MS, 1997, J AM COLL CARDIOL, V29, P370, DOI 10.1016/S0735-1097(96)00477-9; LLOYD M, 2000, CARDIAC PACING DEFIB, P247; LURIA D, IN PRESS AM J CARDIO; LURIA D, 1999, PACE, V22, P705; Marchlinski FE, 1995, CARDIAC ELECTROPHYSI, P863; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; McIvor ME, 1998, PACE, V21, P1847, DOI 10.1111/j.1540-8159.1998.tb00002.x; Miller JM, 1996, J CARDIOVASC ELECTR, V7, P278, DOI 10.1111/j.1540-8167.1996.tb00528.x; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2000, CIRCULATION, V101, P1638; Nair M, 1997, CIRCULATION, V95, P967; Neuzner J, 1999, AM J CARDIOL, V83, p34D; Petch MC, 1998, EUR HEART J, V19, P1165; PINSKI SL, 1995, ANN INTERN MED, V122, P770, DOI 10.7326/0003-4819-122-10-199505150-00007; Santucci PA, 1998, NEW ENGL J MED, V339, P1371, DOI 10.1056/NEJM199811053391905; Saxon LA, 1999, AM J CARDIOL, V83, p120D; Schaumann A, 1998, CIRCULATION, V97, P66, DOI 10.1161/01.CIR.97.1.66; Sheldon R, 2000, CIRCULATION, V101, P1660; Stellbrink C, 1999, AM J CARDIOL, V83, p143D; SWERDLOW CD, 1994, J AM COLL CARDIOL, V24, P416, DOI 10.1016/0735-1097(94)90298-4; SWERDLOW CD, 1994, J AM COLL CARDIOL, V23, P1342, DOI 10.1016/0735-1097(94)90376-X; Swerdlow CD, 2000, CIRCULATION, V101, P878, DOI 10.1161/01.CIR.101.8.878; Trusty JM, 2000, PACE, V23, P842, DOI 10.1111/j.1540-8159.2000.tb00853.x; Viskin S, 1998, PROG CARDIOVASC DIS, V41, P17, DOI 10.1016/S0033-0620(98)80020-0; Wellens HJJ, 1998, CIRCULATION, V98, P1651, DOI 10.1161/01.CIR.98.16.1651; WIETHOLT D, 1993, J AM COLL CARDIOL, V21, P885, DOI 10.1016/0735-1097(93)90343-Y	61	69	70	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1107	1117		10.1016/S0140-6736(00)04263-X	http://dx.doi.org/10.1016/S0140-6736(00)04263-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297981				2022-12-28	WOS:000167996200031
J	Hoerling, MP; Hurrell, JW; Xu, TY				Hoerling, MP; Hurrell, JW; Xu, TY			Tropical origins for recent North Atlantic climate change	SCIENCE			English	Article							MODEL ASSESSMENT; EL NINO; OSCILLATION; MIDLATITUDE; VARIABILITY; TRENDS; TELECONNECTIONS	Evidence is presented that North Atlantic climate change since 1950 is linked to a progressive warming of tropical sea surface temperatures, especially over the Indian and Pacific Oceans. The ocean changes alter the pattern and magnitude of tropical rainfall and atmospheric heating, the atmospheric response to which includes the spatial structure of the North Atlantic Oscillation (NAO), The slow, tropical ocean warming has thus forced a commensurate trend toward one extreme phase of the NAO during the past half-century.	NOAA, Climate Diagnost Ctr, Environm Res Labs, Boulder, CO 80303 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA	Hoerling, MP (corresponding author), NOAA, Climate Diagnost Ctr, Environm Res Labs, Boulder, CO 80303 USA.	mph@cdc.noaa.gov		Hurrell, James Wilson/0000-0002-3169-6384				ALEXANDER MA, 1992, J CLIMATE, V5, P944, DOI 10.1175/1520-0442(1992)005<0944:MAIDEN>2.0.CO;2; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; FLOHN H, 1989, NATURE, V338, P244, DOI 10.1038/338244a0; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; GRAHAM NE, 1994, J CLIMATE, V7, P1416, DOI 10.1175/1520-0442(1994)007<1416:OTROTA>2.0.CO;2; Hoerling MP, 2001, GEOPHYS RES LETT, V28, P755, DOI 10.1029/2000GL012137; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; Knutson TR, 1998, J CLIMATE, V11, P2273, DOI 10.1175/1520-0442(1998)011<2273:MAODVA>2.0.CO;2; Mehta VM, 2000, GEOPHYS RES LETT, V27, P121, DOI 10.1029/1999GL002381; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; Rajagopalan B, 1998, GEOPHYS RES LETT, V25, P3967, DOI 10.1029/1998GL900065; Robertson AW, 2000, J CLIMATE, V13, P122, DOI 10.1175/1520-0442(2000)013<0122:TIOASS>2.0.CO;2; Robinson W., 2000, B AM METEOROL SOC, V81, P567, DOI DOI 10.1175/1520-0477(2000)081; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; Saravanan R, 2000, J CLIMATE, V13, P2177, DOI 10.1175/1520-0442(2000)013<2177:IBTAVA>2.0.CO;2; Saravanan R, 1998, J CLIMATE, V11, P1386, DOI 10.1175/1520-0442(1998)011<1386:ALFVAI>2.0.CO;2; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; SUTTON RT, IN PRESS ATMOS SCI L; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; Yamazaki K, 1999, J METEOROL SOC JPN, V77, P1287, DOI 10.2151/jmsj1965.77.6_1287	28	480	498	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					90	92		10.1126/science.1058582	http://dx.doi.org/10.1126/science.1058582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292869	Green Accepted			2022-12-28	WOS:000167995200043
J	Lewin, RA				Lewin, RA			Why rename things?	NATURE			English	Editorial Material									Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Lewin, RA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.							Knapp S, 2000, NATURE, V408, P33, DOI 10.1038/35040663	1	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					637	637		10.1038/35070679	http://dx.doi.org/10.1038/35070679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287930	Bronze			2022-12-28	WOS:000167875400025
J	Wes, PD; Bargmann, CI				Wes, PD; Bargmann, CI			C-elegans odour discrimination requires asymmetric diversity in olfactory neurons	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; CHEMOTAXIS; RESPONSES; ENCODES	Caenorhabditis elegans senses at least five attractive odours with a single pair of olfactory neurons, AWC, but can distinguish among these odours in behavioural assays(1). The two AWC neurons are structurally and functionally similar, but the G-protein-coupled receptor STR-2 is randomly expressed in either the left or the right AWC neuron, never in both(2). Here we describe the isolation of a mutant, ky542, with specific defects in odour discrimination and odour chemotaxis. ky542 is an allele of nsy-1, a neuronal symmetry, or Nsy, mutant in which STR-2 is expressed in both AWC neurons(2). Other Nsy mutants exhibit discrimination and olfactory defects like those of nsy-1 mutants. Laser ablation of the AWC neuron that does not express STR-2 (AWC(OFF)) recapitulates the behavioural phenotype of Nsy mutants, whereas laser ablation of the STR-2-expressing AWC neuron (AWC(ON)) causes different chemotaxis defects. We propose that odour discrimination can be achieved by segregating the detection of different odours into distinct olfactory neurons or into unique combinations of olfactory neurons.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Wes, Paul/0000-0002-8903-3102; Bargmann, Cornelia/0000-0002-8484-0618				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Chou JH, 2001, GENETICS, V157, P211; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Weinshenker D, 1999, J NEUROSCI, V19, P9831	17	166	170	3	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					698	701		10.1038/35070581	http://dx.doi.org/10.1038/35070581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287957				2022-12-28	WOS:000167875400049
J	Schwetz, BA				Schwetz, BA			Drug for esophagitis and GERD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-28	WOS:000167710600004
J	Giraud, A; Matic, I; Tenaillon, O; Clara, A; Radman, M; Fons, M; Taddei, F				Giraud, A; Matic, I; Tenaillon, O; Clara, A; Radman, M; Fons, M; Taddei, F			Costs and benefits of high mutation rates: Adaptive evolution of bacteria in the mouse gut	SCIENCE			English	Article							ESCHERICHIA-COLI; POPULATIONS; COMPETITION; GENETICS; MUTATORS; STRAINS; CANCER	We have shown that bacterial mutation rates change during the experimental colonization of the mouse gut. A high mutation rate was initially beneficial because it allowed faster adaptation, but this benefit disappeared once adaptation was achieved. Mutator bacteria accumulated mutations that. although neutral in the mouse gut, are often deleterious in secondary environments. Consistently, the competitiveness of mutator bacteria is reduced during transmission to and re-colonization of similar hosts. The short-term advantages and long-term disadvantages of mutator bacteria could account for their frequency in nature.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, E9916, F-75015 Paris, France; INRA, UEPSD FBI, F-78352 Jouy En Josas, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Taddei, F (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, E9916, 156 Rue Vaugirard, F-75015 Paris, France.	taddei@necker.fr	Tenaillon, Olivier/L-9857-2017; Giraud, Antoine/V-5368-2018; Radman, Miroslav/HDM-5955-2022	Giraud, Antoine/0000-0002-8559-5781; Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365; Fons, Michel/0000-0001-8263-3669; Tenaillon, Olivier/0000-0002-3796-1601				Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Funchain P, 2000, GENETICS, V154, P959; GROSS MD, 1981, MUTAT RES, V91, P107, DOI 10.1016/0165-7992(81)90081-6; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Picard B, 2001, INFECT IMMUN, V69, P9, DOI 10.1128/IAI.69.1.9-14.2001; RADMAN M, 1995, PHILOS T ROY SOC B, V347, P97, DOI 10.1098/rstb.1995.0015; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tenaillon O, 1999, GENETICS, V152, P485; TROBNER W, 1984, MOL GEN GENET, V198, P175, DOI 10.1007/BF00328719; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282	19	361	368	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2606	2608		10.1126/science.1056421	http://dx.doi.org/10.1126/science.1056421			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283373				2022-12-28	WOS:000167861000043
J	Kaplan, NM				Kaplan, NM			Cautions over the current epidemic of primary aldosteronism	LANCET			English	Editorial Material							PHEOCHROMOCYTOMA		Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kaplan, NM (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	norman.kaplan@utsouthwestern.edu						ANDERSEN GS, 1988, J HUM HYPERTENS, V2, P187; BUHLER FR, 1973, AM J CARDIOL, V32, P554, DOI 10.1016/S0002-9149(73)80047-5; CONN JW, 1965, J AMER MED ASSOC, V193, P200, DOI 10.1001/jama.1965.03090030022005; DUNN PJ, 1976, AUST NZ J MED, V6, P131, DOI 10.1111/j.1445-5994.1976.tb03306.x; FISHMAN LM, 1968, J AMER MED ASSOC, V205, P854; GALLAY BJ, IN PRESS AM J KIDNEY; Ganguly A, 1998, NEW ENGL J MED, V339, P1828, DOI 10.1056/NEJM199812173392507; Ghose RP, 1999, ANN INTERN MED, V131, P105, DOI 10.7326/0003-4819-131-2-199907200-00005; GORDON RD, 1994, LANCET, V344, P240, DOI 10.1016/S0140-6736(94)93003-1; HAMLET SM, 1985, CLIN EXP PHARMACOL P, V12, P249, DOI 10.1111/j.1440-1681.1985.tb02641.x; He F, 2000, J HYPERTENS, V18, pS53; HIRAMATSU K, 1981, ARCH INTERN MED, V141, P1589, DOI 10.1001/archinte.141.12.1589; KAPLAN NM, 1969, ARCH INTERN MED, V123, P152, DOI 10.1001/archinte.123.2.152; KAPLAN NM, 1998, PRIMARY HYPERTENSION, P60; LACK EE, 1990, CONT ISSUES SURGICAL, V14, P75; LIM PO, 1999, BR J CLIN PHARM, V131, P105; McAlister FA, 1998, CAN J SURG, V41, P299; MCKENNA TJ, 1990, J CLIN ENDOCR METAB, V78, P952; Montori V, 2000, J HYPERTENS, V18, pS84; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Young WF, 1997, ENDOCRIN METAB CLIN, V26, P801, DOI 10.1016/S0889-8529(05)70283-8	21	78	81	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2001	357	9260					953	954		10.1016/S0140-6736(00)04223-9	http://dx.doi.org/10.1016/S0140-6736(00)04223-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289366				2022-12-28	WOS:000167625300035
J	Shkolnikov, V; McKee, M; Leon, DA				Shkolnikov, V; McKee, M; Leon, DA			Changes in life expectancy in Russia in the mid-1990s	LANCET			English	Article							MORTALITY; ALCOHOL; CONSUMPTION; ASSOCIATION; FEDERATION; DISEASE; CANCER; CRISIS; DEATH	Background Between 1987 and 1994, life expectancy in Russia declined substantially. Between 1994 and 1998, this trend reversed, and mortality rates returned to those of the early 1980s. Although the decline in life expectancy has been examined previously, much less is known about the subsequent improvement in mortality rates. We used recently published cause-specific mortality data up to 1998 to clarify this issue. Methods Changes in cause-specific death rates at ages 15-74 years were examined. Rates for 1998 were compared with those for 1994 (the year of lowest life expectancy) and for 1991 (the year the Soviet Union broke up). Findings Death rates among children fell steadily throughout the 1990s, and those in elderly people changed little. The reduction in mortality since 1994 was mainly due to a decrease in the death rate among middle-aged adults, which had increased until 1994. Deaths among those aged 15-30 years, which rose during 1991-94, remained high. Some causes of death, such as stomach cancer and road-traffic accidents, declined throughout the 1990s, whereas others, such as breast and prostate cancers and tuberculosis, increased. The decline in mortality since 1994 was, however, mainly due to a reduction in the rate of deaths from a group of causes associated with alcohol consumption. Interpretation The changing life expectancy in Russia is a consequence of a complex pattern of trends in different causes of death, some of which have their origins long in the past, and others that result from contemporary circumstances. This study provides further support for the view that alcohol has played an important part in the fluctuations In life expectancy in Russia in the 1990s, although there remains a need for a much better understanding of the factors underlying these continuing changes.	Max Planck Inst Demog Res, D-18057 Rostock, Germany; London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	Max Planck Society; University of London; London School of Hygiene & Tropical Medicine	Shkolnikov, V (corresponding author), Max Planck Inst Demog Res, Doberaner Str 114, D-18057 Rostock, Germany.	Shkolnikov@demogr.mpg.de	Leon, David A/G-2195-2010; McKee, Marc D/E-2187-2011; Shkolnikov, Vladimir/D-2986-2017; Mckee, Martin/E-6673-2018	Leon, David A/0000-0001-9747-1762; McKee, Marc D/0000-0001-8349-965X; Shkolnikov, Vladimir/0000-0003-2259-5423; Mckee, Martin/0000-0002-0121-9683				Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; Chenet L, 1998, J EPIDEMIOL COMMUN H, V52, P772, DOI 10.1136/jech.52.12.772; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; FARMER P, 1999, GLOBAL IMPACT DRUG R; HERTRICH V, 1999, HLTH CRISIS BALTIC C; Hintikka J, 1999, SCAND J PUBLIC HEALT, V27, P85, DOI 10.1177/14034948990270020601; Hougen HP, 1999, AM J FOREN MED PATH, V20, P293, DOI 10.1097/00000433-199909000-00015; Laks T, 1999, J INTERN MED, V246, P53, DOI 10.1046/j.1365-2796.1999.00505.x; Leon D., 2000, POVERTY INEQUALITY H; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Macdonald S, 1999, DRUG ALCOHOL DEPEN, V55, P53, DOI 10.1016/S0376-8716(98)00184-7; McKee M, 1999, ALCOHOL ALCOHOLISM, V34, P824, DOI 10.1093/alcalc/34.6.824; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; MESLE F, 2000, WORLD HLTH STAT Q, V53, P191; Mesle F., 1996, SERIE DONNEES STAT, V2; SCHMIDT W, 1981, CANCER-AM CANCER SOC, V47, P1031, DOI 10.1002/1097-0142(19810301)47:5<1031::AID-CNCR2820470534>3.0.CO;2-C; Shkolnikov V, 1999, EUR J EPIDEMIOL, V15, P203, DOI 10.1023/A:1007546800982; Smith GD, 2000, POVERTY INEQUALITY H; Uuskula M, 1998, J CLIN EPIDEMIOL, V51, P577, DOI 10.1016/S0895-4356(98)00034-1; VANGIJN J, 1993, HLTH ISSUES RELATED, P43; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; White S, 1996, RUSSIA GOES DRY; *WHO, 1996, WORLD HLTH STAT ANN; Zohoori N, 1998, WORLD DEV, V26, P1977, DOI 10.1016/S0305-750X(98)00099-0	27	218	237	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					917	921		10.1016/S0140-6736(00)04212-4	http://dx.doi.org/10.1016/S0140-6736(00)04212-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289348				2022-12-28	WOS:000167625300010
J	Hassan, AH; Neely, KE; Workman, JL				Hassan, AH; Neely, KE; Workman, JL			Histone acetyltransferase complexes stabilize SWI/SNF binding to promoter nucleosomes	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR-BINDING; SWI-SNF; ACTIVATION DOMAIN; ORDERED RECRUITMENT; OCTAMER TRANSFER; IN-VITRO; YEAST; DNA; ACETYLATION	To investigate the function of SWI/SNF in site-specific chromatin remodeling at promoters, we have used a purified system to analyze its distribution, function, and retention following recruitment by a sequence-specific transcription activator. Activator recruitment of SWI/SNF bound the complex to promoter proximal nucleosomes and led to localized nucleosome disruption. However, retention of SWI/SNF on the promoter required either the continued binding of the transcription activator or acetylated histones. Histone acetylation by either the SAGA or NuA4 HAT complexes increased the retention of SWI/SNF on the promoter. These data illustrate a functional link between HAT complexes and the SWI/SNF chromatin remodeling complex and provide a mechanistic basis for the ordered recruitment of these complexes.	Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Workman, JL (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.		Hassan, Ahmed/AAB-7241-2019	Al-Marzouqi, Ahmed/0000-0003-4586-5676				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Owen-Hughes T, 1999, METH MOL B, V119, P319; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	56	287	290	4	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					817	827		10.1016/S0092-8674(01)00279-3	http://dx.doi.org/10.1016/S0092-8674(01)00279-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290320	Bronze			2022-12-28	WOS:000167869200005
J	Roberts, SB				Roberts, SB			Prevention of hypertension in adulthood by breastfeeding?	LANCET			English	Editorial Material							CARDIOVASCULAR RISK-FACTORS; LATER BLOOD-PRESSURE; EARLY DETERMINANTS; CHILDREN; CHILDHOOD; CALCIUM; BORN		Tufts Univ, USDA, Human Nutr Res Ctr, Energy Metab Lab, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA)	Roberts, SB (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr, Energy Metab Lab, Boston, MA 02111 USA.							Anderson JW, 1999, AM J CLIN NUTR, V70, P525; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hurtado EK, 1999, AM J CLIN NUTR, V69, P115; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; KOLACEK S, 1993, ACTA PAEDIATR, V82, P699, DOI 10.1111/j.1651-2227.1993.tb18044.x; KOLACEK S, 1993, ACTA PAEDIATR, V82, P377, DOI 10.1111/j.1651-2227.1993.tb12701.x; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; LUCAS A, 1994, BRIT MED J, V309, P304, DOI 10.1136/bmj.309.6950.304; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; ROBERTS SB, 1999, FEEDING YOUR CHILD L; Taittonen L, 1996, PEDIATR RES, V40, P627, DOI 10.1203/00006450-199610000-00019; Viikari J, 1990, Acta Paediatr Scand Suppl, V365, P13; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; WINGARD DL, 1994, AM J PUBLIC HEALTH, V84, P1458, DOI 10.2105/AJPH.84.9.1458; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6	19	8	8	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					406	407		10.1016/S0140-6736(00)04021-6	http://dx.doi.org/10.1016/S0140-6736(00)04021-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273053				2022-12-28	WOS:000166865600002
J	Scheer, S; Chu, PL; Klausner, JD; Katz, MH; Schwarcz, SK				Scheer, S; Chu, PL; Klausner, JD; Katz, MH; Schwarcz, SK			Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS	LANCET			English	Article							VIRAL LOAD; COMBINATION THERAPIES; EPIDEMIOLOGIC SYNERGY; ANTIVIRAL TREATMENT; HIV; TRANSMISSION; RISK; PREVENTION; PROTEASE; SEMEN	Background There has been an increase in high-risk sexual behaviour and sexually transmitted diseases (STD) during the time period when highly active antiretroviral therapy (HAART) became widely available. We examined whether taking HAART increased the risk of acquiring an STD-an epidemiological marker of unsafe sex-in people with AIDS. Methods We did a computerised match of people in the San Francisco STD and AIDS registries. People with AIDS who were diagnosed before 1999 and alive in November, 1995, or later, were classified as having had an STD after AIDS diagnosis or not having had an STD after AIDS diagnosis. We used a Cox proportional hazards model to see whether use of antiretroviral therapy was associated with acquiring an STD after AIDS, after adjustment for sex, age, race, HIV-1 risk category, and CD4 count at AIDS diagnosis. Findings People with AIDS who had had HAART showed an independent increase in the risk of developing an STD (hazard ratio 4.10; 95% CI 2.84-5.94). Americans of African origin, younger age, and higher CD4 count at AIDS diagnosis were also associated with acquiring an STD after AIDS. The number of people living with AIDS who acquired an STD increased over time from 60 (0.66%) in 1995 to 113 (1.32%) in 1998 (p<0.001). Interpretation We have shown that people on HAART are more likely to develop an STD, an epidemiological marker of unsafe sex. More intensive risk-reduction counselling and STD screening for people with AIDS is needed.	San Francisco Dept Publ Hlth, Seroepidemiol & Surveillance Sect, San Francisco, CA 94102 USA; San Francisco Dept Publ Hlth, Sexually Transmitted Dis Prevent & Control Serv, San Francisco, CA 94102 USA	San Francisco Department of Public Health; San Francisco Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, Seroepidemiol & Surveillance Sect, San Francisco, CA 94102 USA.	susan_scheer@dph.sf.ca.us						BOYER CB, 1991, SOC SCI MED, V33, P11, DOI 10.1016/0277-9536(91)90446-J; BUCHBINDER S, 1998, 12 INT AIDS C GEN SW; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P45; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; DETELS R, 1998, JAMA-J AM MED ASSOC, V28, P1497; Dilley JW, 1997, NEW ENGL J MED, V337, P501, DOI 10.1056/NEJM199708143370715; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; EKSTRAND ML, 1990, AM J PUBLIC HEALTH, V80, P973, DOI 10.2105/AJPH.80.8.973; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 1998, NEW ENGL J MED, V339, P1846, DOI 10.1056/NEJM199812173392510; Hamm HE, 1996, FASEB J, V10, P3; Kelly JA, 1998, AIDS, V12, pF91, DOI 10.1097/00002030-199810000-00001; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Kravcik S, 1998, J ACQ IMMUN DEF SYND, V19, P124, DOI 10.1097/00042560-199810010-00004; LEHMAN J, 2000, 7 C RETR OPP INF SAN; Miller M, 2000, AIDS, V14, pF33, DOI 10.1097/00002030-200003100-00001; MURPHY S, 1998, 12 INT C AIDS GEN SW; NABULSI A, 1996, 11 INT C AIDS VANC C; Nieuwkerk PT, 2000, AIDS, V14, P181, DOI 10.1097/00002030-200001280-00014; OSMOND D, 1998, 12 INT AIDS C GEN SW; OTTEN RA, 1996, 12 INT AIDS C VANC C; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PIENIAZEK D, 1996, 3 C RETR OPP INF WAS; Ping LH, 2000, J VIROL, V74, P8946, DOI 10.1128/JVI.74.19.8946-8952.2000; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Remien RH, 1998, AIDS, V12, P1560, DOI 10.1097/00002030-199812000-00025; REMIEN RH, 1998, 12 INT AIDS C GEN SW; *SAN FRANC DEP PUB, 1999, SEX TRANSM DIS PREV; Schwarcz SK, 1999, AIDS, V13, P1109, DOI 10.1097/00002030-199906180-00015; van der Straten A, 2000, AIDS, V14, pF47, DOI 10.1097/00002030-200003100-00003; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	37	138	144	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					432	435		10.1016/S0140-6736(00)04007-1	http://dx.doi.org/10.1016/S0140-6736(00)04007-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273063				2022-12-28	WOS:000166865600012
J	Richman, DD				Richman, DD			HIV chemotherapy	NATURE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; T-LYMPHOCYTE RESPONSES; DRUG-RESISTANCE; VIRAL-LOAD; CYTOMEGALOVIRUS RETINITIS; REVERSE-TRANSCRIPTASE; CD4(+) LYMPHOCYTES; GENITAL SECRETIONS	The use of chemotherapy to suppress replication of the human immunodeficiency virus (HIV) has transformed the face of AIDS in the developed world. Pronounced reductions in illness and death have been achieved and healthcare utilization has diminished. HIV therapy has also provided many new insights into the pathogenesis and the viral and cellular dynamics of HIV infection. But challenges remain. Treatment does not suppress HIV replication in all patients, and the emergence of drug-resistant virus hinders subsequent treatment. Chronic therapy can also result in toxicity. These challenges prompt the search for new drugs and new therapeutic strategies to control chronic viral replication.	Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med 0679, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Richman, DD (corresponding author), Vet Affairs San Diego Healthcare Syst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	drichman@ucsd.edu						ANDRIES K, 2000, AIDS S4, V14; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; *CDCP, 1998, 1996 ASS REPR TECHN, P1; *CDCP, 2000, AIDS SURV TRENDS; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clevenbergh P, 2000, ANTIVIR THER, V5, P65; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; DeGruttola V, 2000, ANTIVIR THER, V5, P41; DONZELLA GA, 1999, NAT MED, V4, P72; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Durant J, 2000, AIDS, V14, P1333, DOI 10.1097/00002030-200007070-00005; Enting RH, 1998, AIDS, V12, P1941, DOI 10.1097/00002030-199815000-00005; EPSTEIN LG, 1991, VIROLOGY, V180, P583, DOI 10.1016/0042-6822(91)90072-J; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Forsythe SS, 1998, AIDS, V12, pS11; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gatti G, 1999, AIDS, V13, P2083, DOI 10.1097/00002030-199910220-00011; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 1999, J VIROL, V73, P9404; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; HAGGERTY S, 1991, Viral Immunology, V4, P123, DOI 10.1089/vim.1991.4.123; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; Havlir DV, 2000, J INFECT DIS, V182, P1658, DOI 10.1086/317620; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hellinger FJ, 2000, J ACQ IMMUN DEF SYND, V24, P182; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOFFMANNLAROCHE E, 1999, MULTIMEDIA LIFECYCLE; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karavellas MP, 1999, J INFECT DIS, V179, P697, DOI 10.1086/314639; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; KEMPF D, 2000, ANTIVIR THER S, V5, P70; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim H S, 1989, J Vet Diagn Invest, V1, P101; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kovacs JA, 2000, NEW ENGL J MED, V342, P1416, DOI 10.1056/NEJM200005113421907; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Little SJ, 2000, ANTIVIR THER, V5, P33; Lori F, 2000, SCIENCE, V290, P1591, DOI 10.1126/science.290.5496.1591; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moore JP, 2000, NAT REV MOL CELL BIO, V1, P40, DOI 10.1038/35036060; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; Mouton Y, 1997, AIDS, V11, pF101, DOI 10.1097/00002030-199712000-00003; O'Brien SJ, 2000, ANNU REV GENET, V34, P563, DOI 10.1146/annurev.genet.34.1.563; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; RICE WG, 1995, SCIENCE, V270, P1194, DOI 10.1126/science.270.5239.1194; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; VINGERHOETS J, 1999, ANTIVIRALT HER S1, V4, P53; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Whitcup SM, 2000, JAMA-J AM MED ASSOC, V283, P653, DOI 10.1001/jama.283.5.653; Wong JK, 1997, J VIROL, V71, P2059, DOI 10.1128/JVI.71.3.2059-2071.1997; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2000, AIDS, V14, P243, DOI 10.1097/00002030-200002180-00006; Zhang ZQ, 1998, P NATL ACAD SCI USA, V95, P1154, DOI 10.1073/pnas.95.3.1154; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	108	428	475	1	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					995	1001		10.1038/35073673	http://dx.doi.org/10.1038/35073673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309630				2022-12-28	WOS:000168152300060
J	Delaney, BC; Wilson, S; Roalfe, A; Roberts, L; Redman, V; Wearn, A; Hobbs, FDR				Delaney, BC; Wilson, S; Roalfe, A; Roberts, L; Redman, V; Wearn, A; Hobbs, FDR			Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care	BRITISH MEDICAL JOURNAL			English	Article							ECONOMIC-EVALUATION; MANAGEMENT; SEROLOGY	Objective To determine the cost effectiveness of a strategy of near patient Helicobacter pylori testing and endoscopy for managing dyspepsia. Design Randomised controlled trial. Setting 21 UK primary care centres. Participants 478 patients under 50 years old presenting with dyspepsia of longer than four weeks duration. Interventions Near patient testing for H. pylori and open access endoscopy for patients with positive results. Control patients received acid suppressing drugs or specialist referral at general practitioner's discretion. Main outcome measures Cost effectiveness based on improvement in symptoms and use of resources at 12 months; quality of life. Results 40% of the study group tested positive for H pylori. 45% of study patients hall endoscopy compared with 25%, of controls. More peptic ulcers were diagnosed in the study group (7.4% v. 2.1% P = 0.011). Paired comparison of symptom scores and quality of life shelved that all patients improved over time with no difference between study and control groups. No significant differences were observed in rats of prescribing, consultation, or referral. Costs were higher in the study group (pound 367.85 v pound 253.16 pet patient). Conclusions The "test and endoscopy" strategy increases endoscopy rates over usual practice in primary care. The additional cost is not offset by benefits in symptom relief or quality of life.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Delaney, BC (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England.		Delaney, Brendan C/C-5578-2008	hobbs, richard/0000-0001-7976-7172; Delaney, Brendan/0000-0002-3518-0131				Asante M, 1999, EUR J GASTROEN HEPAT, V11, P851, DOI 10.1097/00042737-199908000-00007; AXON ATR, 1995, BMJ-BRIT MED J, V310, P853, DOI 10.1136/bmj.310.6983.853; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Bonn D, 1998, LANCET, V351, P576, DOI 10.1016/S0140-6736(05)78569-X; *BRIT MED ASS ROYA, 1997, BRIT NAT FORM; Chiba N, 1998, CAN FAM PHYSICIAN, V44, P1481; COLINJONES DG, 1988, LANCET, V1, P576; DELANEY B, 1998, EUR J GEN PRACT, V4, P149; Delaney BC, 2000, LANCET, V356, P1965, DOI 10.1016/S0140-6736(00)03308-0; Delaney BC, 1999, BMJ-BRIT MED J, V319, P824, DOI 10.1136/bmj.319.7213.824; DELANEY BC, 2000, COCHRANE DATABASE SY; DELANEY BC, 1999, GASTROENTEROLOGY S4, V116; DELANEY RC, 2000, COCHRANE DATABASE SY; Hobbs FDR, 1996, FAM PRACT, V13, P225, DOI 10.1093/fampra/13.3.225; Hobbs R, 1996, BRIT MED J, V312, P263; KORMAN MG, 1993, SCAND J GASTROENTERO, V28, P28, DOI 10.3109/00365529309098352; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; Netten A, 1998, UNIT COSTS HLTH SOCI; *NHS EX, 1998, NEW NHS REF COSTS; PATEL P, 1995, LANCET, V346, P1315, DOI 10.1016/S0140-6736(95)92340-3; Roberts AP, 2000, FAM PRACT, V17, pS12, DOI 10.1093/fampra/17.suppl_2.S12; SOBALA GM, 1991, LANCET, V338, P94, DOI 10.1016/0140-6736(91)90085-4; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24	24	53	56	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					898	901		10.1136/bmj.322.7291.898	http://dx.doi.org/10.1136/bmj.322.7291.898			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302905	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168311300023
J	Yagita, K; Tamanini, F; van der Horst, GTJ; Okamura, H				Yagita, K; Tamanini, F; van der Horst, GTJ; Okamura, H			Molecular mechanisms of the biological clock in cultured fibroblasts	SCIENCE			English	Article							CIRCADIAN GENE-EXPRESSION; PERIPHERAL-TISSUES; OSCILLATORS; PROTEINS; TIME; DBP	In mammals, the central circadian pacemaker resides in the hypothalamic suprachiasmatic nucleus (SCN), but circadian oscillators also exist in peripheral tissues. Here, using wild-type and cryptochrome (mCry)-deficient cell Lines derived from mCry mutant mice, we show that the peripheral oscillator in cultured fibroblasts is identical to the oscillator in the SCN in (i) temporal expression profiles of all known clock genes, (ii) the phase of the various mRNA rhythms (i.e., antiphase oscillation of Bmal1 and mPer genes), (iii) the delay between maximum mRNA Levels and appearance of nuclear mPER1 and mPER2 protein, (iv) the inability to produce oscillations in the absence of functional mCry genes, and (v) the control of period Length by mCRY proteins.	Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Kobe University; Erasmus University Rotterdam	Okamura, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan.	okamurah@kobe-u.ac.jp	Jansen, Heiko T./A-5770-2008; van der Horst, Gijsbertus TJ/E-3661-2015	Jansen, Heiko T./0000-0003-0178-396X; van der Horst, Gijsbertus TJ/0000-0002-7773-6396				Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; ISHIDA Y, IN PRESS J NEUROSCI; Kuwaki T, 1997, PROG NEUROBIOL, V51, P545, DOI 10.1016/S0301-0082(96)00063-9; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2000, GENE DEV, V14, P1353; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Young MW, 2000, SCIENCE, V288, P451, DOI 10.1126/science.288.5465.451	21	348	362	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					278	281		10.1126/science.1059542	http://dx.doi.org/10.1126/science.1059542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303101				2022-12-28	WOS:000168074000044
J	Fleming, PJ; Blair, PS; Ward, M; Tripp, J; Smith, IJ; Golding, J				Fleming, PJ; Blair, PS; Ward, M; Tripp, J; Smith, IJ; Golding, J		CESDI SUDI Res Grp	The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TETANUS-PERTUSSIS IMMUNIZATION; RISK; VACCINATION	Objectives To investigate whether the accelerated immunisation programme in the United Kingdom is associated after adjustment for potential confounding, with the sudden infant death syndrome. Design Population based case-control study; February 1993 to March 1996. Parental interviews were conducted for each death and for four controls matched fur age, locality; and time of sleep, Immunisation status was taken from records held by the parents. Setting Five regions in England with a combined population of over 17 million, Subjects Immunisation details were available for 93% (303/325) of infants whose deaths were attributed to the sudden infant death syndrome (SIDS): 90% (65/72) of infants with explained sudden deaths; and 95%, (1515//1588) of controls. Results After alt potential confounding factors were controlled for, immunisation uptake was strongly associated with a lower risk of SIDS (odds ratio 0.45 (95% confidence interval 0.24 to 0.85), This difference became non-significant (0.67; (0.31 to 1.43)) after further adjustment for other factors specific to the infant's sleeping environment. Similar proportions of SIDS deaths and reference sleeps (corresponding to the time of day during which the index baby had died) among the controls occurred within 48 hours of the last vaccination (5% (7/149) v 5% (41/822)) and within two weeks (21% (31/149) v 27% (224/822)). No longer term temporal association with immunisation was found (P = 0.78). Of the SIDS infants who died within two weeks of vaccination, 16% (5/31) had signs and symptoms of illness that suggested that medical contact was required, compared with 26% (16/61) of the non-immunised SIDS infants of similar age. The findings for the infants who died suddenly and unexpectedly but of explained causes mirrored those for SIDS infants. Conclusions Immunisation does not lead to sudden unexpected death in infancy, and the direction of the relation is towards protection rather than risk.	Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England; Royal Victoria Infirm, Newcastle Neonatal Serv, Ward 35, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Royal Devon & Exeter Hosp, Postgrad Med Sch, Dept Child Hlth, Exeter EX2 5DW, Devon, England; Nuffield Inst Hlth Serv, Leeds LS2 9PL, W Yorkshire, England	Bristol Royal Hospital For Children; University of Bristol; Newcastle University - UK; University of Exeter; University of Leeds	Fleming, PJ (corresponding author), Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England.	peter.fleming@bris.ac.uk	Fleming, Peter J/A-9081-2010; Blair, Peter S/C-1213-2009; Platt, Martin Ward/D-4008-2014; Fleming, Peter/O-3231-2019	Fleming, Peter J/0000-0003-2521-5764; Platt, Martin Ward/0000-0003-0536-5749; Fleming, Peter/0000-0003-2521-5764; Golding, Jean/0000-0003-2826-3307; Blair, Peter/0000-0002-7832-8087				BARAFF LJ, 1983, PEDIATR INFECT DIS J, V2, P7, DOI 10.1097/00006454-198301000-00003; Blair PS, 2000, ARCH DIS CHILD, V82, P462, DOI 10.1136/adc.82.6.462; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; CAMERON MH, 1986, AUST PAEDIATR J, V22, P37; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; FLAHAULT A, 1988, LANCET, V1, P582; Fleming P., 2000, SUDDEN UNEXPECTED DE; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; Hutcheson R, 1979, MMWR-MORBID MORTAL W, V28, P131; JEFFERIES S, 1991, J PUBLIC HEALTH MED, V13, P312; JONVILLEBERA AP, 1995, FUNDAM CLIN PHARM, V9, P263, DOI 10.1111/j.1472-8206.1995.tb00294.x; Leach CEA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e43; MCGLASHAN ND, 1989, SOC SCI MED, V29, P1015, DOI 10.1016/0277-9536(89)90059-2; Mitchell EA, 1995, ARCH DIS CHILD, V73, P498, DOI 10.1136/adc.73.6.498; Platt MJ, 1998, ARCH DIS CHILD, V79, P523, DOI 10.1136/adc.79.6.523; Platt MW, 2000, ARCH DIS CHILD, V82, P98, DOI 10.1136/adc.82.2.98; ROBERTS SC, 1987, ARCH DIS CHILD, V62, P754, DOI 10.1136/adc.62.7.754; *SAS I, 1992, P229 SAS I; Shann F, 1999, BRIT MED J, V319, P4, DOI 10.1136/bmj.319.7201.4; SOLBERG LK, 1985, DTP VACCINATION VISI, P1; TAYLOR EM, 1982, LANCET, V2, P721; TORCH WC, 1982, NEUROLOGY, V32, pA169; WALKER AM, 1987, AM J PUBLIC HEALTH, V77, P945, DOI 10.2105/AJPH.77.8.945	25	45	46	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2001	322	7290					822	825		10.1136/bmj.322.7290.822	http://dx.doi.org/10.1136/bmj.322.7290.822			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290634	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000168063000021
J	Kalliomaki, M; Salminen, S; Arvilommi, H; Kero, P; Koskinen, P; Isolauri, E				Kalliomaki, M; Salminen, S; Arvilommi, H; Kero, P; Koskinen, P; Isolauri, E			Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial	LANCET			English	Article							GROWTH-FACTOR-BETA; 1ST 6 YEARS; ORAL TOLERANCE; 4 REGIONS; COW MILK; CHILDREN; PREVALENCE; MICROFLORA; DERMATITIS; MEASLES	Background Reversal of the progressive increase in frequency of atopic disease would be an important breakthrough for health care and wellbeing in western societies. In the hygiene hypothesis this increase is attributed to reduced microbial exposure in early life. Probiotics are cultures of potentially beneficial bacteria of the healthy gut microflora. We assessed the effect on atopic disease of Lactobacillus GG (which is safe at an early age and effective in treatment of allergic inflammation and food allergy). Methods In a double-blind, randomised placebo-controlled trial we gave Lactobacillus GG prenatally to mothers who had at least one first-degree relative (or partner) with atopic eczema. allergic rhinitis, or asthma, and postnatally for 6 months to their infants. Chronic recurring atopic eczema, which is the main sign of atopic disease in the first years of life, was the primary endpoint. Findings Atopic eczema was diagnosed in 46 of 132 (35%) children aged 2 years. Asthma was diagnosed in six of these children and allergic rhinitis in one. The frequency of atopic eczema in the probiotic group was half that of the placebo group (15/64 [23%] vs 31/68 [46%]; relative risk 0.51 [95% CI 0.32-0.84]). The number needed to treat was 4.5 (95% CI 2.6-15.6). Interpretations Lactobacillus GG was effective in prevention of early atopic disease in children at high risk. Thus, gut microflora might be a hitherto unexplored source of natural immunomodulators and probiotics, for prevention of atopic disease.	Turku Univ Hosp, Dept Paediat, FI-20521 Turku, Finland; Univ Turku, Dept Paediat, Turku, Finland; Univ Turku, Dept Biochem & Food Chem, Turku, Finland; Univ Turku, Dept Clin Chem, Turku, Finland; Natl Publ Hlth Inst, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; Finland National Institute for Health & Welfare	Kalliomaki, M (corresponding author), Turku Univ Hosp, Dept Paediat, POB 52, FI-20521 Turku, Finland.	markal@utu.fi						Barone KS, 2000, CELL IMMUNOL, V199, P65, DOI 10.1006/cimm.1999.1603; Bergmann R L, 1994, Pediatr Allergy Immunol, V5, P19, DOI 10.1111/j.1399-3038.1994.tb00343.x; Bergmann RL, 1998, CLIN EXP ALLERGY, V28, P965; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gaskins H. R., 1997, GASTROINTESTINAL MIC, V2, P537, DOI [10.1007/978-1-4757-0322-1_14, DOI 10.1007/978-1-4757-0322-1_14]; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Harrigan E, 1999, IMMUNOL ALLERGY CLIN, V19, P383, DOI 10.1016/S0889-8561(05)70094-1; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; ISOLAURI E, 1992, J PEDIATR-US, V120, P9, DOI 10.1016/S0022-3476(05)80589-X; ISOLAURI E, 1993, GASTROENTEROLOGY, V105, P1643, DOI 10.1016/0016-5085(93)91059-Q; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kalliomaki M, 1999, J ALLERGY CLIN IMMUN, V104, P1251, DOI 10.1016/S0091-6749(99)70021-7; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Kulig M, 1999, J PEDIATR-US, V134, P453, DOI 10.1016/S0022-3476(99)70203-9; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; Majamaa H, 1996, J ALLERGY CLIN IMMUN, V97, P985, DOI 10.1016/S0091-6749(96)80074-1; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Paunio M, 2000, JAMA-J AM MED ASSOC, V283, P343, DOI 10.1001/jama.283.3.343; Pekkanen J, 1997, EUR RESPIR J, V10, P1787, DOI 10.1183/09031936.97.10081787; Pessi T, 1998, J NUTR, V128, P2313, DOI 10.1093/jn/128.12.2313; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Remes ST, 1998, ALLERGY, V53, P682, DOI 10.1111/j.1398-9995.1998.tb03954.x; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sanfilippo L, 2000, CLIN EXP IMMUNOL, V119, P456, DOI 10.1046/j.1365-2249.2000.01155.x; Sato M, 1999, IMMUNOL LETT, V70, P29, DOI 10.1016/S0165-2478(99)00122-4; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sudo N, 1997, J IMMUNOL, V159, P1739; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; WARNER JO, 1992, ARCH DIS CHILD, V67, P240; WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3	39	1746	1904	5	458	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1076	1079		10.1016/S0140-6736(00)04259-8	http://dx.doi.org/10.1016/S0140-6736(00)04259-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297958				2022-12-28	WOS:000167996200009
J	Smith, CC; Mandel, J; Bush, B				Smith, CC; Mandel, J; Bush, B			Less is more.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SARCOIDOSIS		Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center	Smith, CC (corresponding author), Beth Israel Deaconess Med Ctr, 1 Autumn St, Boston, MA 02115 USA.			Mandel, Jess/0000-0002-2658-6025				Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Newman LS, 1997, NEW ENGL J MED, V337, P139; PROPST A, 1993, DIGEST DIS SCI, V38, P379, DOI 10.1007/BF01307562; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; STUDDY PR, 1989, ANN CLIN BIOCHEM, V26, P13, DOI 10.1177/000456328902600102	6	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1079	1082		10.1056/NEJM200104053441408	http://dx.doi.org/10.1056/NEJM200104053441408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287979				2022-12-28	WOS:000167860400008
J	Snow, V; Lascher, S; Mottur-Pilson, C				Snow, V; Lascher, S; Mottur-Pilson, C		Am Coll Chest Phys; Am Coll Physicians Am Soc Internal	Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Physicians, Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians	Snow, V (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							*AHRQ, AHRQ PUBL; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Turner MO, 1997, ARCH INTERN MED, V157, P1736, DOI 10.1001/archinte.157.15.1736	3	112	119	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					595	599		10.7326/0003-4819-134-7-200104030-00015	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00015			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281744				2022-12-28	WOS:000167931200008
J	Joza, N; Susin, SA; Daugas, E; Stanford, WL; Cho, SK; Li, CYJ; Sasaki, T; Elia, AJ; Cheng, HYM; Ravagnan, L; Ferri, KF; Zamzami, N; Wakeham, A; Hakem, R; Yoshida, H; Kong, YY; Mak, TW; Zuniga-Pflucker, JC; Kroemer, G; Penninger, JM				Joza, N; Susin, SA; Daugas, E; Stanford, WL; Cho, SK; Li, CYJ; Sasaki, T; Elia, AJ; Cheng, HYM; Ravagnan, L; Ferri, KF; Zamzami, N; Wakeham, A; Hakem, R; Yoshida, H; Kong, YY; Mak, TW; Zuniga-Pflucker, JC; Kroemer, G; Penninger, JM			Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death	NATURE			English	Article							EMBRYONIC STEM-CELLS; BLOOD-ISLAND FORMATION; CYTOCHROME-C; BCL-2; ELEGANS; REQUIREMENT; HOMOLOG; COMPLEX; DIFFERENTIATION; CAVITATION	Programmed cell death is a fundamental requirement for embryogenesis, organ metamorphosis and tissue homeostasis, In mammals, release of mitochondrial cytochrome c leads to the cytosolic assembly of the apoptosome - a caspase activation complex involving Apaf1 and caspase-9 that induces hallmarks of apoptosis, There are, however, mitochondrially regulated cell death pathways that are independent of Apaf1/caspase-9, We have previously cloned a molecule associated with programmed cell death called apoptosis-inducing factor (AIF), Like cytochrome c,AIF is localized to mitochondria and released in response to death stimuli. Here we show that genetic inactivation of AIF renders embryonic stem cells resistant to cell death after serum deprivation, Moreover, AIF is essential for programmed cell death during cavitation of embryoid bodies-the very first wave of cell death indispensable for mouse morphogenesis, AIF-dependent cell death displays structural features of apoptosis, and can be genetically uncoupled from Apaf1 and caspase-9 expression. Our data provide genetic evidence for a caspase-independent pathway of programmed cell death that controls early morphogenesis.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Inst Gustave Roussy, CNRS, UMR 1599, F-94805 Villejuif, France; Hop Tenon, Serv Nephrol B, Hop Paris, Assistance Publ, F-75020 Paris, France; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; Penninger, Josef M/I-6860-2013; Zuniga-Pflucker, Juan C/H-1295-2012; Susin, Santos A/Q-6754-2017	KROEMER, Guido/0000-0002-9334-4405; Penninger, Josef M/0000-0002-8194-3777; Susin, Santos A/0000-0002-3366-1628; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Stanford, William/0000-0002-5813-8016; Hakem, Razqallah/0000-0001-5948-7931; DAUGAS, Eric/0000-0001-7256-7979; Sasaki, Takehiko/0000-0003-1837-3748				Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Bautch VL, 1996, DEV DYNAM, V205, P1; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; ROBERTSON EJ, 1987, EMBRYO DERIVED STEM; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	38	1045	1123	5	93	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					549	554		10.1038/35069004	http://dx.doi.org/10.1038/35069004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279485				2022-12-28	WOS:000167859300037
J	Maguire, BA; Zimmermann, RA				Maguire, BA; Zimmermann, RA			The ribosome in focus	CELL			English	Review							X-RAY CRYSTALLOGRAPHY; 70S RIBOSOME; ANGSTROM RESOLUTION; SUBUNIT; RNA; TRANSLATION		Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Maguire, BA (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.							Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Brimacombe R, 2000, STRUCTURE, V8, pR195, DOI 10.1016/S0969-2126(00)00510-4; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; Harms J, 1999, STRUCTURE, V7, P931, DOI 10.1016/S0969-2126(99)80120-8; Lancaster L, 2000, RNA, V6, P717, DOI 10.1017/S1355838200000303; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Puglisi JD, 2000, NAT STRUCT BIOL, V7, P855, DOI 10.1038/79603; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	20	56	58	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					813	816		10.1016/S0092-8674(01)00278-1	http://dx.doi.org/10.1016/S0092-8674(01)00278-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290319	Bronze			2022-12-28	WOS:000167869200004
J	Thompson, AJ; Playford, ED				Thompson, AJ; Playford, ED			Rehabilitation for patients with Parkinson's disease	LANCET			English	Editorial Material							MULTIPLE-SCLEROSIS; ACTIVATION		UCL Inst Neurol, Neurorehabil Unit, London WC1N 3BG, England	University of London; University College London	Thompson, AJ (corresponding author), UCL Inst Neurol, Neurorehabil Unit, Queen Sq, London WC1N 3BG, England.	A.Thompson@ion.ucl.ac.uk	Thompson, Alan J/C-2654-2008; Playford, Diane/F-1467-2010	Thompson, Alan J/0000-0002-4333-8496; Playford, E Diane/0000-0001-7314-787X				Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; DEANE KHO, 2000, PHYSIOTHERAPY PATIEN; DEANE KHO, 2001, COCHRANE REV, V1; DEANE KHO, 2001, IN PRESS COCHRANE RE, V1; DEANE KHO, 2000, COCHRANE REV, V1; Freeman JA, 1997, ANN NEUROL, V42, P236, DOI 10.1002/ana.410420216; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Lee M, 2000, ANN NEUROL, V47, P606, DOI 10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.3.CO;2-C; Marchese R, 2000, MOVEMENT DISORD, V15, P879, DOI 10.1002/1531-8257(200009)15:5<879::AID-MDS1018>3.0.CO;2-9; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Solari A, 1999, NEUROLOGY, V52, P57, DOI 10.1212/WNL.52.1.57; Thompson AJ, 2000, J NEUROL NEUROSUR PS, V69, P718, DOI 10.1136/jnnp.69.6.718; TURNERSTOKES L, 1999, CLIN REHAB S1, V13; Werring DJ, 2000, J NEUROL NEUROSUR PS, V68, P441, DOI 10.1136/jnnp.68.4.441; Wiles CM, 2001, J NEUROL NEUROSUR PS, V70, P174, DOI 10.1136/jnnp.70.2.174	15	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					410	411		10.1016/S0140-6736(00)04024-1	http://dx.doi.org/10.1016/S0140-6736(00)04024-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273056				2022-12-28	WOS:000166865600005
J	Zhang, PZ; Molnar, P; Downs, WR				Zhang, PZ; Molnar, P; Downs, WR			Increased sedimentation rates and grain sizes 2-4 Myr ago due to the influence of climate change on erosion rates	NATURE			English	Article							MOUNTAIN-RANGES; UPLIFT; EOCENE; EVOLUTION; MODEL; BASIN; GLACIATION; QUATERNARY; SUBSIDENCE; PLATEAU	Around the globe, and in a variety of settings including active and inactive mountain belts, increases in sedimentation rates as well as in grain sizes of sediments were recorded at similar to2-4 Myr ago, implying increased erosion rates. A change in climate represents the only process that is globally synchronous and can potentially account for the widespread increase in erosion and sedimentation, but no single process-like a lowering of sea levels or expanded glaciation-can explain increases in sedimentation in all environments, encompassing continental margins and interiors, and tropical as well as higher latitudes. We suggest that climate affected erosion mainly by the transition from a period of climate stability, in which landscapes had attained equilibrium configurations, to a time of frequent and abrupt changes in temperature, precipitation and vegetation, which prevented fluvial and glacial systems from establishing equilibrium states.	State Seismol Bur, Inst Geol, Beijing 100029, Peoples R China; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; No Arizona Univ, Bilby Res Ctr, Flagstaff, AZ 86011 USA	China Earthquake Administration; Massachusetts Institute of Technology (MIT); Northern Arizona University	Molnar, P (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Dept Geol Sci, Campus Box 399, Boulder, CO 80309 USA.	molnar@terra.colorado.edu						ADAMS J, 1980, GEOL SOC AM BULL, V91, P2, DOI 10.1130/0016-7606(1980)91<2:CUAEOT>2.0.CO;2; [Anonymous], 1993, GEOLOGICAL MEMOIRS S, V1; Baker B.H., 1972, 136 GEOL SOC AM; BELL M, 1985, QUATERNARY RES, V23, P154, DOI 10.1016/0033-5894(85)90026-2; Bickert T., 1997, P OCEAN DRILLING PRO, V154, P239, DOI DOI 10.2973/0DP.PR0C.SR.154.110.1997; Billups K., 1997, P ODP SCI RES, P319, DOI DOI 10.2973/ODPPROC.SR.154.115.1997; Bull, 1991, GEOMORPHIC RESPONSES; BULLEN ME, IN PRESS GEOL SOC AM; BULLEN ME, UNPUB J GEOL; Burbank D.W., 1996, TECTONIC EVOLUTION A, P149; BURBANK DW, 1992, NATURE, V357, P680, DOI 10.1038/357680a0; Carter R.M., 1999, PROC OCEAN DRILLING, V181, P1, DOI DOI 10.2973/ODP.PROC.IR.181.103.2000; CHEN J, 1996, QUAT SCI, V1, P263; Cochran J.R., 1990, P ODP SCI RESULTS, V116, P397, DOI DOI 10.1029/2006GC001336; CURRAY JR, 1994, EARTH PLANET SC LETT, V125, P371, DOI 10.1016/0012-821X(94)90227-5; DENG X, 1998, ACTA SEDIMENTOLOGICA, V16, P82; Devyatkin E.V., 1981, CENOZOIC INNER ASIA; DING ZL, 1998, QUAT SCI, V1, P86; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; GERHARD LC, 1982, AAPG BULL, V66, P989; Gilbert G.K., 1900, P AM ASS ADV SCI, V49, P1; GREGORY KM, 1994, J GEOPHYS RES-SOL EA, V99, P20141, DOI 10.1029/94JB00132; GREGORY KM, 1992, GEOLOGY, V20, P581, DOI 10.1130/0091-7613(1992)020<0581:TSOPEC>2.3.CO;2; GUILLAUME A, 1982, ECLOGAE GEOL HELV, V75, P247; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; HARBOR JM, 1992, GEOL SOC AM BULL, V104, P1364, DOI 10.1130/0016-7606(1992)104<1364:NMOTDO>2.3.CO;2; HAY WW, 1988, J GEOPHYS RES-SOLID, V93, P14933, DOI 10.1029/JB093iB12p14933; HAY WW, 1989, GEOL RUNDSCH, V78, P207, DOI 10.1007/BF01988362; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; HILGEN FJ, 1993, EARTH PLANET SC LETT, V118, P167, DOI 10.1016/0012-821X(93)90166-7; Hjelstuen BO, 1999, GEOL SOC AM BULL, V111, P1792; HSU KJ, 1978, INITIAL REPORTS DEEP, V42, P489; King L.C., 1967, MORPHOLOGY EARTH; KNOX JC, 1972, ANN ASSOC AM GEOGR, V62, P401, DOI 10.1111/j.1467-8306.1972.tb00872.x; KOLTERMANN CE, 1992, SCIENCE, V256, P1775, DOI 10.1126/science.256.5065.1775; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; Leopold L.B., 1992, FLUVIAL PROCESSES GE; LETOUZEY J, 1978, INITIAL REPORT DEEP, V42, P1077; LI JJ, 1998, UPLIF ENV CHANGES QU, P17; Liu T.S., 1985, LOESS ENV; Liu TS, 1996, PALAEOGEOGR PALAEOCL, V120, P159; Love J. D., 1970, 495C US GEOL SURV; Maslin MA, 1996, GEOL RUNDSCH, V85, P452, DOI 10.1007/BF02369002; MENG ZF, 1997, KEXUE TONGBAO, V42, P35; Metivier F, 1999, GEOPHYS J INT, V137, P280, DOI 10.1046/j.1365-246X.1999.00802.x; Metivier F, 1998, TECTONICS, V17, P823, DOI 10.1029/98TC02764; MOLNAR P, 1994, J GEOL, V102, P583, DOI 10.1086/629700; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Nathan S., 1986, NZ GEOLOGICAL SURVEY, V1; NOTT J, 1995, J GEOL, V103, P19, DOI 10.1086/629719; Nott J, 1996, GEOLOGY, V24, P883, DOI 10.1130/0091-7613(1996)024<0883:TAPROT>2.3.CO;2; ORI GG, 1986, INT ASS SEDIMENTOLOG, V8, P183; Parsons B., 1982, J GEOPHYS RES, V87, P437; PIERI M, 1986, AAPG BULL, V70, P103; POAG C. W., 1985, GEOLOGIC EVOLUTION U, P217; POAG CW, 1982, AAPG BULL, V66, P1021; Ricci Lucchi F., 1986, INT ASS SEDIMENTOLOG, V8, P103, DOI [10.1002/9781444303810.CH6, DOI 10.1002/9781444303810.CH6]; RIIS F, 1992, NORSK GEOL TIDSSKR, V72, P325; Saggerson E. P., 1965, Q J GEOL SOC LOND, V121, P51, DOI DOI 10.1144/GSJGS.121.1.0051; SCLATER JG, 1980, J GEOPHYS RES, V85, P3711, DOI 10.1029/JB085iB07p03711; Scott G.R., 1975, GEOL SOC AM MEM, V144, P227; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; SHACKLETON NJ, 1997, P OCEAN DRILL PROGRA, V154, P367, DOI DOI 10.2973/0DP.PR0C.SR.154.119.1997; Sun DG, 1998, GEOPHYS J INT, V134, P207, DOI 10.1046/j.1365-246x.1998.00553.x; Taylor G, 1978, P ROYAL SOC VICTORIA, V90, P53; TIEDEMANN R, 1997, P ODP SCI RESULTS, V154, P299; TRUMPY R, 1960, GEOL SOC AM BULL, V71, P843, DOI 10.1130/0016-7606(1960)71[843:PEOTCA]2.0.CO;2; Tucholke B.E., 1985, GEOLOGIC EVOLUTION U, P293; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; TWIDALE CR, 1976, AM J SCI, V276, P77, DOI 10.2475/ajs.276.1.77; VAGNES E, 1992, NORSK GEOL TIDSSKR, V72, P333; Walcott RI, 1998, REV GEOPHYS, V36, P1, DOI 10.1029/97RG03084; WALDER J, 1985, GEOL SOC AM BULL, V96, P336, DOI 10.1130/0016-7606(1985)96<336:ATMOTF>2.0.CO;2; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; WHIPPLE KX, IN PRESS AM J SCI; Wolfe JA, 1998, GEOL SOC AM BULL, V110, P664, DOI 10.1130/0016-7606(1998)110<0664:PEOEAO>2.3.CO;2; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528; ZHANG QM, 1989, SEDIMENTARY BASINS W, V1, P197; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; 1980, REGIONAL STRATIGRAPH	82	299	382	14	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					891	897		10.1038/35073504	http://dx.doi.org/10.1038/35073504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309607				2022-12-28	WOS:000168152300036
J	Cyranoski, D				Cyranoski, D			Ecologists score victory over controversial dyke project	NATURE			English	News Item																			0	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					619	619		10.1038/35070757	http://dx.doi.org/10.1038/35070757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287914	Bronze			2022-12-28	WOS:000167875400011
J	Enquist, BJ; Niklas, KJ				Enquist, BJ; Niklas, KJ			Invariant scaling relations across tree-dominated communities	NATURE			English	Article							PLANT; DENSITY; SIZE; PRODUCTIVITY; ENERGETICS; DIVERSITY; DIMENSION; EVOLUTION; ECOLOGY; RATES	Organizing principles are needed to link organismal, community and ecosystem attributes across spatial and temporal scales. Here we extend allometric theory-how attributes of organisms change with variation in their size-and test its predictions against worldwide data sets for forest communities by quantifying the relationships among tree size-frequency distributions, standing biomass, species number and number of individuals per unit area. As predicted, except for the highest latitudes, the number of individuals scales as the -2 power of basal stem diameter or as the -3/4 power of above-ground biomass. Also as predicted, this scaling relationship varies little with species diversity, total standing biomass, latitude and geographic sampling area. A simulation model in which individuals allocate biomass to leaf, stem and reproduction, and compete for space and light obtains features identical to those of a community. In tandem with allometric theory, our results indicate that many macroecological features of communities may emerge from a few allometric principles operating at the level of the individual.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	University of Arizona; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Cornell University	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@u.arizona.edu	Niklas, Karl/AAV-4760-2021; Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				BARENBLATT GI, 1983, P NATL ACAD SCI-BIOL, V80, P3540, DOI 10.1073/pnas.80.11.3540; Brown J.H., 1995, MACROECOLOGY; Brown S, 1997, 134 FAO; Cannell MGR, 1982, WORLD FOREST BIOMASS; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DELIOCOURT F, 1998, B SOC FORESTIERE FRA; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gentry AH, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P103; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Huston M A, 2000, Science, V289, P1255; Huston M.A., 1994, BIOL DIVERSITY; Jack SB, 1996, FOREST ECOL MANAG, V86, P205, DOI 10.1016/S0378-1127(96)03770-X; MAC ARTHUR ROBERT H., 1967; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; Niklas K.., 1994, PLANT ALLOMETRY; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NIKLAS KJ, 1994, AM J BOT, V81, P134, DOI 10.2307/2445626; NIKLAS KJ, 1994, P NATL ACAD SCI USA, V91, P6772, DOI 10.1073/pnas.91.15.6772; Niklas KJ, 2000, ANN BOT-LONDON, V85, P411, DOI 10.1006/anbo.1999.1100; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; OLSON JS, 1985, NDP017 CDIC ORNL; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman David, 1993, P13; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Waring RH, 1998, TREE PHYSIOL, V18, P129; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; WHITE J, 1981, J THEOR BIOL, V89, P475, DOI 10.1016/0022-5193(81)90363-5; WHITTAKE.RH, 1968, J ECOL, V56, P1, DOI 10.2307/2258063; WHITTAKER R H, 1975, P385; Whittaker RJ, 1999, NATURE, V401, P865, DOI 10.1038/44732	40	427	474	7	140	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					655	660		10.1038/35070500	http://dx.doi.org/10.1038/35070500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287945				2022-12-28	WOS:000167875400037
J	Lepenies, W				Lepenies, W			Cultures of knowledge	NATURE			English	Editorial Material									Wissenschaftskolleg Berlin, Inst Adv Study Berlin, D-14193 Berlin, Germany		Lepenies, W (corresponding author), Wissenschaftskolleg Berlin, Inst Adv Study Berlin, Wallotstr 19, D-14193 Berlin, Germany.								0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					629	630		10.1038/35070769	http://dx.doi.org/10.1038/35070769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287923				2022-12-28	WOS:000167875400019
J	Manne, AS; Richels, RG				Manne, AS; Richels, RG			An alternative approach to establishing trade-offs among greenhouse gases	NATURE			English	Article							EMISSIONS	The Kyoto Protocol permits countries to meet part of their emission reduction obligations by cutting back on gases other than CO2 (ref. 1). This approach requires a definition of trade-offs among the radiatively active gases. The Intergovernmental Panel on Climate Change has suggested global warming potentials for this purpose(2), which use the accumulated radiative forcing of each gas by a set time horizon to establish emission equivalence. But it has been suggested that this approach has serious shortcomings: damages or abatement costs are not considered(3-10) and the choice of time horizon for calculating cumulative radiative force is critical, but arbitrary(5). Here we describe an alternative framework for determining emission equivalence between radiatively active gases that addresses these weaknesses. We focus on limiting temperature change and rate of temperature change, but our framework is also applicable to other objectives. For a proposed ceiling, we calculate how much one should be willing to pay for emitting an additional unit of each gas. The relative prices then determine the trade-off between gases at each point in time, taking into account economical as well as physical considerations. Our analysis shows that the relative prices are sensitive to the lifetime of the gases, the choice of target and the proximity of the target, making short-lived gases more expensive to emit as we approach the prescribed ceiling.	Elect Power Res Inst, Palo Alto, CA 94303 USA; Stanford Univ, Stanford, CA 94305 USA	Electric Power Research Institute (EPRI); Stanford University	Richels, RG (corresponding author), Elect Power Res Inst, POB 10412, Palo Alto, CA 94303 USA.							*CLIM CHANG SECR, 1992, UN FRAM CONV CLIM CH, P6; Eckaus RS, 1992, ENERG J, V13, P25; Fankhauser S, 1995, VALUING CLIMATE CHAN; Hammitt JK, 1996, NATURE, V381, P301, DOI 10.1038/381301a0; KANDLIKAR M, 1995, ENERG POLICY, V23, P879, DOI 10.1016/0301-4215(95)00108-U; PECK SC, 1994, CLIMATIC CHANGE, V28, P289, DOI 10.1007/BF01104138; Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069; Reilly JM., 1993, ENVIRON RESOUR ECON, V3, P41, DOI DOI 10.1007/BF00338319; Schimel D., 1996, CLIMATE CHANGE 1995, P65; Schmalensee R., 1993, ENERG J, V14, P245, DOI 10.5547/issn0195-6574-ej-vol14-no1-10; TOL R, 1999, METHANE EMISSION RED, P1; *UNFCCC, 1998, UNEPINC982 UNFCCC; WUEBBLES DJ, 1995, CLIMATIC CHANGE, V29, P265, DOI 10.1007/BF01091865	13	172	181	1	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					675	677		10.1038/35070541	http://dx.doi.org/10.1038/35070541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287950				2022-12-28	WOS:000167875400042
J	Frisch, M; Biggar, RJ; Engels, EA; Goedert, JJ				Frisch, M; Biggar, RJ; Engels, EA; Goedert, JJ		AIDS-Canc Match Registry Study Grp	Association of cancer with AIDS-related immunosuppression in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-HODGKINS-LYMPHOMA; EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS; HOMOSEXUAL-MEN; TESTICULAR-CANCER; KAPOSIS-SARCOMA; BREAST-CANCER; SAN-FRANCISCO; RISK-FACTORS; DISEASE	nContext Large-scale studies are needed to determine if cancers other than Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer occur in excess in persons with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), Objectives To examine the general cancer pattern among adults with HIV/AIDS and to distinguish immunosuppression-associated cancers from other cancers that may occur in excess among persons with HIV/AIDS, Design, Setting, and Subjects Analysis of linked population-based AIDS and cancer registry data from 11 geographically diverse areas in the United States, including 302834 adults aged 15 to 69 years with HIV/AIDS, The period of study varied by registry between 1978 and 1996, Main Outcome Measure Relative risks (RRs) of cancers, calculated by dividing the number of observed cancer cases by the number expected based on contemporaneous population-based incidence rates. We defined cancers potentially influenced by immunosuppression by 3 criteria: (1) elevated overall RR in the period from 60 months before to 27 months after AIDS; (2) elevated RR in the 4- to 27-month post-AIDS period; and (3) increasing trend in RR from before to after AIDS onset, Results Expected excesses were observed for the AIDS-defining cancers, but non-AIDS-defining cancers also occurred in statistically significant excess (n =4422; overall RR, 2.7; 95% confidence interval [CI], 2,7-2,8), Of individual cancers, only Hodgkin disease (n=612; RR, 11.5; 95% CI, 10.6-12,5), particularly of the mixed cellularity (n=217; RR, 18.3; 95% CI, 15.9-20.9) and lymphocytic depletion (n=36; RR, 35.3; 95% CI, 24.7-48.8) subtypes; lung cancer (n=808; RR, 4.5; 95% CI, 4.2-4.8); penile cancer (n=14; RR, 3.9; 95% CI, 2.1-6.5); soft tissue malignancies (n=78; RR, 3.3; 95% CI, 2.6-4.1); lip cancer (n=20; RR, 3,1; 95% CI, 1.9-4.8); and testicular seminoma (n=115; RR, 2.0; 95% CI, 1.7-2.4) met all 3 criteria for potential association with immunosuppression, Conclusion Although occurring in overall excess, most non-AIDS-defining cancers do not appear to be influenced by the advancing immunosuppression associated with HIV disease progression. Some cancers that met our criteria for potential association with immunosuppression may have occurred in excess in persons with HIV/AIDS because of heavy smoking (lung cancer), frequent exposure to human papillomavirus (penile cancer), or inaccurately recorded cases of Kaposi sarcoma (soft tissue malignancies) in these persons. However, Hodgkin disease, notably of the mixed cellularity and lymphocytic depletion subtypes, and possibly lip cancer and testicular seminoma may be genuinely influenced by immunosuppression.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; NCI, Div Canc Epidemiol & Genet, Viral Epidemiol Branch, Rockville, MD USA	Aarhus University; Statens Serum Institut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Frisch, M (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.	mfr@ssi.dk	Frisch, Morten/E-9206-2016	Frisch, Morten/0000-0002-3864-8860	NCI NIH HHS [Y1-CP-8040-02] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akre O, 1999, INT J CANCER, V82, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1996, IARC MON EV CARC RIS; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Biggar RJ, 2000, JAMA-J AM MED ASSOC, V284, P205, DOI 10.1001/jama.284.2.205; Biggar RJ, 1996, INT J CANCER, V68, P754; Biggar RJ, 2000, BAS CLIN ON, V21, P25; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Blot W., 1996, CANC EPIDEMIOL PREV, P666; BLOT WJ, 1996, CANC EPIDEMIOLOGY PR, P637; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Brennan P, 2000, BRIT J CANCER, V82, P1344; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Cooksley CD, 1999, INT J STD AIDS, V10, P795, DOI 10.1258/0956462991913574; COX DR, 1974, THEORETICAL STATISTI, P279; Franceschi S, 1998, BRIT J CANCER, V78, P966, DOI 10.1038/bjc.1998.610; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Goedert JJ, 1999, CANCER EPIDEM BIOMAR, V8, P293; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Granovsky MO, 1998, J CLIN ONCOL, V16, P1729, DOI 10.1200/JCO.1998.16.5.1729; Gray A, 1998, J GEN VIROL, V79, P573, DOI 10.1099/0022-1317-79-3-573; GREGOIRE L, 1995, JNCI-J NATL CANCER I, V87, P1705, DOI 10.1093/jnci/87.22.1705; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; GUPTA AK, 1986, ARCH DERMATOL, V122, P1288, DOI 10.1001/archderm.122.11.1288; HESSOL NA, 1992, ANN INTERN MED, V117, P309, DOI 10.7326/0003-4819-117-4-309; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; KARP J, 1993, CHEST, V103, P410, DOI 10.1378/chest.103.2.410; Koblin BA, 1996, AM J EPIDEMIOL, V144, P916, DOI 10.1093/oxfordjournals.aje.a008861; Maurer TA, 1997, ARCH DERMATOL, V133, P577, DOI 10.1001/archderm.133.5.577; MELBYE M, 1994, LANCET, V343, P636, DOI 10.1016/S0140-6736(94)92636-0; Mueller N, 1999, J ACQ IMMUN DEF SYND, V21, pS5; Mueller NE, 1996, CANC EPIDEMIOLOGY PR, P893; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; PENN I, 1986, SURG GYNECOL OBSTET, V162, P603; Petruckevitch A, 1999, INT J STD AIDS, V10, P38, DOI 10.1258/0956462991913060; REYNOLDS P, 1993, AM J EPIDEMIOL, V137, P19, DOI 10.1093/oxfordjournals.aje.a116598; ROTHMAN KJ, 1996, CANC EPIDEMIOLOGY PR, P3; Rowlings PA, 1999, J CLIN ONCOL, V17, P3122, DOI 10.1200/JCO.1999.17.10.3122; Serraino D, 1999, AIDS, V13, P2589, DOI 10.1097/00002030-199912240-00013; Shimakage M, 1996, J UROLOGY, V156, P253, DOI 10.1016/S0022-5347(01)66011-7; Stall RD, 1999, AM J PUBLIC HEALTH, V89, P1875, DOI 10.2105/AJPH.89.12.1875; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; Stewart THM, 2000, BRIT J CANCER, V82, P446, DOI 10.1054/bjoc.1999.0941; Tirelli U, 2000, CANCER-AM CANCER SOC, V88, P563, DOI 10.1002/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D; *WHO, 1990, INT CLASS DIS ONC	45	584	591	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1736	1745		10.1001/jama.285.13.1736	http://dx.doi.org/10.1001/jama.285.13.1736			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277828	Bronze			2022-12-28	WOS:000167710600027
J	Bollet, AJ				Bollet, AJ			Edema of the bone marrow can cause pain in osteoarthritis and other diseases of bone and joints	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSIENT OSTEOPOROSIS; OSTEONECROSIS; KNEE; MRI; SCINTIGRAPHY; HIP				Bollet, AJ (corresponding author), 22 Plum Beach Point Rd, Sands Point, NY 11050 USA.							ARNOLDI CC, 1980, ACTA ORTHOP SCAND, V51, P19, DOI 10.3109/17453678008990764; Boegard T, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.1.20; Castro F P Jr, 2000, Am J Orthop (Belle Mead NJ), V29, P187; DIEPPE P, 1999, OSTEOARTHR CARTILAGE, V7, P25; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Grampp S, 1998, J COMPUT ASSIST TOMO, V22, P25, DOI 10.1097/00004728-199801000-00004; HAYES CW, 1993, RADIOGRAPHICS, V13, P1001, DOI 10.1148/radiographics.13.5.8210586; HOFMANN S, 1993, J BONE JOINT SURG BR, V75, P210, DOI 10.1302/0301-620X.75B2.8444939; Koo KH, 1999, RADIOLOGY, V213, P715, DOI 10.1148/radiology.213.3.r99dc06715; Lotke PA, 2000, ARTHROSCOPY, V16, P76, DOI 10.1016/S0749-8063(00)90132-4; MANKAD VN, 1990, BLOOD, V75, P274; Mattila KT, 1999, MAGN RESON IMAGING, V17, P947, DOI 10.1016/S0730-725X(99)00030-2; McQueen FM, 1999, ANN RHEUM DIS, V58, P156, DOI 10.1136/ard.58.3.156; WOJTYS E M, 1990, Arthroscopy, V6, P254, DOI 10.1016/0749-8063(90)90054-H	14	42	51	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					591	593		10.7326/0003-4819-134-7-200104030-00013	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281742				2022-12-28	WOS:000167931200007
J	Baum, M				Baum, M			The uses of error: Quality control	LANCET			English	Editorial Material									UCL, London W1P 7LD, England	University of London; University College London	Baum, M (corresponding author), UCL, London W1P 7LD, England.								0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1007	1007		10.1016/S0140-6736(00)04247-1	http://dx.doi.org/10.1016/S0140-6736(00)04247-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293593				2022-12-28	WOS:000167791500011
J	Gatesy, J; Hayashi, C; Motriuk, D; Woods, J; Lewis, R				Gatesy, J; Hayashi, C; Motriuk, D; Woods, J; Lewis, R			Extreme diversity, conservation, and convergence of spider silk fibroin sequences	SCIENCE			English	Article							EVOLUTION; ELASTICITY; PROTEINS; ARANEAE; GENE	Spiders (Araneae) spin high-performance silks from liquid fibroin proteins. Fibroin sequences from basal spider lineages reveal mosaics of amino acid motifs that differ radically from previously described spider silk sequences. The silk fibers of Araneae are constructed from many protein designs. Yet, the repetitive sequences of fibroins from orb-weaving spiders have been maintained, presumably by stabilizing selection, over 125 million years of evolutionary history. The retention of these conserved motifs since the Mesozoic and their convergent evolution in other structural superproteins imply that these sequences are central to understanding the exceptional mechanical properties of orb weaver silks.	Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Gatesy, J (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.							Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; Calvert P, 1998, NATURE, V393, P309, DOI 10.1038/30610; CAO Q, 1997, CURR BIOL, V7, P677; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; MITA K, 1994, J MOL EVOL, V38, P583; Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; SELDEN PA, 1990, PALAEONTOLOGY, V33, P257; SELDEN PA, 1992, PALAEONTOLOGY, V35, P211; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; TATHAM AS, 1984, FEBS LETT, V177, P205, DOI 10.1016/0014-5793(84)81284-3; Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2	22	407	443	1	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2603	2605		10.1126/science.1057561	http://dx.doi.org/10.1126/science.1057561			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283372				2022-12-28	WOS:000167861000042
J	Toby, S				Toby, S			The good and the bad	NATURE			English	Article									Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Toby, S (corresponding author), Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.							Maddox J.R., 1998, WHAT REMAINS BE DISC; Penrose R, 1991, EMPERORS NEW MIND; Toby S, 1999, J CHEM EDUC, V76, P1584, DOI 10.1021/ed076p1584	3	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					523	523		10.1038/35069157	http://dx.doi.org/10.1038/35069157			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279470				2022-12-28	WOS:000167859300024
J	Mohammed, MA; Cheng, KK; Rouse, A; Marshall, T				Mohammed, MA; Cheng, KK; Rouse, A; Marshall, T			Bristol, Shipman, and clinical governance: Shewhart's forgotten lessons	LANCET			English	Article							STATISTICAL QUALITY-CONTROL; LEAGUE TABLES; MORTALITY; SURGERY; CARE	During the past century, manufacturing industry has achieved great success in improving the quality of its products. An essential factor in this success has been the use of Waiter A Shewhart's pioneering work in the economic control of variation, which culminated in the development of a simple yet powerful graphical method known as the control chart. This chart classifies variation as having a common cause or special cause and thus guides the user to the most appropriate action to effect improvement. Using six case studies, including the excess deaths after paediatric cardiac surgery seen in Bristol, Uh, acid the activities of general practitioner turned murderer Harold Shipman, we show a central role for Shewhart's approach in turning the rhetoric of clinical governance into a reality.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Surg, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.		Cheng, Kar/AAL-8899-2021	Cheng, Kar/0000-0002-1516-1857; Marshall, Tom/0000-0001-9277-5214				Allison J J, 2000, Manag Care Q, V8, P1; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P194; BERWICK DM, 1991, MED CARE, V29, P1212, DOI 10.1097/00005650-199112000-00004; Clark DE, 1998, J AM COLL SURGEONS, V186, P630, DOI 10.1016/S1072-7515(98)00109-4; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; Deming EW., 1986, OUT CRISIS; Deming W. E., 1990, SAMPLE DESIGN BUSINE; DEMING WE, 1995, NEW EC; DUCE R, 2000, TIMES           0201; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; MOSTELLER F, 1949, J AM STAT ASSOC, V44, P174, DOI 10.2307/2280595; Parry GJ, 1998, BRIT MED J, V316, P1931, DOI 10.1136/bmj.316.7149.1931; Poloniecki J, 1998, BRIT MED J, V316, P1697, DOI 10.1136/bmj.316.7146.1697; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; Shahian DM, 1996, ANN THORAC SURG, V62, P1351, DOI 10.1016/0003-4975(96)00796-5; Shewhart WA., 1931, EC CONTROL QUALITY M; SPIEGELHALTER DJ, 1995, OVERVIEW STAT EVIDEN; Steiner SH, 1999, STAT MED, V18, P69, DOI 10.1002/(SICI)1097-0258(19990115)18:1<69::AID-SIM966>3.0.CO;2-L; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; Wheeler D., 1995, ADV TOPICS STAT PROC; Williamson GD, 1999, STAT MED, V18, P3283, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3283::AID-SIM316&gt;3.0.CO;2-Z; 2000, BMJ, V320, P1734	23	165	165	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					463	467		10.1016/S0140-6736(00)04019-8	http://dx.doi.org/10.1016/S0140-6736(00)04019-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273083				2022-12-28	WOS:000166865600037
J	Singhal, A; Cole, TJ; Lucas, A				Singhal, A; Cole, TJ; Lucas, A			Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; BIRTH-WEIGHT; CARDIOVASCULAR-DISEASE; ADULT LIFE; CHILDHOOD; CHILDREN; DIET; GROWTH; DEATH; INTRAUTERINE	Background Despite data relating body size in early life to later cardiovascular outcomes, the hypothesis that nutrition affects such outcomes has not been established. Breastfeeding has been associated with lower blood pressure in later life, but previous studies have not controlled for possible confounding factors by using a randomised design with prospective follow-up. We undertook such a study to test the hypothesis that early diet programmes blood pressure in later life in children randomly assigned different diets at birth. Methods Blood pressure was measured at age 13-16 years in 216 (23%) of a cohort of 926 children who were born prematurely and had participated at birth in two parallel randomised trials in five neonatal units in the UK. Dietary interventions were: donated banked breastmilk versus preterm formula and standard term formula versus preterm formula. Findings Children followed up at age 13-16 years were similar to those not followed up in terms of social class and anthropometry at birth. Mean arterial blood pressure at age 13-16 years was lower in the 66 children assigned banked breastmilk (alone or in addition to mother's milk) than in the 64 assigned preterm formula (mean 81.9 [SD 7.8] vs 86.1 [6.5] mm Hg; 95% Cl for difference -6.6 to -1.6; p=0.001). In non-randomised analyses, the proportion of enteral intake as human milk in the neonatal period was inversely related to later mean arterial pressure (beta=-0.3 mm Hg per 10% increase [95% CI -05 to -0.1]; p=0.006). No differences were found in the term formula (n=44) versus preterm formula (n=42) comparison. Interpretation Breastmilk consumption was associated with lower later blood pressure in children born prematurely. Our data provide experimental evidence of programming of a cardiovascular risk factor by early diet and further support the long-term beneficial effects of breastmilk.	Inst Child Hlth, MRC, Childhood Nutr Res Ctr, London WC1N 1EH, England; Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Singhal, A (corresponding author), Inst Child Hlth, MRC, Childhood Nutr Res Ctr, 30 Guilford St, London WC1N 1EH, England.	a.singhal@ich.ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	MRC [G9827821] Funding Source: UKRI; Medical Research Council [G9827821, G9827821(62595)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anwar, 1997, Blood Press Monit, V2, P105; BARANOWSKI T, 1992, J CLIN EPIDEMIOL, V45, P513, DOI 10.1016/0895-4356(92)90100-2; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; Gore SM, 1999, LIPIDS, V34, P185, DOI 10.1007/s11745-999-0353-0; Laor A, 1997, BRIT MED J, V315, P449, DOI 10.1136/bmj.315.7106.449; Law CM, 1996, J HYPERTENS, V14, P935; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Leeson CPM, 1997, CIRCULATION, V96, P2233; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LEWIS DS, 1986, J CLIN INVEST, V78, P899, DOI 10.1172/JCI112678; LEWIS DS, 1988, ARTERIOSCLEROSIS, V8, P274, DOI 10.1161/01.ATV.8.3.274; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; LUCAS A, 1984, ARCH DIS CHILD, V59, P722, DOI 10.1136/adc.59.8.722; LUCAS A, 1988, ARCH DIS CHILD, V63, P656, DOI 10.1136/adc.63.6.656; LUCAS A, 1994, BRIT MED J, V309, P304, DOI 10.1136/bmj.309.6950.304; SEIDMAN DS, 1991, BMJ-BRIT MED J, V302, P1235, DOI 10.1136/bmj.302.6787.1235; Taittonen L, 1996, PEDIATR RES, V40, P627, DOI 10.1203/00006450-199610000-00019; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773; WHINCUP PH, 1992, ARCH DIS CHILD, V67, P1423, DOI 10.1136/adc.67.12.1423; WHINCUP PH, 1989, BMJ-BRIT MED J, V299, P587, DOI 10.1136/bmj.299.6699.587; WHITTEN CF, 1980, ACTA PAEDIATR SCAND, P1; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21	30	400	411	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					413	419		10.1016/S0140-6736(00)04004-6	http://dx.doi.org/10.1016/S0140-6736(00)04004-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273059				2022-12-28	WOS:000166865600008
